sample_id,temperature,variation_id,label,source_text,variation_text,delta_score_2gram,delta_entropy_2gram,delta_variance_2gram,delta_score_3gram,delta_entropy_3gram,delta_variance_3gram,delta_score_4gram,delta_entropy_4gram,delta_variance_4gram,delta_score_5gram,delta_entropy_5gram,delta_variance_5gram
0,0.9,1,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Does losing consciousness predict neuropsychological deficits after a concussion? Loss of consciousness may indicate neuropsychological deficits after a concussion, but it is not the only factor. The severity of the concussion, the individual's health, and time since injury also play critical roles. Therefore, a thorough neuropsychological evaluation is essential after a concussion.",7.105791820705622e-08,0.09913079746879427,0.06505315624505605,0.005440279394345618,0.08756418518915021,0.021069608809993434,0.0054324046228586,0.08771514212630915,0.020399305555555556,7.105791820705622e-08,0.06062462181643413,0.0
0,0.9,2,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Is loss of consciousness a predictor of neuropsychological decline following a concussion? While loss of consciousness can signal neuropsychological impairments, it alone does not determine outcomes. Other factors such as the severity of the concussion, the person's health status, and time elapsed since injury greatly affect cognitive consequences. Hence, a comprehensive neuropsychological assessment is necessary after concussion.",4.737194547137081e-08,0.06387348466928522,0.01969802687475379,0.0036268529295637453,0.037992417039609094,0.0006853637551643317,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
0,0.9,3,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Can loss of consciousness forecast neuropsychological impairments after a concussion? Loss of consciousness may indicate neuropsychological impairments post-concussion, yet it is not the exclusive predictor. Severity of injury, individual health condition, and time since the concussion also importantly influence cognitive effects. Thus, a detailed neuropsychological evaluation is important following concussion.",1.1842986367842703e-07,0.10502256002462174,0.005600761376495414,0.009067132323909363,0.10181553778793972,0.0019629554726361513,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
0,0.9,4,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Does experiencing loss of consciousness predict cognitive decline after a concussion? Loss of consciousness can be a sign of neuropsychological decline, but it is not the sole determinant. Other factors such as the severity of the concussion, health of the individual, and time since injury also play significant roles. Therefore, a full neuropsychological assessment is crucial after suffering a concussion.",1.1842986367842703e-07,0.09508020695123687,0.004661791187063058,0.009067132323909363,0.09240596745805885,0.0016248741078274467,0.009054007704764333,0.09180754925312229,0.0,1.1842986367842703e-07,0.09352605801082436,0.0
0,0.9,5,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Is loss of consciousness a reliable predictor of neuropsychological problems after a concussion? Loss of consciousness might reflect neuropsychological issues post-concussion, but it is not the only factor involved. The severity of the injury, the individual's health status, and elapsed time since injury also affect cognitive outcomes. Hence, neuropsychological assessment should be comprehensive after concussion.",0.0,0.025672117798516858,0.018381073278597906,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
0,0.9,6,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Does loss of consciousness indicate neuropsychological deficits following concussion? While it can suggest such deficits, loss of consciousness is not the sole predictor. Other variables like injury severity, the individual's physical condition, and duration since the concussion also heavily influence cognitive impact. Thus, thorough neuropsychological evaluation is essential post-concussion.",1.4211583641411244e-07,0.0985289473074955,0.0137754200979847,0.010880558788691236,0.12348343916712068,0.002405593897159969,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
0,0.9,7,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Can loss of consciousness predict neuropsychological impairments after a concussion? It can be indicative, but not the only determining factor. Severity of concussion, the person's overall health, and time since injury also significantly affect cognitive outcomes. Therefore, a comprehensive neuropsychological assessment is critical after concussion.",2.3685972735685406e-07,0.12777805925046293,0.05536332179930796,0.018134264647818726,0.1829353004789378,0.018860946745562133,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
0,0.9,8,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Does the occurrence of loss of consciousness predict neuropsychological issues after a concussion? Loss of consciousness may signal such issues, but it is not the only determinant. Injury severity, health status, and time elapsed since the event also largely influence cognitive effects. Consequently, a thorough neuropsychological assessment is important post-injury.",1.1842986367842703e-07,0.07673083836911365,0.014620904415876525,0.009067132323909363,0.10181553778793972,0.0019629554726361513,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
0,0.9,9,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Is loss of consciousness an indicator of neuropsychological decline after concussion? It can be an indicator, but not the sole predictor. Factors like the concussion's severity, the individual’s health, and time since injury also significantly impact cognitive outcomes. Therefore, a detailed neuropsychological evaluation is necessary after a concussion.",1.6580180914979784e-07,0.06182009145866685,0.05536332179930796,0.012693985253473108,0.11549401968340556,0.018860946745562133,0.012675610786670066,0.14458122881110835,0.0,1.6580180914979784e-07,0.14763599880606337,0.0
0,0.9,10,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Does loss of consciousness serve as a predictor for neuropsychological deficits after a concussion? While it may serve as a predictor, it is not exclusive. Other factors including injury severity, health condition, and duration since concussion also play major roles in cognitive impact. Hence, comprehensive neuropsychological assessments post-concussion are vital.",1.1842986367842703e-07,0.07673083836911365,0.014620904415876525,0.009067132323909363,0.10181553778793972,0.0019629554726361513,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
1,0.9,1,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Is transgastric endoscopic splenectomy feasible? Answer: Yes, performing a transgastric endoscopic splenectomy is feasible. This operation utilizes an endoscope to excise the spleen.",0.0,0.060273667874777725,0.0427793707014486,0.0,0.06301338005090429,0.04535147392290251,0.0,0.0,0.0,0.0,0.0,0.0
1,0.9,2,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Can a transgastric endoscopic splenectomy be done? Answer: Yes, it is possible to perform a transgastric endoscopic splenectomy using an endoscope to remove the spleen.",4.73719454713706e-08,0.022700046520559347,0.07438016528925614,0.003626852929563759,0.028513153103693067,0.08264462809917354,0.003621603081905747,0.030698110330949824,0.04338842975206613,4.737194547137076e-08,0.09531017980432521,0.0
1,0.9,3,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Is it achievable to do a transgastric endoscopic splenectomy? Answer: Yes, a transgastric endoscopic splenectomy can be done by employing an endoscope to extract the spleen.",7.10579182070559e-08,0.07623796218865753,0.03300045913682275,0.005440279394345639,0.0723815970650894,0.03993055555555556,0.005432404622858621,0.13353139262452363,0.0,7.105791820705617e-08,0.13976194237515926,0.0
1,0.9,4,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Is transgastric endoscopic splenectomy a viable procedure? Answer: Yes, the transgastric endoscopic splenectomy is a viable surgical technique involving endoscopic removal of the spleen.",2.36859727356853e-08,0.07045351284641121,0.07906054983977057,0.0018134264647818796,0.015821905303944117,0.04338842975206613,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
1,0.9,5,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Can transgastric endoscopic splenectomy be successfully performed? Answer: Yes, the procedure for transgastric endoscopic splenectomy can be successfully accomplished using an endoscope to remove the spleen.",7.10579182070559e-08,0.02291894829943253,0.07003312034245182,0.005440279394345639,0.0723815970650894,0.03993055555555556,0.005432404622858621,0.13353139262452363,0.0,7.105791820705617e-08,0.13976194237515926,0.0
1,0.9,6,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Is it possible to perform splenectomy endoscopically via the transgastric route? Answer: Yes, transgastric endoscopic splenectomy is possible, involving spleen removal by an endoscope.",2.36859727356853e-08,0.1028332822935738,0.04338842975206613,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
1,0.9,7,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Question: Is transgastric endoscopic spleen removal possible? Answer: Yes, this procedure using an endoscope can remove the spleen transgastrically.",9.474389094274131e-08,0.13078156888793124,0.04338842975206613,0.007253705859127518,0.20067069546215066,0.0,0.007243206163811491,0.21130909366720552,0.0,9.474389094274141e-08,0.22314355131420927,0.0
1,0.9,8,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Can endoscopic splenectomy be done through the stomach? Answer: Yes, a transgastric endoscopic splenectomy is achievable by using an endoscope to excise the spleen.",2.36859727356853e-08,0.045071017246913314,0.0018005280507428709,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
1,0.9,9,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Is a transgastric endoscopic splenectomy feasible? Answer: Yes, it is a feasible procedure that uses an endoscope to remove the spleen via the stomach.",2.36859727356853e-08,0.045071017246913314,0.0018005280507428709,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
1,0.9,10,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Question: Is it possible to do a splenectomy via transgastric endoscopy? Answer: Yes, a transgastric endoscopic splenectomy can be performed with the help of an endoscope to remove the spleen.",1.658018091497971e-07,0.3259768336077835,0.04338842975206613,0.012693985253473157,0.27625337662815763,0.0,0.012675610786670115,0.28768207245178257,0.0,1.658018091497978e-07,0.30010459245033916,0.0
2,0.9,1,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.",Does blood pressure fluctuate in treated hypertensive patients depending on whether the measurement is done by a doctor or a nurse?,1.1606126640485828e-06,1.0700611436124925,0.1467347487234615,0.08885789677431187,1.1935219988849681,0.05859375,0.08872927550669057,1.2729389402673408,0.029822485207100586,1.1606126640485847e-06,1.3564413979702081,0.0
2,0.9,2,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","In treated hypertensive patients, does blood pressure vary based on whether it is taken by a physician or a nurse?",1.1842986367842682e-06,1.1213544380000426,0.1467347487234615,0.09067132323909374,1.2475892201552434,0.05859375,0.09054007704764346,1.3300973541072896,0.029822485207100586,1.18429863678427e-06,1.4170660197866431,0.0
2,0.9,3,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.",Can blood pressure readings in treated hypertensive individuals change depending on if a doctor or nurse performs the measurement?,1.2079846095199536e-06,1.175421659270318,0.1467347487234615,0.09248474970387563,1.3047476339951922,0.05859375,0.09235087858859632,1.3907219759237246,0.029822485207100586,1.2079846095199555e-06,1.4816045409242138,0.0
2,0.9,4,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.",Is there a difference in blood pressure measurements in treated hypertensive patients when taken by a physician versus a nurse?,1.1842986367842682e-06,1.1213544380000426,0.1467347487234615,0.09067132323909374,1.2475892201552434,0.05859375,0.09054007704764346,1.3300973541072896,0.029822485207100586,1.18429863678427e-06,1.4170660197866431,0.0
2,0.9,5,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.",Do blood pressure levels differ in treated hypertensive patients according to whether a nurse or a doctor measures it?,1.2079846095199536e-06,1.175421659270318,0.1467347487234615,0.09248474970387563,1.3047476339951922,0.05859375,0.09235087858859632,1.3907219759237246,0.029822485207100586,1.2079846095199555e-06,1.4816045409242138,0.0
2,0.9,6,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","In patients with treated hypertension, does the person measuring blood pressure—doctor or nurse—affect the readings?",1.302728500462695e-06,1.4267360875512245,0.1467347487234615,0.09973845556300313,1.5730116205898712,0.05859375,0.09959408475240782,1.678404048375505,0.029822485207100586,1.3027285004626967e-06,1.7917594692280536,0.0
2,0.9,7,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.",Are blood pressure values in treated hypertensive patients influenced by whether a doctor or nurse conducts the measurement?,1.231670582255639e-06,1.2325800731102667,0.1467347487234615,0.0942981761686575,1.3653722558116272,0.05859375,0.0941616801295492,1.4552604970612952,0.029822485207100586,1.2316705822556407e-06,1.5505974124111659,0.0
2,0.9,8,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.",Does the identity of the person measuring blood pressure (physician or nurse) impact readings in treated hypertensive patients?,1.231670582255639e-06,1.2325800731102667,0.1467347487234615,0.0942981761686575,1.3653722558116272,0.05859375,0.0941616801295492,1.4552604970612952,0.029822485207100586,1.2316705822556407e-06,1.5505974124111659,0.0
2,0.9,9,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","For patients treated for hypertension, can blood pressure readings vary depending on whether a nurse or physician takes the measurement?",1.1842986367842682e-06,1.1213544380000426,0.1467347487234615,0.09067132323909374,1.2475892201552434,0.05859375,0.09054007704764346,1.3300973541072896,0.029822485207100586,1.18429863678427e-06,1.4170660197866431,0.0
2,0.9,10,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.",Do measurements of blood pressure in treated hypertensive patients differ depending on whether a nurse or physician performs the reading?,1.1842986367842682e-06,1.1213544380000426,0.1467347487234615,0.09067132323909374,1.2475892201552434,0.05859375,0.09054007704764346,1.3300973541072896,0.029822485207100586,1.18429863678427e-06,1.4170660197866431,0.0
3,0.9,1,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Hepatorenal syndrome: are some prognostic factors being overlooked? We reveal for the first time that ESLD etiology serves as a prognostic indicator for survival. Renal function, measured by serum creatinine, and urinary Na levels below 5 mEq/l at diagnosis are linked to survival, implying that early intervention could enhance outcomes.",1.1842986367842703e-07,0.0971637484536485,0.0,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
3,0.9,2,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Are certain prognostic factors missed in hepatorenal syndrome? Our findings identify ESLD etiology as a novel prognostic factor for survival. The renal function, evaluated through serum creatinine, and urinary sodium under 5 mEq/l at diagnosis correlate with survival, indicating that earlier treatment may improve survival rates.",2.1317375462116866e-07,0.18232155679395579,0.0,0.016320838183036854,0.18610227963385917,0.0,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
3,0.9,3,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Regarding hepatorenal syndrome: could we be missing some prognostic factors? We report ESLD etiology as a survival prognostic factor for the first time. Renal function (serum creatinine) and urinary sodium less than 5 mEq/l at diagnosis are associated with survival, suggesting that prompt treatment might boost survival chances.",1.6580180914979784e-07,0.13883644485421742,0.0,0.012693985253473108,0.14165051706302645,0.0,0.012675610786670066,0.14458122881110835,0.0,1.6580180914979784e-07,0.14763599880606337,0.0
3,0.9,4,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Are prognostic factors in hepatorenal syndrome being overlooked? This study reports ESLD etiology as a prognostic survival factor for the first time. Renal function (serum creatinine) and urinary Na below 5 mEq/l at diagnosis correlate with survival, implying that early treatment may increase survival.",2.6054570009253947e-07,0.22778393087071303,0.0,0.0199476911126006,0.2326222952687531,0.0,0.019918816950481533,0.23767165187712003,0.0,2.6054570009253947e-07,0.24294617861038903,0.0
3,0.9,5,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Hepatorenal syndrome: is there a gap in recognizing prognostic factors? Our report identifies ESLD etiology as a prognostic survival factor for the first time. Renal function, defined by serum creatinine, and urinary sodium less than 5 mEq/l at diagnosis were linked to survival, suggesting that treatment started early might improve survival.",9.474389094274162e-08,0.07696104113612989,0.0,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
3,0.9,6,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Are we overlooking some prognostic factors in hepatorenal syndrome? We present ESLD etiology as a prognostic factor for survival for the first time. Renal function (serum creatinine) and urinary Na levels below 5 mEq/l at diagnosis are related to survival, indicating that early treatment could raise survival chances.",1.6580180914979784e-07,0.13883644485421742,0.0,0.012693985253473108,0.14165051706302645,0.0,0.012675610786670066,0.14458122881110835,0.0,1.6580180914979784e-07,0.14763599880606337,0.0
3,0.9,7,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","In hepatorenal syndrome, might we be missing key prognostic factors? This report is the first to identify ESLD etiology as a prognosis factor for survival. Renal function (serum creatinine) and urinary sodium below 5 mEq/l at diagnosis associate with survival, suggesting early treatment may improve outcomes.",2.1317375462116866e-07,0.18232155679395579,0.0,0.016320838183036854,0.18610227963385917,0.0,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
3,0.9,8,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Could some prognostic factors in hepatorenal syndrome be missed? We document for the first time the role of ESLD etiology as a survival prognostic factor. Renal function, as shown by serum creatinine, and urinary Na under 5 mEq/l at diagnosis correlate with survival, implying early treatment might increase survival.",1.4211583641411244e-07,0.11778303565638426,0.0,0.010880558788691236,0.12014431184206309,0.0,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
3,0.9,9,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Are there missing prognostic indicators in hepatorenal syndrome? This study is the first to report ESLD etiology as a survival prognostic factor. Renal function (serum creatinine) and urinary sodium below 5 mEq/l at diagnosis are linked to survival, suggesting that early intervention may benefit survival.",2.3685972735685406e-07,0.2047944126460135,0.0,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
3,0.9,10,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Is it possible that prognostic factors in hepatorenal syndrome are overlooked? Our findings reveal ESLD etiology as a novel prognostic factor for survival. Renal function measured by serum creatinine and urinary Na less than 5 mEq/l at diagnosis were associated with survival, proposing that early treatment might enhance survival outcomes.",1.1842986367842703e-07,0.0971637484536485,0.0,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
4,0.9,1,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Recent research indicates a potential association between Aripiprazole, an antipsychotic drug, and a heightened risk of developing pathological gambling, though more studies are required to confirm this link.",1.421158364141118e-07,0.20067069546215066,0.0,0.010880558788691277,0.20763936477824396,0.0,0.010864809245717241,0.2151113796169466,0.0,1.4211583641411244e-07,0.2231435513142097,0.0
4,0.9,2,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Studies have suggested that Aripiprazole, used as an antipsychotic medication, might be linked to an increased risk of pathological gambling, but additional research is necessary to verify these findings.",1.184298636784265e-07,0.16430305129127598,0.0,0.009067132323909398,0.16989903679539697,0.0,0.009054007704764368,0.17589066646366414,0.0,1.1842986367842703e-07,0.1823215567939549,0.0
4,0.9,3,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","There is emerging evidence that Aripiprazole, an antipsychotic treatment, could be a risk factor for pathological gambling; however, further investigation is needed.",2.842316728282236e-07,0.45198512374305855,0.0,0.021761117577382555,0.47000362924573613,0.0,0.021729618491434483,0.48954822531870645,0.0,2.842316728282247e-07,0.5108256237659901,0.0
4,0.9,4,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Aripiprazole, an antipsychotic medication, may be associated with a higher risk of pathological gambling according to recent studies, but more research is essential to establish this connection.",1.658018091497971e-07,0.23841102344499765,0.0,0.012693985253473157,0.24686007793152642,0.0,0.012675610786670115,0.2559333741372014,0.0,1.6580180914979784e-07,0.26570316573300534,0.0
4,0.9,5,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Recent studies propose a possible connection between Aripiprazole and pathological gambling risk, although further research is required to fully understand this relationship.",2.842316728282236e-07,0.45198512374305855,0.0,0.021761117577382555,0.47000362924573613,0.0,0.021729618491434483,0.48954822531870645,0.0,2.842316728282247e-07,0.5108256237659901,0.0
4,0.9,6,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Research has recently highlighted a potential risk of pathological gambling linked to Aripiprazole, an antipsychotic drug, but additional studies must be conducted.",2.842316728282236e-07,0.45198512374305855,0.0,0.021761117577382555,0.47000362924573613,0.0,0.021729618491434483,0.48954822531870645,0.0,2.842316728282247e-07,0.5108256237659901,0.0
4,0.9,7,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","A potential link between the antipsychotic drug Aripiprazole and an elevated risk of pathological gambling has been suggested by recent research, pending further confirmation.",2.36859727356853e-07,0.36101334553733055,0.0,0.018134264647818796,0.3746934494414109,0.0,0.018108015409528735,0.38946476676172503,0.0,2.36859727356854e-07,0.4054651081081646,0.0
4,0.9,8,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Recent findings hint that Aripiprazole might increase the risk of pathological gambling, but more in-depth research is needed to confirm this association.",2.842316728282236e-07,0.45198512374305855,0.0,0.021761117577382555,0.47000362924573613,0.0,0.021729618491434483,0.48954822531870645,0.0,2.842316728282247e-07,0.5108256237659901,0.0
4,0.9,9,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","There are suggestions from recent studies that Aripiprazole could be a new risk factor for pathological gambling, yet more research is necessary to substantiate this claim.",1.894877818854824e-07,0.2776317365982801,0.0,0.014507411718255037,0.28768207245178123,0.0,0.014486412327622988,0.29849298855599704,0.0,1.8948778188548325e-07,0.3101549283038394,0.0
4,0.9,10,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","The possibility that Aripiprazole, an antipsychotic medication, raises the risk of pathological gambling has been indicated by recent studies, although further research is required to clarify this.",1.658018091497971e-07,0.23841102344499765,0.0,0.012693985253473157,0.24686007793152642,0.0,0.012675610786670115,0.2559333741372014,0.0,1.6580180914979784e-07,0.26570316573300534,0.0
5,0.9,1,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Are there varying degrees of risk for psychosis transition within Ultra High Risk (UHR) criteria? Yes, the risk levels differ based on factors like age, symptom frequency and severity, as well as family history. However, UHR criteria do not guarantee psychosis development for all individuals classified under this category.",5.684633456564497e-07,0.23217831296817826,0.12244897959183675,0.043522235154764985,0.27585536648845155,0.097412109375,0.04345923698286881,0.32083281976598643,0.07100591715976333,5.684633456564497e-07,0.367170346952161,0.04338842975206613
5,0.9,2,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Does the Ultra High Risk (UHR) criteria indicate different levels of risk for developing psychosis? Indeed, risk varies according to age, symptom intensity and frequency, and familial history. Still, UHR is not a definitive predictor— not everyone meeting UHR criteria will progress to psychosis.",6.868932093348768e-07,0.342179208182507,0.12244897959183675,0.05258936747867435,0.38833334991514157,0.097412109375,0.052513244687633145,0.4359021495507731,0.07100591715976333,6.868932093348768e-07,0.48495338260854437,0.04338842975206613
5,0.9,3,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Within Ultra High Risk (UHR) criteria for psychosis, are there multiple risk levels for transition? Yes, risk is influenced by age, symptom severity and frequency, and family history. Nonetheless, UHR status does not confirm that an individual will develop psychosis.",7.816371002776183e-07,0.4398176777464249,0.12244897959183675,0.05984307333780184,0.488416808472123,0.097412109375,0.05975645085144461,0.5385563036108554,0.07100591715976333,7.816371002776184e-07,0.5903138982663703,0.04338842975206613
5,0.9,4,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Is there a spectrum of risk for psychosis transition in Ultra High Risk (UHR) criteria? Yes, varying risk levels exist based on age, how often and intensely symptoms appear, and genetic background. Yet, UHR criteria are not absolute indicators, so not all labeled UHR will experience psychosis.",6.158352911278206e-07,0.2747379273869748,0.12244897959183675,0.04714908808432873,0.3193404784281899,0.097412109375,0.047080840064774546,0.36528458233681915,0.07100591715976333,6.158352911278206e-07,0.41263272102891824,0.04338842975206613
5,0.9,5,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Are there different risk gradations for psychosis transition under UHR criteria? Yes, risk depends on factors including age, symptom frequency/intensity, and family history. Nevertheless, UHR criteria aren't definitive predictors; not all classified as UHR develop psychosis.",8.763809912203595e-07,0.5480312623866559,0.12244897959183675,0.06709677919692933,0.5996424435823475,0.097412109375,0.06699965701525609,0.6529666547886008,0.07100591715976333,8.7638099122036e-07,0.7080969339227541,0.04338842975206613
5,0.9,6,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Do Ultra High Risk (UHR) criteria reflect varying risks for psychosis transition? Yes, these risks differ according to age, symptom intensity and frequency, and family medical history. However, UHR does not assure psychosis development for every individual identified as high risk.",7.57951127541933e-07,0.41449986976213316,0.12244897959183675,0.058029646873019966,0.462441322068865,0.097412109375,0.057945649310491745,0.5118880565286945,0.07100591715976333,7.57951127541933e-07,0.5629149240782549,0.04338842975206613
5,0.9,7,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Regarding Ultra High Risk (UHR) criteria, are there multiple levels of transition risk to psychosis? Yes, risk levels vary depending on age, symptom severity and frequency, and family history. Importantly, UHR is not an absolute predictor, so not all individuals designated UHR will manifest psychosis.",6.632072365991914e-07,0.3191896899578075,0.12244897959183675,0.050775941013892475,0.36480285250494715,0.097412109375,0.05070244314668028,0.4118045979717131,0.07100591715976333,6.632072365991914e-07,0.46026077001817267,0.04338842975206613
5,0.9,8,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Are there distinct levels of risk for psychosis transition within Ultra High Risk (UHR) criteria? Yes, risk is assessed based on factors like age, symptom frequency and intensity, plus family history. However, being classified as UHR does not mean psychosis is inevitable for all.",6.868932093348768e-07,0.342179208182507,0.12244897959183675,0.05258936747867435,0.38833334991514157,0.097412109375,0.052513244687633145,0.4359021495507731,0.07100591715976333,6.868932093348768e-07,0.48495338260854437,0.04338842975206613
5,0.9,9,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Do different degrees of psychosis risk exist in the Ultra High Risk (UHR) criteria? Yes, risk levels vary based on age, how often symptoms occur, their intensity, and family history. Still, UHR criteria do not definitely predict psychosis development in everyone identified as high risk.",6.632072365991914e-07,0.3191896899578075,0.12244897959183675,0.050775941013892475,0.36480285250494715,0.097412109375,0.05070244314668028,0.4118045979717131,0.07100591715976333,6.632072365991914e-07,0.46026077001817267,0.04338842975206613
5,0.9,10,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Is the risk of transitioning to psychosis stratified within Ultra High Risk (UHR) criteria? Yes, risk is influenced by age, symptom occurrence and severity, along with family history. Despite this, UHR classification is not a certain predictor, and not all UHR individuals will develop psychosis.",6.632072365991914e-07,0.3191896899578075,0.12244897959183675,0.050775941013892475,0.36480285250494715,0.097412109375,0.05070244314668028,0.4118045979717131,0.07100591715976333,6.632072365991914e-07,0.46026077001817267,0.04338842975206613
6,0.9,1,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: A model of healing for Los Angeles grades C and D reflux oesophagitis: is there an ideal duration of acid suppression to maximize healing? Answer: Yes, the best healing of Los Angeles grades C and D reflux oesophagitis occurs with proper and timely acid suppression, though the optimal timing differs among patients based on the severity of the condition.",7.105791820705622e-08,0.011699336953479023,0.025808675914816212,0.005440279394345618,0.010856028733417844,0.027386130510347703,0.0054324046228586,0.009947673090992648,0.028989711201649074,7.105791820705622e-08,0.00896894954001759,0.03061941798872029
6,0.9,2,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: Healing model of Los Angeles grades C and D reflux oesophagitis: is there a best period for acid suppression to achieve maximal healing? Answer: Yes, effective healing of Los Angeles grades C and D reflux oesophagitis can be obtained through appropriate and timely acid suppression, but the exact timing depends on individual factors such as the disease severity.",9.474389094274162e-08,0.055126071152287626,0.007784280499902693,0.0072537058591274906,0.054665359089131726,0.009019560378012326,0.007243206163811466,0.054139717617809335,0.010337904224870825,9.474389094274162e-08,0.05354309377843425,0.011739312040478206
6,0.9,3,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: Is there an optimal duration of acid suppression for maximal healing in a model of Los Angeles grades C and D reflux oesophagitis? Answer: Yes, maximal healing is achievable with timely and sufficient acid suppression, although the ideal timing varies between patients and depends on factors like severity.",3.316036182995957e-07,0.10593781490312493,0.1053763721302242,0.025387970506946217,0.10164330299047775,0.11282578875171474,0.025351221573340132,0.1270737296210167,0.09876543209876548,3.316036182995957e-07,0.15339238115913867,0.08401920438957469
6,0.9,4,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: Model of healing for Los Angeles grades C and D reflux oesophagitis: is there a best timing for acid suppression to maximize healing? Answer: Yes, optimal healing is possible with prompt and adequate acid suppression, with the perfect timing varying by individual and influenced by the extent of severity.",3.079176455639103e-07,0.05643739517705848,0.1262002743484225,0.023574544042164344,0.08058989379264458,0.11282578875171474,0.023540420032387266,0.10556752440005335,0.09876543209876548,3.079176455639103e-07,0.13141347444036366,0.08401920438957469
6,0.9,5,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: In a healing model of Los Angeles grades C and D reflux oesophagitis, is there an ideal acid suppression period for best healing? Answer: Yes, timely and sufficient acid suppression can lead to optimal healing, but the ideal timing differs among individuals and depends on severity factors.",3.552895910352811e-07,0.12760571628230588,0.10493373370570039,0.02720139697172809,0.1231495082114411,0.11282578875171474,0.027162023114293,0.1490526363397917,0.09876543209876548,3.552895910352811e-07,0.17586523701119638,0.08401920438957469
6,0.9,6,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: Question: For Los Angeles grades C and D reflux oesophagitis healing models, is there a prime timing for acid suppression to ensure maximal healing? Answer: Yes, optimal healing can be achieved by appropriate acid suppression at the right time, with timing influenced by disease severity and individual differences.",3.316036182995957e-07,0.10593781490312493,0.1053763721302242,0.025387970506946217,0.10164330299047775,0.11282578875171474,0.025351221573340132,0.1270737296210167,0.09876543209876548,3.316036182995957e-07,0.15339238115913867,0.08401920438957469
6,0.9,7,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: A healing model for Los Angeles grades C and D reflux oesophagitis: does an optimal acid suppression timing exist for maximal healing? Answer: Yes, the best healing results from timely and adequate acid suppression, although the optimal timing varies due to factors like severity.",4.263475092423373e-07,0.16406805936942348,0.1262002743484225,0.03264167636607371,0.19059078900697335,0.11282578875171474,0.0325944277371516,0.21804550782674337,0.09876543209876548,4.263475092423373e-07,0.24648280422515034,0.08401920438957469
6,0.9,8,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: Is there an optimal timing of acid suppression in a healing model of Los Angeles grades C and D reflux oesophagitis to maximize healing? Answer: Yes, maximal healing is attained through timely and adequate acid suppression, but the ideal timing depends on individual severity and other factors.",3.552895910352811e-07,0.0981100915776274,0.1262002743484225,0.02720139697172809,0.1231495082114411,0.11282578875171474,0.027162023114293,0.1490526363397917,0.09876543209876548,3.552895910352811e-07,0.17586523701119638,0.08401920438957469
6,0.9,9,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: For healing Los Angeles grades C and D reflux oesophagitis, is there a perfect acid suppression timing to achieve the best healing? Answer: Yes, optimal healing can be achieved with timely and sufficient acid suppression, though timing varies among patients and depends on severity.",4.263475092423373e-07,0.16406805936942348,0.1262002743484225,0.03264167636607371,0.19059078900697335,0.11282578875171474,0.0325944277371516,0.21804550782674337,0.09876543209876548,4.263475092423373e-07,0.24648280422515034,0.08401920438957469
6,0.9,10,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: Healing model regarding Los Angeles grades C and D reflux oesophagitis: is there a best timeframe for acid suppression to maximize healing? Answer: Yes, effective healing requires timely and adequate acid suppression, with the best timing differing based on individual severity and other factors.",4.263475092423373e-07,0.16406805936942348,0.1262002743484225,0.03264167636607371,0.19059078900697335,0.11282578875171474,0.0325944277371516,0.21804550782674337,0.09876543209876548,4.263475092423373e-07,0.24648280422515034,0.08401920438957469
7,0.9,1,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Is it possible to predict discordance between TEOAE and AABR results in newborns? Due to current screening methods, some newborns with certain types of hearing loss may inevitably show conflicting TEOAE and AABR outcomes, even if they appear healthy and had mothers who received prenatal care. The constraints of perinatal morbidity-based targeted screening might explain this limitation.",9.474389094274162e-08,0.07791647314580885,0.002734705075445841,0.0072537058591274906,0.07748444286268352,0.0014244170096021913,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
7,0.9,2,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Can discordance between TEOAE and AABR results be anticipated in newborn infants? With the screening technologies presently available, discordant findings between TEOAE and AABR can occur in some newborns with hearing loss despite their apparent health and prenatal care from their mothers. This highlights potential limitations in using perinatal morbidity to guide targeted screenings.",2.3685972735685406e-08,0.006102283278941911,0.018000000000000016,0.0018134264647818726,0.006718685657224555,0.018800000000000018,0.0018108015409528666,0.007379615078719759,0.019599999999999992,2.3685972735685406e-08,0.02020270731751861,0.0
7,0.9,3,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Is the occurrence of discordant TEOAE and AABR test results predictable in newborns? Given existing screening technology, certain categories of hearing loss may produce inconsistent TEOAE and AABR findings in apparently healthy newborns whose mothers had prenatal care. This suggests targeted screening based on perinatal morbidity might have inherent limitations.",7.105791820705622e-08,0.06268784989259002,0.002342417383431425,0.005440279394345618,0.0623235119648653,0.0012239022181982917,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
7,0.9,4,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Can discordance in TEOAE and AABR outcomes be predicted in newborn babies? At present, due to available screening technologies, some types of hearing loss will inevitably cause discordant TEOAE and AABR results in newborns who appear healthy and whose mothers received prenatal care. This implies that perinatal morbidity-based targeted screening has potential restrictions.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
7,0.9,5,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Is it foreseeable when TEOAE and AABR results will differ in newborns? Current screening methods indicate that discordant results may be unavoidable in some newborns with hearing loss, even those seemingly healthy and with mothers who had prenatal care. This points to the limitations of relying on perinatal morbidities for targeted hearing screenings.",0.0,0.053319013889226774,0.03840000000000001,0.0,0.027182242374899523,0.019599999999999992,0.0,0.0,0.0,0.0,0.0,0.0
7,0.9,6,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Can we predict when newborns will show discordant TEOAE and AABR screening outcomes? Given the existing screening tools, some newborns with certain hearing impairments may inevitably have conflicting TEOAE and AABR results, despite appearing healthy and maternal prenatal care. This reflects the limits of perinatal morbidity-based targeted screening.",1.1842986367842703e-07,0.10676835239150018,0.00406913580246912,0.009067132323909363,0.10613882779771977,0.0021283950617284053,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
7,0.9,7,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Is it possible to forecast discordance between TEOAE and AABR findings in newborns? Available screening technologies suggest that discordant outcomes could be inevitable for some hearing loss categories among newborns who appear healthy and whose mothers had prenatal care, highlighting limitations of using perinatal morbidity for targeted screening.",1.1842986367842703e-07,0.047777102982143216,0.03840000000000001,0.009067132323909363,0.07600199386033113,0.019599999999999992,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
7,0.9,8,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Are discordant results between TEOAE and AABR in newborns predictable? Given the current screening technologies, some newborns with hearing loss may inevitably have mismatched TEOAE and AABR results, even if they seem healthy and had mothers receiving prenatal care, indicating potential constraints in perinatal morbidity-targeted screening.",1.6580180914979784e-07,0.15287529763832097,0.005948296376419672,0.012693985253473108,0.15196044645661644,0.0031149810708491175,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
7,0.9,9,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Can discordance between TEOAE and AABR testing in newborns be anticipated? With the screening methods now available, conflicting TEOAE and AABR results may be unavoidable in certain newborns with hearing loss who appear healthy and whose mothers had prenatal care, pointing to limitations of perinatal morbidity-based targeted screening.",1.1842986367842703e-07,0.10676835239150018,0.00406913580246912,0.009067132323909363,0.10613882779771977,0.0021283950617284053,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
7,0.9,10,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Is it predictable that TEOAE and AABR outcomes will differ in newborn infants? Based on current screening technologies, some newborns with specific hearing impairments may inevitably display discordant TEOAE and AABR results despite appearing healthy and having had mothers with prenatal care, underscoring constraints related to perinatal morbidity as a basis for targeted screening.",2.3685972735685406e-08,0.020054214100678536,0.0007221837754709942,0.0018134264647818726,0.019940821287388832,0.0003766243752402823,0.0018108015409528666,0.019802627296179764,0.0,2.3685972735685406e-08,0.02020270731751861,0.0
8,0.9,1,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This article explores whether cultural factors, attitudes, and faith are relevant to recovery outcome measures, focusing on the suitability of the RAQ in Australian contexts and emphasizing the importance of creating robust, inclusive recovery assessments.",4.73719454713706e-08,0.01865023714217351,0.02775510204081633,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
8,0.9,2,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The paper examines the role of culture, attitudes, and faith in recovery outcome measures, evaluating the RAQ's cultural fit in Australia and highlighting the necessity for developing comprehensive and inclusive measures.",1.421158364141118e-07,0.1438133800961805,0.02775510204081633,0.010880558788691277,0.18805223150294026,0.0,0.010864809245717241,0.19415601444095776,0.0,1.4211583641411244e-07,0.20067069546215066,0.0
8,0.9,3,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This study addresses the question of incorporating culture, attitudes, and faith into recovery outcome measures, analyzing the cultural relevance of the RAQ in Australian settings and advocating for the development of rigorous, inclusive tools.",7.10579182070559e-08,0.048503200291855286,0.02775510204081633,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
8,0.9,4,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The discussion centers on the appropriateness of including culture, attitudes, and faith in recovery outcomes, assessing the RAQ within Australian contexts and underlining the need for reliable, inclusive measures.",1.894877818854824e-07,0.21280625158313127,0.02775510204081633,0.014507411718255037,0.25951119548508395,0.0,0.014486412327622988,0.2682639865946794,0.0,1.8948778188548325e-07,0.2776317365982801,0.0
8,0.9,5,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This research evaluates the place of cultural and faith-related factors in recovery outcome measures, reviewing the RAQ's cultural suitability in Australia and calling for inclusive, methodologically sound assessments.",2.131737546211677e-07,0.24917389575400595,0.02775510204081633,0.016320838183036916,0.29725152346793093,0.0,0.016297213868575862,0.3074846997479619,0.0,2.1317375462116866e-07,0.3184537311185349,0.0
8,0.9,6,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The paper considers whether recovery outcome measures should include culture, attitudes, and faith, critiquing the RAQ's cultural applicability in Australia and signaling the need for robust, inclusive development.",2.131737546211677e-07,0.24917389575400595,0.02775510204081633,0.016320838183036916,0.29725152346793093,0.0,0.016297213868575862,0.3074846997479619,0.0,2.1317375462116866e-07,0.3184537311185349,0.0
8,0.9,7,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This work investigates the cultural relevance of the RAQ in Australian environments, questioning the integration of culture, attitudes, and faith in recovery measures and stressing the requirement for comprehensive, inclusive evaluation tools.",1.184298636784265e-07,0.1110235572731888,0.02775510204081633,0.009067132323909398,0.1541506798272585,0.0,0.009054007704764368,0.15906469462968875,0.0,1.1842986367842703e-07,0.16430305129127598,0.0
8,0.9,8,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This article analyzes the potential role of culture, attitudes, and faith within recovery outcome measures, focusing on the RAQ's cultural appropriateness in Australia and the imperative to design rigorous and inclusive assessments.",1.184298636784265e-07,0.1110235572731888,0.02775510204081633,0.009067132323909398,0.1541506798272585,0.0,0.009054007704764368,0.15906469462968875,0.0,1.1842986367842703e-07,0.16430305129127598,0.0
8,0.9,9,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The study deliberates on whether recovery outcome measures should incorporate cultural and faith elements, examining the RAQ's fit in Australian settings and emphasizing the importance of inclusive, rigorous measure development.",1.658018091497971e-07,0.17771493177186226,0.02775510204081633,0.012693985253473157,0.22314355131420927,0.0,0.012675610786670115,0.23052365861183244,0.0,1.6580180914979784e-07,0.23841102344499765,0.0
8,0.9,10,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This paper discusses the integration of culture, attitudes, and faith into recovery outcome measures, assessing the RAQ's relevance in Australia and identifying a need for the development of inclusive and methodologically robust tools.",9.47438909427412e-08,0.07927485895860897,0.02775510204081633,0.007253705859127518,0.1213608570042668,0.0,0.007243206163811494,0.125163142954007,0.0,9.474389094274162e-08,0.12921173148000697,0.0
9,0.9,1,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Diffusion-weighted echo-planar MR imaging enables the prediction of various histologic subtypes of primary parotid gland tumors by evaluating apparent diffusion coefficient values, facilitating differentiation between benign and malignant tumors for better diagnosis and treatment planning.",5.684633456564491e-07,0.29506621677165557,0.16493055555555555,0.04352223515476496,0.3762970304410662,0.1204,0.04345923698286882,0.4605947621411448,0.07100591715976332,5.684633456564497e-07,0.5481406287269626,0.0181755829903978
9,0.9,2,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Using diffusion-weighted echo-planar MR imaging, it is possible to predict different histologic subtypes of primary parotid gland tumors through the assessment of apparent diffusion coefficient values, which helps distinguish benign from malignant tumors and supports accurate diagnosis and treatment.",4.737194547137079e-07,0.18384058166143102,0.16493055555555555,0.03626852929563745,0.26188667926332077,0.1204,0.03621603081905733,0.342811726484761,0.07100591715976332,4.737194547137081e-07,0.42677977172269577,0.0181755829903978
9,0.9,3,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Primary parotid gland tumors' histologic subtypes can be predicted using diffusion-weighted echo-planar MR imaging by analyzing apparent diffusion coefficient values, allowing differentiation between benign and malignant forms, which assists in precise diagnosis and therapeutic decisions.",5.684633456564491e-07,0.29506621677165557,0.16493055555555555,0.04352223515476496,0.3762970304410662,0.1204,0.04345923698286882,0.4605947621411448,0.07100591715976332,5.684633456564497e-07,0.5481406287269626,0.0181755829903978
9,0.9,4,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","The prediction of different histologic subtypes of primary parotid gland tumors is achievable with diffusion-weighted echo-planar MR imaging by assessing apparent diffusion coefficient values to differentiate benign and malignant tumors, aiding precise diagnosis and treatment planning.",5.447773729207638e-07,0.26607867989840406,0.16493055555555555,0.04170880868998308,0.34644406729138444,0.1204,0.041648435441915946,0.4298231034743911,0.07100591715976332,5.447773729207643e-07,0.5163919304123827,0.0181755829903978
9,0.9,5,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Diffusion-weighted echo-planar MR imaging permits the differentiation of various histologic subtypes of primary parotid gland tumors through apparent diffusion coefficient value evaluation, enabling distinction between benign and malignant tumors for improved diagnosis and treatment strategy.",5.684633456564491e-07,0.29506621677165557,0.16493055555555555,0.04352223515476496,0.3762970304410662,0.1204,0.04345923698286882,0.4605947621411448,0.07100591715976332,5.684633456564497e-07,0.5481406287269626,0.0181755829903978
9,0.9,6,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Through diffusion-weighted echo-planar MR imaging, one can predict different histologic subtypes of primary parotid gland tumors by measuring apparent diffusion coefficient values, which helps in distinguishing benign from malignant tumors and improves diagnostic accuracy and treatment planning.",5.210914001850785e-07,0.2379078029317072,0.16493055555555555,0.0398953822252012,0.31745653041813293,0.1204,0.03983763390096307,0.39997014032470934,0.07100591715976332,5.210914001850789e-07,0.48562027174562905,0.0181755829903978
9,0.9,7,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","By using diffusion-weighted echo-planar MR imaging, it is feasible to predict the histologic subtypes of primary parotid gland tumors. Apparent diffusion coefficient values provide a basis for differentiating between benign and malignant tumors, enhancing diagnosis and treatment.",5.210914001850785e-07,0.2379078029317072,0.16493055555555555,0.0398953822252012,0.31745653041813293,0.1204,0.03983763390096307,0.39997014032470934,0.07100591715976332,5.210914001850789e-07,0.48562027174562905,0.0181755829903978
9,0.9,8,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Diffusion-weighted echo-planar MR imaging allows prediction of distinct histologic subtypes in primary parotid gland tumors by analyzing apparent diffusion coefficient values, which helps identify benign versus malignant tumors and supports precise diagnosis and therapy planning.",5.684633456564491e-07,0.29506621677165557,0.16493055555555555,0.04352223515476496,0.3762970304410662,0.1204,0.04345923698286882,0.4605947621411448,0.07100591715976332,5.684633456564497e-07,0.5481406287269626,0.0181755829903978
9,0.9,9,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","The use of diffusion-weighted echo-planar MR imaging facilitates the prediction of various primary parotid gland tumor histologic subtypes by evaluating apparent diffusion coefficient values, making it possible to distinguish benign from malignant tumors and assist in diagnosis and treatment.",4.737194547137079e-07,0.18384058166143102,0.16493055555555555,0.03626852929563745,0.26188667926332077,0.1204,0.03621603081905733,0.342811726484761,0.07100591715976332,4.737194547137081e-07,0.42677977172269577,0.0181755829903978
9,0.9,10,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Diffusion-weighted echo-planar MR imaging provides the ability to predict different histologic subtypes of primary parotid gland tumors by assessing apparent diffusion coefficient values, aiding in the differentiation of benign and malignant tumors and improving diagnostic and treatment approaches.",4.974054274493932e-07,0.2105088287435919,0.16493055555555555,0.038081955760419325,0.2892856534514361,0.1204,0.0380268323600102,0.37098260345145784,0.07100591715976332,4.974054274493935e-07,0.4557673085959473,0.0181755829903978
10,0.9,1,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Does end-tidal carbon dioxide monitoring correlate with arterial carbon dioxide in extremely low birth weight infants within their first week? Yes, end-tidal CO2 measurements can align with arterial CO2 in these infants during their first week, but the correlation may vary due to factors like illness severity and type of ventilation used.",3.552895910352811e-07,0.05970890389559358,0.30078125,0.02720139697172809,0.014894607756485989,0.1875,0.027162023114293,0.05045429132406287,0.15089163237311393,3.552895910352811e-07,0.11790100869254205,0.109375
10,0.9,2,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Is there a correlation between end-tidal carbon dioxide levels and arterial carbon dioxide in extremely low birth weight infants during the initial week of life? Yes, end-tidal CO2 can correspond with arterial CO2 in these infants in the first week, though the strength of this correlation may be influenced by disease severity and ventilation mode.",2.8423167282822487e-07,0.17274192706172586,0.34086307404770383,0.02176111757738247,0.07316351588046155,0.1875,0.0217296184914344,0.008969129146738197,0.15089163237311393,2.8423167282822487e-07,0.05727638687610792,0.109375
10,0.9,3,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Can end-tidal carbon dioxide measurements be used to reflect arterial carbon dioxide in extremely low birth weight infants within their first week? Yes, end-tidal CO2 has a potential correlation with arterial CO2 in these infants during their first week, but variables such as disease severity and ventilation type might impact accuracy.",3.789755637709665e-07,0.06600122927931684,0.3194444444444444,0.029014823436509962,0.00530809956103262,0.1875,0.028972824655245866,0.07107357852679863,0.15089163237311393,3.789755637709665e-07,0.13895441789037521,0.109375
10,0.9,4,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","In extremely low birth weight infants during the first week, does end-tidal carbon dioxide correlate with arterial carbon dioxide? Yes, end-tidal CO2 measurement may correlate with arterial CO2 in the first week of life, although the correlation can be affected by factors like severity of illness and ventilation method.",4.263475092423373e-07,0.006012388366134491,0.2971527777777778,0.03264167636607371,0.07647642066628002,0.1662334593572779,0.0325944277371516,0.11363319294559515,0.15089163237311393,4.263475092423373e-07,0.18243952983011358,0.109375
10,0.9,5,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Does measuring end-tidal carbon dioxide provide a good correlation with arterial carbon dioxide in extremely low birth weight infants during their first week? Yes, it can, but the correlation may vary depending on disease severity and the mode of ventilation.",6.395212638635059e-07,0.1625543648338721,0.333751731301939,0.04896251454911056,0.259542237945273,0.1875,0.0488916416057274,0.3313566767904641,0.15089163237311393,6.39521263863506e-07,0.40558308114432284,0.109375
10,0.9,6,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Is there a reliable correlation between end-tidal and arterial carbon dioxide levels in extremely low birth weight infants in their first week of life? Yes, the end-tidal CO2 can correlate with arterial CO2 in these infants during that period, though factors such as illness severity and ventilation mode may alter the correlation.",3.552895910352811e-07,0.1412556310202926,0.359375,0.02720139697172809,0.014894607756485989,0.1875,0.027162023114293,0.05045429132406287,0.15089163237311393,3.552895910352811e-07,0.11790100869254205,0.109375
10,0.9,7,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Can end-tidal CO2 levels be used as a proxy for arterial CO2 in extremely low birth weight infants within their first week? Yes, they can correlate, but the accuracy of this correlation may differ due to disease severity and ventilation type.",6.158352911278206e-07,0.10169054759009644,0.359375,0.04714908808432869,0.233566751542015,0.1875,0.04708084006477453,0.30468842970830323,0.15089163237311393,6.158352911278206e-07,0.3781841069562075,0.109375
10,0.9,8,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","In the first week of life for extremely low birth weight infants, does end-tidal carbon dioxide correlate with arterial carbon dioxide? Yes, there can be a correlation, but it is subject to variation based on factors like disease severity and the mode of ventilation.",5.447773729207643e-07,0.029369886010470303,0.359375,0.04170880868998307,0.15945877938829156,0.1875,0.04164843544191593,0.22870252273038183,0.15089163237311393,5.447773729207643e-07,0.30022256548649695,0.109375
10,0.9,9,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Does the measurement of end-tidal carbon dioxide correspond with arterial carbon dioxide in extremely low birth weight infants during their first week? Yes, such a correlation exists, though it can vary depending on disease severity and ventilation methods.",6.868932093348765e-07,0.21711950422520943,0.3323688271604938,0.052589367478674306,0.31360945921554917,0.1875,0.05251324468763313,0.38692652794527627,0.15089163237311393,6.868932093348768e-07,0.4627414949842712,0.109375
10,0.9,10,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Is end-tidal carbon dioxide monitoring reflective of arterial carbon dioxide levels in extremely low birth weight infants in the first week of life? Yes, it can be, but the correlation is influenced by factors such as severity of illness and ventilation mode.",5.921493183921352e-07,0.1108099925880146,0.335,0.045335661619546816,0.20824894355772328,0.1875,0.045270038523821665,0.27871294330504526,0.15089163237311393,5.921493183921352e-07,0.35151585987404665,0.109375
11,0.9,1,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a",Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The findings indicate that the slightly elevated depression rates up to age 35 in the comorbid MD/AUD group can be attributed to greater exposure to adverse childhood conditions in this group. Adolescent comorbidity of MD/AUD likely serves as a risk marker rather than a cause.,7.105791820705622e-08,0.025925279294853887,0.015380859375,0.005440279394345618,0.04800921918636103,0.0,0.0054324046228586,0.04879016416943571,0.0,7.105791820705622e-08,0.04959694113937285,0.0
11,0.9,2,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a",Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Analysis results suggest that mildly higher depression rates to age 35 among the MD/AUD comorbid group were due to increased adverse childhood experiences within that group. MD/AUD comorbidity in adolescence is probably a risk indicator rather than a direct cause.,1.8948778188548325e-07,0.11000839650539529,0.015380859375,0.014507411718254981,0.13353139262452185,0.0,0.014486412327622933,0.13580154115906407,0.0,1.8948778188548325e-07,0.13815033848081626,0.0
11,0.9,3,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a",Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: These analyses suggest that marginal increases in depression up to age 35 among those with both MD and AUD stem from greater exposure to adverse childhood events in the comorbid group. Adolescent MD/AUD comorbidity is more likely a marker of risk than a causal factor.,7.105791820705622e-08,0.025925279294853887,0.015380859375,0.005440279394345618,0.04800921918636103,0.0,0.0054324046228586,0.04879016416943571,0.0,7.105791820705622e-08,0.04959694113937285,0.0
11,0.9,4,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The study results imply that the slightly higher depression rates by age 35 in the comorbid MD/AUD group are explained by greater childhood adversity exposure among group members. Thus, adolescent MD/AUD comorbidity is likely a risk marker, not a cause.",1.8948778188548325e-07,0.11000839650539529,0.015380859375,0.014507411718254981,0.13353139262452185,0.0,0.014486412327622933,0.13580154115906407,0.0,1.8948778188548325e-07,0.13815033848081626,0.0
11,0.9,5,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: According to these findings, the comorbid MD/AUD group's marginally increased depression rates through age 35 are linked to enhanced exposure to childhood adversities. The co-occurrence of MD and AUD in adolescence probably marks risk rather than causes it.",2.3685972735685406e-07,0.14572647910747438,0.015380859375,0.018134264647818726,0.16989903679539609,0.0,0.018108015409528666,0.17284281283941416,0.0,2.3685972735685406e-07,0.1758906664636637,0.0
11,0.9,6,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a",Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Results indicate that slightly higher depression prevalence at age 35 among the MD/AUD comorbid group resulted from increased childhood adversity exposure. Adolescent comorbidity of MD and AUD likely reflects risk status more than a direct cause.,2.8423167282822487e-07,0.18276775078782448,0.015380859375,0.02176111757738247,0.20763936477824352,0.0,0.0217296184914344,0.21130909366720996,0.0,2.8423167282822487e-07,0.21511137961694615,0.0
11,0.9,7,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The data suggest that the modestly elevated depression rates by age 35 in the comorbid MD/AUD group are attributed to greater adverse childhood experiences among them. Thus, adolescent comorbidity is a probable risk marker rather than a causal agent.",2.1317375462116866e-07,0.1277079736047959,0.015380859375,0.016320838183036854,0.15154989812720032,0.0,0.0162972138685758,0.15415067982725983,0.0,2.1317375462116866e-07,0.1568424714929706,0.0
11,0.9,8,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a",Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Findings reveal that the comorbid group’s slightly higher rate of depression up to age 35 is due to increased exposure to adverse childhood environments. Adolescent MD/AUD comorbidity acts more as an indicator of risk than a cause.,2.6054570009253947e-07,0.16407561777567015,0.015380859375,0.0199476911126006,0.18859116980755042,0.0,0.019918816950481533,0.19189100781010726,0.0,2.6054570009253947e-07,0.1953087523207664,0.0
11,0.9,9,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The analyses show that the marginal increase in depression through age 35 within the comorbid MD/AUD group is explained by their increased adverse childhood experiences. Hence, adolescent MD/AUD comorbidity is better viewed as a risk marker, not the cause.",2.1317375462116866e-07,0.1277079736047959,0.015380859375,0.016320838183036854,0.15154989812720032,0.0,0.0162972138685758,0.15415067982725983,0.0,2.1317375462116866e-07,0.1568424714929706,0.0
11,0.9,10,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: These results suggest that the marginal rise in depression prevalence to age 35 for those with both MD and AUD is due to greater exposure to childhood adversities; thus, adolescent comorbid MD/AUD is likely a risk marker rather than a causal factor.",1.4211583641411244e-07,0.07552222043422674,0.015380859375,0.010880558788691236,0.0984400728132524,0.0,0.0108648092457172,0.10008345855698497,0.0,1.4211583641411244e-07,0.10178269430994202,0.0
12,0.9,1,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Does having an optimistic view forecast improved survival rates in older age? Answer: Yes, an optimistic perspective is associated with better survival in advanced years. Studies suggest that optimism correlates with longer life, possibly because it affects how people cope.",9.474389094274162e-08,0.05907260132038994,0.10798042547456571,0.0072537058591274906,0.03131914542397851,0.09204470742932283,0.007243206163811466,0.03406944136079737,0.047500000000000014,9.474389094274162e-08,0.0688420964717924,0.024375
12,0.9,2,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Can optimism predict higher survival chances in old age? Answer: Yes, optimism can be a predictor of increased survival at older ages. Research shows that optimism is related to longevity, likely due to its impact on coping mechanisms.",1.4211583641411222e-07,0.04243666596083662,0.13296398891966763,0.010880558788691236,0.02132458806144033,0.09204470742932283,0.0108648092457172,0.08813666263107356,0.047500000000000014,1.4211583641411244e-07,0.12441194762660457,0.024375
12,0.9,3,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Does being optimistic enhance the likelihood of survival in later life? Answer: Yes, having an optimistic outlook is linked to better survival among the elderly. Evidence suggests optimism contributes to longer lifespan by influencing coping strategies.",1.8948778188548283e-07,0.011630555309439572,0.13296398891966763,0.014507411718254981,0.0768944392162525,0.09204470742932283,0.01448641232762294,0.1452950764710219,0.047500000000000014,1.8948778188548325e-07,0.18325244764953785,0.024375
12,0.9,4,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Is there a connection between optimism and survival in advanced age? Answer: Yes, optimism appears to predict improved survival outcomes in older adults. Studies indicate that optimism is associated with longer life, potentially because it guides how individuals handle challenges.",9.474389094274162e-08,0.09372996034838632,0.13296398891966763,0.0072537058591274906,0.03131914542397851,0.09204470742932283,0.007243206163811466,0.03406944136079737,0.047500000000000014,9.474389094274162e-08,0.0688420964717924,0.024375
12,0.9,5,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Does an optimistic mindset improve survival prospects at older ages? Answer: Yes, optimistic attitudes can predict better survival in advanced age. Research finds that optimism is tied to longevity, possibly due to its role in shaping coping behaviors.",1.4211583641411222e-07,0.04243666596083662,0.13296398891966763,0.010880558788691236,0.02132458806144033,0.09204470742932283,0.0108648092457172,0.08813666263107356,0.047500000000000014,1.4211583641411244e-07,0.12441194762660457,0.024375
12,0.9,6,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Can an optimistic outlook lead to better survival rates among the elderly? Answer: Yes, optimism is linked to improved survival in older populations. Studies reveal that it may influence longevity through positive coping processes.",2.3685972735685343e-07,0.06878896914938792,0.13296398891966763,0.01813426464781874,0.13573493923918578,0.09204470742932283,0.018108015409528687,0.20591969828745738,0.047500000000000014,2.3685972735685406e-07,0.24577280463087137,0.024375
12,0.9,7,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Does maintaining optimism contribute to longer survival in late life? Answer: Yes, optimism is a predictor of enhanced survival at advanced ages. Research suggests this may be due to optimism affecting individuals' coping styles.",2.3685972735685343e-07,0.06878896914938792,0.13296398891966763,0.01813426464781874,0.13573493923918578,0.09204470742932283,0.018108015409528687,0.20591969828745738,0.047500000000000014,2.3685972735685406e-07,0.24577280463087137,0.024375
12,0.9,8,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Is optimism a factor in predicting survival in advanced age? Answer: Yes, an optimistic outlook is associated with better survival among older adults. This is thought to result from the way optimism shapes coping strategies.",2.1317375462116813e-07,0.03980143227613642,0.13296398891966763,0.01632083818303686,0.105881976089504,0.09204470742932283,0.016297213868575813,0.1751480396207037,0.047500000000000014,2.1317375462116866e-07,0.21402410631629154,0.024375
12,0.9,9,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Does having a positive outlook increase survival chances in old age? Answer: Yes, optimism can predict greater survival in later life. Research points to a link between optimism and longevity, possibly through improved coping mechanisms.",2.1317375462116813e-07,0.03980143227613642,0.13296398891966763,0.01632083818303686,0.105881976089504,0.09204470742932283,0.016297213868575813,0.1751480396207037,0.047500000000000014,2.1317375462116866e-07,0.21402410631629154,0.024375
12,0.9,10,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Can an optimistic perspective forecast better survival at advanced ages? Answer: Yes, optimism is connected with higher survival rates among the elderly, likely because it influences coping strategies.",3.7897556377096523e-07,0.2629449835903457,0.13296398891966763,0.029014823436510018,0.33640563470133644,0.09204470742932283,0.028972824655245928,0.41355906306570134,0.047500000000000014,3.789755637709665e-07,0.46088418424781796,0.024375
13,0.9,1,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Is the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia a predictor of adverse maternal and neonatal outcomes? ACR serves as an independent prognostic indicator for adverse outcomes in both mothers and neonates in cases of suspected preeclampsia and can help improve risk prediction models.,7.105791820705622e-08,0.13486314996702387,0.13888888888888887,0.005440279394345618,0.07986714147908369,0.10275824770146022,0.0054324046228586,0.05202453102691784,0.08436992969172526,7.105791820705622e-08,0.022969221016634567,0.06489994591671175
13,0.9,2,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Does the first measurement of urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia predict maternal and neonatal adverse outcomes? The ACR is an independent prognostic factor for these adverse outcomes and may enhance risk assessments within prognostic models.,2.6054570009253926e-07,0.056192086795684215,0.13888888888888887,0.0199476911126006,0.11587743564701025,0.10275824770146022,0.019918816950481533,0.1486461644352337,0.08436992969172526,2.6054570009253947e-07,0.1828828331875143,0.06489994591671175
13,0.9,3,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Can the initial urinary albumin/creatinine ratio (ACR) in suspected preeclampsia cases in women predict negative outcomes for mothers and newborns? ACR independently predicts maternal and neonatal adverse outcomes and can be valuable for risk prediction in prognostic modeling.,2.8423167282822456e-07,0.08286033387784508,0.13888888888888887,0.02176111757738247,0.14327640983512557,0.10275824770146022,0.0217296184914344,0.17681704140193055,0.08436992969172526,2.8423167282822487e-07,0.2118703700607658,0.06489994591671175
13,0.9,4,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Is the first recorded urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a reliable prognostic marker for adverse outcomes in mothers and newborns? This ratio independently forecasts maternal and neonatal risks and may improve prognostic risk predictions.,2.8423167282822456e-07,0.08286033387784508,0.13888888888888887,0.02176111757738247,0.14327640983512557,0.10275824770146022,0.0217296184914344,0.17681704140193055,0.08436992969172526,2.8423167282822487e-07,0.2118703700607658,0.06489994591671175
13,0.9,5,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Does the earliest urinary albumin/creatinine ratio (ACR) measurement in women suspected of having preeclampsia serve as a prognostic factor for adverse maternal and neonatal events? ACR independently predicts these adverse outcomes and may inform risk prediction within prognostic models.,2.6054570009253926e-07,0.056192086795684215,0.13888888888888887,0.0199476911126006,0.11587743564701025,0.10275824770146022,0.019918816950481533,0.1486461644352337,0.08436992969172526,2.6054570009253947e-07,0.1828828331875143,0.06489994591671175
13,0.9,6,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Is the initial urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a significant prognostic indicator for adverse maternal and neonatal outcomes? The ACR acts as an independent predictor and could be helpful in prognostic risk modeling.,3.0791764556390986e-07,0.1102593080659604,0.13888888888888887,0.023574544042164344,0.17144728680182242,0.10275824770146022,0.023540420032387273,0.20580457827518206,0.08436992969172526,3.079176455639103e-07,0.2417233332104476,0.06489994591671175
13,0.9,7,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Can the first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia independently predict maternal and neonatal adverse outcomes? ACR is an independent prognostic factor and might be useful in enhancing risk predictions within prognostic models.,3.3160361829959516e-07,0.13843018503265725,0.13888888888888887,0.025387970506946224,0.20043482367507393,0.10275824770146022,0.025351221573340146,0.23565754142486384,0.08436992969172526,3.316036182995957e-07,0.2724949918772013,0.06489994591671175
13,0.9,8,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Is the initial urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a useful prognostic tool for predicting adverse outcomes in mothers and neonates? ACR independently predicts these adverse outcomes and may aid in risk prediction models.,3.0791764556390986e-07,0.14876748476373525,0.11113378684807254,0.023574544042164344,0.17144728680182242,0.10275824770146022,0.023540420032387273,0.20580457827518206,0.08436992969172526,3.079176455639103e-07,0.2417233332104476,0.06489994591671175
13,0.9,9,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Does the first urinary albumin/creatinine ratio (ACR) recorded in women with suspected preeclampsia serve as an independent prognostic factor for adverse maternal and neonatal outcomes? ACR can be useful for risk prediction in prognostic models.,3.5528959103528046e-07,0.16741772190590876,0.13888888888888887,0.027201396971728103,0.2302877868247557,0.10275824770146022,0.02716202311429302,0.2664292000916175,0.08436992969172526,3.552895910352811e-07,0.3042436901917811,0.06489994591671175
13,0.9,10,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Is the first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia an independent prognostic factor for maternal and neonatal adverse outcomes? ACR may aid in predicting risk within prognostic models.,4.5003348197802166e-07,0.29258086485991575,0.13888888888888887,0.03445510283085562,0.3594995183047627,0.10275824770146022,0.034405229278104514,0.3999605927161398,0.08436992969172526,4.500334819780227e-07,0.44239402867259825,0.06489994591671175
14,0.9,1,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Are glandular cell abnormalities in Pap smears identified through rapid prescreening? Rapid prescreening might not be effective for detecting glandular cell abnormalities in Pap smear tests. More dependable detection usually involves manual slide examination by a cytotechnologist or pathologist.,2.1317375462116844e-07,0.3289915395021401,0.08253968773098032,0.016320838183036854,0.33012572934107753,0.08044982698961935,0.0162972138685758,0.30015990470975895,0.055363321799307974,2.1317375462116866e-07,0.2684499827465596,0.02854671280276816
14,0.9,2,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.","Do rapid prescreening methods detect glandular cell abnormalities in Pap smears? Rapid prescreening often fails to reliably identify glandular cell abnormalities in Pap smears, whereas traditional manual review by a cytotechnologist or pathologist tends to be more accurate.",2.3685972735685374e-07,0.39707114018816725,0.1105693968572779,0.018134264647818726,0.3606469881263088,0.08264462809917354,0.018108015409528666,0.3305312489163281,0.056932966023875105,2.3685972735685406e-07,0.29860247286444963,0.029384756657483937
14,0.9,3,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Can rapid prescreening detect glandular cell abnormalities in Pap smears? Rapid prescreening may not be sufficient for spotting glandular cell abnormalities in Pap smear samples; manual review by experts is generally more effective.,3.5528959103528024e-07,0.5715245681306365,0.1296250917303918,0.027201396971728117,0.5288117108220018,0.09566326530612247,0.027162023114293034,0.4978847321828237,0.06632653061224487,3.552895910352811e-07,0.4646970577635088,0.03443877551020409
14,0.9,4,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.","Is rapid prescreening effective for detecting glandular cell abnormalities in Pap smears? Rapid prescreening might miss glandular cell abnormalities, with manual examination by a cytotechnologist or pathologist being the preferred method for accurate detection.",3.3160361829959494e-07,0.40816225560677166,0.03908725748422898,0.025387970506946238,0.3629054936893681,0.0,0.02535122157334016,0.3726752852851729,0.0,3.316036182995957e-07,0.3829922522561069,0.0
14,0.9,5,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Are glandular cell abnormalities in Pap smears found by rapid prescreening? Rapid prescreening does not always detect glandular cell abnormalities well; traditional slide reviews by cytotechnologists or pathologists provide better identification.,4.0266153650665085e-07,0.5118742194178836,0.045059989969522776,0.030828249901291876,0.5091488203343415,0.03443877551020409,0.03078362619619878,0.4744579795951154,0.0,4.026615365066519e-07,0.48835276791393234,0.0
14,0.9,6,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Does rapid prescreening identify glandular cell abnormalities in Pap smears? Rapid prescreening may not reliably catch glandular cell abnormalities; manual review by professionals remains the standard for accurate diagnosis.,4.5003348197802145e-07,0.587468492624454,0.04973937651704123,0.034455102830855636,0.5328045304847651,0.0,0.03440522927810453,0.548565951748837,0.0,4.500334819780227e-07,0.5653138090500618,0.0
14,0.9,7,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.","Are glandular cell abnormalities detected with rapid prescreening in Pap smears? Rapid prescreening is often inadequate for finding glandular cell abnormalities, and manual slide examination by experts is typically more reliable.",4.0266153650665085e-07,0.5118742194178836,0.045059989969522776,0.030828249901291876,0.4613455665026214,0.0,0.03078362619619878,0.4744579795951154,0.0,4.026615365066519e-07,0.48835276791393234,0.0
14,0.9,8,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.","Is detection of glandular cell abnormalities in Pap smears possible through rapid prescreening? Rapid prescreening might not adequately detect glandular cell abnormalities in Pap smears, so manual review by a cytotechnologist or pathologist is usually preferred.",2.8423167282822434e-07,0.42373755678681047,0.09111639380056612,0.02176111757738248,0.4246009625599809,0.08740894901144641,0.021729618491434413,0.3941727683717118,0.06035379812695108,2.8423167282822487e-07,0.36177542990353295,0.031217481789802305
14,0.9,9,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.","Can rapid prescreening methods find glandular cell abnormalities in Pap smears? Rapid prescreening may miss glandular cell abnormalities, which are more reliably identified via manual slide analysis by a cytotechnologist or pathologist.",3.7897556377096555e-07,0.47610311839893527,0.042942734030286214,0.029014823436509997,0.4274440148269396,0.0,0.028972824655245907,0.43936665978384637,0.0,3.789755637709665e-07,0.45198512374305766,0.0
14,0.9,10,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.","Are glandular cell abnormalities in Pap smears reliably detected by rapid prescreening? Rapid prescreening may fail to effectively detect glandular cell abnormalities, making manual examination by a cytotechnologist or pathologist the more reliable approach.",3.3160361829959494e-07,0.366153335572835,0.009006896857277898,0.025387970506946238,0.3629054936893681,0.0,0.02535122157334016,0.3726752852851729,0.0,3.316036182995957e-07,0.3829922522561069,0.0
15,0.9,1,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Do provider service networks lead to reduced costs relative to HMOs or primary care case management in Florida's Medicaid program? Provider Service Networks (PSNs) in Florida's Medicaid can potentially lower spending compared to HMOs and primary care case management, though the actual savings vary based on factors like PSN efficiency.",2.1317375462116866e-07,0.12764849486574636,0.026041666666666713,0.016320838183036854,0.11256793227350581,0.041584006151480196,0.0162972138685758,0.12569357612795207,0.03566529492455417,2.1317375462116866e-07,0.15348643672301465,0.0181755829903978
15,0.9,2,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Are expenditures lower with provider service networks compared to HMOs or primary care case management within Florida's Medicaid program? PSNs in Florida’s Medicaid may result in cost reductions compared to HMOs and primary care case management, but the degree of savings depends on factors including the effectiveness of the PSN.",2.1317375462116866e-07,0.042773329899222556,0.08394290123456792,0.016320838183036854,0.08368679975017468,0.06221832667237916,0.0162972138685758,0.12569357612795207,0.03566529492455417,2.1317375462116866e-07,0.15348643672301465,0.0181755829903978
15,0.9,3,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","In Florida's Medicaid program, do provider service networks generate lower costs than HMOs or primary care case management? Provider Service Networks could potentially decrease expenditures relative to HMOs and primary care case management, with actual savings influenced by aspects such as PSN efficiency.",3.789755637709665e-07,0.2157851574968208,0.07074773007079105,0.029014823436509962,0.2511775940836758,0.055154025875346076,0.028972824655245866,0.2869617237240738,0.03566529492455417,3.789755637709665e-07,0.31856618708246476,0.0181755829903978
15,0.9,4,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Within Florida’s Medicaid, do provider service networks reduce costs when compared to HMOs or primary care case management? PSNs have the potential to lower spending versus HMOs and primary care case management; however, actual savings depend on factors like the PSN’s operational efficiency.",3.789755637709665e-07,0.14977114030063365,0.11743055555555557,0.029014823436509962,0.21736553649538592,0.07943122837370242,0.028972824655245866,0.2869617237240738,0.03566529492455417,3.789755637709665e-07,0.31856618708246476,0.0181755829903978
15,0.9,5,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Do Florida Medicaid provider service networks achieve lower expenditures compared with HMOs or primary care case management? Provider Service Networks may lead to cost savings compared to HMOs and primary care case management, but these savings vary depending on factors such as the efficiency of the PSN.",2.8423167282822487e-07,0.1133326806482784,0.07876275510204082,0.02176111757738247,0.15207613855752378,0.059457931997282734,0.0217296184914344,0.19165154391974815,0.03566529492455417,2.8423167282822487e-07,0.2209277175185469,0.0181755829903978
15,0.9,6,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Are costs reduced by provider service networks in Florida’s Medicaid program relative to HMOs or primary care case management? Provider Service Networks might lower expenditures in comparison with HMOs and primary care case management, although the precise savings depend on various factors including the PSN's efficiency.",3.079176455639103e-07,0.13799041705037673,0.07688772390772691,0.023574544042164344,0.17594929174404683,0.05845475445079992,0.023540420032387266,0.21464106214444767,0.03566529492455417,3.079176455639103e-07,0.2444582149287413,0.0181755829903978
15,0.9,7,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Can provider service networks reduce expenses compared to HMOs or primary care case management in Florida’s Medicaid program? In Florida Medicaid, Provider Service Networks may potentially decrease spending compared to HMOs and primary care case management, contingent upon multiple factors like PSN efficiency.",3.789755637709665e-07,0.28179917469300575,0.026041666666666685,0.029014823436509962,0.2849896516719661,0.03109154693325919,0.028972824655245866,0.2869617237240738,0.03566529492455417,3.789755637709665e-07,0.31856618708246476,0.0181755829903978
15,0.9,8,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","In Florida Medicaid, do provider service networks incur lower costs than HMOs or primary care case management? Provider Service Networks have the potential to reduce expenditures when compared to HMOs and primary care case management, with actual savings dependent on elements such as the PSN’s efficiency.",3.079176455639103e-07,0.13799041705037673,0.07688772390772691,0.023574544042164344,0.17594929174404683,0.05845475445079992,0.023540420032387266,0.21464106214444767,0.03566529492455417,3.079176455639103e-07,0.2444582149287413,0.0181755829903978
15,0.9,9,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Do provider service networks in Florida’s Medicaid program lower expenditures relative to HMOs or primary care case management? Provider Service Networks might potentially result in decreased costs in comparison to HMOs and primary care case management, though the magnitude of savings depends on factors like PSN efficiency.",2.8423167282822487e-07,0.14346951458566704,0.057851435983872046,0.02176111757738247,0.15207613855752378,0.059457931997282734,0.0217296184914344,0.19165154391974815,0.03566529492455417,2.8423167282822487e-07,0.2209277175185469,0.0181755829903978
15,0.9,10,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Is there a cost advantage for provider service networks over HMOs or primary care case management in Florida’s Medicaid program? Provider Service Networks could lower expenditures compared to HMOs and primary care case management, but the exact amount saved is influenced by factors such as the efficiency of the PSN.",2.1317375462116866e-07,0.042773329899222556,0.08394290123456792,0.016320838183036854,0.08368679975017468,0.06221832667237916,0.0162972138685758,0.12569357612795207,0.03566529492455417,2.1317375462116866e-07,0.15348643672301465,0.0181755829903978
16,0.9,1,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage an effective treatment for postoperative cerebrospinal fluid fistula after spine surgery? Yes, lumbar drainage is typically an effective approach to managing cerebrospinal fluid leaks following spine surgery.",2.605457000925383e-07,0.18773451339864522,0.08542899408284023,0.019947691112600648,0.11808108039753584,0.14876033057851237,0.019918816950481588,0.19582357149890983,0.10380622837370242,2.6054570009253947e-07,0.2778865442919374,0.05387755102040818
16,0.9,2,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Does lumbar drainage effectively treat postoperative CSF fistula after spine surgery? Indeed, lumbar drainage is usually a dependable method for handling cerebrospinal fluid leaks post-spine surgery.",3.552895910352795e-07,0.24819653146655307,0.14756944444444445,0.027201396971728166,0.2722317602247948,0.14876033057851237,0.027162023114293082,0.3561662215740897,0.10380622837370242,3.552895910352811e-07,0.44494062895510433,0.05387755102040818
16,0.9,3,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage successful in treating cerebrospinal fluid fistula after spine surgery? Yes, it is commonly an effective technique for managing CSF leaks after spinal operations.",3.552895910352795e-07,0.19274475702175797,0.1875,0.027201396971728166,0.2722317602247948,0.14876033057851237,0.027162023114293082,0.3561662215740897,0.10380622837370242,3.552895910352811e-07,0.44494062895510433,0.05387755102040818
16,0.9,4,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Can lumbar drainage effectively manage postoperative cerebrospinal fluid fistula following spine surgery? Yes, lumbar drainage is generally considered an effective measure to treat CSF leaks after spine surgery.",3.079176455639089e-07,0.1671279514826618,0.15051775147928995,0.023574544042164407,0.1921890525512575,0.14876033057851237,0.023540420032387335,0.2727846126350393,0.10380622837370242,3.079176455639103e-07,0.35792925196547465,0.05387755102040818
16,0.9,5,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is the use of lumbar drainage efficient for postoperative CSF fistula after spine surgery? Yes, it is often an effective solution for controlling cerebrospinal fluid leaks subsequent to spine surgery.",2.605457000925383e-07,0.04432475190348484,0.1875,0.019947691112600648,0.11808108039753584,0.14876033057851237,0.019918816950481588,0.19582357149890983,0.10380622837370242,2.6054570009253947e-07,0.2778865442919374,0.05387755102040818
16,0.9,6,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Does lumbar drainage work well for postoperative cerebrospinal fluid fistula after spine surgery? Yes, it is a reliable and effective method for managing CSF leaks after spinal surgery.",3.079176455639089e-07,0.11578371588562852,0.1875,0.023574544042164407,0.1921890525512575,0.14876033057851237,0.023540420032387335,0.2727846126350393,0.10380622837370242,3.079176455639103e-07,0.35792925196547465,0.05387755102040818
16,0.9,7,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage a reliable method for treating cerebrospinal fluid fistula after spine surgery? Yes, lumbar drainage is usually effective in managing postoperative CSF leaks following spine procedures.",3.079176455639089e-07,0.1671279514826618,0.15051775147928995,0.023574544042164407,0.1921890525512575,0.14876033057851237,0.023540420032387335,0.2727846126350393,0.10380622837370242,3.079176455639103e-07,0.35792925196547465,0.05387755102040818
16,0.9,8,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage effective in resolving postoperative cerebrospinal fluid fistula after spine surgery? Yes, it generally serves as a reliable treatment for CSF leaks after spine surgery.",3.316036182995942e-07,0.2068430577577023,0.14909999999999998,0.025387970506946286,0.23140976570453997,0.14876033057851237,0.02535122157334021,0.3136066071552941,0.10380622837370242,3.316036182995957e-07,0.4004888663842703,0.05387755102040818
16,0.9,9,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage beneficial for postoperative cerebrospinal fluid fistula after spine surgery? Yes, lumbar drainage is typically an effective way to control CSF leaks following spinal surgery.",3.316036182995942e-07,0.2068430577577023,0.14909999999999998,0.025387970506946286,0.23140976570453997,0.14876033057851237,0.02535122157334021,0.3136066071552941,0.10380622837370242,3.316036182995957e-07,0.4004888663842703,0.05387755102040818
16,0.9,10,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage a successful technique for postoperative cerebrospinal fluid fistula after spine surgery? Yes, it is commonly effective in managing cerebrospinal fluid leaks after surgical spine treatment.",3.079176455639089e-07,0.1671279514826618,0.15051775147928995,0.023574544042164407,0.1921890525512575,0.14876033057851237,0.023540420032387335,0.2727846126350393,0.10380622837370242,3.079176455639103e-07,0.35792925196547465,0.05387755102040818
17,0.9,1,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Does differential symptom reporting explain why women have higher rates of depression? Differential symptom reporting does play a role, as women may be more inclined to report symptoms or seek assistance. However, it",1.894877818854824e-07,0.13650015374421853,0.060226757369614504,0.014507411718255009,0.1676555868053966,0.044166666666666694,0.014486412327622968,0.1634259169526584,0.05246913580246914,1.8948778188548325e-07,0.20615466749235,0.027006172839506164
17,0.9,2,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Are elevated depression rates in women due to differences in symptom reporting? Differences in symptom reporting contribute to higher depression rates among women since they might be more prone to report symptoms or seek help. However, this",9.47438909427412e-08,0.04759825061116496,0.03980435149266319,0.0072537058591274906,0.04118396717949002,0.047842176086120736,0.007243206163811473,0.03826277399865141,0.05246913580246914,9.474389094274162e-08,0.07694293601234303,0.027006172839506164
17,0.9,3,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Is the increased depression prevalence in women explained by their symptom reporting patterns? Differential symptom reporting partially accounts for the higher depression rates in women because women are often more likely to report symptoms or seek help. However, it",4.73719454713706e-08,0.04903063964086263,0.06997984378936759,0.0036268529295637453,0.053994294293033374,0.0763888888888889,0.003621603081905733,0.01889563984129694,0.05246913580246914,4.737194547137081e-08,0.01810243598940975,0.027006172839506164
17,0.9,4,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Can the higher depression rates in women be attributed to differences in how symptoms are reported? Reporting differences do partially explain women's higher depression rates, as they might be more likely to acknowledge symptoms or pursue help. However, it",4.73719454713706e-08,0.08551207019664941,0.09615241275472936,0.0036268529295637453,0.053994294293033374,0.0763888888888889,0.003621603081905733,0.01889563984129694,0.05246913580246914,4.737194547137081e-08,0.01810243598940975,0.027006172839506164
17,0.9,5,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Do differences in symptom reporting explain why women experience more depression? Symptom reporting differences contribute to the elevated depression rates in women, given that women may more readily report symptoms or seek assistance. However, it",1.421158364141118e-07,0.030005497920138513,0.09306422293435279,0.01088055878869125,0.06041605688471208,0.0763888888888889,0.01086480924571722,0.09888739581508688,0.05246913580246914,1.4211583641411244e-07,0.13946329299367655,0.027006172839506164
17,0.9,6,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Are women's higher depression rates the result of differential symptom reporting? Differential reporting of symptoms plays a role in women's higher depression rates since women tend to be more inclined to report symptoms or seek help. However, it",7.10579182070559e-08,0.017076991825933696,0.041999152602217385,0.005440279394345618,0.050421033290631634,0.02102556708958092,0.0054324046228586,0.04888364744311113,0.02392242299970098,7.105791820705622e-08,0.047089972862661256,0.027006172839506164
17,0.9,7,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Is the higher incidence of depression in women caused by differences in symptom reporting? Variations in symptom reporting do contribute to the greater depression rates among women, as they might be more likely to disclose symptoms or seek help. However, it",0.0,0.13862943611198908,0.09746541614673482,0.0,0.10663802777845222,0.0763888888888889,0.0,0.07296286111157313,0.05246913580246914,0.0,0.03746741516540242,0.027006172839506164
17,0.9,8,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Does the variation in symptom reporting account for increased depression rates in women? Differences in how symptoms are reported contribute to the elevated depression in women because they may be more willing to report symptoms or seek assistance. However, it",2.36859727356853e-08,0.14796898715569373,0.12244897959183673,0.0018134264647818726,0.08066254137519424,0.0763888888888889,0.0018108015409528666,0.04629461402941226,0.05246913580246914,2.3685972735685406e-08,0.010068440977287096,0.027006172839506164
17,0.9,9,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Could women's higher depression rates be explained by differential symptom reporting? Yes, differential symptom reporting partially explains the increased depression rates in women since they may be more likely to report symptoms or seek help. However, it",9.47438909427412e-08,0.009090073913390118,0.06708565779252876,0.0072537058591274906,0.001575556861778793,0.0763888888888889,0.007243206163811473,0.03826277399865141,0.05246913580246914,9.474389094274162e-08,0.07694293601234303,0.027006172839506164
17,0.9,10,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Is the disparity in depression rates between women and men due to differential symptom reporting? Differences in symptom reporting do partly explain why women report higher depression rates, as women might be more prone to report symptoms or seek help. However, it",2.3685972735685406e-08,0.19797940773035716,0.12244897959183673,0.0018134264647818726,0.13195583576274394,0.0763888888888889,0.0018108015409528666,0.0989383475148311,0.05246913580246914,2.3685972735685406e-08,0.06413566224756329,0.027006172839506164
18,0.9,1,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Is there a link between crime and the sale of syringes over the counter at pharmacies? Answer: Our research shows that OTC pharmacy syringe sales did not correlate with a rise in reported crimes in Los Angeles communities from 2006 to 2008.,2.1317375462116791e-07,0.3251798968847601,0.06035379812695108,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
18,0.9,2,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Does crime relate to over-the-counter syringe sales at pharmacies? Answer: Findings indicate that OTC pharmacy syringe sales were not connected to any increase in reported crime in Los Angeles local communities during 2006-2008.,0.0,0.042008920033936636,0.030080360626951082,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
18,0.9,3,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Are crime rates affected by over-the-counter syringe sales at pharmacies? Answer: Our results reveal no association between OTC pharmacy syringe sales and increases in reported crime in Los Angeles neighborhoods between 2006 and 2008.,2.36859727356853e-08,0.07309743965520443,0.030969041469467145,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
18,0.9,4,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Is there an association between crime and the sale of syringes without prescriptions at pharmacies? Answer: The data suggests that OTC syringe sales at pharmacies did not lead to higher reported crime in local Los Angeles areas during 2006-2008.,1.421158364141118e-07,0.2510719247310367,0.06035379812695108,0.010880558788691257,0.17185025692666,0.0,0.010864809245717227,0.17693070815907896,0.0,1.4211583641411244e-07,0.18232155679395534,0.0
18,0.9,5,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Does the sale of syringes over the counter at pharmacies contribute to crime? Answer: Evidence from 2006-2008 in Los Angeles shows no link between OTC pharmacy syringe sales and increased reported crime in the community.,4.73719454713706e-08,0.14285834009080567,0.06035379812695108,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
18,0.9,6,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Is there a connection between crime and over-the-counter sales of pharmacy syringes? Answer: Our findings indicate that OTC pharmacy syringe sales were not linked to increased crime reports in Los Angeles localities during 2006 to 2008.,7.10579182070559e-08,0.17102921705750251,0.06035379812695108,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
18,0.9,7,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Are over-the-counter pharmacy syringe sales associated with crime levels? Answer: The study found no association between OTC pharmacy syringe sales and increased crime in Los Angeles communities from 2006 through 2008.,4.73719454713706e-08,0.0679408627921636,0.0038554765460572307,0.003626852929563759,0.11074833317490107,0.033293697978596916,0.003621603081905747,0.06669137449867346,0.0,4.737194547137081e-08,0.06899287148695077,0.0
18,0.9,8,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Is crime connected to the sale of syringes over the counter at pharmacies? Answer: Our analysis shows OTC pharmacy syringe sales did not correspond with increases in reported crime in local Los Angeles communities during the years 2006 to 2008.,1.658018091497971e-07,0.2763897327153284,0.06035379812695108,0.01269398525347313,0.19782574332991798,0.0,0.012675610786670094,0.20359895524123983,0.0,1.6580180914979784e-07,0.20972053098207066,0.0
18,0.9,9,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Do over-the-counter pharmacy syringe sales relate to crime rates? Answer: Research demonstrates no link between OTC syringe sales at pharmacies and rises in reported crime in Los Angeles neighborhoods during 2006-2008.,4.73719454713706e-08,0.023221689852812144,0.02813157590472888,0.003626852929563759,0.06453852113757153,0.0,0.003621603081905747,0.06669137449867346,0.0,4.737194547137081e-08,0.06899287148695077,0.0
18,0.9,10,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Is there a relationship between crime and the over-the-counter sale of syringes at pharmacies? Answer: The findings confirm that OTC pharmacy syringe sales were not associated with an increase in reported crime in local Los Angeles communities between 2006 and 2008.,1.894877818854825e-07,0.3010823453057001,0.06035379812695108,0.014507411718255002,0.2231435513142097,0.0,0.01448641232762296,0.2295744416444978,0.0,1.8948778188548325e-07,0.23638877806423153,0.0
19,0.9,1,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is expert breast pathology evaluation required for the treatment of ductal carcinoma in situ? Answer: Yes, expert breast pathology evaluation is crucial in the management of ductal carcinoma in situ (DCIS).",4.73719454713706e-08,0.03739260602116623,0.017469444444444454,0.003626852929563759,0.0326851620290487,0.024577514792899408,0.003621603081905747,0.027196691915736704,0.03160485710343262,4.737194547137081e-08,0.07410797215372167,0.0
19,0.9,2,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is specialized breast pathology assessment important for handling ductal carcinoma in situ? Answer: Absolutely, specialized breast pathology assessment is vital for effective management of ductal carcinoma in situ (DCIS).",0.0,0.0,0.0,0.0,0.0,1.3877787807814457e-17,0.0,0.0,0.0,0.0,0.0,0.0
19,0.9,3,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Should expert breast pathology analysis be used in the management of ductal carcinoma in situ? Answer: Yes, using expert breast pathology analysis is necessary for managing ductal carcinoma in situ (DCIS).",4.73719454713706e-08,0.08211177896051769,0.009605111768573316,0.003626852929563759,0.07889497406637869,0.006834567901234573,0.003621603081905747,0.07499994574745683,0.0025434730105059547,4.737194547137081e-08,0.07410797215372167,0.0
19,0.9,4,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is it necessary to have expert breast pathology review for managing ductal carcinoma in situ? Answer: Definitely, expert breast pathology review plays an essential role in the management of ductal carcinoma in situ (DCIS).",1.184298636784265e-07,0.19421414597654163,0.02224327850442598,0.009067132323909398,0.1868078298808844,0.015599999999999989,0.009054007704764368,0.17792157360743266,0.005764766730907742,1.1842986367842703e-07,0.17589066646366414,0.0
19,0.9,5,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is expert assessment in breast pathology required for treating ductal carcinoma in situ? Answer: Yes, expert assessment in breast pathology is fundamental for the management of ductal carcinoma in situ (DCIS).",4.73719454713706e-08,0.03739260602116623,0.017469444444444426,0.003626852929563759,0.03268516202904914,0.024577514792899408,0.003621603081905747,0.027196691915736704,0.03160485710343262,4.737194547137081e-08,0.02459745925658252,0.035665294924554176
19,0.9,6,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Does managing ductal carcinoma in situ require expert breast pathology evaluation? Answer: Yes, expert breast pathology evaluation is indispensable for managing ductal carcinoma in situ (DCIS).",7.10579182070559e-08,0.19009710614174846,0.04506944444444441,0.005440279394345639,0.18660424439477064,0.04859501133786848,0.005432404622858621,0.18196333015267374,0.045662379578463495,7.105791820705622e-08,0.18287598996711107,0.04338842975206613
19,0.9,7,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is expert breast pathology consultation necessary for the treatment of ductal carcinoma in situ? Answer: Yes, consultation with expert breast pathology is critical for the management of ductal carcinoma in situ (DCIS).",7.10579182070559e-08,0.07752614926187462,0.012584237343852722,0.005440279394345639,0.11615671418330509,0.00993673469387757,0.005432404622858621,0.11049493921752918,0.003688550542113131,7.105791820705622e-08,0.10919929196499067,0.0
19,0.9,8,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is expert breast pathology input essential for managing ductal carcinoma in situ? Answer: Yes, expert input in breast pathology is essential for the effective management of ductal carcinoma in situ (DCIS).",4.73719454713706e-08,0.12683095189986915,0.038730281207133066,0.003626852929563759,0.17131459814103778,0.07230630202140312,0.003621603081905747,0.12280319957917696,0.03698224852071005,4.737194547137081e-08,0.07410797215372167,0.0
19,0.9,9,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is specialized pathology expertise required for breast cancer in situ management? Answer: Yes, specialized breast pathology expertise is necessary for managing ductal carcinoma in situ (DCIS).",7.10579182070559e-08,0.023178949415156858,0.08854166666666667,0.005440279394345639,0.035202853384412425,0.10560000000000003,0.005432404622858621,0.06643880005935099,0.03698224852071005,7.105791820705622e-08,0.1226023220923329,0.0
19,0.9,10,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Should ductal carcinoma in situ be managed with the help of expert breast pathology assessment? Answer: Yes, management of ductal carcinoma in situ (DCIS) requires expert breast pathology assessment.",0.0,0.0,2.7755575615628914e-17,0.0,8.881784197001252e-16,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20,0.9,1,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is there a first night effect on sleep bruxism? The findings indicated no significant first night impact on RMMA frequency severity in young, healthy individuals with sleep bruxism. For clinical purposes, a single night of sleep recording may suffice for patients with moderate to high RMMA frequency. However, low RMMA frequency observed on the first night should be verified.",7.105791820705622e-08,0.13312913958235928,0.06033766922184626,0.005440279394345618,0.131083574665825,0.05536332179930796,0.0054324046228586,0.08121627456264946,0.018860946745562133,7.105791820705622e-08,0.056089466651043196,0.0
20,0.9,2,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Does the first night influence sleep bruxism? The data revealed no general first night effect on the severity of RMMA frequency in young, healthy sleep bruxism patients. Clinically, a one-night sleep study might be adequate for those with moderate to high RMMA frequency, but low RMMA frequency during the initial night requires confirmation.",7.105791820705622e-08,0.05133723419580116,0.10987155351936687,0.005440279394345618,0.0198579395556,0.05536332179930796,0.0054324046228586,0.03211241074435467,0.018860946745562133,7.105791820705622e-08,0.05942342047080107,0.0
20,0.9,3,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is there a first night effect on sleep bruxism severity? Results demonstrated no overall effect on the frequency of RMMA in healthy young patients during the first night. Thus, one-night sleep recordings might be enough for patients with moderate to high RMMA frequencies, although low frequency during the first night should be confirmed.",7.105791820705622e-08,0.0019817796934256116,0.071882664630478,0.005440279394345618,0.007324302819299522,0.03576332179930797,0.0054324046228586,0.03211241074435467,0.018860946745562133,7.105791820705622e-08,0.05942342047080107,0.0
20,0.9,4,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Does sleep bruxism show a first night effect? The study found no overall first night influence on RMMA frequency severity in young, healthy individuals with bruxism. Clinically, one night of sleep measurement may be sufficient for patients with moderate to high RMMA frequency, but low frequency on the first night should be validated.",7.105791820705622e-08,0.04127476989263679,0.06987155351936691,0.005440279394345618,0.0198579395556,0.05536332179930796,0.0054324046228586,0.03211241074435467,0.018860946745562133,7.105791820705622e-08,0.05942342047080107,0.0
20,0.9,5,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is the first night effect present in sleep bruxism? Results indicated no overall first night effect on RMMA frequency severity among young, healthy patients. One-night sleep recordings could be adequate for patients with moderate to high SB frequency in clinical settings, although low first night RMMA frequency must be confirmed.",1.4211583641411244e-07,0.0786125925540202,0.022839454753934757,0.010880558788691236,0.06964781478416482,0.034539419581109676,0.0108648092457172,0.0939878144624422,0.018860946745562133,1.4211583641411244e-07,0.12260232209233335,0.0
20,0.9,6,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is there an initial night effect on sleep bruxism? Findings showed no significant overall effect on RMMA frequency severity during the first night in healthy young SB patients. For clinical usage, a single night of sleep recording may be sufficient for those with moderate to high RMMA frequency, but low frequency on the first night needs confirmation.",2.3685972735685406e-08,0.10449845089304066,0.09487176711851247,0.0018134264647818726,0.070160140043384,0.03718773880891016,0.0018108015409528666,0.044848630391775224,0.018860946745562133,2.3685972735685406e-08,0.0190481949706931,0.0
20,0.9,7,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Does the first night affect sleep bruxism severity? The results showed no overall impact on RMMA frequency in young, healthy patients during the first night. Clinically, one night of recording might suffice for moderate to high frequency patients, but low RMMA frequency observed on the first night should be confirmed.",1.4211583641411244e-07,0.0786125925540202,0.022839454753934757,0.010880558788691236,0.06964781478416482,0.034539419581109676,0.0108648092457172,0.0939878144624422,0.018860946745562133,1.4211583641411244e-07,0.12260232209233335,0.0
20,0.9,8,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is there a first-night influence on sleep bruxism? The study's results demonstrated no overall first night effect on RMMA frequency severity in young healthy patients with SB. Clinically, a single night sleep recording is likely enough for moderate to high frequency SB patients, but low RMMA frequency on the first night should be checked.",4.737194547137081e-08,0.0713914482964797,0.11059373729483786,0.0036268529295637453,0.0392760254127027,0.05536332179930796,0.003621603081905733,0.012309783448174905,0.018860946745562133,4.737194547137081e-08,0.03922071315328246,0.0
20,0.9,9,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is a first night effect seen in sleep bruxism? The findings revealed no general first night effect on the severity of RMMA frequency in young, healthy patients. For clinical practice, one-night sleep recordings may suffice for those with moderate to high frequency of SB; however, low RMMA frequency in the initial night should be validated.",2.3685972735685406e-08,0.039708104873808825,0.0746715535193669,0.0018134264647818726,0.006011225624154459,0.017685505574778937,0.0018108015409528666,0.007108302408927791,0.018860946745562133,2.3685972735685406e-08,0.019418085857102696,0.0
20,0.9,10,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is there an effect of the first night on sleep bruxism? Results showed no overall first night impact on RMMA frequency severity among young, healthy SB patients. Clinically, one night of sleep recording might be sufficient for patients with moderate to high RMMA frequency, but low frequency on the first night should be confirmed.",4.737194547137081e-08,0.03536234443073605,0.0518715535193669,0.0036268529295637453,0.01261651846808931,0.03613994617454825,0.003621603081905733,0.012309783448174905,0.018860946745562133,4.737194547137081e-08,0.03922071315328246,0.0
21,0.9,1,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access major surgery cause less pain in newborns? Minimal access surgery for repairing esophageal atresia or congenital diaphragmatic hernia does not result in lower total opioid consumption.,9.47438909427412e-08,0.13972020673666385,0.004447813134751871,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
21,0.9,2,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is pain reduced in newborns after minimal access major surgery? The use of minimal access surgery to fix esophageal atresia or congenital diaphragmatic hernia does not lead to decreased overall opioid doses.,2.36859727356853e-08,0.033146172468933255,0.0010047404324198955,0.0018134264647818796,0.0327898228229917,0.0,0.0018108015409528735,0.03390155167568176,0.0,2.3685972735685406e-08,0.035091319811269006,0.0
21,0.9,3,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,"Does undergoing minimal access major surgery mean less pain for newborns? For esophageal atresia or congenital diaphragmatic hernia repairs, minimal access surgery is not linked to reduced cumulative opioid usage.",7.10579182070559e-08,0.10292162785997583,0.003221293720401787,0.005440279394345639,0.10178269430994247,0.0,0.005432404622858621,0.10536051565782545,0.0,7.105791820705622e-08,0.10919929196499067,0.0
21,0.9,4,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is there less pain with minimal access major surgery in newborns? Repairing esophageal atresia or congenital diaphragmatic hernia through minimal access surgery does not correlate with a lower amount of opioids given.,2.36859727356853e-08,0.033146172468933255,0.0010047404324198955,0.0018134264647818796,0.0327898228229917,0.0,0.0018108015409528735,0.03390155167568176,0.0,2.3685972735685406e-08,0.035091319811269006,0.0
21,0.9,5,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access surgery cause less pain in newborns? Minimal access procedures for esophageal atresia or congenital diaphragmatic hernia repair don’t reduce the total opioid dosage needed.,1.421158364141118e-07,0.21763667988247315,0.007182518210197705,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
21,0.9,6,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access major surgery result in less pain for newborns? Minimal access surgery to correct esophageal atresia or congenital diaphragmatic hernia does not decrease the total opioid dosage administered.,7.10579182070559e-08,0.10292162785997583,0.003221293720401787,0.005440279394345639,0.10178269430994247,0.0,0.005432404622858621,0.10536051565782545,0.0,7.105791820705622e-08,0.10919929196499067,0.0
21,0.9,7,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Are newborns less hurt by minimal access major surgery? Minimal access surgery for esophageal atresia or congenital diaphragmatic hernia repair is not associated with diminished cumulative opioid doses.,1.184298636784265e-07,0.17792157360743266,0.005764766730907742,0.009067132323909398,0.17589066646366414,0.0,0.009054007704764368,0.1823215567939549,0.0,1.1842986367842703e-07,0.18924199963852795,0.0
21,0.9,8,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,"Does minimal access surgery reduce pain in newborn major surgeries? In repairing esophageal atresia or congenital diaphragmatic hernia, minimal access surgery does not lower overall opioid usage.",1.421158364141118e-07,0.2709556937716999,0.045171407099086576,0.010880558788691277,0.2705631540617417,0.03993055555555556,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
21,0.9,9,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is there less pain after minimal access major surgery in newborns? The cumulative opioid dose for esophageal atresia or congenital diaphragmatic hernia repair via minimal access surgery remains unchanged.,9.47438909427412e-08,0.13972020673666385,0.004447813134751871,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
21,0.9,10,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,"Does minimal access major surgery cause less pain in newborns? For repairing esophageal atresia or congenital diaphragmatic hernia, minimal access surgery does not reduce the total amount of opioids required.",7.10579182070559e-08,0.10292162785997583,0.003221293720401787,0.005440279394345639,0.10178269430994247,0.0,0.005432404622858621,0.10536051565782545,0.0,7.105791820705622e-08,0.10919929196499067,0.0
22,0.9,1,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Is family practice at residency teaching sites representative of community practice? Answer: Yes, family practice at these teaching sites usually mirrors community practice. Residency programs aim to ready physicians for community work by familiarizing them with prevalent health concerns.",2.36859727356853e-08,0.041330959377241516,0.04606009070294784,0.0018134264647818726,0.07972712007889182,0.07492792295881102,0.0018108015409528666,0.08277604458519949,0.0783673469387755,2.3685972735685406e-08,0.0475358561426904,0.05387755102040818
22,0.9,2,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Does the family practice seen at residency teaching sites mirror that of community practice? Answer: Yes, family practice in residency teaching environments often reflects what is found in community practice. These residency programs prepare doctors by exposing them to typical health problems in the community.",1.1842986367842703e-07,0.22945674807992944,0.07810068321541705,0.009067132323909363,0.2628120248265535,0.1012244897959184,0.009054007704764333,0.2330582476345362,0.0783673469387755,1.1842986367842703e-07,0.201686535969948,0.05387755102040818
22,0.9,3,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Is the family practice at residency teaching sites similar to community practice? Answer: Yes, family practice at residency teaching sites commonly corresponds to community practice. Residency training is structured to ready physicians for community-based care by introducing them to frequent health issues.",4.737194547137081e-08,0.024034907720861032,0.016439909297052135,0.0036268529295637453,0.056946227259440096,0.0048037447265246586,0.003621603081905733,0.05676550897091914,0.0038604075669712717,4.737194547137081e-08,0.056486545297256274,0.0027453377260327275
22,0.9,4,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Does family practice at residency teaching sites align with community practice? Answer: Yes, family practice within residency teaching sites frequently aligns with community practice. These programs train physicians by providing exposure to common health challenges faced in the community.",2.36859727356853e-08,0.005784950117757592,0.02122448979591833,0.0018134264647818726,0.07972712007889182,0.07492792295881102,0.0018108015409528666,0.08277604458519949,0.0783673469387755,2.3685972735685406e-08,0.0475358561426904,0.05387755102040818
22,0.9,5,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Is the family practice model at residency teaching sites reflective of community practice? Answer: Yes, family practice in residency teaching settings often reflects community practice. Residency programs are crafted to prepare physicians for community health by involving them with usual health conditions.",4.737194547137081e-08,0.15606294211323313,0.07494897959183672,0.0036268529295637453,0.19219445761259957,0.1012244897959184,0.003621603081905733,0.16073758605491006,0.0783673469387755,4.737194547137081e-08,0.12757856381622457,0.05387755102040818
22,0.9,6,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Does the family practice conducted at residency teaching sites represent community practice? Answer: Yes, family practice at these sites usually represents community practice. Residency education focuses on preparing doctors for community roles by exposing them to typical health issues.",2.36859727356853e-08,0.11242297789620981,0.09682571089377578,0.0018134264647818726,0.11620855063467816,0.1012244897959184,0.0018108015409528666,0.08277604458519949,0.0783673469387755,2.3685972735685406e-08,0.0475358561426904,0.05387755102040818
22,0.9,7,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Is family practice at residency teaching sites indicative of community practice? Answer: Yes, family practice at residency teaching sites often indicates community practice. Residency programs are designed to equip physicians by highlighting common health concerns in community settings.",4.73719454713706e-08,0.06041365202649773,0.006109330784655448,0.0036268529295637453,0.060329357109093706,0.00529525308746083,0.003621603081905733,0.06014745969624036,0.004277281160398036,4.737194547137081e-08,0.059851841459428456,0.003055415003466927
22,0.9,8,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Does family practice at residency teaching sites correspond to community practice? Answer: Yes, family practice at residency teaching sites often corresponds with community practice. Residency training programs prepare physicians by presenting them with the common health problems encountered in the community.",2.3685972735685406e-08,0.02891911978890782,0.002850214159737921,0.0018134264647818726,0.028872408910239677,0.002459057697152947,0.0018108015409528666,0.02878175029216612,0.001978458049886611,2.3685972735685406e-08,0.028640216301393462,0.001408415217939038
22,0.9,9,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Is family practice at residency teaching sites consistent with community practice? Answer: Yes, family practice at these sites is generally consistent with community practice. Residency programs aim to train physicians for community healthcare by exposing them to prevalent health issues.",0.0,0.03465735902799727,0.023683547493071277,0.0,0.07109201851896785,0.05009227650154295,0.0,0.10944429166736036,0.0783673469387755,0.0,0.07493483033080572,0.05387755102040818
22,0.9,10,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Does family practice at residency teaching sites reflect the reality of community practice? Answer: Yes, family practice at residency teaching sites typically reflects community practice. Residency programs prepare doctors by ensuring exposure to the common health concerns seen in community settings.",2.3685972735685406e-08,0.02891911978890782,0.002850214159737921,0.0018134264647818726,0.028872408910239677,0.002459057697152947,0.0018108015409528666,0.02878175029216612,0.001978458049886611,2.3685972735685406e-08,0.028640216301393462,0.001408415217939038
23,0.9,1,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Does the length of psychological treatment for depression influence the likelihood of returning to therapy? Yes, longer treatment periods for depression may be linked to a higher chance of needing repeat treatments due to the severity or chronic nature of the condition, though individual responses and other factors also play a role.",1.4211583641411244e-07,0.03183879844187931,0.10079999999999999,0.010880558788691236,0.014307659512725834,0.07100591715976332,0.0108648092457172,0.03989683106075903,0.05436390532544381,1.4211583641411244e-07,0.06643880005935054,0.036982248520710054
23,0.9,2,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is there a connection between the duration of depression therapy and the possibility of reentering treatment? Indeed, extended treatment durations can be associated with a higher probability of returning for therapy, particularly in cases of severe or persistent depression, but this also varies based on patient-specific factors.",2.6054570009253947e-07,0.04416319541845182,0.12039999999999998,0.0199476911126006,0.11966817517055173,0.07100591715976332,0.019918816950481533,0.14752749525312403,0.05436390532544381,2.6054570009253947e-07,0.1764396952736793,0.036982248520710054
23,0.9,3,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Can the length of psychological treatment for depression affect whether a patient returns for further treatment? Yes, prolonged therapy may reflect more severe or chronic depression, which can lead to subsequent treatment needs, subject to individual differences and other variables.",4.263475092423372e-07,0.20924294577790192,0.12039999999999998,0.03264167636607371,0.2887445052144848,0.07100591715976332,0.0325944277371516,0.32079921652716026,0.05436390532544381,4.263475092423373e-07,0.35412087251113133,0.036982248520710054
23,0.9,4,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is the duration of treatment for depression linked to the chance of undergoing treatment again? Yes, longer therapies may suggest more intensive or ongoing depression requiring repeated sessions, though this relationship depends on the patient and other circumstances.",4.737194547137078e-07,0.26188667926332077,0.12039999999999998,0.03626852929563745,0.342811726484761,0.07100591715976332,0.03621603081905733,0.3763690676819724,0.05436390532544381,4.737194547137081e-07,0.4112792863510797,0.036982248520710054
23,0.9,5,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Does how long a psychological treatment lasts for depression relate to the likelihood of re-treatment? Yes, longer treatment durations often indicate more serious or long-term depression, which could result in the patient returning for additional therapy, influenced by individual and external factors.",3.789755637709665e-07,0.1592325252032385,0.12039999999999998,0.029014823436509962,0.2374512108269351,0.07100591715976332,0.028972824655245866,0.2681554830417414,0.05436390532544381,3.789755637709665e-07,0.30005365124085515,0.036982248520710054
23,0.9,6,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is the time spent in psychological treatment for depression connected to the return for further treatment? Yes, extended durations might be connected to more severe depression cases, increasing the chance of repeated therapy, influenced by patient response and other elements.",4.263475092423372e-07,0.24478895503738585,0.09477673130193903,0.03264167636607371,0.2887445052144848,0.07100591715976332,0.0325944277371516,0.32079921652716026,0.05436390532544381,4.263475092423373e-07,0.35412087251113133,0.036982248520710054
23,0.9,7,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","How does the duration of depression treatment relate to the chances of returning to therapy? Treatment length can be related; longer periods may point to chronic or severe conditions needing multiple treatment episodes, though outcomes vary by patient and other influences.",4.026615365066519e-07,0.1839251377936102,0.12039999999999998,0.030828249901291835,0.26276901881122683,0.07100591715976332,0.030783626196198732,0.2941309694449994,0.05436390532544381,4.026615365066519e-07,0.326721898323016,0.036982248520710054
23,0.9,8,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is the duration of psychological treatment for depression associated with returning to treatment? Yes, prolonged treatment may be linked to recurrent therapy due to severity or chronicity, but individual patient factors and other aspects also impact this relationship.",4.737194547137078e-07,0.26188667926332077,0.12039999999999998,0.03626852929563745,0.342811726484761,0.07100591715976332,0.03621603081905733,0.3763690676819724,0.05436390532544381,4.737194547137081e-07,0.4112792863510797,0.036982248520710054
23,0.9,9,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Does the length of therapy for depression have a bearing on the likelihood of subsequent treatment? Yes, longer treatment could indicate severe or persistent depression requiring repeat intervention, contingent on personal and other factors.",5.68463345656449e-07,0.3762970304410662,0.12039999999999998,0.043522235154764964,0.4605947621411448,0.07100591715976332,0.043459236982868826,0.4977299246862392,0.05436390532544381,5.684633456564497e-07,0.5364424293050867,0.036982248520710054
23,0.9,10,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is there a relationship between the length of depression treatment and returning to therapy? Yes, extended treatments can be related to recurring therapy sessions for severe or chronic depression, depending on patient-specific responses and other influencing factors.",4.974054274493931e-07,0.2892856534514361,0.12039999999999998,0.038081955760419325,0.37098260345145784,0.07100591715976332,0.038026832360010206,0.40535660455522393,0.05436390532544381,4.974054274493935e-07,0.44113224950076146,0.036982248520710054
24,0.9,1,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Is it possible for a new surgical method targeting the temporomandibular joint to enhance access and minimize complications? Answer: The VMPA offers direct access and excellent visibility to the TMJ area, producing good aesthetic and functional outcomes. It is deemed the preferred approach for typical TMJ surgeries.",2.3685972735685406e-08,0.06497549619081244,0.06137808745645146,0.0018134264647818726,0.007989419483715121,0.021266540642722105,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
24,0.9,2,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can a novel surgical technique for the temporomandibular joint improve surgical access and reduce risks? Answer: The VMPA provides direct entry and clear visualization of the TMJ region, resulting in favorable esthetic and functional results. It is considered the go-to method for standard TMJ operations.",7.105791820705622e-08,0.05098600895575256,0.08264462809917356,0.005440279394345618,0.0364623430871176,0.021266540642722105,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
24,0.9,3,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Does a new surgical approach to the temporomandibular joint enhance access and lower complications? Answer: The VMPA allows direct access and optimal visibility of the TMJ, achieving good cosmetic and functional effects. It can be regarded as the recommended approach for common TMJ procedures.",9.474389094274162e-08,0.0029935369217577446,0.05992964702832444,0.0072537058591274906,0.05945186131181712,0.021266540642722105,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
24,0.9,4,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can a recently developed surgical approach to the TMJ improve access and decrease complications? Answer: The VMPA facilitates direct access and provides excellent visibility to the TMJ region, delivering positive esthetic and functional results. It is viewed as the preferred technique for routine TMJ surgeries.",7.105791820705622e-08,0.04143361511890653,0.016318097486928668,0.005440279394345618,0.06796903311257019,0.0014484404281270048,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
24,0.9,5,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Is a novel TMJ surgical approach capable of improving access and minimizing complications? Answer: The VMPA ensures direct access and favorable visibility around the TMJ, offering good esthetic and functional outcomes. This approach is often considered the best option for usual TMJ surgical interventions.",9.474389094274162e-08,0.03450022694720989,0.03729315417627106,0.0072537058591274906,0.05945186131181712,0.021266540642722105,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
24,0.9,6,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can an innovative surgical approach to the temporomandibular joint enhance access and reduce complication risks? Answer: The VMPA grants direct access and clear visibility to the TMJ area, yielding satisfactory esthetic and functional outcomes. It is typically regarded as the method of choice for typical TMJ surgeries.",2.3685972735685406e-08,0.03547987148613396,0.040175492296704425,0.0018134264647818726,0.007989419483715121,0.021266540642722105,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
24,0.9,7,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Does the VMPA provide improved access and fewer complications for TMJ surgeries? Answer: Yes, the VMPA offers direct access with excellent visibility in the TMJ region, resulting in good esthetic and functional results. It is commonly accepted as the preferred approach for standard TMJ surgeries.",7.105791820705622e-08,0.020179467597532863,0.06043388429752067,0.005440279394345618,0.0364623430871176,0.021266540642722105,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
24,0.9,8,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can the new VMPA surgical technique improve temporomandibular joint access and lower complications? Answer: The VMPA allows for direct access and provides favorable visibility, leading to good esthetic and functional results. It is considered the favored approach for regular TMJ surgeries.",1.6580180914979784e-07,0.07591647169854898,0.058269628099173555,0.012693985253473108,0.13177252289144326,0.021266540642722105,0.012675610786670066,0.1650797503594501,0.0,1.6580180914979784e-07,0.16907633004393308,0.0
24,0.9,9,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Is the VMPA an effective surgical approach to improve access and reduce complications in TMJ surgeries? Answer: Through direct access and clear visibility of the TMJ area, the VMPA achieves positive esthetic and functional outcomes, making it the approach of choice for common TMJ operations.",7.105791820705622e-08,0.010627073760686834,0.03829633172275387,0.005440279394345618,0.0364623430871176,0.021266540642722105,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
24,0.9,10,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Could a novel surgical procedure for the temporomandibular joint enhance accessibility and reduce adverse outcomes? Answer: The VMPA enables direct exposure and good visibility of the TMJ, producing beneficial esthetic and functional results, and is considered the leading approach for routine TMJ surgeries.",1.1842986367842703e-07,0.0055236348789953205,0.08264462809917356,0.009067132323909363,0.08298235872201154,0.021266540642722105,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
25,0.9,1,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French laypersons and healthcare professionals consider it acceptable to violate confidentiality to protect a patient's wife from a sexually transmitted infection? Most people in France base their opinion on situational factors when determining if a doctor should breach confidentiality to safeguard the spouse of an STD-infected patient.,9.474389094274162e-08,0.029626928594246316,0.0373272093572779,0.0072537058591274906,0.027929834494255346,0.039930555555555566,0.007243206163811466,0.0568660866847992,0.020399305555555556,9.474389094274162e-08,0.08701137698962924,0.0
25,0.9,2,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Are French non-professionals and medical professionals in favor of breaching confidentiality to protect a wife from an STD? In France, most individuals weigh situational elements when deciding if a physician should break confidentiality to protect the partner of a patient with an STD.",2.1317375462116866e-07,0.1786233045124419,0.011093749999999986,0.016320838183036854,0.1768112218673319,0.015555555555555566,0.0162972138685758,0.17464912234118257,0.020399305555555556,2.1317375462116866e-07,0.20763936477824663,0.0
25,0.9,3,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Is it acceptable among French health workers and laypeople to breach confidentiality for the sake of a patient's wife exposed to a sexually transmitted disease? The majority of people in France consider the specific circumstances before concluding if a doctor should disclose confidential information to protect a patient's spouse with an STD.,0.0,0.054364484749799935,0.03899375000000001,0.0,0.05545177444479554,0.039930555555555566,0.0,0.028291721655508084,0.020399305555555556,0.0,0.0,0.0
25,0.9,4,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Do French health professionals and the general public find it justifiable to break confidentiality to protect a patient’s wife from sexually transmitted infections? In France, decisions often depend on situational contexts when assessing if a doctor should reveal confidential information to protect the spouse of an infected patient.",9.474389094274162e-08,0.029626928594246316,0.0373272093572779,0.0072537058591274906,0.027929834494255346,0.039930555555555566,0.007243206163811466,0.0568660866847992,0.020399305555555556,9.474389094274162e-08,0.08701137698962924,0.0
25,0.9,5,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Does the French public, including health professionals, accept breaching confidentiality to protect a patient's wife from an STD? Most French people rely on situational factors to decide whether a doctor should breach confidentiality for the sake of a spouse exposed to sexually transmitted diseases.",1.8948778188548325e-07,0.08907878990606344,0.05859375,0.014507411718254981,0.118901612699982,0.039930555555555566,0.014486412327622933,0.14995650975081087,0.020399305555555556,1.8948778188548325e-07,0.1823215567939549,0.0
25,0.9,6,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Are French healthcare providers and lay individuals agreeable to compromising confidentiality to shield a patient's wife from a sexually transmitted infection? The French generally consider the situation's specifics before deciding if confidentiality should be broken to protect the spouse of an infected patient.,2.1317375462116866e-07,0.11260928731625786,0.05859375,0.016320838183036854,0.14299916427904202,0.039930555555555566,0.0162972138685758,0.17464912234118257,0.020399305555555556,2.1317375462116866e-07,0.20763936477824663,0.0
25,0.9,7,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French laypeople and medical experts find it appropriate to violate confidentiality to protect a patient’s wife from a sexually transmitted infection? Most French citizens evaluate the context when determining if a physician should breach confidentiality to protect a patient's partner with an STD.,1.8948778188548325e-07,0.1857970011469865,0.010781249999999992,0.014507411718254981,0.18491562989616606,0.007569444444444448,0.014486412327622933,0.18376856733910074,0.003975694444444445,1.8948778188548325e-07,0.1823215567939549,0.0
25,0.9,8,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Is breaching confidentiality to protect a patient’s wife from an STD deemed acceptable by French health professionals and laypeople? In France, the decision usually hinges on the circumstances influencing whether a doctor should disclose private information to safeguard the spouse of an infected patient.",1.8948778188548325e-07,0.08907878990606344,0.05859375,0.014507411718254981,0.118901612699982,0.039930555555555566,0.014486412327622933,0.14995650975081087,0.020399305555555556,1.8948778188548325e-07,0.1823215567939549,0.0
25,0.9,9,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French health professionals and citizens find it acceptable to disclose confidential information to protect a patient's wife from a sexually transmitted disease? The majority in France take situational factors into account when deciding if a doctor should break confidentiality to protect the spouse of a patient with an STD.,4.737194547137081e-08,0.013249670855493001,0.03819444444444445,0.0036268529295637453,0.014629779924541175,0.039930555555555566,0.003621603081905733,0.013380974745060836,0.020399305555555556,4.737194547137081e-08,0.04255961441879652,0.0
25,0.9,10,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French lay and professional health workers support breaching confidentiality to protect a patient's wife from sexually transmitted infections? Most people in France consider the context when deciding if confidentiality should be breached by a physician to protect the patient's spouse.,2.6054570009253947e-07,0.19605681051368595,0.03361018655489808,0.0199476911126006,0.19300958485370545,0.039930555555555566,0.019918816950481533,0.22594241672873228,0.020399305555555556,2.6054570009253947e-07,0.26028309826366547,0.0
26,0.9,1,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Is the insertion allele of the ACE gene I/D polymorphism a potential candidate gene for insulin resistance? Answer: Yes, research suggests the insertion allele (I) of the ACE gene I/D polymorphism could be a candidate gene for insulin resistance due to its association with increased risk.",9.474389094274162e-08,0.10749107608896225,0.013117283950617259,0.0072537058591274906,0.1027615462592899,0.011388119421360393,0.007243206163811466,0.09751360699811418,0.007355371900826427,9.474389094274162e-08,0.09443504410108705,0.003931816011927075
26,0.9,2,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Could the insertion allele of the ACE gene I/D polymorphism be linked to insulin resistance? Answer: Indeed, the insertion allele (I) of the ACE gene I/D polymorphism may serve as a candidate gene for insulin resistance, supported by studies showing its correlation with higher risk.",1.1842986367842703e-07,0.0437474329413865,0.03722299168975071,0.009067132323909363,0.06712206273106824,0.027120315581854043,0.009054007704764333,0.09119457636192774,0.013269628099173578,1.1842986367842703e-07,0.11950075121351711,0.0050308641975308835
26,0.9,3,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Is the ACE gene I/D polymorphism insertion allele a candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism is considered a candidate gene for insulin resistance, based on findings that link the I allele to an elevated risk.",9.474389094274162e-08,0.07735424215157316,0.0034240321402483898,0.0072537058591274906,0.07195500490107021,0.00871137409598946,0.007243206163811466,0.09751360699811418,0.007355371900826427,9.474389094274162e-08,0.09443504410108705,0.003931816011927075
26,0.9,4,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Does the insertion allele of the ACE gene I/D polymorphism represent a candidate gene for insulin resistance? Answer: Yes, evidence indicates that the insertion allele (I) of the ACE gene I/D polymorphism might be a candidate gene for insulin resistance due to its association with increased susceptibility.",7.105791820705622e-08,0.10906840324557265,0.02469135802469133,0.005440279394345618,0.10623152153208792,0.02731609726069556,0.0054324046228586,0.10304669783534592,0.02673037190082643,7.105791820705622e-08,0.101486788458796,0.0253476399262638
26,0.9,5,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Can the insertion allele of the ACE gene I/D polymorphism be a candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) in the ACE gene I/D polymorphism is potentially a candidate gene for insulin resistance, as research points to a connection between the I allele and heightened risk.",0.0,0.0,0.0,0.0,4.440892098500626e-16,2.7755575615628914e-17,0.0,0.0,0.0,0.0,0.0,0.0
26,0.9,6,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Is the insertion allele of the ACE gene I/D polymorphism linked to insulin resistance as a candidate gene? Answer: Yes, the I allele insertion in the ACE gene I/D polymorphism may be a candidate gene for insulin resistance, supported by studies showing its link to increased risk.",7.105791820705622e-08,0.06790534498249823,0.08262471655328797,0.005440279394345618,0.044452648154857055,0.07398894297217715,0.0054324046228586,0.010627073760686834,0.03829633172275389,7.105791820705622e-08,0.03847340840789171,0.01975415473162002
26,0.9,7,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Could the ACE gene I/D polymorphism's insertion allele be considered a candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism is a possible candidate gene for insulin resistance, based on research indicating an association between the I allele and greater risk.",2.3685972735685406e-08,0.05901411331790385,0.04861111111111113,0.0018134264647818726,0.0618982342924963,0.056244260789715325,0.0018108015409528666,0.03547987148613396,0.04017549229670444,2.3685972735685406e-08,0.0374850441883936,0.04246913580246913
26,0.9,8,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Is the insertion allele of the ACE gene I/D polymorphism associated with insulin resistance as a candidate gene? Answer: Yes, this insertion allele (I) of the ACE gene I/D polymorphism may represent a candidate gene for insulin resistance, given research findings of its connection with increased risk.",7.105791820705622e-08,0.008914095573141267,0.043125,0.005440279394345618,0.014315814217468414,0.05272108843537414,0.0054324046228586,0.04143361511890653,0.01631809748692868,7.105791820705622e-08,0.06998009843334385,0.002882338120433363
26,0.9,9,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Does the ACE gene I/D polymorphism insertion allele serve as a candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) in the ACE gene I/D polymorphism is identified as a candidate gene for insulin resistance, according to studies linking the I allele to higher susceptibility.",7.105791820705622e-08,0.07957277854089417,0.009724251278305313,0.005440279394345618,0.07609468759469884,0.008382642998027628,0.0054324046228586,0.10304669783534592,0.02673037190082643,7.105791820705622e-08,0.101486788458796,0.025347639926263786
26,0.9,10,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Is the insertion allele of the ACE gene I/D polymorphism a candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism could be a candidate gene for insulin resistance, as research has found an association between the I allele and increased risk.",2.3685972735685406e-08,0.05415277330412804,0.01817867036011081,0.0018134264647818726,0.05362629580082823,0.021111111111111164,0.0018108015409528666,0.05300700262790148,0.02223065534753846,2.3685972735685406e-08,0.05292545762377321,0.022430810114242618
27,0.9,1,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Is there a link between androgens and sexual desire in women? Yes, androgens like testosterone significantly influence female sexual desire and responsiveness. Lower androgen levels can reduce sexual desire, indicating a positive correlation.",5.684633456564489e-07,0.29325479837440227,0.33125165401266693,0.04352223515476497,0.3526759593566293,0.22634676324128575,0.04345923698286883,0.42406417767093574,0.15104166666666666,5.684633456564497e-07,0.4983700940471656,0.07496876301541024
27,0.9,2,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Do androgens affect sexual desire in women? Indeed, hormones such as testosterone are important for female sexual desire and response. Reduced androgen levels may diminish sexual desire, showing a positive association.",6.158352911278195e-07,0.36068143276430575,0.3291754378238723,0.04714908808432873,0.4193673338553028,0.22634676324128575,0.04708084006477458,0.4930570491578865,0.15104166666666666,6.158352911278206e-07,0.5698290580293093,0.07496876301541024
27,0.9,3,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Is there a relationship between androgens and sexual desire among women? Yes, androgens, including testosterone, play a key role in female sexual desire and reactivity. Decreased levels of these hormones can lower sexual desire, implying a positive correlation.",4.500334819780224e-07,0.14221850491030796,0.3354629629629631,0.03445510283085558,0.20314422538566568,0.22634676324128575,0.034405229278104466,0.26991349784367724,0.15104166666666666,4.500334819780227e-07,0.33930539941747684,0.07496876301541024
27,0.9,4,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Are androgens connected to sexual desire in women? Yes, androgens like testosterone contribute greatly to female sexual desire and responsiveness. When these hormone levels are low, sexual desire may decrease, suggesting a positive link.",5.447773729207636e-07,0.3190352853470251,0.23759920864326003,0.04170880868998309,0.3209272610420495,0.22634676324128575,0.04164843544191596,0.39127435484794404,0.15104166666666666,5.447773729207643e-07,0.46446854237148383,0.07496876301541024
27,0.9,5,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Does a correlation exist between androgens and sexual desire in women? Yes, androgens such as testosterone are critical for sexual desire and response in females. Low androgen levels can reduce sexual desire, indicating a positive relationship.",4.97405427449393e-07,0.19992935121742894,0.3339224229997011,0.03808195576041933,0.26030263922561403,0.22634676324128575,0.03802683236001021,0.3287539978666105,0.15104166666666666,4.974054274493935e-07,0.3999300212339123,0.07496876301541024
27,0.9,6,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Is sexual desire in women influenced by androgens? Yes, hormones like testosterone are important for female sexual desire and responsiveness. Lower androgen levels might lead to diminished sexual desire, demonstrating a positive correlation.",5.684633456564489e-07,0.29325479837440227,0.33125165401266693,0.04352223515476497,0.3526759593566293,0.22634676324128575,0.04345923698286883,0.42406417767093574,0.15104166666666666,5.684633456564497e-07,0.4983700940471656,0.07496876301541024
27,0.9,7,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Are androgens associated with sexual desire in women? Yes, androgens including testosterone play an essential role in female sexual desire and responsiveness. A decrease in these hormone levels can result in reduced sexual desire, showing a positive association.",4.500334819780224e-07,0.14221850491030796,0.3354629629629631,0.03445510283085558,0.20314422538566568,0.22634676324128575,0.034405229278104466,0.26991349784367724,0.15104166666666666,4.500334819780227e-07,0.33930539941747684,0.07496876301541024
27,0.9,8,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Is there a correlation between androgen hormones and female sexual desire? Yes, androgens such as testosterone significantly impact sexual desire and response in women. Lower levels of these hormones may reduce sexual desire, indicating a positive link.",4.737194547137077e-07,0.13215006393302087,0.36246913580246926,0.03626852929563745,0.23131510235236252,0.22634676324128575,0.03621603081905734,0.29890103471692875,0.15104166666666666,4.737194547137081e-07,0.3691583625671586,0.07496876301541024
27,0.9,9,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Do androgens correlate with sexual desire in women? Yes, androgens like testosterone are important for female sexual desire and responsiveness. Decreased androgen levels may lead to lowered sexual desire, suggesting a positive correlation.",5.684633456564489e-07,0.29325479837440227,0.33125165401266693,0.04352223515476497,0.3526759593566293,0.22634676324128575,0.04345923698286883,0.42406417767093574,0.15104166666666666,5.684633456564497e-07,0.4983700940471656,0.07496876301541024
27,0.9,10,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Is female sexual desire related to androgen levels? Yes, androgens including testosterone play a major role in sexual desire and responsiveness in women. Low levels can cause decreased sexual desire, implying a positive correlation.",5.447773729207636e-07,0.26117036095658674,0.33219569830246926,0.04170880868998309,0.3209272610420495,0.22634676324128575,0.04164843544191596,0.39127435484794404,0.15104166666666666,5.447773729207643e-07,0.46446854237148383,0.07496876301541024
28,0.9,1,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Are sports medicine journals useful and pertinent to practitioners and athletes? Yes, sports medicine journals are extremely relevant to both practitioners and athletes. They deliver the latest research, treatment innovations, and injury prevention strategies related to sports. These journals also provide important knowledge on improving athletic performance and nutrition.",9.474389094274162e-08,0.1263947395214453,0.027777777777777776,0.0072537058591274906,0.12393066880576553,0.025134411171674104,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
28,0.9,2,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Do sports medicine journals hold relevance and utility for practitioners and athletes? Absolutely, sports medicine journals are very relevant for practitioners and athletes. They offer current research findings, advancements in treatment, and preventive techniques for sports injuries. Additionally, they give valuable information on enhancing athletic performance and nutrition.",7.105791820705622e-08,0.07400222907489118,0.00563007030827474,0.005440279394345618,0.07164642041470293,0.003012522062330082,0.0054324046228586,0.06899287148695166,0.0,7.105791820705622e-08,0.07061756721395396,0.0
28,0.9,3,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Are sports medicine journals applicable and significant for practitioners and athletes? Yes, sports medicine journals are highly applicable and significant for practitioners and athletes. They present updated research, new treatment methods, and preventative measures for sports-related injuries. They also share crucial insights into boosting athletic performance and nutrition.",7.105791820705622e-08,0.014484645039144262,0.05437500000000001,0.005440279394345618,0.01876408139746344,0.06067816775728733,0.0054324046228586,0.023426752587707433,0.06632653061224489,7.105791820705622e-08,0.007604187163049225,0.045351473922902494
28,0.9,4,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Are sports medicine journals relevant and useful to both practitioners and athletes? Indeed, sports medicine journals are very useful and relevant to practitioners and athletes. They provide the most recent research, improvements in treatment, and preventive approaches for sports injuries. Moreover, they offer valuable guidance on athletic performance enhancement and nutrition.",1.4211583641411244e-07,0.1706824699444991,0.030244454504300577,0.010880558788691236,0.16680726825550485,0.02600164625884065,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
28,0.9,5,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Is the content of sports medicine journals pertinent to practitioners and athletes? Yes, sports medicine journals are highly pertinent to practitioners and athletes. They supply updated research data, treatment advancements, and injury prevention advice related to sports. They also contain helpful information about enhancing athletic performance and nutrition.",7.105791820705622e-08,0.0445066043702127,0.014875283446712032,0.005440279394345618,0.04150958647731384,0.018498994102315543,0.0054324046228586,0.03818633012873196,0.02221074380165289,7.105791820705622e-08,0.07061756721395396,0.0
28,0.9,6,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Do sports medicine journals have practical value for practitioners and athletes? Yes, these journals are highly valuable to both practitioners and athletes. They feature up-to-date studies, new treatments, and effective preventive measures for sports injuries. Furthermore, they provide key insights into improving athletic performance and nutritional strategies.",4.737194547137081e-08,0.1403416887352531,0.0682716049382716,0.0036268529295637453,0.10994118157070565,0.046400951814396206,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
28,0.9,7,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Are sports medicine journals relevant and practical for practitioners and athletes? Certainly, sports medicine journals are practical and relevant for both groups. They include the latest research, treatment progress, and prevention techniques for sports-related injuries. They also share critical knowledge on athletic performance improvement and nutrition.",2.3685972735685406e-08,0.08688653323742734,0.045651703623580314,0.0018134264647818726,0.055961635693195344,0.023685970743547096,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
28,0.9,8,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Can practitioners and athletes benefit from sports medicine journals? Yes, sports medicine journals are extremely beneficial to practitioners and athletes. They present current research, advancements in treatment, and preventive measures for sports injuries. Additionally, they offer valuable insights into boosting athletic performance and nutrition.",2.3685972735685406e-08,0.03855843438316109,0.04359904818560379,0.0018134264647818726,0.04094831008375399,0.046400951814396206,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
28,0.9,9,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Are sports medicine journals applicable and insightful for practitioners and athletes? Yes, they are very applicable and insightful for practitioners and athletes. These journals provide updated studies, treatment innovations, and preventative methods regarding sports injuries. They also provide important information on enhancing athletic performance and nutrition.",2.3685972735685406e-08,0.005533090837231747,0.019375000000000003,0.0018134264647818726,0.03855843438316109,0.04359904818560379,0.0018108015409528666,0.07318771383072864,0.06937499999999999,2.3685972735685406e-08,0.04191646561712403,0.047500000000000014
28,0.9,10,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Are sports medicine journals valuable and relevant for practitioners and athletes? Yes, sports medicine journals are highly valuable and relevant to both practitioners and athletes. They provide timely research, new treatment options, and preventive strategies for sports injuries, along with essential insights into athletic performance and nutritional improvements.",7.105791820705622e-08,0.0445066043702127,0.014875283446712032,0.005440279394345618,0.07164642041470293,0.003012522062330082,0.0054324046228586,0.06899287148695166,0.0,7.105791820705622e-08,0.07061756721395396,0.0
29,0.9,1,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Does the quantity of needles affect acupuncture treatment for neck pain? Yes, it can influence the outcome, depending on how severe and where the pain is located. For more severe or extensive pain, a greater number of needles may be applied.",1.4211583641411244e-07,0.02373513171620978,0.08209555612658162,0.010880558788691236,0.05068121956601601,0.06632653061224489,0.0108648092457172,0.11509678416642277,0.02271498107084911,1.4211583641411244e-07,0.1502822030493367,0.0
29,0.9,2,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","In treating neck pain with acupuncture, does the needle count matter? Indeed, it does, as it varies with the pain's intensity and position. More needles are often employed for stronger or broader pain areas.",3.0791764556390954e-07,0.18144966533566942,0.10707911957168353,0.023574544042164365,0.248506962895934,0.06632653061224489,0.023540420032387294,0.3186957394076626,0.02271498107084911,3.079176455639103e-07,0.36000273403140737,0.0
29,0.9,3,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Is the number of needles significant in acupuncture for neck pain? Yes, it matters based on the pain's severity and site. More needles could be utilized when dealing with intense or widespread discomfort.",3.3160361829959484e-07,0.2122213240024231,0.10707911957168353,0.025387970506946245,0.2802556612105138,0.06632653061224489,0.025351221573340167,0.3514855622306543,0.02271498107084911,3.316036182995957e-07,0.39390428570708913,0.0
29,0.9,4,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","When using acupuncture to treat neck pain, does needle quantity play a role? Yes, the amount used can depend on how severe the pain is and where it occurs. Greater numbers of needles might be necessary for significant or diffused pain.",1.4211583641411244e-07,0.010922227311786603,0.10707911957168353,0.010880558788691236,0.05068121956601601,0.06632653061224489,0.0108648092457172,0.11509678416642277,0.02271498107084911,1.4211583641411244e-07,0.1502822030493367,0.0
29,0.9,5,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Does the number of needles used in acupuncture impact neck pain treatment? Yes, it does, contingent on the pain's severity and location. Intense or extensive pain may require more needles.",4.0266153650665074e-07,0.3106613968156764,0.10707911957168353,0.030828249901291883,0.3820383555204563,0.06632653061224489,0.030783626196198788,0.45684607788847975,0.02271498107084911,4.026615365066519e-07,0.5031035776720798,0.0
29,0.9,6,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","In acupuncture for neck pain, is needle count important? Yes, the number of needles can affect treatment depending on pain severity and area. Higher needle counts might be chosen for severe or widespread pain.",3.0791764556390954e-07,0.18144966533566942,0.10707911957168353,0.023574544042164365,0.248506962895934,0.06632653061224489,0.023540420032387294,0.3186957394076626,0.02271498107084911,3.079176455639103e-07,0.36000273403140737,0.0
29,0.9,7,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Is the amount of needles important for acupuncture in neck pain treatment? Yes, it can be, influenced by the intensity and location of pain. More needles might be applied for more severe or widespread pain.",2.8423167282822424e-07,0.15159670218598764,0.10707911957168353,0.021761117577382486,0.2177353042291803,0.06632653061224489,0.02172961849143442,0.2869470410930828,0.02271498107084911,2.8423167282822487e-07,0.32721291120841567,0.0
29,0.9,8,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Regarding acupuncture for neck pain, does the number of needles matter? Yes, it can, as the amount depends on the pain's severity and position. A larger number of needles may be used for severe or extensive pain.",2.3685972735685364e-07,0.17145464174158898,0.05171579777237556,0.018134264647818726,0.19850321452395825,0.03777981780947673,0.018108015409528673,0.2263224192766473,0.02271498107084911,2.3685972735685406e-07,0.26469255422708216,0.0
29,0.9,9,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Can the needle count affect acupuncture treatment outcomes for neck pain? Yes, it depends on pain intensity and location, with more needles often used for more severe or widespread pain.",4.0266153650665074e-07,0.3106613968156764,0.10707911957168353,0.030828249901291883,0.3820383555204563,0.06632653061224489,0.030783626196198788,0.45684607788847975,0.02271498107084911,4.026615365066519e-07,0.5031035776720798,0.0
29,0.9,10,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","In neck pain acupuncture treatment, is the number of needles significant? Yes, it is, depending on how intense the pain is and where it's located. More needles might be necessary for widespread or severe pain.",2.8423167282822424e-07,0.15159670218598764,0.10707911957168353,0.021761117577382486,0.2177353042291803,0.06632653061224489,0.02172961849143442,0.2869470410930828,0.02271498107084911,2.8423167282822487e-07,0.32721291120841567,0.0
30,0.9,1,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Are we following guidelines when preparing patients at high risk of falls for discharge home after rehabilitation? Answer: Evidence suggests that systematic falls risk assessment during rehabilitation for high-risk patients is limited. When fall risks are identified, strategies are typically implemented, but overlooking some risk factors may restrict the fall prevention measures provided.",2.3685972735685406e-07,0.06281945084577112,0.07877526753864447,0.018134264647818726,0.10881190705463606,0.048261993679977015,0.018108015409528666,0.13359595731390694,0.03274920999712727,2.3685972735685406e-07,0.15921665077528946,0.016661878770468257
30,0.9,2,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Is the preparation of high fall-risk patients for discharge home post-rehabilitation aligned with guidelines? Answer: There is minimal evidence indicating that patients at high risk for falls undergo comprehensive risk assessments during rehabilitation. Identified risks usually lead to intervention strategies, though missing some risk factors could reduce the effectiveness of fall prevention.",2.6054570009253947e-07,0.08186764581646422,0.07877526753864447,0.0199476911126006,0.12822999291173875,0.048261993679977015,0.019918816950481533,0.1533985846100867,0.03274920999712727,2.6054570009253947e-07,0.17941935809280807,0.016661878770468257
30,0.9,3,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: How well do we adhere to guidelines in preparing patients at high risk of falls for discharge after rehabilitation? Answer: Few patients at high fall risk appear to receive systematic falls risk assessments in rehabilitation. While identified risks prompt strategy implementation, failure to assess all risk factors might limit preventive approaches.",2.8423167282822487e-07,0.1556502164233664,0.03962491351948578,0.02176111757738247,0.1757585074303165,0.02827032354253428,0.0217296184914344,0.17360129192760532,0.03274920999712727,2.8423167282822487e-07,0.20003864529554383,0.016661878770468257
30,0.9,4,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Do we meet guidelines when preparing patients with high fall risk for discharge home after rehabilitation? Answer: Evidence shows limited systematic assessment of falls risk during rehabilitation. When risks are detected, a strategy is usually applied, but an incomplete assessment of risk factors may hinder fall prevention efforts.",3.552895910352811e-07,0.19079148601333173,0.05795136532044619,0.02720139697172809,0.20990802392600605,0.048261993679977015,0.027162023114293,0.2367801935491376,0.03274920999712727,3.552895910352811e-07,0.26457716643311535,0.016661878770468257
30,0.9,5,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Are guidelines followed in preparing patients at high risk of falls for discharge post-rehabilitation? Answer: There is little proof that systematic fall risk assessments are conducted on high-risk patients during rehabilitation. Generally, strategies follow risk identification, yet omitted risk factors may limit the scope of prevention strategies.",3.789755637709665e-07,0.1829637626878342,0.07877526753864447,0.029014823436509962,0.2314142291469694,0.048261993679977015,0.028972824655245866,0.2587591002679126,0.03274920999712727,3.789755637709665e-07,0.28705002228517307,0.016661878770468257
30,0.9,6,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: To what extent are guidelines met when preparing high fall-risk patients for home discharge after rehabilitation? Answer: Systematic falls risk assessment appears scarce among high-risk patients during rehabilitation. Strategies are mostly implemented upon risk detection, but incomplete assessments could compromise fall prevention.",4.974054274493935e-07,0.29544174611452423,0.07877526753864447,0.038081955760419325,0.3464835589317561,0.048261993679977015,0.0380268323600102,0.376542135924296,0.03274920999712727,4.974054274493935e-07,0.40767801007379045,0.016661878770468257
30,0.9,7,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Is the guideline compliance adequate when preparing patients at high fall risk for discharge after rehabilitation? Answer: Evidence is scarce that systematic falls risk assessments occur during rehabilitation for these patients. Although strategies are applied when risks are found, not assessing all risk factors may restrict prevention methods.",3.552895910352811e-07,0.16191035349000105,0.07877526753864447,0.02720139697172809,0.20990802392600605,0.048261993679977015,0.027162023114293,0.2367801935491376,0.03274920999712727,3.552895910352811e-07,0.26457716643311535,0.016661878770468257
30,0.9,8,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: How effective is the preparation of high fall-risk patients for home discharge after rehabilitation in meeting guidelines? Answer: Little evidence exists of systematic falls risk assessments during rehabilitation. Identified risks typically lead to strategies, but missed risk factors may reduce fall prevention effectiveness.",4.737194547137081e-07,0.2719112487043298,0.07877526753864447,0.03626852929563745,0.32238600735269607,0.048261993679977015,0.03621603081905733,0.3518495233339243,0.03274920999712727,4.737194547137081e-07,0.3823602020894987,0.016661878770468257
30,0.9,9,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Are patients at high risk of falls adequately prepared for discharge home after rehabilitation according to guidelines? Answer: Limited evidence shows that systematic falls risk assessments are performed during rehabilitation. When risks are identified, strategies are generally implemented, but failure to evaluate some risk factors may limit fall prevention.",3.316036182995957e-07,0.1412910662872653,0.07877526753864447,0.025387970506946217,0.1888546147281729,0.048261993679977015,0.025351221573340132,0.21527398832817424,0.03274920999712727,3.316036182995957e-07,0.24259825971434035,0.016661878770468257
30,0.9,10,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Do we adequately assess and prepare high fall-risk patients for discharge home after rehabilitation as per guidelines? Answer: There is minimal evidence of systematic falls risk assessments during rehabilitation. While strategies follow risk identification, failure to assess certain risk factors might limit fall prevention strategies.",4.263475092423373e-07,0.22644887462757257,0.07877526753864447,0.03264167636607371,0.27586599171780213,0.048261993679977015,0.0325944277371516,0.30422147434466984,0.03274920999712727,4.263475092423373e-07,0.333570037920067,0.016661878770468257
31,0.9,1,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Do symptoms play a role in selecting patients for phase I clinical trials? Yes, symptoms are important factors in this selection process.",1.184298636784265e-07,0.15965899692652474,0.2326869806094183,0.009067132323909398,0.10956709535456355,0.2160664819944598,0.009054007704764368,0.0551964740518045,0.19390581717451527,1.1842986367842687e-07,0.004027786533873368,0.1662049861495845
31,0.9,2,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","When choosing patients for Phase I clinical trials, are symptoms significant? Yes, symptoms are indeed significant.",2.605457000925386e-07,0.17681323969468643,0.2326869806094183,0.01994769111260066,0.24710784858416845,0.2160664819944598,0.019918816950481606,0.3242931476530986,0.19390581717451527,2.60545700092539e-07,0.40949289464203753,0.1662049861495845
31,0.9,3,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Are symptoms considered when evaluating patients for phase I clinical trials? Yes, symptoms are relevant and matter.",2.3685972735685327e-07,0.1122747185571158,0.2326869806094183,0.018134264647818785,0.17811497709721635,0.2160664819944598,0.018108015409528732,0.25018517549937735,0.19390581717451527,2.3685972735685364e-07,0.32945018696850115,0.1662049861495845
31,0.9,4,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Is the presence of symptoms important in the assessment of patients for Phase I clinical trials? Yes, symptoms are important.",1.658018091497972e-07,0.059575538369543324,0.2326869806094183,0.012693985253473157,0.0042065796967381,0.2160664819944598,0.012675610786670111,0.056029161058419596,0.19390581717451527,1.6580180914979758e-07,0.12181082219025718,0.1662049861495845
31,0.9,5,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Do symptoms influence patient selection for phase I clinical trials? Yes, they do influence the selection.",2.605457000925386e-07,0.17681323969468643,0.2326869806094183,0.01994769111260066,0.24710784858416845,0.2160664819944598,0.019918816950481606,0.3242931476530986,0.19390581717451527,2.60545700092539e-07,0.40949289464203753,0.1662049861495845
31,0.9,6,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","When considering patients for Phase I clinical trials, do symptoms have importance? Yes, symptoms hold importance.",2.605457000925386e-07,0.17681323969468643,0.2326869806094183,0.01994769111260066,0.24710784858416845,0.2160664819944598,0.019918816950481606,0.3242931476530986,0.19390581717451527,2.60545700092539e-07,0.40949289464203753,0.1662049861495845
31,0.9,7,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Are symptoms a factor in determining eligibility for phase I clinical trials? Yes, symptoms are a key factor.",2.1317375462116791e-07,0.05165009674068077,0.2326869806094183,0.01632083818303691,0.11357645595964572,0.2160664819944598,0.01629721386857586,0.18119230401242525,0.19390581717451527,2.1317375462116828e-07,0.2553422148147799,0.1662049861495845
31,0.9,8,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Is symptomatology relevant in the consideration of patients for Phase I clinical trials? Yes, it is relevant.",2.3685972735685327e-07,0.1122747185571158,0.2326869806094183,0.018134264647818785,0.17811497709721635,0.2160664819944598,0.018108015409528732,0.25018517549937735,0.19390581717451527,2.3685972735685364e-07,0.32945018696850115,0.1662049861495845
31,0.9,9,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Do symptoms affect the decision to include patients in phase I clinical trials? Yes, symptoms affect this decision.",2.1317375462116791e-07,0.13319682386538023,0.1740932306094183,0.01632083818303691,0.11357645595964572,0.2160664819944598,0.01629721386857586,0.18119230401242525,0.19390581717451527,2.1317375462116828e-07,0.2553422148147799,0.1662049861495845
31,0.9,10,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Does the symptom profile matter in the patient selection process for Phase I clinical trials? Yes, the symptom profile matters.",1.658018091497972e-07,0.08635018385360294,0.12888075223571588,0.012693985253473157,0.07280977369881114,0.16070316019515182,0.012675610786670111,0.056029161058419596,0.19390581717451527,1.6580180914979758e-07,0.12181082219025718,0.1662049861495845
32,0.9,1,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Does airway surgery reduce serum lipid concentrations in patients with obstructive sleep apnea? Surgery could enhance lipid profiles in OSA patients, particularly those with dyslipidemia before surgery, possibly offering significant metabolic and cardiovascular advantages. Future prospective research should investigate this metabolic impact of airway surgery for OSA.",1.4211583641411244e-07,0.019441621306655943,0.0733372454996116,0.010880558788691236,0.07079865820420617,0.039150354019158694,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
32,0.9,2,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Can airway surgery lower blood lipid levels in individuals suffering from obstructive sleep apnea? Surgical intervention may positively affect lipid levels in OSA patients, especially among those with preoperative dyslipidemia, providing notable metabolic and cardiovascular benefits. Prospective studies are needed to further explore this potential.",1.8948778188548325e-07,0.09676992999100476,0.0497141666384375,0.014507411718254981,0.1485004360279376,0.01590772363367117,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
32,0.9,3,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Is serum lipid reduction achievable through airway surgery in obstructive sleep apnea patients? Airway surgery might improve lipid parameters in OSA patients, mainly in those with dyslipidemia prior to surgery, potentially leading to important metabolic and heart-related benefits. This metabolic benefit warrants investigation in future prospective studies.",1.4211583641411244e-07,0.019441621306655943,0.0733372454996116,0.010880558788691236,0.07079865820420617,0.039150354019158694,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
32,0.9,4,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Does performing airway surgery in obstructive sleep apnea patients lead to decreased serum lipid levels? Surgery may help normalize blood lipid levels in OSA patients, particularly those with underlying dyslipidemia before the operation, thereby possibly improving metabolism and reducing cardiovascular risks. Prospective studies should assess this effect.",1.4211583641411244e-07,0.010695212630732698,0.09506564056134,0.010880558788691236,0.07079865820420617,0.039150354019158694,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
32,0.9,5,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Can surgery on the airway lower lipid levels in the serum of obstructive sleep apnea patients? It is possible that airway surgery improves blood lipid metrics in patients with OSA, especially in those who have dyslipidemia before surgery, potentially resulting in significant metabolic and cardiovascular improvements. This should be validated through prospective studies.",0.0,0.13329753472306605,0.09506564056134,0.0,0.05436448474979949,0.039150354019158694,0.0,0.0,0.0,0.0,0.0,0.0
32,0.9,6,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Does airway surgery have an effect on serum lipid levels in patients with obstructive sleep apnea? Surgery might reduce blood lipid levels in OSA patients, notably in those with preoperative dyslipidemia, which may offer substantial benefits in terms of metabolism and cardiovascular outcomes. Prospective trials should investigate this effect.",9.474389094274162e-08,0.004507437997132602,0.053477738860016735,0.0072537058591274906,0.05680917096914628,0.017883813376436592,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
32,0.9,7,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Is there a reduction in serum lipid levels following airway surgery in obstructive sleep apnea sufferers? Airway surgery may positively influence lipid levels particularly in OSA patients with pre-surgery dyslipidemia, potentially providing key benefits related to metabolism and cardiovascular health. Future research should prospectively examine this possibility.",1.4211583641411244e-07,0.04957845524404503,0.05167721080927387,0.010880558788691236,0.07079865820420617,0.039150354019158694,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
32,0.9,8,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Does airway surgery contribute to lowering serum lipids in patients diagnosed with obstructive sleep apnea? The surgical treatment may improve lipid profiles in OSA patients, especially those exhibiting dyslipidemia before surgery, possibly offering metabolic and cardiovascular advantages. This metabolic effect should be studied in prospective trials.",1.6580180914979784e-07,0.011283694088042306,0.09506564056134,0.012693985253473108,0.09327151405626388,0.039150354019158694,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
32,0.9,9,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Can obstructive sleep apnea patients experience lowered serum lipid levels after airway surgery? Surgery may have beneficial effects on blood lipids, particularly in patients with preoperative dyslipidemia, which could translate into improved metabolism and cardiovascular outcomes. Prospective studies are necessary to explore this effect.",2.1317375462116866e-07,0.056746068164799546,0.09506564056134,0.016320838183036854,0.13979152969115782,0.039150354019158694,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
32,0.9,10,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Is there evidence that airway surgery decreases blood lipid concentrations in obstructive sleep apnea patients? Airway surgery might enhance lipid levels mainly in patients with dyslipidemia before the procedure, potentially leading to important metabolic and cardiovascular benefits. Prospective research should evaluate this metabolic impact.",2.1317375462116866e-07,0.08898547191177375,0.07182301017585246,0.016320838183036854,0.13979152969115782,0.039150354019158694,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
33,0.9,1,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is it possible for computerized tomography to substitute bone scintigraphy in identifying bone metastases in breast cancer? Answer: Our results indicate that routine bone scintigraphy is unnecessary for patients with metastatic breast cancer if CT scans of the thorax, abdomen, and pelvis are conducted.",2.1317375462116813e-07,0.1973348824033958,0.02271498107084911,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
33,0.9,2,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can CT scans replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Findings suggest that routine bone scintigraphy is not needed for patients with metastatic breast cancer if thorax, abdomen, and pelvis CT scans are performed.",7.10579182070559e-08,0.009275237125399904,0.05246913580246914,0.005440279394345625,0.08455738802806367,0.0,0.005432404622858614,0.08701137698963013,0.0,7.105791820705622e-08,0.08961215868968697,0.0
33,0.9,3,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Could computerized tomography serve as an alternative to bone scintigraphy for detecting bone metastases in breast cancer? Answer: Our data imply that routine bone scintigraphy for metastatic breast cancer patients is unnecessary when CT imaging of thorax, abdomen, and pelvis is available.",1.6580180914979731e-07,0.1163075395977704,0.047500000000000014,0.012693985253473115,0.15339948449985608,0.024375,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
33,0.9,4,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is computerized tomography a viable replacement for bone scintigraphy in identifying bone metastases in breast cancer? Answer: The findings suggest that for patients presenting with metastatic breast cancer, routine bone scintigraphy is not needed if CT scans of the thorax, abdomen, and pelvis are done.",2.3685972735685353e-07,0.2205078869226864,0.02221074380165289,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
33,0.9,5,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can computerised tomography be used instead of bone scintigraphy to detect bone metastases from breast cancer? Answer: Our study suggests that routine bone scintigraphy is not required for metastatic breast cancer patients if CT of thorax, abdomen, and pelvis is performed.",1.421158364141119e-07,0.12441194762660457,0.024375,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
33,0.9,6,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Does computerized tomography have the potential to replace bone scintigraphy in bone metastasis detection for breast cancer patients? Answer: Findings indicate that routine bone scintigraphy is unnecessary when CT scans of the thorax, abdomen, and pelvis are done in metastatic breast cancer cases.",1.8948778188548272e-07,0.14137324671020046,0.046400951814396206,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.9,7,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is it feasible for CT to replace bone scintigraphy in the detection of bone metastases from breast cancer? Answer: Our results suggest that routine bone scintigraphy should not be performed if thorax, abdomen, and pelvis CT scans are conducted in patients with metastatic breast cancer.",2.3685972735685353e-07,0.2205078869226864,0.02221074380165289,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
33,0.9,8,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can bone scintigraphy be omitted in favor of CT scans when detecting bone metastases in breast cancer patients? Answer: The evidence suggests routine bone scintigraphy is unnecessary if CT imaging of the thorax, abdomen, and pelvis is performed for metastatic breast cancer patients.",1.8948778188548272e-07,0.14137324671020046,0.046400951814396206,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.9,9,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Could CT scans replace bone scintigraphy for the detection of bone metastases originating from breast cancer? Answer: Our findings imply that routine bone scintigraphy is not essential if patients with metastatic breast cancer undergo CT scans of the thorax, abdomen, and pelvis.",1.6580180914979731e-07,0.1163075395977704,0.047500000000000014,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
33,0.9,10,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is routine bone scintigraphy needed for detecting bone metastases in breast cancer when computerized tomography is performed? Answer: The data suggest that if thorax, abdomen, and pelvis CT scans are done, routine bone scintigraphy in metastatic breast cancer patients is not required.",1.6580180914979731e-07,0.08330053099967571,0.07100591715976329,0.012693985253473115,0.15339948449985608,0.024375,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
34,0.9,1,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a significant concern in general adult psychiatry? Yes, pain is indeed a clinically important issue in general adult psychiatry. Chronic pain frequently coexists with psychiatric conditions such as depression and anxiety. Hence, evaluating and treating pain is essential in psychiatric practice.",7.105791820705622e-08,0.09006617011262907,0.15251490095564946,0.005440279394345618,0.05310382532501512,0.08739357330703484,0.0054324046228586,0.05663695340827024,0.09204470742932283,7.105791820705622e-08,0.024913053640555294,0.0710059171597633
34,0.9,2,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Does pain represent a clinically relevant problem in general adult psychiatry? Yes, pain is a critical clinical problem in this field. Chronic pain is commonly linked with psychiatric illnesses like depression and anxiety, making pain assessment and management vital in psychiatric care.",9.474389094274162e-08,0.09736552915126806,0.1748686156170564,0.0072537058591274906,0.06222327032293329,0.11176857330703485,0.007243206163811466,0.03131914542397851,0.09204470742932283,9.474389094274162e-08,0.0010624327627026808,0.0710059171597633
34,0.9,3,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain considered an important clinical issue in general adult psychiatry? Absolutely, pain is a clinically relevant issue within adult psychiatry. Chronic pain often overlaps with disorders such as depression and anxiety. Therefore, addressing pain is an important aspect of psychiatric treatment.",9.474389094274162e-08,0.09736552915126806,0.1748686156170564,0.0072537058591274906,0.06222327032293329,0.11176857330703485,0.007243206163811466,0.03131914542397851,0.09204470742932283,9.474389094274162e-08,0.0010624327627026808,0.0710059171597633
34,0.9,4,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a clinically significant issue in the practice of general adult psychiatry? Yes, it is. Chronic pain is frequently associated with psychiatric disorders including depression and anxiety, which makes pain evaluation and management a key component of psychiatric care.",1.4211583641411233e-07,0.11497922375318437,0.22352081811541274,0.010880558788691236,0.010929975935383585,0.11176857330703485,0.0108648092457172,0.02132458806144033,0.09204470742932283,1.4211583641411244e-07,0.05512965403297887,0.0710059171597633
34,0.9,5,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","In general adult psychiatry, is pain a clinically relevant problem? Indeed, pain holds clinical relevance in this area. Chronic pain often co-occurs with psychiatric conditions like depression and anxiety, necessitating its assessment and treatment in psychiatric settings.",2.1317375462116823e-07,0.034936516079650204,0.22352081811541274,0.016320838183036854,0.07130812230158945,0.11176857330703485,0.016297213868575806,0.105881976089504,0.09204470742932283,2.1317375462116866e-07,0.142141031022609,0.0710059171597633
34,0.9,6,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a problem of clinical importance in general adult psychiatry? Yes, pain is clinically significant in this context. There is a strong relationship between chronic pain and psychiatric disorders such as depression and anxiety, underscoring the need for proper pain management in psychiatry.",4.737194547137081e-08,0.21261769331710223,0.22352081811541274,0.0036268529295637453,0.111013434492365,0.11176857330703485,0.003621603081905733,0.08132956599864194,0.09204470742932283,4.737194547137081e-08,0.05023086162484702,0.0710059171597633
34,0.9,7,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Does pain pose a clinically relevant issue in general adult psychiatry? Yes, it does. Chronic pain commonly intertwines with psychiatric diagnoses like depression and anxiety, making the evaluation and management of pain essential within psychiatry.",2.6054570009253883e-07,0.022221897760298148,0.22352081811541274,0.019947691112600613,0.13014862232452273,0.11176857330703485,0.019918816950481553,0.16650659790593947,0.09204470742932283,2.6054570009253947e-07,0.2046613880039425,0.0710059171597633
34,0.9,8,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain recognized as a clinically pertinent problem in general adult psychiatry? Yes, pain is indeed a pertinent clinical issue. The frequent association of chronic pain with psychiatric disorders such as depression and anxiety makes pain assessment and treatment crucial in psychiatric care.",7.105791820705622e-08,0.1890871959069078,0.22352081811541274,0.005440279394345618,0.08691588291330499,0.11176857330703485,0.0054324046228586,0.05663695340827024,0.09204470742932283,7.105791820705622e-08,0.024913053640555294,0.0710059171597633
34,0.9,9,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a relevant clinical concern in general adult psychiatry? Yes, it is a relevant clinical issue. Chronic pain is often linked to psychiatric conditions including depression and anxiety, which highlights the importance of pain evaluation and management in psychiatry.",1.4211583641411233e-07,0.043887205234216076,0.1723886048210373,0.010880558788691236,0.025551454620402758,0.08547200646992748,0.0108648092457172,0.02132458806144033,0.09204470742932283,1.4211583641411244e-07,0.05512965403297887,0.0710059171597633
34,0.9,10,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Within general adult psychiatry, is pain a clinically relevant issue? Yes, pain is a clinically relevant problem. Chronic pain frequently coexists with psychiatric disorders like depression and anxiety, making its assessment and management a vital part of psychiatric care.",1.6580180914979763e-07,0.016040876238353263,0.1710516823129436,0.012693985253473108,0.0532056863121797,0.08476240046752868,0.012675610786670066,0.04872356224955565,0.09204470742932283,1.6580180914979784e-07,0.08330053099967571,0.0710059171597633
35,0.9,1,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Do preoperative statins decrease the incidence of atrial fibrillation following coronary artery bypass grafting? Answer: Our research suggests that administering statins before surgery may lower AF occurrence post-CABG.,4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
35,0.9,2,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Can statins given before surgery lower atrial fibrillation rates after CABG? Answer: Our findings indicate that preoperative statin use appears to reduce the chance of developing AF after coronary artery bypass grafting.,1.421158364141118e-07,0.20763936477824396,0.0,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
35,0.9,3,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Is there a reduction in atrial fibrillation after CABG when patients receive statins preoperatively? Answer: The study showed that taking statins before CABG seems to lessen AF development.,4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
35,0.9,4,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,"Question: Do statins administered before coronary artery bypass surgery help in reducing atrial fibrillation? Answer: According to our study, preoperative statin therapy seems effective in decreasing AF after CABG.",4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
35,0.9,5,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Does pre-surgery statin therapy impact the rate of atrial fibrillation post-CABG? Answer: Our investigation suggests that using statins before coronary bypass grafting reduces AF incidence.,2.36859727356853e-08,0.03922071315328246,0.0,0.0018134264647818796,0.04082199452025481,0.0,0.0018108015409528735,0.04255961441879563,0.0,2.3685972735685406e-08,0.04445176257083405,0.0
35,0.9,6,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Are atrial fibrillation rates lower after CABG when statins are given preoperatively? Answer: Our study demonstrates that preoperative statins appear to reduce AF occurrence following surgery.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
35,0.9,7,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Does administering statins prior to coronary artery bypass grafting reduce atrial fibrillation risk? Answer: The study indicates that preoperative statin therapy may diminish AF development post-CABG.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
35,0.9,8,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Can preoperative statin treatment reduce the development of atrial fibrillation after CABG? Answer: Our research points to statins given before surgery as a means to lower AF incidence.,4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
35,0.9,9,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Is the use of statins before coronary artery bypass surgery linked to reduced atrial fibrillation? Answer: Our study found that taking statins preoperatively seems to decrease AF risk after CABG.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
35,0.9,10,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Does giving statins before CABG lessen the chance of atrial fibrillation? Answer: Findings from our study suggest preoperative statin therapy is associated with reduced AF development following coronary bypass surgery.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
36,0.9,1,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals pertinent and useful for practitioners and athletes? The sports medicine literature lacks sufficient studies on diagnostic and treatment interventions. It's essential to expand the evidence base in sports medicine both in quantity and quality.,1.6580180914979753e-07,0.18744301000992758,0.018049886621315223,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
36,0.9,2,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,"Do sports medicine journals hold relevance and practical value for practitioners and athletes? Currently, there is a shortage of research focused on diagnostic and treatment methods within sports medicine literature. Enhancing the volume and quality of evidence in this field is necessary.",7.105791820705622e-08,0.029524241483962932,0.06859552154195009,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
36,0.9,3,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are journals in sports medicine applicable and important for athletes and healthcare providers? The literature shows a scarcity of studies on diagnostic and therapeutic interventions. There is a need to grow the evidence base in sports medicine in terms of both volume and standard.,2.3685972735685406e-08,0.012562942400367039,0.04656956972755389,0.0018134264647818726,0.056537506008286,0.023795359904818555,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
36,0.9,4,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,"Is sports medicine literature relevant and practical for practitioners and athletes? There is a notable lack of studies addressing diagnostics and treatments. To improve the field, the evidence supporting sports medicine must increase in both quantity and quality.",1.6580180914979753e-07,0.13583375312115775,0.06596434870244393,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
36,0.9,5,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Do sports medicine journals provide relevant and applicable information to athletes and practitioners? The literature reveals a deficiency in studies on diagnostic and treatment interventions. The evidence base requires further growth in volume and quality.,2.3685972735685343e-07,0.182923725983819,0.0929705215419501,0.01813426464781874,0.26469255422708216,0.0,0.018108015409528687,0.2719337154836414,0.0,2.3685972735685406e-07,0.27958486221916123,0.0
36,0.9,6,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are practitioners and athletes able to benefit from sports medicine journals? There is a shortage of research concerning diagnostic and treatment approaches in this literature. It is crucial to enhance the quantity and quality of evidence in sports medicine.,1.4211583641411222e-07,0.07169809087359447,0.0929705215419501,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
36,0.9,7,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine publications useful and relevant for athletes and healthcare professionals? The current body of literature is limited in studies about diagnostic and treatment interventions. Expanding the evidence base in terms of quality and quantity is vital.,1.6580180914979753e-07,0.09836633795575533,0.0929705215419501,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
36,0.9,8,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Is the content of sports medicine journals applicable to practitioners and athletes? The sports medicine literature currently lacks sufficient diagnostic and treatment studies. Increasing the volume and improving the quality of evidence in this area is essential.,1.8948778188548283e-07,0.1642734888416455,0.06521541950113377,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
36,0.9,9,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Do sports medicine journals hold significance and practical value for both practitioners and athletes? There are few studies on diagnosis and treatment interventions in the literature. Increasing both the volume and quality of evidence in sports medicine is necessary.,1.4211583641411222e-07,0.10817952142938081,0.06667395470484272,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
36,0.9,10,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals meaningful and applicable for athletes and practitioners? The literature is deficient in diagnostic and therapeutic intervention studies. The field must continue to build its evidence base by enhancing quantity and quality.,2.3685972735685343e-07,0.182923725983819,0.0929705215419501,0.01813426464781874,0.26469255422708216,0.0,0.018108015409528687,0.2719337154836414,0.0,2.3685972735685406e-07,0.27958486221916123,0.0
37,0.9,1,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Does robotically assisted laparoscopic radical prostatectomy cause less tissue trauma compared to retropubic radical prostatectomy? This study demonstrated for the first time that RALP results in less tissue damage than RRP.,4.73719454713706e-08,0.022783059449621224,0.033293697978596916,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
37,0.9,2,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robot-assisted laparoscopic radical prostatectomy less invasive than the retropubic approach? The study revealed that RALP causes less tissue trauma than RRP for the first time.,7.10579182070559e-08,0.11332868530700413,0.0,0.005440279394345639,0.11778303565638426,0.0,0.005432404622858621,0.1226023220923329,0.0,7.105791820705622e-08,0.1278333715098845,0.0
37,0.9,3,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,"Does RALP involve less invasiveness than retropubic radical prostatectomy? The findings show that RALP induces lower tissue trauma compared to RRP, as demonstrated for the first time.",4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
37,0.9,4,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotically assisted laparoscopic radical prostatectomy associated with reduced tissue injury versus retropubic radical prostatectomy? This research indicated for the first time that RALP leads to less tissue trauma than RRP.,4.73719454713706e-08,0.06899287148695077,0.0,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
37,0.9,5,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is RALP less invasive than retropubic radical prostatectomy? This study provided initial evidence that RALP produces less tissue trauma than RRP.,1.8948778188548245e-07,0.33647223662121384,0.0,0.014507411718255037,0.3513978868378893,0.0,0.014486412327622988,0.3677247801253176,0.0,1.8948778188548304e-07,0.38566248081198395,0.0
37,0.9,6,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Does robot-assisted laparoscopic radical prostatectomy cause less tissue damage than retropubic radical prostatectomy? This is the first study to show that RALP results in lower tissue trauma compared to RRP.,2.36859727356853e-08,0.035091319811269006,0.0,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
37,0.9,7,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is the invasiveness of robotically assisted laparoscopic radical prostatectomy less than that of retropubic radical prostatectomy? The study showed for the first time that RALP results in reduced tissue trauma compared to RRP.,9.47438909427412e-08,0.1335313926245223,0.0,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
37,0.9,8,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is RALP a less invasive procedure than retropubic radical prostatectomy? The study demonstrated that RALP induces less tissue trauma than RRP for the first time.,9.47438909427412e-08,0.15415067982725894,0.0,0.007253705859127518,0.1603426500751799,0.0,0.007243206163811494,0.16705408466316696,0.0,9.474389094274162e-08,0.17435338714477844,0.0
37,0.9,9,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Does robotically assisted laparoscopic radical prostatectomy result in less tissue trauma than retropubic radical prostatectomy? This study showed for the first time that RALP reduces tissue trauma more than RRP.,2.36859727356853e-08,0.012711934020451121,0.03443877551020409,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
37,0.9,10,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robot-assisted laparoscopic radical prostatectomy preferable in terms of invasiveness to retropubic radical prostatectomy? The study revealed for the first time that RALP causes lower tissue trauma than RRP.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
38,0.9,1,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","A model of healing in Los Angeles grades C and D reflux oesophagitis: is there an ideal duration of acid suppression for optimal healing? After four weeks of acid suppression therapy for LA grade C or D oesophagitis, healing seems to plateau, with minimal further improvement despite longer periods of intragastric pH >4.",2.3685972735685406e-07,0.22920968035289047,0.03840000000000001,0.018134264647818726,0.2062304738238847,0.019599999999999996,0.018108015409528666,0.182321556793954,0.0,2.3685972735685406e-07,0.1857171457950919,0.0
38,0.9,2,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","A healing model for LA grade C and D reflux oesophagitis: does an optimal acid suppression time exist for maximal recovery? After 4 weeks of acid-suppressive treatment for LA grade C or D oesophagitis, healing reaches a ceiling, beyond which extending intragastric pH >4 hours does not enhance improvement.",3.316036182995957e-07,0.3425767717071935,0.06222222222222222,0.025387970506946217,0.31971751187260944,0.04246913580246913,0.025351221573340132,0.29583999967039354,0.021728395061728398,3.316036182995957e-07,0.2708749541353992,0.0
38,0.9,3,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Optimal acid suppression timing for healing LA grades C and D reflux oesophagitis: a model. After four weeks of acid-suppression therapy in LA grade C or D oesophagitis, healing plateaus and further gains are unlikely even with increased intragastric pH >4 duration.",4.974054274493935e-07,0.4135623183407837,0.0,0.038081955760419325,0.4219944100593742,0.0,0.0380268323600102,0.430782916092455,0.0,4.974054274493935e-07,0.43995128417933227,0.0
38,0.9,4,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Is there a best length of acid suppression therapy for maximal healing of LA grade C and D reflux oesophagitis? After 4 weeks of treatment, healing in LA grade C or D oesophagitis reaches a threshold where more hours with pH >4 don't significantly improve outcomes.",4.026615365066519e-07,0.38208497799121144,0.04434829637641968,0.030828249901291835,0.35819092028050115,0.02271498107084911,0.030783626196198732,0.33314444652853714,0.0,4.026615365066519e-07,0.33986782562235085,0.0
38,0.9,5,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","A healing model for Los Angeles grades C and D reflux oesophagitis: is there an optimal acid suppression duration? After four weeks of therapy for LA grade C or D, healing reaches a level above which longer intragastric pH >4 times do not result in substantial improvement.",3.789755637709665e-07,0.29849298855599704,0.0,0.029014823436509962,0.30421137440299084,0.0,0.028972824655245866,0.3101549283038376,0.0,3.789755637709665e-07,0.31633732821215643,0.0
38,0.9,6,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","In a healing model for LA grade C and D reflux oesophagitis, is there an optimal acid suppression period? Following 4 weeks of acid-suppressive therapy, healing hits a plateau despite increased intragastric pH >4 hours in LA grade C or D oesophagitis.",4.974054274493935e-07,0.48118643351736345,0.04865220249835634,0.038081955760419325,0.4566517690873706,0.02498356344510192,0.0380268323600102,0.430782916092455,0.0,4.974054274493935e-07,0.43995128417933227,0.0
38,0.9,7,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Does maximal healing of LA grade C and D reflux oesophagitis require an optimal acid suppression time? After 4 weeks of acid suppression treatment, improvements plateau, even with greater time at intragastric pH >4.",6.86893209334876e-07,0.6726357436125472,0.0302734375,0.05258936747867433,0.6451379613735839,0.0,0.05251324468763316,0.6603573577369528,0.0,6.868932093348768e-07,0.6763400622435638,0.0
38,0.9,8,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Modeling healing of LA grade C and D reflux oesophagitis: is an optimal duration of acid suppression key? Healing after four weeks reaches a threshold, beyond which increasing intragastric pH >4 hours does not yield further benefit.",6.158352911278201e-07,0.5436154465889813,0.0,0.04714908808432869,0.555525802683897,0.0,0.04708084006477454,0.5679840376059375,0.0,6.158352911278206e-07,0.5810298824392386,0.0
38,0.9,9,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Is there an ideal acid suppression duration for maximal healing of LA grade C and D reflux oesophagitis? After 4 weeks, healing stabilizes despite longer periods of intragastric pH above 4 in these patients.",6.86893209334876e-07,0.6306268235786114,0.0,0.05258936747867433,0.6451379613735839,0.0,0.05251324468763316,0.6603573577369528,0.0,6.868932093348768e-07,0.6763400622435638,0.0
38,0.9,10,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","A model addressing healing in LA grades C and D reflux oesophagitis: does optimal acid suppression time exist for best recovery? After four weeks of acid-suppressive therapy, healing reaches a plateau where increased intragastric pH >4 time offers little added benefit.",5.210914001850789e-07,0.4382549309311554,0.0,0.0398953822252012,0.44731221804366594,0.0,0.039837633900963065,0.456758402495713,0.0,5.210914001850789e-07,0.46661953126149314,0.0
39,0.9,1,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Do viral infections play a role in benign paroxysmal positional vertigo? BPPV is linked with positive viral serology, especially in spring and autumn. Viral infections may trigger BPPV attacks by causing vestibulopathy or lead to secondary BPPV through neurolabyrinthitis related to viral infection.",2.1317375462116866e-07,0.2271630230390489,0.023795359904818555,0.016320838183036854,0.19845093872383757,0.0,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
39,0.9,2,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Is there a connection between viral infections and benign paroxysmal positional vertigo? BPPV shows an association with positive viral serology during specific seasons, mainly spring and autumn. Viral infections can potentially provoke BPPV episodes by inducing vestibulopathy or cause secondary BPPV via viral neurolabyrinthitis.",1.8948778188548325e-07,0.2028649207777371,0.023242630385487524,0.014507411718254981,0.17435338714477755,0.0,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
39,0.9,3,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Are viral infections involved in benign paroxysmal positional vertigo? Positive viral serology, particularly in spring and autumn, is associated with BPPV. Viral infections might facilitate BPPV attacks by fostering vestibulopathy or lead to secondary BPPV through neurolabyrinthitis caused by the virus.",2.6054570009253947e-07,0.2776035376383854,0.02498356344510192,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
39,0.9,4,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Can viral infections influence benign paroxysmal positional vertigo? BPPV is correlated with positive viral serology, notably in spring and autumn months. Viral infections may encourage BPPV attacks due to resulting vestibulopathy or induce secondary BPPV through viral infection-related neurolabyrinthitis.",3.0791764556391007e-07,0.3307209035537251,0.026296566837107373,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
39,0.9,5,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Do viruses have a role in benign paroxysmal positional vertigo? BPPV is connected with positive viral serology, mainly during spring and autumn. Viral infections could trigger BPPV attacks by causing vestibulopathy or lead to secondary BPPV via neurolabyrinthitis linked to viral infection.",2.3685972735685406e-07,0.21825356602001733,0.0,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
39,0.9,6,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Is benign paroxysmal positional vertigo related to viral infections? There is an association between BPPV and positive viral serology, particularly in spring and autumn. Viral infections may promote BPPV episodes due to vestibulopathy development or cause secondary BPPV through viral neurolabyrinthitis.",2.6054570009253947e-07,0.24294617861038903,0.0,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
39,0.9,7,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Could viral infections contribute to benign paroxysmal positional vertigo? BPPV is associated with positive viral serology, especially during spring and autumn months. Viral infections might precipitate BPPV attacks through vestibulopathy or induce secondary BPPV by causing viral neurolabyrinthitis.",3.3160361829959537e-07,0.358375135245502,0.027006172839506164,0.025387970506946217,0.32850406697203516,0.0,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
39,0.9,8,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.",Does viral infection have a role in benign paroxysmal positional vertigo? BPPV correlates with positive viral serology primarily in spring and autumn. Viral infections may lead to BPPV attacks by developing vestibulopathy or cause secondary BPPV through viral neurolabyrinthitis.,3.0791764556391007e-07,0.29423947299793873,0.0,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
39,0.9,9,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Are benign paroxysmal positional vertigo cases influenced by viral infections? Positive viral serology is linked to BPPV, especially in spring and autumn seasons. Viral infection might trigger BPPV attacks due to vestibulopathy or induce secondary BPPV via neurolabyrinthitis caused by the virus.",2.3685972735685406e-07,0.21825356602001733,0.0,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
39,0.9,10,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Is there an association between viral infections and benign paroxysmal positional vertigo? BPPV is connected with positive viral serology during certain months, predominantly spring and autumn. Viral infections could promote BPPV attacks by causing vestibulopathy or lead to secondary BPPV through viral infection-related neurolabyrinthitis.",1.8948778188548325e-07,0.2028649207777371,0.023242630385487524,0.014507411718254981,0.17435338714477755,0.0,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
40,0.9,1,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness affect microvascular function in healthy adults at risk for Type 2 diabetes? In this at-risk population with skin microvascular dysfunction, maximal oxygen uptake was comparable to healthy controls. Yet, within the at-risk group, individuals with greater aerobic fitness demonstrated improved microvascular and endothelial responsiveness.",2.1317375462116866e-07,0.15841791864004184,0.01458345969085259,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
40,0.9,2,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is there an impact of aerobic fitness on microvascular function among healthy adults susceptible to Type 2 diabetes? The at-risk group exhibiting skin microvascular dysfunction did not show decreased maximal oxygen uptake compared to healthy controls. However, among the at-risk individuals, those with higher aerobic fitness levels had enhanced microvascular and endothelial responses.",7.105791820705622e-08,0.05899777649954663,0.0020881452474190224,0.005440279394345618,0.05715841383995013,0.0,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
40,0.9,3,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness influence microvascular function in healthy adults who are at risk of developing Type 2 diabetes? For this at-risk group with impaired skin microvascular function, maximal oxygen uptake remained similar to healthy subjects. Nevertheless, within the at-risk group, higher aerobic fitness was associated with superior microvascular and endothelial responsiveness.",1.1842986367842703e-07,0.07262536298600031,0.016320184615138254,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
40,0.9,4,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","How does aerobic fitness relate to microvascular function in healthy adults at risk for Type 2 diabetes? Among these at-risk individuals with skin microvascular dysfunction, maximal oxygen uptake was not lower than in healthy controls. But within the at-risk group, those with better aerobic fitness showed improved microvascular and endothelial responsiveness.",1.1842986367842703e-07,0.10035125020839786,0.003618700802974578,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
40,0.9,5,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is microvascular function in healthy adults at risk for Type 2 diabetes influenced by aerobic fitness? Although maximal oxygen uptake was not decreased in the at-risk group with skin microvascular dysfunction compared to healthy controls, in this group, individuals with higher aerobic fitness exhibited better microvascular and endothelial function.",1.6580180914979784e-07,0.08572147028385668,0.03631185475258099,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
40,0.9,6,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness impact microvascular function in healthy adults at risk of Type 2 diabetes? In this at-risk cohort with skin microvascular impairment, maximal oxygen uptake did not differ from healthy controls. Still, within this group, greater aerobic fitness correlated with enhanced microvascular and endothelial responsiveness.",2.3685972735685406e-07,0.1810665327796479,0.014101110950928097,0.018134264647818726,0.2047944126460135,0.0,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
40,0.9,7,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness play a role in microvascular function among healthy adults at risk of Type 2 diabetes? For the at-risk group with skin microvascular disruption, maximal oxygen uptake was similar to that of healthy controls. However, within the at-risk group, individuals with elevated aerobic fitness also demonstrated better microvascular and endothelial responses.",7.105791820705622e-08,0.05899777649954663,0.0020881452474190224,0.005440279394345618,0.05715841383995013,0.0,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
40,0.9,8,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is there a connection between aerobic fitness and microvascular function in healthy adults susceptible to Type 2 diabetes? In this at-risk group with impaired skin microvascular function, maximal oxygen uptake was not diminished compared to healthy controls. Yet, higher aerobic fitness in the at-risk individuals was linked to improved microvascular and endothelial responsiveness.",7.105791820705622e-08,0.03233826955493324,0.017088479127821278,0.005440279394345618,0.05715841383995013,0.0,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
40,0.9,9,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness affect the microvascular function of healthy adults at risk for Type 2 diabetes? The at-risk group, despite skin microvascular dysfunction, did not show reduced maximal oxygen uptake relative to healthy controls. However, within this group, those with greater aerobic fitness had better microvascular and endothelial function.",1.6580180914979784e-07,0.11460260280718737,0.015487952534382704,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
40,0.9,10,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","How does aerobic fitness influence microvascular function in healthy adults at risk for Type 2 diabetes? In this population with skin microvascular dysfunction, maximal oxygen uptake was not lower than in healthy controls. Still, within the at-risk group, individuals with higher aerobic fitness exhibited superior microvascular and endothelial responsiveness.",1.6580180914979784e-07,0.1434837353305185,0.005276046948742272,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
41,0.9,1,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Does the ultra high risk (UHR) criteria for psychosis indicate different levels of risk for transitioning to psychosis? Our data shows that UHR intake criteria predict transition within 6 months in the order of Trait alone<APS<BLIPS. The highest short-term risk in BLIPS patients aligns with the 'early' versus 'late' prodrome model, suggesting specific clinical attention is necessary.",3.789755637709665e-07,0.2320603399320209,0.013886133703630227,0.029014823436510004,0.25534669180884517,0.0,0.02897282465524588,0.25951119548508306,0.0,3.789755637709665e-07,0.26381459104514127,0.0
41,0.9,2,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Are there varying levels of risk for psychosis transition according to UHR criteria? According to our findings, UHR intake criteria forecast transition over 6 months in the sequence Trait alone<APS<BLIPS. BLIPS patients face the greatest short-term transition risk, consistent with the 'early' versus 'late' prodrome theory, indicating the need for focused clinical care.",4.737194547137081e-07,0.33282781903035596,0.005337241921129483,0.036268529295637494,0.33085424431699106,0.0,0.036216030819057346,0.33647223662121295,0.0,4.737194547137081e-07,0.34228620648663544,0.0
41,0.9,3,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Do different UHR psychosis criteria levels predict transition risk differently? Our data suggests UHR intake criteria predict 6-month transition risk as Trait alone<APS<BLIPS. The highest risk in BLIPS patients matches the 'early' vs 'late' prodrome concept, pointing to the importance of targeted clinical attention.",6.868932093348768e-07,0.5284513187205824,0.009356496681857297,0.05258936747867435,0.5250102587579484,0.0,0.052513244687633145,0.5349231753450505,0.0,6.868932093348768e-07,0.5452270504833261,0.0
41,0.9,4,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Does the UHR psychosis criteria reflect varying transition risks? Data suggests transition within 6 months follows Trait alone<APS<BLIPS pattern. BLIPS carry the highest short-term risk, consistent with 'early' versus 'late' prodrome model, highlighting need for special clinical focus.",8.290090457489889e-07,0.6464941180229449,0.013886133703630227,0.06346992626736558,0.679160938585206,0.0,0.06337805393335035,0.693147180559945,0.0,8.290090457489892e-07,0.7077459799811003,0.0
41,0.9,5,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Is there a hierarchy of risk for psychosis transition within UHR criteria? Our data indicates a 6-month prediction order: Trait alone<APS<BLIPS. BLIPS individuals have the highest short-term risk, aligning with the 'early' vs 'late' prodrome framework, suggesting particular clinical care is required.",7.342651548062476e-07,0.5438399639628626,0.013886133703630227,0.05621622040823809,0.5738004229273801,0.0,0.05613484776953888,0.584933595919714,0.0,7.342651548062476e-07,0.5965203448708758,0.0
41,0.9,6,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be",Do different levels of UHR psychosis criteria predict transition risk distinctly? Our data points to transition in 6 months ranked Trait alone<APS<BLIPS. BLIPS patients’ highest short-term risk supports 'early' vs 'late' prodrome model and calls for specific clinical attention.,8.053230730133036e-07,0.619825870940784,0.013886133703630227,0.06165649980258371,0.6517619643970907,0.0,0.06156725239239748,0.6649763035932481,0.0,8.053230730133038e-07,0.6787584431078488,0.0
41,0.9,7,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Can UHR criteria differentiate levels of risk for psychosis transition? The data implies transitions occur in 6 months in sequence Trait alone<APS<BLIPS. The highest risk for BLIPS supports the 'early' vs 'late' prodrome theory, necessitating focused clinical monitoring.",8.290090457489889e-07,0.6839615331883473,0.013120039135875937,0.06346992626736558,0.679160938585206,0.0,0.06337805393335035,0.693147180559945,0.0,8.290090457489892e-07,0.7077459799811003,0.0
41,0.9,8,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Are there different transition risk levels within UHR criteria? Our findings reveal transition risk over 6 months follows Trait alone<APS<BLIPS, with BLIPS patients at greatest short-term risk, aligning with 'early' vs 'late' prodrome model and indicating need for precise clinical focus.",7.57951127541933e-07,0.6031899355812307,0.011097429741471694,0.058029646873019966,0.5991182309116718,0.0,0.057945649310491745,0.6109090823229719,0.0,7.57951127541933e-07,0.6231885919530367,0.0
41,0.9,9,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Do UHR intake criteria stratify risk for psychosis transition? Data shows transition within 6 months occurs in order Trait alone<APS<BLIPS, BLIPS having highest risk short-term, consistent with 'early' versus 'late' prodrome hypothesis, suggesting targeted clinical attention is needed.",8.290090457489889e-07,0.6464941180229449,0.013886133703630227,0.06346992626736558,0.679160938585206,0.0,0.06337805393335035,0.693147180559945,0.0,8.290090457489892e-07,0.7077459799811003,0.0
41,0.9,10,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Is there a stratification of transition risk in UHR psychosis criteria? Transition predictions over 6 months rank Trait alone<APS<BLIPS; BLIPS individuals bear highest short-term risks, fitting the 'early' versus 'late' prodrome model and pointing toward the need for particular clinical care.",7.57951127541933e-07,0.5685325765532343,0.013886133703630227,0.058029646873019966,0.5991182309116718,0.0,0.057945649310491745,0.6109090823229719,0.0,7.57951127541933e-07,0.6231885919530367,0.0
42,0.9,1,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Is the preoperative platelet count a prognostic factor in esophageal squamous cell carcinoma? Answer: Yes, the platelet count before surgery in esophageal squamous cell carcinoma may serve as a prognostic indicator. Higher platelet levels preoperatively have been linked to worse outcomes and more aggressive tumors, though more studies are required for confirmation.",4.737194547137081e-08,0.10000438898700059,0.041224245863754685,0.0036268529295637453,0.12709945814143886,0.06157278647670903,0.003621603081905733,0.12862063739118046,0.06265295796173082,4.737194547137081e-08,0.13015957051460436,0.06353305785123965
42,0.9,2,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Does preoperative platelet count have prognostic value in esophageal squamous cell carcinoma? Answer: Yes, preoperative platelet counts can act as a prognostic factor in esophageal squamous cell carcinoma. Elevated counts prior to surgery correlate with poorer prognosis and increased tumor severity, but additional research is necessary for definitive conclusions.",2.3685972735685406e-08,0.06071161661723368,0.05530223210410702,0.0018134264647818726,0.0630770560281424,0.059135238794544465,0.0018108015409528666,0.06497549619081244,0.06137808745645146,2.3685972735685406e-08,0.06698066889307208,0.06353305785123965
42,0.9,3,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Can preoperative platelet count predict prognosis in esophageal squamous cell carcinoma? Answer: Yes, platelet counts measured before surgery in esophageal squamous cell carcinoma patients can predict prognosis. High preoperative platelet counts are associated with a worse outlook and more aggressive tumor behavior, although more research is needed to establish this firmly.",2.3685972735685406e-08,0.07797262597846455,0.039408979052693915,0.0018134264647818726,0.10620954115026304,0.06079258494031216,0.0018108015409528666,0.10785209564055176,0.062245322543618004,2.3685972735685406e-08,0.1095402833118686,0.06353305785123965
42,0.9,4,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Is the preoperative platelet count a useful prognostic factor in esophageal squamous cell carcinoma? Answer: Yes, preoperative platelet count may be a significant prognostic factor in esophageal squamous cell carcinoma. Elevated platelet counts before surgery have been linked to poorer patient prognosis and higher tumor aggressiveness, but further investigation is required.",2.3685972735685406e-08,0.023608141228665058,0.002508894689557478,0.0018134264647818726,0.023031879483069506,0.00195770839710227,0.0018108015409528666,0.051268652329536035,0.021680544923370182,2.3685972735685406e-08,0.05177801826520678,0.021945156149916392
42,0.9,5,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Does platelet count before surgery influence prognosis in esophageal squamous cell carcinoma? Answer: Yes, an increased preoperative platelet count in esophageal squamous cell carcinoma patients can act as a prognostic marker. Higher platelet counts are indicative of more aggressive cancers and worse prognosis, though additional studies are needed to confirm this.",2.3685972735685406e-08,0.10515486835336407,0.0584265998700924,0.0018134264647818726,0.10620954115026304,0.06079258494031216,0.0018108015409528666,0.10785209564055176,0.062245322543618004,2.3685972735685406e-08,0.1095402833118686,0.06353305785123965
42,0.9,6,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Is there a prognostic role for preoperative platelet count in esophageal squamous cell carcinoma? Answer: Yes, preoperative platelet count can play a prognostic role in esophageal squamous cell carcinoma. Elevated platelet levels before surgical intervention have been associated with poorer outcomes and tumor aggressiveness, but further research is necessary for definitive evidence.",4.737194547137081e-08,0.04668537509777382,0.004931861733736692,0.0036268529295637453,0.07273497339163848,0.02285985394086544,0.003621603081905733,0.12862063739118046,0.06265295796173082,4.737194547137081e-08,0.13015957051460436,0.06353305785123965
42,0.9,7,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Does the pre-surgery platelet count serve as a prognostic factor in esophageal squamous cell carcinoma? Answer: Yes, the platelet count before surgery can serve as a prognostic factor for esophageal squamous cell carcinoma. Increased preoperative platelet counts have been correlated with worse prognosis and greater tumor aggressiveness, although further studies are warranted.",4.737194547137081e-08,0.04668537509777382,0.004931861733736692,0.0036268529295637453,0.07273497339163848,0.02285985394086544,0.003621603081905733,0.10089475016878291,0.04271407254361799,4.737194547137081e-08,0.10186784885909628,0.0431337522956841
42,0.9,8,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Is high preoperative platelet count linked to prognosis in esophageal squamous cell carcinoma? Answer: Yes, a high platelet count prior to surgery in esophageal squamous cell carcinoma is linked to prognosis. Elevated preoperative platelet levels suggest poorer survival and more aggressive tumor characteristics, though more research is needed for confirmation.",0.0,0.02772588722239755,0.018521291383772384,0.0,0.08487516496652425,0.05998072311243629,0.0,0.0866433975699934,0.06182072588097527,0.0,0.08848687411403544,0.06353305785123965
42,0.9,9,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Can platelet count before esophageal squamous cell carcinoma surgery be used as a prognostic indicator? Answer: Yes, platelet count measured before surgery in esophageal squamous cell carcinoma patients can be an indicator of prognosis. Higher platelet counts before surgery are associated with worse outcomes and tumor aggressiveness, but additional research is required.",4.737194547137081e-08,0.10000438898700059,0.041224245863754685,0.0036268529295637453,0.12709945814143886,0.06157278647670903,0.003621603081905733,0.12862063739118046,0.06265295796173082,4.737194547137081e-08,0.13015957051460436,0.06353305785123965
42,0.9,10,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Is preoperative platelet count predictive of outcomes in esophageal squamous cell carcinoma? Answer: Yes, preoperative platelet count can predict outcomes in esophageal squamous cell carcinoma. Elevated platelet counts prior to surgery have been linked with increased tumor aggressiveness and poorer prognosis, though definitive conclusions require more research.",7.105791820705622e-08,0.04476794138937423,0.01136424692479722,0.005440279394345618,0.042267629093547754,0.014555340042352968,0.0054324046228586,0.010627073760686834,0.038296331722753874,7.105791820705622e-08,0.008977783703213227,0.04081807678039054
43,0.9,1,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Do the leadership abilities of residents correlate with their technical skill ratings? Research on general surgery residents found that intraoperative leadership correlated significantly with perceptions of skill decay and task difficulty during bowel repair. Assessing residents' directional instructions could serve as an individualized intraoperative evaluation metric. More research is needed on how this relates to operative performance outcomes.,4.737194547137081e-08,0.060923434622440986,0.0181755829903978,0.0036268529295637453,0.036367644170874236,0.0,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
43,0.9,2,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Is there a relationship between residents' leadership skills and their technical skill ratings? Studies in general surgery research residents demonstrated that intraoperative leadership abilities were significantly linked to self-perceived skill decay and task difficulty when performing bowel repair. Analyzing residents' directional guidance might offer an extra personalized intraoperative assessment method. Further investigation into operative performance outcomes is necessary.,4.737194547137081e-08,0.060923434622440986,0.0181755829903978,0.0036268529295637453,0.036367644170874236,0.0,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
43,0.9,3,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,"Are resident leadership skills connected to ratings of their technical competence? General surgery research shows that residents' intraoperative leadership skills have significant correlations with their perceptions of skill decay and task difficulty in bowel repair procedures. Reviewing resident directional instructions could provide an additional, personalized intraoperative skill assessment. More studies on the impact on operative results are warranted.",4.737194547137081e-08,0.036602480918583424,0.0006373176842753465,0.0036268529295637453,0.036367644170874236,0.0,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
43,0.9,4,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Does a resident's leadership ability correlate with technical skill ratings? Research involving general surgery residents indicates that intraoperative leadership significantly correlates with perceived skill decay and task difficulty during bowel repair. Evaluating directional instructions given by residents may serve as an additional individualized assessment tool during surgery. Further research linking these skills to operative outcomes is justified.,2.3685972735685406e-08,0.043223857523040365,0.0181755829903978,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
43,0.9,5,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Is there an association between residents' leadership skills and their technical skill ratings? General surgery research residents' intraoperative leadership abilities were significantly correlated with their perceptions of skill decay and task difficulty in bowel repair operations. Assessing directional instructions provided by residents could offer an additional individualized metric for intraoperative evaluation. More research relating these findings to operative performance outcomes is needed.,1.4211583641411244e-07,0.12874603096120119,0.0181755829903978,0.010880558788691236,0.10536051565782412,0.0,0.0108648092457172,0.10724553035359774,0.0,1.4211583641411244e-07,0.10919929196499112,0.0
43,0.9,6,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Do leadership skills of general surgery residents relate to their technical skill ratings? Intraoperative leadership among these residents correlated significantly with their views on skill decay and task difficulty during bowel repair interventions. Evaluating residents' directional commands may provide a supplementary individualized intraoperative assessment measure. Additional studies examining operative performance outcomes are warranted.,7.105791820705622e-08,0.030884114630681303,0.0181755829903978,0.005440279394345618,0.05715841383995013,0.0,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
43,0.9,7,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,How do residents' leadership skills relate to ratings of their technical abilities? Research on general surgery residents showed significant correlations between intraoperative leadership skills and perceptions of both skill decay and task difficulty during bowel repair. Considering residents' directional instructions might add another personalized intraoperative assessment metric. Further analysis related to operative performance outcomes is recommended.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
43,0.9,8,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Are leadership skills of surgery residents linked to their technical skill ratings? Findings from general surgery resident research revealed significant correlations between intraoperative leadership and perceived skill decay and task difficulty in bowel repair. Evaluating residents' directional instructions could provide a more individualized intraoperative assessment tool. Continued research on operative performance outcomes is necessary.,4.737194547137081e-08,0.011835919659988203,0.0181755829903978,0.0036268529295637453,0.03774032798284743,0.0,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
43,0.9,9,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Can resident leadership skills predict technical skill ratings? Studies of general surgery research residents found significant correlations between intraoperative leadership skills and perceptions of skill decay and task difficulty during bowel repair procedures. Assessing directional instructions by residents may offer an additional individualized metric for intraoperative evaluation. Further research on operative performance outcomes is warranted.,2.3685972735685406e-08,0.01881590444635073,0.0003363429618983803,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
43,0.9,10,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Do residents' leadership capabilities correspond to ratings of their technical skill? Research involving general surgery residents found that intraoperative leadership skills were significantly correlated with their perceptions of skill decay and difficulty of tasks during bowel repair. Evaluating residents' directional instructions could serve as an additional individualized intraoperative assessment metric. More evaluation regarding operative performance outcomes is advisable.,4.737194547137081e-08,0.060923434622440986,0.0181755829903978,0.0036268529295637453,0.036367644170874236,0.0,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
44,0.9,1,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is the angiotensin-converting enzyme-1 (ACE-1) gene polymorphism associated with chronic kidney disease in patients with hypertension? Answer: The ACE-DD genotype is identified as a potential risk factor for causing and progressing chronic kidney failure in hypertensive individuals.,2.36859727356853e-08,0.008827198864009844,0.025462962962962975,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
44,0.9,2,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does the polymorphism of the ACE-1 gene contribute to chronic kidney disease in people with hypertension? Answer: It is concluded that the ACE-DD genotype might increase the risk for chronic kidney failure among those with hypertension.,4.73719454713706e-08,0.019612536856477902,0.02471403376165281,0.0036268529295637453,0.055569851154812167,0.0,0.00362160308190574,0.05715841383994835,0.0,4.737194547137081e-08,0.058840500022933284,0.0
44,0.9,3,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is there a link between ACE-1 gene polymorphism and chronic kidney disease in hypertensive patients? Answer: Findings suggest that the ACE-DD genotype could be a risk factor in the onset and advancement of chronic kidney failure in hypertensive patients.,2.36859727356853e-08,0.027846328995862812,0.0013369225080936895,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
44,0.9,4,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does having the ACE-1 gene polymorphism cause chronic kidney disease in hypertensive patients? Answer: The ACE-DD genotype may represent a risk factor for the development and causation of chronic kidney failure in patients with hypertension.,7.10579182070559e-08,0.04888364744311113,0.02392242299970098,0.005440279394345625,0.08455738802806367,0.0,0.005432404622858614,0.08701137698963013,0.0,7.105791820705622e-08,0.08961215868968697,0.0
44,0.9,5,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is chronic kidney disease among hypertensive patients influenced by polymorphisms in the ACE-1 gene? Answer: The study concludes that the ACE-DD genotype likely plays a role as a risk factor in chronic kidney failure among hypertensive individuals.,2.36859727356853e-08,0.028640216301393462,0.001408415217939038,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
44,0.9,6,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Can ACE-1 gene polymorphism lead to chronic kidney disease in patients with hypertension? Answer: It is determined that the ACE-DD genotype could be a contributing risk factor to the causation and progression of chronic kidney failure in hypertensive patients.,2.36859727356853e-08,0.06339233825534718,0.026845867104408186,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
44,0.9,7,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does the ACE-1 gene polymorphism increase the risk of chronic kidney disease in hypertensive patients? Answer: The ACE-DD genotype may serve as a risk factor for causing and developing chronic kidney failure in those with hypertension.,4.73719454713706e-08,0.019612536856477902,0.02471403376165281,0.0036268529295637453,0.055569851154812167,0.0,0.00362160308190574,0.05715841383994835,0.0,4.737194547137081e-08,0.058840500022933284,0.0
44,0.9,8,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is the ACE-1 gene polymorphism involved in chronic kidney disease development among hypertensive patients? Answer: It is concluded that the ACE-DD genotype might be associated with an increased risk of chronic kidney failure in hypertensive individuals.,4.73719454713706e-08,0.019612536856477902,0.02471403376165281,0.0036268529295637453,0.055569851154812167,0.0,0.00362160308190574,0.05715841383994835,0.0,4.737194547137081e-08,0.058840500022933284,0.0
44,0.9,9,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does the presence of ACE-1 polymorphism affect the incidence of chronic kidney disease in hypertensive patients? Answer: The ACE-DD genotype is considered a potential risk factor in the causation and progression of chronic kidney failure among patients with hypertension.,2.36859727356853e-08,0.027846328995862812,0.0013369225080936895,0.0018134264647818726,0.009813183473625475,0.026296566837107373,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
44,0.9,10,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is the ACE-1 gene polymorphism a risk factor for chronic kidney disease in hypertensive patients? Answer: The conclusion is that the ACE-DD genotype may contribute as a risk factor to chronic kidney failure development in hypertensive patients.,2.36859727356853e-08,0.10357504663219874,0.05405060708091009,0.0018134264647818726,0.06590715088589016,0.02775510204081633,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
45,0.9,1,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Are laboratories accurately reporting serum quantitative hCG results? Several factors lead to errors in hCG result reporting, such as (a) the intricate structure of the hCG molecule and confusion over the different forms of hCG; (b) laboratory staff's unawareness of the differences among hCG forms and their failure to understand assay specificity; (c) lack of",2.3685972735685406e-07,0.07909115538510125,0.0929502975466984,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
45,0.9,2,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Is the reporting of serum quantitative hCG results by laboratories correct? Errors in hCG reporting arise from multiple causes, including (a) the complexity of the hCG molecule and the confusing nomenclature of its various forms; (b) laboratory personnel's insufficient knowledge about the differences in hCG forms and inability to recognize assay specificity; (c) lack of",2.3685972735685406e-07,0.07909115538510125,0.0929502975466984,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
45,0.9,3,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of",Do laboratories report serum quantitative hCG results properly? Incorrect reporting of hCG results stems from factors such as (a) the complexity and confusing nomenclature of the different hCG molecular forms; (b) laboratory workers not being aware of distinctions among hCG forms and not understanding the specificity of measurement assays; (c) lack of,3.079176455639103e-07,0.13775969380143405,0.09186222349899459,0.023574544042164344,0.23111172096338972,0.0,0.023540420032387266,0.23531408693446476,0.0,3.079176455639103e-07,0.23967285326541932,0.0
45,0.9,4,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of",Are serum quantitative hCG results being correctly reported by laboratories? Mistakes in hCG reporting can be attributed to (a) the complexity and confusing naming of various hCG molecules; (b) laboratory personnel's lack of knowledge on hCG form differences and failure to appreciate assay specificity; (c) lack of,4.263475092423373e-07,0.24389852159915382,0.08973382843726618,0.03264167636607371,0.3364722366212156,0.0,0.0325944277371516,0.34294475112682976,0.0,4.263475092423373e-07,0.3496737484797481,0.0
45,0.9,5,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of",Is the serum quantitative hCG reporting by labs accurate? Inaccurate hCG result reporting occurs due to factors including (a) the complicated hCG molecule and confusion about the different hCG forms' names; (b) laboratory staff's ignorance regarding the distinct forms of hCG and their lack of recognition of assay specificity; (c) lack of,3.079176455639103e-07,0.13775969380143405,0.09186222349899459,0.023574544042164344,0.23111172096338972,0.0,0.023540420032387266,0.23531408693446476,0.0,3.079176455639103e-07,0.23967285326541932,0.0
45,0.9,6,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of",Do laboratories report serum quantitative hCG results without errors? Many causes for erroneous hCG result reporting include (a) the complexity of the hCG molecule and confusing names of its forms; (b) lab personnel's failure to recognize differences between forms and assay measurement specificity; (c) lack of,4.500334819780227e-07,0.23574059438054018,0.11146222349899458,0.03445510283085558,0.35894509247327333,0.0,0.034405229278104466,0.3659342693515293,0.0,4.500334819780227e-07,0.3732042458899425,0.0
45,0.9,7,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of",Are laboratories correctly reporting serum quantitative hCG outcomes? Errors in hCG reporting often arise from (a) the complex nature and confusing nomenclature of hCG molecular forms; (b) laboratory staff unawareness of the distinctions between hCG forms and assay specificity; (c) lack of,5.447773729207643e-07,0.32883101744655185,0.11146222349899458,0.04170880868998307,0.454255272277599,0.0,0.04164843544191593,0.46357273891544715,0.0,5.447773729207643e-07,0.4732877044469239,0.0
45,0.9,8,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of",Is the serum quantitative hCG result reporting by labs error-free? Faults in hCG reporting result from (a) the complex hCG molecule and confusion about various forms' names; (b) lab personnel's lack of understanding of hCG form differences and assay specificity; (c) lack of,5.210914001850789e-07,0.3377404744655834,0.08766686359417603,0.0398953822252012,0.4295626596872273,0.0,0.039837633900963065,0.4382549309311554,0.0,5.210914001850789e-07,0.44731221804366594,0.0
45,0.9,9,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of",Are serum quantitative hCG measurements reported correctly by laboratories? Misreporting of hCG results is due to factors like (a) the complex hCG molecule and confusing nomenclature of its forms; (b) laboratory staff's ignorance about hCG form differences and assay specificity; (c) lack of,5.210914001850789e-07,0.30473346586749184,0.11146222349899458,0.0398953822252012,0.4295626596872273,0.0,0.039837633900963065,0.4382549309311554,0.0,5.210914001850789e-07,0.44731221804366594,0.0
45,0.9,10,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of",Do labs provide accurate serum quantitative hCG result reports? Several factors contribute to incorrect hCG reporting including (a) the complexity and confusing names of hCG molecular types; (b) lab personnel's lack of awareness of the differences among hCG forms and failure to recognize assay specificity; (c) lack of,4.026615365066519e-07,0.2217511071454803,0.09019568285627247,0.030828249901291835,0.3144933299024406,0.0,0.030783626196198732,0.32047189527477205,0.0,4.026615365066519e-07,0.32668423025504856,0.0
46,0.9,1,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Does the fibronectin-aggrecan complex exist in cervical disk disease? Current studies show that this complex is present in cervical disk disease and is linked to intervertebral disc degeneration, which is a major factor in the condition. Further research is necessary to clarify its exact role.",1.6580180914979784e-07,0.017068327667025596,0.15259336112306826,0.012693985253473108,0.07215874459196625,0.056152454680675055,0.012675610786670066,0.12585895817175086,0.020399305555555556,1.6580180914979784e-07,0.1576289442035832,0.0
46,0.9,2,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex found in cases of cervical disk disease? Research suggests that it is indeed present and connected to intervertebral disc degeneration, an important contributor to the disease. However, additional studies are required to fully understand its function.",2.8423167282822477e-07,0.04054628007068706,0.19794483504597077,0.02176111757738247,0.16353329681216788,0.07939508506616258,0.0217296184914344,0.25261066381089314,0.020399305555555556,2.8423167282822487e-07,0.2876820724517808,0.0
46,0.9,3,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex involved in cervical disk disease? Existing research confirms the presence of this complex in cervical disk disease and ties it to intervertebral disc degeneration, which plays a critical role in the disease. More investigation is needed for comprehensive insight.",2.1317375462116866e-07,0.03245232511314766,0.15044483504597075,0.016320838183036854,0.12135944742253635,0.05502008506616258,0.0162972138685758,0.17464912234118257,0.020399305555555556,2.1317375462116866e-07,0.20763936477824663,0.0
46,0.9,4,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Does cervical disk disease feature the fibronectin-aggrecan complex? Evidence points to the presence of this complex in cervical disk disease, where it is associated with intervertebral disc degeneration, a key element of the pathology. Further studies are needed to determine its full impact.",2.1317375462116866e-07,0.0005546834849448068,0.1741494751411522,0.016320838183036854,0.08754738983424648,0.07939508506616258,0.0162972138685758,0.17464912234118257,0.020399305555555556,2.1317375462116866e-07,0.20763936477824663,0.0
46,0.9,5,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex observed in cervical disk disease? Current findings indicate that it is present and related to intervertebral disc degeneration, which significantly contributes to cervical disk disease. More research is essential to understand its precise role.",3.3160361829959537e-07,0.13065742872150832,0.17093866220646461,0.025387970506946217,0.21760051808244407,0.07939508506616258,0.025351221573340132,0.3081805149657053,0.020399305555555556,3.316036182995957e-07,0.34484048629172914,0.0
46,0.9,6,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is there a presence of the fibronectin-aggrecan complex in cervical disk disease? Research to date confirms its presence and links it with intervertebral disc degeneration, a primary contributor to the disease. Additional research is required to fully elucidate its role.",2.8423167282822477e-07,0.04054628007068706,0.19794483504597077,0.02176111757738247,0.16353329681216788,0.07939508506616258,0.0217296184914344,0.25261066381089314,0.020399305555555556,2.8423167282822487e-07,0.2876820724517808,0.0
46,0.9,7,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Does the fibronectin-aggrecan complex play a part in cervical disk disease? Research shows that this complex is found in cervical disk disease and is associated with intervertebral disc degeneration, which is a central factor. More studies are needed to better understand its role.",2.1317375462116866e-07,0.03245232511314766,0.15044483504597075,0.016320838183036854,0.12135944742253635,0.05502008506616258,0.0162972138685758,0.17464912234118257,0.020399305555555556,2.1317375462116866e-07,0.20763936477824663,0.0
46,0.9,8,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex detectable in cervical disk disease? Current research indicates its presence and association with intervertebral disc degeneration, a key driver of cervical disk disease. Further investigation is needed for complete understanding.",4.2634750924233657e-07,0.2496092847677871,0.16767139754597077,0.03264167636607373,0.3353835537388279,0.07939508506616258,0.03259442773715163,0.4295413719699721,0.020399305555555556,4.263475092423373e-07,0.47000362924573613,0.0
46,0.9,9,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex present in patients with cervical disk disease? Studies suggest it is present and linked to intervertebral disc degeneration, a significant factor in the disease’s development. More research is necessary to clarify its exact role.",3.3160361829959537e-07,0.0931900135561059,0.19794483504597077,0.025387970506946217,0.21760051808244407,0.07939508506616258,0.025351221573340132,0.3081805149657053,0.020399305555555556,3.316036182995957e-07,0.34484048629172914,0.0
46,0.9,10,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Can the fibronectin-aggrecan complex be found in cervical disk disease? Existing research confirms its presence and connection to intervertebral disc degeneration, an important aspect of cervical disk disease. More research is needed to fully comprehend its role.",3.5528959103528067e-07,0.15909716444199606,0.17018973300515444,0.02720139697172809,0.24577139504914092,0.07939508506616258,0.027162023114293006,0.3371680518389568,0.020399305555555556,3.552895910352811e-07,0.3746934494414109,0.0
47,0.9,1,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Does the criteria for residency selection forecast success in Orthopaedic Surgery Residency? Residency selection benchmarks can somewhat reflect a candidate’s potential to perform well in Orthopaedic Surgery Residency. Elements such as medical school grades, board examination results, recommendation letters, and interview outcomes offer some predictive value regarding a resident's success. Nevertheless, personal commitment and adaptability remain vital factors.",0.0,0.04864190740771601,0.03443914822119958,0.0,0.04951051289713915,0.035548546731432915,0.0,0.025205352020361893,0.0181755829903978,0.0,0.0,0.0
47,0.9,2,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Is performance in Orthopaedic Surgery Residency predicted by the residency selection criteria? The standards used for selecting residents may indicate a candidate’s likelihood of excelling in Orthopaedic Surgery Residency. Medical school grades, board scores, recommendation letters, and interview results can help estimate a resident's performance. Still, the individual’s dedication and flexibility are essential components.",9.474389094274162e-08,0.003467580522380942,0.04923046779913968,0.0072537058591274906,0.026501709752626113,0.03417641077609469,0.007243206163811466,0.050302200487784,0.0181755829903978,9.474389094274162e-08,0.07696104113612989,0.0
47,0.9,3,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Can Residency Selection Criteria predict how well one will perform in Orthopaedic Surgery Residency? Selection criteria for residency provide some insight into a candidate’s potential success in Orthopaedic Surgery Residency. Key factors like academic grades, board scores, recommendation letters, and interview evaluations have some predictive ability. Yet, the candidate’s own dedication and adaptability are critical influences.",4.737194547137081e-08,0.010270629856125701,0.03254437869822491,0.0036268529295637453,0.012226007376317849,0.034887860448558225,0.003621603081905733,0.011835919659988203,0.0181755829903978,4.737194547137081e-08,0.03774032798284743,0.0
47,0.9,4,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Do Residency Selection Criteria serve as predictors of performance in Orthopaedic Surgery Residency? These criteria can offer an indication of a candidate’s potential achievements during Orthopaedic Surgery Residency. Medical school grades, board examination outcomes, letters of recommendation, and interviews contribute to predicting residents' capability. However, personal commitment and adaptability significantly impact success.",1.4211583641411244e-07,0.016803108965834923,0.0673082840236687,0.010880558788691236,0.039062915961295186,0.0533997864008544,0.0108648092457172,0.09030753510148237,0.0181755829903978,1.4211583641411244e-07,0.11778303565638426,0.0
47,0.9,5,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Are Residency Selection Criteria reliable predictors of performance in Orthopaedic Surgery Residency? The criteria used to select residents can give some indication of how well a candidate might perform. Academic records, board scores, recommendation letters, and interview performances provide partial predictive insight. Nonetheless, dedication and adaptability are important for success.",1.8948778188548325e-07,0.029626201204633773,0.0869082840236687,0.014507411718254981,0.07988491048154955,0.0533997864008544,0.014486412327622933,0.1319802315020513,0.0181755829903978,1.8948778188548325e-07,0.16034265007518078,0.0
47,0.9,6,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Does the Residency Selection Criteria help foresee success in Orthopaedic Surgery Residency? Selection benchmarks can partially predict a candidate’s performance potential in Orthopaedic Surgery Residency. Factors such as grades, board exam results, recommendation letters, and interviews offer some foresight. Yet, individual commitment and adaptability remain key.",2.8423167282822487e-07,0.17639709226138045,0.04255998764724901,0.02176111757738247,0.19840297749663138,0.030684805330005293,0.0217296184914344,0.2209277175185469,0.0181755829903978,2.8423167282822487e-07,0.25131442828090744,0.0
47,0.9,7,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Is performance in Orthopaedic Surgery Residency influenced by the residency selection criteria? Selection criteria can somewhat anticipate a candidate’s potential success. Medical grades, board scores, letters of recommendation, and interview results provide predictive clues, but personal dedication and adaptability are crucial too.",3.789755637709665e-07,0.20787443261095273,0.0869082840236687,0.029014823436509962,0.26220646727550445,0.0533997864008544,0.028972824655245866,0.31856618708246476,0.0181755829903978,3.789755637709665e-07,0.35139788683788886,0.0
47,0.9,8,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Can the selection criteria for residency predict a candidate's performance in Orthopaedic Surgery Residency? These criteria provide some indication of potential success, including medical school grades, board exam scores, recommendation letters, and interview performance, though dedication and adaptability also play essential roles.",3.789755637709665e-07,0.20787443261095273,0.0869082840236687,0.029014823436509962,0.26220646727550445,0.0533997864008544,0.028972824655245866,0.31856618708246476,0.0181755829903978,3.789755637709665e-07,0.35139788683788886,0.0
47,0.9,9,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Do the criteria used for residency selection predict performance in Orthopaedic Surgery Residency? They offer some indication of a candidate’s ability to succeed. Academic achievement, board results, recommendation letters, and interviews can partly forecast performance, with dedication and adaptability also being important.",3.789755637709665e-07,0.20787443261095273,0.0869082840236687,0.029014823436509962,0.26220646727550445,0.0533997864008544,0.028972824655245866,0.31856618708246476,0.0181755829903978,3.789755637709665e-07,0.35139788683788886,0.0
47,0.9,10,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Are the Residency Selection Criteria effective predictors of success in Orthopaedic Surgery Residency? They can somewhat signal a candidate’s future performance. Factors like medical grades, board scores, recommendation letters, and interview assessments help predict success, yet personal commitment and adaptability remain critical.",3.789755637709665e-07,0.20787443261095273,0.0869082840236687,0.029014823436509962,0.26220646727550445,0.0533997864008544,0.028972824655245866,0.31856618708246476,0.0181755829903978,3.789755637709665e-07,0.35139788683788886,0.0
48,0.9,1,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Does amblyopia cause permanent vision loss? In older individuals who have amblyopia, if the eye that was previously normal begins to lose vision, the amblyopic eye may regain visual function gradually over time. This restoration happens following the vision loss in the better eye.",1.4211583641411244e-07,0.060487214608413886,0.2130881557598702,0.010880558788691236,0.13353139262452318,0.0,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
48,0.9,2,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Is the vision loss from amblyopia irreversible? Among elderly patients with amblyopia, when the previously unaffected eye suffers vision loss, there can be a gradual recovery of sight in the amblyopic eye. This improvement in function follows the decline in the normal eye.",1.6580180914979784e-07,0.003949708600127888,0.18929279585505165,0.012693985253473108,0.1576289442035832,0.0,0.012675610786670066,0.16126814759612174,0.0,1.6580180914979784e-07,0.1650797503594501,0.0
48,0.9,3,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Is visual impairment due to amblyopia permanent? In older adults with a history of amblyopia, vision loss in the previously good eye can lead to recovery of vision in the amblyopic eye over time. This recovery occurs subsequent to the loss of vision in the normal eye.",7.105791820705622e-08,0.003993799992664915,0.07930130768730784,0.005440279394345618,0.12615160385401092,0.04434829637641969,0.0054324046228586,0.09746465781724867,0.022714981070849107,7.105791820705622e-08,0.06744128079553224,0.0
48,0.9,4,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,Does visual loss from amblyopia last forever? Older individuals with amblyopia who experience vision loss in their previously normal eye may recover visual ability in their amblyopic eye over a certain period. This improvement follows the loss in the unaffected eye.,2.1317375462116866e-07,0.08114816502720634,0.16322665991499485,0.016320838183036854,0.20763936477824663,0.0,0.0162972138685758,0.21256144198367144,0.0,2.1317375462116866e-07,0.21772348384486895,0.0
48,0.9,5,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Is the visual loss caused by amblyopia permanent? For older people with amblyopia, if the previously normal eye undergoes vision loss, visual function in the amblyopic eye can improve gradually after the loss in the good eye.",3.0791764556390986e-07,0.15570213932681298,0.18533305371905387,0.023574544042164344,0.31585294941847764,0.0,0.023540420032387273,0.323787077093896,0.0,3.079176455639103e-07,0.3321338350226144,0.0
48,0.9,6,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Is vision loss from amblyopia permanent? In elderly patients with amblyopia, when the previously normal eye suffers visual loss, the amblyopic eye can regain visual function over time. This happens following the loss in the normal eye.",3.0791764556390986e-07,0.11719396262903814,0.2130881557598702,0.023574544042164344,0.31585294941847764,0.0,0.023540420032387273,0.323787077093896,0.0,3.079176455639103e-07,0.3321338350226144,0.0
48,0.9,7,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Is amblyopic vision loss permanent? Among older individuals with amblyopia, the onset of vision loss in the formerly normal eye can lead to functional recovery in the amblyopic eye over time. This recovery occurs after the vision loss in the normal eye.",1.8948778188548325e-07,0.18172542201812192,0.017621720783339567,0.014507411718254981,0.251636274849949,0.049861495844875335,0.014486412327622933,0.2221319648398974,0.025623268698060954,1.8948778188548325e-07,0.19105523676270808,0.0
48,0.9,8,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Is the loss of vision from amblyopia permanent? In older adults who have amblyopia, if the previously normal eye loses sight, the amblyopic eye may experience a gradual restoration of visual function. This takes place after vision loss in the previously good eye.",1.6580180914979784e-07,0.003949708600127888,0.18929279585505165,0.012693985253473108,0.1576289442035832,0.0,0.012675610786670066,0.16126814759612174,0.0,1.6580180914979784e-07,0.1650797503594501,0.0
48,0.9,9,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Will vision loss from amblyopia ever recover? In elderly individuals with amblyopia, visual loss in the previously normal eye can prompt a recovery of vision in the amblyopic eye over a period of time. This recovery follows the loss in the normal eye.",1.6580180914979784e-07,0.07452259773331038,0.09080018731805557,0.012693985253473108,0.19144100179187307,0.024375,0.012675610786670066,0.16126814759612174,0.0,1.6580180914979784e-07,0.1650797503594501,0.0
48,0.9,10,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Is the vision loss due to amblyopia lasting? Among older people with a history of amblyopia, if the previously normal eye develops visual loss, visual function in the amblyopic eye can recover gradually over time. This recovery happens after the loss of vision in the normal eye.",7.105791820705622e-08,0.09779166146655749,0.1913597606981418,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
49,0.9,1,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Do high flow nasal cannulae produce more noise than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not louder than bubble CPAP for preterm infants.",4.73719454713706e-08,0.14759007193636497,0.02682516425905998,0.003626852929563759,0.1464694910033857,0.039867674858222985,0.003621603081905747,0.1447354321242127,0.044820011337868504,4.737194547137081e-08,0.14224822387763325,0.04424462809917353
49,0.9,2,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Are high flow nasal cannulae louder compared to bubble CPAP in preterm infants? Answer: No, high flow nasal cannulae do not generate more noise than bubble CPAP for preterm infants.",7.10579182070559e-08,0.3312751522847708,0.11358979822649115,0.005440279394345639,0.3335068676369093,0.1414128943758573,0.005432404622858621,0.28562527018904804,0.11852971641331433,7.105791820705622e-08,0.233307565749707,0.08264462809917354
49,0.9,3,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Is the noise level of high flow nasal cannulae higher than that of bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP in preterm infants.",1.421158364141118e-07,0.4433889001026703,0.12486124881011589,0.010880558788691277,0.44091005054360854,0.14777777777777773,0.010864809245717241,0.39219930445677864,0.1219727891156463,1.4211583641411244e-07,0.33866808140753246,0.08264462809917354
49,0.9,4,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Compared to bubble CPAP, do high flow nasal cannulae make more noise for preterm infants? Answer: No, high flow nasal cannulae do not cause more noise than bubble CPAP for preterm infants.",1.184298636784265e-07,0.36404442764667744,0.09287568064627669,0.009067132323909398,0.40636640392032053,0.14579072532699167,0.009054007704764368,0.3579188425358084,0.1209013133592716,1.1842986367842703e-07,0.3047665297318507,0.08264462809917354
49,0.9,5,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Are high flow nasal cannulae associated with greater noise than bubble CPAP in preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.",7.10579182070559e-08,0.28506534024744123,0.08376731301939058,0.005440279394345639,0.2857036138051887,0.10792899408284021,0.005432404622858621,0.28562527018904804,0.11852971641331433,7.105791820705622e-08,0.233307565749707,0.08264462809917354
49,0.9,6,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Do high flow nasal cannulae generate more noise than bubble CPAP in preterm infants? Answer: No, high flow nasal cannulae are not louder than bubble CPAP for preterm infants.",4.73719454713706e-08,0.24319657959980656,0.07883675746383503,0.003626852929563759,0.24549051679766398,0.10439999999999992,0.003621603081905747,0.24742390331827924,0.11721276281715845,4.737194547137081e-08,0.19556723776686002,0.08264462809917354
49,0.9,7,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Is there more noise from high flow nasal cannulae than from bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae produce no more noise than bubble CPAP for preterm infants.",1.184298636784265e-07,0.2774010300766845,0.04216731301939056,0.009067132323909398,0.3169280580416176,0.08379972565157745,0.009054007704764368,0.31170903049847887,0.08786848072562363,1.1842986367842703e-07,0.3047665297318507,0.08264462809917354
49,0.9,8,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae do not emit more noise than bubble CPAP in preterm infants.",4.73719454713706e-08,0.243196579599807,0.078836757463835,0.003626852929563759,0.2454905167976631,0.10439999999999994,0.003621603081905747,0.24742390331827924,0.11721276281715845,4.737194547137081e-08,0.19556723776686002,0.08264462809917354
49,0.9,9,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Does the high flow nasal cannula produce more noise than bubble CPAP in preterm infants? Answer: No, high flow nasal cannulae are not louder than bubble CPAP for preterm infants.",7.10579182070559e-08,0.3312751522847712,0.11358979822649115,0.005440279394345639,0.3335068676369093,0.1414128943758573,0.005432404622858621,0.3351357830861872,0.1541950113378685,7.105791820705622e-08,0.233307565749707,0.08264462809917354
49,0.9,10,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: For preterm infants, are high flow nasal cannulae noisier than bubble CPAP? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.",0.0,0.1026884711940661,0.03968568036632933,0.0,0.15995704166768032,0.09657844990548202,0.0,0.16635532333438796,0.11426445578231295,0.0,0.11552453009332275,0.08264462809917354
50,0.9,1,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is emergency double-balloon enteroscopy with real-time capsule endoscopy viewing a viable method for acute overt-obscure gastrointestinal bleeding? Yes, this combined technique is effective for immediate diagnosis and treatment, reducing complication risks and enhancing patient outcomes.",5.921493183921345e-07,0.2222257149560254,0.21432098765432098,0.04533566161954683,0.32491917992133734,0.16493055555555558,0.045270038523821686,0.3827477354039619,0.13660974593919203,5.921493183921352e-07,0.44283294755858593,0.10560000000000004
50,0.9,2,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Can emergency double-balloon enteroscopy paired with live capsule endoscopy viewing be used in acute overt-obscure gastrointestinal bleeding? Yes, this approach is practical and allows for prompt diagnosis and treatment, improving patient prognosis and decreasing complications.",5.921493183921345e-07,0.2222257149560254,0.21432098765432098,0.04533566161954683,0.32491917992133734,0.16493055555555558,0.045270038523821686,0.3827477354039619,0.13660974593919203,5.921493183921352e-07,0.44283294755858593,0.10560000000000004
50,0.9,3,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Does combining emergency double-balloon enteroscopy with real-time capsule endoscopy viewing provide a feasible solution for acute overt-obscure gastrointestinal bleeding? Yes, it enables rapid diagnosis and therapeutic intervention, minimizing complications and benefiting patient recovery.",6.395212638635051e-07,0.28285033677246085,0.21432098765432098,0.04896251454911059,0.38743953690267086,0.16493055555555558,0.04889164160572743,0.4472862565415334,0.13660974593919203,6.39521263863506e-07,0.5095243220572594,0.10560000000000004
50,0.9,4,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is the use of emergency double-balloon enteroscopy alongside real-time capsule endoscopy feasible for acute overt-obscure gastrointestinal bleeding? Yes, this dual approach facilitates immediate diagnosis and treatment, which helps reduce risks and improve outcomes.",6.395212638635051e-07,0.28285033677246085,0.21432098765432098,0.04896251454911059,0.38743953690267086,0.16493055555555558,0.04889164160572743,0.4472862565415334,0.13660974593919203,6.39521263863506e-07,0.5095243220572594,0.10560000000000004
50,0.9,5,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is emergency double-balloon enteroscopy combined with real-time capsule endoscopy a workable method in cases of acute overt-obscure gastrointestinal bleeding? Yes, it is effective and allows for timely diagnosis and treatment, leading to fewer complications and better patient outcomes.",5.210914001850786e-07,0.13766832692796172,0.21432098765432098,0.0398953822252012,0.2379078029317072,0.16493055555555558,0.039837633900963065,0.2931355767142749,0.13660974593919203,5.210914001850789e-07,0.35045962742757064,0.10560000000000004
50,0.9,6,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Does emergency double-balloon enteroscopy with real-time capsule endoscopy enable a feasible combined approach for acute overt-obscure gastrointestinal bleeding? Yes, this method supports immediate diagnosis and therapy, reducing complication rates and enhancing patient results.",6.395212638635051e-07,0.28285033677246085,0.21432098765432098,0.04896251454911059,0.38743953690267086,0.16493055555555558,0.04889164160572743,0.4472862565415334,0.13660974593919203,6.39521263863506e-07,0.5095243220572594,0.10560000000000004
50,0.9,7,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Can combining emergency double-balloon enteroscopy and real-time viewing of capsule endoscopy effectively address acute overt-obscure gastrointestinal bleeding? Yes, it is a viable technique for prompt diagnosis and treatment, improving outcomes and lowering complication risks.",6.158352911278198e-07,0.25207867810570717,0.21432098765432098,0.04714908808432871,0.35569083858809103,0.16493055555555558,0.04708084006477456,0.4144964337185417,0.13660974593919203,6.158352911278206e-07,0.47562277038157763,0.10560000000000004
50,0.9,8,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is it feasible to use emergency double-balloon enteroscopy together with real-time capsule endoscopy viewing in acute overt-obscure gastrointestinal bleeding? Yes, this combination allows for swift diagnosis and intervention, decreasing the chance of complications and improving patient care.",5.447773729207639e-07,0.16506730111607704,0.21432098765432098,0.04170880868998307,0.26607867989840406,0.16493055555555558,0.04164843544191594,0.32212311358752643,0.13660974593919203,5.447773729207643e-07,0.3803125905772524,0.10560000000000004
50,0.9,9,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Does the combination of emergency double-balloon enteroscopy and real-time capsule endoscopy viewing work well in acute overt-obscure gastrointestinal bleeding? Yes, this approach permits immediate diagnosis and treatment, reducing complications and supporting better patient outcomes.",6.158352911278198e-07,0.25207867810570717,0.21432098765432098,0.04714908808432871,0.35569083858809103,0.16493055555555558,0.04708084006477456,0.4144964337185417,0.13660974593919203,6.158352911278206e-07,0.47562277038157763,0.10560000000000004
50,0.9,10,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Can emergency double-balloon enteroscopy combined with capsule endoscopy in real time be applied effectively in acute overt-obscure gastrointestinal bleeding? Yes, this strategy offers prompt diagnosis and treatment, which lowers the risk of complications and enhances patient recovery.",5.447773729207639e-07,0.16506730111607704,0.21432098765432098,0.04170880868998307,0.26607867989840406,0.16493055555555558,0.04164843544191594,0.32212311358752643,0.13660974593919203,5.447773729207643e-07,0.3803125905772524,0.10560000000000004
51,0.9,1,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Does misclassification of gestational age account for the birthweight differences between Australian Aborigines and whites? It is unlikely that gestational age misclassification explains the observed differences in average birthweights between Aborigines and whites. These findings could aid in understanding other population comparisons.,7.105791820705622e-08,0.043721612314176816,0.01916457323037659,0.005440279394345618,0.04008125783265193,0.023242630385487524,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
51,0.9,2,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Is gestational age misclassification responsible for the birthweight disparities between Australian Aborigines and whites? Gestational age misclassification probably does not explain the reported birthweight differences between Aborigines and whites. The results may assist in interpreting other comparisons between populations.,1.4211583641411222e-07,0.16152769578287884,0.010550571210042575,0.010880558788691236,0.15551021446776492,0.0037635424540186403,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
51,0.9,3,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Could errors in gestational age classification explain the birthweight variation between Australian Aborigines and whites? It is improbable that gestational age misclassification accounts for the noted difference in average birthweights between Aborigines and whites. The findings might contribute to interpreting other inter-population comparisons.,4.737194547137081e-08,0.018013962754721113,0.020316775728732916,0.0036268529295637453,0.01538864524228023,0.023242630385487524,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
51,0.9,4,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Does incorrect gestational age estimation explain the birthweight gap between Australian Aborigines and whites? Gestational age misclassification is unlikely to be the cause of the reported disparities in birthweights between Aborigines and whites. These results could help interpret other population differences.,9.474389094274162e-08,0.07010482778396288,0.017955279883857596,0.0072537058591274906,0.06539906581694366,0.023242630385487524,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
51,0.9,5,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Is the difference in birthweights between Australian Aborigines and whites due to gestational age misclassification? Misclassification of gestational age is an unlikely reason for the observed birthweight difference between Aborigines and whites. The findings may provide insight into other comparisons across populations.,7.105791820705622e-08,0.043721612314176816,0.01916457323037659,0.005440279394345618,0.04008125783265193,0.023242630385487524,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
51,0.9,6,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Can gestational age misclassification clarify the birthweight differences between Australian Aborigines and whites? It is doubtful that gestational age misclassification explains the reported birthweight divergence for Aborigines and whites. The results may support understanding other between-population analyses.,1.8948778188548283e-07,0.2216751554791192,0.014827852370440611,0.014507411718254981,0.2132210607748859,0.005304082417280635,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
51,0.9,7,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Does gestational age misclassification underlie the difference in birthweights between Australian Aborigines and whites? Gestational age misclassification is not a likely explanation for the birthweight differences observed between Aborigines and whites. The findings could help interpret other cross-population comparisons.,1.4211583641411222e-07,0.16152769578287884,0.010550571210042575,0.010880558788691236,0.15551021446776492,0.0037635424540186403,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
51,0.9,8,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Is gestational age misclassification a factor in the birthweight differences between Australian Aborigines and whites? The difference in average birthweights between Aborigines and whites is unlikely due to gestational age misclassification. These findings might assist in interpreting other population-level comparisons.,1.1842986367842692e-07,0.0971999362312288,0.01668456243435748,0.009067132323909363,0.09137455222020163,0.023242630385487524,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
51,0.9,9,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Might gestational age misclassification explain the birthweight differences between Australian Aborigines and whites? It seems unlikely that gestational age misclassification accounts for the reported birthweight differences for Aborigines and whites. The results may help interpret other between-population comparisons.,1.6580180914979753e-07,0.22862131185929035,0.0387029671546463,0.012693985253473108,0.18394995018825266,0.004512471655328806,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
51,0.9,10,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Is the discrepancy in birthweights between Australian Aborigines and whites attributable to gestational age misclassification? Gestational age misclassification is an improbable explanation for the noted birthweight divergence between Aborigines and whites. These findings may aid in the interpretation of other cross-population comparisons.,7.105791820705622e-08,0.043721612314176816,0.01916457323037659,0.005440279394345618,0.04008125783265193,0.023242630385487524,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
52,0.9,1,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Question: Is a zero central line-associated bloodstream infection (CLABSI) rate achievable long-term? Answer: Striving for a zero CLABSI rate is a crucial target in healthcare, yet sustaining it continuously is difficult. It demands strict infection prevention protocols, ongoing staff education, and diligent surveillance. Nonetheless, sporadic cases might still happen because of",4.737194547137081e-08,0.03862504712498804,0.05513508500578443,0.0036268529295637453,0.0687236348859015,0.07786328655500228,0.003621603081905733,0.042355667146938725,0.05975554549569943,4.737194547137081e-08,0.014910746910446804,0.040742417383431435
52,0.9,2,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Question: Can zero central line-associated bloodstream infection rates be maintained indefinitely? Answer: Maintaining a zero CLABSI rate is an important objective in clinical environments but keeping it indefinitely is challenging. It requires rigorous infection control practices, constant training of personnel, and thorough monitoring. Despite these precautions, occasional infections may still occur due to",0.0,0.13329753472306605,0.09506564056134,0.0,0.10872896949959987,0.07786328655500228,0.0,0.08317766166719309,0.05975554549569943,0.0,0.056583443311015724,0.040742417383431435
52,0.9,3,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Question: Is it feasible to sustain a zero central line-associated bloodstream infection rate? Answer: Achieving zero infections related to central lines is an ideal healthcare goal, however, continuous maintenance is tough. This requires strict infection control measures, ongoing education for staff, and meticulous monitoring. Even with these strategies, isolated incidents may arise because",0.0,0.13329753472306605,0.09506564056134,0.0,0.10872896949959987,0.07786328655500228,0.0,0.08317766166719309,0.05975554549569943,0.0,0.056583443311015724,0.040742417383431435
52,0.9,4,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Question: Is zero incidence of central line-associated bloodstream infections maintainable? Answer: While zero CLABSI rates represent a perfect standard in healthcare, sustaining this outcome constantly is challenging. It involves stringent infection prevention protocols, regular staff training, and continuous oversight. Despite such efforts, occasional infections may still occur due to",9.474389094274162e-08,0.05325482704952922,0.09506564056134,0.0072537058591274906,0.027050938485332576,0.07786328655500228,0.007243206163811466,0.00020394727185779615,0.05975554549569943,9.474389094274162e-08,0.02857436502929156,0.040742417383431435
52,0.9,5,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Question: Can healthcare settings sustain zero central line-associated bloodstream infection rates? Answer: Aiming for zero CLABSI is an excellent healthcare ambition, but maintaining it over time can be difficult. It calls for strict infection control policies, ongoing education, and vigilant surveillance. Nonetheless, infrequent cases might still arise owing to",9.474389094274162e-08,0.05325482704952922,0.09506564056134,0.0072537058591274906,0.027050938485332576,0.07786328655500228,0.007243206163811466,0.00020394727185779615,0.05975554549569943,9.474389094274162e-08,0.02857436502929156,0.040742417383431435
52,0.9,6,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Question: Is a continuous zero central line-associated bloodstream infection rate realistic? Answer: Seeking zero bloodstream infections from central lines is a key healthcare goal, yet sustaining it is demanding. It requires strict infection control regimes, permanent training of staff, and vigilant monitoring. Even with these measures, sporadic cases may still occur due to",0.0,0.10663802777845266,0.07584226493658028,0.0,0.10872896949959987,0.07786328655500228,0.0,0.08317766166719309,0.05975554549569943,0.0,0.056583443311015724,0.040742417383431435
52,0.9,7,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Question: How sustainable is a zero central line-associated bloodstream infection rate? Answer: Achieving zero CLABSI is an ideal aim in healthcare settings but maintaining it consistently proves challenging. This demands rigorous infection control measures, continuous staff development, and strict monitoring. Despite these efforts, occasional instances may still happen because of",7.105791820705622e-08,0.07387411425226498,0.09506564056134,0.005440279394345618,0.04810434768316574,0.07786328655500228,0.0054324046228586,0.021302257949105563,0.05975554549569943,7.105791820705622e-08,0.006595458310516555,0.040742417383431435
52,0.9,8,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Question: Is it possible to maintain zero central line-associated bloodstream infection rates indefinitely? Answer: Zero CLABSI rates are a desirable target in healthcare; however, preserving them indefinitely is difficult. It necessitates stringent infection control practices, ongoing training of healthcare workers, and constant surveillance. Despite such efforts, occasional infections may still occur due to",0.0,0.13329753472306605,0.09506564056134,0.0,0.10872896949959987,0.07786328655500228,0.0,0.08317766166719309,0.05975554549569943,0.0,0.056583443311015724,0.040742417383431435
52,0.9,9,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Question: Can a zero central line-associated bloodstream infection rate be upheld over time? Answer: Achieving zero bloodstream infections associated with central lines is a vital goal, but keeping it up continually is challenging. It requires rigorous infection control strategies, continuous personnel training, and persistent monitoring. Nevertheless, occasional cases might still arise due to",0.0,0.13329753472306605,0.09506564056134,0.0,0.10872896949959987,0.07786328655500228,0.0,0.08317766166719309,0.05975554549569943,0.0,0.056583443311015724,0.040742417383431435
52,0.9,10,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Question: Is the zero rate of central line-associated bloodstream infections sustainable in healthcare? Answer: Reaching a zero CLABSI rate is an ideal objective for healthcare facilities, but sustaining it perpetually is difficult. It demands strict infection prevention measures, ongoing staff education, and intensive monitoring. Despite these, isolated infections may still occur due to",0.0,0.13329753472306605,0.09506564056134,0.0,0.10872896949959987,0.07786328655500228,0.0,0.08317766166719309,0.05975554549569943,0.0,0.056583443311015724,0.040742417383431435
53,0.9,1,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,How is gender dimorphism characterized after injury and hemorrhagic shock: do hormonal differences play a role? The independent protective effect of being female on rates of multiple organ failure and nosocomial infections remains significant in both premenopausal and postmenopausal women compared to men of similar age. This finding contrasts with earlier experimental studies and known physiological changes in sex hormones following injury.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
53,0.9,2,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"In examining gender dimorphism after injury and hemorrhagic shock, are hormonal differences the cause? Female gender independently offers protection against multiple organ failure and nosocomial infection rates in both premenopausal and postmenopausal women when compared to age-matched men. This observation challenges prior experimental studies and the established hormone changes after injury.",2.6054570009253947e-07,0.19885085874516495,0.0,0.0199476911126006,0.20252426411147262,0.0,0.019918816950481533,0.20633643299782767,0.0,2.6054570009253947e-07,0.2102954088363611,0.0
53,0.9,3,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"What characterizes gender dimorphism after injury and hemorrhagic shock, and are hormonal differences to blame? Female gender consistently provides an independent protective effect against multiple organ failure and hospital-acquired infections in both premenopausal and postmenopausal women relative to similarly aged men. This is contrary to previous experimental research and the recognized physiological sex hormone changes post-injury.",1.4211583641411244e-07,0.10354067894083929,0.0,0.010880558788691236,0.10536051565782412,0.0,0.0108648092457172,0.10724553035359774,0.0,1.4211583641411244e-07,0.10919929196499112,0.0
53,0.9,4,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"How does gender dimorphism present after injury and hemorrhagic shock, and is it due to hormonal differences? Female gender shows an independent protective effect on the incidence of multiple organ failure and nosocomial infections in both pre- and postmenopausal women compared to men of the same age, contradicting earlier experimental findings and known sex hormone fluctuations.",1.4211583641411244e-07,0.10354067894083929,0.0,0.010880558788691236,0.10536051565782412,0.0,0.0108648092457172,0.10724553035359774,0.0,1.4211583641411244e-07,0.10919929196499112,0.0
53,0.9,5,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,What is the nature of gender dimorphism following injury and hemorrhagic shock: are hormonal differences responsible? The female gender independently protects against multiple organ failure and hospital infection rates in both premenopausal and postmenopausal women when compared with men of similar ages. This contradicts prior experimental studies and known sex hormone alterations after injury.,1.8948778188548325e-07,0.1405819506211894,0.0,0.014507411718254981,0.14310084364067155,0.0,0.014486412327622933,0.14571181118139354,0.0,1.8948778188548325e-07,0.14842000511827358,0.0
53,0.9,6,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"How can gender dimorphism be characterized after injury and hemorrhagic shock, and are hormones the cause? Female gender maintains an independent protective role against multiple organ failure and nosocomial infections in both pre- and postmenopausal women relative to age-matched men. This contrasts previous experimental data and the known physiological changes in sex hormones post-trauma.",1.8948778188548325e-07,0.1405819506211894,0.0,0.014507411718254981,0.14310084364067155,0.0,0.014486412327622933,0.14571181118139354,0.0,1.8948778188548325e-07,0.14842000511827358,0.0
53,0.9,7,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"What is the characterization of gender dimorphism after injury and hemorrhagic shock, and do hormonal differences explain it? Female gender independently reduces the risk of multiple organ failure and hospital-acquired infections in both premenopausal and postmenopausal women compared to men of similar age, opposing previous experimental results and documented sex hormone changes.",2.3685972735685406e-07,0.17904823144898518,0.0,0.018134264647818726,0.182321556793954,0.0,0.018108015409528666,0.1857171457950919,0.0,2.3685972735685406e-07,0.18924199963852795,0.0
53,0.9,8,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"How is gender dimorphism defined after injury and hemorrhagic shock, and are hormonal differences the reason? Female gender independently offers protection from multiple organ failure and nosocomial infection in both pre- and postmenopausal women compared to age-matched men, which contradicts earlier experimental studies and known sex hormone variations post-injury.",3.079176455639103e-07,0.23967285326541932,0.0,0.023574544042164344,0.24419696051204154,0.0,0.023540420032387266,0.2488960474166242,0.0,3.079176455639103e-07,0.25378052077609947,0.0
53,0.9,9,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"What describes gender dimorphism after injury and hemorrhagic shock, and does it result from hormonal differences? The female gender provides an independent protective effect against multiple organ failure and hospital infections in both pre- and postmenopausal women relative to age-similar men, a finding contrary to previous experimental studies and known physiological sex hormone changes.",1.8948778188548325e-07,0.1405819506211894,0.0,0.014507411718254981,0.14310084364067155,0.0,0.014486412327622933,0.14571181118139354,0.0,1.8948778188548325e-07,0.14842000511827358,0.0
53,0.9,10,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"How can we characterize gender dimorphism following injury and hemorrhagic shock, and are hormones responsible? Female gender independently confers protection against multiple organ failure and nosocomial infections in both pre- and postmenopausal women compared to age-matched men, challenging prior experimental studies and the known sex hormone dynamics following injury.",3.079176455639103e-07,0.23967285326541932,0.0,0.023574544042164344,0.24419696051204154,0.0,0.023540420032387266,0.2488960474166242,0.0,3.079176455639103e-07,0.25378052077609947,0.0
54,0.9,1,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Do African American women need less calories to keep their weight? Caloric needs for weight maintenance are influenced by individual factors such as age, height, weight, and physical activity, not race or ethnicity.",7.10579182070559e-08,0.08961215868968697,0.0,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
54,0.9,2,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Is a lower calorie intake necessary for African American women to maintain weight? Weight maintenance calories depend on personal characteristics like age, height, weight, and activity level, rather than racial or ethnic identity.",7.10579182070559e-08,0.08961215868968697,0.0,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
54,0.9,3,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Are fewer calories required by African American women to stay at their weight? Caloric requirements for maintaining weight are based on personal attributes including age, height, weight, and physical activity, not race or ethnicity.",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
54,0.9,4,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Do African American women have a lower caloric need to maintain weight? The calories needed for weight maintenance relate to factors like age, height, weight, and physical activity rather than race or ethnicity.",7.10579182070559e-08,0.08961215868968697,0.0,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
54,0.9,5,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Is caloric intake for weight maintenance lower for African American women? Calorie needs depend on age, height, weight, and physical activity, and not on racial or ethnic background.",1.894877818854824e-07,0.25951119548508395,0.0,0.014507411718255037,0.2682639865946794,0.0,0.014486412327622988,0.2776317365982801,0.0,1.8948778188548325e-07,0.28768207245178123,0.0
54,0.9,6,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Do African American women require fewer calories to maintain their weight? Caloric intake for weight maintenance is determined by individual characteristics such as age, height, weight, and physical activity level, not by race or ethnicity.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
54,0.9,7,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Are fewer calories necessary for African American women to maintain weight? Caloric needs are influenced by factors including age, height, weight, and physical activity, not by racial or ethnic factors.",1.421158364141118e-07,0.18805223150294026,0.0,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
54,0.9,8,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Do African American women have reduced caloric needs to sustain weight? Caloric intake for weight maintenance is shaped by age, height, weight, and activity level, not by ethnic or racial differences.",1.184298636784265e-07,0.1541506798272585,0.0,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
54,0.9,9,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Is a lower caloric intake required for African American women to keep their weight stable? The calories necessary for maintaining weight depend on individual factors like age, height, weight, and physical activity, not on race or ethnicity.",2.36859727356853e-08,0.028170876966696845,0.0,0.0018134264647818796,0.028987536873251507,0.0,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
54,0.9,10,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Do African American women need fewer calories to maintain their weight? The amount of calories needed for weight maintenance depends on personal factors such as age, height, weight, and physical activity rather than race or ethnicity.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
55,0.9,1,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Does increased neutrophil migratory activity following major trauma contribute to the development of acute respiratory distress syndrome (ARDS)? Yes, heightened neutrophil migration after significant trauma can play a role in causing ARDS by promoting lung inflammation and releasing damaging agents.",5.447773729207642e-07,0.14209904215023705,0.24826388888888892,0.04170880868998307,0.22330019670399315,0.17159999999999997,0.04164843544191593,0.2754824954098911,0.14532871972318342,5.447773729207643e-07,0.32954290328284186,0.11649408284023667
55,0.9,2,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Is the elevation of neutrophil migratory activity after major trauma a contributing factor to acute respiratory distress syndrome? Indeed, increased neutrophil movement post-trauma may lead to ARDS due to enhanced lung inflammation and toxic substance release.",6.395212638635054e-07,0.25031262679046806,0.24826388888888892,0.04896251454911057,0.3345258318142177,0.17159999999999997,0.04889164160572741,0.38989284658763657,0.14532871972318342,6.39521263863506e-07,0.4473259389392257,0.11649408284023667
55,0.9,3,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Can augmented neutrophil migratory activity after major trauma be a cause of acute respiratory distress syndrome? Yes, because higher neutrophil activity can induce lung inflammation and harmful secretions that may result in ARDS.",7.105791820705613e-07,0.33992478548015503,0.24826388888888892,0.05440279394345621,0.426899151945233,0.17159999999999997,0.05432404622858603,0.4852030263919618,0.14532871972318342,7.105791820705622e-07,0.545766011752479,0.11649408284023667
55,0.9,4,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Does major trauma-induced increase in neutrophil migration influence the etiology of acute respiratory distress syndrome? Yes, such an increase can cause lung inflammation and release injurious substances that contribute to ARDS development.",7.342651548062466e-07,0.37167348379473486,0.24826388888888892,0.056216220408238086,0.4596889747682247,0.17159999999999997,0.056134847769538906,0.5191045780676435,0.14532871972318342,7.342651548062476e-07,0.580857331563748,0.11649408284023667
55,0.9,5,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Is the rise in neutrophil migratory activity following major trauma linked to the onset of ARDS? Yes, as increased neutrophil activity can exacerbate lung inflammation and trigger the release of damaging compounds leading to ARDS.",6.632072365991907e-07,0.27930016366371957,0.24826388888888892,0.05077594101389245,0.36437879496389947,0.17159999999999997,0.050702443146680286,0.42066450525439025,0.14532871972318342,6.632072365991914e-07,0.4790746372538055,0.11649408284023667
55,0.9,6,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Could increased neutrophil migration after major trauma be a factor in the pathogenesis of acute respiratory distress syndrome? Yes, since enhanced neutrophil activity promotes lung inflammation and the discharge of harmful agents potentially causing ARDS.",6.632072365991907e-07,0.27930016366371957,0.24826388888888892,0.05077594101389245,0.36437879496389947,0.17159999999999997,0.050702443146680286,0.42066450525439025,0.14532871972318342,6.632072365991914e-07,0.4790746372538055,0.11649408284023667
55,0.9,7,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Is heightened neutrophil migratory activity post-major trauma a factor in acute respiratory distress syndrome etiology? Yes; this activity elevates lung inflammation and harmful substance release, contributing to ARDS.",8.290090457489878e-07,0.509823822275552,0.24826388888888892,0.06346992626736561,0.6027898184088971,0.17159999999999997,0.0633780539333504,0.6675245831859167,0.14532871972318342,8.290090457489892e-07,0.7350080113910069,0.11649408284023667
55,0.9,8,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Does increased neutrophil migratory activity after severe trauma contribute to acute respiratory distress syndrome? Yes, because it can intensify lung inflammation and the production of injurious substances that may provoke ARDS.",7.579511275419319e-07,0.40446330661772656,0.24826388888888892,0.058029646873019966,0.49359052644390644,0.17159999999999997,0.05794564931049178,0.5541958978789125,0.14532871972318342,7.57951127541933e-07,0.6172249757346226,0.11649408284023667
55,0.9,9,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Can the increased movement of neutrophils after major trauma play a role in causing acute respiratory distress syndrome? Yes, as elevated neutrophil activity can lead to lung inflammation and the release of harmful molecules resulting in ARDS.",6.158352911278201e-07,0.22214174982377122,0.24826388888888892,0.04714908808432869,0.3055382949409662,0.17159999999999997,0.04708084006477454,0.3600398834379548,0.14532871972318342,6.158352911278206e-07,0.416554280272472,0.11649408284023667
55,0.9,10,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Is increased neutrophil migratory activity after major trauma a contributing factor to ARDS? Yes, since it promotes inflammation in the lungs and the secretion of damaging substances that can lead to acute respiratory distress syndrome.",6.632072365991907e-07,0.27930016366371957,0.24826388888888892,0.05077594101389245,0.36437879496389947,0.17159999999999997,0.050702443146680286,0.42066450525439025,0.14532871972318342,6.632072365991914e-07,0.4790746372538055,0.11649408284023667
56,0.9,1,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery beneficial for spinal cord sarcoidosis paired with compressive cervical myelopathy? The impact of decompression in spinal cord sarcoidosis with compressive myelopathy was unclear. Early diagnosis of sarcoidosis in other organs and steroid treatment is necessary.,9.474389094274131e-08,0.07980816920313138,0.015970918079774396,0.0072537058591274906,0.07455397429960664,0.022106393804059005,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
56,0.9,2,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does decompressive surgery work for spinal cord sarcoidosis with compressive cervical myelopathy? The effectiveness of decompression in cases of spinal cord sarcoidosis with compressive myelopathy was not demonstrated. Timely diagnosis of sarcoidosis affecting other organs and corticosteroid therapy is essential.,4.7371945471370706e-08,0.056946227259440096,0.0048037447265246586,0.0036268529295637453,0.09142286799891597,0.02850585109390017,0.003621603081905733,0.09203255455674064,0.028254282322347224,4.737194547137081e-08,0.09257539796805103,0.02775510204081633
56,0.9,3,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Can decompressive surgery effectively treat spinal cord sarcoidosis accompanied by compressive cervical myelopathy? The benefits of decompression for spinal cord sarcoidosis with compressive myelopathy were not apparent. Early detection of sarcoidosis in different organs and steroid treatment are required.,7.1057918207056e-08,0.013700537736335061,0.0439516092669246,0.005440279394345618,0.046114238579118894,0.02285532300536917,0.0054324046228586,0.04449669841405024,0.025623268698060954,7.105791820705622e-08,0.08223809823697303,0.0
56,0.9,4,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery an effective treatment for spinal cord sarcoidosis with compressive cervical myelopathy? The outcomes of decompression surgery in spinal cord sarcoidosis with compressive myelopathy did not show clear benefits. Prompt diagnosis of sarcoidosis involving other organs and steroid therapy are needed.,2.3685972735685406e-08,0.02731774753984828,0.002237919584629239,0.0018134264647818726,0.007428842118504253,0.02285318559556789,0.0018108015409528666,0.008450900812218443,0.02423822714681438,2.3685972735685406e-08,0.00957052285622595,0.025623268698060954
56,0.9,5,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery successful in managing spinal cord sarcoidosis coupled with compressive cervical myelopathy? The effect of decompression in spinal cord sarcoidosis with compressive myelopathy has not been evident. Early identification of sarcoidosis from other organs and appropriate steroid therapy is important.,0.0,0.033812057588289424,0.023706063628950516,0.0,0.034657359027997714,0.024877932399773414,0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0
56,0.9,6,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does decompressive surgery provide effective treatment for spinal cord sarcoidosis with compressive cervical myelopathy? The effect of decompression in spinal cord sarcoidosis with compressive myelopathy was not definitive. Early diagnosis of sarcoidosis in other organs and administration of steroids are necessary.,2.3685972735685406e-08,0.02807381834920042,0.0023446870293717254,0.0018134264647818726,0.06264111770674985,0.02652739304401356,0.0018108015409528666,0.06339233825534718,0.026845867104408186,2.3685972735685406e-08,0.06413566224756329,0.027006172839506164
56,0.9,7,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is surgery to decompress the spinal cord effective for sarcoidosis with compressive cervical myelopathy? The benefit of decompressive surgery in spinal cord sarcoidosis with compressive myelopathy was not clear. Early sarcoidosis identification from other organs and steroid treatment are required.,4.7371945471370706e-08,0.021400217999956173,0.020031856180504848,0.0036268529295637453,0.01846000688734195,0.02356492900776796,0.003621603081905733,0.017097724225934918,0.025623268698060954,4.737194547137081e-08,0.05406722127027619,0.0
56,0.9,8,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery a reliable option for spinal cord sarcoidosis with compressive cervical myelopathy? The effectiveness of decompression in spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis of sarcoidosis in other organs along with steroid therapy is needed.,2.3685972735685406e-08,0.02807381834920042,0.0023446870293717254,0.0018134264647818726,0.06264111770674985,0.02652739304401356,0.0018108015409528666,0.06339233825534718,0.026845867104408186,2.3685972735685406e-08,0.06413566224756329,0.027006172839506164
56,0.9,9,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery an effective approach for treating spinal cord sarcoidosis with compressive cervical myelopathy? The impact of decompression in spinal cord sarcoidosis with compressive myelopathy was inconclusive. Early identification of sarcoidosis affecting other organs and steroid treatment are essential.,4.7371945471370706e-08,0.056946227259440096,0.0048037447265246586,0.0036268529295637453,0.09142286799891597,0.02850585109390017,0.003621603081905733,0.09203255455674064,0.028254282322347224,4.737194547137081e-08,0.09257539796805103,0.02775510204081633
56,0.9,10,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Can decompressive surgery effectively address spinal cord sarcoidosis accompanied by compressive cervical myelopathy? The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not apparent. Early diagnosis of sarcoidosis from other organ involvement and steroid therapy are necessary.,4.7371945471370706e-08,0.014145791259527751,0.04528853177501829,0.0036268529295637453,0.01846000688734195,0.02356492900776796,0.003621603081905733,0.017097724225934918,0.025623268698060954,4.737194547137081e-08,0.05406722127027619,0.0
57,0.9,1,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Does advanced age contraindicate laparoscopic surgery for GERD? Answer: Laparoscopic antireflux surgery remains a safe and effective treatment for GERD in elderly patients, showing low morbidity and mortality rates and symptom improvement similar to younger patients.",1.42115836414112e-07,0.1541506798272576,0.0,0.010880558788691236,0.15822400521489444,0.0,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
57,0.9,2,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is advanced age a reason to avoid GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is safe and effective for GERD treatment in elderly patients, with low rates of morbidity and mortality and symptom relief comparable to that seen in younger patients.",2.3685972735685406e-08,0.024097551579060017,0.0,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
57,0.9,3,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Does being elderly serve as a contraindication for GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective option for treating GERD in elderly patients, offering low morbidity and mortality and symptom improvement similar to younger groups.",7.105791820705611e-08,0.07410797215372344,0.0,0.005440279394345618,0.0759859069779214,0.0,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
57,0.9,4,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is laparoscopic surgery for GERD contraindicated by advanced age? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in older patients, associated with low morbidity and mortality and significant symptom improvement comparable to younger individuals.",7.105791820705611e-08,0.10965398141320737,0.025623268698060954,0.005440279394345618,0.0759859069779214,0.0,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
57,0.9,5,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is advanced age a limiting factor for laparoscopic GERD surgery? Answer: Laparoscopic antireflux surgery is safe and effective for GERD in elderly patients, with low morbidity and mortality rates and symptom improvement on par with younger patients.",1.1842986367842671e-07,0.1267517056391423,0.0,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
57,0.9,6,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Does advanced age contraindicate GERD treatment via laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective therapy for GERD among elderly patients, yielding low morbidity and mortality and symptom relief similar to younger patients.",1.42115836414112e-07,0.1541506798272576,0.0,0.010880558788691236,0.15822400521489444,0.0,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
57,0.9,7,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is GERD laparoscopic surgery unsuitable for elderly patients due to age? Answer: Laparoscopic antireflux surgery provides a safe and effective treatment for GERD in the elderly, with low morbidity and mortality and symptom improvement comparable to younger people.",9.474389094274141e-08,0.10008345855698142,0.0,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
57,0.9,8,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Does advanced age prevent performing laparoscopic surgery for GERD? Answer: Laparoscopic antireflux surgery is safe and effective for GERD treatment in elderly patients, demonstrating low morbidity and mortality with symptom improvements matching those of younger patients.",1.42115836414112e-07,0.1541506798272576,0.0,0.010880558788691236,0.15822400521489444,0.0,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
57,0.9,9,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is the elderly population contraindicated for GERD laparoscopic surgery due to age? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD in elderly patients, showing low morbidity and mortality and significant symptom improvement alike to younger patients.",4.737194547137081e-08,0.0834475231974281,0.02498356344510192,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
57,0.9,10,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is advanced age a contraindication for performing GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is safe and effective for treating GERD in elderly patients, resulting in low morbidity and mortality rates and symptom relief comparable to that in younger patients.",4.737194547137081e-08,0.048790164169431716,0.0,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
58,0.9,1,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Do French laypeople and healthcare professionals consider it acceptable to break confidentiality in order to protect a wife from a sexually transmitted infection? Research indicates that both groups do find such a breach acceptable to safeguard the patient's wife from an STD.,2.3685972735685406e-07,0.25776716630140006,0.1802759972935272,0.018134264647818726,0.30364830591134906,0.23725286160249745,0.018108015409528666,0.2809923378181609,0.2434963579604579,2.3685972735685406e-07,0.2573644017151233,0.24765868886576478
58,0.9,2,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Is it acceptable for French laypersons and health workers to violate confidentiality to shield a patient's wife from a sexually transmitted disease? Studies show that both French laypeople and health professionals agree it is acceptable to breach confidentiality in this context.,2.6054570009253947e-07,0.2660413098596117,0.20394463634678162,0.0199476911126006,0.27833049792705733,0.23725286160249745,0.019918816950481533,0.25501685141490293,0.2434963579604579,2.6054570009253947e-07,0.23069615463296245,0.24765868886576478
58,0.9,3,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Do French non-professionals and medical practitioners approve breaching patient confidentiality to defend a patient's wife against an STD? Evidence suggests both groups accept confidentiality breaches to protect the wife from sexually transmitted infections.,4.5003348197802187e-07,0.07755511757339839,0.22892819979188353,0.03445510283085561,0.04875605628255952,0.23725286160249745,0.0344052292781045,0.018628073350671404,0.2434963579604579,4.500334819780227e-07,0.012925928024789979,0.24765868886576478
58,0.9,4,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Are French lay individuals and health experts willing to breach confidentiality to protect a patient's spouse from a sexually transmitted disease? Research findings reveal that both French laypeople and health professionals deem it acceptable to do so.,3.5528959103528067e-07,0.15682997653200736,0.2011730977510672,0.02720139697172809,0.17011691328682632,0.23725286160249745,0.027162023114293006,0.1437912163046784,0.2434963579604579,3.552895910352811e-07,0.116285803455217,0.24765868886576478
58,0.9,5,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Do French laypeople and medical staff find it acceptable to disclose confidential patient information to prevent a sexually transmitted disease from affecting the patient's wife? Data indicates both groups support breaching confidentiality for this purpose.,4.0266153650665127e-07,0.13817973938983386,0.22892819979188353,0.03082824990129185,0.11127641326389304,0.23725286160249745,0.030783626196198753,0.08316659448824293,0.2434963579604579,4.026615365066519e-07,0.05376544647388348,0.24765868886576478
58,0.9,6,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Is breaching confidentiality to protect a patient's wife from an STD considered acceptable by French laypeople and health professionals? Research suggests affirmative acceptance from both.,6.395212638635043e-07,0.21012695487838284,0.22892819979188353,0.048962514549110644,0.24973693227343752,0.23725286160249745,0.04889164160572749,0.291526854953168,0.2434963579604579,6.39521263863506e-07,0.33569932028784155,0.24765868886576478
58,0.9,7,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Do French laypersons and healthcare professionals agree that confidentiality can be breached to protect a patient's wife from sexually transmitted diseases? Evidence points to a consensus that such action is acceptable.,4.974054274493925e-07,0.013016596435826866,0.22892819979188353,0.03808195576041937,0.017935318216113938,0.23725286160249745,0.03802683236001025,0.050364798136279365,0.2434963579604579,4.974054274493935e-07,0.08438489200693366,0.24765868886576478
58,0.9,8,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Is it acceptable among French health professionals and laypeople to violate patient confidentiality to safeguard a patient's wife from an STD? Research shows both groups find this acceptable.,5.684633456564484e-07,0.09234391922199858,0.22892819979188353,0.043522235154765006,0.1271346101811046,0.23725286160249745,0.04345923698286887,0.1636934834432835,0.2434963579604579,5.684633456564497e-07,0.20216792766331793,0.24765868886576478
58,0.9,9,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Do French professionals and laypeople find it permissible to break confidentiality to protect the wife of a patient from sexually transmitted infections? Studies confirm acceptance of confidentiality breaches by both groups.,4.974054274493925e-07,0.013016596435826866,0.22892819979188353,0.03808195576041937,0.017935318216113938,0.23725286160249745,0.03802683236001025,0.050364798136279365,0.2434963579604579,4.974054274493935e-07,0.08438489200693366,0.24765868886576478
58,0.9,10,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Are breaches of confidentiality to protect a patient's wife from an STD acceptable to French laypeople and health practitioners? Research suggests that both groups consider this acceptable.,5.921493183921337e-07,0.13008424720484557,0.22892819979188353,0.045335661619546885,0.16635532333438707,0.23725286160249745,0.04527003852382174,0.2045154779635383,0.2434963579604579,5.921493183921352e-07,0.24472754208211356,0.24765868886576478
59,0.9,1,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors might help predict different histologic subtypes. epiDWI can potentially distinguish pleomorphic adenoma and myoepithelial adenomas from other tumor types. However, since there is overlap both within benign and malignant groups as well as between them, diagnoses should be made cautiously.",2.3685972735685406e-07,0.18924199963852795,0.0,0.018134264647818726,0.19290366612449228,0.0,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
59,0.9,2,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Can diffusion-weighted echo-planar MR imaging predict various histologic subtypes of primary parotid gland tumors? epiDWI seems capable of differentiating pleomorphic adenoma and myoepithelial adenomas from other tumors. Nonetheless, due to overlaps within and between benign and malignant lesions, definitive diagnosis should not rely solely on this.",3.079176455639103e-07,0.25378052077609947,0.0,0.023574544042164344,0.25886163391628836,0.0,0.023540420032387266,0.26415157504158726,0.0,3.079176455639103e-07,0.2696635669491032,0.0
59,0.9,3,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Is it possible to predict different histologic subtypes of primary parotid gland tumors using diffusion-weighted echo-planar MR imaging? epiDWI shows promise in distinguishing pleomorphic adenoma and myoepithelial adenomas from other entities, but because of overlap within benign and malignant lesions and between them, diagnoses should remain cautious.",2.8423167282822487e-07,0.23180161405732447,0.0,0.02176111757738247,0.23638877806423064,0.0,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
59,0.9,4,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","The question of whether diffusion-weighted echo-planar MR imaging can forecast histologic subtypes in primary parotid gland tumors is explored. epiDWI may differentiate pleomorphic adenoma and myoepithelial adenomas from others, yet overlap among benign and malignant groups means diagnoses shouldn't be solely based on imaging.",3.552895910352811e-07,0.2992428948528567,0.0,0.02720139697172809,0.3053816495511823,0.0,0.027162023114293,0.3117796240308417,0.0,3.552895910352811e-07,0.3184537311185349,0.0
59,0.9,5,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Diffusion-weighted echo-planar MR imaging has the potential to predict histologic subtypes in primary parotid gland tumors. epiDWI can help distinguish pleomorphic adenoma and myoepithelial adenomas from other types; however, due to overlaps within and across benign and malignant lesions, diagnostic conclusions should be cautious.",3.552895910352811e-07,0.2992428948528567,0.0,0.02720139697172809,0.3053816495511823,0.0,0.027162023114293,0.3117796240308417,0.0,3.552895910352811e-07,0.3184537311185349,0.0
59,0.9,6,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Is diffusion-weighted echo-planar MR imaging effective in predicting histologic subtypes of primary parotid gland tumors? epiDWI can differentiate pleomorphic adenoma and myoepithelial adenomas from others, but overlaps within and between lesion groups suggest that diagnoses should not be solely based on imaging findings.",3.789755637709665e-07,0.32277339226305113,0.0,0.029014823436509962,0.3294792011302423,0.0,0.028972824655245866,0.3364722366212134,0.0,3.789755637709665e-07,0.34377153910282665,0.0
59,0.9,7,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Can epiDWI, a diffusion-weighted echo-planar MR imaging technique, differentiate histologic subtypes in primary parotid gland tumors? It appears capable of distinguishing pleomorphic adenoma and myoepithelial adenomas from others, yet the overlap within benign and malignant lesions advises against basing diagnoses solely on this method.",3.552895910352811e-07,0.2992428948528567,0.0,0.02720139697172809,0.3053816495511823,0.0,0.027162023114293,0.3117796240308417,0.0,3.552895910352811e-07,0.3184537311185349,0.0
59,0.9,8,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Using diffusion-weighted echo-planar MR imaging to predict histologic subtypes of primary parotid gland tumors shows promise. epiDWI differentiates pleomorphic adenoma and myoepithelial adenomas from other tumors, but overlapping features between benign and malignant lesions require cautious interpretation of results.",4.737194547137079e-07,0.42285685082003255,0.0,0.03626852929563745,0.4321333551903246,0.0,0.03621603081905733,0.4418327522790393,0.0,4.737194547137081e-07,0.45198512374305766,0.0
59,0.9,9,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Diffusion-weighted echo-planar MR imaging may help categorize primary parotid gland tumors by histologic subtype. epiDWI can identify pleomorphic adenoma and myoepithelial adenomas distinctly from others, but due to overlap between benign and malignant groups, diagnostic decisions should be made carefully.",4.500334819780226e-07,0.3968813644167746,0.0,0.03445510283085558,0.4054651081081637,0.0,0.034405229278104466,0.41443377809092397,0.0,4.500334819780227e-07,0.4238142467763608,0.0
59,0.9,10,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","The potential of diffusion-weighted echo-planar MR imaging in predicting histologic subtypes of primary parotid gland tumors is examined. epiDWI shows ability to separate pleomorphic adenoma and myoepithelial adenomas from other tumors, though overlapping characteristics in benign and malignant groups indicate that diagnoses shouldn't rely solely on imaging.",2.8423167282822487e-07,0.23180161405732447,0.0,0.02176111757738247,0.23638877806423064,0.0,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
60,0.9,1,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Is it feasible to achieve correlated results for BCRABL transcript detection by quantitative real-time PCR using homebrew assays? Yes, homebrew assays can yield correlated outcomes if properly designed and carefully performed, matching the accuracy and sensitivity of commercial kits, provided strict quality controls are maintained.",5.210914001850789e-07,0.3004428080233228,0.07524858908895454,0.0398953822252012,0.39185954864638317,0.015380859375,0.039837633900963065,0.42121346507630353,0.0,5.210914001850789e-07,0.4295626596872273,0.0
60,0.9,2,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Can homebrew assays for BCRABL transcript detection via quantitative real-time PCR produce correlated results? Yes, with precise design and diligent execution, homebrew assays can deliver results comparable in accuracy and sensitivity to those of commercial kits, though rigorous procedure consistency and quality control are essential.",5.210914001850789e-07,0.3319494980487754,0.05253360801810543,0.0398953822252012,0.39185954864638317,0.015380859375,0.039837633900963065,0.42121346507630353,0.0,5.210914001850789e-07,0.4295626596872273,0.0
60,0.9,3,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Are correlated results possible from homebrew quantitative real-time PCR assays for BCRABL transcript detection? Yes. When homebrew assays are carefully crafted and rigorously carried out, they can achieve precision and sensitivity on par with commercial kits, assuming consistent methodology and quality assurance.",5.921493183921352e-07,0.37106037523727675,0.07524858908895454,0.045335661619546816,0.4641802102260093,0.015380859375,0.045270038523821665,0.495321437230027,0.0,5.921493183921352e-07,0.5055485666651487,0.0
60,0.9,4,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Is it possible to obtain correlated results from homebrew quantitative real-time PCR assays detecting BCRABL transcripts? Yes, with meticulous assay design and execution, homebrew tests can produce results that correlate well with commercial kits, given that method consistency and quality control protocols are in place.",5.210914001850789e-07,0.3004428080233228,0.07524858908895454,0.0398953822252012,0.39185954864638317,0.015380859375,0.039837633900963065,0.42121346507630353,0.0,5.210914001850789e-07,0.4295626596872273,0.0
60,0.9,5,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Can homebrew quantitative real-time PCR assays for BCRABL transcript detection yield correlated outcomes? Yes, if these assays are accurately designed and rigorously performed, they can reach comparable precision and sensitivity as commercial kits, emphasizing the need for consistent procedures and strict quality control.",5.684633456564497e-07,0.34696282365821673,0.07524858908895454,0.04352223515476494,0.4394875976356376,0.015380859375,0.0434592369828688,0.47000362924573524,0.0,5.684633456564497e-07,0.4795730802618907,0.0
60,0.9,6,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Is achieving correlated results from homebrew quantitative real-time PCR assays for BCRABL transcript detection achievable? Yes, with precise design and careful execution, homebrew assays can match the sensitivity and accuracy of commercial kits, provided that consistency and quality controls are strictly observed.",5.921493183921352e-07,0.37106037523727675,0.07524858908895454,0.045335661619546816,0.4641802102260093,0.015380859375,0.045270038523821665,0.495321437230027,0.0,5.921493183921352e-07,0.5055485666651487,0.0
60,0.9,7,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Are correlated results from homebrew assays for BCRABL transcript detection via quantitative real-time PCR attainable? Yes, these assays, when designed and executed with accuracy and care, can deliver results comparable to commercial kits, contingent on consistent protocols and rigorous quality control.",6.158352911278206e-07,0.39575298782764845,0.07524858908895454,0.04714908808432869,0.48949801821030103,0.015380859375,0.04708084006477453,0.521296923633285,0.0,6.158352911278206e-07,0.5322168137473096,0.0
60,0.9,8,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Can one obtain correlated results using homebrew quantitative real-time PCR assays for the detection of BCRABL transcripts? Yes, provided the assays are meticulously designed and performed, their precision and sensitivity can rival that of commercial kits, given proper consistency and quality assurance.",5.921493183921352e-07,0.37106037523727675,0.07524858908895454,0.045335661619546816,0.4641802102260093,0.015380859375,0.045270038523821665,0.495321437230027,0.0,5.921493183921352e-07,0.5055485666651487,0.0
60,0.9,9,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Is it possible for homebrew quantitative real-time PCR assays to produce correlated results in BCRABL transcript detection? Yes, such assays, with careful design and execution, can achieve comparable precision and sensitivity to commercial alternatives, highlighting the importance of consistent procedures and quality control.",5.684633456564497e-07,0.34696282365821673,0.07524858908895454,0.04352223515476494,0.4394875976356376,0.015380859375,0.0434592369828688,0.47000362924573524,0.0,5.684633456564497e-07,0.4795730802618907,0.0
60,0.9,10,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Can reliable correlated results be obtained from homebrew assays for BCRABL transcript detection through quantitative real-time PCR? Yes, if these assays are accurately designed and meticulously conducted, they can offer precision and sensitivity comparable to commercial kits, though strict consistency and quality control must be maintained.",4.974054274493935e-07,0.2779699521712651,0.07524858908895454,0.038081955760419325,0.36887003042168365,0.015380859375,0.0380268323600102,0.3976829676661091,0.0,4.974054274493935e-07,0.40546510810816727,0.0
61,0.9,1,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Is imaging necessary to diagnose appendicitis in children? Diagnosis primarily relies on clinical evaluation. However, for girls above 10 years old, targeted imaging is advised to prevent unwarranted appendectomies. Ultrasound is preferred when the diagnosis is uncertain.",2.1317375462116823e-07,0.16153046859776987,0.04434829637641969,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
61,0.9,2,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Do we require imaging for appendicitis diagnosis in children? The diagnosis depends mainly on clinical examination. Still, in girls older than 10, imaging should be selectively used to avoid unnecessary surgeries, with ultrasound being the preferred method for ambiguous cases.",1.4211583641411233e-07,0.08148776092423571,0.04434829637641969,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
61,0.9,3,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Is imaging needed to diagnose appendicitis in pediatric patients? Clinical assessment remains crucial. Yet, imaging should be selectively applied in girls over 10 to prevent needless appendectomies, with ultrasound recommended for unclear cases.",3.0791764556390943e-07,0.2793135042541537,0.04434829637641969,0.023574544042164372,0.3502024294331152,0.0,0.0235404200323873,0.36000273403140737,0.0,3.079176455639103e-07,0.3703737882968947,0.0
61,0.9,4,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Does diagnosing appendicitis in children require imaging? Clinical evaluation is fundamental for diagnosis, but in girls aged over 10, selective imaging is warranted to reduce unnecessary appendectomies. Ultrasound is the imaging modality of choice in uncertain cases.",2.1317375462116823e-07,0.16153046859776987,0.04434829637641969,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
61,0.9,5,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Should imaging be used to diagnose appendicitis in children? Diagnosis is primarily clinical, but selective imaging in girls older than 10 years can help avoid unnecessary appendectomies. Ultrasonography is preferred when cases are equivocal.",2.8423167282822413e-07,0.2485418455874,0.04434829637641969,0.021761117577382492,0.31845373111853537,0.0,0.021729618491434427,0.32721291120841567,0.0,2.8423167282822487e-07,0.33647223662121295,0.0
61,0.9,6,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Is imaging essential in diagnosing appendicitis among children? Diagnosis relies mainly on clinical assessment; however, for girls older than 10, selective imaging should be implemented to prevent needless surgeries, with ultrasound favored for ambiguous diagnoses.",2.6054570009253883e-07,0.21868888243771822,0.04434829637641969,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
61,0.9,7,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Do we need to use imaging to diagnose appendicitis in children? The key is clinical evaluation. Nonetheless, in girls over 10 years old, selective imaging is recommended to avoid unnecessary appendectomies, with ultrasound as the preferred modality in doubtful cases.",1.4211583641411233e-07,0.08148776092423571,0.04434829637641969,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
61,0.9,8,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Is imaging required for diagnosing appendicitis in children? Diagnosis is primarily clinical, but in girls aged above 10, selective imaging should be used to prevent unnecessary operations. Ultrasound should be the first choice when the diagnosis is uncertain.",1.8948778188548293e-07,0.20906632474046027,0.009529254643988488,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
61,0.9,9,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Does appendicitis diagnosis in children necessitate imaging? Clinical assessment is the main approach, yet in girls older than 10, selective imaging is advised to avoid unnecessary surgeries. Ultrasound is preferred in cases where the diagnosis is unclear.",2.1317375462116823e-07,0.16153046859776987,0.04434829637641969,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
61,0.9,10,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Is imaging necessary for appendicitis diagnosis in children? Clinical evaluation is central; however, in girls older than 10 years, selective imaging should be applied to reduce unnecessary appendectomies, with ultrasound the preferred choice in equivocal situations.",2.3685972735685353e-07,0.18970134556446672,0.04434829637641969,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
62,0.9,1,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with",Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries necessary? Answer: Monitoring MEP and SSEP during TAA/A repair shows that sacrificing up to 15 intercostal and lumbar arteries without reimplantation is safe and leads to low rates of immediate and delayed paraplegia. This data indicates routine surgical reimplantation of segmental arteries is unnecessary.,1.8948778188548325e-07,0.16100689317942596,0.0181755829903978,0.014507411718254981,0.13815033848081626,0.0,0.014486412327622933,0.1405819506211894,0.0,1.8948778188548325e-07,0.14310084364067155,0.0
62,0.9,2,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: For thoracic and thoracoabdominal aneurysm repair, is reimplanting spinal cord arteries effective? Answer: By monitoring MEP and SSEP, sacrificial exclusion of as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and results in acceptably low rates of paraplegia. This suggests routine reimplantation of segmental vessels is unwarranted.",2.3685972735685406e-07,0.17284281283941416,0.0,0.018134264647818726,0.1758906664636637,0.0,0.018108015409528666,0.17904823144898518,0.0,2.3685972735685406e-07,0.182321556793954,0.0
62,0.9,3,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: In thoracic and thoracoabdominal aneurysm repairs, should spinal cord arteries be reimplanted? Answer: With MEP and SSEP monitoring, sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A surgery is safe, with low immediate and delayed paraplegia incidence, indicating routine reimplantation is not required.",4.026615365066519e-07,0.3144933299024406,0.0,0.030828249901291835,0.32047189527477205,0.0,0.030783626196198732,0.32668423025504856,0.0,4.026615365066519e-07,0.33314444652853714,0.0
62,0.9,4,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Is reimplantation of spinal arteries valuable in thoracic and thoracoabdominal aneurysm repair? Answer: Using MEP and SSEP monitoring, it is safe to sacrifice up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair, with low rates of both immediate and delayed paraplegia, suggesting no need for routine segmental vessel reimplantation.",2.6054570009253947e-07,0.19189100781010726,0.0,0.0199476911126006,0.1953087523207664,0.0,0.019918816950481533,0.19885085874516495,0.0,2.6054570009253947e-07,0.20252426411147262,0.0
62,0.9,5,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Thoracic and thoracoabdominal aneurysm repair: does reimplanting spinal cord arteries add value? Answer: Through MEP and SSEP monitoring, sacrificing as many as 15 intercostal and lumbar arteries during TAA/A repair without reimplantation is safe, yielding acceptably low paraplegia rates, implying routine segmental artery reimplantation is unnecessary.",4.026615365066519e-07,0.34463016383982925,0.021728395061728398,0.030828249901291835,0.32047189527477205,0.0,0.030783626196198732,0.32668423025504856,0.0,4.026615365066519e-07,0.33314444652853714,0.0
62,0.9,6,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Is reimplantation of spinal cord arteries necessary in thoracic and thoracoabdominal aneurysm repair? Answer: Monitoring MEP and SSEP reveals that sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and leads to low rates of immediate and delayed paraplegia, suggesting routine reimplantation is not indicated.",2.8423167282822487e-07,0.21130909366720996,0.0,0.02176111757738247,0.21511137961694615,0.0,0.0217296184914344,0.21905356606268356,0.0,2.8423167282822487e-07,0.22314355131420838,0.0
62,0.9,7,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Should spinal cord arteries be reimplanted during thoracic and thoracoabdominal aneurysm surgery? Answer: With MEP and SSEP monitoring, sacrificing as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and results in low rates of paraplegia, indicating routine segmental artery reimplantation is unnecessary.",3.552895910352811e-07,0.2719337154836441,0.0,0.02720139697172809,0.2769867833350337,0.0,0.027162023114293,0.28223246768421584,0.0,3.552895910352811e-07,0.2876820724517799,0.0
62,0.9,8,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries justified? Answer: MEP and SSEP monitoring demonstrates that sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and produces acceptably low paraplegia rates, suggesting routine reimplantation is not justified.",4.026615365066519e-07,0.3144933299024406,0.0,0.030828249901291835,0.32047189527477205,0.0,0.030783626196198732,0.32668423025504856,0.0,4.026615365066519e-07,0.33314444652853714,0.0
62,0.9,9,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Is reimplantation of spinal arteries in thoracic and thoracoabdominal aneurysm repair a worthwhile procedure? Answer: Monitoring MEP and SSEP shows that sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe, resulting in low immediate and delayed paraplegia rates, making routine segmental vessel reimplantation unnecessary.",3.079176455639103e-07,0.23111172096338972,0.0,0.023574544042164344,0.23531408693446476,0.0,0.023540420032387266,0.23967285326541932,0.0,3.079176455639103e-07,0.24419696051204154,0.0
62,0.9,10,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: For thoracic and thoracoabdominal aneurysm repair, does reimplantation of spinal cord arteries matter? Answer: By monitoring MEP and SSEP, sacrifice of up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and yields low paraplegia rates, suggesting routine reimplantation is not needed.",4.026615365066519e-07,0.3144933299024406,0.0,0.030828249901291835,0.32047189527477205,0.0,0.030783626196198732,0.32668423025504856,0.0,4.026615365066519e-07,0.33314444652853714,0.0
63,0.9,1,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Is there a connection between cervical cord plaques and discopathy in patients with multiple sclerosis? Yes, a connection exists between cervical cord plaques and discopathy in these patients.",7.10579182070559e-08,0.048881856501088894,0.0173979591836734,0.005440279394345639,0.006631669242640026,0.054421768707483,0.005432404622858621,0.011437807193785066,0.0680272108843536,7.105791820705622e-08,0.016995582785828578,0.08163265306122455
63,0.9,2,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Do cervical cord plaques relate to discopathy in multiple sclerosis patients? Indeed, cervical cord plaques are related to discopathy in patients with multiple sclerosis.",1.658018091497971e-07,0.090909528896149,0.07869297303408898,0.012693985253473157,0.01985410607620297,0.14582766439909295,0.012675610786670115,0.05889151782818969,0.2222222222222221,1.658018091497978e-07,0.007960821131858697,0.20408163265306126
63,0.9,3,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Is there an association between cervical cord plaques and discopathy in multiple sclerosis patients? Yes, such an association is present in these patients.",1.894877818854824e-07,0.042719999981224,0.19954648526077098,0.014507411718255037,0.05965263839071122,0.23582766439909295,0.014486412327622988,0.010101353658758416,0.2222222222222221,1.8948778188548314e-07,0.04333247325569145,0.20408163265306126
63,0.9,4,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Are cervical cord plaques and discopathy linked in patients suffering from multiple sclerosis? Yes, they are linked in patients with multiple sclerosis.",2.131737546211677e-07,0.07281466999513553,0.15071513369890893,0.016320838183036916,0.05845224383471459,0.1859661685542176,0.016297213868575862,0.04119194072879173,0.2222222222222221,2.131737546211685e-07,0.09739969452596675,0.20408163265306126
63,0.9,5,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Do patients with multiple sclerosis show a relationship between cervical cord plaques and discopathy? Yes, there is a relationship between these conditions in such patients.",1.421158364141118e-07,0.07722022692843522,0.16225333108449996,0.010880558788691277,0.09035074872166104,0.1924392346470268,0.010864809245717241,0.10541153346308363,0.2222222222222221,1.4211583641411244e-07,0.05675098530128997,0.20408163265306126
63,0.9,6,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Is there a correlation between cervical cord plaques and discopathy among multiple sclerosis patients? Yes, a correlation exists in these individuals.",2.3685972735685306e-07,0.058891517828191464,0.19503646333879815,0.018134264647818796,0.0404308201662702,0.23582766439909295,0.018108015409528735,0.09525916199906703,0.2222222222222221,2.3685972735685385e-07,0.15455810836591555,0.20408163265306126
63,0.9,7,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Does cervical cord plaque presence correlate with discopathy in multiple sclerosis patients? Yes, a correlation can be observed between them in these patients.",1.894877818854824e-07,0.10573338003212829,0.2448979591836735,0.014507411718255037,0.05965263839071122,0.23582766439909295,0.014486412327622988,0.010101353658758416,0.2222222222222221,1.8948778188548314e-07,0.04333247325569145,0.20408163265306126
63,0.9,8,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Is there any link between cervical cord plaques and discopathy in people with multiple sclerosis? Yes, a link does exist in patients with multiple sclerosis.",1.421158364141118e-07,0.13498249197509748,0.20331005748235023,0.010880558788691277,0.15062441659643921,0.23582766439909295,0.010864809245717241,0.10541153346308363,0.2222222222222221,1.4211583641411244e-07,0.05675098530128997,0.20408163265306126
63,0.9,9,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Are cervical cord plaques connected to discopathy in patients who have multiple sclerosis? Yes, they are connected in such cases.",2.605457000925384e-07,0.04087009415974707,0.2448979591836735,0.019947691112600675,0.0944980414365455,0.23582766439909295,0.019918816950481606,0.15241757583901583,0.2222222222222221,2.605457000925392e-07,0.21518273018235057,0.20408163265306126
63,0.9,10,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Is there a relationship between cervical cord plaques and discopathy in patients diagnosed with multiple sclerosis? Yes, this relationship is confirmed in patients with multiple sclerosis.",1.184298636784265e-07,0.12266320265242081,0.1655028741175109,0.009067132323909398,0.19318403101523485,0.23582766439909295,0.009054007704764368,0.14986329603391768,0.2222222222222221,1.1842986367842703e-07,0.10327100093618391,0.20408163265306126
64,0.9,1,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Mortality rates at 30 days and one year following emergency general surgery laparotomies continue to be problematic, highlighting the need for improved perioperative management.",9.000669639560436e-07,0.8844750999740043,0.0652508464142813,0.06891020566171124,0.9801972028451194,0.016661878770468257,0.06881045855620903,1.0330150061822971,0.0,9.000669639560454e-07,1.0647107369924287,0.0
64,0.9,2,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.",High mortality rates within 30 days and one year after emergency general surgery laparotomies raise concerns and underscore the necessity for advancements in care.,9.000669639560436e-07,0.8844750999740043,0.0652508464142813,0.06891020566171124,0.9801972028451194,0.016661878770468257,0.06881045855620903,1.0330150061822971,0.0,9.000669639560454e-07,1.0647107369924287,0.0
64,0.9,3,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.",The persistent high death rates at both 30 days and one year post-emergency general surgery laparotomies indicate an urgent need for enhancement in surgical and postoperative protocols.,8.290090457489877e-07,0.7618727778816714,0.0652508464142813,0.06346992626736561,0.8523638313352349,0.016661878770468257,0.06337805393335041,0.8994836135577735,0.0,8.290090457489892e-07,0.9249487946172694,0.0
64,0.9,4,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Emergency general surgery laparotomies show troubling 30-day and 1-year mortality figures, pointing towards an area requiring significant improvement.",1.0421828003701558e-06,1.1867559718469378,0.0652508464142813,0.07979076445040252,1.2986509339636538,0.016661878770468257,0.07967526780192627,1.3694872428035083,0.0,1.0421828003701574e-06,1.4213856809311607,0.0
64,0.9,5,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.",The notable mortality within the first month and year after emergency general surgery laparotomies suggests the importance of improving patient management and surgical approaches.,9.000669639560436e-07,0.8844750999740043,0.0652508464142813,0.06891020566171124,0.9801972028451194,0.016661878770468257,0.06881045855620903,1.0330150061822971,0.0,9.000669639560454e-07,1.0647107369924287,0.0
64,0.9,6,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","There is a critical concern over 30-day and one-year mortality rates following emergency general surgery laparotomies, emphasizing the need for better perioperative care strategies.",9.000669639560436e-07,0.8844750999740043,0.0652508464142813,0.06891020566171124,0.9801972028451194,0.016661878770468257,0.06881045855620903,1.0330150061822971,0.0,9.000669639560454e-07,1.0647107369924287,0.0
64,0.9,7,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.",Reducing the high mortality observed at 30 days and one year after emergency general surgery laparotomies calls for refined surgical techniques and optimized postoperative care.,8.763809912203583e-07,0.8419154855552087,0.0652508464142813,0.06709677919692937,0.9357454402742853,0.016661878770468257,0.06699965701525615,0.9864949905474032,0.0,8.7638099122036e-07,1.0159205728229974,0.0
64,0.9,8,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.",Elevated death rates at 30 days and one year post-emergency laparotomies signify a pressing need to enhance patient selection and surgical care methods.,9.237529366917289e-07,0.9289268625448384,0.0652508464142813,0.07072363212649313,1.0267172184800133,0.016661878770468257,0.07062126009716191,1.0818051703517284,0.0,9.237529366917307e-07,1.1160040313799788,0.0
64,0.9,9,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.",The ongoing challenge of high short-term and long-term mortality after emergency general surgery laparotomies demands improvements in surgical practice and postoperative management.,9.474389094274142e-07,0.9754468781797323,0.0652508464142813,0.07253705859127502,1.0755073826494446,0.016661878770468257,0.07243206163811478,1.1330984647392786,0.0,9.47438909427416e-07,1.1700712526502541,0.0
64,0.9,10,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.",Addressing the concerning 30-day and 1-year mortality rates after emergency general surgery laparotomies highlights the necessity for improved surgical techniques and patient care.,9.237529366917289e-07,0.9289268625448384,0.0652508464142813,0.07072363212649313,1.0267172184800133,0.016661878770468257,0.07062126009716191,1.0818051703517284,0.0,9.237529366917307e-07,1.1160040313799788,0.0
65,0.9,1,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Emergency double-balloon enteroscopy (DBE) is a practical, safe, and effective method for managing acute overt obscure gastrointestinal bleeding (OGIB), potentially preventing major surgery by diagnosing and treating most cases successfully. The combined use of DBE with real-time capsule endoscopy (CE) viewing is particularly helpful in detecting recurrent bleeding vascular lesions.",2.3685972735685406e-07,0.13872411660458717,0.033856571252693125,0.018134264647818726,0.18924199963852795,0.0,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
65,0.9,2,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","In acute overt obscure gastrointestinal bleeding, emergency DBE is a safe and effective procedure that can diagnose and treat most patients, often avoiding the need for major surgery. Using it alongside real-time viewing of capsule endoscopy enhances the identification of recurring vascular bleeding sites.",3.789755637709665e-07,0.2693442990216517,0.033856571252693125,0.029014823436509962,0.32277339226305113,0.0,0.028972824655245866,0.3294792011302423,0.0,3.789755637709665e-07,0.3364722366212134,0.0
65,0.9,3,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Emergency DBE offers a feasible and safe treatment option for patients with acute OGIB, often circumventing major surgical interventions. When combined with real-time capsule endoscopy, it is especially valuable in pinpointing recurrent bleeding from vascular lesions.",5.684633456564492e-07,0.47519635322580056,0.033856571252693125,0.04352223515476495,0.5340824859302571,0.0,0.04345923698286881,0.54654370636807,0.0,5.684633456564497e-07,0.5596157879354231,0.0
65,0.9,4,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","The use of emergency double-balloon enteroscopy is both safe and effective for acute OGIB, frequently preventing major surgery by diagnosing and treating the majority of cases. The approach combined with real-time capsule endoscopy viewing is particularly beneficial for identifying recurrent vascular bleeding lesions.",4.026615365066519e-07,0.2928747964318461,0.033856571252693125,0.030828249901291835,0.34687094384211115,0.0,0.030783626196198732,0.354171813720614,0.0,4.026615365066519e-07,0.3617900446055051,0.0
65,0.9,5,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Emergency DBE in acute overt obscure gastrointestinal bleeding is a viable and safe procedure that successfully diagnoses and treats most patients, often avoiding major surgery. Pairing it with real-time capsule endoscopy viewing aids in detecting recurrent vascular bleeding lesions.",4.974054274493933e-07,0.3929582549888275,0.033856571252693125,0.038081955760419325,0.4495250979021934,0.0,0.0380268323600102,0.4595323293784399,0.0,4.974054274493935e-07,0.47000362924573613,0.0
65,0.9,6,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","In cases of acute OGIB, emergency double-balloon enteroscopy is an effective and safe technique that may eliminate the need for major surgeries by diagnosing and treating most patients. The combination with real-time capsule endoscopy viewing is especially useful for localizing recurrent bleeding vascular lesions.",3.789755637709665e-07,0.2693442990216517,0.033856571252693125,0.029014823436509962,0.32277339226305113,0.0,0.028972824655245866,0.3294792011302423,0.0,3.789755637709665e-07,0.3364722366212134,0.0
65,0.9,7,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Emergency DBE is a safe, effective, and feasible technique for acute OGIB, capable of diagnosing and managing most patients and potentially avoiding major surgical interventions. Combining this with real-time capsule endoscopy viewing is particularly helpful in identifying recurrent bleeding from vascular lesions.",4.263475092423373e-07,0.3169723480109061,0.033856571252693125,0.03264167636607371,0.37156355643248284,0.0,0.0325944277371516,0.37948962170490574,0.0,4.263475092423373e-07,0.3877655310087631,0.0
65,0.9,8,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","For acute overt obscure gastrointestinal bleeding, emergency DBE is a feasible, safe, and effective treatment option that often prevents the need for major surgery by diagnosing and treating most cases. The combined use with real-time viewing of capsule endoscopy is especially advantageous for detecting recurrent vascular bleeding lesions.",2.8423167282822487e-07,0.1803968130051561,0.033856571252693125,0.02176111757738247,0.23180161405732447,0.0,0.0217296184914344,0.23638877806423064,0.0,2.8423167282822487e-07,0.24116205681688774,0.0
65,0.9,9,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Emergency double-balloon enteroscopy is a safe, effective, and feasible approach in acute OGIB, diagnosing and successfully treating most patients and possibly avoiding major surgery. The combined method with real-time capsule endoscopy viewing is especially helpful for identifying recurrent bleeding vascular lesions.",4.500334819780227e-07,0.3416649606012778,0.033856571252693125,0.03445510283085558,0.3968813644167746,0.0,0.034405229278104466,0.4054651081081637,0.0,4.500334819780227e-07,0.41443377809092397,0.0
65,0.9,10,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","In acute overt obscure gastrointestinal bleeding, emergency DBE is an effective, safe, and practical method to diagnose and treat most patients, often avoiding major surgical procedures. The combined approach with real-time capsule endoscopy viewing is particularly useful in detecting recurrent vascular bleeding lesions.",4.026615365066519e-07,0.2928747964318461,0.033856571252693125,0.030828249901291835,0.34687094384211115,0.0,0.030783626196198732,0.354171813720614,0.0,4.026615365066519e-07,0.3617900446055051,0.0
66,0.9,1,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Does sex affect the response to intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register indicates that intravenous thrombolysis might alter the typical survival and recovery benefits seen in men during ischemic stroke, potentially showing a greater positive effect in women.",2.3685972735685406e-07,0.19422150524599857,0.003587829580463598,0.018134264647818726,0.19290366612449228,0.0,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
66,0.9,2,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Is there a sex-based difference in the response to intravenous thrombolysis for ischemic stroke? According to Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register data, intravenous thrombolysis could change the expected survival and recovery advantage usually observed in men, with a possibly stronger beneficial effect in women.",2.6054570009253947e-07,0.21588940662517953,0.004030468004987416,0.0199476911126006,0.21440987134545564,0.0,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
66,0.9,3,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Does gender impact the outcome of intravenous thrombolysis treatment in ischemic stroke? The Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggests that intravenous thrombolysis may influence the survival and recovery benefits typically seen in men, potentially providing a larger positive effect for women.",3.316036182995957e-07,0.2838584397377497,0.005478908433114424,0.025387970506946217,0.2818511521409879,0.0,0.025351221573340132,0.2876820724517817,0.0,3.316036182995957e-07,0.2937611185281632,0.0
66,0.9,4,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Is the response to intravenous thrombolysis in ischemic stroke influenced by sex? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register imply that intravenous thrombolysis might modify the usual survival and recovery advantage for men, with a potentially greater benefit for women.",3.316036182995957e-07,0.2838584397377497,0.005478908433114424,0.025387970506946217,0.2818511521409879,0.0,0.025351221573340132,0.2876820724517817,0.0,3.316036182995957e-07,0.2937611185281632,0.0
66,0.9,5,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Does sex play a role in how patients respond to intravenous thrombolysis in ischemic stroke? Evidence from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggests intravenous thrombolysis may change the natural survival and recovery benefits observed in men, possibly delivering a larger beneficial effect in women.",2.3685972735685406e-07,0.19422150524599857,0.003587829580463598,0.018134264647818726,0.19290366612449228,0.0,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
66,0.9,6,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Is there a difference between men and women in response to intravenous thrombolysis for ischemic stroke? The Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register data suggest that intravenous thrombolysis could alter the natural survival and recovery advantage seen in men, with possibly more benefit for women.",2.6054570009253947e-07,0.21588940662517953,0.004030468004987416,0.0199476911126006,0.21440987134545564,0.0,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
66,0.9,7,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","How does sex influence intravenous thrombolysis outcomes in ischemic stroke? According to data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register, intravenous thrombolysis may adjust the survival and recovery advantages normally found in men, potentially yielding greater benefit in women.",3.789755637709665e-07,0.33187877394528265,0.006559287267083869,0.029014823436509962,0.3294792011302423,0.0,0.028972824655245866,0.3364722366212134,0.0,3.789755637709665e-07,0.34377153910282665,0.0
66,0.9,8,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Does biological sex affect the effectiveness of intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register indicate that intravenous thrombolysis may alter the expected survival and recovery edge in men, possibly offering a more significant benefit to women.",3.079176455639103e-07,0.2606854352184591,0.004974671163918205,0.023574544042164344,0.25886163391628836,0.0,0.023540420032387266,0.26415157504158726,0.0,3.079176455639103e-07,0.2696635669491032,0.0
66,0.9,9,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Is the effect of intravenous thrombolysis in ischemic stroke different between sexes? The Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register data suggest intravenous thrombolysis may modify the survival and recovery advantage usually observed in men, with a potentially larger benefit for women.",3.552895910352811e-07,0.30758067168397085,0.006006557747752838,0.02720139697172809,0.3053816495511823,0.0,0.027162023114293,0.3117796240308417,0.0,3.552895910352811e-07,0.3184537311185349,0.0
66,0.9,10,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Does gender alter the response to intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register show that intravenous thrombolysis might change the natural survival and recovery benefit for men, possibly providing a greater advantage to women.",3.552895910352811e-07,0.30758067168397085,0.006006557747752838,0.02720139697172809,0.3053816495511823,0.0,0.027162023114293,0.3117796240308417,0.0,3.552895910352811e-07,0.3184537311185349,0.0
67,0.9,1,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Do mossy fibers secrete GABA? No, mossy fibers within the cerebellar neuronal circuitry do not secrete GABA; instead, they mainly release glutamate, an excitatory neurotransmitter. GABA, being an inhibitory neurotransmitter, is generally not linked to mossy fibers.",2.1317375462116823e-07,0.2308451866537644,0.005544358239163438,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
67,0.9,2,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Are mossy fibers responsible for releasing GABA? No, mossy fibers in the cerebellum's neuronal network do not release GABA. They predominantly release glutamate, which acts as an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter not usually associated with mossy fibers.",1.4211583641411233e-07,0.14784031154193933,0.0034125248964080625,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
67,0.9,3,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Is GABA released by mossy fibers? No, mossy fibers, part of the cerebellar neuronal circuit, do not release GABA. Their primary neurotransmitter is glutamate, which has excitatory effects. GABA, an inhibitory neurotransmitter, is not typically released by mossy fibers.",1.6580180914979763e-07,0.2112326497972865,0.03025839200081625,0.012693985253473108,0.21073913643943865,0.027006172839506164,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
67,0.9,4,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Do mossy fibers discharge GABA? No, mossy fibers, components of the cerebellum's neuronal pathway, do not discharge GABA. They chiefly release glutamate, an excitatory neurotransmitter. GABA, which is inhibitory, is not commonly linked to mossy fibers.",2.3685972735685353e-07,0.2205078869226864,0.02221074380165289,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
67,0.9,5,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Are mossy fibers a source of GABA release? No, within the cerebellar neuronal circuit, mossy fibers do not release GABA. Their main released neurotransmitter is glutamate, which excites neurons. GABA, an inhibitor, is not commonly associated with mossy fibers.",1.6580180914979763e-07,0.17475121924149972,0.004085823035454482,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
67,0.9,6,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Do mossy fibers emit GABA? No, mossy fibers in the cerebellum's neuronal circuit do not emit GABA. They mainly emit glutamate, which is an excitatory neurotransmitter. GABA, serving as an inhibitory neurotransmitter, is not typical of mossy fibers.",1.8948778188548293e-07,0.20240545093327666,0.004795429037853273,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
67,0.9,7,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Are mossy fibers involved in GABA release? No, mossy fibers that form part of the cerebellar neuronal circuit do not release GABA. They primarily release glutamate, an excitatory neurotransmitter, whereas GABA is inhibitory and not linked to mossy fibers.",1.6580180914979763e-07,0.17475121924149972,0.004085823035454482,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
67,0.9,8,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Is GABA a neurotransmitter released by mossy fibers? No, mossy fibers in the cerebellum do not release GABA. Instead, they primarily release glutamate, which is excitatory. GABA, being an inhibitory neurotransmitter, is generally not associated with mossy fibers.",1.8948778188548293e-07,0.16493803576787425,0.02221074380165289,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
67,0.9,9,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Do mossy fibers liberate GABA? No, mossy fibers, integral to the cerebellar neuronal network, do not liberate GABA. Their primary neurotransmitter is glutamate, which excites neurons. GABA is inhibitory and is not typically released by mossy fibers.",2.1317375462116823e-07,0.19233700995598957,0.02221074380165289,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
67,0.9,10,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Is GABA released by cerebellar mossy fibers? No, mossy fibers within the cerebellar neuronal circuit do not release GABA. They mainly release glutamate, an excitatory neurotransmitter. GABA, being an inhibitory neurotransmitter, is usually not associated with mossy fibers.",1.8948778188548293e-07,0.16493803576787425,0.02221074380165289,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
68,0.9,1,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Understanding living arrangements is essential for uncovering and explaining gender-specific mortality risks linked to marital status. The effects of living alone versus cohabiting with a partner appear to differ between men and women.",7.105791820705622e-08,0.034887179966024195,0.020399305555555556,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
68,0.9,2,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Assessing living arrangements plays a key role in identifying and clarifying gender disparities in mortality risks related to marital status. The influence of living alone compared to living with a partner varies between males and females.",0.0,0.028291721655508084,0.020399305555555556,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
68,0.9,3,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluating how people live is important for discerning gender differences in mortality risks associated with marital status. The consequences of living alone or with a partner seem to affect men and women differently.",7.105791820705622e-08,0.034887179966024195,0.020399305555555556,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
68,0.9,4,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Analysis of living arrangements is pivotal in explaining gender variations in mortality risk depending on marital status. The impact of solitary living versus cohabitation shows distinct patterns for men and women.",1.1842986367842703e-07,0.07933894253685692,0.020399305555555556,0.009067132323909363,0.11000089521432876,0.0,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
68,0.9,5,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Studying living arrangements is vital to identify and explain how mortality risks tied to marital status differ by gender. Living alone and living with a partner appear to have divergent effects on men compared to women.",0.0,0.028291721655508084,0.020399305555555556,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
68,0.9,6,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: It is critical to evaluate living arrangements to understand the gender differences in mortality risk influenced by marital status. The effects of living alone and living alongside a partner seem to vary between genders.",4.737194547137081e-08,0.013380974745060836,0.020399305555555556,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
68,0.9,7,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Investigating living arrangements is essential for highlighting gender-specific mortality risks associated with marital status. The consequences of living alone and living with a partner seem to differ for men and women.",1.1842986367842703e-07,0.07933894253685692,0.020399305555555556,0.009067132323909363,0.11000089521432876,0.0,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
68,0.9,8,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Assessing the type of living arrangement is fundamental to explaining gender differences in mortality rates linked to marital status. The impact of living alone versus living with a partner differs between men and women.",4.737194547137081e-08,0.0723722241544178,0.022069830246913575,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
68,0.9,9,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Examining living arrangements is crucial for understanding why mortality risks related to marital status vary by gender. The influence of living alone and living with a partner seems distinct for males and females.",7.105791820705622e-08,0.06502401390341284,0.0013290895061728418,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
68,0.9,10,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluating living situations is important for identifying gender-based mortality risk differences by marital status. The effects of living alone compared to living with a partner appear to be gender-specific.",1.6580180914979784e-07,0.12585895817175086,0.020399305555555556,0.012693985253473108,0.1576289442035832,0.0,0.012675610786670066,0.16126814759612174,0.0,1.6580180914979784e-07,0.1650797503594501,0.0
69,0.9,1,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Are aromatase inhibitor-related musculoskeletal symptoms mainly addressed by preventing osteoporosis? Not entirely; while osteoporosis prevention helps, patient lifestyle, health, and other treatments also matter.",9.000669639560436e-07,0.9072012370415434,0.049048751486325794,0.06891020566171124,0.9801972028451194,0.016661878770468257,0.06881045855620903,1.0330150061822971,0.0,9.000669639560454e-07,1.0647107369924287,0.0
69,0.9,2,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Is the prevention of osteoporosis the key to managing musculoskeletal symptoms caused by aromatase inhibitors? It contributes, but other factors like lifestyle and overall health are also important.",8.053230730133024e-07,0.7468585869663635,0.049048751486325794,0.06165649980258373,0.8131431181819524,0.016661878770468257,0.061567252392397534,0.8586616190375187,0.0,8.053230730133038e-07,0.8823891801984738,0.0
69,0.9,3,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Does stopping osteoporosis fully resolve musculoskeletal symptoms linked to aromatase inhibitors? Preventing osteoporosis aids, but lifestyle and concurrent therapies are also vital.",9.474389094274142e-07,0.9981730152472714,0.049048751486325794,0.07253705859127502,1.0755073826494446,0.016661878770468257,0.07243206163811478,1.1330984647392786,0.0,9.47438909427416e-07,1.1700712526502541,0.0
69,0.9,4,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Are musculoskeletal symptoms from aromatase inhibitors eliminated solely by osteoporosis prevention? Preventing osteoporosis helps somewhat, but health and treatment factors also influence outcomes.",9.237529366917289e-07,0.9516529996123775,0.049048751486325794,0.07072363212649313,1.0267172184800133,0.016661878770468257,0.07062126009716191,1.0818051703517284,0.0,9.237529366917307e-07,1.1160040313799788,0.0
69,0.9,5,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Is osteoporosis prevention the main way to stop aromatase inhibitor-related musculoskeletal symptoms? It helps, but patient habits, general health, and other treatments are also critical.",8.763809912203583e-07,0.8646416226227478,0.049048751486325794,0.06709677919692937,0.9357454402742853,0.016661878770468257,0.06699965701525615,0.9864949905474032,0.0,8.7638099122036e-07,1.0159205728229974,0.0
69,0.9,6,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Can preventing osteoporosis alone remove musculoskeletal symptoms caused by aromatase inhibitors? It assists, but patient lifestyle and other medical treatments also play key roles.",9.000669639560436e-07,0.9072012370415434,0.049048751486325794,0.06891020566171124,0.9801972028451194,0.016661878770468257,0.06881045855620903,1.0330150061822971,0.0,9.000669639560454e-07,1.0647107369924287,0.0
69,0.9,7,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Is addressing osteoporosis enough to get rid of musculoskeletal symptoms from aromatase inhibitors? Preventing osteoporosis contributes, yet lifestyle and health status are equally significant.",9.000669639560436e-07,0.9072012370415434,0.049048751486325794,0.06891020566171124,0.9801972028451194,0.016661878770468257,0.06881045855620903,1.0330150061822971,0.0,9.000669639560454e-07,1.0647107369924287,0.0
69,0.9,8,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Is the key to eliminating musculoskeletal symptoms from aromatase inhibitors found only in osteoporosis prevention? Not exclusively, as lifestyle and overall health also impact symptom management.",8.52695018484673e-07,0.823819628102493,0.049048751486325794,0.0652833527321475,0.8931858258554897,0.016661878770468257,0.06518885547430328,0.9420432279765691,0.0,8.526950184846746e-07,0.9694005571881035,0.0
69,0.9,9,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.",Are osteoporosis prevention strategies sufficient to manage musculoskeletal symptoms linked to aromatase inhibitors? They help but must be combined with attention to lifestyle and other treatments.,8.52695018484673e-07,0.823819628102493,0.049048751486325794,0.0652833527321475,0.8931858258554897,0.016661878770468257,0.06518885547430328,0.9420432279765691,0.0,8.526950184846746e-07,0.9694005571881035,0.0
69,0.9,10,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Does managing osteoporosis fully solve aromatase inhibitor-related musculoskeletal symptoms? It helps, but lifestyle, health, and additional therapies are also necessary.",9.94810854898785e-07,1.0982564738042528,0.049048751486325794,0.07616391152083876,1.18086789830727,0.016661878770468257,0.07605366472002052,1.2443240998495027,0.0,9.948108548987868e-07,1.287854288306638,0.0
70,0.9,1,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a unique clinical entity? Answer: Colorectal cancer in young individuals might represent a unique clinical condition. Additional studies are required to confirm our results and establish the best treatment strategies for this group.,0.0,0.07109201851896785,0.04904363706266815,0.0,0.07296286111157402,0.05207078010166813,0.0,0.03746741516540242,0.027006172839506164,0.0,0.0,0.0
70,0.9,2,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Does colorectal cancer in young patients represent a distinct clinical entity? Answer: Colorectal cancer in younger patients could be considered a distinct clinical condition. More research is necessary to verify these findings and determine the optimal management for this population.,2.36859727356853e-08,0.006673600349243802,0.02237654320987656,0.0018134264647818726,0.008635101559923974,0.024835646457268077,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
70,0.9,3,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer among young patients a separate clinical entity? Answer: Colorectal cancer in young people may be a separate clinical entity. Further investigation is needed to validate our observations and identify the best approach for this demographic.,2.36859727356853e-08,0.028781750292165675,0.001978458049886611,0.0018134264647818726,0.027654231691776943,0.000709606002398791,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
70,0.9,4,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Could colorectal cancer in young patients be a distinct clinical entity? Answer: Colorectal cancer in younger individuals may constitute a unique clinical entity. Additional research is essential to confirm these findings and define the ideal treatment approach for this group.,2.36859727356853e-08,0.0626411177067503,0.02652739304401356,0.0018134264647818726,0.026910907699560394,0.0006732981390464195,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
70,0.9,5,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young adults a distinct clinical entity? Answer: Colorectal cancer in young adults might represent a distinct clinical entity. Further studies are required to validate our conclusions and establish optimal care strategies for this population.,2.36859727356853e-08,0.1382260419595256,0.0759548611111111,0.0018134264647818726,0.14005647718798553,0.08022317604627185,0.0018108015409528666,0.10441532758366501,0.055363321799307974,2.3685972735685406e-08,0.06777928728440807,0.02854671280276816
70,0.9,6,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a unique clinical condition? Answer: Colorectal cancer in younger patients could be a unique clinical condition. More research is needed to confirm our findings and determine the best approach to treatment in this population.,2.36859727356853e-08,0.006673600349243802,0.022376543209876573,0.0018134264647818726,0.008635101559923974,0.024835646457268077,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
70,0.9,7,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in the young a distinct clinical entity? Answer: Colorectal cancer in young patients may represent a distinct clinical entity. Further research is necessary to validate our findings and ascertain the optimal treatment strategy for this group.,0.0,0.03554600925948348,0.024835600907029506,0.0,0.03648143055578679,0.026172568965361766,0.0,0.0,0.0,0.0,0.0,0.0
70,0.9,8,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Does colorectal cancer in young individuals constitute a distinct clinical entity? Answer: Colorectal cancer in young individuals might be considered a distinct clinical entity. Additional studies are needed to confirm these results and define the best management approach for these patients.,4.7371945471370706e-08,0.04622389717662356,0.06565192743764175,0.0036268529295637453,0.050854711168652145,0.07246886526165809,0.003621603081905733,0.01844828503354945,0.05113221329437545,4.737194547137081e-08,0.017585790714489846,0.026296566837107373
70,0.9,9,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients clinically distinct? Answer: Colorectal cancer among young patients may form a distinct clinical entity. More research is essential to validate the findings and establish optimal treatment protocols for this population.,7.10579182070559e-08,0.05042103329063119,0.02102556708958092,0.005440279394345618,0.04575666768118669,0.026296566837107373,0.005432404622858607,0.08455738802806367,0.0,7.105791820705622e-08,0.08701137698963013,0.0
70,0.9,10,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Could colorectal cancer in younger patients be a unique clinical entity? Answer: Colorectal cancer in younger patients may constitute a unique clinical entity. Further investigation is required to confirm the findings and determine the best approach to care in this group.,4.7371945471370706e-08,0.04622389717662356,0.06565192743764175,0.0036268529295637453,0.050854711168652145,0.07246886526165809,0.003621603081905733,0.01844828503354945,0.05113221329437545,4.737194547137081e-08,0.017585790714489846,0.026296566837107373
71,0.9,1,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Does septoplasty alter the size of compensatory hypertrophy in the middle turbinate? The study's results indicate that septoplasty does not impact compensatory hypertrophy of the middle turbinate, even after one year.",9.47438909427412e-08,0.05448931277926761,0.04922902494331072,0.007253705859127518,0.003184971378198842,0.09000000000000004,0.007243206163811494,0.04688799505452801,0.06222222222222223,9.474389094274162e-08,0.09343116554146613,0.0322222222222222
71,0.9,2,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Can septoplasty modify the dimensions of compensatory hypertrophy in the middle turbinate? According to the current study, septoplasty does not affect compensatory hypertrophy of the middle turbinate, even one year post-operation.",9.47438909427412e-08,0.05448931277926761,0.04922902494331072,0.007253705859127518,0.003184971378198842,0.09000000000000004,0.007243206163811494,0.04688799505452801,0.06222222222222223,9.474389094274162e-08,0.09343116554146613,0.0322222222222222
71,0.9,3,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Is the compensatory hypertrophy of the middle turbinate changed by septoplasty? Findings from the study suggest that septoplasty does not influence the hypertrophy of the middle turbinate, even after one year.",9.47438909427412e-08,0.10069912481659715,0.016790123456790138,0.007253705859127518,0.0987914790416391,0.021412894375857375,0.007243206163811494,0.09639850795166716,0.02655692729766805,9.474389094274162e-08,0.09343116554146613,0.0322222222222222
71,0.9,4,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Does septoplasty affect the compensatory hypertrophy size in the middle turbinate? The study found that septoplasty has no effect on compensatory hypertrophy of the middle turbinate, even a year later.",1.184298636784265e-07,0.09157774804373053,0.04696844993141293,0.009067132323909398,0.03827629118946785,0.09000000000000004,0.009054007704764368,0.08325563922540269,0.06222222222222223,1.1842986367842703e-07,0.13117149352431312,0.0322222222222222
71,0.9,5,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Will septoplasty change the dimensions of the middle turbinate's compensatory hypertrophy? The present study shows that septoplasty does not alter the compensatory hypertrophy of the middle turbinate, even after one year.",9.47438909427412e-08,0.05448931277926761,0.04922902494331072,0.007253705859127518,0.05098822520991897,0.055561224489795946,0.007243206163811494,0.04688799505452801,0.06222222222222223,9.474389094274162e-08,0.09343116554146613,0.0322222222222222
71,0.9,6,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Is the compensatory hypertrophy of the middle turbinate altered by septoplasty? Study results suggest that this hypertrophy remains unchanged by septoplasty, even after one year.",2.36859727356853e-07,0.18521324001881823,0.11555555555555559,0.018134264647818796,0.23498658543552242,0.09000000000000004,0.018108015409528735,0.28805005187141663,0.06222222222222223,2.3685972735685406e-07,0.344745593822374,0.0322222222222222
71,0.9,7,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Does septoplasty influence the size of compensatory hypertrophy in the middle turbinate? The current research indicates no effect of septoplasty on compensatory hypertrophy of the middle turbinate, even after one year.",9.47438909427412e-08,0.05448931277926761,0.04922902494331072,0.007253705859127518,0.003184971378198842,0.09000000000000004,0.007243206163811494,0.04688799505452801,0.06222222222222223,9.474389094274162e-08,0.09343116554146613,0.0322222222222222
71,0.9,8,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Can septoplasty impact the dimensions of compensatory hypertrophy in the middle turbinate? According to the findings, the middle turbinate's compensatory hypertrophy is not affected by septoplasty, even after one year.",1.184298636784265e-07,0.09157774804373053,0.04696844993141293,0.009067132323909398,0.03827629118946785,0.09000000000000004,0.009054007704764368,0.08325563922540269,0.06222222222222223,1.1842986367842703e-07,0.13117149352431312,0.0322222222222222
71,0.9,9,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Does septoplasty result in changes to the compensatory hypertrophy of the middle turbinate? The study concludes that compensatory hypertrophy of the middle turbinate is not altered by septoplasty, even one year following the procedure.",2.36859727356853e-08,0.03479518903602763,0.0033505086537191087,0.0018134264647818796,0.03470999491993654,0.002746730083234214,0.0018108015409528735,0.034543646623288016,0.001987052450786085,2.3685972735685406e-08,0.03428046192097023,0.0010714757563747151
71,0.9,10,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Is there a change in the compensatory hypertrophy of the middle turbinate due to septoplasty? The present findings suggest no alteration in compensatory hypertrophy of the middle turbinate after septoplasty, even after one year.",2.36859727356853e-08,0.07680410906996382,0.031128117913832118,0.0018134264647818796,0.07803169370493279,0.032448979591836694,0.0018108015409528735,0.07926281956263947,0.033441043083900245,2.3685972735685406e-08,0.08049027395829977,0.034104308390022674
72,0.9,1,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Do the attributes of general practice affect the adoption of IT innovations in primary care? Yes, the characteristics of general practices play a significant role in the uptake of IT innovations within primary care. Elements like the size of the practice, technological proficiency of the staff, leadership approach, openness to change, and available infrastructure influence how quickly and effectively new IT systems are adopted and integrated.",1.6580180914979784e-07,0.17204359862161756,0.04079715480186812,0.012693985253473108,0.16713382724419823,0.03684807256235825,0.012675610786670066,0.11778303565638559,0.0,1.6580180914979784e-07,0.1198011998126205,0.0
72,0.9,2,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Does the nature of general practice impact the implementation of IT innovation in primary care? Indeed, general practice traits considerably affect how IT innovations are embraced in primary care. Factors including practice scale, staff technology skills, leadership style, readiness for change, and infrastructure can determine the adoption speed and successful integration of new IT systems.",9.474389094274162e-08,0.02060656191598431,0.06508875739644968,0.0072537058591274906,0.00020350682914438423,0.05246913580246911,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
72,0.9,3,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Are general practice features influential in the adoption of IT innovations in primary care? Yes, the characteristics of general practices have a profound effect on the uptake of IT innovations in primary care settings. Variables such as the size of the practice, technological aptitude among staff, leadership style, willingness to adapt, and infrastructure availability play a crucial role in the integration and acceptance of IT systems.",1.6580180914979784e-07,0.12133841606770446,0.023180358633256834,0.012693985253473108,0.12381212845920064,0.0057075125829044795,0.012675610786670066,0.07377369085892838,0.03171190540177372,1.6580180914979784e-07,0.09744161334294432,0.016124697661918846
72,0.9,4,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Do characteristics of general practices affect the uptake of information technology innovations in primary care? Absolutely, the specific traits of general practices significantly shape the adoption of IT innovations in the primary care environment. Factors like practice size, staff competency with technology, leadership dynamics, change readiness, and infrastructure impact adoption rates and system integration.",1.1842986367842703e-07,0.025210827637998534,0.04567100591715973,0.009067132323909363,0.0455041950861621,0.0332457601777094,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
72,0.9,5,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Can general practice attributes influence the adoption of IT innovations in primary care? Yes, the characteristics of general practices substantially influence the uptake of IT innovations in primary care. Elements such as the scale of the practice, technological literacy of staff, leadership style, change willingness, and available infrastructure affect how efficiently new IT systems are adopted and integrated.",2.3685972735685406e-08,0.004413250264002855,0.015162721893491049,0.0018134264647818726,0.01900248533353599,0.0009306505983852909,0.0018108015409528666,0.06842920954340181,0.03631185475258099,2.3685972735685406e-08,0.04402125646671262,0.01851192595229618
72,0.9,6,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Is the uptake of IT innovation in primary care impacted by general practice characteristics? Yes, the uptake of IT innovation in primary care is significantly influenced by general practice characteristics. Factors including practice size, staff's technological skills, leadership approach, willingness to embrace change, and infrastructure play a critical role in the adoption and integration process of new IT systems.",0.0,0.07170488074758019,0.047866520113660785,0.0,0.09728381481543025,0.06793086419753086,0.0,0.12377628224284765,0.08842752787389466,0.0,0.10082140808144713,0.07227989234909649
72,0.9,7,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Do traits of general practice impact the adoption of information technology innovations in primary care? Yes, general practice traits strongly influence the extent to which IT innovations are embraced in primary care. Factors such as the size of the practice, technological literacy within the staff, leadership methods, readiness for change, and infrastructure contribute to the adoption rate and integration success.",2.3685972735685406e-08,0.09001465106870388,0.05136947530491484,0.0018134264647818726,0.0903546038234424,0.05246913580246911,0.0018108015409528666,0.01769957709940062,0.0,2.3685972735685406e-08,0.018018505502678472,0.0
72,0.9,8,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Do the qualities of general practice affect the implementation of IT innovations in primary care? Yes, the qualities of general practice markedly influence the uptake of information technology innovations in primary care. Variables such as practice size, staff technology knowledge, leadership style, change openness, and infrastructure availability impact the rate and effectiveness of IT system adoption.",7.105791820705622e-08,0.08613752796131902,0.02249496630506248,0.005440279394345618,0.08379283135276827,0.021130864197530887,0.0054324046228586,0.1073727719422699,0.037677816224529016,7.105791820705622e-08,0.08274897359565658,0.01922337562475971
72,0.9,9,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Does the general practice environment affect the acceptance of IT innovations in primary care? Yes, the environment and characteristics of general practices play a major role in the uptake of IT innovations in primary care. Elements including the size of the practice, staff technological literacy, leadership approach, willingness to change, and infrastructure influence adoption rates and integration depth.",2.3685972735685406e-08,0.02873420396786086,0.032295285020043335,0.0018134264647818726,0.01900248533353599,0.0009306505983852909,0.0018108015409528666,0.06842920954340181,0.03631185475258099,2.3685972735685406e-08,0.04402125646671262,0.01851192595229618
72,0.9,10,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Are general practice characteristics a factor in the uptake of IT innovations in primary care? Yes, general practice characteristics are key influencers in the adoption of IT innovations in primary care. Factors such as practice size, technological competency of the staff, leadership style, openness to change, and infrastructure impact how successfully new IT systems are adopted and integrated.",2.3685972735685406e-08,0.04422865714371138,0.01832899408284025,0.0018134264647818726,0.04375774178210534,0.018536781357294203,0.0018108015409528666,0.06842920954340181,0.03631185475258099,2.3685972735685406e-08,0.04402125646671262,0.01851192595229618
73,0.9,1,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is fragility of the esophageal mucosa a definitive endoscopic marker for primary eosinophilic esophagitis? Yes, the fragility observed in the esophageal lining is a hallmark endoscopic sign of this condition, characterized by its tendency to tear easily during endoscopy due to high eosinophil infiltration.",3.552895910352811e-07,0.0834445097211507,0.18335459183673472,0.02720139697172809,0.13513497362417848,0.1204,0.027162023114293,0.18800334178799405,0.08842752787389467,3.552895910352811e-07,0.2428376750574497,0.05436390532544381
73,0.9,2,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Does the fragility of the esophageal mucosa serve as a pathognomonic endoscopic indicator for primary eosinophilic esophagitis? Indeed, this fragility is a distinctive feature seen during endoscopy, reflecting the mucosa's vulnerability caused by elevated eosinophil levels.",5.447773729207638e-07,0.25705716017832536,0.20659722222222224,0.04170880868998308,0.34644406729138444,0.1204,0.041648435441915946,0.40506784702582177,0.08842752787389467,5.447773729207643e-07,0.4659812263716594,0.05436390532544381
73,0.9,3,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Can the fragile nature of the esophageal mucosa be considered a specific endoscopic sign of primary eosinophilic esophagitis? Absolutely, the fragility is a diagnostic hallmark revealing the mucosa's susceptibility to damage, often seen as mucosal tears or crepe-paper appearance during endoscopy due to dense eosinophilic infiltration.",3.079176455639103e-07,0.005742731897419251,0.20659722222222224,0.023574544042164344,0.08861495798928454,0.1204,0.023540420032387266,0.14037529279873961,0.08842752787389467,3.079176455639103e-07,0.19404751088801797,0.05436390532544381
73,0.9,4,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is the fragile esophageal mucosa a unique endoscopic sign of primary eosinophilic esophagitis? Yes, fragility of the mucosa is pathognomonic and presents as easily torn tissue or crepe-paper esophagus under endoscopic examination, indicating a high eosinophil count.",5.210914001850785e-07,0.22888628321162852,0.20659722222222224,0.0398953822252012,0.31745653041813293,0.1204,0.03983763390096307,0.37521488387614,0.08842752787389467,5.210914001850789e-07,0.4352095677049057,0.05436390532544381
73,0.9,5,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Does primary eosinophilic esophagitis present with fragile esophageal mucosa as a pathognomonic endoscopic sign? Yes, fragility of the esophageal lining, which can result in tearing or a crepe-paper-like appearance during endoscopy, uniquely identifies the condition and reflects eosinophil accumulation.",4.737194547137079e-07,0.17481906194135233,0.20659722222222224,0.03626852929563745,0.26188667926332077,0.1204,0.03621603081905733,0.31805647003619164,0.08842752787389467,4.737194547137081e-07,0.3763690676819724,0.05436390532544381
73,0.9,6,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is the characteristic fragility of the esophageal mucosa a definitive endoscopic sign for primary eosinophilic esophagitis? Yes, this fragility, visible during endoscopy as tissue that tears easily, is a pathognomonic indication of high eosinophil presence in the esophageal mucosa.",4.737194547137079e-07,0.21130049249713867,0.18030065538511486,0.03626852929563745,0.26188667926332077,0.1204,0.03621603081905733,0.31805647003619164,0.08842752787389467,4.737194547137081e-07,0.3763690676819724,0.05436390532544381
73,0.9,7,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Can fragile esophageal mucosa be used as a definitive endoscopic marker for primary eosinophilic esophagitis? Yes, fragility is a distinctive endoscopic sign that demonstrates the mucosa’s reduced resilience and the presence of abundant eosinophils.",5.921493183921344e-07,0.31589766020125865,0.20659722222222224,0.04533566161954684,0.4070686891078199,0.1204,0.04527003852382169,0.4675882040071553,0.08842752787389467,5.921493183921352e-07,0.5305197475092309,0.05436390532544381
73,0.9,8,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is the fragility in the esophageal mucosa pathognomonic for primary eosinophilic esophagitis when observed endoscopically? Yes, such fragility, which may cause mucosal tearing or crepe-paper appearance during endoscopy, is a hallmark feature indicating eosinophil-driven mucosal damage.",5.447773729207638e-07,0.25705716017832536,0.20659722222222224,0.04170880868998308,0.34644406729138444,0.1204,0.041648435441915946,0.40506784702582177,0.08842752787389467,5.447773729207643e-07,0.4659812263716594,0.05436390532544381
73,0.9,9,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Does the fragile esophageal lining indicate primary eosinophilic esophagitis as a pathognomonic endoscopic sign? Yes, fragility of the esophageal mucosa is a key endoscopic indicator, often presenting as tears or delicate, paper-thin mucosa due to significant eosinophilic infiltration.",4.974054274493932e-07,0.2014873090235132,0.20659722222222224,0.038081955760419325,0.2892856534514361,0.1204,0.0380268323600102,0.3462273470028885,0.08842752787389467,4.974054274493935e-07,0.40535660455522393,0.05436390532544381
73,0.9,10,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is esophageal mucosal fragility a pathognomonic sign in endoscopy for primary eosinophilic esophagitis? Indeed, the mucosa's fragility, manifesting as easy tearing or crepe-paper texture during endoscopy, is a diagnostic hallmark reflecting a high eosinophil count.",5.684633456564491e-07,0.28604469705157687,0.20659722222222224,0.04352223515476496,0.3762970304410662,0.1204,0.04345923698286882,0.43583950569257546,0.08842752787389467,5.684633456564497e-07,0.4977299246862392,0.05436390532544381
74,0.9,1,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is spinal cord untethering needed before scoliosis correction in a patient with myelomeningocele? The study indicates that untethering might not be required for MM patients undergoing scoliosis surgery if they lack clinical signs of tethered cord, despite radiographic evidence.",2.8423167282822466e-07,0.27443684570175897,0.0,0.02176111757738247,0.2809023854664012,0.0,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
74,0.9,2,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Should patients with myelomeningocele undergo untethering before scoliosis correction? According to the study, untethering the spinal cord may be unnecessary in MM patients having scoliosis surgery who show no clinical symptoms of tethered cord, even when imaging shows tethering.",2.8423167282822466e-07,0.27443684570175897,0.0,0.02176111757738247,0.2809023854664012,0.0,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
74,0.9,3,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","In patients with myelomeningocele, is untethering the spinal cord necessary before scoliosis surgery? The findings suggest that if there are no clinical symptoms of tethered cord, untethering may not be needed despite radiographic signs.",4.0266153650665116e-07,0.4155154439616653,0.0,0.030828249901291856,0.42608439531090037,0.0,0.03078362619619876,0.43721380642274443,0.0,4.026615365066519e-07,0.44895022004790297,0.0
74,0.9,4,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Does a patient with myelomeningocele require untethering prior to scoliosis correction? Study results imply that patients without clinical signs of tethered cord may not need untethering, even when tethering appears on imaging.",4.5003348197802176e-07,0.4780358009429988,0.0,0.034455102830855615,0.4906229164484719,0.0,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
74,0.9,5,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","For myelomeningocele patients undergoing scoliosis correction, is untethering the spinal cord required? The research suggests untethering may be unnecessary if there are no clinical symptoms, regardless of radiographic tethering.",5.210914001850777e-07,0.5798184952529413,0.0,0.039895382225201254,0.5959834321062973,0.0,0.03983763390096313,0.6131044728864086,0.0,5.210914001850789e-07,0.6312717768418579,0.0
74,0.9,6,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is it essential to perform spinal cord untethering before scoliosis correction in a patient with myelomeningocele? The study suggests it may not be necessary when there are no clinical signs of tethered cord, even if radiology shows tethering.",3.0791764556390996e-07,0.30110509278391984,0.0,0.023574544042164344,0.30830135965451655,0.0,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
74,0.9,7,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Do patients with myelomeningocele need untethering before their scoliosis surgery? Evidence from the study shows untethering might be unnecessary if clinical symptoms of tethered cord are absent, despite radiographic tethering.",4.974054274493924e-07,0.5447271754416723,0.0,0.038081955760419374,0.5596157879354227,0.0,0.038026832360010254,0.5753641449035616,0.0,4.974054274493935e-07,0.5920510636885754,0.0
74,0.9,8,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Prior to scoliosis surgery in myelomeningocele patients, is untethering required? The study's results suggest that spinal cord untethering is not necessary if clinical symptoms are not present, although imaging may show tethering.",4.5003348197802176e-07,0.4780358009429988,0.0,0.034455102830855615,0.4906229164484719,0.0,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
74,0.9,9,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Must a patient with myelomeningocele undergo untethering before scoliosis correction? According to the study, untethering may be avoidable in patients with no clinical tethered cord symptoms even if tethering appears on radiographic exams.",4.2634750924233646e-07,0.446287102628419,0.0,0.032641676366073735,0.4578330936254802,0.0,0.032594427737151634,0.47000362924573613,0.0,4.263475092423373e-07,0.48285177172358473,0.0
74,0.9,10,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.",Is untethering the spinal cord a prerequisite for scoliosis correction in myelomeningocele patients? The study indicates it may be unnecessary in those without clinical manifestations of tethered cord even when tethering is seen on imaging.,3.7897556377096586e-07,0.3856624808119835,0.0,0.029014823436509976,0.3953127366441467,0.0,0.028972824655245887,0.4054651081081646,0.0,3.789755637709665e-07,0.41616039722491127,0.0
75,0.9,1,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","The clinical importance of bile duct sludge and bile duct stones differs, despite their similarities. Bile duct sludge is a thickened bile substance that may cause temporary blockage but often clears on its own.",2.3685972735685332e-07,0.21943137537910173,0.24307034845496403,0.018134264647818747,0.315255414268639,0.031217481789802305,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
75,0.9,2,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Although bile duct sludge and bile duct stones share similarities, their clinical implications are distinct. Sludge, a viscous bile, can lead to transient obstruction and usually resolves without intervention.",3.552895910352798e-07,0.29136217510920703,0.3640717201970765,0.027201396971728145,0.4418327522790384,0.0,0.02716202311429306,0.45547552868282537,0.0,3.552895910352811e-07,0.47000362924573613,0.0
75,0.9,3,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Bile duct sludge and stones, while alike, have varying clinical significance. Sludge is a thick bile fluid that often causes short-term blockage and typically resolves spontaneously.",4.263475092423357e-07,0.355180347519072,0.3997370151216307,0.032641676366073784,0.5596157879354227,0.0,0.03259442773715168,0.5780778507751583,0.0,4.263475092423373e-07,0.5978370007556206,0.0
75,0.9,4,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct",The clinical roles of bile duct sludge and stones differ despite their resemblance. Sludge is a thickened bile that can cause brief obstruction and generally clears up on its own.,3.316036182995945e-07,0.20676034240079888,0.3997370151216307,0.025387970506946266,0.4054651081081637,0.0,0.025351221573340188,0.4177352006999784,0.0,3.316036182995957e-07,0.43078291609245367,0.0
75,0.9,5,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","While bile duct sludge and stones are similar, their clinical significance is not the same. Sludge often causes temporary obstruction and resolves naturally.",4.974054274493916e-07,0.4830137190289565,0.3997370151216307,0.03808195576041942,0.6931471805599463,0.0,0.0380268323600103,0.7178397931503175,0.0,4.974054274493934e-07,0.744440474947496,0.0
75,0.9,6,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct",Bile duct sludge and stones have distinct clinical implications even though they appear similar. Sludge is a thickened bile fluid that frequently results in transient blockage and resolves on its own.,3.079176455639092e-07,0.17285879072511712,0.3997370151216307,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
75,0.9,7,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","The clinical significance of bile duct sludge differs from that of bile duct stones, although they are similar. Sludge tends to cause temporary obstruction and usually resolves spontaneously.",3.789755637709651e-07,0.3809077775770091,0.3261370151216307,0.029014823436510025,0.5328920941511122,0.03840000000000001,0.028972824655245935,0.49469624183610783,0.0,3.789755637709665e-07,0.5108256237659909,0.0
75,0.9,8,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Despite similarities between bile duct sludge and stones, their clinical meanings differ. Sludge, a thick bile, often leads to temporary obstruction and spontaneously resolves.",4.737194547137063e-07,0.43856195645812246,0.3997370151216307,0.03626852929563754,0.6466271649250523,0.0,0.03621603081905743,0.6690496289808863,0.0,4.7371945471370807e-07,0.6931471805599458,0.0
75,0.9,9,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Though bile duct sludge and stones are alike, their clinical importance varies. Sludge, being a thickened bile fluid, commonly causes transient obstruction with spontaneous resolution.",4.50033481978021e-07,0.3960023420393268,0.3997370151216307,0.03445510283085566,0.6021754023542183,0.0,0.034405229278104556,0.6225296133459923,0.0,4.500334819780227e-07,0.6443570163905146,0.0
75,0.9,10,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct",Bile duct sludge and stones have different clinical significance despite their similarities. Sludge is thick bile that often causes temporary blockage but resolves spontaneously.,4.737194547137063e-07,0.43856195645812246,0.3997370151216307,0.03626852929563754,0.6466271649250523,0.0,0.03621603081905743,0.6690496289808863,0.0,4.7371945471370807e-07,0.6931471805599458,0.0
76,0.9,1,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Do BCRABL transcript detection results by quantitative real-time PCR show correlation across homebrew assays? The findings imply that quantitative real-time PCR assays for BCRABL detection may produce comparable results between labs even with methodological differences, provided the same positive control cell line and quality control gene are employed. Ensuring some assay standardization among labs is essential, not just for consistency.",1.6580180914979784e-07,0.11710140727727492,0.0035831337526931253,0.012693985253473108,0.11651828070938652,0.001855213262734686,0.012675610786670066,0.11583181552512123,0.0,1.6580180914979784e-07,0.11778303565638559,0.0
76,0.9,2,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Is it possible to achieve correlated results in BCRABL transcript detection using quantitative real-time PCR with homebrew assays? The data indicates that despite varying methodologies, quantitative real-time PCR assays for BCRABL can yield comparable outcomes between laboratories if the identical positive control cell line and quality control gene are utilized. A baseline standardization of assays across laboratories is crucial, beyond just accuracy.",1.1842986367842703e-07,0.08222423195425677,0.002475772497127271,0.009067132323909363,0.08182000813651058,0.0012810193954682567,0.009054007704764333,0.08134563945395268,0.0,1.1842986367842703e-07,0.08269171584511614,0.0
76,0.9,3,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Can quantitative real-time PCR for BCRABL transcript detection generate correlated results using homebrew assays? Results suggest that even with methodological differences, labs can obtain comparable BCRABL detection results if the same positive control cell line and quality control gene are applied. Adoption of assay standardization practices between laboratories is vital, not only for reliability.",3.079176455639103e-07,0.1773539084403679,0.0302734375,0.023574544042164344,0.20181594575851758,0.015380859375,0.023540420032387266,0.22705745063534621,0.0,3.079176455639103e-07,0.23111172096338972,0.0
76,0.9,4,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Are correlated results achievable from BCRABL transcript detection by quantitative real-time PCR among homebrew assays? The evidence shows that quantitative real-time PCR assays for detecting BCRABL can be consistent across labs despite methodology variations, as long as the same positive control cell line and quality control gene are used. Implementing a degree of assay standardization between labs is necessary, not only for reproducibility.",9.474389094274162e-08,0.06523060988674878,0.0019487847222222007,0.0072537058591274906,0.06491193723417421,0.0010080295138888973,0.007243206163811466,0.06453852113757197,0.0,9.474389094274162e-08,0.06559728248581642,0.0
76,0.9,5,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Does quantitative real-time PCR allow for correlated BCRABL transcript detection results from homebrew assays? Findings suggest that even with significant methodological differences, comparable results are possible between labs if they use the same positive control cell line and quality control gene. Standardizing assays between laboratories is critical, beyond mere procedural alignment.",3.789755637709665e-07,0.23562281656434347,0.0302734375,0.029014823436509962,0.26123936622931865,0.015380859375,0.028972824655245866,0.28768207245178035,0.0,3.789755637709665e-07,0.29298712468147725,0.0
76,0.9,6,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Are consistent results from homebrew quantitative real-time PCR assays for BCRABL transcript detection feasible? The results indicate that disparate methodologies can still lead to comparable BCRABL detection outcomes between labs, provided the same positive control cell line and quality control gene are maintained. It is essential to establish some assay standardization across laboratories, not just for uniformity.",2.3685972735685406e-07,0.12229413125733934,0.0302734375,0.018134264647818726,0.14572647910747438,0.015380859375,0.018108015409528666,0.16989903679539609,0.0,2.3685972735685406e-07,0.17284281283941416,0.0
76,0.9,7,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Can homebrew quantitative real-time PCR assays for BCRABL transcript detection yield correlated results? The analysis suggests that despite notable methodological differences, quantitative real-time PCR for BCRABL can produce comparable results among labs if the same positive control cell line and quality control gene are implemented. Some level of assay standardization between laboratories is imperative, not only for consistency.",2.1317375462116866e-07,0.1775574152695123,0.022195698302469112,0.016320838183036854,0.1524632300533657,0.002470380294421492,0.0162972138685758,0.15154989812720032,0.0,2.1317375462116866e-07,0.15415067982725983,0.0
76,0.9,8,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Is it possible to obtain correlated BCRABL transcript detection results from quantitative real-time PCR homebrew assays? The data supports that quantitative real-time PCR detection of BCRABL can be comparable across laboratories despite methodological variations, when using the same positive control cell line and quality control gene. Adopting assay standardization among laboratories is important, not just for quality control.",2.1317375462116866e-07,0.15323646156565474,0.0047678848140496055,0.016320838183036854,0.1524632300533657,0.002470380294421492,0.0162972138685758,0.15154989812720032,0.0,2.1317375462116866e-07,0.15415067982725983,0.0
76,0.9,9,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Can quantitative real-time PCR assays for BCRABL transcript detection produce correlated results across homebrew assays? The findings indicate that labs can achieve comparable BCRABL detection results even with different methodologies if they utilize the same positive control cell line and quality control gene. Establishing assay standardization between labs is necessary, beyond just technical measures.",3.079176455639103e-07,0.1773539084403679,0.0302734375,0.023574544042164344,0.20181594575851758,0.015380859375,0.023540420032387266,0.22705745063534621,0.0,3.079176455639103e-07,0.23111172096338972,0.0
76,0.9,10,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Are correlated outcomes from homebrew quantitative real-time PCR assays for BCRABL transcript detection possible? Results suggest that despite methodological differences, labs can have comparable quantitative real-time PCR results for BCRABL if the same positive control cell line and quality control gene are used. It is crucial to implement some assay standardization between laboratories, not merely for consistency.",2.3685972735685406e-07,0.1965599006030483,0.023126348900854403,0.018134264647818726,0.17093183112783628,0.002794723615397801,0.018108015409528666,0.16989903679539609,0.0,2.3685972735685406e-07,0.17284281283941416,0.0
77,0.9,1,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Does the fibronectin-aggrecan complex exist in cervical disk disease? Biochemical studies of damaged cervical intervertebral disks show inflammatory markers like MCP, fragments of matrix proteins like FAC, and a pH correlation. Further analysis considers FAC as a diagnostic or therapeutic marker.",2.6054570009253947e-07,0.2157639362354895,0.019599999999999996,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
77,0.9,2,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Is the fibronectin-aggrecan complex detectable in cervical disk disease? Injured cervical intervertebral disks undergo biochemical analysis revealing inflammatory markers including MCP, structural protein fragments such as FAC, and a pH association. FAC is further evaluated for diagnostic or therapeutic use.",2.8423167282822477e-07,0.24108174421978124,0.019599999999999996,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
77,0.9,3,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Is there a presence of the fibronectin-aggrecan complex in cervical disk disease? Biochemical examination of injured cervical disks identifies inflammatory markers like MCP, fragments of matrix proteins such as FAC, and a link to pH levels. The FAC is also studied as a possible diagnostic biomarker or treatment target.",7.105791820705622e-08,0.03344237944153461,0.019599999999999996,0.005440279394345618,0.06187540371808753,0.0,0.0054324046228586,0.06317890162153228,0.0,7.105791820705622e-08,0.06453852113757153,0.0
77,0.9,4,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","In cervical disk disease, is the fibronectin-aggrecan complex found? Analysis of damaged cervical intervertebral disks shows inflammatory markers (MCP), structural protein fragments (FAC), and correlation with pH. FAC is further investigated for diagnostic or therapeutic potential.",3.7897556377096597e-07,0.34929532886001224,0.019599999999999996,0.02901482343650997,0.3856624808119835,0.0,0.02897282465524588,0.3953127366441467,0.0,3.789755637709665e-07,0.4054651081081646,0.0
77,0.9,5,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Is the fibronectin-aggrecan complex involved in cervical disk disease? Injured cervical disks reveal inflammatory markers like MCP, fragments of matrix proteins such as FAC, and pH correlation by biochemical analysis; FAC is evaluated for diagnostic and therapeutic roles.",3.3160361829959537e-07,0.2937254777052001,0.019599999999999996,0.025387970506946217,0.32850406697203516,0.0,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
77,0.9,6,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Can the fibronectin-aggrecan complex be detected in cervical disk disease? Biochemical analysis of injured cervical disks shows inflammatory markers including MCP, structural protein fragments like FAC, and a pH correlation. FAC is studied as a diagnostic or therapeutic marker.",3.0791764556391007e-07,0.2670572306230392,0.019599999999999996,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
77,0.9,7,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Is the fibronectin-aggrecan complex present in cases of cervical disk disease? Biochemical assessment of injured cervical disks reveals inflammatory markers such as MCP, fragments of structural proteins like FAC, and a correlation with pH. FAC is further examined for diagnostic or therapeutic purposes.",2.1317375462116866e-07,0.1669737720660578,0.019599999999999996,0.016320838183036854,0.19845093872383757,0.0,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
77,0.9,8,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Does cervical disk disease feature the fibronectin-aggrecan complex? Biochemical analyses of injured cervical disks demonstrate inflammatory markers like MCP, fragments of matrix proteins such as FAC, and a pH correlation. FAC is explored as a potential biomarker or therapy.",3.0791764556391007e-07,0.2670572306230392,0.019599999999999996,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
77,0.9,9,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Is the fibronectin-aggrecan complex identified in cervical disk disease? Injured cervical intervertebral disks analyzed biochemically show inflammatory markers like MCP, fragments of structural matrix proteins like FAC, and pH correlation, with FAC evaluated for diagnostic or therapeutic use.",3.3160361829959537e-07,0.2937254777052001,0.019599999999999996,0.025387970506946217,0.32850406697203516,0.0,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
77,0.9,10,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Is the fibronectin-aggrecan complex detected in cervical disk disease? Biochemical analysis reveals inflammatory markers including MCP, fragments of structural proteins such as FAC, and a correlation with pH in injured cervical disks, with FAC studied as a potential diagnostic or therapeutic biomarker.",2.3685972735685406e-07,0.1910713236451178,0.019599999999999996,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
78,0.9,1,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Could Alveolar Macrophage Phagocytic Dysfunction in Children with Protracted Bacterial Bronchitis Predict the Development of Bronchiectasis? Answer: A diminished phagocytic response of alveolar macrophages to apoptotic cells or NTHi might play a role in neutrophilic inflammation and NTHi colonization seen in both PBB and bronchiectasis. It is still unclear if this process drives the progression from PBB to bronchiectasis.,9.474389094274162e-08,0.12061496271397099,0.03631185475258099,0.0072537058591274906,0.09713108178066054,0.01851192595229618,0.007243206163811466,0.07275935428242919,0.0,9.474389094274162e-08,0.07410797215372167,0.0
78,0.9,2,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Pediatric Protracted Bacterial Bronchitis an Indicator for Bronchiectasis? Answer: Impaired alveolar macrophage phagocytosis towards apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis cases. Whether this mechanism leads to the development of bronchiectasis from PBB is yet unknown.,7.105791820705622e-08,0.03233826955493324,0.017088479127821278,0.005440279394345618,0.03148629604143327,0.01851192595229618,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
78,0.9,3,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Does Dysfunction of Alveolar Macrophage Phagocytosis in Children with Protracted Bacterial Bronchitis Precede Bronchiectasis? Answer: A compromised phagocytic alveolar macrophage response to apoptotic cells or NTHi could promote neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. It remains uncertain if this dysfunction causes PBB to progress into bronchiectasis.,1.1842986367842703e-07,0.07262536298600031,0.016320184615138254,0.009067132323909363,0.07149163065513164,0.01851192595229618,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
78,0.9,4,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children with Protracted Bacterial Bronchitis a Potential Precursor to Bronchiectasis? Answer: Reduced phagocytic activity of alveolar macrophages against apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization observed in both PBB and bronchiectasis. The role of this mechanism in advancing PBB to bronchiectasis is not yet determined.,2.3685972735685406e-08,0.06842920954340181,0.03631185475258099,0.0018134264647818726,0.04402125646671262,0.01851192595229618,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
78,0.9,5,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Could Alveolar Macrophage Phagocytosis Defects in Children with Protracted Bacterial Bronchitis Lead to Bronchiectasis? Answer: A lower phagocytic response by alveolar macrophages to apoptotic cells or NTHi could underlie neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this contributes to the transition from PBB to bronchiectasis is still unknown.,7.105791820705622e-08,0.005678762610319854,0.03631185475258099,0.005440279394345618,0.03148629604143327,0.01851192595229618,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
78,0.9,6,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Pediatric Protracted Bacterial Bronchitis a Sign of Impending Bronchiectasis? Answer: Impaired alveolar macrophages' phagocytic response to apoptotic cells or NTHi might cause neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. The impact of this on PBB progressing to bronchiectasis remains unclear.,1.4211583641411244e-07,0.06510218308112092,0.03631185475258099,0.010880558788691236,0.0921109178578674,0.01851192595229618,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
78,0.9,7,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Does Phagocytic Dysfunction of Alveolar Macrophages in Children with Protracted Bacterial Bronchitis Anticipate Bronchiectasis? Answer: A reduced phagocytic function of alveolar macrophages towards apoptotic cells or NTHi may facilitate neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this factor contributes to progression to bronchiectasis is not yet known.,9.474389094274162e-08,0.07946133321722204,0.0028384992665777056,0.0072537058591274906,0.07901481056001103,0.0014797441851465525,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
78,0.9,8,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is Alveolar Macrophage Phagocytic Impairment in Protracted Bacterial Bronchitis a Predictor for Bronchiectasis in Children? Answer: Decreased phagocytic activity of alveolar macrophages against apoptotic cells or NTHi might promote neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. It remains to be established if this leads to bronchiectasis development.,1.4211583641411244e-07,0.06510218308112092,0.03631185475258099,0.010880558788691236,0.0921109178578674,0.01851192595229618,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
78,0.9,9,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Can Alveolar Macrophage Phagocytic Dysfunction in Children with Protracted Bacterial Bronchitis Lead to Bronchiectasis? Answer: A diminished host phagocytic response of alveolar macrophages to apoptotic cells or NTHi could contribute to neutrophilic inflammation and colonization by NTHi in both PBB and bronchiectasis. The role of this mechanism in the progression from PBB to bronchiectasis is unknown.,2.3685972735685406e-08,0.06842920954340181,0.03631185475258099,0.0018134264647818726,0.04402125646671262,0.01851192595229618,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
78,0.9,10,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is Alveolar Macrophage Dysfunction in Phagocytosis a Precursor to Bronchiectasis in Children with Protracted Bacterial Bronchitis? Answer: Reduced alveolar macrophage phagocytosis of apoptotic cells or NTHi may help promote neutrophilic inflammation and NTHi colonization in PBB as well as bronchiectasis. It is still unknown if this process accelerates progression of PBB to bronchiectasis.,4.737194547137081e-08,0.012787065019247645,0.017450908007018855,0.0036268529295637453,0.012068210184330574,0.01851192595229618,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
79,0.9,1,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Are biochemical markers of bone turnover truly indicative of bone histomorphometry in 370 postmenopausal women? Biochemical markers might not consistently mirror bone histomorphometry in postmenopausal women due to influences like age, hormones, and lifestyle factors.",2.3685972735685343e-07,0.1884837301059581,0.09189513838162477,0.01813426464781874,0.17774385927312153,0.06177126992932283,0.018108015409528687,0.20591969828745738,0.047500000000000014,2.3685972735685406e-07,0.24577280463087137,0.024375
79,0.9,2,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Do biochemical markers of bone turnover reliably represent bone histomorphometry in 370 postmenopausal women? These markers may not always accurately reflect bone histomorphometry because of variables such as age, hormonal changes, and lifestyle.",2.84231672828224e-07,0.12933659645799267,0.17623321214737805,0.0217611175773825,0.1982552962205193,0.09204470742932283,0.021729618491434434,0.2704582194250289,0.047500000000000014,2.8423167282822487e-07,0.31246417912954483,0.024375
79,0.9,3,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Is there a reliable correlation between biochemical markers of bone turnover and bone histomorphometry in 370 postmenopausal women? Biochemical markers may not consistently correspond to bone histomorphometry owing to factors like hormonal levels, age, and lifestyle.",2.1317375462116813e-07,0.07561955961873013,0.15051772791330525,0.01632083818303686,0.105881976089504,0.09204470742932283,0.016297213868575813,0.1751480396207037,0.047500000000000014,2.1317375462116866e-07,0.21402410631629154,0.024375
79,0.9,4,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Can biochemical markers of bone turnover be considered representative of bone histomorphometry in 370 postmenopausal women? Often, these markers do not accurately capture bone histomorphometry due to age, hormone fluctuations, and lifestyle influences.",2.84231672828224e-07,0.17265829524298937,0.14522847171495812,0.0217611175773825,0.1982552962205193,0.09204470742932283,0.021729618491434434,0.2704582194250289,0.047500000000000014,2.8423167282822487e-07,0.31246417912954483,0.024375
79,0.9,5,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Are biochemical markers of bone turnover dependable indicators of bone histomorphometry in 370 postmenopausal women? Such markers may fail to fully represent bone histomorphometry because of age, hormonal variation, and lifestyle factors.",3.0791764556390933e-07,0.20720194186627738,0.14324141926417205,0.02357454404216438,0.231045119043511,0.09204470742932283,0.023540420032387308,0.30435977110071066,0.047500000000000014,3.079176455639103e-07,0.34755549894081383,0.024375
79,0.9,6,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Is the representation of bone histomorphometry by biochemical markers of bone turnover accurate in 370 postmenopausal women? They may not always be representative, affected by age, hormones, and lifestyle elements.",3.5528959103527993e-07,0.2322582243179685,0.17301191842697627,0.027201396971728138,0.30003799053046176,0.09204470742932283,0.027162023114293055,0.37581873508285435,0.047500000000000014,3.552895910352811e-07,0.4216634710945355,0.024375
79,0.9,7,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Do biochemical markers of bone turnover effectively represent bone histomorphometry in 370 postmenopausal women? Often, they do not due to various factors including age, hormonal status, and lifestyle.",4.0266153650665053e-07,0.25591393446839206,0.20745069393718035,0.030828249901291897,0.37414596268418343,0.09204470742932283,0.0307836261961988,0.4527797762189838,0.047500000000000014,4.026615365066519e-07,0.5017061787680728,0.024375
79,0.9,8,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","To what extent do biochemical markers of bone turnover correspond to bone histomorphometry in 370 postmenopausal women? These markers may not always be indicative because of influences like age, hormone levels, and lifestyle.",2.84231672828224e-07,0.08601489767299508,0.20745069393718035,0.0217611175773825,0.1982552962205193,0.09204470742932283,0.021729618491434434,0.2704582194250289,0.047500000000000014,2.8423167282822487e-07,0.31246417912954483,0.024375
79,0.9,9,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Are the biochemical markers for bone turnover representative of bone histomorphometry among 370 postmenopausal women? They might not consistently reflect bone histomorphometry due to age, hormonal fluctuations, and lifestyle differences.",3.5528959103527993e-07,0.2322582243179685,0.17301191842697627,0.027201396971728138,0.30003799053046176,0.09204470742932283,0.027162023114293055,0.37581873508285435,0.047500000000000014,3.552895910352811e-07,0.4216634710945355,0.024375
79,0.9,10,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Is there a consistent representation of bone histomorphometry by biochemical markers of bone turnover in 370 postmenopausal women? Such markers can vary in accuracy because of factors including age, hormones, and lifestyle.",3.0791764556390933e-07,0.16248276892692592,0.17522847171495815,0.02357454404216438,0.231045119043511,0.09204470742932283,0.023540420032387308,0.30435977110071066,0.047500000000000014,3.079176455639103e-07,0.34755549894081383,0.024375
80,0.9,1,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and methadone maintenance treatment (MMT) recorded in the medical record? Yes, opioid dependence and MMT are generally noted in the medical record. This includes diagnosis, treatment plans, medication information, and monitoring the patient’s response, offering essential details for current and future healthcare providers.",3.079176455639103e-07,0.12896889733029848,0.11855439057439356,0.023574544042164344,0.15162833804018927,0.0750485260770975,0.023540420032387266,0.14037529279873961,0.08842752787389466,3.079176455639103e-07,0.19404751088801797,0.05436390532544381
80,0.9,2,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Is opioid dependence and methadone maintenance treatment (MMT) documented within the medical record? Indeed, both conditions are usually documented in the medical record, encompassing diagnosis, treatment strategies, medication specifics, and patient response monitoring, which are vital for healthcare professionals managing the patient.",4.026615365066519e-07,0.13264521255172124,0.18222222222222223,0.030828249901291835,0.1839251377936102,0.12039999999999998,0.030783626196198732,0.23801376236265748,0.08842752787389466,4.026615365066519e-07,0.2941309694449994,0.05436390532544381
80,0.9,3,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Does the medical record include documentation of opioid dependence and methadone maintenance treatment (MMT)? Yes, the medical record typically contains documentation of opioid dependence and MMT. This includes diagnosis, treatment plans, medication details, and ongoing patient monitoring, which are important for healthcare providers.",3.789755637709665e-07,0.2727776549729275,0.06770833333333337,0.029014823436509962,0.29448075555639797,0.023979254930606236,0.028972824655245866,0.28201067243435984,0.03856603202901932,3.789755637709665e-07,0.30370149230122534,0.028740636627382854
80,0.9,4,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and methadone maintenance treatment (MMT) noted in the patient’s medical record? Yes, both opioid dependence and MMT are commonly recorded in medical records. This documentation involves diagnosis, treatment approaches, medication data, and evaluation of the patient’s response, providing critical information for healthcare staff.",3.079176455639103e-07,0.09816235597207879,0.14027069160997735,0.023574544042164344,0.12012164801473713,0.09768501892915087,0.023540420032387266,0.14037529279873961,0.08842752787389466,3.079176455639103e-07,0.19404751088801797,0.05436390532544381
80,0.9,5,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Is there documentation of opioid dependence and methadone maintenance treatment (MMT) in the medical record? Yes, these conditions are normally documented, including the diagnosis, treatment plans, medication details, and monitoring of the patient’s response, supplying key information for care providers.",4.500334819780226e-07,0.1488435755380948,0.20659722222222224,0.03445510283085558,0.2352184321811599,0.12039999999999998,0.034405229278104466,0.2906574958480763,0.08842752787389466,4.500334819780227e-07,0.3481981907152756,0.05436390532544381
80,0.9,6,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and methadone maintenance treatment (MMT) logged in the medical record? Yes, both opioid dependence and MMT are usually documented, with details on diagnosis, treatment plans, medications, and patient response monitoring, which are crucial for both current and future medical care.",3.789755637709665e-07,0.1407496205805554,0.15909722222222222,0.029014823436509962,0.19304458279152836,0.09602499999999997,0.028972824655245866,0.21269595437836575,0.08842752787389466,3.789755637709665e-07,0.2681554830417414,0.05436390532544381
80,0.9,7,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Is opioid dependence alongside methadone maintenance treatment (MMT) documented in the medical record? Yes, medical records generally capture opioid dependence and MMT, including diagnosis, treatment regimens, medication information, and patient monitoring, aiding healthcare professionals.",5.921493183921344e-07,0.35790658023519484,0.17632378472222224,0.04533566161954684,0.4070686891078199,0.12039999999999998,0.04527003852382169,0.4675882040071553,0.08842752787389466,5.921493183921352e-07,0.5305197475092309,0.05436390532544381
80,0.9,8,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Does the medical record contain documentation of opioid dependence and methadone maintenance treatment (MMT)? Yes, it typically includes records of opioid dependence and MMT, covering diagnosis, treatment plans, medication details, and patient response tracking, essential for healthcare providers.",4.974054274493932e-07,0.3138895545197222,0.12614739523260288,0.038081955760419325,0.3663020068469858,0.065036678200692,0.0380268323600102,0.3858357573205997,0.0598808150711265,4.974054274493935e-07,0.40535660455522393,0.05436390532544381
80,0.9,9,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and methadone maintenance treatment (MMT) found documented in medical records? Yes, both are usually recorded with diagnosis, treatment planning, medication details, and monitoring of patient outcomes, providing vital information for healthcare teams.",5.684633456564491e-07,0.2860446970515773,0.20659722222222224,0.04352223515476496,0.3762970304410662,0.12039999999999998,0.04345923698286882,0.43583950569257546,0.08842752787389466,5.684633456564497e-07,0.4977299246862392,0.05436390532544381
80,0.9,10,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Is the presence of opioid dependence and methadone maintenance treatment (MMT) recorded in the medical record? Yes, these are typically documented, including comprehensive details such as diagnosis, treatment plans, medications, and patient response monitoring, important for continuous patient care.",4.737194547137079e-07,0.17481906194135277,0.20659722222222224,0.03626852929563745,0.26188667926332077,0.12039999999999998,0.03621603081905733,0.31805647003619164,0.08842752787389466,4.737194547137081e-07,0.3763690676819724,0.05436390532544381
81,0.9,1,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The existing prediction formulas for assessing basal metabolic rate (BMR) might not fully apply to the Chinese population because of specific genetic, environmental, and lifestyle influences. Hence, developing a",4.737194547137081e-08,0.044091525220392835,0.06297404818560379,0.0036268529295637453,0.014993045843371355,0.044021415823914375,0.003621603081905733,0.01538864524228023,0.023242630385487524,4.737194547137081e-08,0.048790164169431716,0.0
81,0.9,2,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Estimating basal metabolic rate in Chinese: do current prediction equations hold? Answer: Present equations used to predict basal metabolic rate (BMR) may not be completely suitable for the Chinese population given unique genetic, environmental, and lifestyle factors. Therefore, there is a need to create a",0.0,0.09241962407465909,0.06502670362358032,0.0,0.06301338005090429,0.04510179465788382,0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0
81,0.9,3,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Basal metabolic rate estimation in Chinese: can current prediction equations be used? Answer: The current formulas for estimating basal metabolic rate (BMR) might not be wholly appropriate for the Chinese population due to distinct genetic, environmental, and lifestyle conditions. Thus, formulating a",7.105791820705622e-08,0.019025818107962778,0.061874999999999986,0.005440279394345618,0.009909554725886949,0.04344177572873293,0.0054324046228586,0.04008125783265193,0.023242630385487524,7.105791820705622e-08,0.07410797215372344,0.0
81,0.9,4,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: How applicable are current basal metabolic rate prediction equations for the Chinese? Answer: The existing prediction equations to estimate basal metabolic rate (BMR) may not be entirely relevant for the Chinese population because of certain genetic, environmental, and lifestyle disparities. Consequently, designing a",4.737194547137081e-08,0.02038728227355513,0.01733029257067717,0.0036268529295637453,0.014993045843371355,0.044021415823914375,0.003621603081905733,0.01538864524228023,0.023242630385487524,4.737194547137081e-08,0.048790164169431716,0.0
81,0.9,5,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Applicability of current basal metabolic rate estimation equations to Chinese population? Answer: The currently used prediction equations for basal metabolic rate (BMR) estimation might not be fully applicable to the Chinese population owing to genetic, environmental, and lifestyle differences. Therefore, establishing a",7.105791820705622e-08,0.019025818107962778,0.061874999999999986,0.005440279394345618,0.009909554725886949,0.04344177572873293,0.0054324046228586,0.04008125783265193,0.023242630385487524,7.105791820705622e-08,0.07410797215372344,0.0
81,0.9,6,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Are current basal metabolic rate prediction formulas suitable for the Chinese population? Answer: The existing basal metabolic rate (BMR) prediction equations may not be perfectly suited for the Chinese population due to particular genetic, environmental, and lifestyle variables. Thus, creating a",9.474389094274162e-08,0.07430594662807266,0.012954254930606257,0.0072537058591274906,0.07010482778396288,0.017955279883857596,0.007243206163811466,0.06539906581694366,0.023242630385487524,9.474389094274162e-08,0.10008345855698142,0.0
81,0.9,7,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Can current basal metabolic rate estimation equations be applied to Chinese individuals? Answer: The prediction formulas currently in use for estimating basal metabolic rate (BMR) might not be entirely accurate for the Chinese population because of specific genetic, environmental, and lifestyle factors. Hence, developing a",0.0,0.09241962407465909,0.06502670362358032,0.0,0.06301338005090429,0.04510179465788382,0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0
81,0.9,8,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Evaluation of basal metabolic rate prediction formulas for Chinese population: Are they applicable? Answer: Current basal metabolic rate (BMR) prediction equations may not completely apply to the Chinese population given certain genetic, environmental, and lifestyle considerations. Therefore, the development of a",9.474389094274162e-08,0.006681831451492926,0.06072279750164366,0.0072537058591274906,0.03544746875596516,0.04283321228363101,0.007243206163811466,0.06539906581694366,0.023242630385487524,9.474389094274162e-08,0.10008345855698142,0.0
81,0.9,9,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Are the present basal metabolic rate estimation equations valid for the Chinese population? Answer: The current equations used to predict basal metabolic rate (BMR) might not be fully valid for the Chinese population due to unique genetic, environmental, and lifestyle influences. Thus, there is a requirement to devise a",9.474389094274162e-08,0.09773190685386579,0.008651859504132275,0.0072537058591274906,0.09488804949599317,0.0055945535065107105,0.007243206163811466,0.09169126505879133,0.0019760897427654224,9.474389094274162e-08,0.09097177820572666,0.0
81,0.9,10,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Is the application of current basal metabolic rate prediction equations appropriate for Chinese people? Answer: The prediction equations in use for estimating basal metabolic rate (BMR) may not be completely appropriate for the Chinese population because of distinct genetic, environmental, and lifestyle factors. Therefore, initiating a",2.3685972735685406e-08,0.05546427776031804,0.023207199546485244,0.0018134264647818726,0.0861863845701949,0.04560603192708004,0.0018108015409528666,0.05522892197167373,0.023242630385487524,2.3685972735685406e-08,0.023530497410194418,0.0
82,0.9,1,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Question: Can bezafibrate, the lipid-lowering ligand of peroxisome proliferator-activated receptors, prevent colon cancer in coronary artery disease patients? Answer: Our findings from coronary artery disease patients support the idea that bezafibrate may help prevent colon cancer.",1.8948778188548272e-07,0.22795907391635906,0.015585937500000008,0.014507411718254988,0.18606844003337164,0.018115243342516078,0.014486412327622947,0.18325244764953785,0.024375,1.8948778188548325e-07,0.2231435513142097,0.0
82,0.9,2,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Question: Is the lipid-lowering agent bezafibrate, which activates peroxisome proliferator-activated receptors, effective in preventing colon cancer in patients with coronary artery disease? Answer: Data from our coronary artery disease patients suggest a potential protective role of bezafibrate against colon cancer development.",7.105791820705622e-08,0.04491716839469717,0.019513504155124657,0.005440279394345618,0.008093954957539395,0.047500000000000014,0.0054324046228586,0.042173849389631535,0.024375,7.105791820705622e-08,0.07796154146971057,0.0
82,0.9,3,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Question: Does bezafibrate, a peroxisome proliferator-activated receptor ligand used to lower lipids, have a preventive effect on colon cancer in coronary artery disease patients? Answer: Our study data from patients with coronary artery disease endorse the hypothesis that bezafibrate might prevent colon cancer.",2.3685972735685406e-08,0.007173696634544591,0.021874999999999985,0.0018134264647818726,0.008104408028834165,0.023125000000000014,0.0018108015409528666,0.009119444997918169,0.024375,2.3685972735685406e-08,0.02531780798429173,0.0
82,0.9,4,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.",Question: Can the peroxisome proliferator-activated receptor ligand bezafibrate reduce colon cancer risk in patients suffering from coronary artery disease? Answer: The evidence from our coronary artery disease patient cohort supports the possibility that bezafibrate offers protection against colon cancer.,1.1842986367842682e-07,0.06337717528203912,0.043078433162892615,0.009067132323909363,0.06073768844295824,0.047500000000000014,0.009054007704764333,0.09624107065990772,0.024375,1.1842986367842703e-07,0.13353139262452274,0.0
82,0.9,5,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Question: Does the lipid-lowering drug bezafibrate, which targets peroxisome proliferator-activated receptors, prevent colon cancer in individuals with coronary artery disease? Answer: Our data from patients with coronary artery disease align with the hypothesis that bezafibrate could prevent colon cancer development.",9.474389094274152e-08,0.14310429536093094,0.031849489795918395,0.0072537058591274906,0.1070323024723705,0.004969135802469125,0.007243206163811466,0.0688420964717924,0.024375,9.474389094274162e-08,0.10536051565782589,0.0
82,0.9,6,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Question: Is there a preventive effect of bezafibrate, a peroxisome proliferator-activated receptor lipid-lowering ligand, against colon cancer in patients with coronary artery disease? Answer: Findings from our coronary artery disease patient data support the theory of bezafibrate’s potential to prevent colon cancer.",4.737194547137081e-08,0.015278104663378755,0.04499999999999999,0.0036268529295637453,0.017223853026752334,0.047500000000000014,0.003621603081905733,0.01619836298637356,0.024375,4.737194547137081e-08,0.051293294387549704,0.0
82,0.9,7,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Question: Does treatment with bezafibrate, a ligand of peroxisome proliferator-activated receptors that lowers lipids, prevent colon cancer in coronary artery disease patients? Answer: Our data obtained from patients with coronary artery disease back the hypothesis that bezafibrate may prevent colon cancer development.",4.737194547137081e-08,0.08615806810149085,0.027045745069393737,0.0036268529295637453,0.05209086502924176,0.0023614958448753207,0.003621603081905733,0.01619836298637356,0.024375,4.737194547137081e-08,0.051293294387549704,0.0
82,0.9,8,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Question: Can bezafibrate, which activates peroxisome proliferator-activated receptors to lower lipids, inhibit colon cancer in patients with coronary artery disease? Answer: Data from our coronary artery disease patients support the notion that bezafibrate might have a preventive impact on colon cancer.",7.105791820705622e-08,0.010259809366699457,0.04439143655489808,0.005440279394345618,0.008093954957539395,0.047500000000000014,0.0054324046228586,0.042173849389631535,0.024375,7.105791820705622e-08,0.07796154146971057,0.0
82,0.9,9,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Question: Is bezafibrate, the lipid-lowering peroxisome proliferator-activated receptor ligand, effective in stopping colon cancer in patients with coronary artery disease? Answer: Our findings from a coronary artery disease patient group support the hypothesis suggesting bezafibrate could prevent colon cancer.",1.1842986367842682e-07,0.06337717528203912,0.043078433162892615,0.009067132323909363,0.06073768844295824,0.047500000000000014,0.009054007704764333,0.09624107065990772,0.024375,1.1842986367842703e-07,0.13353139262452274,0.0
82,0.9,10,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.",Question: Does the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate play a role in colon cancer prevention among patients with coronary artery disease? Answer: Data derived from patients with coronary artery disease confirm support for the hypothesis that bezafibrate may prevent colon cancer.,4.737194547137081e-08,0.05234601051320098,0.0033396814404432346,0.0036268529295637453,0.05209086502924176,0.0023614958448753207,0.003621603081905733,0.051744372245857484,0.0012482686980609496,4.737194547137081e-08,0.051293294387549704,0.0
83,0.9,1,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Are UK radiologists content with the training and support provided for suspected child abuse cases? Answer: The survey reveals considerable dissatisfaction among consultant radiologists regarding the existing service, notes a limited number of paediatric radiologists handling this work, and indicates that the number of radiology child abuse experts could increase by 27% with enhanced training.",2.3685972735685406e-08,0.04367395309483202,0.018460615083159496,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
83,0.9,2,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Do UK radiologists feel satisfied with the training and support they receive in suspected child abuse cases? Answer: The survey indicates notable dissatisfaction among consultant radiologists about the current service, highlights the low engagement of paediatric radiologists in this field, and suggests a 27% increase in radiology child abuse specialists if better training is provided.",2.3685972735685406e-08,0.01846860107447057,0.0003243433209763093,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
83,0.9,3,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Are radiologists in the UK happy with their training and support when dealing with suspected child abuse? Answer: The survey demonstrates significant dissatisfaction among consultant radiologists with the current provision, confirms the small number of paediatric radiologists involved, and proposes that improved training could lead to a 27% rise in radiology child abuse experts.",4.737194547137081e-08,0.01161238772230444,0.017851239669421492,0.0036268529295637453,0.037041271680350096,0.0,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
83,0.9,4,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: How satisfied are UK radiologists with the training and support related to suspected child abuse? Answer: Survey results show considerable dissatisfaction among consultant radiologists with the current service, confirm the low number of paediatric radiologists undertaking this work, and suggest that better training could boost the number of radiology child abuse experts by 27%.",4.737194547137081e-08,0.08862874111785457,0.037512082129886465,0.0036268529295637453,0.06319776905997099,0.018860946745562133,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
83,0.9,5,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Are consultant radiologists in the UK satisfied with the support and training they receive for suspected child abuse cases? Answer: The survey reveals significant dissatisfaction among them regarding the existing service, a low number of paediatric radiologists engaging in this field, and a potential 27% increase in specialists if training improves.",1.1842986367842703e-07,0.06877080156225457,0.017851239669421492,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
83,0.9,6,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: What is the level of satisfaction among UK radiologists concerning training and support for suspected child abuse? Answer: The survey indicates marked dissatisfaction from consultant radiologists with current services, confirms few paediatric radiologists working in this area, and suggests that enhanced training could raise the number of radiology child abuse specialists by 27%.",7.105791820705622e-08,0.030304520734458773,0.017851239669421492,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
83,0.9,7,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Are UK radiologists satisfied with their training and support when managing suspected child abuse? Answer: The survey shows considerable dissatisfaction among consultants with the current service, identifies a limited number of paediatric radiologists in the role, and suggests that improved training could increase child abuse radiology experts by 27%.",1.6580180914979784e-07,0.10877613617595294,0.017851239669421492,0.012693985253473108,0.13613217432458002,0.0,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
83,0.9,8,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Does the training and support for suspected child abuse meet the satisfaction of UK radiologists? Answer: The survey highlights substantial dissatisfaction among consultant radiologists, corroborates the low involvement of paediatric radiologists, and estimates a 27% rise in child abuse radiology experts with better training.",2.8423167282822487e-07,0.24791349039377053,0.004863741401427618,0.02176111757738247,0.2461330695389088,0.0,0.0217296184914344,0.25131442828090744,0.0,2.8423167282822487e-07,0.2567198468478131,0.0
83,0.9,9,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: How do UK radiologists rate their training and support in suspected child abuse cases? Answer: Survey findings reveal significant dissatisfaction among consultant radiologists with the current system, confirm few paediatric radiologists participate, and suggest potential growth of 27% in child abuse radiology experts if training is enhanced.",2.1317375462116866e-07,0.17994445728120034,0.00341530097330061,0.016320838183036854,0.17869178874337655,0.0,0.0162972138685758,0.18232155679395579,0.0,2.1317375462116866e-07,0.18610227963385917,0.0
83,0.9,10,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Are UK radiologists content with the current training and support for suspected child abuse? Answer: The survey shows notable dissatisfaction among consultant radiologists, a low number of paediatric radiologists involved, and indicates a possible 27% increase in the number of radiology child abuse specialists if more effective training is provided.",1.4211583641411244e-07,0.11629931608083233,0.002140430468021242,0.010880558788691236,0.11551288712184427,0.0,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
84,0.9,1,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Our study identified that USMLE Step 2 scores, the count of honors earned during medical school clerkships, and AOA membership showed the strongest links to resident performance. Our aim with this analysis was to offer residency programs a clearer idea of which selection factors might be most predictive.",4.737194547137081e-08,0.03448617607116855,0.0,0.0036268529295637453,0.03509131981126945,0.0,0.003621603081905733,0.03571808260207909,0.0,4.737194547137081e-08,0.036367644170874236,0.0
84,0.9,2,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Are Residency Selection Criteria Predictive of Orthopaedic Surgery Residency Performance? Answer: We discovered that USMLE Step 2 results, the number of honors achieved in medical school clerkships, and membership in AOA were the most strongly correlated with resident success. The purpose of our data evaluation was to help residency programs understand which criteria have the highest predictive value.",2.3685972735685406e-08,0.01739174271186883,0.0,0.0018134264647818726,0.01769957709940062,0.0,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
84,0.9,3,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Can Residency Selection Standards Forecast Performance in Orthopaedic Surgery Residency? Answer: Findings indicated that USMLE Step 2 scores, honors received during medical school clerkships, and AOA membership had the strongest association with resident performance. We conducted this analysis to guide residency programs regarding which criteria might be most valuable.",1.8948778188548325e-07,0.15123096972392336,0.0,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
84,0.9,4,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Does the Residency Selection Process Predict Performance in Orthopaedic Surgery Residency? Answer: The strongest correlations with resident outcomes were seen in USMLE Step 2 scores, medical school clerkship honors, and AOA membership. Our objective was to inform residency programs on which selection factors are likely to be most effective.",1.8948778188548325e-07,0.15123096972392336,0.0,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
84,0.9,5,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Are Criteria Used for Residency Selection Indicative of Success in Orthopaedic Surgery Residency? Answer: USMLE Step 2 performance, number of medical school clerkship honors, and AOA membership were the top predictors of resident performance. This analysis aimed to provide residency programs with insight into which criteria are 'high yield'.",1.8948778188548325e-07,0.15123096972392336,0.0,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
84,0.9,6,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Does Residency Selection Criteria Serve as a Predictor for Orthopaedic Surgery Residency Performance? Answer: We identified strong correlations between resident success and USMLE Step 2 scores, honors in clerkships during medical school, and AOA membership. The goal was to assist residency programs in recognizing the most informative selection criteria.",1.8948778188548325e-07,0.15123096972392336,0.0,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
84,0.9,7,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: To What Extent Do Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Our results showed that USMLE Step 2, the number of honors in medical school clerkships, and AOA membership correlated most strongly with resident achievement. The analysis was intended to help residency programs determine which factors are most valuable.",1.1842986367842703e-07,0.09180754925312229,0.0,0.009067132323909363,0.09352605801082436,0.0,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
84,0.9,8,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Is There a Correlation Between Residency Selection Criteria and Performance in Orthopaedic Surgery Residency? Answer: We found USMLE Step 2 scores, honors in medical school clerkships, and AOA membership to be the strongest performance predictors. Our purpose was to provide residency programs guidance on identifying high-yield criteria.",2.3685972735685406e-07,0.19290366612449228,0.0,0.018134264647818726,0.19671029424605502,0.0,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
84,0.9,9,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: How Well Do Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The data revealed that USMLE Step 2, medical school clerkship honors, and AOA membership had the strongest relationships with resident performance. This analysis aimed to help residency programs prioritize selection criteria.",3.079176455639103e-07,0.25886163391628836,0.0,0.023574544042164344,0.26415157504158726,0.0,0.023540420032387266,0.2696635669491032,0.0,3.079176455639103e-07,0.27541197985996746,0.0
84,0.9,10,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Can the Selection Criteria for Residency Predict Resident Performance in Orthopaedic Surgery? Answer: Our findings showed that USMLE Step 2 scores, number of honors in medical school clerkships, and AOA membership best predicted resident success. We sought to aid residency programs by highlighting the most effective criteria.",2.3685972735685406e-07,0.19290366612449228,0.0,0.018134264647818726,0.19671029424605502,0.0,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
85,0.9,1,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external palliative radiotherapy effective for treating gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative treatment for gallbladder carcinoma, but additional research is needed to clarify its role in palliative and adjuvant therapy.",1.8948778188548283e-07,0.13765731541124682,0.045351473922902494,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.9,2,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Does external radiotherapy provide effective palliative care for gallbladder carcinoma? It seems that external radiotherapy is both safe and effective for palliative management of gallbladder carcinoma, though more studies are required to define its exact role in palliative or adjuvant treatment.",9.474389094274162e-08,0.0669541587814173,0.020367910477800573,0.0072537058591274906,0.06539906581694366,0.023242630385487524,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
85,0.9,3,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external palliative radiotherapy beneficial for gallbladder carcinoma patients? External radiotherapy is considered a safe and effective approach for palliation in gallbladder carcinoma, yet further investigation is necessary to establish its role in palliative or adjunctive treatment.",1.8948778188548283e-07,0.13765731541124682,0.045351473922902494,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.9,4,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","How effective is external palliative radiotherapy for gallbladder carcinoma? External radiotherapy shows promise as a safe and effective palliative option for gallbladder carcinoma; however, more studies must be conducted to determine its use in palliative and adjuvant therapy.",1.6580180914979753e-07,0.1477257563885339,0.01834530108339633,0.012693985253473108,0.14544177349047782,0.023242630385487524,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
85,0.9,5,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Can external palliative radiotherapy effectively manage gallbladder carcinoma? External radiotherapy appears to be a safe and effective method for palliative care in gallbladder carcinoma, but additional research is needed to understand its role in palliative or adjuvant settings.",1.6580180914979753e-07,0.1102583412231315,0.045351473922902494,0.012693985253473108,0.14544177349047782,0.023242630385487524,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
85,0.9,6,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external radiotherapy a safe and effective palliative treatment for gallbladder carcinoma? It seems so, though further studies are essential to define the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.",2.605457000925387e-07,0.22466869240087695,0.045351473922902494,0.01994769111260062,0.26322480914686164,0.023242630385487524,0.01991881695048156,0.30368241379822125,0.0,2.6054570009253947e-07,0.31237468504215293,0.0
85,0.9,7,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Does external radiotherapy work well as palliative care for gallbladder carcinoma? External radiotherapy seems safe and effective for palliation in gallbladder carcinoma, but more research is necessary to determine its exact role in palliative or adjuvant therapy.",1.8948778188548283e-07,0.17616549210902166,0.017596371882086164,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.9,8,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external palliative radiotherapy effective in managing gallbladder carcinoma? External radiotherapy is regarded as a safe and effective palliative treatment for gallbladder carcinoma, yet further studies are needed to elucidate its role in palliative or adjuvant treatment.",1.8948778188548283e-07,0.13765731541124682,0.045351473922902494,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.9,9,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","What is the effectiveness of external palliative radiotherapy for gallbladder carcinoma? External radiotherapy appears safe and effective for palliative management of gallbladder carcinoma, although additional studies are required to clarify its role in palliative or adjuvant therapies.",1.8948778188548283e-07,0.13765731541124682,0.045351473922902494,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.9,10,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external radiotherapy a valid palliative option for gallbladder carcinoma? It is considered a safe and effective palliative treatment method for gallbladder carcinoma, but further research is necessary to determine its role in palliative or adjuvant care.",1.8948778188548283e-07,0.17616549210902166,0.017596371882086164,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
86,0.9,1,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is central venous pressure a reliable indicator of fluid responsiveness? Answer: Current evidence does not support using central venous pressure as a guide for fluid therapy. This method of fluid resuscitation should be discontinued.,2.36859727356853e-08,0.07209080692487779,0.030475982987571308,0.0018134264647818796,0.031088519621267796,0.0008886808425160632,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
86,0.9,2,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Can central venous pressure predict how a patient will respond to fluid administration? Answer: There is no data backing the common use of central venous pressure to direct fluid therapy. This practice should be stopped.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
86,0.9,3,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Does measuring central venous pressure help in assessing fluid responsiveness? Answer: No evidence supports the routine use of central venous pressure to guide fluid treatment. This approach should be abandoned.,1.184298636784265e-07,0.16735348326649557,0.00939356458836977,0.009067132323909398,0.16609458489905915,0.005054018852720155,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
86,0.9,4,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Question: Is central venous pressure an effective predictor of fluid responsiveness? Answer: Data does not support the widespread use of central venous pressure for guiding fluid therapy, and this practice ought to be ceased.",4.73719454713706e-08,0.06364151945538365,0.003420832103075977,0.003626852929563759,0.06317295703908332,0.0018327251323183684,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
86,0.9,5,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Can central venous pressure be used to predict fluid responsiveness? Answer: The current data do not endorse using central venous pressure to guide fluid therapy. This technique for fluid resuscitation should be stopped.,4.73719454713706e-08,0.06364151945538365,0.003420832103075977,0.003626852929563759,0.06317295703908332,0.0018327251323183684,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
86,0.9,6,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Does central venous pressure accurately predict the body's response to fluids? Answer: There is a lack of evidence supporting the routine use of central venous pressure in fluid management. This practice should be discontinued.,2.36859727356853e-08,0.031317443362529396,0.0016607839761248952,0.0018134264647818796,0.031088519621267796,0.0008886808425160632,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
86,0.9,7,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is it advisable to use central venous pressure to predict fluid responsiveness? Answer: No reliable data back the common practice of using central venous pressure for fluid therapy guidance. This method should be abandoned.,2.36859727356853e-08,0.031317443362529396,0.0016607839761248952,0.0018134264647818796,0.031088519621267796,0.0008886808425160632,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
86,0.9,8,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Question: Does central venous pressure serve as a good indicator for fluid responsiveness? Answer: The existing evidence does not justify the widespread use of central venous pressure to guide fluid treatment, and the practice should end.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
86,0.9,9,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Question: Can central venous pressure be trusted to predict fluid responsiveness? Answer: There are no supportive data for using central venous pressure in guiding fluid therapy, so this approach should be abandoned.",9.47438909427412e-08,0.13158238224754726,0.007276308649133208,0.007253705859127518,0.1305995914289868,0.003908941321112979,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
86,0.9,10,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Question: Is the use of central venous pressure effective in predicting how patients respond to fluids? Answer: The evidence does not support using central venous pressure to direct fluid therapy, and this practice should be halted.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
87,0.9,1,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,"Is (18)F-FDG an effective surrogate tracer for assessing tumor hypoxia? This research indicates that FDG does not serve well as a surrogate tracer for tumor hypoxia, regardless of ambient or hypoxic environments. Tumor hypoxia measurement should rely solely on specialized hypoxia tracers.",0.0,0.03381205758828987,0.024062478942086886,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
87,0.9,2,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Can (18)F-FDG be used as a surrogate tracer to detect tumor hypoxia? Findings from this study reveal that FDG is inadequate as a surrogate tracer for tumor hypoxia under both normal and low-oxygen conditions. Specialized hypoxia tracers are necessary for accurate tumor hypoxia measurement.,4.737194547137081e-08,0.020106606766227664,0.019330025988879604,0.0036268529295637453,0.017433506001244048,0.022516436554898094,0.003621603081905733,0.01619836298637356,0.024375,4.737194547137081e-08,0.051293294387549704,0.0
87,0.9,3,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Does (18)F-FDG function as a surrogate tracer for tumor hypoxia? The study demonstrated that FDG is ineffective as a surrogate tracer for tumor hypoxia in either ambient or hypoxic settings. Measurement of tumor hypoxia must be done with specific hypoxia tracers.,2.3685972735685406e-08,0.13120059399348527,0.0726140382827402,0.0018134264647818726,0.1328444859942315,0.07624092635081647,0.0018108015409528666,0.13541977807061834,0.0783673469387755,2.3685972735685406e-08,0.10160307741296659,0.05387755102040818
87,0.9,4,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,"Is (18)F-FDG suitable as a surrogate tracer for tumor hypoxia? According to the study, FDG fails to be a reliable surrogate tracer for tumor hypoxia under both ambient and hypoxic conditions. Only dedicated hypoxia tracers should be employed to assess tumor hypoxia.",0.0,0.0,0.0,0.0,0.034657359027997714,0.024877932399773414,0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0
87,0.9,5,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Can tumor hypoxia be measured using (18)F-FDG as a surrogate tracer? This study found that FDG is not a valid surrogate tracer for tumor hypoxia in normal or hypoxic conditions. Measurement should be performed exclusively with hypoxia-specific tracers.,9.474389094274131e-08,0.038685396460615085,0.04570850860093706,0.0072537058591274906,0.07070315662982951,0.02498356344510192,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
87,0.9,6,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Is (18)F-FDG a reliable surrogate tracer for tumor hypoxia? The study shows that FDG is not appropriate as a surrogate tracer for tumor hypoxia regardless of oxygen levels. Specific hypoxia tracers are required for measuring tumor hypoxia.,1.1842986367842661e-07,0.14414148557665252,0.009929946658730315,0.009067132323909363,0.17809085423194837,0.031949402578773184,0.00905400770476434,0.17797448507583224,0.029384756657483937,1.1842986367842703e-07,0.14107859825990632,0.0
87,0.9,7,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Does (18)F-FDG serve as a surrogate tracer to evaluate tumor hypoxia? The research indicated that FDG is not an adequate surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Use of specific hypoxia tracers is essential to measure tumor hypoxia.,0.0,0.06762411517657974,0.048339681440443226,0.0,0.03465735902799638,0.02498356344510192,0.0,0.0,0.0,0.0,0.0,0.0
87,0.9,8,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,"Is (18)F-FDG an appropriate surrogate tracer to detect tumor hypoxia? According to the findings, FDG is unsuitable as a surrogate tracer for tumor hypoxia in both normal and hypoxic environments. Tumor hypoxia should be measured using only dedicated hypoxia tracers.",4.7371945471370706e-08,0.019666266328762116,0.021582468146067776,0.0036268529295637453,0.016635935359553322,0.02498356344510192,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
87,0.9,9,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Can (18)F-FDG reliably indicate tumor hypoxia as a surrogate tracer? This study concluded that FDG is not a good surrogate tracer for tumor hypoxia under any oxygen condition. Measurement of tumor hypoxia requires specific hypoxia tracers.,1.421158364141119e-07,0.15095460005014782,0.04482434518949252,0.010880558788691243,0.12786157046977786,0.02498356344510192,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
87,0.9,10,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Is (18)F-FDG adequate as a surrogate tracer for tumor hypoxia? The study demonstrated that FDG does not effectively serve as a surrogate tracer for tumor hypoxia in either ambient or hypoxic conditions. Specific hypoxia tracers must be used for accurate tumor hypoxia assessment.,2.3685972735685406e-08,0.07250832724462652,0.06617420744844567,0.0018134264647818726,0.07589825873479139,0.07143718162429183,0.0018108015409528666,0.07865426909969919,0.07450693937180423,2.3685972735685406e-08,0.04511653211571032,0.05113221329437545
88,0.9,1,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Expert breast pathology assessments are still essential for managing DCIS.,9.47438909427412e-08,0.0681105386809846,0.05500491493383737,0.007253705859127518,0.11289191907964069,0.02941801545844007,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
88,0.9,2,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Does the management of ductal carcinoma in situ require expert breast pathology assessment? Answer: Expert breast pathology evaluations remain crucial in the treatment of DCIS.,9.47438909427412e-08,0.0681105386809846,0.05500491493383737,0.007253705859127518,0.11289191907964069,0.02941801545844007,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
88,0.9,3,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is it necessary to have expert breast pathology assessment in managing ductal carcinoma in situ? Answer: Expert breast pathology assessments continue to be important for DCIS management.,4.73719454713706e-08,0.01706558015067028,0.06079999999999998,0.003626852929563759,0.028405960248669704,0.03260591715976332,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
88,0.9,4,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is expert breast pathology needed for the management of ductal carcinoma in situ? Answer: Expert breast pathology assessments remain indispensable in the management of DCIS.,9.47438909427412e-08,0.1790140875705757,0.01979501133786854,0.007253705859127518,0.17065418412630295,0.011638710939410213,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
88,0.9,5,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is expert breast pathology assessment required for ductal carcinoma in situ management? Answer: The management of DCIS still depends on expert breast pathology assessments.,1.184298636784265e-07,0.11355351440497019,0.05175537190082642,0.009067132323909398,0.157962936326554,0.0276174874076972,0.009054007704764368,0.20479441264601395,0.0,1.1842986367842703e-07,0.2135741002980609,0.0
88,0.9,6,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Does effective management of ductal carcinoma in situ rely on expert breast pathology assessment? Answer: Expert breast pathology assessments are necessary for DCIS treatment.,1.184298636784265e-07,0.11355351440497019,0.05175537190082642,0.009067132323909398,0.157962936326554,0.0276174874076972,0.009054007704764368,0.20479441264601395,0.0,1.1842986367842703e-07,0.2135741002980609,0.0
88,0.9,7,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is specialist breast pathology assessment necessary in the management of ductal carcinoma in situ? Answer: Expert breast pathology evaluations continue to be vital in managing DCIS.,7.10579182070559e-08,0.02869470947266306,0.09599999999999995,0.005440279394345639,0.01430765951272539,0.07100591715976333,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
88,0.9,8,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is expert pathology evaluation of the breast important for managing ductal carcinoma in situ? Answer: Expert breast pathology assessments remain required in DCIS management.,1.184298636784265e-07,0.001971015688352562,0.13439999999999996,0.009067132323909398,0.09768926845177583,0.07100591715976333,0.009054007704764368,0.20479441264601395,0.0,1.1842986367842703e-07,0.2135741002980609,0.0
88,0.9,9,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is the involvement of expert breast pathology assessment crucial in managing ductal carcinoma in situ? Answer: Expert breast pathology assessment continues to be essential for managing DCIS.,4.73719454713706e-08,0.03427865544636299,0.025024999999999964,0.003626852929563759,0.08172497413789648,0.005382971729125552,0.003621603081905747,0.13241281558092455,0.03993055555555556,4.737194547137081e-08,0.08004270767353727,0.0
88,0.9,10,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is expert breast pathology review necessary for the management of ductal carcinoma in situ? Answer: Expert breast pathology assessment remains necessary in the treatment of DCIS.,7.10579182070559e-08,0.024624304416563714,0.05801111111111108,0.005440279394345639,0.06975943395752049,0.03107536160420777,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
89,0.9,1,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration during pregnancy harm the kidneys of women with multiple pregnancies? Our study indicates that glomerular hyperfiltration from pregnancy does not negatively impact the kidneys of women with higher parity. Pregnancy may offer protective mechanisms against the harmful effects of glomerular hyperfiltration on the kidneys.,1.1842986367842703e-07,0.13228674525721962,0.06194444444444443,0.009067132323909363,0.11460247806529189,0.006570985116545455,0.009054007704764333,0.11406060093225401,0.004609056539471058,1.1842986367842703e-07,0.11335916643797228,0.00241872816728924
89,0.9,2,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Is kidney damage caused by glomerular hyperfiltration in pregnant women who have had multiple births? We propose that glomerular hyperfiltration associated with pregnancy does not damage the kidneys in women with increased parity. Pregnancy might provide protective effects against kidney damage from glomerular hyperfiltration.,1.8948778188548325e-07,0.07201087027531194,0.06915460374115937,0.014507411718254981,0.09117572547758446,0.05975554549569943,0.014486412327622933,0.12166478809530323,0.040742417383431435,1.8948778188548325e-07,0.1534404242706242,0.020823902218198284
89,0.9,3,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does the increase in glomerular filtration during pregnancy cause kidney injury in women with several childbirths? Our research suggests that pregnancy-induced glomerular hyperfiltration does not adversely affect kidney function in women with more parities. Pregnancy may have protective roles against negative effects of glomerular hyperfiltration on the kidneys.,9.474389094274162e-08,0.007071450878903374,0.05202249770431591,0.0072537058591274906,0.030340781209246437,0.038027150433971035,0.007243206163811466,0.02857436502929156,0.040742417383431435,9.474389094274162e-08,0.05813024446629855,0.020823902218198284
89,0.9,4,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration associated with pregnancy lead to kidney damage in women having multiple pregnancies? Findings from our study imply that glomerular hyperfiltration during pregnancy does not harm kidneys in women with higher parity. Pregnancy could potentially protect kidneys from the adverse effects of glomerular hyperfiltration.,1.4211583641411244e-07,0.02368277142104569,0.07120725917913588,0.010880558788691236,0.044655709842690516,0.05975554549569943,0.0108648092457172,0.0740367391060488,0.040742417383431435,1.4211583641411244e-07,0.1046502601011925,0.020823902218198284
89,0.9,5,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.","Is kidney impairment linked to glomerular hyperfiltration in women with multiple pregnancies? According to our study, glomerular hyperfiltration caused by pregnancy does not produce detrimental effects on the kidneys of women having greater parity. Pregnancy may possess protective mechanisms against kidney damage from hyperfiltration.",1.8948778188548325e-07,0.03977146652833774,0.09231292517006803,0.014507411718254981,0.09117572547758446,0.05975554549569943,0.014486412327622933,0.12166478809530323,0.040742417383431435,1.8948778188548325e-07,0.1534404242706242,0.020823902218198284
89,0.9,6,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Can glomerular hyperfiltration during pregnancy cause kidney harm in women with many parities? Our study suggests no harmful impact of pregnancy-related glomerular hyperfiltration on kidneys of women with increased parity. Pregnancy might offer protective mechanisms shielding kidneys from adverse effects of hyperfiltration.,2.3685972735685406e-07,0.1227842269471977,0.06690335305719923,0.018134264647818726,0.13996588964701617,0.05975554549569943,0.018108015409528666,0.17167520866996666,0.040742417383431435,2.3685972735685406e-07,0.2047337186581739,0.020823902218198284
89,0.9,7,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration from pregnancy damage kidneys in women with numerous births? The study suggests that glomerular hyperfiltration due to pregnancy does not negatively affect kidney health in women with higher parity. Pregnancy may provide protective mechanisms against kidney damage caused by hyperfiltration.,2.1317375462116866e-07,0.1300835859858367,0.04454963839579226,0.016320838183036854,0.14908533464493434,0.03538054549569943,0.0162972138685758,0.14635740068567493,0.040742417383431435,2.1317375462116866e-07,0.17875823225491594,0.020823902218198284
89,0.9,8,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Is there kidney damage caused by pregnancy-induced glomerular hyperfiltration in women with more pregnancies? Our research supports that glomerular hyperfiltration in pregnancy does not harm the kidneys of women with larger parity. Pregnancy could have protective effects against the detrimental consequences of glomerular hyperfiltration on kidneys.,1.4211583641411244e-07,0.09692359066558609,0.021267763897151168,0.010880558788691236,0.0761623998681431,0.03704056442485032,0.0108648092457172,0.0740367391060488,0.040742417383431435,1.4211583641411244e-07,0.1046502601011925,0.020823902218198284
89,0.9,9,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration during pregnancy result in kidney injury in women with multiple childbirths? We believe from our study that pregnancy-related glomerular hyperfiltration does not harm the kidneys in women with greater parity. Pregnancy may protect kidneys from the adverse impact of glomerular hyperfiltration.,1.8948778188548325e-07,0.1042502740222866,0.04618055555555557,0.014507411718254981,0.12418273407567604,0.03596018559088088,0.014486412327622933,0.12166478809530323,0.040742417383431435,1.8948778188548325e-07,0.1534404242706242,0.020823902218198284
89,0.9,10,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Is the kidney affected by glomerular hyperfiltration in pregnancy among women with multiple parities? Our findings suggest that glomerular hyperfiltration from pregnancy does not adversely affect the kidneys in women with more parities. Pregnancy might have protective mechanisms guarding the kidneys against harmful effects of hyperfiltration.,1.4211583641411244e-07,0.054489312779265386,0.049229024943310676,0.010880558788691236,0.044655709842690516,0.05975554549569943,0.0108648092457172,0.0740367391060488,0.040742417383431435,1.4211583641411244e-07,0.1046502601011925,0.020823902218198284
90,0.9,1,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Are stroke patients' home blood pressure readings dependable? They can be, provided the measurements are done correctly. Yet, factors like using the wrong cuff size, poor measurement methods, or cognitive issues may affect accuracy. Thus, ensuring patients are properly instructed on measuring and reporting blood pressure is essential.",2.6054570009253947e-07,0.07247964513001826,0.0971494532057977,0.0199476911126006,0.06848414912230938,0.10380622837370242,0.019918816950481533,0.09491291872198238,0.08842752787389466,2.6054570009253947e-07,0.12232214323276214,0.07227989234909649
90,0.9,2,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Can stroke patients be trusted to report their home blood pressure readings accurately? Their reports can be reliable if measurements are taken properly. Nonetheless, accuracy might be compromised by incorrect cuff sizing, flawed technique, or cognitive impairments. Hence, it is vital to educate patients on correct blood pressure measurement and reporting.",1.8948778188548325e-07,0.00883450392965024,0.09842432371107707,0.014507411718254981,0.005305247500777099,0.10380622837370242,0.014486412327622933,0.03037439758441085,0.08842752787389466,1.8948778188548325e-07,0.05636417544096606,0.07227989234909649
90,0.9,3,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Is the self-reported home blood pressure by stroke patients trustworthy? It can be, as long as the readings are performed correctly. However, accuracy can be influenced by factors including inappropriate cuff size, incorrect method, or mental impairments. Therefore, patients must be coached on how to properly measure and report their blood pressure.",1.6580180914979784e-07,0.03869401058892752,0.1184159938485198,0.012693985253473108,0.01489745981674151,0.10380622837370242,0.012675610786670066,0.009755110381675092,0.08842752787389466,1.6580180914979784e-07,0.035310766243132896,0.07227989234909649
90,0.9,4,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Do stroke patients provide reliable home blood pressure readings? When measurements are conducted correctly, their reports can be dependable. Factors like wrong cuff size, improper technique, or cognitive deficits may affect accuracy, so teaching patients accurate measurement and reporting is critical.",4.263475092423373e-07,0.2042521680214615,0.1184159938485198,0.03264167636607371,0.23356389948175948,0.10380622837370242,0.0325944277371516,0.26398924876591545,0.08842752787389466,4.263475092423373e-07,0.29559386450679836,0.07227989234909649
90,0.9,5,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Are home blood pressure readings from stroke patients accurate? They can be, if the measurements are done properly. Still, accuracy may be affected by improper cuff size, incorrect technique, or cognitive challenges. It is important to ensure patients know how to correctly measure and report their blood pressure.",2.6054570009253947e-07,0.042984020425339775,0.1184159938485198,0.0199476911126006,0.06848414912230938,0.10380622837370242,0.019918816950481533,0.09491291872198238,0.08842752787389466,2.6054570009253947e-07,0.12232214323276214,0.07227989234909649
90,0.9,6,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Can reports of home blood pressure from stroke patients be trusted? Yes, if the readings are taken correctly. Accuracy may be influenced by factors such as the wrong cuff size, poor technique, or cognitive impairments, making patient education on accurate measurement crucial.",4.026615365066519e-07,0.1795595554310898,0.1184159938485198,0.030828249901291835,0.20824609149746776,0.10380622837370242,0.030783626196198732,0.23801376236265748,0.08842752787389466,4.026615365066519e-07,0.2689256174246375,0.07227989234909649
90,0.9,7,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","How reliable are stroke patients' accounts of their home blood pressure? They may be reliable given correct measurement procedures. Accuracy can be impacted by using an improper cuff size, incorrect technique, or cognitive limitations. Therefore, it is imperative to instruct patients thoroughly on how to measure and report blood pressure correctly.",1.8948778188548325e-07,0.018891383292747754,0.1184159938485198,0.014507411718254981,0.005305247500777099,0.10380622837370242,0.014486412327622933,0.03037439758441085,0.08842752787389466,1.8948778188548325e-07,0.05636417544096606,0.07227989234909649
90,0.9,8,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Are stroke patients' home blood pressure readings trustworthy? They can be reliable if proper technique is used. Factors like incorrect cuff sizing, faulty methodology, or cognitive impairment might influence accuracy, so proper patient training on measurement and reporting is necessary.",4.500334819780226e-07,0.22956997600575324,0.1184159938485198,0.03445510283085558,0.25953938588501746,0.10380622837370242,0.034405229278104466,0.2906574958480763,0.08842752787389466,4.500334819780227e-07,0.3229928386949137,0.07227989234909649
90,0.9,9,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Is it reliable to rely on stroke patients' reports of their home blood pressure readings? These reports can be accurate if done correctly. Nonetheless, issues like wrong cuff size, improper technique, or cognitive impairment may reduce accuracy, making patient education on correct measurement essential.",3.552895910352811e-07,0.13193150644183538,0.1184159938485198,0.02720139697172809,0.15945592732803604,0.10380622837370242,0.027162023114293,0.18800334178799405,0.08842752787389466,3.552895910352811e-07,0.2176323230370878,0.07227989234909649
90,0.9,10,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Do stroke patients' self-reported home blood pressure measurements hold accuracy? They are potentially accurate when done right. Accuracy might be compromised by factors such as incorrect cuff size, improper technique, or cognitive difficulties, thus emphasizing the importance of patient guidance on proper measurement and reporting.",3.316036182995957e-07,0.10894198821713585,0.1184159938485198,0.025387970506946217,0.13592542991784162,0.10380622837370242,0.025351221573340132,0.16390579020893403,0.08842752787389466,3.316036182995957e-07,0.1929397104467161,0.07227989234909649
91,0.9,1,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Question: Could elevated carotid artery pulsatility and resistance indices indicate early vascular abnormalities in young obese males? Our findings indicate that reduced vessel compliance and heightened vascular resistance are characteristic of young, obese, normotensive individuals, beyond traditional cardiovascular risk factors, as alterations in arterial wall properties may be implicated.",9.474389094274162e-08,0.08004270767353683,0.0,0.0072537058591274906,0.0816780310142673,0.0,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
91,0.9,2,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Question: Are increased pulsatility and resistance indexes of the carotid artery indicative of early vascular issues in young obese men? The study suggests that young, obese, normotensive subjects show decreased vessel compliance and increased vascular resistance independently of other cardiovascular risks, reflecting changes in arterial wall structure.",1.4211583641411244e-07,0.12260232209233335,0.0,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
91,0.9,3,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Question: Do higher carotid artery pulsatility and resistance indexes signal early vascular abnormalities in young obese males? Our data points to impaired vessel compliance and elevated vascular resistance in this group, regardless of cardiovascular risk factors, likely due to modifications in arterial wall properties.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
91,0.9,4,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Question: Is an increase in carotid artery pulsatility and resistance indexes an early indicator of vascular abnormalities in young obese males? Results demonstrate that young, obese, normotensive individuals possess reduced vessel compliance and increased vascular resistance apart from cardiovascular risk factors, potentially linked to changes in arterial walls.",1.1842986367842703e-07,0.10109611687136999,0.0,0.009067132323909363,0.10318423623523065,0.0,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
91,0.9,5,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Question: Are early signs of vascular abnormalities in young obese men shown by raised carotid artery pulsatility and resistance indices? Findings reveal depressed vessel compliance and increased vascular resistance in young obese normotensive subjects independent of cardiovascular risks, possibly due to arterial wall property changes.",1.8948778188548325e-07,0.2300674647140708,0.045351473922902494,0.014507411718254981,0.2028649207777371,0.023242630385487524,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
91,0.9,6,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Question: Might increased carotid artery pulsatility and resistance indexes serve as early markers of vascular abnormalities in young obese males? Evidence suggests that young, obese normotensive subjects have reduced vessel compliance and heightened vascular resistance beyond cardiovascular risk factors, associated with alterations in arterial wall properties.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
91,0.9,7,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Question: Can elevated pulsatility and resistance indexes in the carotid artery act as early signs of vascular abnormalities in young obese men? Our findings support that diminished vessel compliance and increased vascular resistance are present in young obese normotensive individuals, regardless of known cardiovascular risks, reflecting arterial wall changes.",9.474389094274162e-08,0.13780497272019865,0.04158790170132326,0.0072537058591274906,0.11117365571894577,0.021266540642722105,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
91,0.9,8,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Question: Are increased carotid artery pulsatility and resistance indexes early markers of vascular abnormalities in young obese males? Results indicate that young, obese, normotensive subjects exhibit lowered vessel compliance and increased vascular resistance independent from cardiovascular risks, related to changes in arterial walls.",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
91,0.9,9,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Question: Does increased carotid artery pulsatility and resistance indexes indicate early vascular abnormalities in young obese males? Data shows that young, obese normotensive individuals display compromised vessel compliance and raised vascular resistance beyond cardiovascular risk factors, possibly due to arterial wall modifications.",2.6054570009253947e-07,0.23767165187712003,0.0,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
91,0.9,10,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Question: Are higher carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Study results suggest that young obese normotensive subjects have impaired vessel compliance and elevated vascular resistance independently of cardiovascular risks, linked to changes in arterial wall properties.",1.8948778188548325e-07,0.19856077468861866,0.02271498107084911,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
92,0.9,1,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Does having an optimistic perspective predict improved survival in very old age? An optimistic outlook seems to be a key indicator of survival in the oldest-old women, and it might also be important for men, although the male sample is small.",9.474389094274162e-08,0.007091447733060363,0.06190707746215952,0.0072537058591274906,0.0009202583229948047,0.06937499999999999,0.007243206163811466,0.06707644995888984,0.023795359904818555,9.474389094274162e-08,0.10265415406008227,0.0
92,0.9,2,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Is optimism linked to better survival rates among the elderly? Optimism appears to significantly predict survival in the oldest-old women and potentially in men, but the male sample size is limited.",3.3160361829959463e-07,0.2254588021288475,0.11176857330703485,0.02538797050694626,0.2971860744661661,0.06937499999999999,0.02535122157334018,0.37245809951007214,0.023795359904818555,3.316036182995957e-07,0.4177352006999784,0.0
92,0.9,3,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Can optimism forecast longer survival at advanced ages? For the oldest-old women, optimism is a significant survival predictor, and it might be important for men too, despite a small sample size.",3.3160361829959463e-07,0.2254588021288475,0.11176857330703485,0.02538797050694626,0.2971860744661661,0.06937499999999999,0.02535122157334018,0.37245809951007214,0.023795359904818555,3.316036182995957e-07,0.4177352006999784,0.0
92,0.9,4,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Does a positive outlook increase likelihood of survival in advanced age? Optimism is a significant survival predictor for the oldest-old women and possibly for men, although the number of male participants is small.",2.84231672828224e-07,0.16092028099127598,0.11176857330703485,0.0217611175773825,0.2304946999674926,0.06937499999999999,0.021729618491434434,0.30346522802312137,0.023795359904818555,2.8423167282822487e-07,0.3462762367178347,0.0
92,0.9,5,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Is there a relationship between optimism and longevity in very old individuals? An optimistic outlook significantly predicts survival among the oldest-old women, and it could also be significant for men given the small sample size.",2.3685972735685343e-07,0.10029565917484051,0.11176857330703485,0.01813426464781874,0.1679743429861591,0.06937499999999999,0.018108015409528687,0.23892670688554984,0.023795359904818555,2.3685972735685406e-07,0.27958486221916123,0.0
92,0.9,6,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Does optimism predict better survival outcomes at advanced ages? Among the oldest-old women, optimism is a notable predictor of survival, and it may be significant for men as well, despite a small sample size.",2.605457000925387e-07,0.1301486223245223,0.11176857330703485,0.01994769111260062,0.19874600165291278,0.06937499999999999,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
92,0.9,7,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Can an optimistic mindset forecast improved survival in advanced age? Optimism is a strong predictor of survival in oldest-old women and may be important for men, though the male sample group is small.",2.84231672828224e-07,0.20424197977627356,0.08055109151723255,0.0217611175773825,0.2304946999674926,0.06937499999999999,0.021729618491434434,0.30346522802312137,0.023795359904818555,2.8423167282822487e-07,0.3462762367178347,0.0
92,0.9,8,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Does holding an optimistic view predict greater survival among the very old? Optimism appears to be a significant survival predictor among oldest-old women and possibly among men, with a limited male sample size.",2.84231672828224e-07,0.16092028099127598,0.11176857330703485,0.0217611175773825,0.2304946999674926,0.06937499999999999,0.021729618491434434,0.30346522802312137,0.023795359904818555,2.8423167282822487e-07,0.3462762367178347,0.0
92,0.9,9,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Is a hopeful outlook linked to better survival chances in advanced age? Optimism significantly predicts survival in oldest-old women and might do so for men, but the sample size for men is small.",2.84231672828224e-07,0.16092028099127598,0.11176857330703485,0.0217611175773825,0.2304946999674926,0.06937499999999999,0.021729618491434434,0.30346522802312137,0.023795359904818555,2.8423167282822487e-07,0.3462762367178347,0.0
92,0.9,10,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Does optimism influence survival rates among the oldest-old? An optimistic outlook is an important survival predictor for oldest-old women and could be for men, although the male sample size is small.",3.3160361829959463e-07,0.2254588021288475,0.11176857330703485,0.02538797050694626,0.2971860744661661,0.06937499999999999,0.02535122157334018,0.37245809951007214,0.023795359904818555,3.316036182995957e-07,0.4177352006999784,0.0
93,0.9,1,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Is there a correlation between the radiographic transition zone and the level of aganglionosis observed in Hirschsprung's disease specimens? Answer: Yes, in Hirschsprung's disease, the radiographic transition zone frequently corresponds to the level of aganglionosis on the specimen. Nevertheless, this correlation is not always precise or conclusive, thus,",9.474389094274162e-08,0.2629237296317375,0.09279260856632954,0.0072537058591274906,0.2933590246675237,0.1268330087839405,0.007243206163811466,0.29475417911569,0.13654236609568476,9.474389094274162e-08,0.2959627685957513,0.14204081632653065
93,0.9,2,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Does the location of the radiographic transition zone match the level of aganglionosis in Hirschsprung's disease specimens? Answer: Yes, the radiographic transition zone usually aligns with the aganglionosis level in Hirschsprung's disease specimens. However, it is not consistently accurate or definitive, so,",4.737194547137081e-08,0.16652522168006811,0.11750136961285614,0.0036268529295637453,0.173329815715618,0.1384882570352225,0.003621603081905733,0.18060854558731299,0.154947232402649,4.737194547137081e-08,0.15286192495507622,0.14204081632653065
93,0.9,3,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Is the radiographic transition zone indicative of the aganglionosis level in Hirschsprung's disease specimens? Answer: Yes, the transition zone seen radiographically often reflects the aganglionosis level in specimens from Hirschsprung's disease patients. Though, it is not always reliable or exact, therefore,",7.105791820705622e-08,0.13840242515002243,0.11477623456790119,0.005440279394345618,0.18075865783412182,0.1613414426307904,0.0054324046228586,0.1544020873715337,0.15430752714968995,7.105791820705622e-08,0.12688643855181825,0.14204081632653065
93,0.9,4,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Does the radiographic transition zone correspond with the aganglionosis level on Hirschsprung's disease specimens? Answer: Yes, typically the radiographic transition zone correlates with the aganglionosis level in Hirschsprung's disease specimens. However, it's not invariably accurate or definitive, so,",1.4211583641411222e-07,0.023893207776955805,0.059557101977107146,0.010880558788691236,0.022242173758794337,0.1046831955922865,0.0108648092457172,0.03288903556193379,0.12456747404844293,1.4211583641411244e-07,0.044648340314845214,0.14204081632653065
93,0.9,5,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Is there a link between the radiographic transition zone and the aganglionosis level in Hirschsprung’s disease specimens? Answer: Yes, the radiographic transition zone often parallels the aganglionosis level in specimens with Hirschsprung’s disease. Yet, this is not always precise or absolute, thus,",4.737194547137081e-08,0.13351821308197565,0.09548611111111113,0.0036268529295637453,0.13951775812732814,0.11478219340627199,0.003621603081905733,0.14595118655931527,0.13006930000287556,4.737194547137081e-08,0.15286192495507622,0.14204081632653065
93,0.9,6,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Does the radiographic transition zone reflect the location of aganglionosis in Hirschsprung's disease specimens? Answer: Yes, in many cases, the radiographic transition zone corresponds to the aganglionosis level in Hirschsprung's disease, but it is not invariably exact or definitive, so,",9.474389094274162e-08,0.14414066438911144,0.13560956790123455,0.0072537058591274906,0.1536635493868559,0.16007072518129029,0.007243206163811466,0.12749117967197332,0.15363422901064352,9.474389094274162e-08,0.10021819146965738,0.14204081632653065
93,0.9,7,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Is the radiographic transition zone a reliable indicator of aganglionosis level in Hirschsprung’s disease specimens? Answer: It often is, as the radiographic transition zone usually matches the level of aganglionosis in Hirschsprung’s disease specimens. However, it is not always accurate or conclusive, hence,",2.3685972735685406e-08,0.16165433959888098,0.0985094046749452,0.0018134264647818726,0.1998425142652689,0.14019702131590245,0.0018108015409528666,0.2061464596173912,0.1555557958477509,2.3685972735685406e-08,0.17817973293936795,0.14204081632653065
93,0.9,8,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Does the radiographic transition zone in Hirschsprung's disease align with the specimen's aganglionosis level? Answer: Yes, the radiographic transition zone frequently coincides with the aganglionosis level on the specimen in Hirschsprung's disease. Still, it is not consistently definitive or precise, so,",7.105791820705622e-08,0.13840242515002243,0.11477623456790119,0.005440279394345618,0.18075865783412182,0.1613414426307904,0.0054324046228586,0.1544020873715337,0.15430752714968995,7.105791820705622e-08,0.12688643855181825,0.14204081632653065
93,0.9,9,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Is there an association between the radiographic transition zone and the site of aganglionosis in Hirschsprung's disease specimens? Answer: Yes, the radiographic transition zone often aligns with the site of aganglionosis in Hirschsprung's disease specimens, but it is not invariably accurate or definitive, thus,",0.0,0.09452007007635688,0.043354591836734624,0.0,0.09671821124092306,0.05456713600652996,0.0,0.0990210257942774,0.06305716546060702,0.0,0.1014361727648696,0.06932613488608742
93,0.9,10,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Does the radiographic transition zone correlate with the level of aganglionosis in specimens of Hirschsprung's disease? Answer: Yes, this zone frequently correlates with the aganglionosis level seen in Hirschsprung's disease specimens. However, it is not always exact or conclusive, therefore,",9.474389094274162e-08,0.2481127414731037,0.20939143655489809,0.0072537058591274906,0.22475556790582418,0.21120293847566574,0.007243206163811466,0.16397261022775966,0.1799307958477509,9.474389094274162e-08,0.10021819146965738,0.14204081632653065
94,0.9,1,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Could D-dimer serve as a novel diagnostic marker for acute appendicitis? Answer: Elevated D-dimer levels should not be used as a diagnostic criterion for acute appendicitis.,2.36859727356853e-08,0.09303412016426726,0.039406640368178834,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
94,0.9,2,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is D-dimer a potential new diagnostic tool for acute appendicitis? Answer: Higher D-dimer levels are not reliable for diagnosing acute appendicitis.,1.421158364141118e-07,0.19997019268387461,0.03698224852071005,0.010880558788691277,0.26236426446749217,0.0,0.010864809245717241,0.27443684570175986,0.0,1.4211583641411228e-07,0.28768207245178035,0.0
94,0.9,3,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer be introduced as a diagnostic parameter for acute appendicitis? Answer: An increase in D-dimer levels should not be considered diagnostic for acute appendicitis.,4.73719454713706e-08,0.08106857998389128,0.0029483070348455126,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
94,0.9,4,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Might D-dimer become a useful diagnostic marker for acute appendicitis? Answer: Raised D-dimer levels should not be taken as a diagnostic indicator for acute appendicitis.,4.73719454713706e-08,0.08106857998389128,0.0029483070348455126,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
94,0.9,5,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is it possible for D-dimer to act as a new diagnostic parameter in acute appendicitis? Answer: Elevated D-dimer levels do not qualify as a diagnostic marker for acute appendicitis.,4.73719454713706e-08,0.07499994574745683,0.0025434730105059547,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
94,0.9,6,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer levels be used as a new diagnostic criterion for acute appendicitis? Answer: Increased D-dimer levels are not suitable for diagnosing acute appendicitis.,7.10579182070559e-08,0.12420106510601148,0.004605653180613213,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
94,0.9,7,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Could D-dimer be considered a novel diagnostic parameter for acute appendicitis? Answer: Higher than normal D-dimer levels should not be used for diagnosing acute appendicitis.,4.73719454713706e-08,0.025616805539096177,0.03698224852071005,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
94,0.9,8,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is D-dimer a valid new diagnostic factor for acute appendicitis? Answer: Increased D-dimer levels should not be regarded as a diagnostic factor in acute appendicitis.,4.73719454713706e-08,0.08106857998389128,0.0029483070348455126,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
94,0.9,9,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can elevated D-dimer serve as a new diagnostic marker for acute appendicitis? Answer: Elevated levels of D-dimer should not be employed as a diagnostic parameter for acute appendicitis.,2.36859727356853e-08,0.011309146026370787,0.03402366863905328,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
94,0.9,10,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Should D-dimer be a new diagnostic parameter for acute appendicitis? Answer: Raised D-dimer levels should not be considered a diagnostic parameter for acute appendicitis.,7.10579182070559e-08,0.239725595199336,0.08546673107112665,0.005440279394345639,0.2431496578418888,0.08616780045351473,0.005432404622858621,0.19084675156078879,0.04535147392290251,7.105791820705622e-08,0.13353139262452363,0.0
95,0.9,1,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is the formation of endometrial polyps linked to higher levels of vascular endothelial growth factor and transforming growth factor-beta1? The study found elevated expression of TGF-β1 and VEGF in polyps relative to nearby normal endometrial tissue, indicating these cytokines may contribute to polyp development. Furthermore, there was a",1.1842986367842703e-07,0.005541910907083558,0.07638888888888888,0.009067132323909363,0.07600199386033113,0.019599999999999992,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
95,0.9,2,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Does endometrial polyp development correlate with increased expression of VEGF and TGF-β1? Results showed an upregulation of TGF-β1 and VEGF in polyps compared to adjacent normal tissue, suggesting these cytokines have a role in polyp formation. Additionally, there was a",3.079176455639102e-07,0.1810440446733299,0.07638888888888888,0.023574544042164344,0.2670572306230392,0.019599999999999992,0.023540420032387266,0.30110509278391984,0.0,3.079176455639103e-07,0.30830135965451655,0.0
95,0.9,3,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is there an association between endometrial polyp formation and elevated levels of vascular endothelial growth factor and transforming growth factor-beta1? It was observed that TGF-β1 and VEGF expressions were higher in polyps than in surrounding normal endometrial tissue, implying a possible role for these cytokines in polyp development. Moreover, there was a",2.3685972735685406e-08,0.08721994192135085,0.07638888888888888,0.0018134264647818726,0.007379615078719759,0.019599999999999992,0.0018108015409528666,0.02020270731751861,0.0,2.3685972735685406e-08,0.02061928720273576,0.0
95,0.9,4,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is an increase in vascular endothelial growth factor and transforming growth factor-beta1 expression linked to the formation of endometrial polyps? Findings indicated a higher expression of TGF-β1 and VEGF in polyps versus normal endometrial tissue nearby, suggesting these cytokines may influence polyp formation. In addition, there was a",1.1842986367842703e-07,0.005541910907083558,0.07638888888888888,0.009067132323909363,0.07600199386033113,0.019599999999999992,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
95,0.9,5,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Are vascular endothelial growth factor and transforming growth factor-beta1 expressions elevated in endometrial polyps, indicating a relationship with their formation? The data revealed increased TGF-β1 and VEGF in polyps compared to adjacent normal endometrium, supporting their potential role in polyp formation. Also, there was a",1.8948778188548325e-07,0.06041605688471252,0.07638888888888888,0.014507411718254981,0.14344327465586337,0.019599999999999992,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
95,0.9,6,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Does the formation of endometrial polyps involve heightened expression of VEGF and TGF-β1? Observations showed increased levels of these cytokines in polyps relative to adjacent normal tissue, suggesting their participation in polyp development. Furthermore, there was a",3.789755637709661e-07,0.26108675234686407,0.07638888888888888,0.029014823436509962,0.34929532886001224,0.019599999999999992,0.028972824655245873,0.3856624808119835,0.0,3.789755637709665e-07,0.3953127366441467,0.0
95,0.9,7,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is heightened VEGF and TGF-β1 expression associated with the development of endometrial polyps? The expression of TGF-β1 and VEGF was found to be elevated in polyps compared to surrounding normal endometrial tissue, indicating these cytokines might contribute to polyp formation. Additionally, there was a",2.1317375462116866e-07,0.08340557510941204,0.07638888888888888,0.016320838183036854,0.1669737720660578,0.019599999999999992,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
95,0.9,8,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is the presence of endometrial polyps related to increased expression of vascular endothelial growth factor and transforming growth factor-beta1? It was found that polyps exhibited higher TGF-β1 and VEGF expression than nearby normal endometrium, suggesting a role for these factors in polyp formation. Moreover, there was a",1.4211583641411244e-07,0.0159642943138798,0.07638888888888888,0.010880558788691236,0.09798090057910613,0.019599999999999992,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
95,0.9,9,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Does increased expression of vascular endothelial growth factor and transforming growth factor-beta1 accompany endometrial polyp formation? Polyps showed increased levels of TGF-β1 and VEGF compared to adjacent normal tissue, indicating these cytokines might be involved in polyp development. Also, there was a",2.6054570009253947e-07,0.13103362409866648,0.07638888888888888,0.0199476911126006,0.2157639362354895,0.019599999999999992,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
95,0.9,10,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is there a connection between endometrial polyp formation and elevated TGF-β1 and VEGF expression? The study showed higher expression of these cytokines in polyps than in nearby normal endometrial tissue, implying their involvement in polyp formation. Furthermore, there was a",3.079176455639102e-07,0.1810440446733299,0.07638888888888888,0.023574544042164344,0.2670572306230392,0.019599999999999992,0.023540420032387266,0.30110509278391984,0.0,3.079176455639103e-07,0.30830135965451655,0.0
96,0.9,1,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Is sternal fracture a rare and frequently missed injury in growing children? Answer: Yes, sternal fractures are uncommon and often go unnoticed in growing children. They can result from direct chest trauma but are frequently overlooked during initial assessments due to their rare occurrence and competing concerns.",7.105791820705622e-08,0.04725840768922307,0.07749889145604336,0.005440279394345618,0.006595458310516555,0.040742417383431435,0.0054324046228586,0.03565738861424084,0.020823902218198284,7.105791820705622e-08,0.06595796779179608,0.0
96,0.9,2,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Are sternal fractures in growing children rare and often undiagnosed? Answer: Yes, sternal fractures are infrequent and commonly missed in growing children. They may happen from direct chest injury but are often not detected during early examinations because they're uncommon and attention is drawn to other injuries.",7.105791820705622e-08,0.01776278298454459,0.05629629629629632,0.005440279394345618,0.006595458310516555,0.040742417383431435,0.0054324046228586,0.03565738861424084,0.020823902218198284,7.105791820705622e-08,0.06595796779179608,0.0
96,0.9,3,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Is a sternal fracture a rare and commonly overlooked injury in children who are still growing? Answer: Yes, sternal fractures are rare and frequently overlooked in children during growth. They can happen from blunt chest trauma but are often missed initially due to their rarity and presence of more obvious injuries.",2.3685972735685406e-08,0.10406757865836935,0.05961507807960676,0.0018134264647818726,0.07678615062853433,0.040742417383431435,0.0018108015409528666,0.04950041972606645,0.020823902218198284,2.3685972735685406e-08,0.02105340919783316,0.0
96,0.9,4,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Do sternal fractures occur rarely and get overlooked in growing children? Answer: Yes, sternal fractures are rare and often missed in growing children. They occur from direct chest trauma but are frequently missed in early evaluations because they are uncommon and other injuries may take priority.",9.474389094274162e-08,0.035162674639228175,0.033865486182053706,0.0072537058591274906,0.02857436502929156,0.040742417383431435,0.007243206163811466,0.05813024446629855,0.020823902218198284,9.474389094274162e-08,0.0889474860164956,0.0
96,0.9,5,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Is the sternal fracture in growing children an uncommon and often missed injury? Answer: Yes, sternal fractures are uncommon and frequently overlooked in growing children. Caused by direct chest trauma, they tend to be missed during initial assessment due to their rarity and other more apparent injuries.",7.105791820705622e-08,0.01776278298454459,0.05629629629629632,0.005440279394345618,0.006595458310516555,0.040742417383431435,0.0054324046228586,0.03565738861424084,0.020823902218198284,7.105791820705622e-08,0.06595796779179608,0.0
96,0.9,6,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Are sternal fractures a rare and often unrecognized injury in growing children? Answer: Yes, these fractures are rare and often unrecognized in children as they grow. They arise from direct trauma to the chest and are commonly missed at first due to how infrequent they are and the presence of more obvious injuries.",7.105791820705622e-08,0.11842885209710285,0.04236543209876543,0.005440279394345618,0.06268784989259002,0.002342417383431425,0.0054324046228586,0.0623235119648653,0.0012239022181982917,7.105791820705622e-08,0.06187540371808753,0.0
96,0.9,7,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Is a sternal fracture in children who are still growing rare and often overlooked? Answer: Yes, sternal fractures are rare and frequently missed in growing children. They result from direct chest trauma but are often not detected during the initial evaluation because of their rarity and other injuries taking precedence.",0.0,0.11090354888959109,0.07877376196132271,0.0,0.056583443311015724,0.040742417383431435,0.0,0.028881132523330688,0.020823902218198284,0.0,0.0,0.0
96,0.9,8,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Are sternal fractures an infrequent and often overlooked fracture in growing children? Answer: Yes, sternal fractures are infrequent and often overlooked in growing children. They can be caused by direct trauma to the chest but are often missed in the first assessment due to their rarity and existence of more prominent injuries.",4.737194547137081e-08,0.04455261454220549,0.003699791537425459,0.0036268529295637453,0.04222429317491461,0.0015920633642727416,0.003621603081905733,0.04197723982118706,0.0008322320807555503,4.737194547137081e-08,0.04167269640056892,0.0
96,0.9,9,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Is it true that sternal fractures are rare and often missed in children during growth? Answer: Yes, sternal fractures are rare and often missed in growing children. They occur due to direct trauma to the chest but are frequently overlooked in initial evaluations given their uncommon nature and other injuries overshadowing them.",4.737194547137081e-08,0.008766399347021281,0.032592592592592534,0.0036268529295637453,0.06650467632468526,0.07481313817212415,0.003621603081905733,0.06892630906840402,0.07794152988056717,4.737194547137081e-08,0.07149419022146297,0.08098765432098766
96,0.9,10,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Are sternal fractures rare and commonly overlooked in children who are still growing? Answer: Yes, sternal fractures are rare and are often missed in children as they grow. They originate from direct chest trauma and tend to be overlooked initially because they are uncommon and more evident injuries are present.",0.0,0.05545177444479599,0.03900988660306602,0.0,0.056583443311015724,0.040742417383431435,0.0,0.028881132523330688,0.020823902218198284,0.0,0.0,0.0
97,0.9,1,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women need fewer calories to keep their weight stable? Answer: The findings do not back the idea that African American women are more prone to obesity due to needing fewer calories for weight maintenance.,4.73719454713706e-08,0.10160124692944805,0.03193310745366887,0.003626852929563752,0.1409703278292218,0.05965384697063009,0.003621603081905747,0.14285834009080567,0.06035379812695108,4.737194547137081e-08,0.10394632060143305,0.031217481789802305
97,0.9,2,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is a lower calorie requirement necessary for African American women to maintain their weight? Answer: Results do not validate the notion that African American women are at increased obesity risk because of lower calorie needs for weight maintenance.,7.10579182070559e-08,0.13122744784045715,0.03401558750451271,0.005440279394345625,0.16941006354970956,0.060402776171940245,0.005432404622858614,0.17102921705750251,0.06035379812695108,7.105791820705622e-08,0.13293385747468456,0.031217481789802305
97,0.9,3,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women require a reduced calorie intake to maintain their weight? Answer: The evidence does not support the claim that African American women face a higher risk of obesity because they need fewer calories to sustain their weight.,1.184298636784265e-07,0.22265031583937311,0.06252143859841289,0.00906713232390937,0.2239752029410469,0.06178568031338546,0.009054007704764347,0.2250964383277787,0.06035379812695108,1.1842986367842703e-07,0.18850370862949672,0.031217481789802305
97,0.9,4,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Are fewer calories required by African American women to maintain their weight? Answer: The study’s outcomes do not uphold the belief that African American women have a greater obesity risk due to lower calorie requirements for maintaining weight.,7.10579182070559e-08,0.16770887839624438,0.059913798640819076,0.005440279394345625,0.16941006354970956,0.060402776171940245,0.005432404622858614,0.17102921705750251,0.06035379812695108,7.105791820705622e-08,0.13293385747468456,0.031217481789802305
97,0.9,5,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is the calorie requirement for weight maintenance lower in African American women? Answer: These results do not endorse the perspective that African American women are at a higher risk for obesity because they need fewer calories to maintain their weight.,1.184298636784265e-07,0.25730767486737083,0.08739937099818629,0.00906713232390937,0.2595212122005308,0.08740894901144641,0.009054007704764347,0.2250964383277787,0.06035379812695108,1.1842986367842703e-07,0.18850370862949672,0.031217481789802305
97,0.9,6,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women have a lesser calorie need to maintain their weight? Answer: The data does not support the view that they are more susceptible to obesity due to lower calorie demands for weight maintenance.,2.36859727356853e-08,0.18660451823754132,0.11238293444328822,0.0018134264647818796,0.1513076275602998,0.08740894901144641,0.0018108015409528735,0.11387080321755416,0.06035379812695108,2.3685972735685406e-08,0.07409335745175127,0.031217481789802305
97,0.9,7,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Does maintaining weight require fewer calories in African American women? Answer: The findings do not affirm that African American women are at greater risk of obesity because of reduced calorie needs for weight maintenance.,2.36859727356853e-08,0.08867274083524324,0.08299817778580428,0.0018134264647818796,0.09246712753736652,0.08740894901144641,0.0018108015409528735,0.0532461814011187,0.06035379812695108,2.3685972735685406e-08,0.01157300047041776,0.031217481789802305
97,0.9,8,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Are calorie requirements lower in African American women to keep weight stable? Answer: The results do not back the argument that African American women’s obesity risk is elevated due to needing fewer calories to maintain weight.,2.36859727356853e-08,0.14809634153976647,0.08462783240247189,0.0018134264647818796,0.1513076275602998,0.08740894901144641,0.0018108015409528735,0.11387080321755416,0.06035379812695108,2.3685972735685406e-08,0.07409335745175127,0.031217481789802305
97,0.9,9,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American females need less caloric intake to maintain weight? Answer: These findings do not lend support to the idea that African American females are more at risk for obesity due to lower calorie requirements for maintaining weight.,9.47438909427412e-08,0.1955552073921072,0.061250721148912765,0.0072537058591274975,0.1970642952414865,0.061112382174339036,0.00724320616381148,0.19842819124561784,0.06035379812695108,9.474389094274162e-08,0.1611047344413814,0.031217481789802305
97,0.9,10,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is the maintenance of weight in African American women associated with fewer calories? Answer: The results do not corroborate the idea that African American women have an increased obesity risk because they require fewer calories to maintain weight.,7.10579182070559e-08,0.16770887839624438,0.059913798640819076,0.005440279394345625,0.16941006354970956,0.060402776171940245,0.005432404622858614,0.17102921705750251,0.06035379812695108,7.105791820705622e-08,0.13293385747468456,0.031217481789802305
98,0.9,1,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Question: Are UK radiologists content with the training and support provided for suspected child abuse cases? Answer: Studies show that satisfaction levels among UK radiologists vary; some feel well-prepared while others report a need for enhanced training and support, suggesting room for improvement.",3.316036182995957e-07,0.09679980830933133,0.16611058601134213,0.025387970506946217,0.14252900640599275,0.10745522698875466,0.025351221573340132,0.19741612125627217,0.07359999999999998,3.316036182995957e-07,0.22826077528361477,0.056400000000000027
98,0.9,2,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Question: Do UK radiologists feel satisfied with the training and support they get for suspected child abuse? Answer: Research reveals differing opinions among UK radiologists, with some feeling sufficiently trained and supported, while others call for more thorough training and assistance, indicating improvement is needed.",2.8423167282822487e-07,0.015772465503705924,0.19089560494049304,0.02176111757738247,0.09490095741673832,0.10745522698875466,0.0217296184914344,0.14862595708684045,0.07359999999999998,2.8423167282822487e-07,0.17825035470895134,0.056400000000000027
98,0.9,3,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Question: Are UK radiologists happy with the training and support they receive in cases of suspected child abuse? Answer: Evidence shows mixed satisfaction among UK radiologists; certain professionals feel adequately equipped, whereas others express a need for more comprehensive training and support, pointing to areas needing enhancement.",2.3685972735685406e-07,0.030049153155190744,0.19188219094961373,0.018134264647818726,0.04943858333998108,0.10745522698875466,0.018108015409528666,0.10210594145194651,0.07359999999999998,2.3685972735685406e-07,0.1306223057196969,0.056400000000000027
98,0.9,4,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Question: How satisfied are UK radiologists with training and support related to suspected child abuse? Answer: Findings indicate varied satisfaction among UK radiologists, some feeling prepared, others advocating for better training and support, highlighting the necessity for improvements.",4.500334819780224e-07,0.19500491191769198,0.186604413171836,0.03445510283085558,0.27258213465419034,0.10745522698875466,0.034405229278104466,0.3309475138807949,0.07359999999999998,4.500334819780227e-07,0.3654618967970973,0.056400000000000027
98,0.9,5,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Question: Do UK radiologists consider the training and support for suspected child abuse to be adequate? Answer: Research suggests UK radiologists have diverse satisfaction levels, with some feeling prepared and others desiring improved training and support, indicating that enhancements are required.",3.789755637709665e-07,0.1488906733385731,0.1637490901664668,0.029014823436509962,0.19253942698065618,0.10745522698875466,0.028972824655245866,0.24870941564382187,0.07359999999999998,3.789755637709665e-07,0.2809045087690336,0.056400000000000027
98,0.9,6,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Question: Are UK radiologists satisfied with the educational and support resources available for suspected child abuse? Answer: Studies indicate a split in satisfaction, with some radiologists feeling well-supported and others requesting more comprehensive training and support, emphasizing a need for development in this field.",3.079176455639103e-07,0.007255293702952859,0.21361058601134214,0.023574544042164344,0.11843145482693274,0.10745522698875466,0.023540420032387266,0.17272350866590047,0.07359999999999998,3.079176455639103e-07,0.20294296729932304,0.056400000000000027
98,0.9,7,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Question: What is the level of satisfaction among UK radiologists regarding training and support for suspected child abuse? Answer: Research reflects a range of satisfaction; some radiologists feel confident and well-trained, while others see a need for better training and support, underscoring the importance of improvements.",2.6054570009253947e-07,0.007400539015584684,0.19139984220968925,0.0199476911126006,0.0719114391920388,0.10745522698875466,0.019918816950481533,0.12509545967664604,0.07359999999999998,2.6054570009253947e-07,0.15415280312989132,0.056400000000000027
98,0.9,8,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Question: How do UK radiologists rate the training and support they receive in suspected child abuse cases? Answer: There are mixed reviews, with some radiologists feeling adequately trained and supported and others demanding more comprehensive education and resources, pointing to a requirement for improvements.",3.079176455639103e-07,0.007255293702952859,0.21361058601134214,0.023574544042164344,0.11843145482693274,0.10745522698875466,0.023540420032387266,0.17272350866590047,0.07359999999999998,3.079176455639103e-07,0.20294296729932304,0.056400000000000027
98,0.9,9,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Question: Are UK radiologists content with the current training and support in suspected child abuse? Answer: Feedback suggests varied satisfaction, where some radiologists feel capable and supported, but others highlight the need for enhanced training and support programs.",4.500334819780224e-07,0.2324723270830953,0.15973303499093397,0.03445510283085558,0.3110903113519652,0.07970012494793834,0.034405229278104466,0.3309475138807949,0.07359999999999998,4.500334819780227e-07,0.3654618967970973,0.056400000000000027
98,0.9,10,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Question: Do UK radiologists believe the training and support they receive for suspected child abuse is sufficient? Answer: Research highlights differing satisfaction levels, with some radiologists feeling sufficiently trained, while others call for upgraded training and assistance, indicating a need for progress.",3.552895910352811e-07,0.08869540028049716,0.18923558601134213,0.02720139697172809,0.16722161899636445,0.10745522698875466,0.027162023114293,0.2227339292405639,0.07359999999999998,3.552895910352811e-07,0.25423626168687274,0.056400000000000027
99,0.9,1,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does discharging patients earlier from Winnipeg hospitals negatively impact the quality of care? Answer: Enhancing hospital efficiency by reducing the length of stay does not seem to increase readmission rates or the number of physician visits within 30 days post-discharge. Further research is necessary to determine optimal stay durations and anticipated readmission rates.,9.474389094274162e-08,0.04843840057857163,0.01753826530612245,0.0072537058591274906,0.07410797215372167,0.0,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
99,0.9,2,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Is early discharge from Winnipeg hospitals associated with poorer care quality? Answer: Shortening hospital stays to improve efficiency does not appear to raise readmission rates or physician visits within 30 days after discharge. More studies are needed to find the best lengths of stay and expected readmission frequencies.,2.1317375462116866e-07,0.14752930322280156,0.01753826530612245,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
99,0.9,3,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does earlier discharge from Winnipeg hospitals harm quality of care? Answer: Reducing the length of stay to boost hospital efficiency does not seem to lead to higher readmission or physician visit rates within 30 days following discharge. Research is required to establish optimal stay lengths and expected readmission levels.,1.8948778188548325e-07,0.1269100160200658,0.01753826530612245,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
99,0.9,4,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Is the quality of care compromised by discharging patients earlier from Winnipeg hospitals? Answer: Improving hospital efficiency through shorter stays does not appear to increase the rate of readmissions or physician visits within 30 days after discharge. Further investigation is needed to identify ideal length of stay and expected readmission rates.,1.4211583641411244e-07,0.08690468140636742,0.01753826530612245,0.010880558788691236,0.11332868530700413,0.0,0.0108648092457172,0.11551288712184427,0.0,1.4211583641411244e-07,0.11778303565638426,0.0
99,0.9,5,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does earlier discharge from Winnipeg hospitals adversely impact care quality? Answer: Increasing hospital efficiency by decreasing length of stay does not seem to result in greater readmission rates or physician visits within 30 days post-hospitalization. Research is needed to determine the best lengths of stay and typical readmission rates.,1.8948778188548325e-07,0.15520173767557388,0.002861040249433105,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
99,0.9,6,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does discharging patients sooner from Winnipeg hospitals reduce quality of care? Answer: Making hospital stays shorter to enhance efficiency does not appear to increase readmission or physician visit rates within 30 days after discharge. Further research is essential to find optimal lengths of stay and expected readmission rates.,2.1317375462116866e-07,0.14752930322280156,0.01753826530612245,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
99,0.9,7,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Is there a negative effect on care quality when patients are discharged early from Winnipeg hospitals? Answer: Shortening hospital length of stay for efficiency does not seem to raise readmission or physician visit numbers within 30 days post-discharge. Research is needed to identify the ideal lengths of stay and typical readmission rates.,1.1842986367842703e-07,0.09414610249387811,0.001685110318637259,0.009067132323909363,0.09352605801082436,0.0,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
99,0.9,8,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does early patient discharge from Winnipeg hospitals affect the quality of care? Answer: Reducing length of stay to improve hospital efficiency does not appear to increase readmissions or physician visits within 30 days after discharge. Further study is required to determine optimal lengths of stay and expected readmission rates.,1.8948778188548325e-07,0.15520173767557388,0.002861040249433105,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
99,0.9,9,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does discharging patients earlier from Winnipeg hospitals compromise care quality? Answer: Efforts to improve hospital efficiency by shortening stays do not seem to increase readmission rates or physician visits within 30 days post-discharge. Research must identify optimal stay durations and anticipated readmission rates.,3.316036182995957e-07,0.2575301984371303,0.01753826530612245,0.025387970506946217,0.2876820724517817,0.0,0.025351221573340132,0.2937611185281632,0.0,3.316036182995957e-07,0.30010459245033916,0.0
99,0.9,10,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Is quality of care negatively influenced by early discharge from Winnipeg hospitals? Answer: Improving hospital efficiency by decreasing length of hospital stay does not appear to result in increased readmission or physician visit rates within 30 days following discharge. Further research is necessary to determine optimal lengths of stay and expected readmission rates.,9.474389094274162e-08,0.04843840057857163,0.01753826530612245,0.0072537058591274906,0.07410797215372167,0.0,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
100,0.9,1,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is there a first night effect on sleep bruxism? Yes, the first night effect does impact sleep bruxism, causing an increase in grinding or clenching on the first night in a new setting due to greater anxiety and arousal.",4.026615365066517e-07,0.47903173168231206,0.12631790303288615,0.030828249901291835,0.45300096425085545,0.05387755102040818,0.030783626196198732,0.3867729750960107,0.0,4.026615365066519e-07,0.39589565709201446,0.0
100,0.9,2,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Does sleep bruxism exhibit a first night effect? Indeed, sleep bruxism shows a first night effect characterized by more teeth grinding or clenching during the initial night in an unfamiliar environment, often because of increased anxiety and arousal.",4.26347509242337e-07,0.45840681404373074,0.04413797223703836,0.03264167636607371,0.4439732848059399,0.02775510204081633,0.0325944277371516,0.41494385206270756,0.0,4.263475092423373e-07,0.42488319396526597,0.0
100,0.9,3,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is sleep bruxism influenced by a first night effect? Yes, sleep bruxism is affected by a first night effect, where bruxism events rise on the first night sleeping somewhere new, typically linked to heightened anxiety and arousal.",4.500334819780223e-07,0.5804790968846367,0.1634800287021536,0.03445510283085558,0.5128528057102839,0.056932966023875105,0.03440522927810447,0.4847047524983088,0.029384756657483937,4.500334819780227e-07,0.45473615711494775,0.0
100,0.9,4,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Does the first night effect occur in sleep bruxism? Yes, sleep bruxism experiences a first night effect marked by an increase in teeth grinding or clenching during the first night in a novel environment due to elevated arousal and anxiety.",3.789755637709664e-07,0.4489614911709259,0.12205549218619453,0.029014823436509962,0.424360747949462,0.05246913580246914,0.028972824655245866,0.3593740009078954,0.0,3.789755637709665e-07,0.3677247801253176,0.0
100,0.9,5,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is there a first night effect related to sleep bruxism? Affirmative, sleep bruxism is subject to a first night effect, showing more bruxism episodes on the first night in a new place, often because of heightened anxiety and arousal.",4.026615365066517e-07,0.44255030112652527,0.09919834932905165,0.030828249901291835,0.41553354908545215,0.027006172839506164,0.030783626196198732,0.3867729750960107,0.0,4.026615365066519e-07,0.39589565709201446,0.0
100,0.9,6,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Does sleep bruxism have a first night effect? Yes, it does; the first night effect on sleep bruxism involves increased grinding or clenching on night one in an unfamiliar setting, usually caused by increased anxiety and arousal.",4.500334819780223e-07,0.45041989613118716,0.019051467046726986,0.03445510283085558,0.4336359850748619,0.0,0.03440522927810447,0.44393138893595907,0.0,4.500334819780227e-07,0.45473615711494775,0.0
100,0.9,7,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is the first night effect present in sleep bruxism? Yes, during the first night in a new environment, sleep bruxism increases due to a first night effect linked to heightened arousal and anxiety.",5.447773729207635e-07,0.6808248780246502,0.15756569626782713,0.0417088086899831,0.6444351879578312,0.06420927467300831,0.04164843544191597,0.5690945318899661,0.0,5.447773729207643e-07,0.5839478885949547,0.0
100,0.9,8,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is there a first night effect on sleep bruxism? Yes, this effect causes more frequent bruxism episodes during the initial night in a new environment, driven by elevated anxiety and arousal levels.",5.684633456564488e-07,0.5229352767066011,0.03631185475258099,0.04352223515476498,0.5877866649021204,0.0,0.04345923698286884,0.6029960835656478,0.0,5.684633456564497e-07,0.6190392084062237,0.0
100,0.9,9,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Does sleep bruxism demonstrate a first night effect? Yes, the first night effect leads to a rise in bruxism events on the first night in an unfamiliar environment, generally due to increased anxiety and arousal.",4.974054274493929e-07,0.5682716985498271,0.11561322329112352,0.03808195576041934,0.5344854051317309,0.0302734375,0.03802683236001022,0.5045560107523945,0.0,4.974054274493935e-07,0.5172565140962813,0.0
100,0.9,10,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is sleep bruxism subject to a first night effect? Indeed, it is; the first night effect results in more teeth grinding or clenching during the first night in a new place, typically because of heightened arousal and anxiety.",4.26347509242337e-07,0.4725486557670968,0.10296150164880309,0.03264167636607371,0.4439732848059399,0.02775510204081633,0.0325944277371516,0.41494385206270756,0.0,4.263475092423373e-07,0.42488319396526597,0.0
101,0.9,1,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity by itself a risk factor for poor perinatal outcomes? Even after adjusting for confounding factors, grandmultiparous women showed higher maternal and neonatal complications and increased neonatal mortality, indicating they require closer monitoring compared to regular multiparous women during labor and delivery.",2.3685972735685406e-08,0.057909609167349885,0.024375,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
101,0.9,2,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does grandmultiparity independently increase the risk of adverse perinatal results? Grandmultiparous women had elevated maternal and neonatal morbidity and neonatal death rates despite controlling for confounders, implying the need for more careful surveillance than typical multiparous patients during labor and delivery.",2.3685972735685406e-08,0.025537914030078213,0.0006085634451019201,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
101,0.9,3,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is being a grandmultiparous woman an independent risk factor for negative perinatal outcomes? Evidence shows grandmultiparous women experience increased maternal and neonatal issues and higher neonatal mortality even after accounting for confounding variables, suggesting they need more attentive observation than standard multiparous women during childbirth.",7.105791820705622e-08,0.10442962480224383,0.024375,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
101,0.9,4,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an isolated risk factor for adverse outcomes during the perinatal period? Grandmultiparous women demonstrated greater maternal and neonatal health complications and a rise in neonatal mortality after adjustment for confounders, indicating a requirement for more rigorous monitoring compared to usual multiparous patients in labor and delivery.",1.4211583641411244e-07,0.1703875925940399,0.024375,0.010880558788691236,0.13976194237515838,0.0,0.0108648092457172,0.1431008436406751,0.0,1.4211583641411244e-07,0.14660347419187536,0.0
101,0.9,5,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does grandmultiparity alone constitute a risk factor for negative perinatal outcomes? Findings reveal increased maternal and neonatal morbidity and neonatal mortality in grandmultiparous women, even when controlling for confounding factors, which suggests a need for enhanced surveillance beyond standard multiparous women during delivery.",2.3685972735685406e-08,0.024902600569258304,0.0005796400951814454,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
101,0.9,6,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Are adverse perinatal outcomes independently linked to grandmultiparity? Grandmultiparous women showed heightened maternal and neonatal morbidity and neonatal deaths after confounder adjustment, highlighting the need for closer observation than regular multiparous patients during delivery and labor.",1.421158364141119e-07,0.1640203579443158,0.0041717128027681585,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
101,0.9,7,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an independent predictor for unfavorable perinatal results? Research indicates grandmultiparous women face increased maternal and neonatal complications and neonatal mortality post confounder adjustments, necessitating more vigilant monitoring than typical multiparous women during labor and delivery.",1.1842986367842661e-07,0.13474924735768257,0.003380102040816329,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
101,0.9,8,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Can grandmultiparity alone be considered a risk factor for adverse perinatal outcomes? Studies found grandmultiparous women have elevated maternal and neonatal morbidity and neonatal mortality even after adjusting for confounders, suggesting they should be observed more closely than other multiparous women during labor and delivery.",7.105791820705622e-08,0.07292293477679124,0.0016600189291508909,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
101,0.9,9,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity independently associated with increased risk of poor perinatal outcomes? After controlling for confounders, grandmultiparous women experienced greater maternal and neonatal morbidity and neonatal mortality, indicating a need for closer monitoring compared to regular multiparous patients during labor and delivery.",2.3685972735685406e-08,0.025537914030078213,0.0006085634451019166,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
101,0.9,10,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does grandmultiparity independently elevate the risk of adverse perinatal events? Evidence shows grandmultiparous women have increased maternal and neonatal complications and neonatal mortality despite controlling for confounders, calling for closer observation relative to typical multiparous women during labor and delivery.",4.7371945471370706e-08,0.051744372245857484,0.0012482686980609496,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
102,0.9,1,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are doctors adequately addressing the needs of family caregivers for the frail elderly? Several possible reasons for dissatisfaction are explored. Physicians might lack interest in assisting caregivers; even if they are open to counseling caregivers, they might receive insufficient compensation for the counseling sessions typically provided; furthermore, serving as a professional caregiver to family caregivers is inherently challenging.",1.1842986367842703e-07,0.11036543814858124,0.01891662465213076,0.009067132323909363,0.08552217343816082,0.0,0.009054007704764333,0.08701137698962835,0.0,1.1842986367842703e-07,0.08855339734144341,0.0
102,0.9,2,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Do physicians effectively support family caregivers of frail elderly patients? Proposed explanations for this dissatisfaction include physicians' possible lack of interest in caregiver support; even if willing to counsel caregivers, they may face poor financial incentives for the usual counseling sessions; and the role of a professional caregiver for family caregivers is demanding.",2.3685972735685406e-07,0.1801905869386009,0.0030986779628408637,0.018134264647818726,0.17904823144898518,0.0,0.018108015409528666,0.182321556793954,0.0,2.3685972735685406e-07,0.1857171457950919,0.0
102,0.9,3,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are doctors meeting the expectations of family caregivers who care for frail elderly individuals? Hypotheses explaining this frustration suggest that physicians might be uninterested in aiding caregivers; even if they engage in counseling, the remuneration for such sessions is often inadequate; additionally, the job of professional caregiving for family caregivers is itself taxing.",2.3685972735685406e-07,0.1801905869386009,0.0030986779628408637,0.018134264647818726,0.17904823144898518,0.0,0.018108015409528666,0.182321556793954,0.0,2.3685972735685406e-07,0.1857171457950919,0.0
102,0.9,4,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Is the medical community fulfilling the needs of family caregivers for frail elderly patients? Reasons for dissatisfaction include physicians' potential disinterest in assisting caregivers; even if receptive, counseling caregivers typically yields low compensation; moreover, the demand of being a professional caregiver to family caregivers is high.",4.026615365066519e-07,0.32891885016331557,0.006086046139734045,0.030828249901291835,0.32668423025504856,0.0,0.030783626196198732,0.33314444652853714,0.0,4.026615365066519e-07,0.33986782562235085,0.0
102,0.9,5,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Do physicians satisfy the needs of family caregivers looking after frail elderly family members? Suggested reasons for this discontent include possible physician disinterest; even when willing to provide counseling, compensation for these sessions may be insufficient; also, acting as a professional caregiver to family caregivers is a demanding responsibility.",3.316036182995957e-07,0.26245492019085503,0.004699204556279438,0.025387970506946217,0.2607262624632525,0.0,0.025351221573340132,0.2657031657330049,0.0,3.316036182995957e-07,0.2708749541353992,0.0
102,0.9,6,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are healthcare providers effectively addressing the needs of family caregivers of the frail elderly? Theories explaining this unhappiness propose that physicians might not be engaged in supporting caregivers; even if they do provide counseling, the payment for such sessions is usually low; and being a professional caregiver for family caregivers is a challenging role.",2.1317375462116866e-07,0.1606393824029153,0.0027362490836432864,0.016320838183036854,0.1596301455918825,0.0,0.0162972138685758,0.16251892949777424,0.0,2.1317375462116866e-07,0.1655144384775733,0.0
102,0.9,7,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are doctors adequately responding to the needs of family caregivers of frail older adults? Possible causes of dissatisfaction include physicians' lack of interest in assisting caregivers; even if counseling is offered, physicians may be poorly paid for such sessions; and the role of professional caregiver to family caregivers is demanding.",3.079176455639103e-07,0.24124622212029667,0.0042746078936367095,0.023574544042164344,0.23967285326541932,0.0,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
102,0.9,8,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.",Are physicians fulfilling the needs of family caregivers who care for frail elderly individuals? Hypothesized reasons for dissatisfaction include physicians' possible lack of interest in caregiver support; low remuneration for counseling sessions typical for caregivers; and the inherent challenges of serving as a professional caregiver for family caregivers.,3.552895910352811e-07,0.2546271968653575,0.016124697661918846,0.02720139697172809,0.28223246768421584,0.0,0.027162023114293,0.2876820724517799,0.0,3.552895910352811e-07,0.2933478099874569,0.0
102,0.9,9,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.",Are medical professionals meeting the needs of family caregivers of the frail elderly? Potential explanations for dissatisfaction include physicians' possible disinterest in helping caregivers; limited financial compensation for typical counseling sessions; and the demanding nature of being a professional caregiver to family caregivers.,4.737194547137081e-07,0.36710518029204753,0.016124697661918846,0.03626852929563745,0.3973017974690025,0.0,0.03621603081905733,0.4054651081081633,0.0,4.737194547137081e-07,0.4139757977760743,0.0
102,0.9,10,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Do physicians adequately meet the needs of family caregivers of frail elderly patients? Proposed reasons for this dissatisfaction are physicians may be disinterested in caregiver support; even if receptive, counseling sessions may be poorly remunerated; and the professional caregiving role to family caregivers is inherently demanding.",4.026615365066519e-07,0.35972539152153526,0.028223598714500843,0.030828249901291835,0.32668423025504856,0.0,0.030783626196198732,0.33314444652853714,0.0,4.026615365066519e-07,0.33986782562235085,0.0
103,0.9,1,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Question: Can airway surgery reduce serum lipid levels in patients with obstructive sleep apnea? Answer: Studies suggest that airway surgery may help improve serum lipid levels in obstructive sleep apnea patients, though definitive conclusions need more research due to influencing factors like patient lifestyle and postoperative conditions.",1.4211583641411244e-07,0.19330797094543728,0.04960306792653567,0.010880558788691236,0.18677622567044505,0.04434829637641968,0.0108648092457172,0.1593400615353362,0.02271498107084911,1.4211583641411244e-07,0.13062018241706452,0.0
103,0.9,2,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Question: Does performing airway surgery affect serum lipid levels in obstructive sleep apnea sufferers? Answer: Research shows that airway surgery has the potential to improve serum lipid profiles in obstructive sleep apnea patients, but further studies are necessary since outcomes can be affected by lifestyle and postoperative variables.",1.1842986367842703e-07,0.16859571956092223,0.04739923180156416,0.009067132323909363,0.16345790411000838,0.043388429752066124,0.009054007704764333,0.1361670570160456,0.02221074380165289,1.1842986367842703e-07,0.107630664192365,0.0
103,0.9,3,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Question: Is there an impact of airway surgery on serum lipid levels in patients with obstructive sleep apnea? Answer: Evidence points to airway surgery potentially enhancing serum lipid profiles in obstructive sleep apnea patients; however, more research is needed as the effects depend on factors such as lifestyle and postoperative care.",4.737194547137081e-08,0.04241985398663539,0.002279493850551567,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
103,0.9,4,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Question: Does airway surgery contribute to lowering serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery might improve serum lipid profiles in these patients, yet conclusive evidence requires additional studies due to various influencing factors including lifestyle and recovery.",2.1317375462116866e-07,0.17454388954797384,0.01107509983075166,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
103,0.9,5,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Question: Can airway surgery lead to a decrease in serum lipid levels for obstructive sleep apnea patients? Answer: Findings suggest airway surgery may improve serum lipid levels in patients with obstructive sleep apnea, but further investigation is necessary because results can be influenced by lifestyle and postoperative factors.",1.1842986367842703e-07,0.13910009485624375,0.02689387804657739,0.009067132323909363,0.1333210701726193,0.021728395061728398,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
103,0.9,6,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Question: Is there a connection between airway surgery and reduced serum lipid levels in obstructive sleep apnea? Answer: Studies indicate airway surgery could enhance serum lipid profiles in these patients; however, a firm conclusion requires more research given the influence of lifestyle and postoperative conditions.",1.8948778188548325e-07,0.15008894388023064,0.012124577722245372,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
103,0.9,7,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Question: Does airway surgery improve serum lipid profiles in obstructive sleep apnea patients? Answer: Research suggests airway surgery can potentially improve lipid profiles in patients with obstructive sleep apnea, although definitive conclusions require further study due to lifestyle and postoperative factors.",2.8423167282822487e-07,0.32101517974563976,0.04128938045361759,0.02176111757738247,0.3038099958541647,0.025623268698060954,0.0217296184914344,0.27443684570175897,0.0,2.8423167282822487e-07,0.2809023854664012,0.0
103,0.9,8,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Question: Can serum lipid levels be lowered in obstructive sleep apnea patients through airway surgery? Answer: Evidence shows airway surgery might benefit serum lipid profiles, but more research is necessary as outcomes are affected by lifestyle and postoperative influences.",3.316036182995955e-07,0.2701604685769876,0.031179484808040493,0.025387970506946217,0.3209077200800996,0.0,0.025351221573340132,0.32850406697203516,0.0,3.316036182995957e-07,0.3364722366212134,0.0
103,0.9,9,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Question: Will airway surgery affect serum lipid levels in patients suffering from obstructive sleep apnea? Answer: Research indicates a potential improvement in serum lipid profiles from airway surgery, but firm conclusions depend on additional studies considering lifestyle and postoperative factors.",3.079176455639102e-07,0.24324956087742722,0.03185278294708691,0.023574544042164344,0.29423947299793873,0.0,0.023540420032387266,0.30110509278391984,0.0,3.079176455639103e-07,0.30830135965451655,0.0
103,0.9,10,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Question: Is airway surgery effective in reducing serum lipid levels in obstructive sleep apnea patients? Answer: Studies suggest it can improve serum lipid profiles, yet further investigation is required due to variables like patient lifestyle and postoperative recovery.",3.552895910352808e-07,0.29781470026876455,0.0304698788056417,0.02720139697172809,0.3483066942682149,0.0,0.027162023114293,0.356674943938732,0.0,3.552895910352811e-07,0.3654597734944649,0.0
104,0.9,1,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","The use of audits to detect maternal mortality is not solely about the gap between wealthy and impoverished areas; it also reveals factors such as care quality, medical methods, cultural beliefs, and education influencing mortality rates in various regions.",7.816371002776182e-07,0.48104711630642605,0.128662109375,0.059843073337801825,0.5781647139285662,0.042771218534194695,0.0597564508514446,0.6104051208912957,0.028959679215860994,7.816371002776184e-07,0.6437729619055204,0.014702606371129419
104,0.9,2,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Auditing maternal mortality cannot be simply viewed as a rich-versus-poor issue because it uncovers multiple influences including healthcare quality, medical procedures, cultural perspectives, and education across different environments.",1.0421828003701566e-06,0.822796410028483,0.128662109375,0.07979076445040248,0.9309860885513093,0.042771218534194695,0.0796752678019262,0.975048234479206,0.028959679215860994,1.0421828003701579e-06,1.0210671930469886,0.014702606371129419
104,0.9,3,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Using audits to identify maternal mortality goes beyond a mere rich-poor divide; it exposes how care standards, medical practices, cultural norms, and educational levels impact mortality rates in multiple settings.",9.948108548987858e-07,0.7513374460463393,0.128662109375,0.07616391152083873,0.8568781163975876,0.042771218534194695,0.07605366472002045,0.8980871933430765,0.028959679215860994,9.94810854898787e-07,0.9410244853734513,0.014702606371129419
104,0.9,4,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Maternal mortality audits do not only differentiate between affluent and disadvantaged areas; they also shed light on factors like the quality of healthcare, medical approaches, cultural attitudes, and education that affect mortality in varied contexts.",8.763809912203594e-07,0.5922727514166506,0.128662109375,0.06709677919692933,0.6925750651063116,0.042771218534194695,0.06699965701525609,0.7281881565476795,0.028959679215860994,8.7638099122036e-07,0.7651338189097872,0.014702606371129419
104,0.9,5,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","The identification of maternal mortality through audits is not restricted to wealth disparities; these audits also reveal significant roles played by healthcare quality, clinical methods, cultural influences, and educational attainment in different environments.",9.2375293669173e-07,0.652897373233086,0.128662109375,0.07072363212649309,0.7550954220876451,0.042771218534194695,0.07062126009716183,0.7927266776852511,0.028959679215860994,9.237529366917308e-07,0.8318251934084606,0.014702606371129419
104,0.9,6,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Auditing to identify maternal mortality is not purely a question of rich vs. poor; it also uncovers critical factors such as the level of care, medical protocols, cultural values, and education that influence mortality in diverse settings.",8.290090457489888e-07,0.5351143375767022,0.128662109375,0.06346992626736557,0.6337345650833783,0.042771218534194695,0.06337805393335033,0.6675635347312441,0.028959679215860994,8.290090457489892e-07,0.7026134619284536,0.014702606371129419
104,0.9,7,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","The role of audits in recognizing maternal mortality transcends the difference between rich and poor by highlighting care quality, medical practices, cultural outlooks, and education levels as key determinants in varied settings.",9.474389094274153e-07,0.6846460715476659,0.128662109375,0.07253705859127496,0.7878852449106368,0.042771218534194695,0.0724320616381147,0.8266282293609328,0.028959679215860994,9.474389094274162e-07,0.8669165132197296,0.014702606371129419
104,0.9,8,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Identifying maternal mortality through audits is more complex than a simple rich-poor dichotomy; it involves examining quality of care, medical strategy, cultural attitudes, and education across different environments.",1.0421828003701566e-06,0.822796410028483,0.128662109375,0.07979076445040248,0.9309860885513093,0.042771218534194695,0.0796752678019262,0.975048234479206,0.028959679215860994,1.0421828003701579e-06,1.0210671930469886,0.014702606371129419
104,0.9,9,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Audits used to determine maternal mortality do more than distinguish economic disparities; they also emphasize the importance of healthcare quality, clinical practice, cultural perspectives, and education in shaping mortality rates across settings.",9.474389094274153e-07,0.6846460715476659,0.128662109375,0.07253705859127496,0.7878852449106368,0.042771218534194695,0.0724320616381147,0.8266282293609328,0.028959679215860994,9.474389094274162e-07,0.8669165132197296,0.014702606371129419
104,0.9,10,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","The application of audits in maternal mortality is not limited to contrasting wealthy and poor settings; it also brings attention to factors such as quality healthcare, medical methodology, cultural attitudes, and educational background that influence mortality rates widely.",8.053230730133035e-07,0.5077153633885869,0.128662109375,0.0616564998025837,0.6055636881166815,0.042771218534194695,0.061567252392397465,0.6385759978579926,0.028959679215860994,8.053230730133038e-07,0.6727604987787719,0.014702606371129419
105,0.9,1,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","How does gender dimorphism manifest after injury and hemorrhagic shock, and are hormonal differences the cause?",1.0895547458415264e-06,1.3119191148009435,0.0652508464142813,0.08341761737996628,1.4321823265881766,0.016661878770468257,0.08329687088383202,1.5125880864441816,0.0,1.0895547458415283e-06,1.5755363607584183,0.0
105,0.9,2,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.",Is the observed gender dimorphism following injury and hemorrhagic shock driven by hormonal variations?,1.136926691312897e-06,1.4550199584416168,0.0652508464142813,0.08704447030953003,1.5863330064154342,0.016661878770468257,0.08691847396573776,1.6796421711073481,0.0,1.1369266913128989e-06,1.7578579175523736,0.0
105,0.9,3,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.",In what way do hormonal differences contribute to gender dimorphism after injury and hemorrhagic shock?,1.1132407185772118e-06,1.3809119862878956,0.0652508464142813,0.08523104384474815,1.5062902987418978,0.016661878770468257,0.08510767242478488,1.592630794117718,0.0,1.1132407185772135e-06,1.6625477377480484,0.0
105,0.9,4,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.",Are the hormonal differences responsible for the gender-specific responses seen after injury and hemorrhagic shock?,1.1132407185772118e-06,1.3809119862878956,0.0652508464142813,0.08523104384474815,1.5062902987418978,0.016661878770468257,0.08510767242478488,1.592630794117718,0.0,1.1132407185772135e-06,1.6625477377480484,0.0
105,0.9,5,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.",Does gender dimorphism after injury and hemorrhagic shock result from differences in hormone levels?,1.136926691312897e-06,1.4550199584416168,0.0652508464142813,0.08704447030953003,1.5863330064154342,0.016661878770468257,0.08691847396573776,1.6796421711073481,0.0,1.1369266913128989e-06,1.7578579175523736,0.0
105,0.9,6,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.",To what extent do hormonal factors explain gender dimorphism following injury and hemorrhagic shock?,1.136926691312897e-06,1.4550199584416168,0.0652508464142813,0.08704447030953003,1.5863330064154342,0.016661878770468257,0.08691847396573776,1.6796421711073481,0.0,1.1369266913128989e-06,1.7578579175523736,0.0
105,0.9,7,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.",Are hormonal disparities the underlying reason for gender dimorphism observed in injury and hemorrhagic shock scenarios?,1.0895547458415264e-06,1.3119191148009435,0.0652508464142813,0.08341761737996628,1.4321823265881766,0.016661878770468257,0.08329687088383202,1.5125880864441816,0.0,1.0895547458415283e-06,1.5755363607584183,0.0
105,0.9,8,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.",How significant are hormonal differences in causing gender dimorphism after injury and hemorrhagic shock?,1.136926691312897e-06,1.4550199584416168,0.0652508464142813,0.08704447030953003,1.5863330064154342,0.016661878770468257,0.08691847396573776,1.6796421711073481,0.0,1.1369266913128989e-06,1.7578579175523736,0.0
105,0.9,9,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.",Could hormonal differences be the key factor behind gender dimorphism seen after injury and hemorrhagic shock?,1.0895547458415264e-06,1.3119191148009435,0.0652508464142813,0.08341761737996628,1.4321823265881766,0.016661878770468257,0.08329687088383202,1.5125880864441816,0.0,1.0895547458415283e-06,1.5755363607584183,0.0
105,0.9,10,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.",What role do hormonal differences play in the gender dimorphism observed after injury and hemorrhagic shock?,1.0895547458415264e-06,1.3119191148009435,0.0652508464142813,0.08341761737996628,1.4321823265881766,0.016661878770468257,0.08329687088383202,1.5125880864441816,0.0,1.0895547458415283e-06,1.5755363607584183,0.0
106,0.9,1,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,What is the influence of MPH programs on strengthening health systems in low- and middle-income countries? Answer: The impact was notable across multiple levels; graduates were seen as making significant contributions to their workplaces and often held influence nationally. Much of the reported impact aligned with public health education objectives. The qualitative study provided deeper insights into graduates' impact and career paths.,2.3685972735685406e-07,0.15180601286800588,0.0,0.018134264647818754,0.15415067982725894,0.0,0.018108015409528666,0.15656906069154353,0.0,2.3685972735685406e-07,0.15906469462968964,0.0
106,0.9,2,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,How do MPH programs affect health system strengthening in low- and middle-income countries? Answer: There was a substantial impact at various levels; graduates were regarded as valuable contributors to their workplaces and frequently had national-level influence. Most of the impact corresponded with public health education goals. The qualitative research offered a more detailed understanding of graduates' impact and their careers.,2.8423167282822487e-07,0.18514243313559753,0.0,0.0217611175773825,0.18805223150293937,0.0,0.0217296184914344,0.19105523676271208,0.0,2.8423167282822487e-07,0.1941560144409591,0.0
106,0.9,3,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,What is the role of MPH programs in enhancing health systems in low- and middle-income countries? Answer: Significant impact was observed at multiple levels; graduates were perceived as key contributors within their workplaces and often influenced national policy. Much of the described impact was consistent with public health education aims. The qualitative study provided deeper insights into graduates' impact and career development.,2.3685972735685406e-07,0.174532149935545,0.016388888888888894,0.018134264647818754,0.15415067982725894,0.0,0.018108015409528666,0.15656906069154353,0.0,2.3685972735685406e-07,0.15906469462968964,0.0
106,0.9,4,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,How do MPH programs contribute to health system strengthening in low- and middle-income countries? Answer: Considerable impact was evident at many levels; graduates were seen as making significant contributions to their workplaces and frequently held influence at the national level. Most of the impact aligned with public health educational goals. The qualitative study revealed a deeper understanding of graduates' impact and careers.,2.3685972735685406e-07,0.15180601286800588,0.0,0.018134264647818754,0.15415067982725894,0.0,0.018108015409528666,0.15656906069154353,0.0,2.3685972735685406e-07,0.15906469462968964,0.0
106,0.9,5,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,What impact do MPH programs have on health system strengthening in low- and middle-income countries? Answer: There was notable impact across various levels; graduates were viewed as significant contributors to their workplaces and often had national influence. Much of the impact matched the aims of public health education. The qualitative method study uncovered a more in-depth understanding of graduates' impact and their career paths.,1.8948778188548325e-07,0.1195451506497811,0.0,0.014507411718255009,0.1213608570042668,0.0,0.014486412327622933,0.12323264042395188,0.0,1.8948778188548325e-07,0.1251631429540092,0.0
106,0.9,6,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,How significant is the impact of MPH programs on strengthening health systems in low- and middle-income countries? Answer: Impact was considerable at multiple levels; graduates were perceived to contribute significantly at work and often influence nationally. Much of the impact aligned with public health educational objectives. The qualitative study provided deeper insight into graduates' impact and careers.,3.552895910352811e-07,0.2620834427547365,0.017851239669421492,0.027201396971728117,0.2411620568168873,0.0,0.027162023114293,0.24512245803298693,0.0,3.552895910352811e-07,0.24921579162398766,0.0
106,0.9,7,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,What effect do MPH programs have on health system strengthening within low- and middle-income countries? Answer: There was a significant impact at many levels; graduates were seen as important contributors to their workplaces and often had influence at the national level. Much of the impact was consistent with public health educational goals. The qualitative research revealed deeper understanding of graduates' impact and career progression.,1.8948778188548325e-07,0.1195451506497811,0.0,0.014507411718255009,0.1213608570042668,0.0,0.014486412327622933,0.12323264042395188,0.0,1.8948778188548325e-07,0.1251631429540092,0.0
106,0.9,8,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,In what ways do MPH programs impact health system strengthening in low- and middle-income countries? Answer: Considerable impact was reported on multiple levels; graduates were perceived as key contributors to their workplaces and often influenced national-level policies. Much of the impact corresponded with public health education objectives. The qualitative study offered deeper insights into graduates' impact and their career trajectories.,2.8423167282822487e-07,0.18514243313559753,0.0,0.0217611175773825,0.18805223150293937,0.0,0.0217296184914344,0.19105523676271208,0.0,2.8423167282822487e-07,0.1941560144409591,0.0
106,0.9,9,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,How do graduates of MPH programs contribute to health system strengthening in low- and middle-income countries? Answer: There was notable impact at various levels; graduates were viewed as significant contributors at their workplaces and frequently had national influence. Much of the impact aligned with the goals of public health education. The qualitative study revealed a more in-depth understanding of graduates' impact and careers.,2.1317375462116866e-07,0.13554549199622468,0.0,0.01632083818303688,0.137621377876048,0.0,0.0162972138685758,0.13976194237516282,0.0,2.1317375462116866e-07,0.14197026127038992,0.0
106,0.9,10,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,What is the contribution of MPH programs to health system strengthening in low- and middle-income countries? Answer: The impact was considerable at many levels; graduates were perceived to make significant contributions to their workplaces and often had influence at the national level. Much of the impact described aligned with public health educational aims. The qualitative study provided deeper understanding of graduates' impact and career progression.,1.6580180914979784e-07,0.12545764307414142,0.015621063240110858,0.012693985253473136,0.10536051565782323,0.0,0.012675610786670066,0.10697211955217067,0.0,1.6580180914979784e-07,0.10863384100279827,0.0
107,0.9,1,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Could the scope of lymphadenectomy be altered by neoadjuvant chemotherapy in cervical cancer? The occurrence and location of lymph node metastases remain unchanged by NACT, with clinical non-responders exhibiting more affected lymph nodes. Therefore, a comprehensive systemic lymphadenectomy is advised for patients undergoing NACT followed by surgery, irrespective of their response to NACT.",4.737194547137081e-08,0.012068210184330574,0.01851192595229618,0.0036268529295637453,0.038466280827795796,0.0,0.003621603081905733,0.03922071315328246,0.0,4.737194547137081e-08,0.04000533461369837,0.0
107,0.9,2,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Is it possible to change the extent of lymphadenectomy through neoadjuvant chemotherapy in cervical cancer? The frequency and distribution of lymph node metastases are not affected by NACT; patients who do not respond clinically have more involved lymph nodes. Hence, patients receiving NACT and surgery should undergo extensive systemic lymphadenectomy regardless of NACT response.",2.3685972735685406e-08,0.006979984786362525,0.01851192595229618,0.0018134264647818726,0.0190481949706931,0.0,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
107,0.9,3,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Can neoadjuvant chemotherapy influence the extent of lymphadenectomy in cervical cancer? NACT does not alter the frequency or anatomical distribution of lymph node metastasis, and those with no clinical response have greater lymph node involvement. Thus, comprehensive lymphadenectomy should be performed in all patients treated with both NACT and surgery, regardless of their response to chemotherapy.",2.3685972735685406e-08,0.01881590444635073,0.0003363429618983803,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
107,0.9,4,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Does neoadjuvant chemotherapy modify lymphadenectomy extent in cervical cancer? The pattern and frequency of lymph node metastasis remain unchanged after NACT, with clinical non-responders showing increased lymph node involvement. Consequently, patients treated with NACT plus surgery should always have a wide and systemic lymphadenectomy regardless of how they respond to NACT.",9.474389094274162e-08,0.07901481056001103,0.0014797441851465525,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
107,0.9,5,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Is the extent of lymphadenectomy in cervical cancer patients affected by neoadjuvant chemotherapy? The rate and topographic spread of lymph node metastases are not modified by NACT, and clinical non-responders have more affected nodes. Therefore, a systemic and extensive lymphadenectomy is recommended for all patients who undergo NACT followed by surgery, irrespective of their response status.",2.3685972735685406e-08,0.04402125646671262,0.01851192595229618,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
107,0.9,6,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Can the lymphadenectomy extent be adjusted after neoadjuvant chemotherapy in cervical cancer? The frequency and locations of lymph node metastases remain consistent post-NACT, with more involved nodes found in clinical non-responders. Accordingly, an extensive systemic lymphadenectomy is warranted for all patients treated with NACT and surgery regardless of the response.",1.1842986367842703e-07,0.07149163065513164,0.01851192595229618,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
107,0.9,7,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Does neoadjuvant chemotherapy change how far lymphadenectomy should extend in cervical cancer cases? NACT does not impact the frequency or site distribution of lymph node metastases, and clinical non-responders show more lymph node involvement. Thus, a thorough systemic lymphadenectomy is necessary for patients receiving NACT plus surgery, no matter their response.",9.474389094274162e-08,0.07901481056001103,0.0014797441851465525,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
107,0.9,8,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Could lymphadenectomy be tailored after neoadjuvant chemotherapy in cervical cancer? The frequency and anatomical distribution of lymph node metastases remain unaffected by NACT; those not responding clinically display increased lymph node involvement. Therefore, all patients treated with NACT and surgery require systemic and extensive lymphadenectomy regardless of response.",1.6580180914979784e-07,0.14265995176037904,0.0027546146904259237,0.012693985253473108,0.14165051706302645,0.0,0.012675610786670066,0.14458122881110835,0.0,1.6580180914979784e-07,0.14763599880606337,0.0
107,0.9,9,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Is neoadjuvant chemotherapy a factor in changing lymphadenectomy extent in cervical cancer? The occurrence and location of lymph node metastases do not vary with NACT, and clinical non-responders exhibit higher lymph node involvement. Hence, a systemic, extensive lymphadenectomy should be carried out for patients treated with NACT plus surgery, irrespective of treatment response.",4.737194547137081e-08,0.03872771712894396,0.0007114496724635287,0.0036268529295637453,0.038466280827795796,0.0,0.003621603081905733,0.03922071315328246,0.0,4.737194547137081e-08,0.04000533461369837,0.0
107,0.9,10,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Can the scope of lymphadenectomy be influenced by neoadjuvant chemotherapy in cervical cancer? NACT does not modify the frequency or site-specific spread of lymph node metastases, and patients who fail to respond clinically have more involved nodes. Thus, extensive systemic lymphadenectomy is recommended for all patients undergoing NACT and surgery, regardless of their response outcome.",0.0,0.025672117798516858,0.01851192595229618,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
108,0.9,1,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Are doctors fulfilling the requirements of family caregivers for the elderly who are frail? Although some doctors effectively meet the needs of family caregivers of frail elderly patients, this is not always the case. Time constraints during visits, limited resources, and knowledge gaps often hinder their capacity to support caregivers fully. Improvements in training and policy are needed.",1.1842986367842703e-07,0.020927092269878322,0.04498330064686146,0.009067132323909363,0.042099018684113254,0.031197511816904302,0.009054007704764333,0.04080156495229925,0.033293697978596916,1.1842986367842703e-07,0.06505688274619104,0.01694411414982164
108,0.9,2,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Do physicians adequately support family caregivers of frail elderly individuals? While certain physicians do address these caregivers' needs well, this is not consistently true. Factors such as limited appointment time, insufficient resources, and knowledge deficits can impede their ability to provide full support. Enhanced training and policy reforms are necessary.",3.079176455639103e-07,0.12351615458608567,0.08002462296091106,0.023574544042164344,0.17149444206280196,0.049048751486325794,0.023540420032387266,0.19798714847471244,0.033293697978596916,3.079176455639103e-07,0.22539953282137182,0.01694411414982164
108,0.9,3,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","To what extent are physicians addressing the needs of family caregivers for frail elderly patients? Some physicians do meet these needs effectively, but this is not uniform. Challenges including time pressure during consultations, lack of resources, and insufficient knowledge can limit their support. Training enhancements and policy updates are needed.",3.079176455639103e-07,0.12351615458608567,0.08002462296091106,0.023574544042164344,0.17149444206280196,0.049048751486325794,0.023540420032387266,0.19798714847471244,0.033293697978596916,3.079176455639103e-07,0.22539953282137182,0.01694411414982164
108,0.9,4,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Are the needs of family caregivers of frail elderly patients being met by physicians? Some doctors do adequately address these needs, but it is not consistent. Constraints like appointment time limitations, resource shortages, and knowledge gaps may restrict their support. Revisions in training and policies are essential.",3.789755637709665e-07,0.18669505620761795,0.08002462296091106,0.029014823436509962,0.23603296320037348,0.049048751486325794,0.028972824655245866,0.2639451162665085,0.033293697978596916,3.789755637709665e-07,0.29284081361690406,0.01694411414982164
108,0.9,5,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","How well do physicians meet the needs of family caregivers of the frail elderly? Certain physicians provide adequate support, but this is not universal. Barriers such as insufficient time during appointments, lack of resources, and knowledge deficits can reduce their ability to help. Policy changes and better training are needed.",3.079176455639103e-07,0.12351615458608567,0.08002462296091106,0.023574544042164344,0.17149444206280196,0.049048751486325794,0.023540420032387266,0.19798714847471244,0.033293697978596916,3.079176455639103e-07,0.22539953282137182,0.01694411414982164
108,0.9,6,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Are family caregivers of frail elderly individuals receiving sufficient support from physicians? While some physicians meet their needs effectively, it is not always consistent. Time constraints, resource inadequacies, and gaps in knowledge can limit effective support. Changes in training and policies are required.",4.737194547137081e-07,0.2776668344133446,0.08002462296091106,0.03626852929563745,0.32912338626638515,0.049048751486325794,0.03621603081905733,0.3592552960708342,0.033293697978596916,4.737194547137081e-07,0.3904792831808219,0.01694411414982164
108,0.9,7,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Do physicians consistently meet the needs of family caregivers for the frail elderly? Although some physicians do so well, this is not uniform. Issues like limited appointment time, scarce resources, and knowledge shortfalls may restrict their ability to fully assist caregivers. Training improvements and policy adjustments are necessary.",3.552895910352811e-07,0.1651888509866546,0.08002462296091106,0.02720139697172809,0.21405405648159848,0.049048751486325794,0.027162023114293,0.2414722604144508,0.033293697978596916,3.552895910352811e-07,0.26985129539220454,0.01694411414982164
108,0.9,8,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Are physicians adequately addressing the needs of family caregivers of the frail elderly? Some do, but consistency is lacking. Challenges such as appointment time restrictions, insufficient resources, and knowledge gaps can prevent full support. Training and policy reforms are needed to improve this.",4.737194547137081e-07,0.2776668344133446,0.08002462296091106,0.03626852929563745,0.32912338626638515,0.049048751486325794,0.03621603081905733,0.3592552960708342,0.033293697978596916,4.737194547137081e-07,0.3904792831808219,0.01694411414982164
108,0.9,9,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Is the support provided by physicians to family caregivers of frail elderly individuals sufficient? In some cases yes, but not consistently. Time limitations during appointments, inadequate resources, and lack of knowledge can hinder support. Enhancements in policy and physician training are necessary.",4.974054274493935e-07,0.3017643859924046,0.08002462296091106,0.038081955760419325,0.35381599885675685,0.049048751486325794,0.0380268323600102,0.3845731040551259,0.033293697978596916,4.974054274493935e-07,0.4164547695840799,0.01694411414982164
108,0.9,10,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Are physicians meeting family caregivers' needs for the frail elderly effectively? Some physicians do, yet it is not consistent across all cases. Constraints like limited appointment time, insufficient resources, and knowledge gaps can restrict their ability. Policy changes and better training are essential.",4.737194547137081e-07,0.2776668344133446,0.08002462296091106,0.03626852929563745,0.32912338626638515,0.049048751486325794,0.03621603081905733,0.3592552960708342,0.033293697978596916,4.737194547137081e-07,0.3904792831808219,0.01694411414982164
109,0.9,1,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,"Is neck pain linked to a decline in health-related quality of life six months later? Our findings indicate that neck pain adversely affects physical HRQoL, but not mental HRQoL. The data imply neck pain could lead to poorer physical HRQoL in the future. Increasing awareness about the potential long-term effects of neck pain is important.",2.3685972735685406e-08,0.010702599166914517,0.06151480199923123,0.0018134264647818726,0.006979984786362525,0.018511925952296185,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
109,0.9,2,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,"Does neck pain correlate with a lower health-related quality of life after six months? We observed that neck pain was associated with worse physical health-related quality of life, though mental HRQoL remained unaffected. This suggests neck pain might contribute to future declines in physical HRQoL. Promoting understanding of neck pain's possible future impact is recommended.",2.3685972735685406e-08,0.020392379606999356,0.002104421376393717,0.0018134264647818726,0.019176512593258366,0.00034902079326594795,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
109,0.9,3,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,"Is there a relationship between neck pain and reduced health-related quality of life half a year later? Our study found neck pain to be negatively linked with physical, but not mental, HRQoL. These results imply that neck pain may lead to diminished physical HRQoL over time. Awareness about the potential future consequences of neck pain should be increased.",4.737194547137081e-08,0.048769278481995304,0.05208466828997413,0.0036268529295637453,0.062039761969391094,0.018511925952296185,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
109,0.9,4,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,"Does experiencing neck pain predict poorer health-related quality of life six months later? We discovered that neck pain was associated with worse physical health quality, with no significant effect on mental health. This analysis suggests neck pain could be a factor in future physical HRQoL declines. Highlighting the possible future impact of neck pain is vital.",0.0,0.009513602613901107,0.058252942086452764,0.0,0.025672117798516858,0.018511925952296185,0.0,0.0,0.0,0.0,0.0,0.0
109,0.9,5,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,"Is neck pain associated with a decline in health-related quality of life six months afterwards? Our findings show a negative association between neck pain and physical health-related quality of life, but not mental HRQoL. The evidence suggests neck pain may contribute to future deterioration in physical HRQoL. Raising awareness about this potential consequence is important.",2.3685972735685406e-08,0.020392379606999356,0.002104421376393717,0.0018134264647818726,0.019176512593258366,0.00034902079326594795,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
109,0.9,6,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Can neck pain affect health-related quality of life six months later? Our analysis revealed that neck pain negatively impacted physical HRQoL but did not affect mental HRQoL. Neck pain might therefore be a contributor to poorer physical quality of life in the future. It's important to inform people about the potential long-term effects of neck pain.,0.0,0.0,0.0,0.0,0.0,3.469446951953614e-18,0.0,0.0,0.0,0.0,0.0,0.0
109,0.9,7,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,"Is there an association between neck pain and health-related quality of life six months later? We found that neck pain was linked with poorer physical HRQoL, but mental HRQoL remained unchanged. These findings suggest that neck pain could lead to future declines in physical health quality. Raising awareness of neck pain's possible future impact is crucial.",0.0,0.025205352020361893,0.01867013483662401,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
109,0.9,8,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,"Does neck pain relate to worsened health-related quality of life six months on? Our results indicate that neck pain negatively correlates with physical health-related quality of life, but not mental. This suggests neck pain may contribute to future physical HRQoL impairment. Emphasizing the potential long-term impact of neck pain is needed.",1.1842986367842703e-07,0.1513304924433645,0.12060318680849233,0.009067132323909363,0.09978335231063973,0.001887379603259371,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
109,0.9,9,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Is experiencing neck pain associated with lower health-related quality of life after six months? Study findings show neck pain adversely affects physical HRQoL but has no effect on mental HRQoL. The data imply neck pain might be a factor in future physical health decline. Increasing awareness about neck pain's future implications is necessary.,7.105791820705622e-08,0.009135934148086555,0.03309557862360632,0.005440279394345618,0.03148629604143327,0.018511925952296185,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
109,0.9,10,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,"Is neck pain connected to poorer health-related quality of life six months later? Our research found a negative association between neck pain and physical, but not mental, HRQoL. This suggests neck pain may contribute to future physical health deterioration. It is important to raise awareness of the possible future effects of neck pain.",7.105791820705622e-08,0.009135934148086555,0.03309557862360632,0.005440279394345618,0.03148629604143327,0.018511925952296185,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
110,0.9,1,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: What is the clinical importance of bile duct sludge? Is it different from bile duct stones? Answer: The results suggest that the clinical significance of symptomatic bile duct sludge is comparable to that of common bile duct stones. Bile duct sludge appears to represent an early phase of choledocholithiasis.,1.4211583641411244e-07,0.08317396091217288,0.23223716046256962,0.010880558788691236,0.17066427729737654,0.02667609778180173,0.0108648092457172,0.1703875925940399,0.024375,1.4211583641411244e-07,0.13976194237515838,0.0
110,0.9,2,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: How clinically significant is bile duct sludge compared to bile duct stones? Answer: Findings show that the clinical relevance of symptomatic bile duct sludge parallels that of common bile duct stones. Bile duct sludge may be considered an initial stage of choledocholithiasis.,2.3685972735685406e-08,0.1202369750061143,0.36088027085257024,0.0018134264647818726,0.0384697994073715,0.052434253780407655,0.0018108015409528666,0.009119444997918169,0.024375,2.3685972735685406e-08,0.02531780798429173,0.0
110,0.9,3,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Does bile duct sludge have clinical significance distinct from bile duct stones? Answer: Evidence indicates that symptomatic bile duct sludge has a similar clinical significance to common bile duct stones. It is likely that bile duct sludge is an early form of choledocholithiasis.,0.0,0.12266513581234229,0.3786271844328172,0.0,0.01245828913725111,0.04999999999999999,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0
110,0.9,4,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: What differentiates the clinical significance of bile duct sludge from bile duct stones? Answer: The clinical significance of symptomatic bile duct sludge aligns closely with that of common bile duct stones. Bile duct sludge is thought to be a precursor stage of choledocholithiasis.,0.0,0.1871439433062907,0.43950387715783745,0.0,0.07847230633343827,0.09931440443213291,0.0,0.0,0.0,0.0,0.0,0.0
110,0.9,5,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Is the clinical impact of bile duct sludge different from that of bile duct stones? Answer: The findings reveal that symptomatic bile duct sludge has clinical significance comparable to common bile duct stones. Bile duct sludge appears to be an early stage in the development of choledocholithiasis.,9.474389094274162e-08,0.00852354630392238,0.32747749307479246,0.0072537058591274906,0.05520033394268875,0.06391157382368849,0.007243206163811466,0.12690248065430154,0.024375,9.474389094274162e-08,0.09531017980432566,0.0
110,0.9,6,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,"Question: How does the clinical significance of bile duct sludge compare with bile duct stones? Answer: Studies indicate the clinical significance of symptomatic bile duct sludge is similar to that of common bile duct stones, suggesting that bile duct sludge represents an early stage of choledocholithiasis.",4.737194547137081e-08,0.12565892373957555,0.4094913819636812,0.0036268529295637453,0.025384730538107192,0.09250000000000003,0.003621603081905733,0.0492007028305701,0.0011323696145124768,4.737194547137081e-08,0.048790164169431716,0.0
110,0.9,7,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: What is the clinical relevance of bile duct sludge versus bile duct stones? Answer: The data suggest that symptomatic bile duct sludge shares clinical significance akin to common bile duct stones and may represent an initial phase of choledocholithiasis.,9.474389094274152e-08,0.10200293564357166,0.1057555542992821,0.0072537058591274906,0.07055087191658371,0.02120343316289264,0.007243206163811466,0.0688420964717924,0.024375,9.474389094274162e-08,0.10536051565782589,0.0
110,0.9,8,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Is there a difference in clinical significance between bile duct sludge and bile duct stones? Answer: Findings show that symptomatic bile duct sludge holds clinical importance comparable to that of common bile duct stones; bile duct sludge may be an early stage of choledocholithiasis.,2.3685972735685406e-08,0.06144095674332384,0.33448753462603875,0.0018134264647818726,0.01289714562953348,0.04768143961927421,0.0018108015409528666,0.057909609167349885,0.024375,2.3685972735685406e-08,0.0246926125903717,0.0
110,0.9,9,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: How significant is bile duct sludge clinically compared to bile duct stones? Answer: The evidence suggests that the clinical significance of symptomatic bile duct sludge is on par with common bile duct stones and that bile duct sludge likely represents an early stage of choledocholithiasis.,4.737194547137081e-08,0.033239299664916455,0.3222543668420509,0.0036268529295637453,0.0376286495127971,0.04547052154195008,0.003621603081905733,0.0814401065775443,0.024375,4.737194547137081e-08,0.048790164169431716,0.0
110,0.9,10,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Does bile duct sludge differ clinically from bile duct stones? Answer: Clinical findings indicate that symptomatic bile duct sludge has similar significance to common bile duct stones and appears to be an initial stage of choledocholithiasis.,1.6580180914979742e-07,0.19685648050855864,0.1299774930747923,0.012693985253473108,0.15591594991548163,0.018953287197231855,0.012675610786670073,0.15339948449985608,0.024375,1.6580180914979784e-07,0.19237189264745602,0.0
111,0.9,1,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Does a previous benign prostate biopsy forecast the outcome for patients undergoing radical perineal prostatectomy? Prior benign prostate biopsy does not directly determine the outcome for patients treated with radical perineal prostatectomy, although it offers useful patient information.",9.474389094274131e-08,0.02315012675788708,0.04606102855098851,0.0072537058591274906,0.021716467444830467,0.08448117539026632,0.007243206163811466,0.02990805133947827,0.09688581314878891,9.474389094274162e-08,0.0017813434428641806,0.0783673469387755
111,0.9,2,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,Can prior benign prostate biopsy predict the results for patients receiving radical perineal prostatectomy? A prior benign prostate biopsy does not directly predict the outcomes for such patients but can provide important insights about the patient's condition.,1.1842986367842661e-07,0.020222683255312734,0.0927734375,0.009067132323909363,0.029853299936036137,0.11019283746556477,0.00905400770476434,0.00024443877841173745,0.09604776929407313,1.1842986367842703e-07,0.03163430659254596,0.0783673469387755
111,0.9,3,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Is the outcome for patients treated with radical perineal prostatectomy influenced by a prior benign prostate biopsy? Prior benign prostate biopsy does not directly predict patient outcomes post radical perineal prostatectomy, but it may supply valuable data regarding the patient.",4.7371945471370706e-08,0.14766006994149405,0.1257595486111111,0.0036268529295637453,0.15482678825264484,0.1408292366523325,0.003621603081905733,0.12508631281200167,0.12543252595155707,4.737194547137081e-08,0.05537707039708417,0.0783673469387755
111,0.9,4,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Does having a prior benign prostate biopsy affect the prognosis for patients who undergo radical perineal prostatectomy? Prior benign prostate biopsy itself does not predict patient outcomes after this surgery, though it offers valuable clinical information.",1.421158364141119e-07,0.02725928212658202,0.1171875,0.010880558788691243,0.0014641434264932585,0.10853205348943987,0.010864809245717214,0.031332958399679534,0.09515908845155707,1.4211583641411244e-07,0.062405965259299645,0.0783673469387755
111,0.9,5,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,Does a history of benign prostate biopsy serve as a predictor for outcomes in patients treated with radical perineal prostatectomy? Prior benign prostate biopsy does not directly impact the outcome but provides helpful patient details.,1.658018091497972e-07,0.03555024908176385,0.1435546875,0.012693985253473122,0.008220700514589119,0.13685236598943987,0.012675610786670087,0.020095697032497473,0.12543252595155707,1.6580180914979784e-07,0.09415466357387947,0.0783673469387755
111,0.9,6,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Can the outcome of radical perineal prostatectomy be anticipated by previous benign prostate biopsy results? Previous benign prostate biopsy does not directly forecast the outcome, although it can yield useful patient information.",2.368597273568531e-07,0.10943386274260547,0.10648517219387753,0.01813426464781876,0.13750018333045944,0.10079927287719499,0.018108015409528708,0.1663390236774709,0.09099375044135298,2.3685972735685406e-07,0.19593735788382194,0.0783673469387755
111,0.9,7,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,Is prior benign prostate biopsy a predictor of the outcome for radical perineal prostatectomy patients? It does not directly predict outcomes for such patients but can offer relevant insights about the patient.,2.368597273568531e-07,0.024723656075448464,0.2021484375,0.01813426464781876,0.045080559255800345,0.16712580348943987,0.018108015409528708,0.11853576984575076,0.12543252595155707,2.3685972735685406e-07,0.19593735788382194,0.0783673469387755
111,0.9,8,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Does prior benign prostate biopsy status predict treatment results for patients undergoing radical perineal prostatectomy? It does not directly predict results, but it can contribute valuable information about the patient's condition.",2.605457000925384e-07,0.008066166747543235,0.2021484375,0.01994769111260064,0.07898211093148211,0.16712580348943987,0.01991881695048158,0.15362708965701977,0.12543252595155707,2.6054570009253947e-07,0.23230500205469662,0.0783673469387755
111,0.9,9,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,Can outcomes following radical perineal prostatectomy be predicted by a previous benign prostate biopsy? A prior benign biopsy does not directly dictate outcomes but can provide important patient-related information.,3.07917645563909e-07,0.077059038234494,0.2021484375,0.0235745440421644,0.1504410749136258,0.16712580348943987,0.02354042003238733,0.22773506181074143,0.12543252595155707,3.079176455639103e-07,0.30926604319082607,0.0783673469387755
111,0.9,10,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Does a previous benign prostate biopsy influence the outcome for patients treated by radical perineal prostatectomy? Prior benign prostate biopsy doesn't directly predict outcomes, yet it supplies useful patient information.",2.842316728282237e-07,0.13757422608666525,0.13356133187585734,0.02176111757738252,0.16358394363989026,0.1314605085648857,0.021729618491434455,0.18999473382789445,0.12543252595155707,2.8423167282822487e-07,0.2700453300375436,0.0783673469387755
112,0.9,1,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Advanced epithelial ovarian cancer in Thai women: is it still advisable to perform second-look laparotomy? The second-look laparotomy does not improve overall or disease-free survival rates. Tumor grade remains the sole independent prognostic factor for patient survival.,1.1842986367842661e-07,0.1300531282481976,0.0,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
112,0.9,2,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"In cases of advanced epithelial ovarian carcinoma among Thai women, should second-look laparotomy be maintained? Second-look laparotomy shows no beneficial effect on overall survival or disease-free survival, with tumor grade being the only independent predictor of survival.",1.1842986367842661e-07,0.16856130494597243,0.02775510204081633,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
112,0.9,3,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"For Thai women with advanced epithelial ovarian carcinoma, is continuing second-look laparotomy justified? There is no positive impact of second-look laparotomy on overall or disease-free survival. The tumor grade is the only independent prognostic indicator for survival outcomes.",9.474389094274131e-08,0.1401215692254847,0.027006172839506164,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
112,0.9,4,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Should second-look laparotomy still be offered to Thai women with advanced epithelial ovarian carcinoma? It does not favorably influence overall survival or survival without disease. Survival is independently predicted only by tumor grade.,2.131737546211678e-07,0.2478361639045814,0.0,0.01632083818303688,0.25489224962878954,0.0,0.016297213868575834,0.2623642644674895,0.0,2.1317375462116866e-07,0.2702903297399133,0.0
112,0.9,5,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"In Thai women with advanced epithelial ovarian carcinoma, should second-look laparotomy continue to be an option? The procedure does not benefit overall or disease-free survival, and tumor grade stands as the only independent prognostic factor.",1.658018091497972e-07,0.18721154208814594,0.0,0.012693985253473122,0.19237189264745602,0.0,0.012675610786670087,0.19782574332991798,0.0,1.6580180914979784e-07,0.20359895524123983,0.0
112,0.9,6,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Is the practice of second-look laparotomy warranted for advanced epithelial ovarian carcinoma in Thai women? This procedure does not improve overall or disease-free survival, with tumor grade as the sole independent survival predictor.",2.131737546211678e-07,0.2478361639045814,0.0,0.01632083818303688,0.25489224962878954,0.0,0.016297213868575834,0.2623642644674895,0.0,2.1317375462116866e-07,0.2702903297399133,0.0
112,0.9,7,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Regarding advanced epithelial ovarian carcinoma in Thai women, should second-look laparotomy be continued? It has no favorable effect on either overall or disease-free survival, while tumor grade independently forecasts patient survival.",2.605457000925384e-07,0.31237468504215293,0.0,0.01994769111260064,0.321583624127463,0.0,0.01991881695048158,0.3313571359544403,0.0,2.6054570009253947e-07,0.341749293722057,0.0
112,0.9,8,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Should advanced epithelial ovarian carcinoma in Thai women be managed by continuing second-look laparotomy? The surgery offers no improvement in overall survival or disease-free survival, with tumor grade being the singular independent prognostic factor.",1.894877818854825e-07,0.21706450523782772,0.0,0.014507411718255002,0.2231435513142097,0.0,0.01448641232762296,0.2295744416444978,0.0,1.8948778188548325e-07,0.23638877806423153,0.0
112,0.9,9,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"For Thai women suffering from advanced epithelial ovarian carcinoma, does second-look laparotomy remain beneficial? There is no positive impact on overall or disease-free survival; tumor grade is the only independent prognostic variable.",2.368597273568531e-07,0.27958486221916123,0.0,0.01813426464781876,0.28768207245178123,0.0,0.018108015409528708,0.29626581614317127,0.0,2.3685972735685406e-07,0.3053816495511823,0.0
112,0.9,10,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Is it appropriate to keep offering second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women? This procedure does not positively affect overall or disease-free survival, and tumor grade is the only independent predictor of patient survival.",1.1842986367842661e-07,0.1300531282481976,0.0,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
113,0.9,1,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.","Can bedside assessment alone definitively rule out aspiration after an acute stroke? Bedside assessment by itself cannot reliably exclude aspiration following acute stroke. Although it is helpful as an initial screening step, it requires complementary diagnostic tests such as instrumental swallowing evaluations to fully and accurately identify aspiration risk.",1.1842986367842703e-07,0.023346045649078384,0.05414486079721195,0.009067132323909363,0.047777102982143216,0.03840000000000001,0.009054007704764333,0.07600199386033113,0.019599999999999992,1.1842986367842703e-07,0.10536051565782589,0.0
113,0.9,2,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Is bedside assessment sufficient to reliably exclude aspiration after acute stroke? Bedside assessment alone is not reliable enough to exclude aspiration after an acute stroke. It functions as an initial screening method but must be complemented with diagnostic tools like instrumental swallowing studies for accurate detection of aspiration risk.,1.1842986367842703e-07,0.08110831069574065,0.012746540793188016,0.009067132323909363,0.0772727276868217,0.01713345935727791,0.009054007704764333,0.07600199386033113,0.019599999999999992,1.1842986367842703e-07,0.10536051565782589,0.0
113,0.9,3,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.","Does bedside assessment reliably rule out aspiration post-acute stroke? Bedside assessment cannot by itself reliably exclude aspiration following an acute stroke. While it is a useful first screening procedure, it needs to be supplemented with diagnostic techniques such as instrumental swallowing assessments to accurately identify aspiration risk.",1.6580180914979784e-07,0.06716136148193286,0.05324036795368184,0.012693985253473108,0.09126221492188158,0.03840000000000001,0.012675610786670066,0.12045375643116385,0.019599999999999992,1.6580180914979784e-07,0.15082288973458313,0.0
113,0.9,4,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.","Can we rely on bedside assessment alone to exclude aspiration after an acute stroke? Bedside assessment on its own is insufficient to reliably rule out aspiration post-acute stroke. It serves as a preliminary screening tool but must be paired with other diagnostic methods, including instrumental swallowing evaluations, to comprehensively and accurately detect aspiration risk.",0.0,0.07846949213886134,0.05610781626984811,0.0,0.053319013889226774,0.03840000000000001,0.0,0.027182242374899523,0.019599999999999992,0.0,0.0,0.0
113,0.9,5,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Is bedside assessment a dependable method to exclude aspiration following an acute stroke? Bedside assessment cannot reliably exclude aspiration on its own after an acute stroke. It is valuable as an initial screening but requires additional diagnostic approaches like instrumental swallowing evaluations for accurate aspiration risk identification.,1.6580180914979784e-07,0.12743502935671103,0.010068817098698488,0.012693985253473108,0.09126221492188158,0.03840000000000001,0.012675610786670066,0.12045375643116385,0.019599999999999992,1.6580180914979784e-07,0.15082288973458313,0.0
113,0.9,6,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.","Does excluding aspiration after an acute stroke depend solely on bedside assessment? Bedside assessment by itself cannot reliably exclude aspiration after an acute stroke. It is beneficial as an initial screen, yet it must be combined with other diagnostic measures such as instrumental swallowing tests for thorough and accurate detection of aspiration.",4.737194547137081e-08,0.015387018434012578,0.016375013015410236,0.0036268529295637453,0.04135347370885123,0.0015305555555555558,0.003621603081905733,0.041114813894306934,0.0007993055555555635,4.737194547137081e-08,0.04082199452025437,0.0
113,0.9,7,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Can bedside assessment independently exclude aspiration following acute stroke? Bedside assessment cannot independently exclude aspiration with reliability after an acute stroke. It acts as an initial screening procedure but needs to be augmented by other diagnostic tools like instrumental swallowing assessments to ensure comprehensive and precise identification of aspiration risk.,9.474389094274162e-08,0.058720790889535746,0.014004679839606862,0.0072537058591274906,0.05560482630764074,0.017576097781801726,0.007243206163811466,0.05449578863936777,0.019599999999999992,9.474389094274162e-08,0.08338160893905089,0.0
113,0.9,8,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Is bedside assessment adequate to rule out aspiration after acute stroke? Bedside assessment alone does not reliably exclude aspiration following acute stroke. It is useful as a first screening method but requires combination with further diagnostic techniques such as instrumental swallowing evaluations to fully and accurately identify aspiration risk.,1.1842986367842703e-07,0.023346045649078384,0.05414486079721195,0.009067132323909363,0.047777102982143216,0.03840000000000001,0.009054007704764333,0.07600199386033113,0.019599999999999992,1.1842986367842703e-07,0.10536051565782589,0.0
113,0.9,9,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.","Can we conclusively exclude aspiration after acute stroke using only bedside assessment? Bedside assessment cannot conclusively exclude aspiration following acute stroke by itself. While it is an important initial screening step, it must be integrated with additional diagnostic evaluations like instrumental swallowing studies for comprehensive and precise aspiration risk determination.",9.474389094274162e-08,0.058720790889535746,0.014004679839606862,0.0072537058591274906,0.05560482630764074,0.017576097781801726,0.007243206163811466,0.05449578863936777,0.019599999999999992,9.474389094274162e-08,0.08338160893905089,0.0
113,0.9,10,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.","Is bedside assessment enough to reliably exclude aspiration post-acute stroke? Bedside assessment is not enough on its own to reliably exclude aspiration after an acute stroke. It provides initial screening value but must be supplemented with other diagnostic methods, including instrumental swallowing evaluations, for thorough and accurate aspiration risk assessment.",9.474389094274162e-08,0.08701251254504383,0.006018891305577423,0.0072537058591274906,0.08448595883097187,0.0031879017013232494,0.007243206163811466,0.08399141334404625,0.0016665406427221093,9.474389094274162e-08,0.08338160893905089,0.0
114,0.9,1,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the Catholic bishops' boycott call impact polio vaccination rates in Kenya in 2015? Yes, their boycott call notably reduced polio vaccination coverage in Kenya in 2015, causing lower immunization rates and increased vaccine skepticism, which contributed to a public health crisis.",3.552895910352811e-07,0.14996477700116673,0.10192636236862274,0.02720139697172809,0.15146827398363794,0.1162568168174603,0.027162023114293,0.17138969364353063,0.109375,3.552895910352811e-07,0.2280797643072523,0.07496876301541025
114,0.9,2,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Was the polio vaccination coverage in Kenya in 2015 influenced by the Catholic bishops' boycott call? Indeed, the boycott call by the Catholic bishops had a significant negative impact on polio vaccination coverage in Kenya in 2015, resulting in decreased immunization and greater vaccine hesitancy, leading to a public health emergency.",1.4211583641411244e-07,0.010346818480954312,0.0620572210129218,0.010880558788691236,0.055328679236490874,0.040517239766694496,0.0108648092457172,0.05039372643527695,0.04715277777777778,1.4211583641411244e-07,0.07450957173293782,0.03249962721294112
114,0.9,3,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the 2015 boycott call from Catholic bishops affect Kenya's polio vaccination coverage? Yes, the boycott by Catholic bishops in 2015 significantly diminished polio vaccination coverage in Kenya, lowering immunization rates and raising doubts about vaccines, which fueled a public health crisis.",3.552895910352811e-07,0.08234066182458699,0.14969490493966014,0.02720139697172809,0.11681091495564155,0.14124038026256222,0.027162023114293,0.17138969364353063,0.109375,3.552895910352811e-07,0.2280797643072523,0.07496876301541025
114,0.9,4,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","In 2015, did the Catholic bishops' call for a boycott influence polio vaccination coverage in Kenya? Yes, their boycott call led to a significant drop in polio vaccination rates in Kenya in 2015, increasing skepticism about vaccines and contributing to a public health crisis.",3.079176455639103e-07,0.06380670889967588,0.1289721074380165,0.023574544042164344,0.06802075078620984,0.14124038026256222,0.023540420032387266,0.1213792730688672,0.109375,3.079176455639103e-07,0.1767864699197026,0.07496876301541025
114,0.9,5,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Was there an effect on Kenya's polio vaccination coverage in 2015 due to the Catholic bishops' boycott call? Yes, the boycott call from Catholic bishops in 2015 substantially decreased polio vaccination coverage in Kenya, reducing immunizations and amplifying vaccine skepticism, which contributed to a public health crisis.",2.3685972735685406e-07,0.02019455261277603,0.11217930698450172,0.018134264647818726,0.060640962015697575,0.09689208388614254,0.018108015409528666,0.08226839588036583,0.08666001892915089,2.3685972735685406e-07,0.10446580834007646,0.07496876301541025
114,0.9,6,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the Catholic bishops' boycott call in 2015 impact polio vaccination coverage in Kenya? Yes, their call for boycott in 2015 significantly lowered polio vaccination coverage in Kenya, resulting in fewer immunizations and heightened doubts about vaccines, contributing to a public health crisis.",3.316036182995957e-07,0.12264702946131845,0.10416428195325197,0.025387970506946217,0.1597424175418496,0.09258817776420589,0.025351221573340132,0.18072924468723528,0.08439143655489809,3.316036182995957e-07,0.20210427790399432,0.07496876301541025
114,0.9,7,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Can the polio vaccination coverage drop in Kenya in 2015 be attributed to the Catholic bishops' boycott? Yes, the boycott called by Catholic bishops in 2015 considerably affected polio vaccination coverage in Kenya, decreasing immunization levels and increasing skepticism towards vaccines, thus causing a public health crisis.",2.3685972735685406e-07,0.009942281324613056,0.13344716152130473,0.018134264647818726,0.029834420657477878,0.11902963646090933,0.018108015409528666,0.05076170585491324,0.109375,2.3685972735685406e-07,0.10446580834007646,0.07496876301541025
114,0.9,8,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the polio vaccine coverage in Kenya in 2015 get affected by the Catholic bishops' boycott call? Yes, the boycott by Catholic bishops in 2015 markedly reduced polio vaccine coverage in Kenya, leading to declining immunization rates and greater vaccine hesitancy, which resulted in a public health crisis.",2.1317375462116866e-07,0.00387648953902886,0.11397717774629122,0.016320838183036854,0.0373226404552609,0.0978519505104961,0.0162972138685758,0.05909539136107522,0.08716425619834711,2.1317375462116866e-07,0.08147629011537694,0.07496876301541025
114,0.9,9,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Was Kenya's polio vaccination coverage in 2015 impacted by the Catholic bishops' call for boycott? Yes, the 2015 boycott call from Catholic bishops significantly impacted polio vaccination coverage in Kenya, reducing immunization rates and raising skepticism about vaccines, thereby contributing to a public health crisis.",2.8423167282822487e-07,0.038619049510410175,0.13053033170928355,0.02176111757738247,0.10896906086996383,0.09483942844816601,0.0217296184914344,0.13028873008789876,0.08557964009518144,2.8423167282822487e-07,0.1520938573293309,0.07496876301541025
114,0.9,10,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","In 2015, did the call for boycott by Catholic bishops influence polio vaccination coverage in Kenya? Yes, the boycott call by Catholic bishops in 2015 significantly affected polio vaccination coverage in Kenya, causing a decline in immunization rates and increased skepticism around vaccines, which led to a public health crisis.",1.6580180914979784e-07,0.022073076480771725,0.09762396694214875,0.012693985253473108,0.02113275573167961,0.07901815804034,0.012675610786670066,0.014299362767795643,0.0881084593572779,1.6580180914979784e-07,0.03702452754454422,0.07496876301541025
115,0.9,1,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is transgastric endoscopic splenectomy achievable? Answer: Performing transgastric endoscopic splenectomy in a pig model seems technically possible. Further long-term survival studies are scheduled.,0.0,0.060273667874777725,0.0427793707014486,0.0,0.06301338005090429,0.04535147392290251,0.0,0.0,0.0,0.0,0.0,0.0
115,0.9,2,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Can transgastric endoscopic splenectomy be done? Answer: It appears technically feasible to carry out transgastric endoscopic splenectomy in a porcine model. More long-term survival investigations are planned.,9.47438909427412e-08,0.11792784675589152,0.030211570247933854,0.007253705859127518,0.11373507077394018,0.03840000000000001,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
115,0.9,3,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is it feasible to perform transgastric endoscopic splenectomy? Answer: Transgastric endoscopic splenectomy in a pig model seems doable from a technical standpoint. Future long-term survival experiments are planned.,1.184298636784265e-07,0.2074734492236936,0.007723134827511954,0.009067132323909398,0.20479441264601395,0.0,0.009054007704764368,0.2135741002980609,0.0,1.1842986367842698e-07,0.2231435513142097,0.0
115,0.9,4,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Transgastric endoscopic splenectomy: is it achievable? Answer: Performing this procedure in a porcine model looks technically feasible. Additional long-term survival research is intended.,0.0,0.06027366787477817,0.04338842975206613,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
115,0.9,5,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is transgastric endoscopic splenectomy possible? Answer: The procedure appears technically achievable in a porcine model. Plans for long-term survival studies are underway.,2.36859727356853e-08,0.015821905303944117,0.04338842975206613,0.0018134264647818796,0.04652001563489394,0.0,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
115,0.9,6,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Can transgastric endoscopic splenectomy be technically performed? Answer: It seems feasible to conduct this surgery in a pig model. Further long-term survival tests are planned.,4.73719454713706e-08,0.14365527681382861,0.04338842975206613,0.003626852929563759,0.08701137698962969,0.0,0.003621603081905747,0.090971778205728,0.0,4.737194547137076e-08,0.09531017980432521,0.0
115,0.9,7,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is transgastric endoscopic splenectomy technically doable? Answer: It looks technically achievable in a porcine model. More long-term survival experiments are planned.,4.73719454713706e-08,0.030698110330949824,0.04338842975206613,0.003626852929563759,0.09531017980432521,0.0,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
115,0.9,8,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Does transgastric endoscopic splenectomy work? Answer: Technically, it appears feasible in a porcine model. Additional long-term survival trials are forthcoming.",7.105791820705595e-08,0.0794882745003811,0.04338842975206613,0.005440279394345639,0.14660347419187536,0.0,0.005432404622858621,0.15415067982725672,0.0,7.105791820705606e-08,0.16251892949777424,0.0
115,0.9,9,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is it possible to conduct transgastric endoscopic splenectomy? Answer: This procedure seems technically feasible in a pig model. Further long-term survival experiments will be conducted.,4.73719454713706e-08,0.14365527681382861,0.04338842975206613,0.003626852929563759,0.08701137698962969,0.0,0.003621603081905747,0.090971778205728,0.0,4.737194547137076e-08,0.09531017980432521,0.0
115,0.9,10,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Transgastric endoscopic splenectomy: can it be done? Answer: It appears technically possible to perform this surgery in a porcine model. Planned studies include long-term survival assessments.,7.10579182070559e-08,0.18287598996711107,0.04338842975206613,0.005440279394345639,0.1278333715098845,0.0,0.005432404622858621,0.13353139262452363,0.0,7.105791820705617e-08,0.13976194237515926,0.0
116,0.9,1,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Question: Is fondaparinux used in perioperative bridging? Answer: The use of fondaparinux as a perioperative bridging agent is not well defined and has significant limitations preventing its routine application.,1.894877818854824e-07,0.17429807488535642,0.055363321799307974,0.014507411718255037,0.21990278516737272,0.02854671280276816,0.014486412327622988,0.2682639865946794,0.0,1.8948778188548325e-07,0.2776317365982801,0.0
116,0.9,2,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Does fondaparinux have a role in perioperative bridging? Answer: Fondaparinux’s role in perioperative bridging therapy remains unclear, with notable restrictions limiting its regular use.",2.842316728282236e-07,0.4439732848059381,0.027281306299865568,0.021761117577382555,0.4405191031173308,0.014841716949297971,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
116,0.9,3,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Question: Can fondaparinux be used for perioperative bridge therapy? Answer: Fondaparinux has not been established as a standard perioperative bridging therapy and has important constraints that hinder its routine use.,1.658018091497971e-07,0.13920675507408742,0.055363321799307974,0.012693985253473157,0.18353514099649804,0.02854671280276816,0.012675610786670115,0.23052365861183244,0.0,1.6580180914979784e-07,0.23841102344499765,0.0
116,0.9,4,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is fondaparinux recommended for perioperative bridging? Answer: The recommendation for fondaparinux in perioperative bridging has not been established, and its routine use is limited by key factors.",2.131737546211677e-07,0.2106657190562311,0.055363321799307974,0.016320838183036916,0.2576431131502197,0.02854671280276816,0.016297213868575862,0.3074846997479619,0.0,2.1317375462116866e-07,0.3184537311185349,0.0
116,0.9,5,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: What is fondaparinux’s role in perioperative bridging? Answer: Fondaparinux’s role during perioperative bridging has yet to be determined, with critical limitations precluding it from routine bridging agent status.",1.894877818854824e-07,0.22380858778249557,0.019698026874753798,0.014507411718255037,0.21990278516737272,0.02854671280276816,0.014486412327622988,0.2682639865946794,0.0,1.8948778188548325e-07,0.2776317365982801,0.0
116,0.9,6,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is there an established use for fondaparinux in perioperative bridging? Answer: An established role for fondaparinux in perioperative bridging does not exist, and there are important limitations to its routine application.",1.184298636784265e-07,0.25139207233281935,0.07083695254911454,0.009067132323909398,0.20696189358420636,0.037779817809476715,0.009054007704764368,0.20686794846140888,0.03443877551020409,1.1842986367842703e-07,0.16430305129127598,0.0
116,0.9,7,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Does fondaparinux serve as a perioperative bridging agent? Answer: Fondaparinux is not established as a perioperative bridging agent, and its use is limited by significant restrictions.",2.36859727356853e-07,0.4083630887067571,0.05805822829520997,0.018134264647818796,0.40776737519309414,0.050848372263394434,0.018108015409528735,0.4060689593148772,0.04158790170132326,2.3685972735685406e-07,0.36101334553733055,0.0
116,0.9,8,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is fondaparinux a suitable perioperative bridging therapy? Answer: The suitability of fondaparinux for perioperative bridging therapy remains unproven, with notable limitations for routine use.",2.842316728282236e-07,0.38621101975927585,0.013775420097984714,0.021761117577382555,0.3802454352425526,0.02854671280276816,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
116,0.9,9,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Question: Can fondaparinux routinely be used in perioperative bridging? Answer: Routine use of fondaparinux in perioperative bridging has not been established due to important limitations.,2.842316728282236e-07,0.38621101975927585,0.013775420097984714,0.021761117577382555,0.3802454352425526,0.02854671280276816,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
116,0.9,10,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is fondaparinux effectively used for perioperative bridging? Answer: Fondaparinux has not been effectively established for perioperative bridging, and there are considerable limitations restricting its routine use.",2.36859727356853e-07,0.30172506092830487,0.016963321799307964,0.018134264647818796,0.29686382630350217,0.02854671280276816,0.018108015409528735,0.3483066942682167,0.0,2.3685972735685406e-07,0.36101334553733055,0.0
117,0.9,1,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do people with episodic migraines pay special attention to headache-related visual cues? Studies suggest that those with episodic migraines tend to focus more on visual stimuli related to headaches. This selective attention arises from a cognitive bias towards headache-related information, which might influence how often and how severe their migraines become. Nevertheless, experiences differ widely among individuals.",1.6580180914979784e-07,0.22547948800492312,0.06505784557131356,0.012693985253473108,0.19757021987421108,0.04404663923182442,0.012675610786670066,0.19782769426357438,0.04246913580246913,1.6580180914979784e-07,0.1717873510004151,0.021728395061728398
117,0.9,2,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Are episodic migraine sufferers more likely to notice headache-associated visual stimuli? Evidence shows that individuals experiencing episodic migraines exhibit a tendency to selectively attend to visual signs linked to headaches. This behavior stems from a cognitive bias that may impact the frequency and severity of their migraine attacks. Still, the degree of this effect varies among different people.",1.8948778188548325e-07,0.29268957800146334,0.10072314049586772,0.014507411718254981,0.24079407739725145,0.06222222222222222,0.014486412327622933,0.21617683293177015,0.04246913580246913,1.8948778188548325e-07,0.19047948401256942,0.021728395061728398
117,0.9,3,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do migraineurs with episodic patterns exhibit selective attention to headache-related visual signals? Research findings indicate such migraine sufferers have a cognitive bias that leads them to focus more on headache-related visual stimuli, which may play a role in the occurrence and severity of migraine episodes. However, this varies greatly from person to person.",7.105791820705622e-08,0.17422252180372766,0.08149976487110802,0.005440279394345618,0.14726801938642708,0.06222222222222222,0.0054324046228586,0.12086665312744449,0.04246913580246913,7.105791820705622e-08,0.09331573555892092,0.021728395061728398
117,0.9,4,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Is selective attention to headache-related visual stimuli present in individuals with episodic migraines? Research supports that episodic migraineurs demonstrate a cognitive preference for focusing on visual cues associated with headaches, potentially exacerbating migraine frequency and intensity. Yet, this tendency is not uniform across all sufferers.",1.1842986367842703e-07,0.03382794408517498,0.10072314049586772,0.009067132323909363,0.023357497644335812,0.06222222222222222,0.009054007704764333,0.05348673401733306,0.04246913580246913,1.1842986367842703e-07,0.08493249584739804,0.021728395061728398
117,0.9,5,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do individuals with episodic migraines selectively concentrate on visual stimuli connected to headaches? Studies reveal that episodic migraine patients exhibit selective attention towards headache-related images due to a cognitive bias, which might affect how often and how intensely migraines occur. Nonetheless, individual variation is considerable.",1.1842986367842703e-07,0.03382794408517498,0.10072314049586772,0.009067132323909363,0.023357497644335812,0.06222222222222222,0.009054007704764333,0.05348673401733306,0.04246913580246913,1.1842986367842703e-07,0.08493249584739804,0.021728395061728398
117,0.9,6,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do people experiencing episodic migraines show selective attention to headache-related visual cues? Research indicates a cognitive bias in episodic migraineurs that causes increased attention to headache-associated visual stimuli, possibly influencing migraine occurrence and severity. However, individual responses can vary significantly.",2.3685972735685396e-07,0.12234605296292633,0.07509987179780678,0.018134264647818726,0.14697145361151165,0.06222222222222222,0.018108015409528666,0.18023843965647535,0.04246913580246913,2.3685972735685406e-07,0.21498562409559563,0.021728395061728398
117,0.9,7,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do those with episodic migraines focus selectively on visual stimuli related to headaches? Evidence suggests that episodic migraine sufferers demonstrate a bias toward attending to headache-related visual cues, which may contribute to the frequency and intensity of their migraines. Individual experiences, however, differ markedly.",1.4211583641411244e-07,0.010838425860475454,0.10072314049586772,0.010880558788691236,0.04688799505453023,0.06222222222222222,0.0108648092457172,0.07758428559639308,0.04246913580246913,1.4211583641411244e-07,0.10962510843776974,0.021728395061728398
117,0.9,8,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Are individuals who suffer from episodic migraines selectively attentive to headache-related visual stimuli? Research points to a cognitive bias in such individuals that leads to heightened attention to headache-related visual information, potentially affecting migraine frequency and severity. Still, individual experiences vary widely.",1.8948778188548325e-07,0.10441373830535872,0.052070937997511384,0.014507411718254981,0.13033551825195833,0.0372386587771203,0.014486412327622933,0.1275947061710565,0.04246913580246913,1.8948778188548325e-07,0.16091840282531944,0.021728395061728398
117,0.9,9,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do episodic migraine patients selectively attend to visual stimuli linked with headaches? Studies show that episodic migraineurs have a tendency to focus on headache-related visual cues because of a cognitive bias, which could influence how often and how severely migraines occur. Nevertheless, this effect is not consistent across all individuals.",0.0,0.14145860827753998,0.10072314049586772,0.0,0.08664339756999295,0.06222222222222222,0.0,0.05899124940935696,0.04246913580246913,0.0,0.03013683393738864,0.021728395061728398
117,0.9,10,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Does selective attention to headache-related visual stimuli occur in episodic migraine sufferers? Research suggests episodic migraineurs are cognitively biased to focus more on visual cues associated with headaches, possibly impacting migraine frequency and intensity, although individual variability is substantial.",2.6054570009253926e-07,0.11277553010670038,0.10072314049586772,0.0199476911126006,0.17363970069367252,0.06222222222222222,0.019918816950481533,0.20763741384459067,0.04246913580246913,2.6054570009253947e-07,0.24315650106229247,0.021728395061728398
118,0.9,1,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is a surgeon's previous experience a factor in their ability to perform transurethral resection of the prostate? Yes, previous experience significantly affects a surgeon's skill in performing transurethral resection of the prostate. As surgeons gain practice, their proficiency improves, resulting in fewer complications and better patient outcomes. Hence, prior experience is essential for successful surgery.",1.1842986367842703e-07,0.06504418880900031,0.09850279299273405,0.009067132323909363,0.09655217740506217,0.12725273933102654,0.009054007704764333,0.07610057343312615,0.1173863703144323,1.1842986367842703e-07,0.05500548068059263,0.10560000000000003
118,0.9,2,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Does a surgeon's prior experience impact their capability to perform transurethral resection of the prostate? Indeed, experience plays a crucial role in a surgeon’s ability to carry out transurethral resection of the prostate. Practice enhances skill, reducing complications and improving outcomes for patients. Thus, previous experience is vital for effective procedures.",2.1317375462116866e-07,0.03326607499826073,0.13037573562698052,0.016320838183036854,0.013810113411793612,0.12418813817212412,0.0162972138685758,0.0061637598191279785,0.11578584372099372,2.1317375462116866e-07,0.02667255033367466,0.10560000000000003
118,0.9,3,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is the surgeon’s experience a determining factor in performing transurethral resection of the prostate? Yes, a surgeon's prior experience influences their competency in this operation. With more practice, surgeons achieve better proficiency, leading to fewer complications and improved results. Therefore, experience is important for successful transurethral prostate resections.",2.8423167282822487e-07,0.054568332947366294,0.19013128112267996,0.02176111757738247,0.0072146551012770566,0.16493055555555555,0.0217296184914344,0.041821148433368815,0.136609745939192,2.8423167282822487e-07,0.09263051812547074,0.10560000000000003
118,0.9,4,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Does prior surgical experience influence the ability to perform transurethral resection of the prostate? Yes, the ability to perform this procedure depends significantly on the surgeon’s previous experience. Increased practice leads to higher proficiency, fewer complications, and enhanced patient outcomes. Consequently, prior experience is critical for success.",3.079176455639103e-07,0.05734837408576343,0.12523133520596821,0.023574544042164344,0.07637733433393734,0.12058225917913587,0.023540420032387266,0.09580069431087912,0.1138947648683429,3.079176455639103e-07,0.11562003635017026,0.10560000000000003
118,0.9,5,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is the capability to perform transurethral resection of the prostate dependent on the surgeon's past experience? Yes, a surgeon's past experience affects their skill in conducting transurethral resection of the prostate. Proficiency grows with practice, resulting in reduced complications and better patient outcomes. Therefore, prior experience is essential for successful surgery.",2.1317375462116866e-07,0.005540187775862737,0.11073619605651738,0.016320838183036854,0.013810113411793612,0.12418813817212412,0.0162972138685758,0.0061637598191279785,0.11578584372099372,2.1317375462116866e-07,0.02667255033367466,0.10560000000000003
118,0.9,6,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Does experience affect the surgeon’s ability to perform transurethral resection of the prostate? Certainly, a surgeon’s previous experience impacts their ability to perform this procedure. With more practice, their proficiency improves, which leads to fewer complications and enhanced patient outcomes. Hence, experience is key to success.",3.316036182995957e-07,0.05052986170881146,0.14578298474626028,0.025387970506946217,0.06874379749500825,0.14221557448470645,0.025351221573340132,0.08728352251012605,0.136609745939192,3.316036182995957e-07,0.13915053376036468,0.10560000000000003
118,0.9,7,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is the surgeon’s prior experience influential in their ability to perform transurethral resection of the prostate? Yes, previous experience is a major factor in a surgeon's competence with this procedure. As surgeons gain more experience, their skills improve, resulting in fewer complications and better results for patients. Therefore, prior experience is critical for successful outcomes.",1.1842986367842703e-07,0.14206054220455044,0.1531490326019699,0.009067132323909363,0.1488651721643035,0.16493055555555555,0.009054007704764333,0.10276008037773954,0.136609745939192,1.1842986367842703e-07,0.05500548068059263,0.10560000000000003
118,0.9,8,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Does the surgeon's experience play a role in their ability to perform transurethral resection of the prostate? Yes, the ability to perform this surgery is influenced by how much experience a surgeon has. Greater experience leads to increased proficiency, which decreases complications and improves patient outcomes. Thus, prior experience is crucial for success.",1.6580180914979784e-07,0.10234543592950951,0.15173128112267995,0.012693985253473108,0.08321664896160819,0.14533055555555557,0.012675610786670066,0.06353936722445708,0.136609745939192,1.6580180914979784e-07,0.01500014606689426,0.10560000000000003
118,0.9,9,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is a surgeon’s experience important for performing transurethral resection of the prostate? Yes, the surgeon’s past experience is important in performing this procedure. Skillfulness increases with practice, which contributes to fewer complications and improved patient outcomes. Hence, previous experience is vital for successful operations.",3.789755637709665e-07,0.06661855681610351,0.16688865073719245,0.029014823436509962,0.0837571231044496,0.16493055555555555,0.028972824655245866,0.1349115714993805,0.136609745939192,3.789755637709665e-07,0.1879406979297964,0.10560000000000003
118,0.9,10,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Does the ability to carry out transurethral resection of the prostate depend on the surgeon's past experience? Yes, the surgeon’s experience has a significant impact on their ability to perform this procedure effectively. With ongoing practice, proficiency improves, complications are minimized, and patient outcomes are better. Therefore, prior experience is essential for success.",1.6580180914979784e-07,0.1290049428741229,0.17090790549792026,0.012693985253473108,0.11039889133650771,0.16493055555555555,0.012675610786670066,0.06353936722445708,0.136609745939192,1.6580180914979784e-07,0.01500014606689426,0.10560000000000003
119,0.9,1,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: How do marital status, living arrangements, and mortality relate, and does gender influence this association? Answer: Yes, gender influences the relationship between marital status, living arrangements, and mortality. Research indicates men have higher death rates when single or living alone, whereas women frequently show higher rates under similar conditions.",0.0,0.0,0.0,0.0,0.057762265046662264,0.041398320004023936,0.0,0.05899124940935696,0.04246913580246913,0.0,0.03013683393738864,0.021728395061728398
119,0.9,2,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Does the link between marital status, living situation, and mortality differ by gender? Answer: Yes, the association varies by gender. Men tend to experience increased mortality when unmarried or living alone, while women often exhibit higher mortality rates under these circumstances.",1.8948778188548325e-07,0.06508134478428707,0.08098765432098766,0.014507411718254981,0.1534404242706242,0.020823902218198284,0.014486412327622933,0.18658595558041347,0.0,1.8948778188548325e-07,0.19105523676270808,0.0
119,0.9,3,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Is there a gender difference in how marital status and living arrangements affect mortality? Answer: Yes, gender differences exist. Men typically have higher mortality risk when single or living alone, and women also show increased mortality rates, though the patterns vary.",1.8948778188548325e-07,0.06508134478428707,0.08098765432098766,0.014507411718254981,0.1534404242706242,0.020823902218198284,0.014486412327622933,0.18658595558041347,0.0,1.8948778188548325e-07,0.19105523676270808,0.0
119,0.9,4,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Does gender affect the relationship between marital status, living arrangements, and mortality? Answer: Yes, the impact differs by gender. Men generally show higher mortality rates when unmarried or living alone, whereas women often demonstrate different mortality trends.",2.8423167282822456e-07,0.16773549884436934,0.08098765432098766,0.02176111757738247,0.2588009399284501,0.020823902218198284,0.0217296184914344,0.2947995402206445,0.0,2.8423167282822487e-07,0.3022808718729326,0.0
119,0.9,5,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Are the effects of marital status and living arrangements on mortality influenced by gender? Answer: Yes, gender influences these effects. Men have higher death rates when living alone or unmarried, while women show different mortality patterns.",3.0791764556390986e-07,0.19513447303248466,0.08098765432098766,0.023574544042164344,0.28697181689514695,0.020823902218198284,0.023540420032387273,0.323787077093896,0.0,3.079176455639103e-07,0.3321338350226144,0.0
119,0.9,6,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: How does gender moderate the association between marital status, living situation, and mortality? Answer: It does moderate it. Men tend to die more frequently when unmarried or living solo, in contrast, women often exhibit different mortality outcomes.",2.8423167282822456e-07,0.16773549884436934,0.08098765432098766,0.02176111757738247,0.2588009399284501,0.020823902218198284,0.0217296184914344,0.2947995402206445,0.0,2.8423167282822487e-07,0.3022808718729326,0.0
119,0.9,7,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Does the relationship between marital status, living arrangements, and mortality change depending on gender? Answer: Yes, it changes. Men are more vulnerable to mortality when living alone or unmarried, whereas women display different mortality associations.",3.3160361829959516e-07,0.2233053499991815,0.08098765432098766,0.025387970506946224,0.31595935376839845,0.020823902218198284,0.025351221573340146,0.35364004024357776,0.0,3.316036182995957e-07,0.3629054936893681,0.0
119,0.9,8,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Is the association of marital status and living conditions with mortality affected by gender? Answer: Yes, gender affects the association. Men tend to have higher mortality when single or living alone, and women often exhibit distinct mortality trends.",2.6054570009253926e-07,0.14106725176220847,0.08098765432098766,0.0199476911126006,0.23140196574033478,0.020823902218198284,0.019918816950481533,0.26662866325394763,0.0,2.6054570009253947e-07,0.2732933349996811,0.0
119,0.9,9,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Does gender cause variation in the link between marital status, living arrangements, and mortality? Answer: Yes, gender causes variation. Men show increased mortality rates when unmarried or living alone, while women present different mortality patterns.",3.3160361829959516e-07,0.2233053499991815,0.08098765432098766,0.025387970506946224,0.31595935376839845,0.020823902218198284,0.025351221573340146,0.35364004024357776,0.0,3.316036182995957e-07,0.3629054936893681,0.0
119,0.9,10,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Are marital status and living arrangement impacts on mortality different for men and women? Answer: Yes, these impacts differ by gender. Men often face higher mortality if unmarried or living alone, while women’s mortality rates differ under similar conditions.",2.3685972735685396e-07,0.11509176535895049,0.08098765432098766,0.018134264647818726,0.2047337186581739,0.020823902218198284,0.018108015409528666,0.2392296890658323,0.0,2.3685972735685406e-07,0.24512245803298427,0.0
120,0.9,1,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Living in an urban area in Thailand is linked to higher behavioral and physiological risk factors for non-communicable diseases, but these may not directly lead to increased biological risk factors, which likely stem from complex long-term interactions.",5.447773729207639e-07,0.42352896166385134,0.0507015306122449,0.04170880868998307,0.5050949490570056,0.0,0.04164843544191594,0.5166907432183883,0.0,5.447773729207643e-07,0.5288441292686694,0.0
120,0.9,2,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Urban living in Thailand correlates with elevated behavioral and physiological risks, though this does not necessarily increase biological risk factors, which probably arise from a complicated interplay over time.",7.342651548062463e-07,0.6748433899447575,0.0507015306122449,0.05621622040823811,0.7646061445420895,0.0,0.05613484776953893,0.7849547298130677,0.0,7.342651548062476e-07,0.8064758658669495,0.0
120,0.9,3,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","In Thailand, urban residency is connected to greater behavioral and physiological risk factors; however, this doesn't always result in higher biological risks, which are likely due to complex long-term influences.",7.10579182070561e-07,0.6397520701334884,0.0507015306122449,0.05440279394345623,0.7282385003712148,0.0,0.054324046228586054,0.7472144018302207,0.0,7.105791820705622e-07,0.7672551527136671,0.0
120,0.9,4,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","The association between urban living and behavioral and physiological risk factors in Thailand exists, but this may not straightforwardly increase biological risks, as these factors probably involve a complex long-term interaction.",6.868932093348757e-07,0.6058505184578067,0.0507015306122449,0.05258936747867435,0.6931471805599458,0.0,0.05251324468763318,0.710846757659346,0.0,6.868932093348768e-07,0.7295148247308201,0.0
120,0.9,5,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Urbanicity in Thailand relates to increased behavioral and physiological risks, yet these do not automatically translate to biological risk increases, which may result from a sophisticated long-term interplay.",7.579511275419316e-07,0.7112110341156321,0.0507015306122449,0.05802964687301999,0.8023464725249365,0.0,0.0579456493104918,0.8241754429663501,0.0,7.57951127541933e-07,0.8472978603872043,0.0
120,0.9,6,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Living in urban Thailand is linked with rises in behavioral and physiological risk factors, but these associations might not directly cause higher biological risks, likely due to complex long-term interactions.",7.10579182070561e-07,0.6397520701334884,0.0507015306122449,0.05440279394345623,0.7282385003712148,0.0,0.054324046228586054,0.7472144018302207,0.0,7.105791820705622e-07,0.7672551527136671,0.0
120,0.9,7,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Urban residence in Thailand is associated with higher behavioral and physiological risk factors for disease, but such connections may not directly lead to elevated biological risk factors, which likely result from complex long-term processes.",6.158352911278198e-07,0.5105403386534815,0.0507015306122449,0.04714908808432871,0.5947071077466926,0.0,0.04708084006477456,0.6090640633494036,0.0,6.158352911278206e-07,0.6241543090729946,0.0
120,0.9,8,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","In the Thai context, urbanicity is connected to behavioral and physiological risk increases, though these may not directly increase biological risks, presumed to be from intricate long-term interactions.",7.579511275419316e-07,0.7112110341156321,0.0507015306122449,0.05802964687301999,0.8023464725249365,0.0,0.0579456493104918,0.8241754429663501,0.0,7.57951127541933e-07,0.8472978603872043,0.0
120,0.9,9,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Thailand's urban living shows increases in behavioral and physiological risk factors, but these do not necessarily correspond to increased biological risks, which are likely driven by complex, long-term mechanisms.",7.342651548062463e-07,0.6748433899447575,0.0507015306122449,0.05621622040823811,0.7646061445420895,0.0,0.05613484776953893,0.7849547298130677,0.0,7.342651548062476e-07,0.8064758658669495,0.0
120,0.9,10,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","The correlation between urban living and behavioral and physiological health risks in Thailand exists, but it may not directly increase biological risk factors, which probably arise from complex long-term interactions.",7.10579182070561e-07,0.6397520701334884,0.0507015306122449,0.05440279394345623,0.7282385003712148,0.0,0.054324046228586054,0.7472144018302207,0.0,7.105791820705622e-07,0.7672551527136671,0.0
121,0.9,1,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Does sex affect the response to intravenous thrombolysis in ischemic stroke? Yes, sex can impact how patients respond to intravenous thrombolysis in ischemic stroke. Research shows women might have a greater risk of symptomatic intracranial hemorrhage after treatment, although overall functional outcomes tend to be similar between men and women. More studies are necessary for a complete understanding.",2.3685972735685406e-08,0.052635830883720924,0.048640272951403385,0.0018134264647818726,0.053960375778036695,0.050406441972848014,0.0018108015409528666,0.05534707269944583,0.05211567312131367,2.3685972735685406e-08,0.056800151614734506,0.0537679663968003
121,0.9,2,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Is the response to intravenous thrombolysis in ischemic stroke influenced by sex? Indeed, sex influences the treatment response, with evidence suggesting women have a higher chance of symptomatic intracranial hemorrhage following therapy. Despite this, both sexes typically achieve comparable functional recovery after thrombolysis, but further investigation is required.",2.6054570009253947e-07,0.042984020425339775,0.1184159938485198,0.0199476911126006,0.06848414912230938,0.10380622837370242,0.019918816950481533,0.09491291872198238,0.08842752787389466,2.6054570009253947e-07,0.12232214323276214,0.07227989234909649
121,0.9,3,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Does gender play a role in the effectiveness of intravenous thrombolysis for ischemic stroke? Yes, gender can affect response to intravenous thrombolysis in ischemic stroke. Women appear to be at increased risk for symptomatic intracranial hemorrhage post-treatment. Yet, functional outcomes post-thrombolysis are generally alike in both men and women, necessitating additional research to clarify these effects.",7.105791820705622e-08,0.08899621107671152,0.10024041085812199,0.005440279394345618,0.0918585009528714,0.10380622837370242,0.0054324046228586,0.06871650505981908,0.08842752787389466,7.105791820705622e-08,0.04473194143040393,0.07227989234909649
121,0.9,4,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Is there a sex difference in the response to intravenous thrombolysis in ischemic stroke? Yes, sex differences exist, as studies reveal that women may face a higher risk of symptomatic intracranial hemorrhage after receiving thrombolysis. Overall, functional outcomes after treatment are usually similar between males and females. Further research is essential for deeper insights.",1.1842986367842703e-07,0.07716029141672331,0.1184159938485198,0.009067132323909363,0.05411817297002397,0.10380622837370242,0.009054007704764333,0.03025022423202328,0.08842752787389466,1.1842986367842703e-07,0.0055112282771214716,0.07227989234909649
121,0.9,5,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Can sex influence how patients respond to intravenous thrombolysis in ischemic stroke? Yes, sex can influence response; women may be more prone to symptomatic intracranial hemorrhage post-thrombolysis. Nonetheless, males and females generally show comparable functional outcomes, and more research is needed to fully understand these dynamics.",3.079176455639103e-07,0.08646913236507814,0.1184159938485198,0.023574544042164344,0.1129359116931421,0.10380622837370242,0.023540420032387266,0.14037529279873961,0.08842752787389466,3.079176455639103e-07,0.16884215886765608,0.07227989234909649
121,0.9,6,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Does intravenous thrombolysis response in ischemic stroke vary by sex? Yes, sex does affect the response. Women are reported to have an increased risk of symptomatic intracranial hemorrhage following thrombolysis, while functional recovery rates are similar across sexes. Additional studies are needed to explore this further.",3.079176455639103e-07,0.08646913236507814,0.1184159938485198,0.023574544042164344,0.1129359116931421,0.10380622837370242,0.023540420032387266,0.14037529279873961,0.08842752787389466,3.079176455639103e-07,0.16884215886765608,0.07227989234909649
121,0.9,7,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Is sex a factor in the response to intravenous thrombolysis in ischemic stroke? Yes, sex is a factor. Research indicates women may have a higher likelihood of symptomatic intracranial hemorrhage after treatment, but functional outcomes post-thrombolysis are generally equivalent between men and women. More research is required to gain a fuller understanding.",1.6580180914979784e-07,0.03869401058892752,0.1184159938485198,0.012693985253473108,0.01489745981674151,0.10380622837370242,0.012675610786670066,0.009755110381675092,0.08842752787389466,1.6580180914979784e-07,0.035310766243132896,0.07227989234909649
121,0.9,8,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","How does sex impact the response to intravenous thrombolysis in ischemic stroke? Sex can impact treatment response; women tend to have a greater risk of symptomatic intracranial hemorrhage after thrombolysis. However, functional outcomes are typically similar between sexes, warranting further research.",4.263475092423373e-07,0.2042521680214615,0.1184159938485198,0.03264167636607371,0.23356389948175948,0.10380622837370242,0.0325944277371516,0.26398924876591545,0.08842752787389466,4.263475092423373e-07,0.29559386450679836,0.07227989234909649
121,0.9,9,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Does the patient's sex affect the response to intravenous thrombolysis in ischemic stroke? Yes, female patients may have a higher risk of symptomatic intracranial hemorrhage following thrombolysis, although functional outcomes post-treatment are generally similar for both sexes. More research is necessary for comprehensive knowledge.",3.552895910352811e-07,0.13193150644183538,0.1184159938485198,0.02720139697172809,0.15945592732803604,0.10380622837370242,0.027162023114293,0.18800334178799405,0.08842752787389466,3.552895910352811e-07,0.2176323230370878,0.07227989234909649
121,0.9,10,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Is there an influence of sex on the effectiveness of intravenous thrombolysis in ischemic stroke? Yes, sex influences the effectiveness; women may experience a higher risk of symptomatic intracranial hemorrhage after thrombolysis, yet both men and women usually attain comparable functional outcomes, highlighting the need for further research.",2.6054570009253947e-07,0.042984020425339775,0.1184159938485198,0.0199476911126006,0.06848414912230938,0.10380622837370242,0.019918816950481533,0.09491291872198238,0.08842752787389466,2.6054570009253947e-07,0.12232214323276214,0.07227989234909649
122,0.9,1,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is anxiety caused by withdrawal in alcoholism linked to a deficiency of beta-endorphin? Yes, anxiety triggered by withdrawal in alcoholism is connected to a lack of beta-endorphin, a peptide that helps regulate stress and pain.",2.36859727356853e-08,0.007213730997908563,0.025555555555555554,0.0018134264647818796,0.03339721616887559,0.0018684240952711456,0.0018108015409528735,0.033146172468933255,0.0010047404324198955,2.3685972735685406e-08,0.0327898228229917,0.0
122,0.9,2,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Does withdrawal-induced anxiety in alcoholism stem from beta-endorphin deficiency? Indeed, anxiety during alcohol withdrawal is associated with reduced beta-endorphin levels, a peptide responsible for managing stress and pain.",1.421158364141118e-07,0.07464393536034253,0.09000000000000004,0.010880558788691277,0.12099596720824968,0.06222222222222223,0.010864809245717241,0.17039220667759558,0.0322222222222222,1.4211583641411244e-07,0.2231435513142097,0.0
122,0.9,3,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is the anxiety experienced during alcohol withdrawal due to beta-endorphin shortage? Yes, withdrawal anxiety in alcoholism correlates with beta-endorphin deficiency, a peptide crucial for stress and pain control.",1.421158364141118e-07,0.07464393536034253,0.09000000000000004,0.010880558788691277,0.12099596720824968,0.06222222222222223,0.010864809245717241,0.17039220667759558,0.0322222222222222,1.4211583641411244e-07,0.2231435513142097,0.0
122,0.9,4,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is beta-endorphin deficiency the cause of withdrawal-induced anxiety in alcoholism? Yes, anxiety during alcohol withdrawal is linked to a deficiency in beta-endorphin, a peptide involved in stress and pain management.",9.47438909427412e-08,0.003184971378198842,0.09000000000000004,0.007253705859127518,0.04688799505452801,0.06222222222222223,0.007243206163811494,0.09343116554146613,0.0322222222222222,9.474389094274162e-08,0.14310084364067244,0.0
122,0.9,5,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is withdrawal anxiety in alcoholism based on a lack of beta-endorphin? Yes, this anxiety is indeed related to beta-endorphin deficiency, a peptide that regulates stress and pain.",1.658018091497971e-07,0.11238426334318952,0.09000000000000004,0.012693985253473157,0.16021668036153214,0.06222222222222223,0.012675610786670115,0.2112142011978504,0.0322222222222222,1.6580180914979784e-07,0.26570316573300534,0.0
122,0.9,6,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Does a deficiency in beta-endorphin underlie withdrawal-induced anxiety in alcoholism? Yes, the anxiety seen in alcohol withdrawal is associated with reduced beta-endorphin, which modulates stress and pain.",1.658018091497971e-07,0.11238426334318952,0.09000000000000004,0.012693985253473157,0.16021668036153214,0.06222222222222223,0.012675610786670115,0.2112142011978504,0.0322222222222222,1.6580180914979784e-07,0.26570316573300534,0.0
122,0.9,7,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is withdrawal-related anxiety in alcoholism due to beta-endorphin deficiency? Yes, this anxiety is connected to a beta-endorphin deficit, a peptide involved in managing pain and stress.",1.894877818854824e-07,0.15160497649647198,0.09000000000000004,0.014507411718255037,0.20103867488178695,0.06222222222222223,0.014486412327622988,0.253773815616646,0.0322222222222222,1.8948778188548325e-07,0.3101549283038394,0.0
122,0.9,8,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is anxiety caused by alcohol withdrawal related to deficient beta-endorphin levels? Yes, withdrawal anxiety in alcoholism is linked to a shortage of beta-endorphin, a peptide that helps handle stress and pain.",7.10579182070559e-08,0.03071658029748292,0.09000000000000004,0.005440279394345639,0.011796675243259003,0.06222222222222223,0.005432404622858621,0.05706352137059145,0.0322222222222222,7.105791820705622e-08,0.10536051565782545,0.0
122,0.9,9,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Does beta-endorphin deficiency contribute to withdrawal-induced anxiety in alcoholism? Yes, anxiety during withdrawal is indeed associated with a lack of beta-endorphin, which plays a role in stress and pain regulation.",9.47438909427412e-08,0.003184971378198842,0.09000000000000004,0.007253705859127518,0.04688799505452801,0.06222222222222223,0.007243206163811494,0.09343116554146613,0.0322222222222222,9.474389094274162e-08,0.14310084364067244,0.0
122,0.9,10,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is the occurrence of anxiety during alcohol withdrawal connected to a beta-endorphin deficit? Yes, withdrawal-induced anxiety in alcoholism is associated with beta-endorphin deficiency, a peptide that manages stress and pain.",9.47438909427412e-08,0.003184971378198842,0.09000000000000004,0.007253705859127518,0.04688799505452801,0.06222222222222223,0.007243206163811494,0.09343116554146613,0.0322222222222222,9.474389094274162e-08,0.14310084364067244,0.0
123,0.9,1,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Are we adhering to the guidelines when preparing high fall-risk patients to go home after rehab? Compliance with these protocols varies, but thorough assessments, tailored care plans, patient education, and home safety checks are essential. Research shows inconsistent implementation, indicating room for improvement.",4.974054274493935e-07,0.40546510810816727,0.0,0.038081955760419325,0.4135623183407837,0.0,0.0380268323600102,0.4219944100593742,0.0,4.974054274493935e-07,0.430782916092455,0.0
123,0.9,2,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","How well do we follow guidelines for discharging patients at high risk of falls after rehabilitation? While it’s crucial to conduct comprehensive assessments, develop individualized care plans, provide education, and ensure home safety, compliance is variable and often incomplete, revealing a need to enhance practices.",4.500334819780227e-07,0.35894509247327333,0.0,0.03445510283085558,0.3659342693515293,0.0,0.034405229278104466,0.3732042458899425,0.0,4.500334819780227e-07,0.3807724955177916,0.0
123,0.9,3,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Do we meet established guidelines in preparing patients vulnerable to falls for discharge post-rehabilitation? Ensuring detailed assessments, personalized care, education, and home safety is vital, yet studies show inconsistent adherence, pointing to the necessity for better compliance.",6.395212638635055e-07,0.5596157879354249,0.0,0.04896251454911056,0.5717863235556782,0.0,0.048891641605727405,0.5845133395571485,0.0,6.39521263863506e-07,0.5978370007556193,0.0
123,0.9,4,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Are the discharge preparations for patients at high fall risk after rehabilitation aligned with recommended guidelines? Critical elements include thorough evaluations, customized care strategies, patient education, and home safety measures, though implementation is uneven, suggesting improvements are needed.",6.158352911278202e-07,0.5322168137473096,0.0,0.04714908808432869,0.5436154465889813,0.0,0.04708084006477453,0.555525802683897,0.0,6.158352911278206e-07,0.5679840376059375,0.0
123,0.9,5,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Is guideline compliance adequate when preparing high fall-risk patients for home discharge following rehab? Comprehensive assessments, individualized plans, education, and home safety are key, but evidence indicates varying levels of adherence, emphasizing improvement requirements.",7.105791820705614e-07,0.646627164925055,0.0,0.0544027939434562,0.6613984822453651,0.0,0.054324046228586026,0.6768866596881637,0.0,7.105791820705622e-07,0.6931471805599445,0.0
123,0.9,6,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","To what extent do we follow guidelines in preparing high-risk fall patients for discharge home after rehab? While comprehensive evaluations, tailored care plans, education, and safety measures are imperative, current practices show inconsistent compliance, highlighting the need for enhanced implementation.",5.684633456564496e-07,0.4795730802618907,0.0,0.04352223515476494,0.4895482253187051,0.0,0.0434592369828688,0.4999559515290848,0.0,5.684633456564497e-07,0.5108256237659892,0.0
123,0.9,7,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Do we meet the recommended standards for preparing patients prone to falls for discharge after rehabilitation? Essential steps include thorough assessments, personalized care plans, patient instruction, and home safety checks; however, adherence is inconsistent, underscoring room for improvement.",6.158352911278202e-07,0.5322168137473096,0.0,0.04714908808432869,0.5436154465889813,0.0,0.04708084006477453,0.555525802683897,0.0,6.158352911278206e-07,0.5679840376059375,0.0
123,0.9,8,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Are guidelines for preparing high fall-risk patients for discharge post-rehabilitation being met? It is critical to conduct comprehensive assessments, design individualized care plans, educate patients, and ensure home safety, but inconsistent adherence has been documented, calling for improvement.",6.158352911278202e-07,0.5322168137473096,0.0,0.04714908808432869,0.5436154465889813,0.0,0.04708084006477453,0.555525802683897,0.0,6.158352911278206e-07,0.5679840376059375,0.0
123,0.9,9,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","How effectively do we implement guidelines when preparing patients at elevated fall risk for home discharge post-rehabilitation? Ensuring detailed assessments, personalized care, education, and home safety is fundamental, yet compliance is variable, showing the need for better adherence.",6.158352911278202e-07,0.5322168137473096,0.0,0.04714908808432869,0.5436154465889813,0.0,0.04708084006477453,0.555525802683897,0.0,6.158352911278206e-07,0.5679840376059375,0.0
123,0.9,10,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Do current practices meet guidelines in preparing patients susceptible to falls for discharge after rehabilitation? Compliance with necessary assessments, individualized plans, education, and home safety measures is inconsistent, signaling a significant need for enhanced guideline implementation.",6.632072365991908e-07,0.5877866649021217,0.0,0.05077594101389244,0.6007738604289297,0.0,0.05070244314668028,0.6143663027068302,0.0,6.632072365991914e-07,0.628608659422373,0.0
124,0.9,1,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage an effective treatment for postoperative cerebrospinal fluid fistula following spine surgery? Lumbar drainage appears to be both effective and safe in preventing CSF fistula in patients with large dural tears and compromised or irradiated tissues, as well as in treating existing CSF leaks.",1.1842986367842703e-07,0.12163385332616006,0.0027728196434490295,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
124,0.9,2,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Does lumbar drainage work well for postoperative cerebrospinal fluid fistulas after spine surgery? It seems that lumbar drainage is a safe and effective method to prevent CSF fistulas in cases involving significant dural tears and weakened or irradiated patients, and it is also effective in managing CSF leaks.",1.6580180914979784e-07,0.16642988191943964,0.0037170228023798192,0.012693985253473108,0.1650797503594501,0.0,0.012675610786670066,0.16907633004393308,0.0,1.6580180914979784e-07,0.17327172127403623,0.0
124,0.9,3,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is the use of lumbar drainage successful in managing postoperative CSF fistulas after spine surgery? Lumbar drainage is considered effective and safe for both preventing CSF fistula in patients with large dural tears and debilitated or irradiated conditions, and for treating CSF leaks when they occur.",1.1842986367842703e-07,0.12163385332616006,0.0027728196434490295,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
124,0.9,4,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Can lumbar drainage effectively prevent and treat postoperative cerebrospinal fluid fistulas after spine surgery? Lumbar drainage is shown to be a safe and effective approach in preventing CSF fistulas in extensive dural tears and compromised patients, as well as in treating cerebrospinal fluid leaks.",7.105791820705622e-08,0.042499213113674106,0.021417388369294285,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
124,0.9,5,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Does lumbar drainage provide an effective solution for CSF fistulas after spine surgery? Evidence suggests lumbar drainage is both a safe and effective method in preventing CSF fistula in cases of large dural tears and in patients who are debilitated or irradiated, and it also successfully treats CSF leaks.",1.8948778188548325e-07,0.1880977832986206,0.004159661226903637,0.014507411718254981,0.18658595558041347,0.0,0.014486412327622933,0.19105523676270808,0.0,1.8948778188548325e-07,0.19574457712609394,0.0
124,0.9,6,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage an effective and safe option for postoperative CSF fistulas following spine surgery? It appears to be both effective and safe in preventing cerebrospinal fluid fistulas in patients with major dural tears and those debilitated or subjected to irradiation, along with treating existing CSF leaks.",1.4211583641411244e-07,0.11414563352837703,0.018404866306964203,0.010880558788691236,0.1122943022824554,0.02221074380165289,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
124,0.9,7,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"How effective is lumbar drainage in preventing and managing postoperative cerebrospinal fluid fistula after spine surgery? Lumbar drainage is considered both safe and effective for preventing CSF fistula in large dural tear cases and debilitated/irradiated patients, as well as for treating CSF leaks.",4.737194547137081e-08,0.05044051459933652,0.0011882035402833654,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
124,0.9,8,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage a reliable treatment for postoperative cerebrospinal fluid fistulas after spinal surgery? Lumbar drainage has been found to be effective and safe for the prevention of CSF fistula in patients with significant dural tears and those debilitated or irradiated, and for the treatment of CSF leaks.",1.6580180914979784e-07,0.10743863251008268,0.038549494406137745,0.012693985253473108,0.1650797503594501,0.0,0.012675610786670066,0.16907633004393308,0.0,1.6580180914979784e-07,0.17327172127403623,0.0
124,0.9,9,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,Does lumbar drainage effectively prevent and manage postoperative CSF fistulas following spine surgery? Lumbar drainage appears to act as a safe and efficient method to both prevent CSF fistulas in large dural tears and compromised patients and to treat CSF leaks.,0.0,0.034657359027997714,0.024877932399773414,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
124,0.9,10,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage a beneficial intervention for postoperative cerebrospinal fluid fistula after spine surgery? It seems effective and safe in preventing CSF fistulas in cases involving large dural tears and debilitated or irradiated patients, and is also successful in treating CSF leaks.",2.3685972735685406e-08,0.05934997161836808,0.02498356344510192,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
125,0.9,1,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Question: Does using a neuroendoscope simultaneously affect the rate of ventriculoperitoneal shunt infections? Answer: Using a neuroendoscope at the same time does not directly impact the rate of ventriculoperitoneal shunt infections. However, it permits",4.73719454713706e-08,0.08519008295056141,0.0671604938271605,0.003626852929563759,0.09227549154237513,0.09056877188745313,0.003621603081905747,0.10009481734358028,0.10863023149983118,4.737194547137081e-08,0.06253846196508617,0.08915528161323982
125,0.9,2,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Question: Is there an effect of simultaneous neuroendoscope use on ventriculoperitoneal shunt infection rates? Answer: The concurrent use of a neuroendoscope does not directly affect the incidence of infections in ventriculoperitoneal shunts. However, it enables",2.36859727356853e-08,0.36709656630385945,0.24,0.0018134264647818796,0.29633394534911606,0.21301775147928986,0.0018108015409528735,0.22128186153686258,0.1728395061728395,2.3685972735685406e-08,0.1415380968254074,0.12244897959183673
125,0.9,3,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Question: Does simultaneous neuroendoscope application alter ventriculoperitoneal shunt infection occurrence? Answer: The use of a neuroendoscope simultaneously does not have a direct effect on the occurrence of ventriculoperitoneal shunt infections. However, it facilitates",7.10579182070559e-08,0.2631502457024264,0.2087825182101977,0.005440279394345639,0.23381358836778254,0.21301775147928986,0.005432404622858621,0.15674334039929105,0.1728395061728395,7.105791820705622e-08,0.07484672232673395,0.12244897959183673
125,0.9,4,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Question: Does the simultaneous deployment of a neuroendoscope influence ventriculoperitoneal shunt infection frequency? Answer: Simultaneous deployment of a neuroendoscope does not directly affect the frequency of ventriculoperitoneal shunt infections. However, it allows for",7.10579182070559e-08,0.0898634505624405,0.08910836762688609,0.005440279394345639,0.09965606954972861,0.11735448617316739,0.005432404622858621,0.06432371632463196,0.10651297556059462,7.105791820705622e-08,0.027043468495013823,0.08801020408163264
125,0.9,5,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Question: Does performing neuroendoscopy concurrently impact the incidence of ventriculoperitoneal shunt infections? Answer: Concurrent neuroendoscopy use does not directly influence the incidence of ventriculoperitoneal shunt infections. However, it allows for",1.421158364141118e-07,0.01681885634729019,0.10560000000000003,0.010880558788691277,0.016500644633577366,0.10741775147928984,0.010864809245717241,0.05130564645260094,0.09923950617283951,1.4211583641411244e-07,0.0876715835274835,0.08404897959183671
125,0.9,6,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Question: Is the infection rate of ventriculoperitoneal shunts affected by simultaneous neuroendoscope use? Answer: The simultaneous use of a neuroendoscope does not directly impact the infection rate of ventriculoperitoneal shunts. However, it permits",7.10579182070559e-08,0.13318514934743675,0.11755102040816326,0.005440279394345639,0.09965606954972861,0.11735448617316739,0.005432404622858621,0.06432371632463196,0.10651297556059462,7.105791820705622e-08,0.027043468495013823,0.08801020408163264
125,0.9,7,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Question: Does the use of a neuroendoscope at the same time affect ventriculoperitoneal shunt infection rates? Answer: Using a neuroendoscope simultaneously does not directly affect ventriculoperitoneal shunt infection rates. However, it enables",9.47438909427412e-08,0.09584655441543877,0.1137997256515775,0.007253705859127518,0.10860414147013175,0.146691220867045,0.007243206163811494,0.07503853489188916,0.13840073066263542,9.474389094274162e-08,0.039755402515464944,0.12244897959183673
125,0.9,8,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Question: Does the simultaneous application of a neuroendoscope change the likelihood of ventriculoperitoneal shunt infections? Answer: Applying a neuroendoscope simultaneously does not directly modify the likelihood of ventriculoperitoneal shunt infections. However, it facilitates",7.10579182070559e-08,0.0898634505624405,0.08910836762688609,0.005440279394345639,0.09965606954972861,0.11735448617316739,0.005432404622858621,0.06432371632463196,0.10651297556059462,7.105791820705622e-08,0.027043468495013823,0.08801020408163264
125,0.9,9,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Question: Does neuroendoscope use concurrent with shunt placement influence infection incidence? Answer: Neuroendoscope use at the same time as shunt placement does not directly influence infection incidence. However, it allows for",1.184298636784265e-07,0.10330398723786383,0.14123456790123454,0.009067132323909398,0.16712221386910908,0.21301775147928986,0.009054007704764368,0.08775046891234028,0.1728395061728395,1.1842986367842703e-07,0.0033877583445902637,0.12244897959183673
125,0.9,10,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Question: Does simultaneous neuroendoscopic use impact ventriculoperitoneal shunt infection occurrence? Answer: Using a neuroendoscope at the same time does not directly impact the occurrence of ventriculoperitoneal shunt infections. However, it permits",1.184298636784265e-07,0.19572361131252292,0.20670630202140308,0.009067132323909398,0.16712221386910908,0.21301775147928986,0.009054007704764368,0.08775046891234028,0.1728395061728395,1.1842986367842703e-07,0.0033877583445902637,0.12244897959183673
126,0.9,1,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Does using an automatic transmission enhance driving behavior in elderly drivers? Switching to an automatic transmission might be advised for older drivers to help them drive safely and preserve their transport mobility quality.,7.10579182070559e-08,0.13664714594197003,0.03367550941945407,0.005440279394345639,0.1370924930703663,0.0322222222222222,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
126,0.9,2,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Can automatic transmissions improve how older drivers behave behind the wheel? It is suggested that older drivers switch to automatic transmissions to ensure safe driving and maintain their transportation mobility.,1.421158364141118e-07,0.24405032884866928,0.040040392821374504,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
126,0.9,3,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Is driving behavior better among older drivers who use automatic transmissions? Older drivers are often encouraged to switch to automatic transmissions as a way to keep their driving safe and preserve their mobility.,7.10579182070559e-08,0.09332544715697333,0.002670768987034146,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
126,0.9,4,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Does the use of automatic transmission positively affect driving habits in senior drivers? Recommending automatic transmission for older drivers can promote safer driving and sustain their ability to travel independently.,1.421158364141118e-07,0.19624707501694916,0.005892062707435933,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
126,0.9,5,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Do automatic transmissions contribute to improved driving behavior in elderly drivers? Switching to automatic transmission is frequently recommended for older drivers to maintain safe driving and support their transport mobility.,1.421158364141118e-07,0.14844382118522903,0.02854671280276816,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
126,0.9,6,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Is there an improvement in driving behavior among older drivers who use automatic transmission? It may be suggested that older drivers adopt automatic transmissions to help them drive safely and retain their transportation independence.,4.73719454713706e-08,0.0612410097391578,0.0017267246972318406,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
126,0.9,7,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Does automatic transmission enhance the driving performance of older drivers? Older drivers might be advised to switch to automatic transmissions to ensure safer driving and preserve their quality of mobility.,1.421158364141118e-07,0.14844382118522903,0.02854671280276816,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
126,0.9,8,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,"Can switching to automatic transmission improve how seniors drive? For older drivers, choosing automatic transmission can be recommended to maintain safety on the road and their mobility quality.",1.894877818854824e-07,0.271247020764406,0.008435535717941887,0.014507411718255037,0.2682639865946794,0.0,0.014486412327622988,0.2776317365982801,0.0,1.8948778188548325e-07,0.28768207245178123,0.0
126,0.9,9,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Is an automatic transmission beneficial for the driving safety of older drivers? Recommending automatic transmission for elderly drivers can help maintain safe driving habits and uphold their transportation mobility.,1.658018091497971e-07,0.23304565389363718,0.007118582121786017,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
126,0.9,10,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Are driving habits better in older drivers who use automatic transmissions? Suggesting a switch to automatic transmission for seniors may help them drive more safely and sustain their transport mobility.,1.421158364141118e-07,0.14844382118522903,0.02854671280276816,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
127,0.9,1,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does preoperative anemia negatively impact outcomes in colon and rectal surgery? Answer: This extensive multicenter database study indicates that severe, moderate, and even mild preoperative anemia independently increases the risk of complications and prolongs hospital stays following colon surgery.",1.1842986367842692e-07,0.12466730702264872,0.002908287627211844,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
127,0.9,2,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Is there an adverse effect of preoperative anemia on colon and rectal surgery results? Answer: Analysis of a large multicenter database reveals that severe, moderate, and mild preoperative anemia are independent risk factors for complications and extended hospitalization after colon surgery.",7.105791820705622e-08,0.07292293477679124,0.0016600189291508909,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
127,0.9,3,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: How does preoperative anemia affect the outcomes of colon and rectal surgeries? Answer: Findings from a large multicenter database analysis show that all degrees of preoperative anemia—severe, moderate, and mild—serve as independent risk factors for postoperative complications and longer hospital stays after colon surgery.",0.0,0.03150669002545259,0.02271498107084911,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
127,0.9,4,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does having anemia before surgery worsen the outcomes for colon and rectal operations? Answer: A comprehensive analysis of a multicenter database suggests that severe, moderate, and mild preoperative anemia independently contribute to increased complications and longer hospitalizations following colon surgery.",9.474389094274162e-08,0.06380348977887307,0.02271498107084911,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
127,0.9,5,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: What is the impact of preoperative anemia on colon and rectal surgery outcomes? Answer: Data from a large multicenter database study demonstrate that the presence of severe, moderate, and mild anemia before surgery is an independent risk factor for post-surgical complications and lengthier hospital stays after colon surgery.",9.474389094274162e-08,0.11851806701508183,0.02271498107084911,0.0072537058591274906,0.0889474860164956,0.0,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
127,0.9,6,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Is preoperative anemia a risk factor for poor outcomes in colon and rectal surgery? Answer: This large-scale multicenter database analysis suggests that severe, moderate, and even mild anemia before surgery independently raises the risk of complications and leads to longer hospitalization after colon surgery.",0.0,0.03150669002545259,0.02271498107084911,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
127,0.9,7,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does anemia prior to surgery affect the results of colon and rectal procedures? Answer: Evidence from a large multicenter database indicates that severe, moderate, and mild preoperative anemia are independent predictors of complications and prolonged hospital stay following colon surgery.",9.474389094274162e-08,0.06380348977887307,0.02271498107084911,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
127,0.9,8,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: How does preoperative anemia influence colon and rectal surgery outcomes? Answer: Results from a large multicenter database analysis imply that any level of preoperative anemia—severe, moderate, or mild—independently increases the likelihood of complications and longer hospital stays post colon surgery.",9.474389094274162e-08,0.06380348977887307,0.02271498107084911,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
127,0.9,9,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Can preoperative anemia affect complication rates and hospital length of stay after colon surgery? Answer: This extensive multicenter database review suggests that severe, moderate, and mild anemia prior to surgery independently heighten the risk of complications and extended hospitalization after colon surgery.",4.737194547137081e-08,0.04802033420753293,0.0010803788339694455,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
127,0.9,10,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does the presence of preoperative anemia impact postoperative outcomes in colon and rectal surgery? Answer: Analysis of a large multicenter dataset demonstrates that severe, moderate, and mild preoperative anemia independently elevate the risk of complications and prolong hospital stay after colon surgery.",4.737194547137081e-08,0.04802033420753293,0.0010803788339694455,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
128,0.9,1,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Is the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia a predictor of adverse maternal and neonatal outcomes? Research suggests that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia could be a prognostic indicator for negative maternal and neonatal outcomes.,1.1842986367842703e-07,0.1527817737731061,0.09562679761687368,0.009067132323909363,0.1620190739007663,0.13366795631968142,0.009054007704764333,0.17194411193985149,0.16515325239040973,1.1842986367842703e-07,0.1488117283499113,0.16685800158327635
128,0.9,2,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Does the first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia predict adverse outcomes in mothers and newborns? Studies show that the initial urinary albumin/creatinine ratio (ACR) may act as a prognostic factor for maternal and neonatal complications in suspected preeclampsia cases.,1.6580180914979784e-07,0.22778756252209797,0.1780175203402367,0.012693985253473108,0.20796392846980272,0.19928168179916433,0.012675610786670066,0.18751761453670213,0.2111756061050711,1.6580180914979784e-07,0.1664254229518276,0.21551020408163268
128,0.9,3,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Can the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia serve as a prognostic marker for maternal and neonatal adverse outcomes? Evidence suggests that the initial ACR measurement could help predict negative outcomes for both mother and child.,2.3685972735685396e-07,0.25270061616265327,0.2490234375,0.018134264647818726,0.19960213666846105,0.24793388429752067,0.018108015409528666,0.14421343209498794,0.23615916955017302,2.3685972735685406e-07,0.08638271527829344,0.21551020408163268
128,0.9,4,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Is the initial urinary albumin/creatinine ratio (ACR) a prognostic factor for poor maternal and neonatal outcomes in women with suspected preeclampsia? Research indicates that measuring the first ACR may provide prognostic information regarding adverse maternal and neonatal events.,2.8423167282822456e-07,0.1251220523464287,0.19514588647959183,0.02176111757738247,0.10702673870041002,0.22017878225670434,0.0217296184914344,0.08864358094017577,0.23615916955017302,2.8423167282822487e-07,0.02922430143834509,0.21551020408163268
128,0.9,5,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Does the initial urinary albumin/creatinine ratio (ACR) in suspected preeclampsia cases predict adverse maternal and neonatal outcomes? Scientific studies suggest that the first urinary ACR might be used as a prognostic factor for complications affecting both mother and newborn.,2.6054570009253926e-07,0.2267251297593953,0.2490234375,0.0199476911126006,0.17293388958630018,0.24793388429752067,0.019918816950481533,0.11681445790687262,0.23615916955017302,2.6054570009253947e-07,0.0582118383115966,0.21551020408163268
128,0.9,6,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia an indicator for predicting maternal and neonatal adverse outcomes? Research points to the potential of the initial ACR as a prognostic factor for such complications.,3.0791764556390986e-07,0.1726579084891191,0.2490234375,0.023574544042164344,0.11736403843148802,0.24793388429752067,0.023540420032387273,0.05965604406692426,0.23615916955017302,3.079176455639103e-07,0.0006286617113366866,0.21551020408163268
128,0.9,7,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Can the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia predict maternal and neonatal adverse outcomes? Evidence supports that the first ACR value may serve as a prognostic indicator for negative outcomes in these patients.,3.0791764556390986e-07,0.1726579084891191,0.2490234375,0.023574544042164344,0.11736403843148802,0.24793388429752067,0.023540420032387273,0.05965604406692426,0.23615916955017302,3.079176455639103e-07,0.0006286617113366866,0.21551020408163268
128,0.9,8,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Is measuring the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia useful for prognosticating adverse maternal and neonatal outcomes? Research findings suggest that initial ACR levels could predict complications in both mother and infant.,3.3160361829959516e-07,0.14448703152242226,0.2490234375,0.025387970506946224,0.08837650155823651,0.24793388429752067,0.025351221573340146,0.029803080917242486,0.23615916955017302,3.316036182995957e-07,0.031400320378090374,0.21551020408163268
128,0.9,9,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Does the first urinary albumin/creatinine ratio (ACR) serve as a prognostic factor for poor outcomes in mothers and neonates among women with suspected preeclampsia? Studies indicate that initial ACR measurement might be predictive of adverse events.,3.3160361829959516e-07,0.14448703152242226,0.2490234375,0.025387970506946224,0.08837650155823651,0.24793388429752067,0.025351221573340146,0.029803080917242486,0.23615916955017302,3.316036182995957e-07,0.031400320378090374,0.21551020408163268
128,0.9,10,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Is the initial urinary albumin/creatinine ratio (ACR) predictive of maternal and neonatal adverse outcomes in women suspected of preeclampsia? Research suggests that the first ACR value could function as a prognostic marker for these adverse outcomes.,3.3160361829959516e-07,0.14448703152242226,0.2490234375,0.025387970506946224,0.08837650155823651,0.24793388429752067,0.025351221573340146,0.029803080917242486,0.23615916955017302,3.316036182995957e-07,0.031400320378090374,0.21551020408163268
129,0.9,1,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","Preoperative staging of liver metastases in colorectal carcinoma patients benefits from PET/CT as it offers crucial metabolic details that complement multidetector CT, improving tumor extent assessment, lesion detection, and treatment planning.",8.053230730133027e-07,0.5410772077725348,0.15089163237311393,0.06165649980258371,0.5998015172152349,0.124297520661157,0.06156725239239751,0.6384127695821564,0.11107438016528923,8.053230730133038e-07,0.6786801757637453,0.09719008264462808
129,0.9,2,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","PET/CT significantly enhances the preoperative evaluation of colorectal cancer patients with liver metastases by providing metabolic insights that multidetector CT alone cannot, leading to better tumor mapping and therapy guidance.",8.29009045748988e-07,0.5749787594482165,0.15089163237311393,0.06346992626736558,0.6348928370265039,0.124297520661157,0.06337805393335039,0.6747804137530311,0.11107438016528923,8.290090457489892e-07,0.7164205037465923,0.09719008264462808
129,0.9,3,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","In patients with colorectal carcinoma and liver metastases, PET/CT adds valuable metabolic information during preoperative staging, which when combined with multidetector CT, improves detection of tumor spread and additional lesions for optimal treatment decisions.",7.342651548062468e-07,0.44576702796820955,0.15089163237311393,0.05621622040823807,0.5013614444019816,0.124297520661157,0.05613484776953889,0.536630075272214,0.11107438016528923,7.342651548062476e-07,0.5733196601059198,0.09719008264462808
129,0.9,4,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.",The use of PET/CT in conjunction with multidetector CT provides substantial added value in preoperative staging of colorectal liver metastases by delivering detailed metabolic data that aids in accurately defining tumor burden and planning treatment.,7.105791820705615e-07,0.4159140648185278,0.15089163237311393,0.05440279394345619,0.4705897857352279,0.124297520661157,0.05432404622858602,0.5048813769576341,0.11107438016528923,7.105791820705622e-07,0.5405298372829281,0.09719008264462808
129,0.9,5,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","When staging liver metastases from colorectal cancer preoperatively, PET/CT offers important metabolic information that supplements multidetector CT scans, resulting in more precise tumor evaluation and identification of extra lesions for better treatment management.",7.579511275419321e-07,0.47653868663496324,0.15089163237311393,0.05802964687301995,0.5331101427165614,0.124297520661157,0.057945649310491766,0.5694198980952057,0.11107438016528923,7.57951127541933e-07,0.6072212117816016,0.09719008264462808
129,0.9,6,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","For preoperative staging of patients with colorectal carcinoma liver metastases, PET/CT contributes critical metabolic insights beyond multidetector CT, enhancing the detection of tumor extent and additional lesions and aiding effective therapy planning.",7.816371002776174e-07,0.5082873849495431,0.15089163237311393,0.05984307333780183,0.5658999655395531,0.124297520661157,0.05975645085144464,0.6033214497708874,0.11107438016528923,7.816371002776184e-07,0.6423125315928706,0.09719008264462808
129,0.9,7,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","Combining PET/CT with multidetector CT in the preoperative staging of colorectal liver metastases provides significant added diagnostic information, especially metabolic details that improve tumor characterization and treatment strategies.",8.763809912203587e-07,0.6464377234303602,0.15089163237311393,0.06709677919692936,0.7090008091802256,0.124297520661157,0.06699965701525613,0.7517414548891606,0.11107438016528923,8.7638099122036e-07,0.7964632114201295,0.09719008264462808
129,0.9,8,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","PET/CT adds significant metabolic detail to multidetector CT in preoperative staging of colorectal carcinoma patients with liver metastases, leading to improved tumor extent determination, lesion detection, and treatment planning.",8.526950184846733e-07,0.6100700792594855,0.15089163237311393,0.06528335273214747,0.6712604811973786,0.124297520661157,0.06518885547430325,0.7125207417358781,0.11107438016528923,8.526950184846746e-07,0.7556412168998747,0.09719008264462808
129,0.9,9,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","In the preoperative setting for colorectal cancer patients with liver metastases, PET/CT offers vital metabolic information that complements multidetector CT, facilitating more accurate staging, lesion identification, and effective treatment guidance.",8.29009045748988e-07,0.5749787594482165,0.15089163237311393,0.06346992626736558,0.6348928370265039,0.124297520661157,0.06337805393335039,0.6747804137530311,0.11107438016528923,8.290090457489892e-07,0.7164205037465923,0.09719008264462808
129,0.9,10,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","PET/CT provides important metabolic data that enhances the preoperative staging accuracy of colorectal carcinoma liver metastases beyond multidetector CT, helping to delineate tumor spread, discover additional lesions, and optimize treatment approaches.",8.053230730133027e-07,0.5410772077725348,0.15089163237311393,0.06165649980258371,0.5998015172152349,0.124297520661157,0.06156725239239751,0.6384127695821564,0.11107438016528923,8.053230730133038e-07,0.6786801757637453,0.09719008264462808
130,0.9,1,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the long-term importance of postictal psychotic episodes II? Do they predict interictal psychotic episodes? Answer: Having a history of PIPE might increase the risk of developing IPE, but multivariate analysis shows it is not an independent predictor.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
130,0.9,2,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: How significant are postictal psychotic episodes II in the long term? Can they forecast interictal psychotic episodes? Answer: A history of PIPE could be a risk factor for IPE, though multivariate analysis suggests it lacks independent predictive value.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
130,0.9,3,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the long-term impact of postictal psychotic episodes II? Are they indicators of interictal psychotic episodes? Answer: While PIPE history may raise IPE risk, multivariate analysis reveals it is not an independent predictor.",2.6054570009253883e-07,0.2803019651541576,0.0,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
130,0.9,4,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: Long-term relevance of postictal psychotic episodes II: do they serve as predictors for interictal psychotic episodes? Answer: A history of PIPE might predispose individuals to IPE, but this association is not independently significant per multivariate analysis.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
130,0.9,5,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the prolonged significance of postictal psychotic episodes II? Are they predictive of interictal psychotic episodes? Answer: PIPE history may be a risk factor for IPE development; however, multivariate analysis demonstrates it is not an independent predictor.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
130,0.9,6,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: Regarding long-term significance, do postictal psychotic episodes II predict interictal psychotic episodes? Answer: Although PIPE history is a potential risk factor for IPE, it is not an independent predictor based on multivariate analysis.",2.8423167282822413e-07,0.3101549283038394,0.0,0.021761117577382492,0.31845373111853537,0.0,0.021729618491434427,0.32721291120841567,0.0,2.8423167282822487e-07,0.33647223662121295,0.0
130,0.9,7,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the long-term predictive value of postictal psychotic episodes II for interictal psychotic episodes? Answer: A prior history of PIPE may indicate increased IPE risk, yet it does not independently predict IPE as shown by multivariate analysis.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
130,0.9,8,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: Can postictal psychotic episodes II predict interictal psychotic episodes in the long term? Answer: PIPE history may raise the risk for IPE, but multivariate analysis shows it is not an independent predictor.",3.0791764556390943e-07,0.38424828575559067,0.031217481789802305,0.023574544042164372,0.3502024294331152,0.0,0.0235404200323873,0.36000273403140737,0.0,3.079176455639103e-07,0.3703737882968947,0.0
130,0.9,9,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the long-term role of postictal psychotic episodes II in predicting interictal psychotic episodes? Answer: Although a history of PIPE could indicate higher IPE risk, it fails to be an independent predictor according to multivariate analysis.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
130,0.9,10,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: Do postictal psychotic episodes II have long-term significance as predictors of interictal psychotic episodes? Answer: While a history of PIPE may be a risk factor for IPE, multivariate analysis finds it is not an independent predictor.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
131,0.9,1,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Can a previous benign prostate biopsy predict the outcomes for patients undergoing radical perineal prostatectomy? Answer: Having a prior benign prostate biopsy might be independently linked to better surgical and biochemical results following prostatectomy. Further research is required to validate these observations.,2.3685972735685406e-08,0.059519707147746015,0.025214681440443212,0.0018134264647818726,0.06019527305807593,0.025486495844875334,0.0018108015409528666,0.06086381724377565,0.025623268698060954,2.3685972735685406e-08,0.025975486403257975,0.0
131,0.9,2,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Does a history of benign prostate biopsy influence the prognosis of patients treated with radical perineal prostatectomy? Answer: A previous benign prostate biopsy could be independently correlated with improved surgical and biochemical outcomes post-prostatectomy. Additional studies are necessary to confirm these findings.,2.3685972735685406e-08,0.059519707147746015,0.025214681440443212,0.0018134264647818726,0.06019527305807593,0.025486495844875334,0.0018108015409528666,0.06086381724377565,0.025623268698060954,2.3685972735685406e-08,0.025975486403257975,0.0
131,0.9,3,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Is prior benign prostate biopsy a predictor of outcomes in patients receiving radical perineal prostatectomy? Answer: Prior benign prostate biopsy may independently predict more favorable surgical and biochemical outcomes after prostatectomy. Further investigations are needed to verify these results.,4.7371945471370706e-08,0.055212275588245596,0.0036742074484456683,0.0036268529295637453,0.05494143744312874,0.0026076399575938047,0.003621603081905733,0.054565139391337336,0.0013829041414452105,4.737194547137081e-08,0.05406722127027619,0.0
131,0.9,4,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Does having had a benign prostate biopsy before impact the results of radical perineal prostatectomy? Answer: A prior benign prostate biopsy might be independently associated with better surgical and biochemical outcomes following prostatectomy. Additional research is needed to confirm these findings.,0.0,0.03381205758829031,0.024062478942086886,0.0,0.034657359027997714,0.024877932399773414,0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0
131,0.9,5,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Can prior benign prostate biopsy serve as an indicator for outcomes in patients treated with radical perineal prostatectomy? Answer: An earlier benign prostate biopsy may independently correlate with more favorable surgical and biochemical outcomes after prostatectomy. Further studies must confirm these results.,2.3685972735685406e-08,0.059519707147746015,0.025214681440443212,0.0018134264647818726,0.06019527305807593,0.025486495844875334,0.0018108015409528666,0.06086381724377565,0.025623268698060954,2.3685972735685406e-08,0.025975486403257975,0.0
131,0.9,6,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Does a previous benign prostate biopsy predict the outcome in patients undergoing radical perineal prostatectomy? Answer: Prior benign prostate biopsy may independently relate to improved surgical and biochemical outcomes post-prostatectomy. More research is required to substantiate these findings.,7.1057918207056e-08,0.047512595324624485,0.020245545637974087,0.005440279394345618,0.046114238579118894,0.02285532300536917,0.0054324046228586,0.04449669841405024,0.025623268698060954,7.105791820705622e-08,0.08223809823697303,0.0
131,0.9,7,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Is outcome prediction possible through prior benign prostate biopsy in patients treated with radical perineal prostatectomy? Answer: A history of benign prostate biopsy might be independently linked to better surgical and biochemical outcomes after prostatectomy. Additional studies are needed for confirmation.,0.0,0.03381205758829031,0.024062478942086886,0.0,0.034657359027997714,0.024877932399773414,0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0
131,0.9,8,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Does a benign prostate biopsy done earlier affect the outcomes of radical perineal prostatectomy? Answer: Prior benign prostate biopsy may be independently associated with improved surgical and biochemical results following prostatectomy. Further research is necessary to verify these findings.,4.7371945471370706e-08,0.019666266328761672,0.021582468146067776,0.0036268529295637453,0.01846000688734195,0.02356492900776796,0.003621603081905733,0.017097724225934918,0.025623268698060954,4.737194547137081e-08,0.05406722127027619,0.0
131,0.9,9,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Can prior benign prostate biopsy independently predict outcomes in patients with radical perineal prostatectomy? Answer: An earlier benign prostate biopsy might be linked to more favorable surgical and biochemical outcomes post-prostatectomy. Additional studies are needed for confirmation.,9.474389094274131e-08,0.07615281162601795,0.01883713042003505,0.0072537058591274906,0.07455397429960664,0.022106393804059005,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
131,0.9,10,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Does previous benign prostate biopsy status influence surgical and biochemical outcomes after radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with better surgical and biochemical outcomes after prostatectomy. Further research is essential to confirm these results.,0.0,0.1014361727648696,0.06932613488608742,0.0,0.0693147180559941,0.04890393625389012,0.0,0.03554600925948437,0.025508944596314496,0.0,0.03648143055578634,0.026296566837107373
132,0.9,1,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Could neoadjuvant chemotherapy alter the extent of lymphadenectomy in cervical cancer? Yes, neoadjuvant chemotherapy in cervical cancer might change how extensive lymphadenectomy needs to be. It can shrink the tumor and lessen lymph node involvement, potentially reducing the surgery's scope. Further studies are still needed.",2.3685972735685406e-07,0.13944720370433483,0.046277014207043374,0.018134264647818726,0.1306223057196969,0.05640000000000001,0.018108015409528666,0.18691459335344662,0.01922337562475971,2.3685972735685406e-07,0.21825356602001733,0.0
132,0.9,2,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Is it possible for neoadjuvant chemotherapy to influence the extent of lymphadenectomy in cervical cancer? Yes, it can potentially modify the extent by decreasing tumor size and the number of affected lymph nodes, thereby limiting the surgical extent. More research is necessary to confirm this.",2.3685972735685406e-07,0.10794051367888269,0.06891350705909675,0.018134264647818726,0.1306223057196969,0.05640000000000001,0.018108015409528666,0.18691459335344662,0.01922337562475971,2.3685972735685406e-07,0.21825356602001733,0.0
132,0.9,3,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Can neoadjuvant chemotherapy affect the lymphadenectomy extent in cervical cancer? Yes, this treatment may reduce tumor dimensions and lymph node involvement, which could decrease the extent of lymphadenectomy. Additional research is required to validate this.",4.737194547137075e-07,0.33426293295553,0.09162848812994587,0.03626852929563747,0.39531485994677906,0.05640000000000001,0.03621603081905735,0.45884830883708805,0.01922337562475971,4.737194547137081e-07,0.49783842823917857,0.0
132,0.9,4,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Does neoadjuvant chemotherapy have the potential to change the extent of lymphadenectomy in cervical cancer? Yes, it could reduce tumor size and lymph node involvement, leading to a less extensive lymphadenectomy. However, more investigation is still needed.",4.263475092423369e-07,0.27710451911558165,0.09162848812994587,0.03264167636607371,0.3364743599238458,0.05640000000000001,0.032594427737151606,0.3982236870206526,0.01922337562475971,4.263475092423373e-07,0.43531807125784505,0.0
132,0.9,5,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Might the extent of lymphadenectomy be altered by neoadjuvant chemotherapy in cervical cancer? Yes, this chemotherapy may shrink tumors and reduce the number of involved lymph nodes, which could limit the surgical intervention. Further research remains necessary.",4.263475092423369e-07,0.27710451911558165,0.09162848812994587,0.03264167636607371,0.3364743599238458,0.05640000000000001,0.032594427737151606,0.3982236870206526,0.01922337562475971,4.263475092423373e-07,0.43531807125784505,0.0
132,0.9,6,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Could neoadjuvant chemotherapy modify the required extent of lymphadenectomy in cervical cancer? Yes, by potentially reducing both tumor size and lymph node involvement, it might decrease the needed surgical extent. More studies are needed to support this.",4.263475092423369e-07,0.27710451911558165,0.09162848812994587,0.03264167636607371,0.3364743599238458,0.05640000000000001,0.032594427737151606,0.3982236870206526,0.01922337562475971,4.263475092423373e-07,0.43531807125784505,0.0
132,0.9,7,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Is the extent of lymphadenectomy in cervical cancer amenable to modification by neoadjuvant chemotherapy? Yes, neoadjuvant chemotherapy can lessen tumor burden and lymph node involvement, which may reduce the scope of lymphadenectomy. Further research is warranted.",4.500334819780222e-07,0.3052753960822785,0.09162848812994587,0.03445510283085559,0.3654618967970973,0.05640000000000001,0.03440522927810448,0.42807665017033436,0.01922337562475971,4.500334819780227e-07,0.46608972992459874,0.0
132,0.9,8,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Does neoadjuvant chemotherapy potentially impact the extent of lymphadenectomy in cervical cancer? Yes, it can reduce tumor size and lymph node involvement, potentially leading to a narrower lymphadenectomy. However, additional research is required.",5.210914001850781e-07,0.39488755477196547,0.09162848812994587,0.039895382225201226,0.4578352169281126,0.05640000000000001,0.0398376339009631,0.5233868299746596,0.01922337562475971,5.210914001850789e-07,0.564529802737852,0.0
132,0.9,9,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Can neoadjuvant chemotherapy influence the extent of lymphadenectomy in cervical cancer treatment? Yes, it may reduce the tumor and the number of involved lymph nodes, thus limiting the surgical extent. More studies are necessary to confirm these effects.",4.026615365066516e-07,0.24970554492746633,0.09162848812994587,0.030828249901291835,0.30830348295714893,0.05640000000000001,0.030783626196198732,0.3692361501474011,0.01922337562475971,4.026615365066519e-07,0.4054651081081633,0.0
132,0.9,10,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Is it feasible for neoadjuvant chemotherapy to change how much lymphadenectomy is performed in cervical cancer? Yes, it might reduce tumor size and lymph node involvement, potentially decreasing the extent of lymphadenectomy. Nonetheless, further research is needed.",4.263475092423369e-07,0.27710451911558165,0.09162848812994587,0.03264167636607371,0.3364743599238458,0.05640000000000001,0.032594427737151606,0.3982236870206526,0.01922337562475971,4.263475092423373e-07,0.43531807125784505,0.0
133,0.9,1,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Is there an important role of environmental factors in primary systemic vasculitis? A novel significant link between farming and PSV has been found. Additionally, findings reinforce earlier associations with silica, solvents, and allergies.",4.73719454713706e-08,0.060624621816435464,0.0,0.003626852929563759,0.06252035698133351,0.0,0.003621603081905747,0.06453852113757153,0.0,4.737194547137081e-08,0.06669137449867346,0.0
133,0.9,2,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Do environmental factors play a crucial role in primary systemic vasculitis? For the first time, a significant connection between farming and PSV has been identified. The results also affirm prior findings related to silica, solvents, and allergic reactions.",7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
133,0.9,3,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Are environmental influences significant in primary systemic vasculitis? A strong association between farming and PSV has been newly discovered. The data also backs previous links with silica, solvents, and allergies.",1.184298636784265e-07,0.15906469462968875,0.0,0.009067132323909398,0.16430305129127598,0.0,0.009054007704764368,0.16989903679539697,0.0,1.1842986367842703e-07,0.17589066646366414,0.0
133,0.9,4,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Is primary systemic vasculitis affected by environmental factors? A significant correlation between farming and PSV has been established for the first time. The study also supports earlier reported associations with silica, solvents, and allergy.",2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
133,0.9,5,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Does primary systemic vasculitis have important environmental risk factors? A significant farming-PSV connection has been identified for the first time. The results further support previously noted associations involving silica, solvents, and allergies.",7.10579182070559e-08,0.09237332013101529,0.0,0.005440279394345639,0.09531017980432521,0.0,0.005432404622858621,0.09844007281325329,0.0,7.105791820705622e-08,0.10178269430994247,0.0
133,0.9,6,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Are environmental factors relevant to primary systemic vasculitis? For the first time, a notable association between farming and PSV has been found, along with confirmation of earlier links to silica, solvents, and allergic conditions.",2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
133,0.9,7,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Is there a significant impact of environmental factors on primary systemic vasculitis? A first-time detection of a strong farming-PSV association has been reported, with results also confirming earlier links to silica, solvents, and allergies.",2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
133,0.9,8,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Do environmental elements significantly influence primary systemic vasculitis? A newly identified strong association between farming and PSV has emerged, alongside previously documented connections to silica, solvents, and allergies.",1.658018091497971e-07,0.23052365861183244,0.0,0.012693985253473157,0.23841102344499765,0.0,0.012675610786670115,0.24686007793152642,0.0,1.6580180914979784e-07,0.2559333741372014,0.0
133,0.9,9,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Is primary systemic vasculitis significantly associated with environmental factors? A substantial farming correlation with PSV has been identified for the first time, supporting earlier findings involving silica, solvents, and allergy.",1.184298636784265e-07,0.15906469462968875,0.0,0.009067132323909398,0.16430305129127598,0.0,0.009054007704764368,0.16989903679539697,0.0,1.1842986367842703e-07,0.17589066646366414,0.0
133,0.9,10,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Are environmental exposures important in primary systemic vasculitis? A significant association between farming and PSV has been recognized for the first time. The evidence also supports previously known associations with silica, solvents, and allergic reactions.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
134,0.9,1,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Does the Supplemental Security Income program decrease disability rates among the elderly? The program itself does not directly lower disability in older adults, but it offers financial support to elderly disabled individuals, which can indirectly benefit their health by helping them access essential medical care, medications, and therapies.",2.1317375462116866e-07,0.001917293885105309,0.12244897959183677,0.016320838183036854,0.05266502864156797,0.08999999999999998,0.0162972138685758,0.10530520339840521,0.05536332179930796,2.1317375462116866e-07,0.15994578225423828,0.018860946745562133
134,0.9,2,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Is disability among the elderly reduced by the Supplemental Security Income program? While the program does not directly diminish disability, it supplies financial aid to elderly people with disabilities, aiding them in affording crucial treatments and healthcare, which may improve their overall well-being.",3.316036182995957e-07,0.11439527731179533,0.12244897959183677,0.025387970506946217,0.16773435842635465,0.08999999999999998,0.025351221573340132,0.22308823905478858,0.05536332179930796,3.316036182995957e-07,0.28057377004285566,0.018860946745562133
134,0.9,3,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Does the Supplemental Security Income program help reduce elderly disability? The program does not directly affect disability levels but provides monetary assistance to disabled elderly individuals, which can indirectly promote health by enabling access to necessary medical services and treatments.",4.026615365066518e-07,0.18850324946551877,0.12244897959183677,0.030828249901291835,0.24372026540427605,0.08999999999999998,0.030783626196198732,0.30104978052449916,0.05536332179930796,4.026615365066519e-07,0.3606164777163898,0.018860946745562133
134,0.9,4,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Can the Supplemental Security Income program lower disability rates in the elderly? The program itself does not directly reduce disability, but by providing financial resources to elderly individuals with disabilities, it allows them to obtain medical care and medications that support their health.",3.316036182995957e-07,0.11439527731179533,0.12244897959183677,0.025387970506946217,0.16773435842635465,0.08999999999999998,0.025351221573340132,0.22308823905478858,0.05536332179930796,3.316036182995957e-07,0.28057377004285566,0.018860946745562133
134,0.9,5,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Does the Supplemental Security Income program have a role in reducing disability among elderly people? It does not directly reduce disability but offers financial help to disabled elderly persons, facilitating access to medical treatments and therapies that can indirectly improve their health.",3.552895910352811e-07,0.13849282889085535,0.12244897959183677,0.02720139697172809,0.19242697101672634,0.08999999999999998,0.027162023114293,0.2484060470390803,0.05536332179930796,3.552895910352811e-07,0.30654925644611364,0.018860946745562133
134,0.9,6,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Is disability in the elderly decreased by the Supplemental Security Income program? The program does not directly reduce disability but gives financial support to elderly disabled individuals, helping them afford necessary healthcare and therapies, indirectly influencing their health.",4.500334819780224e-07,0.24114698295093762,0.12244897959183677,0.03445510283085558,0.29778748667455224,0.08999999999999998,0.034405229278104466,0.3566196316793113,0.05536332179930796,4.500334819780227e-07,0.4177748915563382,0.018860946745562133
134,0.9,7,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Does the Supplemental Security Income program directly reduce disability in the elderly? No, it doesn’t, but it provides financial assistance to elderly people with disabilities, which can indirectly impact their health by enabling access to essential medical treatments and care.",4.026615365066518e-07,0.18850324946551877,0.12244897959183677,0.030828249901291835,0.24372026540427605,0.08999999999999998,0.030783626196198732,0.30104978052449916,0.05536332179930796,4.026615365066519e-07,0.3606164777163898,0.018860946745562133
134,0.9,8,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Does the Supplemental Security Income program lower disability rates among older adults? While it does not directly reduce disability, it offers financial aid to elderly individuals with disabilities, which can help them obtain medical care and medications, indirectly benefiting their well-being.",3.789755637709665e-07,0.16318544148122704,0.12244897959183677,0.029014823436509962,0.21774477900101807,0.08999999999999998,0.028972824655245866,0.2743815334423383,0.05536332179930796,3.789755637709665e-07,0.3332175035282745,0.018860946745562133
134,0.9,9,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Is there a reduction in elderly disability due to the Supplemental Security Income program? The program itself does not directly reduce disability but supplies financial assistance to disabled elderly individuals, which helps them afford necessary medical care, thereby indirectly improving their health.",3.552895910352811e-07,0.13849282889085535,0.12244897959183677,0.02720139697172809,0.19242697101672634,0.08999999999999998,0.027162023114293,0.2484060470390803,0.05536332179930796,3.552895910352811e-07,0.30654925644611364,0.018860946745562133
134,0.9,10,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Does the Supplemental Security Income program reduce disability among elderly individuals? Directly, no; however, it provides financial support to disabled elderly people, indirectly enhancing their health by allowing them to access essential medical treatments and therapies.",4.97405427449393e-07,0.2967168341057498,0.12244897959183677,0.03808195576041933,0.3549459005145006,0.08999999999999998,0.03802683236001021,0.4154601317022446,0.05536332179930796,4.974054274493935e-07,0.47839951337277364,0.018860946745562133
135,0.9,1,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is primary angioplasty a valid alternative to thrombolysis? Yes, primary angioplasty is regarded as an acceptable and frequently preferable alternative to thrombolysis, typically linked to reduced mortality, lower risk of reinfarction, and decreased incidence of intracranial bleeding. The decision between",9.474389094274152e-08,0.10425168058893775,0.004731261479979244,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
135,0.9,2,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Can primary angioplasty substitute thrombolysis effectively? Indeed, primary angioplasty is accepted as a suitable and often superior option compared to thrombolysis, usually resulting in fewer deaths, diminished reinfarction risk, and less intracranial hemorrhage. The selection between",1.8948778188548272e-07,0.1809816570279117,0.017854239011628047,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
135,0.9,3,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is it appropriate to use primary angioplasty instead of thrombolysis? Yes, primary angioplasty is widely accepted and often deemed better than thrombolysis, as it generally leads to lower death rates, decreased chances of reinfarction, and fewer cases of intracranial hemorrhage. The choice between",2.3685972735685406e-08,0.007941301485662411,0.02260559190957765,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
135,0.9,4,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Does primary angioplasty serve as an acceptable alternative to thrombolysis? Yes, it is considered a valid and often superior alternative, usually associated with reduced mortality, less reinfarction risk, and a lower likelihood of intracranial bleeding. The choice between",1.4211583641411212e-07,0.0858033955553883,0.046400951814396206,0.010880558788691236,0.1541506798272576,0.0,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
135,0.9,5,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is primary angioplasty an effective substitute for thrombolysis? Yes, primary angioplasty is an accepted and frequently better choice than thrombolysis, commonly linked with lower mortality rates, reduced reinfarction risk, and fewer intracranial hemorrhages. The choice between",1.8948778188548272e-07,0.1809816570279117,0.017854239011628047,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
135,0.9,6,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Can primary angioplasty replace thrombolysis as an acceptable treatment? Yes, it is recognized as an acceptable and often superior alternative, generally resulting in lower mortality, reduced reinfarction risk, and decreased intracranial hemorrhage. The decision between",2.1317375462116802e-07,0.25190751070815187,0.012192798185603794,0.016320838183036868,0.2831709768508235,0.0302734375,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
135,0.9,7,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is primary angioplasty considered a proper alternative to thrombolysis? Yes, it is viewed as an acceptable and often preferable alternative, typically associated with lower death rates, less chance of reinfarction, and reduced intracranial bleeding. The choice between",1.6580180914979742e-07,0.11320236974350362,0.046400951814396206,0.012693985253473108,0.18232155679395445,0.0,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
135,0.9,8,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Should primary angioplasty be used as an alternative to thrombolysis? Yes, primary angioplasty is an accepted and often better alternative to thrombolysis, often linked to lower mortality, decreased reinfarction risk, and less intracranial hemorrhage. The choice between",1.6580180914979742e-07,0.1902187231390533,0.008962369984911768,0.012693985253473108,0.18232155679395445,0.0,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
135,0.9,9,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is primary angioplasty an acceptable option instead of thrombolysis? Yes, it is regarded as a valid and often superior alternative, usually associated with less mortality, lower risk of reinfarction, and fewer incidents of intracranial hemorrhage. The decision between",1.4211583641411212e-07,0.0858033955553883,0.046400951814396206,0.010880558788691236,0.1541506798272576,0.0,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
135,0.9,10,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is primary angioplasty a preferable alternative to thrombolysis? Yes, primary angioplasty is considered acceptable and frequently superior, commonly accompanied by lower mortality rates, reduced reinfarction risk, and a diminished chance of intracranial hemorrhage. The choice between",1.8948778188548272e-07,0.1809816570279117,0.017854239011628047,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
136,0.9,1,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Indeed, recovery outcome measures must take into account culture, attitudes, and faith, as these elements greatly affect an individual's view of recovery and their methods.",4.73719454713706e-08,0.06014745969624036,0.004277281160398022,0.0036268529295637453,0.05771084630712098,0.001540539963261995,0.00362160308190574,0.05715841383994835,0.0,4.737194547137081e-08,0.058840500022933284,0.0
136,0.9,2,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Recovery Outcome Measures: Should Culture, Attitudes, and Faith Be Included? Answer: Yes, culture, attitudes, and faith are crucial and should be incorporated into recovery outcome measures since they shape how a person perceives and approaches recovery.",0.0,0.03850817669777484,0.026730371900826458,0.0,0.039608410317710785,0.028386253221106945,0.0,0.04077336356234973,0.029384756657483937,0.0,0.0,0.0
136,0.9,3,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Recovery Outcome Measures: Are Culture, Attitudes, and Faith Relevant? Answer: Absolutely, including culture, attitudes, and faith in recovery outcome measures is important because they influence a person’s perception and strategy towards recovery.",9.47438909427412e-08,0.17554530070304653,0.03980435149266319,0.007253705859127518,0.17119079256525804,0.03566256187024015,0.007243206163811494,0.17137295499133653,0.033293697978596916,9.474389094274162e-08,0.12921173148000697,0.0
136,0.9,4,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Recovery Outcome Measures: Is it Important to Consider Culture, Attitudes, and Faith? Answer: Yes, considering culture, attitudes, and faith is vital in recovery outcome measures as they significantly impact how an individual perceives recovery and responds to it.",4.73719454713706e-08,0.06014745969624036,0.004277281160398022,0.0036268529295637453,0.05771084630712098,0.001540539963261995,0.00362160308190574,0.05715841383994835,0.0,4.737194547137081e-08,0.058840500022933284,0.0
136,0.9,5,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Question: Should Recovery Outcome Measures Account for Culture, Attitudes, and Faith? Answer: Yes, these factors play a significant role in shaping a person's perception and approach to recovery, hence they should be reflected in the measures.",0.0,0.11552453009332453,0.08264462809917354,0.0,0.03960841031771123,0.02854671280276816,0.0,0.0,0.0,0.0,0.0,0.0
136,0.9,6,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Recovery Outcome Measures: Do Culture, Attitudes, and Faith Matter? Answer: Yes, they do; culture, attitudes, and faith strongly influence an individual's recovery perception and approach, so they should be included in outcome measures.",7.10579182070559e-08,0.09751360699811373,0.007355371900826496,0.005440279394345639,0.13664714594197003,0.03367550941945407,0.005432404622858621,0.1370924930703663,0.0322222222222222,7.105791820705622e-08,0.09531017980432521,0.0
136,0.9,7,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Recovery Outcome Measures: Is It Necessary to Include Culture, Attitudes, and Faith? Answer: Yes, because these aspects substantially affect how a person views and approaches recovery, they should be considered in outcome measurements.",7.10579182070559e-08,0.0285131531036944,0.08264462809917354,0.005440279394345639,0.05000374837197574,0.02854671280276816,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
136,0.9,8,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Question: Are Culture, Attitudes, and Faith Relevant in Recovery Outcome Measures? Answer: Yes, these factors are important as they deeply impact a person's perception and method of recovery and should be included.",9.47438909427412e-08,0.0022585055630592876,0.08264462809917354,0.007253705859127518,0.08175244668655557,0.02854671280276816,0.007243206163811494,0.125163142954007,0.0,9.474389094274162e-08,0.12921173148000697,0.0
136,0.9,9,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Recovery Outcome Measures: Should Cultural, Attitudinal, and Faith Elements Be Considered? Answer: Yes, as these components critically shape a person's perception of recovery and their approach to it, they deserve inclusion.",1.184298636784265e-07,0.034007203877639114,0.08264462809917354,0.009067132323909398,0.11454226950954727,0.02854671280276816,0.009054007704764368,0.15906469462968875,0.0,1.1842986367842703e-07,0.16430305129127598,0.0
136,0.9,10,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Recovery Outcome Measures: Is There Value in Incorporating Culture, Attitudes, and Faith? Answer: Certainly, because culture, attitudes, and faith significantly influence how individuals perceive and manage recovery, they should be factored into the measures.",4.73719454713706e-08,0.023180610871323726,0.024050878099173542,0.003626852929563759,0.0612410097391578,0.0017267246972318406,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
137,0.9,1,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is cholecystectomy a definite indication for simultaneous splenectomy in mild hereditary spherocytosis? No, cholecystectomy alone does not automatically indicate the need for splenectomy in mild hereditary spherocytosis. While both surgeries can be used to manage hereditary spherocytosis, their application depends on the severity of the patient's condition. Splenectomy is usually reserved for more severe cases. Decisions should be made on a case-by-case basis.",2.1317375462116866e-07,0.272859193741287,0.08075501955253714,0.016320838183036854,0.2741349131244837,0.08067234009739073,0.0162972138685758,0.2753252353536091,0.0802190286019325,2.1317375462116866e-07,0.2764179873671644,0.07939508506616257
137,0.9,2,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Does cholecystectomy always warrant a concurrent splenectomy in mild hereditary spherocytosis? No, performing a cholecystectomy does not necessarily mean a splenectomy must be done at the same time in patients with mild hereditary spherocytosis. Both procedures are treatment options but are based on individual patient severity, with splenectomy generally reserved for severe presentations. Clinical judgement is essential.",7.105791820705622e-08,0.2134000023918028,0.11116577356309267,0.005440279394345618,0.21604650831872263,0.113421550094518,0.0054324046228586,0.19306962571444952,0.09688090737240077,7.105791820705622e-08,0.16917245701356665,0.07939508506616257
137,0.9,3,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is simultaneous splenectomy required when performing cholecystectomy in mild hereditary spherocytosis? No, cholecystectomy does not inherently indicate splenectomy in mild hereditary spherocytosis. Although both surgeries are options for managing hereditary spherocytosis, the choice depends on how severe the disease is, with splenectomy typically recommended for severe cases. Treatment decisions should be personalized.",4.737194547137081e-08,0.09026471607974873,0.08986665921335546,0.0036268529295637453,0.09301044129199898,0.09342987995707527,0.003621603081905733,0.09590587726080102,0.09688090737240077,4.737194547137081e-08,0.07008155436933672,0.07939508506616257
137,0.9,4,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Does mild hereditary spherocytosis need concomitant splenectomy when cholecystectomy is performed? No, mild hereditary spherocytosis patients undergoing cholecystectomy do not always need a splenectomy at the same time. Both procedures treat hereditary spherocytosis, but splenectomy is mostly reserved for severe disease cases. Individual patient assessment guides treatment choice.",1.4211583641411244e-07,0.003959920405923967,0.08654787743004502,0.010880558788691236,0.007217885637957444,0.0916931550327896,0.0108648092457172,0.010748068920493736,0.09688090737240077,1.4211583641411244e-07,0.016929822620292523,0.07939508506616257
137,0.9,5,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is it necessary to do splenectomy during cholecystectomy in mild hereditary spherocytosis? No, cholecystectomy alone does not mandate a concurrent splenectomy in mild hereditary spherocytosis. While both surgeries are used to treat hereditary spherocytosis, splenectomy is usually reserved for more severe forms of the disease, and treatment depends on patient-specific factors.",7.105791820705622e-08,0.06937479908857291,0.0890864576769586,0.005440279394345618,0.07224189954137028,0.09302224453896245,0.0054324046228586,0.07528659005806526,0.09688090737240077,7.105791820705622e-08,0.04902814517150356,0.07939508506616257
137,0.9,6,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Should splenectomy be performed alongside cholecystectomy in mild hereditary spherocytosis? No, a cholecystectomy does not automatically require a splenectomy in patients with mild hereditary spherocytosis. Both operations are treatment strategies, but splenectomy is generally indicated for severe cases. Decisions should be individualized based on the patient’s condition.",1.6580180914979784e-07,0.011308130656928927,0.10728861817078576,0.012693985253473108,0.01537581285657108,0.113421550094518,0.012675610786670066,0.01172478693156398,0.09688090737240077,1.6580180914979784e-07,0.039919340844992046,0.07939508506616257
137,0.9,7,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is concomitant splenectomy indicated during cholecystectomy for mild hereditary spherocytosis? No, performing a cholecystectomy does not necessarily mean splenectomy should be done simultaneously in mild hereditary spherocytosis. Both are treatment approaches, but splenectomy is usually reserved for severe disease, and choices depend on the patient's specific clinical status.",1.4211583641411244e-07,0.03345554511060245,0.10775047258979206,0.010880558788691236,0.037354719575346085,0.113421550094518,0.0108648092457172,0.010748068920493736,0.09688090737240077,1.4211583641411244e-07,0.016929822620292523,0.07939508506616257
137,0.9,8,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Does undergoing cholecystectomy mean splenectomy is required in mild hereditary spherocytosis? No, cholecystectomy is not a compulsory indication for splenectomy in mild hereditary spherocytosis. Both procedures treat hereditary spherocytosis but splenectomy is typically saved for severe cases, with treatment tailored to the patient’s individual needs.",2.1317375462116866e-07,0.09752686805287203,0.06120023750378123,0.016320838183036854,0.06232596496716036,0.09017891970903047,0.0162972138685758,0.05824480256645792,0.09688090737240077,2.1317375462116866e-07,0.08754738983424648,0.07939508506616257
137,0.9,9,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is a splenectomy obligatorily performed with cholecystectomy in mild hereditary spherocytosis? No, cholecystectomy does not obligatorily mean a splenectomy is needed in mild hereditary spherocytosis. While both surgeries are treatment options, splenectomy is mostly reserved for severe cases, and the decision depends on patient condition.",2.1317375462116866e-07,0.12903355807832462,0.039017013232514164,0.016320838183036854,0.06232596496716036,0.09017891970903047,0.0162972138685758,0.05824480256645792,0.09688090737240077,2.1317375462116866e-07,0.08754738983424648,0.07939508506616257
137,0.9,10,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","In mild hereditary spherocytosis, does cholecystectomy indicate the need for a splenectomy as well? No, the presence of mild hereditary spherocytosis does not mean that splenectomy must be done with cholecystectomy. Both surgeries can be used to treat the disease, but splenectomy is generally only indicated for severe cases. Treatment decisions are individualized.",2.3685972735685406e-08,0.13738777974203753,0.10979363760775446,0.0018134264647818726,0.14053895581057674,0.113421550094518,0.0018108015409528666,0.11610858457831963,0.09688090737240077,2.3685972735685406e-08,0.09070084157207248,0.07939508506616257
138,0.9,1,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Is aneurysm repair recommended for patients aged 80 or above following aneurysmal subarachnoid hemorrhage? It is usually considered appropriate by doctors, mainly based on the patient’s overall health and surgical fitness rather than age alone, while weighing the risks and benefits.",3.079176455639103e-07,0.07216048040121992,0.14617283950617282,0.023574544042164344,0.12772503078410402,0.113421550094518,0.023540420032387266,0.15832826112343934,0.09688090737240077,3.079176455639103e-07,0.19020154389432875,0.07939508506616257
138,0.9,2,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","For patients 80 years or older who have experienced aneurysmal subarachnoid hemorrhage, is aneurysm repair justified? Physicians generally justify the procedure, focusing more on the patient's general condition and suitability for surgery rather than just their chronological age, while considering associated risks and advantages.",2.3685972735685406e-07,0.0001601811784062157,0.14617283950617282,0.018134264647818726,0.053617058630380576,0.113421550094518,0.018108015409528666,0.08234235414551794,0.09688090737240077,2.3685972735685406e-07,0.11224000242461818,0.07939508506616257
138,0.9,3,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","In patients aged 80 or older with aneurysmal subarachnoid hemorrhage, does aneurysm repair make sense? Medical professionals often approve the surgery, emphasizing the patient's overall health and operative candidacy over age, alongside evaluating potential risks and benefits.",4.026615365066515e-07,0.1775209960590458,0.14617283950617282,0.030828249901291835,0.23593861542433503,0.113421550094518,0.03078362619619874,0.2695538962336639,0.09688090737240077,4.026615365066519e-07,0.3046118950720742,0.07939508506616257
138,0.9,4,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Is it appropriate to perform aneurysm repair on patients aged 80+ after aneurysmal subarachnoid hemorrhage? Typically, clinicians justify the repair based largely on the patient's general health status and surgical fitness instead of age alone, balancing the risks and benefits.",3.316036182995956e-07,0.09747828838551165,0.14617283950617282,0.025387970506946217,0.153700517187362,0.113421550094518,0.025351221573340132,0.1849965082056002,0.09688090737240077,3.316036182995957e-07,0.21760051808244407,0.07939508506616257
138,0.9,5,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Should patients aged 80 or over receive aneurysm repair after aneurysmal subarachnoid hemorrhage? This treatment is usually deemed justified by physicians, who prioritize the patient’s physical fitness and health rather than age, while assessing risk and benefit factors.",3.789755637709662e-07,0.1501220218709305,0.14617283950617282,0.029014823436509962,0.20776773845763818,0.113421550094518,0.028972824655245866,0.24056635936041237,0.09688090737240077,3.789755637709665e-07,0.2747589319223924,0.07939508506616257
138,0.9,6,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Is aneurysm repair suitable for patients 80 years or older following an aneurysmal subarachnoid hemorrhage? Doctors typically justify the procedure based on overall patient health and surgical suitability, not solely age, considering associated risks and benefits.",4.263475092423368e-07,0.20569187302574266,0.14617283950617282,0.032641676366073714,0.26492615229758654,0.113421550094518,0.03259442773715161,0.29940685938334566,0.09688090737240077,4.263475092423373e-07,0.3353835537388279,0.07939508506616257
138,0.9,7,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","For patients aged 80 and above after aneurysmal subarachnoid hemorrhage, is aneurysm repair warranted? Physicians often support the repair, focusing on the patient’s general health and fitness for surgery more than their age, while weighing potential risks and benefits.",3.552895910352809e-07,0.12345377478876962,0.14617283950617282,0.02720139697172809,0.18036876426952286,0.113421550094518,0.027162023114293,0.21239548239371553,0.09688090737240077,3.552895910352811e-07,0.24577139504914092,0.07939508506616257
138,0.9,8,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Does aneurysm repair justify itself in patients aged 80 or older post-aneurysmal subarachnoid hemorrhage? Medical experts usually base this decision on the patient’s overall condition and readiness for surgery instead of age, considering the balance of risks and benefits.",3.552895910352809e-07,0.12345377478876962,0.14617283950617282,0.02720139697172809,0.18036876426952286,0.113421550094518,0.027162023114293,0.21239548239371553,0.09688090737240077,3.552895910352811e-07,0.24577139504914092,0.07939508506616257
138,0.9,9,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Is performing aneurysm repair on patients aged 80 or older after aneurysmal subarachnoid hemorrhage justified? The decision is typically grounded in the patient's general physical health and surgical candidacy rather than age alone, taking into account the risks and benefits.",3.316036182995956e-07,0.09747828838551165,0.14617283950617282,0.025387970506946217,0.153700517187362,0.113421550094518,0.025351221573340132,0.1849965082056002,0.09688090737240077,3.316036182995957e-07,0.21760051808244407,0.07939508506616257
138,0.9,10,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","When treating patients aged 80+ with aneurysmal subarachnoid hemorrhage, is aneurysm repair justified? Physicians generally consider it appropriate, prioritizing the patient’s overall health and ability to undergo surgery over chronological age, while evaluating risks and benefits.",4.263475092423368e-07,0.20569187302574266,0.14617283950617282,0.032641676366073714,0.26492615229758654,0.113421550094518,0.03259442773715161,0.29940685938334566,0.09688090737240077,4.263475092423373e-07,0.3353835537388279,0.07939508506616257
139,0.9,1,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","In treated hypertensive patients, systolic blood pressure recorded by nurses is notably lower than that taken by physicians and closely matches ambulatory blood pressure monitoring, making nurse measurements preferable for diagnosis and control assessment.",8.526950184846739e-07,0.6112947757339384,0.11646131122346151,0.06528335273214744,0.6926117570328567,0.044023668639053264,0.06518885547430323,0.750014454292089,0.014921946740128552,8.526950184846746e-07,0.7884573603642693,0.0
139,0.9,2,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","For patients under treatment for hypertension, systolic BP values measured by nurses are significantly less than those recorded by doctors and are nearly the same as ambulatory BP readings, suggesting nurse measurements are beneficial for diagnosis and monitoring control.",7.342651548062474e-07,0.42820725744009636,0.1467347487234615,0.05621622040823805,0.5474297471883576,0.044023668639053264,0.056134847769538865,0.6004827203211254,0.014921946740128552,7.342651548062476e-07,0.6343066805370108,0.0
139,0.9,3,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","Among treated hypertensive individuals, systolic blood pressure readings by nurses are considerably lower compared to physician measurements and resemble ambulatory BP monitoring, indicating nurse-based measurement is valuable for diagnosis and control evaluation.",9.000669639560445e-07,0.6318062126813362,0.1467347487234615,0.06891020566171119,0.7571502781704282,0.044023668639053264,0.06881045855620897,0.8167058287907625,0.014921946740128552,9.000669639560454e-07,0.85745023185122,0.0
139,0.9,4,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","In patients with treated hypertension, systolic blood pressure measured by nurses is markedly lower than readings by physicians and aligns closely with ambulatory monitoring, supporting the use of nurse measurements for both diagnosis and control assessment.",8.053230730133033e-07,0.5104453556770694,0.1467347487234615,0.06165649980258368,0.6319871352164212,0.044023668639053264,0.06156725239239748,0.6874940973107555,0.014921946740128552,8.053230730133038e-07,0.7239188392266978,0.0
139,0.9,5,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","Systolic BP in treated hypertensive patients, when measured by nurses, is significantly reduced relative to physician readings and corresponds closely to ambulatory BP, making nurse measurements advantageous for diagnosis and control evaluation.",9.000669639560445e-07,0.6318062126813362,0.1467347487234615,0.06891020566171119,0.7571502781704282,0.044023668639053264,0.06881045855620897,0.8167058287907625,0.014921946740128552,9.000669639560454e-07,0.85745023185122,0.0
139,0.9,6,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","Treated hypertensive patients exhibit lower systolic blood pressure readings when measured by nurses compared to physicians, with these readings almost matching ambulatory BP monitoring, thus nurse measurement is preferred for diagnosis and assessing control.",8.526950184846739e-07,0.5692858557000027,0.1467347487234615,0.06528335273214744,0.6926117570328567,0.044023668639053264,0.06518885547430323,0.750014454292089,0.014921946740128552,8.526950184846746e-07,0.7884573603642693,0.0
139,0.9,7,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","The systolic blood pressure of treated hypertensive patients measured by nurses is significantly less than that by doctors and nearly identical to ambulatory monitoring, supporting nurse-based measurement for diagnosis and control management.",9.000669639560445e-07,0.6318062126813362,0.1467347487234615,0.06891020566171119,0.7571502781704282,0.044023668639053264,0.06881045855620897,0.8167058287907625,0.014921946740128552,9.000669639560454e-07,0.85745023185122,0.0
139,0.9,8,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","In treated hypertension, nurses measure systolic blood pressure at levels significantly lower than physicians do, closely resembling ambulatory BP readings, making nurse measurement ideal for diagnosis and control assessment.",9.711248821631004e-07,0.7335889069912787,0.1467347487234615,0.07435048505605683,0.8625107938282537,0.044023668639053264,0.07424286317906759,0.9259051207557532,0.014921946740128552,9.711248821631017e-07,0.9707789171582242,0.0
139,0.9,9,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","Systolic blood pressure readings taken by nurses in treated hypertensive patients are significantly lower than those taken by physicians and closely match ambulatory blood pressure levels, suggesting nurse measurement is desirable for diagnosis and control evaluation.",8.053230730133033e-07,0.5896621763124914,0.08980178269958641,0.06165649980258368,0.6319871352164212,0.044023668639053264,0.06156725239239748,0.6874940973107555,0.014921946740128552,8.053230730133038e-07,0.7239188392266978,0.0
139,0.9,10,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","For patients treated for hypertension, systolic blood pressure measured by nurses is substantially lower than physician measurements and nearly equals ambulatory BP monitoring, favoring nurse-based detection for diagnosis and control evaluation.",9.237529366917298e-07,0.6645960355043279,0.1467347487234615,0.07072363212649307,0.79105182984611,0.044023668639053264,0.07062126009716185,0.8517971486020315,0.014921946740128552,9.237529366917308e-07,0.8938178760220947,0.0
140,0.9,1,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","The application of audits to detect maternal mortality across various environments: is it merely a contrast between wealth and poverty? Variations in maternal mortality extend beyond just economic disparities. Recognizing the scale of maternal mortality and mobilizing robust political commitment are crucial. Yet, no universal remedy exists to lower maternal mortality, and pinpointing issues is essential.",3.789755637709665e-07,0.21027494283862458,0.026273691966756524,0.02901482343650999,0.21990278516737227,0.02854671280276816,0.028972824655245866,0.24372336842021047,0.014489619377162637,3.789755637709665e-07,0.26826398659468076,0.0
140,0.9,2,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Audit usage to uncover maternal mortality in different contexts: is it simply a matter of rich versus poor? Maternal mortality differences surpass economic divides. Understanding the extent of maternal mortality and fostering strong political will to address it are key. Nonetheless, there is no one-size-fits-all approach to decrease maternal mortality, and diagnosing problems is vital.",4.026615365066519e-07,0.22973379088931356,0.024877608793692718,0.030828249901291863,0.2385949181795266,0.02854671280276816,0.030783626196198732,0.2627715633909036,0.014489619377162637,4.026615365066519e-07,0.28768207245178345,0.0
140,0.9,3,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Using audits to identify maternal mortality in diverse settings: is it only about economic disparities? The differences in maternal mortality involve more than just wealth gaps. Recognizing the severity of maternal mortality and having political determination to confront it are critical. However, there isn't a single universal solution to reduce maternal mortality, and problem identification is necessary.",3.552895910352811e-07,0.19118636043139992,0.02761906381435003,0.027201396971728117,0.2015536464991765,0.02854671280276816,0.027162023114293,0.22503123540805614,0.014489619377162637,3.552895910352811e-07,0.24921579162398766,0.0
140,0.9,4,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","The role of audits in identifying maternal mortality in various locations: is it just a matter of wealth differences? Maternal mortality disparities involve more than poverty versus affluence. Appreciating the magnitude of maternal mortality and securing strong political resolve to tackle it are important. Still, no singular universal solution exists to lower maternal mortality, and recognizing issues is crucial.",3.079176455639103e-07,0.1540655844218506,0.03016833455145143,0.023574544042164372,0.16583556389709742,0.02854671280276816,0.023540420032387266,0.1886635912371819,0.014489619377162637,3.079176455639103e-07,0.21217451994363756,0.0
140,0.9,5,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Employing audits to detect maternal mortality across different settings: is the difference solely between rich and poor? Differences in maternal mortality go beyond economic status. Acknowledging the seriousness of maternal mortality and cultivating strong political will are vital. Yet, no universal solution exists, and identifying challenges is imperative.",5.684633456564497e-07,0.3776604083448034,0.013407815529027658,0.04352223515476497,0.38024543524255305,0.02854671280276816,0.0434592369828688,0.4073527922020119,0.014489619377162637,5.684633456564497e-07,0.43531807125784683,0.0
140,0.9,6,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Use of audit to pinpoint maternal mortality in various settings: is it just a gap between the wealthy and the poor? Maternal mortality variations are more complex than simple economic differences. Recognizing the extent of maternal mortality and harnessing political commitment are essential. However, no single general solution can reduce maternal mortality, and problem identification is key.",3.552895910352811e-07,0.19118636043139992,0.02761906381435003,0.027201396971728117,0.2015536464991765,0.02854671280276816,0.027162023114293,0.22503123540805614,0.014489619377162637,3.552895910352811e-07,0.24921579162398766,0.0
140,0.9,7,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Applying audits to find maternal mortality in multiple environments: is it purely an economic divide? The disparity in maternal mortality is more than just about wealth. Recognizing maternal mortality's scale and engaging political willpower are important. Nonetheless, there is no one general fix to reduce maternal mortality; identifying issues remains crucial.",4.974054274493935e-07,0.2733867032107238,0.08032972563849852,0.03808195576041935,0.3170665336210208,0.02854671280276816,0.0380268323600102,0.3428142710644404,0.014489619377162637,4.974054274493935e-07,0.36936010346605075,0.0
140,0.9,8,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Audit as a tool to recognize maternal mortality in different contexts: is it merely a rich-poor divide? The differences in maternal mortality surpass economic lines. Acknowledging how extensive maternal mortality is and driving strong political will to address it are necessary. However, no single universal solution exists, and problem identification is vital.",4.737194547137081e-07,0.2904824409667408,0.020354715226170314,0.03626852929563748,0.29686382630350217,0.02854671280276816,0.03621603081905733,0.32219498386170464,0.014489619377162637,4.737194547137081e-07,0.3483066942682176,0.0
140,0.9,9,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Using audits to reveal maternal mortality in different settings: is it simply an issue of socioeconomic status? Maternal mortality differences are more complex than just wealth disparities. Understanding the magnitude of maternal mortality and encouraging political resolve are important factors. Yet, there is no single general approach to reduce maternal mortality, and identifying problems is essential.",3.789755637709665e-07,0.21027494283862458,0.026273691966756524,0.02901482343650999,0.21990278516737227,0.02854671280276816,0.028972824655245866,0.24372336842021047,0.014489619377162637,3.789755637709665e-07,0.26826398659468076,0.0
140,0.9,10,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Utilizing audits to identify maternal mortality across varied settings: is it only about the divide between rich and poor? The differences in maternal mortality involve more than economic factors. Recognizing the scale of maternal mortality and mobilizing strong political will are critical. Still, there's no one universal solution to reduce maternal mortality, and problem identification is fundamental.",3.552895910352811e-07,0.19118636043139992,0.02761906381435003,0.027201396971728117,0.2015536464991765,0.02854671280276816,0.027162023114293,0.22503123540805614,0.014489619377162637,3.552895910352811e-07,0.24921579162398766,0.0
141,0.9,1,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Is it possible for visceral adipose tissue (VAT) area measurement at one level to represent the entire VAT volume? VAT area measured at a single point 3 cm above the lower border of the L3 vertebra is practical and can indicate variations in VAT volume and body weight. New insights: VAT area measured at a CT slice 3 cm above the lower margin of L3 vertebra can correlate with VAT volume and body weight changes.,3.316036182995957e-07,0.22468590257237864,0.04391259105098852,0.025387970506946286,0.17848190050716317,0.02390978969326553,0.025351221573340146,0.16775592055691924,0.03461892108146444,3.316036182995957e-07,0.20489901752696493,0.010607082309924604
141,0.9,2,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Can a single-level measurement of visceral adipose tissue area adequately represent total visceral adipose tissue volume? Measuring VAT area at a single level located 3 cm above the inferior margin of L3 vertebra is feasible and capable of reflecting alterations in VAT volume and body weight. Updated knowledge: VAT area at a CT slice 3 cm above the lower border of L3 vertebra is informative.,9.474389094274162e-08,0.06603904040281527,0.03552865788536841,0.0072537058591274906,0.02904714867097491,0.025355795610425308,0.007243206163811466,0.04741586892136507,0.013823218169772923,9.474389094274162e-08,0.09214355004261776,0.017538265306122455
141,0.9,3,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Does measuring visceral adipose tissue area at a specific level effectively represent the visceral adipose tissue volume? The VAT area recorded at a point 3 cm above the lower edge of the L3 vertebra is a viable measure that reflects changes in both VAT volume and body weight. Knowledge advances: VAT area at a CT slice 3 cm above the L3 vertebra's lower margin correlates with VAT volume.,1.6580180914979784e-07,0.1353986398267617,0.020252385349338264,0.012693985253473108,0.1455820310290945,0.023665406262623596,0.012675610786670066,0.1404199076252466,0.019057916135204092,1.6580180914979784e-07,0.1401527692289788,0.017538265306122455
141,0.9,4,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Can the measurement of visceral adipose tissue area at one level serve as a representation of visceral adipose tissue volume? VAT area assessed 3 cm above the lower margin of the L3 vertebra is both feasible and indicative of changes in VAT volume and body weight. New findings: VAT area on a CT slice 3 cm above the L3 vertebra lower edge is informative.,7.105791820705622e-08,0.09051797516360338,0.061111111111111144,0.005440279394345618,0.055281581767254284,0.003994581428663643,0.0054324046228586,0.052781833323533256,0.0016895655130768211,7.105791820705622e-08,0.07561424809140682,0.017538265306122455
141,0.9,5,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Is a measurement of visceral adipose tissue area at a single anatomical level an accurate representation of visceral adipose tissue volume? Measuring VAT area 3 cm above the lower border of the L3 vertebra is practical and reflects changes in VAT volume and body weight. Progress in knowledge: VAT area on CT at 3 cm above L3 vertebra lower margin corresponds to VAT volume.,7.105791820705622e-08,0.13452731996105882,0.09062500000000001,0.005440279394345618,0.10000075470660574,0.03575721070959768,0.0054324046228586,0.07550797039107238,0.018049886621315195,7.105791820705622e-08,0.07561424809140682,0.017538265306122455
141,0.9,6,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Can a single-level measurement of visceral adipose tissue area reflect the overall visceral adipose tissue volume? VAT area measured 3 cm above the lower margin of L3 vertebra is feasible and mirrors changes in VAT volume and body weight. Advances: VAT area at a CT slice positioned 3 cm above the lower edge of L3 vertebra is representative.,7.105791820705622e-08,0.054732968843403285,0.03250339520144857,0.005440279394345618,0.08323471888572564,0.02158079561042535,0.0054324046228586,0.08092262754331303,0.01992512981523971,7.105791820705622e-08,0.05541838536493415,0.0009736606461737303
141,0.9,7,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,"Is visceral adipose tissue area measurement at a single site sufficient to represent visceral adipose tissue volume? Measuring VAT area at a single level, 3 cm above the L3 vertebra's lower boundary, is practical and can indicate changes in VAT volume and body weight. Knowledge development: VAT area at a CT slice 3 cm above L3 vertebra lower margin can reflect VAT volume.",4.737194547137081e-08,0.06288392098888229,0.02128871484514064,0.0036268529295637453,0.03718830790615657,0.0027054288793706,0.003621603081905733,0.05859989948873601,0.017776896739735835,4.737194547137081e-08,0.05880712977502611,0.017538265306122455
141,0.9,8,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Can the visceral adipose tissue area at one level serve as a proxy for visceral adipose tissue volume? VAT area measurement 3 cm above the lower border of the L3 vertebra is feasible and reflects changes in VAT volume and body weight. Advances in understanding: VAT area on CT slice 3 cm above L3 vertebra lower edge correlates with VAT volume.,0.0,0.10114042647073518,0.10123456790123456,0.0,0.07048954378575578,0.05016263313688157,0.0,0.04780325383172013,0.03443877551020409,0.0,0.024320953703857562,0.017538265306122455
141,0.9,9,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Is the visceral adipose tissue area at a single level representative of the visceral adipose tissue volume? VAT area assessed at 3 cm above the L3 vertebra's lower border is feasible and reflects changes in VAT volume and body weight. Knowledge enhancement: VAT area at a CT slice 3 cm above L3 lower margin correlates with VAT volume.,7.105791820705622e-08,0.006091061435688161,0.063390254060808,0.005440279394345618,0.03372420598858694,0.013013287229811377,0.0054324046228586,0.03051192350258969,0.01626319251980629,7.105791820705622e-08,0.029746267566417295,0.017538265306122455
141,0.9,10,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Does measuring the visceral adipose tissue area at a single level accurately represent visceral adipose tissue volume? VAT area measurement at a single point 3 cm above the lower margin of the L3 vertebra is feasible and reflects changes in VAT volume and body weight. Advances in knowledge: VAT area at a CT slice above the L3 vertebra is indicative.,2.3685972735685406e-08,0.04436752888761175,0.018315972222222227,0.0018134264647818726,0.019119994962340403,0.001420453851792347,0.0018108015409528666,0.006090557415993736,0.01690051020408164,2.3685972735685406e-08,0.006621376604456941,0.017538265306122455
142,0.9,1,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does the menopausal transition influence quality of life? Indeed, it does. Commonly, it brings physical symptoms like hot flashes and sleep problems, alongside psychological challenges such as mood swings and depression.",2.605457000925384e-07,0.17712645468899346,0.09642074506939374,0.01994769111260064,0.2522689060714689,0.049861495844875335,0.01991881695048158,0.29581112669495635,0.025623268698060954,2.6054570009253947e-07,0.341749293722057,0.0
142,0.9,2,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Is quality of life impacted by the menopausal transition? Yes, this transition often leads to physical issues including hot flashes and disrupted sleep, as well as mental health concerns like mood changes and depression.",1.894877818854825e-07,0.08181627488466825,0.09642074506939374,0.014507411718255002,0.1538288332582156,0.049861495844875335,0.01448641232762296,0.19402843238501388,0.025623268698060954,1.8948778188548325e-07,0.23638877806423153,0.0
142,0.9,3,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does experiencing menopausal transition change one's quality of life? Yes, it typically causes physical symptoms such as hot flashes and sleep disturbances, coupled with psychological effects like mood swings and depression.",2.605457000925384e-07,0.17712645468899346,0.09642074506939374,0.01994769111260064,0.2522689060714689,0.049861495844875335,0.01991881695048158,0.29581112669495635,0.025623268698060954,2.6054570009253947e-07,0.341749293722057,0.0
142,0.9,4,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Can the menopausal transition affect quality of life? Yes, it is frequently linked to physical symptoms like hot flashes and sleep disturbance, plus psychological conditions such as mood swings and depression.",2.605457000925384e-07,0.17712645468899346,0.09642074506939374,0.01994769111260064,0.2522689060714689,0.049861495844875335,0.01991881695048158,0.29581112669495635,0.025623268698060954,2.6054570009253947e-07,0.341749293722057,0.0
142,0.9,5,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Is there an effect on quality of life during menopausal transition? Yes, menopausal transition is usually accompanied by physical symptoms like hot flashes and sleep problems, along with psychological disturbances such as mood swings and depression.",1.421158364141119e-07,0.022975774861734966,0.09642074506939374,0.010880558788691243,0.09320421144178015,0.049861495844875335,0.010864809245717214,0.13150807540368037,0.025623268698060954,1.4211583641411244e-07,0.17185025692666,0.0
142,0.9,6,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does the transition through menopause alter quality of life? Yes, it often results in physical symptoms including hot flashes and sleep disruption, as well as psychological issues like mood swings and depression.",2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
142,0.9,7,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does the menopausal transition have an impact on quality of life? Yes, it is commonly associated with physical symptoms like hot flashes, sleep difficulties, and psychological problems including mood swings and depression.",2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
142,0.9,8,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Is quality of life affected by menopausal transition? Yes, this period often involves physical symptoms such as hot flashes and sleep disturbances, in addition to psychological challenges like mood swings and depression.",2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
142,0.9,9,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does undergoing menopausal transition influence quality of life? Yes, it frequently brings about physical symptoms like hot flashes and sleep issues, along with psychological symptoms such as mood swings and depression.",2.605457000925384e-07,0.17712645468899346,0.09642074506939374,0.01994769111260064,0.2522689060714689,0.049861495844875335,0.01991881695048158,0.29581112669495635,0.025623268698060954,2.6054570009253947e-07,0.341749293722057,0.0
142,0.9,10,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does the menopausal transition impact quality of life? Yes, it is regularly associated with physical symptoms such as hot flashes and disrupted sleep, and psychological factors including mood swings and depression.",2.605457000925384e-07,0.17712645468899346,0.09642074506939374,0.01994769111260064,0.2522689060714689,0.049861495844875335,0.01991881695048158,0.29581112669495635,0.025623268698060954,2.6054570009253947e-07,0.341749293722057,0.0
143,0.9,1,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"What is the prognosis for low-tone sudden deafness—is progression to Meniere's disease inevitable? Our findings indicate that not every patient with low-tone sudden deafness (SD), even those experiencing vertigo at onset, has endolymphatic hydrops, and that electrocochleography (ECochG) serves as a valuable prognostic instrument.",7.105791820705622e-08,0.03940701666772872,0.0201457993665786,0.005440279394345618,0.03818633012873196,0.02221074380165289,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
143,0.9,2,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness always progress to Meniere's disease? We conclude that patients with low-tone sudden deafness (SD) do not necessarily have endolymphatic hydrops, despite initial vertigo attacks, and that electrocochleography (ECochG) is a useful tool for prognosis.",2.1317375462116834e-07,0.23238464630089695,0.010489121268342054,0.016320838183036854,0.2308451866537644,0.005544358239163438,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
143,0.9,3,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is progression to Meniere's disease unavoidable in cases of low-tone sudden deafness? Our study shows that not all low-tone sudden deafness patients with early vertigo suffer from endolymphatic hydrops, and electrocochleography (ECochG) proves to be a helpful prognostic method.",1.8948778188548304e-07,0.1672629994437167,0.01709186291495875,0.014507411718254981,0.16493803576787425,0.02221074380165289,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
143,0.9,4,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness inevitably lead to Meniere's disease? We found that endolymphatic hydrops is not present in all patients with low-tone sudden deafness (SD) even if vertigo occurs initially, and that electrocochleography (ECochG) is a reliable prognostic test.",1.8948778188548304e-07,0.20374442999950348,0.009080706050403016,0.014507411718254981,0.20240545093327666,0.004795429037853273,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
143,0.9,5,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is Meniere's disease a guaranteed outcome for patients with low-tone sudden deafness? Our research indicates that endolymphatic hydrops does not affect every SD patient experiencing vertigo at onset, and that electrocochleography (ECochG) is beneficial for prognosis.",2.6054570009253894e-07,0.2130196671249034,0.043388429752066124,0.019947691112600606,0.24949542379593792,0.02221074380165289,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
143,0.9,6,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness always result in Meniere's disease? We conclude that not all patients with low-tone sudden deafness (SD), despite having vertigo attacks at onset, develop endolymphatic hydrops, and that electrocochleography (ECochG) is a useful prognostic tool.",2.1317375462116834e-07,0.23238464630089695,0.010489121268342054,0.016320838183036854,0.2308451866537644,0.005544358239163438,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
143,0.9,7,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Can low-tone sudden deafness progress inevitably to Meniere's disease? Findings suggest that endolymphatic hydrops is not universal among low-tone sudden deafness (SD) patients experiencing initial vertigo, and electrocochleography (ECochG) offers valuable prognostic information.",3.3160361829959484e-07,0.38927522338458465,0.018833792470156104,0.025387970506946245,0.3865879168663042,0.01001147842056931,0.025351221573340167,0.3829922522561069,0.0,3.316036182995957e-07,0.39390428570708913,0.0
143,0.9,8,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is it inevitable that low-tone sudden deafness leads to Meniere's disease? We conclude that even with vertigo at onset, not all low-tone sudden deafness patients have endolymphatic hydrops, and electrocochleography (ECochG) serves as an effective prognostic tool.",2.3685972735685364e-07,0.26186514355375623,0.01197489204724185,0.018134264647818726,0.26011629724039764,0.006335969001115268,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
143,0.9,9,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Will patients with low-tone sudden deafness definitely develop Meniere's disease? Evidence shows that endolymphatic hydrops is not present in every such patient with vertigo initially, and electrocochleography (ECochG) is a useful method for prognosis.",3.0791764556390954e-07,0.2718601671478367,0.043388429752066124,0.023574544042164365,0.3101200456123734,0.02221074380165289,0.023540420032387294,0.3502024294331152,0.0,3.079176455639103e-07,0.36000273403140737,0.0
143,0.9,10,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does the prognosis of low-tone sudden deafness necessarily include progression to Meniere's disease? Our conclusion is that not all patients with low-tone sudden deafness (SD) who experience vertigo at the onset have endolymphatic hydrops, with electrocochleography (ECochG) being a helpful prognostic tool.",1.1842986367842703e-07,0.12241977708658869,0.005263772746290217,0.009067132323909363,0.12163385332616006,0.0027728196434490295,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
144,0.9,1,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Is there a connection between a resident's leadership skills and their technical skill ratings? Answer: Yes, a resident's leadership abilities can be connected to their technical skill ratings. Strong leaders frequently possess excellent technical skills because they must comprehend and supervise the tasks. Their technical expertise affects their credibility, decision-making, and leadership effectiveness.",4.737194547137081e-08,0.02646425294240551,0.02752741190013426,0.0036268529295637453,0.011629129321992782,0.035199999999999974,0.003621603081905733,0.013846713931445542,0.037677816224529016,4.737194547137081e-08,0.012561206208669073,0.01922337562475971
144,0.9,2,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Do residents' leadership skills impact their technical skill ratings? Answer: Yes, residents' leadership skills can influence how their technical skills are rated. Effective leaders often demonstrate high technical competence as they need to understand and manage the work. This proficiency can enhance their credibility, decision-making, and guidance abilities.",1.6580180914979784e-07,0.0715434597724025,0.04523300476653244,0.012693985253473108,0.06564359836482891,0.05233345935727789,0.012675610786670066,0.08933752230378511,0.037677816224529016,1.6580180914979784e-07,0.11792172186649497,0.01922337562475971
144,0.9,3,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Are a resident’s leadership skills associated with their technical skill ratings? Answer: Yes, there is a relationship between residents’ leadership skills and technical skill ratings. Competent leaders tend to have strong technical skills to effectively understand and oversee tasks. Their technical ability boosts their credibility, decision-making, and ability to lead.",1.1842986367842703e-07,0.02725572934934828,0.04769968149305523,0.009067132323909363,0.005524722740418486,0.07359999999999998,0.009054007704764333,0.04677790788498859,0.037677816224529016,1.1842986367842703e-07,0.0744366099267566,0.01922337562475971
144,0.9,4,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Does leadership ability in residents correlate with ratings of technical skill? Answer: Yes, residents' leadership ability can correlate with technical skill ratings. Successful leaders usually possess solid technical skills as understanding and overseeing work is essential. Their technical competence impacts credibility, decision-making, and their leadership capacity.",2.1317375462116866e-07,0.0877333444959838,0.06406679723668854,0.016320838183036854,0.0796330855998888,0.07359999999999998,0.0162972138685758,0.13378928487461783,0.037677816224529016,2.1317375462116866e-07,0.1633840959432522,0.01922337562475971
144,0.9,5,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Do leadership skills of residents relate to assessments of their technical skills? Answer: Yes, the leadership skills of residents can be related to evaluations of their technical skills. Effective leaders often have high technical proficiency to properly comprehend and supervise tasks. This proficiency influences their credibility, decision-making, and leadership.",1.4211583641411244e-07,0.10573938327721377,0.006732086492886938,0.010880558788691236,0.10173796203231023,0.011377777777777764,0.0108648092457172,0.09732694178750023,0.016411275581806915,1.4211583641411244e-07,0.09594281514771996,0.01922337562475971
144,0.9,6,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Is there a link between residents’ leadership skills and technical skill ratings? Answer: Yes, residents’ leadership skills can be linked to their technical skill ratings. Effective leaders often master technical skills to understand and manage work well. Their technical expertise enhances their credibility, decision-making, and guiding abilities.",1.8948778188548325e-07,0.12393597021895664,0.023085297297029406,0.014507411718254981,0.08779101281850243,0.05187160493827159,0.014486412327622933,0.11131642902256011,0.037677816224529016,1.8948778188548325e-07,0.14039457771855268,0.01922337562475971
144,0.9,7,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Do resident leadership skills correspond with ratings of their technical skills? Answer: Yes, residents’ leadership skills correspond with technical skill ratings. Leaders who are effective usually have strong technical understanding to oversee work tasks. Their technical prowess affects their credibility, decision-making, and their ability to lead others.",1.8948778188548325e-07,0.12393597021895664,0.023085297297029406,0.014507411718254981,0.11792784675589152,0.03021157024793386,0.014486412327622933,0.1421229703807798,0.015467072422876125,1.8948778188548325e-07,0.14039457771855268,0.01922337562475971
144,0.9,8,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Are residents' leadership capabilities related to their technical skill ratings? Answer: Yes, leadership capabilities of residents are related to how their technical skills are rated. Effective leaders often exhibit proficient technical skills necessary to oversee and understand their work. These skills impact their credibility, decision-making, and leadership effectiveness.",1.6580180914979784e-07,0.10042459229573364,0.024810598889581092,0.012693985253473108,0.036147973660150434,0.07359999999999998,0.012675610786670066,0.08933752230378511,0.037677816224529016,1.6580180914979784e-07,0.11792172186649497,0.01922337562475971
144,0.9,9,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Does a resident’s leadership skill level affect their technical skill rating? Answer: Yes, the level of leadership skill in residents can affect their technical skill ratings. Effective leadership typically requires strong technical skills to manage and comprehend tasks. This proficiency boosts their credibility, decision-making, and leadership capacity.",1.8948778188548325e-07,0.12393597021895664,0.023085297297029406,0.014507411718254981,0.11792784675589152,0.03021157024793386,0.014486412327622933,0.1421229703807798,0.015467072422876125,1.8948778188548325e-07,0.14039457771855268,0.01922337562475971
144,0.9,10,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Is there an association between the leadership skills of residents and their technical skill ratings? Answer: Yes, residents’ leadership skills are associated with ratings of their technical skills. Good leaders often have technical expertise to oversee and guide work effectively. Their technical skill level influences their credibility, decision-making, and ability to lead.",7.105791820705622e-08,0.02155784661049065,0.010600328566800918,0.005440279394345618,0.018347814979217336,0.05399999999999999,0.0054324046228586,0.005955913364734222,0.037677816224529016,7.105791820705622e-08,0.03276391352618768,0.01922337562475971
145,0.9,1,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Is it acceptable for student examiners to serve as reasonable substitutes for faculty in an undergraduate OSCE focused on medical emergencies? Answer: Student examiners may be deemed reasonable substitutes for faculty in such OSCEs, offering beneficial peer review and assessment. However, they might...",4.737194547137081e-08,0.039792938054130644,0.05520083608351943,0.0036268529295637453,0.0434990987235393,0.061958071759904323,0.003621603081905733,0.04594485456903641,0.06561372547948291,4.737194547137081e-08,0.04858051119494311,0.06919926203966259
145,0.9,2,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Can student examiners adequately replace faculty members in an undergraduate OSCE on medical emergencies? Answer: Student examiners can reasonably substitute faculty during an undergraduate OSCE on medical emergencies, contributing valuable peer assessment and review. Still, they may...",1.8948778188548293e-07,0.1366293220873489,0.03763082656135869,0.014507411718254981,0.1271550854027641,0.05031936082049408,0.014486412327622933,0.1238718561047003,0.05733296195396415,1.8948778188548325e-07,0.12005442283718448,0.06479806882728058
145,0.9,3,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Are student examiners appropriate substitutes for faculty in an undergraduate OSCE assessing medical emergencies? Answer: Student examiners are reasonable alternatives to faculty in undergraduate OSCEs on medical emergencies, providing useful peer feedback and evaluation. Nonetheless, they might...",1.8948778188548293e-07,0.024227076591141206,0.11558921304095052,0.014507411718254981,0.011630555309439572,0.13296398891966763,0.014486412327622933,0.04465503546927829,0.11426592797783926,1.8948778188548325e-07,0.07928105927483475,0.09418282548476452
145,0.9,4,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: May student examiners serve as suitable substitutes for faculty in an undergraduate medical emergencies OSCE? Answer: Student examiners can be reasonably used in place of faculty for undergraduate OSCEs on medical emergencies, offering meaningful peer review and assessment. However, they may...",9.474389094274162e-08,0.11954985021145692,0.14509176406135868,0.0072537058591274906,0.09372996034838632,0.13296398891966763,0.007243206163811466,0.06355854917095272,0.11426592797783926,9.474389094274162e-08,0.03194457583538979,0.09418282548476452
145,0.9,5,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Is it reasonable for student examiners to act as substitute examiners for faculty in undergraduate OSCEs related to medical emergencies? Answer: Student examiners are reasonable substitutes for faculty during undergraduate OSCEs on medical emergencies and can provide valuable peer assessments. Yet, they may...",4.737194547137081e-08,0.10427174554807817,0.1000917640613587,0.0036268529295637453,0.14252012451781804,0.13296398891966763,0.003621603081905733,0.11356896974561614,0.11426592797783926,4.737194547137081e-08,0.08323787022293949,0.09418282548476452
145,0.9,6,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Can student examiners be considered effective substitutes for faculty in undergraduate OSCEs on medical emergencies? Answer: They can be regarded as reasonable replacements, adding valuable peer review and assessment, although they may...",3.0791764556390943e-07,0.09447425610483462,0.1694667640613587,0.023574544042164372,0.16116228928040321,0.13296398891966763,0.0235404200323873,0.1988057152965368,0.11426592797783926,3.079176455639103e-07,0.2383457539045235,0.09418282548476452
145,0.9,7,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Are student examiners reasonable replacements for faculty examiners in an undergraduate OSCE covering medical emergencies? Answer: Student examiners can serve as reasonable substitutes for faculty, contributing useful peer assessment in such OSCEs. However, they may...",2.3685972735685353e-07,0.04447050773285888,0.14092005125859053,0.018134264647818733,0.06878896914938792,0.13296398891966763,0.01810801540952868,0.10349553549221158,0.11426592797783926,2.3685972735685406e-07,0.13990568109127022,0.09418282548476452
145,0.9,8,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Could student examiners reasonably replace faculty members in an undergraduate OSCE focused on medical emergencies? Answer: Student examiners are reasonable substitutes who can provide important peer reviews and assessments, but they may...",3.0791764556390943e-07,0.1377959548898322,0.1382492822715564,0.023574544042164372,0.16116228928040321,0.13296398891966763,0.0235404200323873,0.1988057152965368,0.11426592797783926,3.079176455639103e-07,0.2383457539045235,0.09418282548476452
145,0.9,9,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Is it feasible for student examiners to function as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be considered appropriate alternatives, offering beneficial peer review and assessment, although they may...",1.8948778188548293e-07,0.0132403385742621,0.14246059122185253,0.014507411718254981,0.011630555309439572,0.13296398891966763,0.014486412327622933,0.04465503546927829,0.11426592797783926,1.8948778188548325e-07,0.07928105927483475,0.09418282548476452
145,0.9,10,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Might student examiners be acceptable substitute examiners for faculty in an undergraduate medical emergencies OSCE? Answer: Student examiners can reasonably substitute for faculty and provide valuable peer assessment and review. However, they may...",2.8423167282822413e-07,0.14772043750595332,0.10911296593440761,0.021761117577382492,0.1294135909658234,0.13296398891966763,0.021729618491434427,0.1660158924735451,0.11426592797783926,2.8423167282822487e-07,0.20444420222884174,0.09418282548476452
146,0.9,1,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy could be an important new tool for enhancing population health, particularly for low-income individuals. Although the results are strong, additional studies are necessary to verify their accuracy. Future investigations should explore various forms of income support.",7.105791820705622e-08,0.030304520734458773,0.017851239669421492,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
146,0.9,2,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Policies providing income assistance might serve as a powerful new strategy to improve the health of populations, especially among low-income groups. Despite the robust findings, further analysis is required to confirm their validity. Subsequent research should consider multiple types of income support measures.",2.3685972735685406e-08,0.042454833547970416,0.017851239669421492,0.0018134264647818726,0.018018505502678472,0.0,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
146,0.9,3,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support initiatives may represent a vital approach for boosting public health, particularly for those with lower incomes. While the evidence is compelling, more research is needed to validate these outcomes. Future studies should assess diverse forms of income support.",4.737194547137081e-08,0.01161238772230444,0.017851239669421492,0.0036268529295637453,0.037041271680350096,0.0,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
146,0.9,4,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Financial assistance policies may provide a key opportunity to enhance health outcomes on a population level, especially among financially disadvantaged groups. The findings are substantial, but additional examination is warranted to establish their reliability. Further research should investigate a range of income support programs.",4.737194547137081e-08,0.059846576259839246,0.017851239669421492,0.0036268529295637453,0.03571808260207909,0.0,0.003621603081905733,0.036367644170874236,0.0,4.737194547137081e-08,0.037041271680350096,0.0
146,0.9,5,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policies could be an effective new mechanism to improve health across populations, particularly for those with lower economic status. Although the findings are robust, more study is necessary to ensure their credibility. Future research ought to explore different kinds of income support.",4.737194547137081e-08,0.059846576259839246,0.017851239669421492,0.0036268529295637453,0.03571808260207909,0.0,0.003621603081905733,0.036367644170874236,0.0,4.737194547137081e-08,0.037041271680350096,0.0
146,0.9,6,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Policies offering income support may become an essential strategy in advancing population health, most notably for low-income individuals. Despite strong evidence, further analysis is needed to confirm these results. Research moving forward should assess various types of income assistance.",7.105791820705622e-08,0.030304520734458773,0.017851239669421492,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
146,0.9,7,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support could act as a significant new lever in promoting better health outcomes, especially for lower-income populations. Although the current findings are strong, more comprehensive analyses are required to validate them. Future studies should look into multiple income support interventions.",2.3685972735685406e-08,0.01846860107447057,0.0003243433209763093,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
146,0.9,8,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Providing income support may be a promising new approach to improving health for populations, particularly among those with limited income. While the findings are robust, further research is necessary to verify their consistency. Subsequent investigations should explore different income support options.",2.3685972735685406e-08,0.01846860107447057,0.0003243433209763093,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
146,0.9,9,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income assistance policies might serve as important new tools for enhancing public health, especially for economically disadvantaged groups. The evidence is strong, but additional research is required to confirm its reliability. Future studies should evaluate various forms of income assistance.",4.737194547137081e-08,0.01161238772230444,0.017851239669421492,0.0036268529295637453,0.037041271680350096,0.0,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
146,0.9,10,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support strategies may represent a vital new means to boost population health, particularly for lower-income individuals. Despite robust findings, further research is needed to establish their dependability. Future investigations should explore a range of income support programs.",9.474389094274162e-08,0.07601222264976526,0.0013721359553382183,0.0072537058591274906,0.07550755250814589,0.0,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
147,0.9,1,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,"In Hirschsprung's disease, the radiographic transition zone observed on contrast enema shows a low correlation with the extent of aganglionosis on the specimen.",5.21091400185077e-07,0.5671204204581373,0.09,0.039895382225201295,0.6844382742231665,0.023242630385487524,0.03983763390096317,0.7419373447293776,0.0,5.210914001850788e-07,0.7691330875378677,0.0
147,0.9,2,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,The level of the radiographic transition zone does not strongly correlate with the length of aganglionosis in Hirschsprung's disease cases.,5.92149318392133e-07,0.7137238946500126,0.09,0.045335661619546934,0.8385889540504232,0.023242630385487524,0.04527003852382179,0.9044562742271518,0.0,5.921493183921349e-07,0.9409833444645268,0.0
147,0.9,3,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,Contrast enema findings of the radiographic transition zone have a poor correlation with aganglionosis extent in Hirschsprung's disease.,6.395212638635037e-07,0.8249495297602367,0.09,0.048962514549110686,0.956371989706807,0.023242630385487524,0.04889164160572754,1.0296194171811575,0.0,6.395212638635055e-07,1.0745147370890495,0.0
147,0.9,4,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,There is a weak correlation between the radiographic transition zone level on contrast enema and the length of aganglionosis in Hirschsprung's disease.,5.447773729207623e-07,0.6136404360930312,0.09,0.041708808689983175,0.7332284383925978,0.023242630385487524,0.04164843544191604,0.7932306391169277,0.0,5.447773729207641e-07,0.823200308808143,0.0
147,0.9,5,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,"In Hirschsprung's disease, the radiographic transition zone identified via contrast enema minimally correlates with the actual aganglionosis length.",6.395212638635037e-07,0.8249495297602367,0.09,0.048962514549110686,0.956371989706807,0.023242630385487524,0.04889164160572754,1.0296194171811575,0.0,6.395212638635055e-07,1.0745147370890495,0.0
147,0.9,6,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,Low correlation exists between contrast enema radiographic transition zone and the segment length of aganglionosis in Hirschsprung's disease.,6.395212638635037e-07,0.8249495297602367,0.09,0.048962514549110686,0.956371989706807,0.023242630385487524,0.04889164160572754,1.0296194171811575,0.0,6.395212638635055e-07,1.0745147370890495,0.0
147,0.9,7,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,The radiographic transition zone level on contrast enema does not reliably correspond to the aganglionosis length in Hirschsprung's disease specimens.,5.92149318392133e-07,0.7137238946500126,0.09,0.045335661619546934,0.8385889540504232,0.023242630385487524,0.04527003852382179,0.9044562742271518,0.0,5.921493183921349e-07,0.9409833444645268,0.0
147,0.9,8,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,Hirschsprung's disease shows limited correlation between radiographic transition zone level and the extent of aganglionosis on tissue specimens.,6.395212638635037e-07,0.8249495297602367,0.09,0.048962514549110686,0.956371989706807,0.023242630385487524,0.04889164160572754,1.0296194171811575,0.0,6.395212638635055e-07,1.0745147370890495,0.0
147,0.9,9,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,Correlation between the radiographic transition zone from contrast enemas and aganglionosis length in Hirschsprung's disease patients remains poor.,6.395212638635037e-07,0.8249495297602367,0.09,0.048962514549110686,0.956371989706807,0.023242630385487524,0.04889164160572754,1.0296194171811575,0.0,6.395212638635055e-07,1.0745147370890495,0.0
147,0.9,10,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,"In cases of Hirschsprung's disease, the radiographic transition zone on contrast enema does not strongly indicate the length of aganglionosis, necessitating systematic preoperative biopsy via coelioscopy or umbilical incision.",3.7897556377096523e-07,0.32595836364124864,0.09,0.029014823436510018,0.4331238459422586,0.023242630385487524,0.028972824655245928,0.4795730802618854,0.0,3.789755637709665e-07,0.49469624183610783,0.0
148,0.9,1,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,Sternal fractures in growing children are uncommon and frequently missed injuries.,9.474389094274136e-07,1.581712025211702,0.01999167013744273,0.07253705859127506,1.6945957207744073,0.0,0.07243206163811484,1.7917594692280554,0.0,9.474389094274155e-07,1.904237452654744,0.0
148,0.9,2,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,Fractures of the sternum in children are rare and often go undiagnosed.,9.237529366917283e-07,1.4864018454073769,0.01999167013744273,0.07072363212649319,1.5892352051165815,0.0,0.07062126009716198,1.6739764335716716,0.0,9.237529366917302e-07,1.7707060600302222,0.0
148,0.9,3,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"In children, isolated sternal fractures happen due to typical age-specific trauma but are rarely seen.",8.526950184846723e-07,1.2452397885904891,0.01999167013744273,0.06528335273214755,1.3268709406490897,0.0,0.06518885547430335,1.3862943611198904,0.0,8.526950184846741e-07,1.4522523289116873,0.0
148,0.9,4,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Growing children rarely experience sternal fractures, and these injuries are often overlooked.",9.237529366917283e-07,1.4864018454073769,0.01999167013744273,0.07072363212649319,1.5892352051165815,0.0,0.07062126009716198,1.6739764335716716,0.0,9.237529366917302e-07,1.7707060600302222,0.0
148,0.9,5,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,Isolated sternal fractures in children result from common traumatic events and are usually under-recognized.,8.763809912203576e-07,1.3193477607442103,0.01999167013744273,0.06709677919692943,1.406913648322626,0.0,0.06699965701525623,1.4733057381095205,0.0,8.763809912203594e-07,1.5475625087160125,0.0
148,0.9,6,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,A sternal fracture in a growing child is an uncommon injury that is often unnoticed.,8.526950184846723e-07,1.2452397885904891,0.01999167013744273,0.06528335273214755,1.3268709406490897,0.0,0.06518885547430335,1.3862943611198904,0.0,8.526950184846741e-07,1.4522523289116873,0.0
148,0.9,7,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,Sternal fractures in the pediatric population occur infrequently and may be easily missed.,9.000669639560429e-07,1.3993904684177467,0.01999167013744273,0.0689102056617113,1.4939250253122562,0.0,0.0688104585562091,1.5686159179138457,0.0,9.000669639560448e-07,1.6529230243738384,0.0
148,0.9,8,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"In childhood, sternal fractures are rare and commonly overlooked in diagnosis.",9.474389094274136e-07,1.581712025211702,0.01999167013744273,0.07253705859127506,1.6945957207744073,0.0,0.07243206163811484,1.7917594692280554,0.0,9.474389094274155e-07,1.904237452654744,0.0
148,0.9,9,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Children seldom suffer isolated sternal fractures, which are often not detected initially.",9.237529366917283e-07,1.4864018454073769,0.01999167013744273,0.07072363212649319,1.5892352051165815,0.0,0.07062126009716198,1.6739764335716716,0.0,9.237529366917302e-07,1.7707060600302222,0.0
148,0.9,10,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,Isolated sternal fractures in children are rare occurrences resulting from typical trauma and often go unnoticed.,8.290090457489869e-07,1.176246917103537,0.01999167013744273,0.06346992626736567,1.2527629684953685,0.0,0.06337805393335048,1.306251653446354,0.0,8.290090457489888e-07,1.3652409519220572,0.0
149,0.9,1,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could aripiprazole be a new risk factor for pathological gambling? Answer: Adverse drug reactions were compared with previously published case reports. The dopamine partial agonist action of aripiprazole might explain why pathological gambling occurs.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
149,0.9,2,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is aripiprazole a novel risk factor for pathological gambling? Answer: Adverse drug reactions were analyzed alongside other published case studies. The dopamine partial agonist mechanism of aripiprazole could account for the development of pathological gambling.,4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
149,0.9,3,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Aripiprazole as a potential new risk factor for pathological gambling? Answer: Reported adverse drug reactions were examined in relation to existing case reports. The dopamine partial agonist activity of aripiprazole may underlie pathological gambling.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
149,0.9,4,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could pathological gambling be linked to aripiprazole as a new risk factor? Answer: Adverse reactions to the drug were reviewed in comparison with previously documented cases. The dopamine partial agonist effect of aripiprazole might explain the emergence of pathological gambling.,1.658018091497971e-07,0.19237189264745602,0.0,0.01269398525347313,0.19782574332991798,0.0,0.012675610786670094,0.20359895524123983,0.0,1.6580180914979784e-07,0.20972053098207066,0.0
149,0.9,5,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is pathological gambling a possible side effect of aripiprazole? Answer: Adverse drug reactions were confronted with earlier published case reports. The mechanism of aripiprazole as a dopamine partial agonist could justify pathological gambling occurrence.,2.36859727356853e-08,0.010920400412667952,0.029384756657483937,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
149,0.9,6,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Aripiprazole: Is it a new risk factor for pathological gambling? Answer: Adverse drug reactions were evaluated against other published case reports. The dopamine partial agonist mechanism of aripiprazole could elucidate pathological gambling cases.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
149,0.9,7,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could aripiprazole induce pathological gambling as a new risk factor? Answer: Adverse drug reactions were studied alongside existing case reports. The dopamine partial agonist properties of aripiprazole might explain the occurrence of pathological gambling.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
149,0.9,8,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is aripiprazole linked to pathological gambling as a new risk factor? Answer: The adverse reactions were compared with previously reported cases. The dopamine partial agonist mechanism of aripiprazole could clarify the pathological gambling phenomenon.,2.36859727356853e-08,0.010920400412667952,0.029384756657483937,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
149,0.9,9,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Does aripiprazole represent a new risk factor for pathological gambling? Answer: Adverse drug reactions were assessed in relation to other published case reports. The dopamine partial agonist action of aripiprazole may explain pathological gambling occurrence.,4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
149,0.9,10,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could the use of aripiprazole be associated with pathological gambling? Answer: Adverse drug reactions were reviewed along with other case reports in the literature. The dopamine partial agonist mechanism of aripiprazole may account for pathological gambling.,7.10579182070559e-08,0.048503200291855286,0.02775510204081633,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
150,0.9,1,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Do preoperative statins lower the incidence of atrial fibrillation after coronary artery bypass grafting? Answer: Yes, studies show that preoperative statins can decrease the occurrence of postoperative atrial fibrillation.",7.10579182070559e-08,0.1680340659117241,0.04195011337868479,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
150,0.9,2,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Are preoperative statins effective in reducing atrial fibrillation following coronary artery bypass graft surgery? Answer: Yes, evidence suggests that preoperative statins help reduce postoperative atrial fibrillation rates.",2.36859727356853e-08,0.04168988456723399,0.0027888888888888963,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
150,0.9,3,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Can preoperative statins prevent atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research supports that preoperative statins reduce the frequency of atrial fibrillation post-surgery.",2.36859727356853e-08,0.04348623426442089,0.0030061961772737122,0.0018134264647818796,0.04082199452025481,0.0,0.0018108015409528735,0.04255961441879563,0.0,2.3685972735685406e-08,0.04445176257083405,0.0
150,0.9,4,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Do statins given before surgery reduce the chance of atrial fibrillation after coronary artery bypass? Answer: Yes, research has found that administering statins preoperatively lowers the risk of postoperative atrial fibrillation.",1.184298636784265e-07,0.2825286942421177,0.07638888888888888,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
150,0.9,5,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Is there a reduction in atrial fibrillation after coronary artery bypass grafting with preoperative statin use? Answer: Yes, studies indicate preoperative statins decrease postoperative atrial fibrillation occurrence.",2.36859727356853e-08,0.09303412016426726,0.039406640368178834,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
150,0.9,6,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Does using statins prior to coronary artery bypass surgery reduce atrial fibrillation? Answer: Yes, evidence shows that preoperative statins can reduce the incidents of atrial fibrillation after surgery.",4.73719454713706e-08,0.18074599993217522,0.07638888888888888,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
150,0.9,7,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Are preoperative statins associated with reduced atrial fibrillation following coronary artery bypass grafting? Answer: Yes, research suggests that using statins before surgery lowers the rate of postoperative atrial fibrillation.",7.10579182070559e-08,0.21583731974344422,0.07638888888888888,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
150,0.9,8,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Can taking statins before coronary artery bypass surgery reduce postoperative atrial fibrillation? Answer: Yes, studies demonstrate that preoperative statins help in decreasing atrial fibrillation after the procedure.",2.36859727356853e-08,0.14437835576130054,0.07638888888888888,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
150,0.9,9,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Do preoperative statins contribute to lowering atrial fibrillation rates after coronary bypass graft surgery? Answer: Yes, findings indicate that preoperative statins reduce the incidence of postoperative atrial fibrillation.",4.73719454713706e-08,0.13123548703503607,0.040723593964334705,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
150,0.9,10,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Is the occurrence of atrial fibrillation after coronary artery bypass reduced by statins given before surgery? Answer: Yes, research indicates preoperative statin use decreases the frequency of postoperative atrial fibrillation.",9.47438909427412e-08,0.24973887141912599,0.07638888888888888,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
151,0.9,1,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Is there disagreement between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Significant differences exist between clinicians and clinical pathologists regarding the clinical relevance of specific RBC morphology terms. Adding interpretive comments on CBC reports is the most effective way to guarantee RBC morphology changes are understood as intended by clinical pathologists. Reporting methods need to be critically evaluated.,4.737194547137081e-08,0.011929350116359316,0.0322222222222222,0.0036268529295637453,0.03333642026759165,0.0,0.003621603081905733,0.03390155167568043,0.0,4.737194547137081e-08,0.03448617607116855,0.0
151,0.9,2,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,"Are clinical pathologists and clinicians aligned in how they report and interpret red blood cell morphology? There are notable differences in how clinicians and clinical pathologists view the clinical importance of certain RBC morphology terms. To ensure RBC morphology findings are interpreted correctly, including interpretive notes on CBC reports is essential. Reporting procedures warrant thorough review.",1.1842986367842703e-07,0.1626274330507136,0.0543639053254438,0.009067132323909363,0.08855339734144341,0.0,0.009054007704764333,0.09015109699429802,0.0,1.1842986367842703e-07,0.09180754925312229,0.0
151,0.9,3,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Do clinical pathologists and clinicians differ in their interpretation and reporting of red blood cell morphology? Important discrepancies exist regarding the clinical significance of some RBC morphology terminology between clinicians and clinical pathologists. The best way to ensure the correct interpretation of RBC morphology changes is to include interpretive comments on CBC reports. Reporting practices should be carefully examined.,4.737194547137081e-08,0.057803178591540494,0.017236072637734686,0.0036268529295637453,0.03448617607116855,0.0,0.003621603081905733,0.03509131981126945,0.0,4.737194547137081e-08,0.03571808260207909,0.0
151,0.9,4,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Is there a lack of consensus between clinical pathologists and clinicians on red blood cell morphology reporting and interpretation? Clinicians and clinical pathologists differ significantly in their understanding of the clinical relevance of certain RBC morphology terms. The clearest approach to ensure RBC morphology changes are interpreted as clinical pathologists intend is incorporating interpretive comments within CBC reports. It is important to critically assess reporting practices.,1.1842986367842703e-07,0.008009919563934709,0.07830385015608742,0.009067132323909363,0.08134563945395268,0.0,0.009054007704764333,0.08269171584511614,0.0,1.1842986367842703e-07,0.0840831172105414,0.0
151,0.9,5,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Do clinicians and clinical pathologists disagree in reporting and interpreting red blood cell morphology? There exist crucial differences about the clinical relevance of some RBC morphology terms between these two groups. Including interpretive comments on complete blood count reports is the clearest method to make sure RBC morphology changes are interpreted as per clinical pathologists’ intent. Reporting methods should be critically evaluated.,2.3685972735685406e-08,0.006196835116328181,0.016388888888888894,0.0018134264647818726,0.01680711831638071,0.0,0.0018108015409528666,0.01709443335929972,0.0,2.3685972735685406e-08,0.01739174271186883,0.0
151,0.9,6,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Is there discordance between clinicians and clinical pathologists in interpreting and reporting RBC morphology? There are significant differences in opinions about the clinical relevance of RBC morphology terms between clinicians and pathologists. Ensuring RBC morphology changes are understood as clinical pathologists mean can best be done by adding interpretive comments to CBC reports. Reporting practices deserve close scrutiny.,7.105791820705622e-08,0.14857710920298084,0.06977572089711641,0.005440279394345618,0.07694100961913897,0.017851239669421492,0.0054324046228586,0.05310982531394792,0.0,7.105791820705622e-08,0.05406722127027486,0.0
151,0.9,7,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Are clinical pathologists and clinicians at odds over reporting and interpreting red blood cell morphology? Differences exist in the clinical implications assigned to certain RBC morphology terms by clinicians versus clinical pathologists. The clearest way to ensure RBC morphology changes are interpreted as intended by clinical pathologists is through inclusion of interpretive comments on CBC reports. Reporting practices need to be critically reviewed.,4.737194547137081e-08,0.011929350116359316,0.0322222222222222,0.0036268529295637453,0.03333642026759165,0.0,0.003621603081905733,0.03390155167568043,0.0,4.737194547137081e-08,0.03448617607116855,0.0
151,0.9,8,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Is there a difference of opinion between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Important discrepancies exist regarding the clinical relevance of particular RBC morphology terms between clinicians and clinical pathologists. Including interpretive remarks on CBC reports is the clearest way to guarantee RBC morphology changes are interpreted correctly. It is essential to critically analyze reporting practices.,2.3685972735685406e-08,0.006196835116328181,0.016388888888888894,0.0018134264647818726,0.01680711831638071,0.0,0.0018108015409528666,0.01709443335929972,0.0,2.3685972735685406e-08,0.01739174271186883,0.0
151,0.9,9,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Do clinical pathologists and clinicians differ in how they interpret and report red blood cell morphology? There are important differences in the clinical relevance attributed to certain RBC morphology terms by clinicians and clinical pathologists. The clearest way to ensure RBC morphology changes are interpreted as intended by clinical pathologists is by including interpretive comments on CBC reports. Reporting procedures should be subject to critical review.,1.1842986367842703e-07,0.037387496562156564,0.030738221214411676,0.009067132323909363,0.08134563945395268,0.0,0.009054007704764333,0.08269171584511614,0.0,1.1842986367842703e-07,0.0840831172105414,0.0
151,0.9,10,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Is there discordance between clinicians and clinical pathologists regarding the reporting and interpretation of red blood cell morphology? There are significant differences about the clinical importance of some RBC morphology terms between clinical pathologists and clinicians. Adding interpretive comments to CBC reports is the most straightforward way to ensure RBC morphology changes are understood as clinical pathologists intend. Reporting practices should be critically examined.,7.105791820705622e-08,0.02552937911825115,0.08083333333333335,0.005440279394345618,0.04959694113937285,0.0,0.0054324046228586,0.05043085362689137,0.0,7.105791820705622e-08,0.05129329438754926,0.0
152,0.9,1,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Do viral infections contribute to benign paroxysmal positional vertigo? Yes, they can. Viruses might induce inflammation or injury in the inner ear, causing calcium crystals to become dislodged, which results in BPPV. However, this is only one factor.",3.3160361829959537e-07,0.13063202345580072,0.1337809917355372,0.025387970506946217,0.21760051808244407,0.07939508506616257,0.025351221573340132,0.2515970716546896,0.060964083175803374,3.316036182995957e-07,0.2870782212450673,0.04158790170132326
152,0.9,2,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Can viral infections influence benign paroxysmal positional vertigo? Indeed, viral infections may be involved. They can cause damage or inflammation in the inner ear, leading to the displacement of calcium crystals that trigger BPPV, though it's just one cause.",3.0791764556391007e-07,0.1404452069294262,0.10748442489842983,0.023574544042164344,0.19020154389432875,0.07939508506616257,0.023540420032387266,0.22342619468799274,0.060964083175803374,3.079176455639103e-07,0.2580906843718158,0.04158790170132326
152,0.9,3,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Are viral infections linked to benign paroxysmal positional vertigo? Yes, viral infections can have a role by causing inner ear inflammation or damage, which dislodges calcium crystals and leads to BPPV. This is only one possible cause.",3.5528959103528067e-07,0.19653917434169088,0.10602588969472088,0.02720139697172809,0.24577139504914092,0.07939508506616257,0.027162023114293006,0.2805846085279411,0.060964083175803374,3.552895910352811e-07,0.3169311843947491,0.04158790170132326
152,0.9,4,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Is there a connection between viral infections and benign paroxysmal positional vertigo? Yes, viruses can contribute by causing inflammation or harm to the inner ear, resulting in calcium crystals dislodging and causing BPPV; however, it's only one factor.",3.3160361829959537e-07,0.13063202345580072,0.1337809917355372,0.025387970506946217,0.21760051808244407,0.07939508506616257,0.025351221573340132,0.2515970716546896,0.060964083175803374,3.316036182995957e-07,0.2870782212450673,0.04158790170132326
152,0.9,5,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Do viruses have a part in benign paroxysmal positional vertigo? Yes, they can cause inner ear inflammation or damage that dislodges calcium crystals, leading to BPPV, although this is only one contributing factor.",4.5003348197802187e-07,0.27581403330029985,0.1337809917355372,0.03445510283085561,0.3671322520534077,0.07939508506616257,0.0344052292781045,0.4057477514819481,0.060964083175803374,4.500334819780227e-07,0.4461429158747561,0.04158790170132326
152,0.9,6,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Can viral infections cause benign paroxysmal positional vertigo? Yes, because they may lead to inflammation or injury within the inner ear, dislodging calcium crystals that result in BPPV, but it is just one of the causes.",3.7897556377096597e-07,0.18620187461061288,0.1337809917355372,0.02901482343650997,0.2747589319223924,0.07939508506616257,0.02897282465524588,0.31043757167762287,0.060964083175803374,3.789755637709665e-07,0.3477028430615028,0.04158790170132326
152,0.9,7,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Are viral infections implicated in benign paroxysmal positional vertigo? Yes, viral infections may cause inflammation or damage in the inner ear, which dislodges calcium crystals and triggers BPPV, but this is only one reason.",4.2634750924233657e-07,0.2870512946674819,0.1035075542355372,0.03264167636607373,0.3353835537388279,0.07939508506616257,0.03259442773715163,0.3729579286589564,0.060964083175803374,4.263475092423373e-07,0.4122413641990743,0.04158790170132326
152,0.9,8,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Do viral infections affect benign paroxysmal positional vertigo? Yes, as they can cause inner ear inflammation or injury that results in the dislodgement of calcium crystals responsible for BPPV, though it's only one cause.",4.2634750924233657e-07,0.24504237463354617,0.1337809917355372,0.03264167636607373,0.3353835537388279,0.07939508506616257,0.03259442773715163,0.3729579286589564,0.060964083175803374,4.263475092423373e-07,0.4122413641990743,0.04158790170132326
152,0.9,9,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Can benign paroxysmal positional vertigo be caused by viral infections? Yes, viral infections might lead to inflammation or damage in the inner ear that displaces calcium crystals, causing BPPV, but this is just one factor involved.",3.7897556377096597e-07,0.18620187461061288,0.1337809917355372,0.02901482343650997,0.2747589319223924,0.07939508506616257,0.02897282465524588,0.31043757167762287,0.060964083175803374,3.789755637709665e-07,0.3477028430615028,0.04158790170132326
152,0.9,10,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Is benign paroxysmal positional vertigo related to viral infections? Yes, viral infections can provoke inner ear inflammation or damage that causes calcium crystals to dislodge and result in BPPV, though this is only one contributing cause.",3.7897556377096597e-07,0.18620187461061288,0.1337809917355372,0.02901482343650997,0.2747589319223924,0.07939508506616257,0.02897282465524588,0.31043757167762287,0.060964083175803374,3.789755637709665e-07,0.3477028430615028,0.04158790170132326
153,0.9,1,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Does transient tachypnea of the newborn (TTN) involve polymorphisms in the beta-adrenergic receptor (ADRB) genes? Answer: Studies indicate a possible involvement of polymorphisms in the beta-adrenergic receptor (ADRB) genes in transient tachypnea of the newborn.,4.73719454713706e-08,0.039704433122926375,0.035578039139292666,0.003626852929563752,0.044774995065926415,0.053854875283446624,0.003621603081905747,0.050382692065300105,0.0685939357907253,4.737194547137081e-08,0.05659879842531845,0.08046505482890734
153,0.9,2,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Is there a connection between transient tachypnea of the newborn (TTN) and polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research points to a potential association of polymorphisms in ADRB genes with transient tachypnea of the newborn.,2.36859727356853e-08,0.29288409167844165,0.1402766118629839,0.0018134264647818726,0.2990377341372823,0.168344671201814,0.0018108015409528666,0.2669215724928997,0.15974489795918367,2.3685972735685406e-08,0.2328543546849997,0.14268727705112957
153,0.9,3,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Could polymorphisms in beta-adrenergic receptor (ADRB) genes influence transient tachypnea of the newborn (TTN)? Answer: Evidence suggests that polymorphisms in ADRB encoding genes may play a role in TTN.,1.894877818854824e-07,0.12071623032995538,0.20964406472648223,0.01450741171825503,0.09525916199906659,0.22222222222222218,0.014486412327622988,0.01774767673889377,0.1875,1.8948778188548325e-07,0.06439716878293122,0.14268727705112957
153,0.9,4,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Transient tachypnea of the newborn (TTN): might polymorphisms in beta-adrenergic receptor (ADRB) genes be involved? Answer: Findings propose a possible contribution of ADRB gene polymorphisms to TTN.,2.36859727356853e-07,0.09706052017953182,0.24408284023668633,0.01813426464781879,0.02115118984534492,0.22222222222222218,0.018108015409528735,0.05921336439723568,0.1875,2.3685972735685406e-07,0.1444398764564685,0.14268727705112957
153,0.9,5,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Are beta-adrenergic receptor (ADRB) gene polymorphisms implicated in transient tachypnea of the newborn (TTN)? Answer: Research implies that polymorphisms in ADRB genes could affect TTN development.,2.605457000925383e-07,0.05932019219668483,0.24408284023668633,0.01994769111260067,0.01806952330793754,0.22222222222222218,0.01991881695048161,0.10003535891749049,0.1875,2.6054570009253947e-07,0.18699949087526413,0.14268727705112957
153,0.9,6,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: What role do polymorphisms in the beta-adrenergic receptor (ADRB) genes play in transient tachypnea of the newborn (TTN)? Answer: Studies suggest polymorphisms in ADRB genes may have a role in TTN.,1.421158364141118e-07,0.19049168572099795,0.21186061801446412,0.01088055878869127,0.16425203348601736,0.22222222222222218,0.010864809245717241,0.08920664072103746,0.1875,1.4211583641411244e-07,0.009710803370790444,0.14268727705112957
153,0.9,7,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Is transient tachypnea of the newborn (TTN) associated with polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Scientific data indicates a potential link between ADRB gene polymorphisms and TTN.,1.658018091497971e-07,0.20242103583735727,0.24408284023668633,0.01269398525347315,0.1303504818103356,0.22222222222222218,0.012675610786670115,0.05411532090976845,0.1875,1.6580180914979784e-07,0.026656840800084236,0.14268727705112957
153,0.9,8,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Could variations in the beta-adrenergic receptor (ADRB) genes contribute to transient tachypnea of the newborn (TTN)? Answer: Research supports a possible involvement of ADRB polymorphisms in TTN.,2.36859727356853e-07,0.09706052017953182,0.24408284023668633,0.01813426464781879,0.02115118984534492,0.22222222222222218,0.018108015409528735,0.05921336439723568,0.1875,2.3685972735685406e-07,0.1444398764564685,0.14268727705112957
153,0.9,9,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Investigation into transient tachypnea of the newborn (TTN): do beta-adrenergic receptor (ADRB) gene polymorphisms have a role? Answer: Evidence points to a potential role of ADRB encoding gene polymorphisms in TTN.,1.421158364141118e-07,0.19049168572099795,0.21186061801446412,0.01088055878869127,0.16425203348601736,0.22222222222222218,0.010864809245717241,0.08920664072103746,0.1875,1.4211583641411244e-07,0.009710803370790444,0.14268727705112957
153,0.9,10,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Does transient tachypnea of the newborn (TTN) relate to polymorphisms in beta-adrenergic receptor (ADRB) genes? Answer: Research findings suggest that polymorphisms in ADRB genes may contribute to TTN.,2.131737546211677e-07,0.08391765145326735,0.20841754531213216,0.01632083818303691,0.05889151782819191,0.22222222222222218,0.016297213868575862,0.01999265124395322,0.1875,2.1317375462116866e-07,0.10361788193621368,0.14268727705112957
154,0.9,1,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image can vary among parents, children, and physicians. Parents may be influenced by cultural or personal beliefs, children by their self-esteem and peers, and physicians by medical criteria and health concerns. Therefore, each group",4.737194547137081e-08,0.0137382103785062,0.016686089100914785,0.0036268529295637453,0.012068210184330574,0.01851192595229618,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
154,0.9,2,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's doctors have differing views on body image? Answer: Yes, body image perception often differs between parents, children, and their doctors. Parents' views might stem from cultural or personal beliefs, children's views from self-esteem and peer pressure, and doctors' views from medical standards and health issues. Thus, each group",4.737194547137081e-08,0.038371277551590754,0.0018947695229746889,0.0036268529295637453,0.0372845055208213,0.0006606862828746896,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
154,0.9,3,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their kids, and their children's doctors see body image differently? Answer: Yes, body image perceptions tend to differ between parents, children, and their doctors. Parents' opinions are shaped by cultural or personal beliefs, children by their self-esteem and peer influence, and doctors by medical guidelines and health implications. Hence, each group",0.0,0.025205352020361893,0.018052050572862813,0.0,0.025672117798516858,0.01851192595229618,0.0,0.0,0.0,0.0,0.0,0.0
154,0.9,4,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and children’s physicians perceive body image in different ways? Answer: Yes, parents, children, and physicians may have differing perceptions of body image. Parents’ views may reflect cultural or personal beliefs, children’s views are influenced by self-esteem and peers, and physicians’ views are based on medical standards and health concerns. Therefore, each group",7.105791820705622e-08,0.08092262754331303,0.01992512981523971,0.005440279394345618,0.07973933906879171,0.01851192595229618,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
154,0.9,5,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's doctors differ in how they perceive body image? Answer: Yes, perceptions of body image often differ among parents, children, and physicians. Parents’ perspectives are influenced by cultural or personal beliefs; children’s views by self-esteem and peer relations; physicians' views by medical norms and health considerations. Hence, each group",4.737194547137081e-08,0.06269223125544832,0.019322583011394202,0.0036268529295637453,0.062039761969391094,0.01851192595229618,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
154,0.9,6,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and the children’s doctors have different perceptions of body image? Answer: Yes, parents, children, and physicians may perceive body image differently. Parents’ opinions are often shaped by cultural or personal beliefs; children’s by self-esteem and peer influences; physicians’ by medical standards and health implications. Therefore, each group",4.737194547137081e-08,0.012418287001114248,0.03550295857988167,0.0036268529295637453,0.012068210184330574,0.01851192595229618,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
154,0.9,7,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children’s physicians view body image differently? Answer: Yes, perception of body image can vary among parents, children, and physicians. Parents' perceptions may be influenced by cultural or personal beliefs; children's by self-esteem and peer impact; physicians' by medical criteria and health concerns. Thus, each group",4.737194547137081e-08,0.0137382103785062,0.016686089100914785,0.0036268529295637453,0.012068210184330574,0.01851192595229618,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
154,0.9,8,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, children, and children’s physicians have different views on body image? Answer: Yes, parents, children, and their physicians often perceive body image differently. Parents' perspectives might be shaped by cultural or personal beliefs; children’s by self-esteem and peer influence; physicians’ by medical standards and health considerations. Hence, each group",7.105791820705622e-08,0.033792424479184735,0.01596390532544379,0.005440279394345618,0.058668538416332794,0.001088074047703811,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
154,0.9,9,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children’s doctors perceive body image differently? Answer: Yes, there are differences in how parents, children, and physicians see body image. Parents’ views are influenced by cultural or personal beliefs; children’s views by self-esteem and peer factors; physicians’ views by medical standards and health risks. Therefore, each group",0.0,0.025205352020361893,0.018052050572862813,0.0,0.025672117798516858,0.01851192595229618,0.0,0.0,0.0,0.0,0.0,0.0
154,0.9,10,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, children, and their children's physicians perceive body image differently? Answer: Yes, parents, children, and physicians may have differing perceptions of body image. Parents' views are shaped by cultural or personal beliefs; children's by self-esteem and peer pressure; physicians' by medical guidelines and health implications. Hence, each group",9.474389094274162e-08,0.05425598119686015,0.015213551306285107,0.0072537058591274906,0.07901481056001103,0.0014797441851465525,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
155,0.9,1,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is there a link between neck pain and a decline in health-related quality of life after 6 months? Yes, studies indicate that neck pain correlates with poorer health-related quality of life half a year later. Ongoing neck pain may lead to emotional distress, reduced physical function, and challenges in daily activities, adversely affecting overall health and wellbeing.",2.3685972735685406e-08,0.09605492518368619,0.05615035760351958,0.0018134264647818726,0.07062690582153941,0.037288145247419,0.0018108015409528666,0.07148950735249926,0.03788807404770385,2.3685972735685406e-08,0.07236720885991987,0.03840000000000001
155,0.9,2,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Does neck pain influence health-related quality of life negatively 6 months down the line? Indeed, evidence shows that neck pain is connected with a decline in health-related quality of life six months later. Chronic neck pain can cause emotional strain, limited physical capabilities, and hinder the performance of everyday tasks, impacting overall health and wellness.",2.3685972735685406e-08,0.05475691067593047,0.051348757091365965,0.0018134264647818726,0.03168334342267132,0.03592218377547097,0.0018108015409528666,0.0327617902235553,0.037176624375240316,2.3685972735685406e-08,0.03390092803212408,0.03840000000000001
155,0.9,3,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is neck pain linked to a lower health-related quality of life 6 months afterwards? Yes, research has found that neck pain is associated with diminished health-related quality of life at the 6-month mark. Persistent neck pain often results in emotional distress, restricted physical functioning, and decreased ability to manage daily activities, affecting overall health and wellbeing.",0.0,0.07561605606108479,0.05379357175192409,0.0,0.05134423559703327,0.03661775147928993,0.0,0.052312994759240894,0.03753905325443789,0.0,0.053319013889226774,0.03840000000000001
155,0.9,4,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Does experiencing neck pain relate to worse health-related quality of life after 6 months? Yes, studies suggest that neck pain is tied to poorer health-related quality of life six months later. Continuous neck pain can lead to emotional difficulties, reduced physical function, and impaired daily living activities, negatively influencing overall health and wellbeing.",7.105791820705622e-08,0.011706953099520412,0.04617473970122235,0.005440279394345618,0.008834427395682631,0.03444964598084129,0.0054324046228586,0.007525303207511769,0.03640832986255729,7.105791820705622e-08,0.006104406581574295,0.03840000000000001
155,0.9,5,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is there an association between neck pain and a reduction in health-related quality of life 6 months later? Yes, research indicates that neck pain corresponds with a worsened health-related quality of life half a year later. Ongoing pain in the neck may contribute to emotional stress, limited physical ability, and decreased capacity for daily tasks, impacting overall wellbeing.",4.737194547137081e-08,0.14959068656344154,0.11401785085480766,0.0036268529295637453,0.08954560246780163,0.037934705075445815,0.003621603081905733,0.09030541179884999,0.038224417009602225,4.737194547137081e-08,0.0910593418720742,0.03840000000000001
155,0.9,6,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Does neck pain impact health-related quality of life six months later? Yes, evidence shows that neck pain is linked to diminished health-related quality of life at 6 months. Persistent neck pain may cause emotional distress, impair physical functionality, and reduce the ability to perform everyday activities, affecting overall health and wellbeing.",1.1842986367842703e-07,0.03324816001481112,0.04058369520871416,0.009067132323909363,0.05105872057059724,0.03285758261656855,0.009054007704764333,0.04950254302869883,0.03557609778180174,1.1842986367842703e-07,0.047777102982143216,0.03840000000000001
155,0.9,7,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is neck pain associated with a decline in health-related quality of life six months later? Yes, studies confirm that neck pain correlates with worse health-related quality of life six months afterwards. Chronic neck pain can contribute to emotional hardships, limited physical functioning, and reduced capacity for daily routines, impacting overall wellbeing.",1.1842986367842703e-07,0.08869993445960711,0.0009920574198526433,0.009067132323909363,0.1076421638816134,0.007387654320987674,0.009054007704764333,0.1072648080753611,0.005822222222222194,1.1842986367842703e-07,0.10676835239150018,0.00406913580246912
155,0.9,8,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is there a connection between neck pain and poorer health-related quality of life after six months? Yes, research suggests that neck pain is associated with decreased health-related quality of life six months post onset. Persistent neck pain may lead to emotional distress, lower physical function, and hinder daily activities, adversely affecting overall health and wellbeing.",2.3685972735685406e-08,0.05475691067593047,0.051348757091365965,0.0018134264647818726,0.03168334342267132,0.03592218377547097,0.0018108015409528666,0.0327617902235553,0.037176624375240316,2.3685972735685406e-08,0.03390092803212408,0.03840000000000001
155,0.9,9,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Can neck pain predict worse health-related quality of life six months later? Yes, research indicates that neck pain is linked with a negative impact on health-related quality of life after six months. Continued neck pain often causes emotional distress, restricted physical function, and decreased ability to perform daily activities, influencing overall health and wellbeing.",4.737194547137081e-08,0.03346005371221805,0.048810932863035145,0.0036268529295637453,0.011629129321992782,0.035199999999999974,0.003621603081905733,0.012820968936166466,0.036800000000000034,4.737194547137081e-08,0.014098300735944314,0.03840000000000001
155,0.9,10,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is neck pain related to a deterioration in health-related quality of life six months later? Yes, studies suggest that neck pain is associated with poorer health-related quality of life six months later. Persistent neck pain can lead to emotional distress, reduced physical functionality, and limitations in daily activities, affecting overall health and wellbeing.",7.105791820705622e-08,0.04161206078970636,0.007991102616121654,0.005440279394345618,0.06319891214548301,0.004263286555002299,0.0054324046228586,0.06297707765230687,0.0033555454956994066,7.105791820705622e-08,0.06268784989259002,0.002342417383431425
156,0.9,1,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG a tracer used as a surrogate to measure tumor hypoxia? No, (18)F-FDG does not measure tumor hypoxia; it primarily assesses glucose metabolism in tissues. Specialized tracers like (18)F-fluoromisonidazole are used for hypoxia measurement.",1.658018091497972e-07,0.012350410272839785,0.16979891681190382,0.012693985253473122,0.05374245653546783,0.09876543209876547,0.012675610786670087,0.09118771555146576,0.0763888888888889,1.6580180914979784e-07,0.1306360941296667,0.05246913580246914
156,0.9,2,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Can (18)F-FDG be used as a surrogate tracer for tumor hypoxia? No, (18)F-FDG is not suitable for detecting tumor hypoxia. Its main function is to evaluate glucose metabolism in tissues, while other tracers such as (18)F-fluoromisonidazole target hypoxia.",9.474389094274131e-08,0.11298034131757362,0.19918367346938776,0.0072537058591274906,0.0332689204541623,0.09876543209876547,0.007243206163811466,0.001575556861778793,0.0763888888888889,9.474389094274162e-08,0.03826277399865141,0.05246913580246914
156,0.9,3,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG an appropriate surrogate tracer to detect tumor hypoxia? No, (18)F-FDG measures glucose metabolism rather than tumor hypoxia. Tracers like (18)F-fluoromisonidazole are specifically designed to measure hypoxia.",3.316036182995943e-07,0.2021007053223225,0.19918367346938776,0.02538797050694628,0.2921534799804655,0.09876543209876547,0.025351221573340202,0.3380477934829922,0.0763888888888889,3.316036182995957e-07,0.3865694682668681,0.05246913580246914
156,0.9,4,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Does (18)F-FDG serve as a surrogate tracer for tumor hypoxia measurement? No, it does not. (18)F-FDG is primarily used to assess tissue glucose metabolism. Tumor hypoxia is assessed with other tracers like (18)F-fluoromisonidazole.",2.131737546211678e-07,0.0755233673119231,0.16796619167958546,0.01632083818303688,0.11626281351680134,0.09876543209876547,0.016297213868575834,0.1557262366890373,0.0763888888888889,2.1317375462116866e-07,0.19732746862834016,0.05246913580246914
156,0.9,5,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG used as a surrogate tracer for tumor hypoxia? No, because (18)F-FDG measures glucose metabolism in tissues and not hypoxia. For hypoxia imaging, specific tracers such as (18)F-fluoromisonidazole are utilized.",2.605457000925384e-07,0.09674018966449704,0.19918367346938776,0.01994769111260064,0.1829541880154748,0.09876543209876547,0.01991881695048158,0.22471910817598806,0.0763888888888889,2.6054570009253947e-07,0.26878643261048385,0.05246913580246914
156,0.9,6,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Can (18)F-FDG act as a surrogate tracer to evaluate tumor hypoxia? No, it mainly quantifies glucose metabolism, not tumor hypoxia. Other tracers, including (18)F-fluoromisonidazole, are preferred for hypoxia detection.",3.07917645563909e-07,0.1657330611514478,0.19918367346938776,0.0235745440421644,0.2544131519976185,0.09876543209876547,0.02354042003238733,0.2988270803297097,0.0763888888888889,3.079176455639103e-07,0.3457474737466133,0.05246913580246914
156,0.9,7,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG considered a surrogate tracer to monitor tumor hypoxia? No, (18)F-FDG tracks glucose metabolism rates and is not used to measure tumor hypoxia; instead, tracers like (18)F-fluoromisonidazole are employed.",2.842316728282237e-07,0.1306417413401788,0.19918367346938776,0.02176111757738252,0.2180455078267438,0.09876543209876547,0.021729618491434455,0.26108675234686274,0.0763888888888889,2.8423167282822487e-07,0.30652676059333084,0.05246913580246914
156,0.9,8,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Does (18)F-FDG function as a surrogate tracer for tumor hypoxia? No, it is primarily focused on glucose metabolism measurement, not hypoxia. Tumor hypoxia is measured using specialized tracers such as (18)F-fluoromisonidazole.",2.605457000925384e-07,0.09674018966449704,0.19918367346938776,0.01994769111260064,0.1829541880154748,0.09876543209876547,0.01991881695048158,0.22471910817598806,0.0763888888888889,2.6054570009253947e-07,0.26878643261048385,0.05246913580246914
156,0.9,9,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG a tracer used to surrogate tumor hypoxia? No, (18)F-FDG evaluates glucose metabolism rather than hypoxia, and tracers like (18)F-fluoromisonidazole are specifically used for hypoxia imaging.",3.552895910352796e-07,0.23984103330516948,0.19918367346938776,0.02720139697172816,0.33137419313374794,0.09876543209876547,0.027162023114293075,0.378869788003247,0.0763888888888889,3.552895910352811e-07,0.42912908268566374,0.05246913580246914
156,0.9,10,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG an effective surrogate tracer for tumor hypoxia? No, since (18)F-FDG measures the glucose metabolism rate in tissue and not tumor hypoxia, which is better assessed by other tracers like (18)F-fluoromisonidazole.",2.368597273568531e-07,0.06395036684150535,0.19918367346938776,0.01813426464781876,0.14905263633979304,0.09876543209876547,0.018108015409528708,0.18962778836471905,0.0763888888888889,2.3685972735685406e-07,0.23241878843960917,0.05246913580246914
157,0.9,1,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Is pain considered a clinically significant issue in general adult psychiatry? Our research indicates that pain is indeed a notable clinical concern among psychiatric patients, though it appears to be undervalued in psychiatry. Patients examined in general adult psychiatry exhibit particular risk factors.",7.105791820705622e-08,0.042587264608476616,0.018826530612244874,0.005440279394345618,0.07292293477679124,0.0016600189291508909,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
157,0.9,2,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Is pain a relevant clinical problem in the context of general adult psychiatry? Evidence suggests that pain constitutes a substantial clinical issue for psychiatric patients, yet it seems to be underestimated in the psychiatric field. The patients studied in adult general psychiatry show distinct risk factors.",0.0,0.061613082716439393,0.044115786810592,0.0,0.03150669002545259,0.02271498107084911,0.0,0.0,0.0,0.0,0.0,0.0
157,0.9,3,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Does pain represent a clinically important problem in general adult psychiatry? Studies reveal that pain is a meaningful clinical challenge in psychiatric patients, often underappreciated within psychiatry. Patients assessed in general adult psychiatry have specific associated risk factors.",1.8948778188548293e-07,0.17825978338224058,0.01244897959183671,0.014507411718254981,0.2076721821344738,0.00504012096996722,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
157,0.9,4,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,Can pain be considered a clinically important problem in adult general psychiatry? Our findings demonstrate that pain is a significant clinical issue among psychiatric patients and is apparently underrecognized in psychiatric practice. The patients investigated in adult general psychiatry possess unique risk factors.,7.105791820705622e-08,0.042587264608476616,0.018826530612244874,0.005440279394345618,0.07292293477679124,0.0016600189291508909,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
157,0.9,5,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Is pain a clinically pertinent problem in the setting of general adult psychiatry? The data we found indicate that pain can be a major clinical problem in psychiatric patients, which seems to be overlooked in psychiatry. Individuals treated in general adult psychiatry show distinct risk factors.",0.0,0.030806541358219697,0.021978234235825206,0.0,0.03150669002545259,0.02271498107084911,0.0,0.0,0.0,0.0,0.0,0.0
157,0.9,6,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"In general adult psychiatry, is pain a clinical issue of importance? We have found proof that pain poses a significant clinical problem for psychiatric patients and appears to be underestimated in this medical field. The patients studied in adult general psychiatry carry specific risk factors.",2.3685972735685406e-08,0.06994676822260137,0.06632653061224489,0.0018134264647818726,0.008517171800753065,0.02271498107084911,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
157,0.9,7,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Is pain a relevant clinical problem within general adult psychiatry? Evidence points to pain being a significant clinical concern among psychiatric patients, and it seems psychiatry underestimates this issue. The patients analyzed in general adult psychiatry present particular risk factors.",1.4211583641411233e-07,0.08622722882549994,0.040703261914183934,0.010880558788691236,0.11509678416642277,0.02271498107084911,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
157,0.9,8,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Is pain a clinically meaningful issue in adult general psychiatry? Our findings suggest that pain represents an important clinical problem for psychiatric patients, a factor often undervalued in psychiatry. The adult general psychiatry patients examined demonstrate specific risk factors.",1.6580180914979763e-07,0.11313813652506033,0.04002996377513751,0.012693985253473108,0.14176503124858364,0.02271498107084911,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
157,0.9,9,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Does pain constitute a clinically relevant problem in the realm of general adult psychiatry? Research indicates that pain is a noteworthy clinical challenge for psychiatric patients, but it appears to be underappreciated by psychiatry. The patients in general adult psychiatry are characterized by particular risk factors.",0.0,0.061613082716439393,0.044115786810592,0.0,0.03150669002545259,0.02271498107084911,0.0,0.0,0.0,0.0,0.0,0.0
157,0.9,10,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Is pain a significant clinical problem in the context of general adult psychiatry? Evidence shows that pain can be a considerable clinical concern among psychiatric patients, which psychiatry seems to underestimate. The patients studied in general adult psychiatry have specific risk factors.",9.474389094274162e-08,0.03448285657964245,0.04195153061224489,0.0072537058591274906,0.06380348977887307,0.02271498107084911,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
158,0.9,1,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Are clinical predictors adequate for identifying cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors might not be fully sufficient to detect cervical spine fractures in geriatric blunt trauma cases with low-energy impact.,9.47438909427412e-08,0.2592973238366518,0.07805625,0.007253705859127504,0.33353796108449263,0.14286801110976932,0.007243206163811487,0.3392050516685887,0.14975969085859195,9.474389094274162e-08,0.34495672170102365,0.15532544378698224
158,0.9,2,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,"Question: In geriatric blunt trauma patients with low-energy mechanisms, are clinical predictors reliable for cervical spine fracture detection? Answer: Clinical predictors may not completely suffice for recognizing cervical spine fractures in elderly blunt trauma patients with low-energy injury.",7.10579182070559e-08,0.22671316909679673,0.07431259105098847,0.005440279394345632,0.2655492871338585,0.11410093403100395,0.005432404622858621,0.2703255307642447,0.12058182687553318,7.105791820705622e-08,0.2751958212654224,0.1259406871294983
158,0.9,3,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: How effective are clinical predictors in diagnosing cervical spine fractures among geriatric blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors may fall short in accurately identifying cervical spine fractures in elderly patients with blunt trauma caused by low-energy mechanisms.,1.421158364141118e-07,0.35619240641893635,0.10795102040816326,0.01088055878869125,0.42557051564123327,0.17112229343211655,0.01086480924571722,0.43178044963663975,0.17751479289940827,1.4211583641411244e-07,0.4005265728558358,0.15532544378698224
158,0.9,4,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Are clinical predictors adequate for cervical spine fracture identification in elderly patients with low-energy blunt trauma? Answer: Clinical predictors might not be entirely reliable for detecting cervical spine fractures in geriatric blunt trauma cases with low-energy mechanisms.,7.10579182070559e-08,0.33911541459300265,0.14995017301038066,0.005440279394345632,0.38107381722718303,0.1967455621301775,0.005432404622858621,0.3495423513996667,0.17751479289940827,7.105791820705622e-08,0.31596918482777214,0.15532544378698224
158,0.9,5,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Does the use of clinical predictors adequately identify cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors may not be fully adequate for pinpointing cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms.,1.421158364141118e-07,0.25222032933494365,0.042899999999999994,0.01088055878869125,0.2833864786032967,0.07131303617862045,0.01086480924571722,0.3223361579692794,0.09914744596063277,1.4211583641411244e-07,0.3630591576904334,0.12831927094747608
158,0.9,6,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Can clinical predictors sufficiently detect cervical spine fractures in geriatric blunt trauma patients who experienced low-energy trauma? Answer: Clinical predictors might not be completely effective for identifying cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms.,9.47438909427412e-08,0.2592973238366518,0.07805625,0.007253705859127504,0.29607054591908977,0.11629573514055815,0.007243206163811487,0.3392050516685887,0.14975969085859195,9.474389094274162e-08,0.34495672170102365,0.15532544378698224
158,0.9,7,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Are clinical predictors sufficient for identifying cervical spine fractures in elderly patients with blunt trauma from low-energy events? Answer: Clinical predictors may be inadequate for fully recognizing cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms.,9.47438909427412e-08,0.2592973238366518,0.07805625,0.007253705859127504,0.33353796108449263,0.14286801110976932,0.007243206163811487,0.3392050516685887,0.14975969085859195,9.474389094274162e-08,0.34495672170102365,0.15532544378698224
158,0.9,8,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: How adequate are clinical predictors in identifying cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors may not provide complete adequacy in detecting cervical spine fractures in geriatric blunt trauma cases involving low-energy trauma.,1.184298636784265e-07,0.32643134727720957,0.10496747404844295,0.009067132323909377,0.3621781773858861,0.14427642632770835,0.009054007704764354,0.36764478738907647,0.15050862005990212,1.1842986367842703e-07,0.3731275986677205,0.15532544378698224
158,0.9,9,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Are clinical predictors effective in detecting cervical spine fractures in geriatric patients with blunt trauma caused by low-energy mechanisms? Answer: Clinical predictors might not be fully effective in diagnosing cervical spine fractures in elderly blunt trauma patients with low-energy injuries.,1.421158364141118e-07,0.2868776883629409,0.06327419651056013,0.01088055878869125,0.3900245063817489,0.14561334883580204,0.01086480924571722,0.3952990190808534,0.1512182260623009,1.4211583641411244e-07,0.4005265728558358,0.15532544378698224
158,0.9,10,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Is the application of clinical predictors sufficient to identify cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors may not be altogether sufficient to identify cervical spine fractures in geriatric blunt trauma patients with low-energy impact.,1.658018091497972e-07,0.18223918067810319,0.0018222222222221696,0.012693985253473122,0.2091754606610312,0.009245562130177493,0.012675610786670087,0.2444798804829933,0.028754462320895874,1.6580180914979784e-07,0.28126909771484954,0.051519215413279806
159,0.9,1,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Does the motion of the prostate bed target vary between the superior and inferior parts of the clinical target volume when using RTOG consensus definitions and daily CT imaging? No significant motion differences are observed between the superior and inferior CTV, and current PTV margins sufficiently cover both regions.",2.1317375462116866e-07,0.2676140121355983,0.06771692538741061,0.016320838183036854,0.2389357066905573,0.04568181818181816,0.0162972138685758,0.23896545661815427,0.043388429752066124,2.1317375462116866e-07,0.21312809815217548,0.02221074380165289
159,0.9,2,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Is there a difference in interfractional motion between the superior and inferior segments of the clinical target volume of the prostate bed according to RTOG definitions with daily CT on rails? Statistical analysis shows no notable motion difference between SUP-CTV and INF-CTV, and existing uniform PTV margins are adequate.",2.1317375462116866e-07,0.1520894820422738,0.014217420095851314,0.016320838183036854,0.15044883257652186,0.017851239669421492,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
159,0.9,3,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Using RTOG consensus definitions and daily CT on rails, does the prostate bed target motion differ between the superior and inferior portions of the clinical target volume? There is no statistically significant difference, and the current uniform PTV margins effectively cover both areas.",3.552895910352811e-07,0.2567397421434663,0.0350413223140496,0.02720139697172809,0.2870243675822719,0.017851239669421492,0.027162023114293,0.3184537311185349,0.0,3.552895910352811e-07,0.3254224004346309,0.0
159,0.9,4,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Are there differences in interfractional motion of the prostate bed target between the superior and inferior clinical target volume sections using RTOG consensus definitions and daily CT? The motion between SUP-CTV and INF-CTV is statistically similar, with current PTV margins appropriate for both.",3.552895910352811e-07,0.2567397421434663,0.0350413223140496,0.02720139697172809,0.2870243675822719,0.017851239669421492,0.027162023114293,0.3184537311185349,0.0,3.552895910352811e-07,0.3254224004346309,0.0
159,0.9,5,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Does daily CT imaging reveal differences in motion between the superior and inferior parts of the prostate bed clinical target volume as per RTOG consensus? No significant motion discrepancies were found, and uniform PTV margins are sufficient.",4.974054274493931e-07,0.4108904219707239,0.0350413223140496,0.038081955760419325,0.44524837279716634,0.017851239669421492,0.038026832360010206,0.48097266061630917,0.0,4.974054274493935e-07,0.4924764850977952,0.0
159,0.9,6,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Is motion variability different between the superior and inferior regions of the prostate bed CTV using RTOG definitions with daily CT on rails? There are no statistical differences, and the uniform PTV margins cover both adequately.",5.210914001850784e-07,0.43906129893742074,0.0350413223140496,0.039895382225201205,0.47423590967041784,0.017851239669421492,0.03983763390096308,0.5108256237659909,0.0,5.210914001850789e-07,0.5232481437645489,0.0
159,0.9,7,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"When using RTOG consensus criteria and daily CT on rails, does prostate bed target motion differ between superior and inferior CTV portions? No statistically meaningful differences exist, and uniform PTV margins remain appropriate.",5.921493183921343e-07,0.5286734576271077,0.0350413223140496,0.045335661619546844,0.5666092298014331,0.017851239669421492,0.0452700385238217,0.6061358035703162,0.0,5.921493183921352e-07,0.6216882165778022,0.0
159,0.9,8,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Does the prostate bed target motion vary between the superior versus inferior clinical target volume areas according to daily CT and RTOG definitions? Statistically, the motion is consistent between the two, and current PTV margins are sufficient.",4.974054274493931e-07,0.44939859866849874,0.007286220273233269,0.038081955760419325,0.44524837279716634,0.017851239669421492,0.038026832360010206,0.48097266061630917,0.0,4.974054274493935e-07,0.4924764850977952,0.0
159,0.9,9,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Is there a statistically significant difference in interfractional prostate bed target motion between superior and inferior clinical target volume segments using RTOG definitions and daily CT? No significant difference exists, with adequate PTV margin coverage.",5.447773729207637e-07,0.508822199373022,0.005656565656565662,0.041708808689983085,0.5040888728200996,0.017851239669421492,0.04164843544191595,0.5415972824327446,0.0,5.447773729207643e-07,0.5549968420791287,0.0
159,0.9,10,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Using RTOG consensus definitions and daily CT on rails, are superior and inferior clinical target volume portions of the prostate bed subject to different target motions? The motion does not differ significantly, and uniform planning target volume margins adequately cover both.",4.026615365066519e-07,0.3401872653408944,0.010057758868947678,0.030828249901291835,0.3370347881569353,0.017851239669421492,0.030783626196198732,0.3697470255060846,0.0,4.026615365066519e-07,0.37806613392004973,0.0
160,0.9,1,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Are labs accurately reporting serum quantitative hCG outcomes? The precision of lab-reported serum quantitative hCG results mainly hinges on the individual laboratory and its compliance with testing standards. Many labs deliver dependable and precise results, yet inconsistencies might arise from issues like equipment calibration, reagent quality, and staff expertise. Consistent audits and quality control processes are vital for ensuring accuracy.",1.1842986367842703e-07,0.020034421681966563,0.043707347161555644,0.009067132323909363,0.018574653166061772,0.045964157181282855,0.009054007704764333,0.01700435780151377,0.048261993679977015,1.1842986367842703e-07,0.04006989930308258,0.03274920999712727
160,0.9,2,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Do laboratories correctly report serum quantitative hCG levels? The reliability of serum quantitative hCG reporting varies by lab and their strictness in following test protocols. Although numerous laboratories provide trustworthy and accurate data, errors may happen due to factors such as calibration of instruments, quality of reagents, and training of technicians. Routine inspections and quality assurance checks are crucial to maintain accuracy.",7.105791820705622e-08,0.014842753641051587,0.0448147084171215,0.005440279394345618,0.01612361940681417,0.04653835104854929,0.0054324046228586,0.01748181826965478,0.048261993679977015,7.105791820705622e-08,0.004978579491813129,0.03274920999712727
160,0.9,3,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Is the reporting of serum quantitative hCG by labs accurate? The correctness of serum quantitative hCG results reported by laboratories depends significantly on the particular lab's adherence to testing procedures. While many laboratories yield accurate and dependable results, discrepancies can result from equipment calibration issues, reagent standards, and technician skills. Conducting regular quality audits and control evaluations is essential for accuracy.",9.474389094274162e-08,0.025548992231074763,0.027702422569373435,0.0072537058591274906,0.02457162208140673,0.02934365856632442,0.007243206163811466,0.023514242005505004,0.03102592104224233,9.474389094274162e-08,0.022370322203681958,0.03274920999712727
160,0.9,4,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Are serum quantitative hCG results being reported accurately by laboratories? The accuracy with which laboratories report serum quantitative hCG is mostly dependent on the lab’s implementation of testing protocols. Many labs offer reliable results, but discrepancies may occur due to factors like instrument calibration, reagent effectiveness, and personnel training. Regular quality control checks and audits are important to ensure result validity.",9.474389094274162e-08,0.0024440862124102125,0.044270220435651854,0.0072537058591274906,0.0010751074861543586,0.04625611566919591,0.007243206163811466,0.00038738491035505973,0.048261993679977015,9.474389094274162e-08,0.022370322203681958,0.03274920999712727
160,0.9,5,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Do laboratories report serum quantitative hCG outcomes correctly? The correctness of serum quantitative hCG results from laboratories is largely contingent upon the specific lab's adherence to testing guidelines. Numerous labs produce accurate and reliable results, yet errors can stem from equipment calibration, reagent quality, and technician training. It is crucial to perform periodic audits and quality assessments for accuracy assurance.",1.1842986367842703e-07,0.020034421681966563,0.043707347161555644,0.009067132323909363,0.018574653166061772,0.045964157181282855,0.009054007704764333,0.01700435780151377,0.048261993679977015,1.1842986367842703e-07,0.04006989930308258,0.03274920999712727
160,0.9,6,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Are laboratories providing accurate serum quantitative hCG reports? The fidelity of serum quantitative hCG reporting by labs depends on their compliance with testing protocols. While many labs ensure accurate and dependable results, deviations can occur because of calibration, reagent quality, or technician proficiency. Regular quality control and audits are necessary to guarantee accuracy.",2.8423167282822487e-07,0.15265413170497943,0.03916391841424876,0.02176111757738247,0.15047264644719505,0.04360022981901755,0.0217296184914344,0.14803262020791852,0.048261993679977015,2.8423167282822487e-07,0.17360129192760532,0.03274920999712727
160,0.9,7,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Is the reporting of serum quantitative hCG in labs accurate? The precision of serum quantitative hCG results reported by laboratories largely depends on the individual lab and how well they follow testing protocols. Although many labs deliver accurate and reliable data, occasional discrepancies arise due to factors like equipment calibration, reagent quality, and technician experience. Frequent audits and quality control measures are essential for maintaining correctness.",2.3685972735685406e-08,0.0598256168313851,0.031518132774290386,0.0018134264647818726,0.06044534777805577,0.03198274802921525,0.0018108015409528666,0.06107442835674348,0.032393107103494176,2.3685972735685406e-08,0.061712795006859444,0.03274920999712727
160,0.9,8,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Are serum quantitative hCG test results accurately reported by laboratories? The accuracy of these results mostly depends on the lab's adherence to proper testing procedures. Many labs provide reliable and accurate serum quantitative hCG results, but issues such as calibration, reagent quality, and technician training can cause inconsistencies. Regular audit and quality control processes are fundamental to ensure accuracy.",1.4211583641411244e-07,0.03793907968248167,0.04312514290404468,0.010880558788691236,0.0363857226659281,0.04566196451289509,0.0108648092457172,0.03470393490091439,0.048261993679977015,1.4211583641411244e-07,0.05808840480576105,0.03274920999712727
160,0.9,9,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Do labs correctly report serum quantitative hCG test results? The dependability of serum quantitative hCG reporting is greatly influenced by the lab’s compliance with testing protocols. Many laboratories produce accurate results; however, factors like equipment calibration, reagent quality, and staff training can introduce errors. Conducting regular quality checks and audits is critical for ensuring data correctness.",2.1317375462116866e-07,0.0936563552054328,0.04125206366166778,0.016320838183036854,0.09180410803086225,0.04468830386672136,0.0162972138685758,0.08976371208394296,0.048261993679977015,2.1317375462116866e-07,0.11417787145680425,0.03274920999712727
160,0.9,10,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Are the serum quantitative hCG results from laboratories reported accurately? The accuracy of these results depends mainly on the specific laboratory and their strict adherence to testing protocols. While many provide reliable measurements, discrepancies may arise due to equipment calibration, reagent quality, or technician expertise. Routine audits and quality control are necessary to uphold result accuracy.",2.1317375462116866e-07,0.043245651164709464,0.07756391841424877,0.016320838183036854,0.0661319902323454,0.06320022981901754,0.0162972138685758,0.08976371208394296,0.048261993679977015,2.1317375462116866e-07,0.11417787145680425,0.03274920999712727
161,0.9,1,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Question: Hepatorenal syndrome: are there prognostic factors we have overlooked? Answer: The prognosis of Hepatorenal syndrome (HRS) mainly depends on the severity of liver disease and kidney function. Still, research indicates that additional factors like systemic inflammation, infections, circulatory issues, and genetic predispositions may be overlooked. More studies are necessary to clarify and incorporate these factors.",2.3685972735685406e-08,0.018349138668195764,0.0,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
161,0.9,2,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Question: Hepatorenal syndrome: could we be missing key prognostic indicators? Answer: Prognosis for Hepatorenal syndrome (HRS) is typically based on the extent of liver disease and renal function. Nevertheless, evidence points to missing prognostic elements such as systemic inflammation, infections, circulatory dysfunction, and genetic susceptibility. Additional research is required to better understand and integrate these factors.",2.3685972735685406e-08,0.018349138668195764,0.0,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
161,0.9,3,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Question: Hepatorenal syndrome: are there unidentified prognostic factors? Answer: The prognosis of Hepatorenal syndrome (HRS) is largely determined by liver disease severity and kidney function, but emerging research suggests that systemic inflammation, infection, circulatory dysfunction, and genetic predispositions might also play important roles. Further investigation is needed to fully recognize and include these elements.",2.3685972735685406e-08,0.018692133012154333,0.0,0.0018134264647818726,0.0190481949706931,0.0,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
161,0.9,4,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Question: Hepatorenal syndrome: might some prognostic factors be overlooked? Answer: Prognosis in Hepatorenal syndrome (HRS) primarily relies on liver severity and renal status. However, studies propose that other factors such as systemic inflammation, infection, circulatory impairment, and genetic factors may be missed. More research is essential to incorporate these into prognostic evaluations.",7.105791820705622e-08,0.05715841383995013,0.0,0.005440279394345618,0.05826890812397556,0.0,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
161,0.9,5,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Question: Hepatorenal syndrome: are we overlooking prognostic factors? Answer: The outcome prediction for Hepatorenal syndrome (HRS) is mainly based on liver disease severity and kidney function, but findings indicate additional contributors like systemic inflammatory response, infections, circulatory abnormalities, and inherent genetic predispositions may be neglected. Further research is needed for comprehensive assessment.",7.105791820705622e-08,0.05715841383995013,0.0,0.005440279394345618,0.05826890812397556,0.0,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
161,0.9,6,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Question: Hepatorenal syndrome: are additional prognostic factors going unnoticed? Answer: HRS prognosis is chiefly determined by the degree of liver disease and renal function, yet studies imply other influences such as systemic inflammation, infections, circulatory dysfunction, and genetic predispositions could be missing. Deeper research is warranted to understand and include these factors fully.",4.737194547137081e-08,0.03774032798284743,0.0,0.0036268529295637453,0.038466280827795796,0.0,0.003621603081905733,0.03922071315328246,0.0,4.737194547137081e-08,0.04000533461369837,0.0
161,0.9,7,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Question: Hepatorenal syndrome: could prognostic factors be missing? Answer: The prediction of Hepatorenal syndrome (HRS) outcomes depends mainly on liver and kidney disease severity, but data suggest further factors like systemic inflammation, infection, circulatory dysfunction, and genetic predisposition might not be considered adequately. More research is required to elucidate and integrate them.",7.105791820705622e-08,0.05715841383995013,0.0,0.005440279394345618,0.05826890812397556,0.0,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
161,0.9,8,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Question: Hepatorenal syndrome: have some prognostic elements been overlooked? Answer: Prognostic assessments for Hepatorenal syndrome (HRS) are largely based on liver disease severity and renal function, though studies highlight potential missing factors such as systemic inflammation, infection, circulatory dysfunction, and genetic predispositions. Additional research is necessary to incorporate these.",1.4211583641411244e-07,0.11778303565638426,0.0,0.010880558788691236,0.12014431184206309,0.0,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
161,0.9,9,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Question: Hepatorenal syndrome: are there prognostic factors we fail to consider? Answer: Hepatorenal syndrome prognosis centers on liver and kidney function; however, research suggests that systemic inflammation, infections, circulatory problems, and genetic predispositions might also significantly influence outcomes. Further studies are imperative to recognize and include these factors.",1.6580180914979784e-07,0.13883644485421742,0.0,0.012693985253473108,0.14165051706302645,0.0,0.012675610786670066,0.14458122881110835,0.0,1.6580180914979784e-07,0.14763599880606337,0.0
161,0.9,10,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Question: Hepatorenal syndrome: is our understanding of prognostic factors incomplete? Answer: The prognosis of Hepatorenal syndrome (HRS) focuses on liver disease severity and renal function, but studies suggest other prognostic factors like systemic inflammation, infections, circulatory dysfunction, and genetic predispositions may be overlooked. Further investigation is needed to fully incorporate these factors.",7.105791820705622e-08,0.08434065621484965,0.019599999999999992,0.005440279394345618,0.05826890812397556,0.0,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
162,0.9,1,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does cup-cage reconstruction using oversized cups offer initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures? Most acetabular components in this group remained stable despite the limited contact area between the implant and pelvic bone. However, 3 out of 10 components shifted beyond the threshold that typically forecasts future loosening in primary surgeries.",2.3685972735685406e-08,0.018692133012154333,0.0,0.0018134264647818726,0.0190481949706931,0.0,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
162,0.9,2,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Is initial stability provided by cup-cage reconstruction with oversized cups during THA for osteoporotic acetabular fractures? In this cohort, the majority of acetabular components were stable even though the contact surface between the component and pelvic bone was small. Three of ten implants moved more than the limits that indicate probable later loosening in primary cases.",4.737194547137081e-08,0.037041271680350096,0.0,0.0036268529295637453,0.03774032798284743,0.0,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
162,0.9,3,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does using oversized cups in cup-cage reconstruction ensure initial stability in total hip arthroplasty for osteoporotic acetabular fractures? The bulk of acetabular components in the study remained stable despite limited contact surface with the pelvic bone. Nevertheless, three out of ten implants migrated beyond the threshold predicting later loosening in primary procedures.",4.737194547137081e-08,0.038466280827795796,0.0,0.0036268529295637453,0.03922071315328246,0.0,0.003621603081905733,0.04000533461369837,0.0,4.737194547137081e-08,0.04082199452025437,0.0
162,0.9,4,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Can the cup-cage reconstruction technique with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Most acetabular components in this cohort held steady despite the minimal contact area with the pelvic bone. Still, 3 of 10 implants migrated beyond limits associated with future loosening in primary THA.",1.1842986367842703e-07,0.09909090264422993,0.0,0.009067132323909363,0.10109611687136999,0.0,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
162,0.9,5,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does the use of oversized cups in cup-cage reconstruction confer initial stability in total hip arthroplasty for patients with osteoporotic acetabular fractures? Most acetabular components were stable despite the small interface between the component and pelvic bone, although three out of ten migrated beyond the limits predicting future loosening after primary surgery.",4.737194547137081e-08,0.038466280827795796,0.0,0.0036268529295637453,0.03922071315328246,0.0,0.003621603081905733,0.04000533461369837,0.0,4.737194547137081e-08,0.04082199452025437,0.0
162,0.9,6,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Is initial mechanical stability achieved by cup-cage reconstruction with oversized cups in THA for osteoporotic acetabular fractures? The majority of acetabular components remained stable despite limited contact surfaces with pelvic bone, but 3 out of 10 migrated beyond thresholds linked to later loosening in primary cases.",1.8948778188548325e-07,0.16362942378180145,0.0,0.014507411718254981,0.16705408466316607,0.0,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
162,0.9,7,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does cup-cage reconstruction with oversized cups provide sufficient initial stability in total hip arthroplasty for osteoporotic acetabular fractures? Despite a small contact area between the component and pelvic bone, most acetabular components were stable, though three of ten showed migration beyond limits that predict subsequent loosening in primary cases.",1.1842986367842703e-07,0.09909090264422993,0.0,0.009067132323909363,0.10109611687136999,0.0,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
162,0.9,8,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does the application of oversized cups in cup-cage reconstruction ensure initial stability in THA for osteoporotic acetabular fractures? Stability was observed in most acetabular components despite the narrow contact surface, but 3 out of 10 implants exhibited migration exceeding the boundaries predictive of future loosening in primary treatments.",1.4211583641411244e-07,0.12014431184206309,0.0,0.010880558788691236,0.12260232209233335,0.0,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
162,0.9,9,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does employing oversized cups in cup-cage reconstruction achieve initial stability in total hip arthroplasty for osteoporotic acetabular fractures? The majority of components were stable despite limited contact with pelvic bone, although three of ten implants migrated beyond limits forecasting later loosening after primary procedures.",2.3685972735685406e-07,0.2090917978585587,0.0,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
162,0.9,10,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does cup-cage reconstruction with oversized cups provide reliable initial stability in THA for osteoporotic acetabular fractures? Most acetabular components were stable even with a small contact area between implant and pelvic bone, yet 3 out of 10 implants migrated past thresholds that predict future loosening in primary surgeries.",1.4211583641411244e-07,0.12014431184206309,0.0,0.010880558788691236,0.12260232209233335,0.0,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
163,0.9,1,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Question: Is there a connection between cervical cord plaques and discopathy in multiple sclerosis patients? Answer: The study data indicates a potential link between cervical discopathy and cervical MS plaques.,2.36859727356853e-08,0.035494993470072345,0.0011450775316071762,0.0018134264647818796,0.035091319811269006,0.0,0.0018108015409528735,0.03636764417087468,0.0,2.3685972735685406e-08,0.03774032798284699,0.0
163,0.9,2,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Question: Are cervical cord plaques related to discopathy in patients with multiple sclerosis? Answer: Data from the study suggests a probable association between cervical discopathy and cervical MS plaques.,4.73719454713706e-08,0.022783059449621224,0.033293697978596916,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
163,0.9,3,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Question: Does a relationship exist between cervical cord plaques and discopathy in multiple sclerosis patients? Answer: The study findings imply a possible correlation between cervical discopathy and cervical MS plaques.,2.36859727356853e-08,0.035494993470072345,0.0011450775316071762,0.0018134264647818796,0.035091319811269006,0.0,0.0018108015409528735,0.03636764417087468,0.0,2.3685972735685406e-08,0.03774032798284699,0.0
163,0.9,4,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,"Question: Is there any association between cervical cord plaques and discopathy among patients with multiple sclerosis? Answer: According to the study data, there might be a link between cervical discopathy and cervical MS plaques.",7.10579182070559e-08,0.09951107180771901,0.003020260478596916,0.005440279394345639,0.09844007281325329,0.0,0.005432404622858621,0.10178269430994247,0.0,7.105791820705622e-08,0.10536051565782545,0.0
163,0.9,5,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Question: Can cervical cord plaques be related to discopathy in multiple sclerosis patients? Answer: The study data points to a potential connection between cervical discopathy and cervical MS plaques.,4.73719454713706e-08,0.022783059449621224,0.033293697978596916,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
163,0.9,6,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Question: Is there any link between cervical cord plaques and discopathy in multiple sclerosis patients? Answer: The study suggests a potential association between cervical discopathy and cervical MS plaques.,4.73719454713706e-08,0.07229357234676037,0.0023715969459572606,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
163,0.9,7,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Question: Do cervical cord plaques have any relationship with discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible connection between cervical discopathy and cervical MS plaques.,2.36859727356853e-08,0.012308260361647783,0.033293697978596916,0.0018134264647818796,0.035091319811269006,0.0,0.0018108015409528735,0.03636764417087468,0.0,2.3685972735685406e-08,0.03774032798284699,0.0
163,0.9,8,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Question: Is a correlation present between cervical cord plaques and discopathy in multiple sclerosis patients? Answer: Study data indicates that cervical discopathy may be related to cervical MS plaques.,4.73719454713706e-08,0.022783059449621224,0.033293697978596916,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
163,0.9,9,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Question: Is there an observed relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data shows a possible correlation between cervical discopathy and cervical MS plaques.,2.36859727356853e-08,0.03428046192097023,0.0010714757563747151,0.0018134264647818796,0.03390155167568176,0.0,0.0018108015409528735,0.035091319811269006,0.0,2.3685972735685406e-08,0.03636764417087468,0.0
163,0.9,10,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Question: Are cervical cord plaques and discopathy connected in patients with multiple sclerosis? Answer: The data from the study suggests a possible link between cervical discopathy and cervical MS plaques.,2.36859727356853e-08,0.012308260361647783,0.033293697978596916,0.0018134264647818796,0.035091319811269006,0.0,0.0018108015409528735,0.03636764417087468,0.0,2.3685972735685406e-08,0.03774032798284699,0.0
164,0.9,1,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is it appropriate to perform aneurysm repair on patients aged 80 or older after aneurysmal subarachnoid hemorrhage? The study found that repairing ruptured aneurysms in elderly patients leads to better outcomes compared to conservative treatment. Therefore, definitive surgery should be considered without hesitation for elderly patients with aSAH.",1.4211583641411244e-07,0.09732694178750023,0.016411275581806918,0.010880558788691236,0.12260232209233335,0.0,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
164,0.9,2,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Should aneurysm repair be performed on patients 80 years or older following aneurysmal subarachnoid hemorrhage? The results indicate that elderly patients who undergo rupture repair have a better prognosis than those treated conservatively. Based on this study, definitive surgery should be offered confidently to elderly patients with aSAH.",1.4211583641411244e-07,0.09732694178750023,0.016411275581806918,0.010880558788691236,0.12260232209233335,0.0,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
164,0.9,3,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is aneurysm repair justified in patients aged 80+ after aneurysmal subarachnoid hemorrhage? This study shows improved prognosis when ruptured aneurysms are surgically repaired in elderly patients versus conservative management. Consequently, definitive surgery ought to be offered readily to elderly aSAH patients.",3.079176455639103e-07,0.2290994646789435,0.03767781622452902,0.023574544042164344,0.28768207245178345,0.0,0.023540420032387266,0.29423947299793873,0.0,3.079176455639103e-07,0.30110509278391984,0.0
164,0.9,4,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","For patients aged 80 or older with aneurysmal subarachnoid hemorrhage, is aneurysm repair warranted? Findings from this study reveal that surgical repair of ruptured aneurysms in the elderly results in better outcomes than conservative treatment, supporting the recommendation to proceed with definitive surgery in these cases.",1.8948778188548325e-07,0.11131642902256011,0.03767781622452902,0.014507411718254981,0.16705408466316607,0.0,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
164,0.9,5,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Does aneurysm repair benefit patients aged 80 or more after aneurysmal subarachnoid hemorrhage? The study demonstrates that elderly patients receiving repair of ruptured aneurysms have superior prognosis compared to conservative care. Hence, definitive surgery should not be withheld from elderly aSAH patients.",2.8423167282822487e-07,0.2044068520885718,0.03767781622452902,0.02176111757738247,0.2623642644674917,0.0,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
164,0.9,6,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is it advisable to perform aneurysm repair on elderly patients aged 80 or above after aneurysmal subarachnoid hemorrhage? Repair of ruptured aneurysms resulted in better prognosis than conservative treatment in the elderly, suggesting that definitive surgery should be confidently offered to these patients.",2.6054570009253947e-07,0.18030930050951177,0.03767781622452902,0.0199476911126006,0.23767165187712003,0.0,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
164,0.9,7,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is undergoing aneurysm repair justified for patients 80 years and older following aneurysmal subarachnoid hemorrhage? The study indicates improved outcomes with surgical repair of ruptured aneurysms in elderly patients compared to conservative treatment, implying definitive surgery is appropriate for elderly aSAH cases.",2.8423167282822487e-07,0.2044068520885718,0.03767781622452902,0.02176111757738247,0.2623642644674917,0.0,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
164,0.9,8,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Should elderly patients aged 80+ with aneurysmal subarachnoid hemorrhage receive aneurysm repair? Evidence from this study shows that the prognosis is better with rupture repair than conservative treatment, recommending that definitive surgery should be pursued for elderly patients.",3.789755637709662e-07,0.30706100614865406,0.03767781622452902,0.029014823436509962,0.3677247801253176,0.0,0.028972824655245866,0.37647757123491177,0.0,3.789755637709665e-07,0.3856624808119835,0.0
164,0.9,9,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is performing aneurysm repair on patients aged 80 or older after aneurysmal subarachnoid hemorrhage justified? According to the study, elderly patients who undergo rupture repair have better prognosis than those managed conservatively, supporting the offering of definitive surgery to elderly aSAH patients.",2.8423167282822487e-07,0.2044068520885718,0.03767781622452902,0.02176111757738247,0.2623642644674917,0.0,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
164,0.9,10,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","For elderly patients aged 80 or more with aneurysmal subarachnoid hemorrhage, is aneurysm repair warranted? This study’s results demonstrate improved outcomes with surgical repair of ruptured aneurysms versus conservative treatment, indicating that definitive surgery should be provided to elderly aSAH patients.",3.079176455639103e-07,0.2290994646789435,0.03767781622452902,0.023574544042164344,0.28768207245178345,0.0,0.023540420032387266,0.29423947299793873,0.0,3.079176455639103e-07,0.30110509278391984,0.0
165,0.9,1,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Do individuals with episodic migraines specifically focus on headache-related visual cues? Considering the substantial sample size and earlier pilot tests of the images shown, findings indicate that episodic migraineurs do not show selective attention to headache-related facial images. Although there is some limited evidence of attentional biases in chronic headache groups, these results suggest otherwise.",1.1842986367842703e-07,0.1820389134201723,0.060964083175803374,0.009067132323909363,0.12797203516756062,0.020823902218198284,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
165,0.9,2,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Are episodic migraine sufferers particularly attentive to visual stimuli associated with headaches? Based on a large sample and previous pilot testing of the images presented, the data imply that those with episodic migraines do not selectively focus on headache-related facial stimuli. While minor evidence exists for attentional biases in chronic headache populations, these findings do not support that.",1.8948778188548325e-07,0.2117851809865896,0.04342581786968092,0.014507411718254981,0.18303181235058918,0.020823902218198284,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
165,0.9,3,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Do people experiencing episodic migraines pay selective attention to headache-related visual stimuli? Given the considerable sample size and prior pilot studies of the images used, the results indicate that episodic migraineurs do not differentially attend to facial stimuli linked to headaches. Although some modest proof exists of attentional biases in chronic headache sufferers, these outcomes suggest otherwise.",1.6580180914979784e-07,0.21840655759104655,0.060964083175803374,0.012693985253473108,0.1650133068479107,0.020823902218198284,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
165,0.9,4,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Is there selective attention to headache-related facial stimuli among episodic migraineurs? With a large sample size and earlier pilot testing of the images, findings show that episodic migraine patients do not preferentially attend to headache-related visual cues. Despite limited evidence of attentional biases in chronic headache groups, these results suggest no significant bias.",7.105791820705622e-08,0.11763907849271149,0.041740707551043664,0.005440279394345618,0.08950575433976482,0.020823902218198284,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
165,0.9,5,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Do episodic migraine patients show selective attention towards headache-related visual stimuli? Considering the large sample and previous pilot testing of the presented images, it appears that episodic migraineurs do not specifically focus on headache-related facial stimuli. While some slight evidence of attentional biases exists in chronic headache samples, the findings indicate otherwise.",4.737194547137081e-08,0.12488049958022218,0.060964083175803374,0.0036268529295637453,0.06970312704358506,0.020823902218198284,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
165,0.9,6,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Are headache-related visual stimuli selectively attended to by episodic migraine sufferers? In light of a large sample size and prior pilot testing of images, the results suggest episodic migraineurs do not exhibit differential attention toward headache-related facial stimuli. Despite modest indications of attentional biases in chronic headache groups, these findings suggest no such bias in episodic cases.",1.6580180914979784e-07,0.21840655759104655,0.060964083175803374,0.012693985253473108,0.1650133068479107,0.020823902218198284,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
165,0.9,7,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Do episodic migraineurs pay particular attention to headache-associated visual stimuli? Given the large sample and earlier pilot-tested images, the data suggest that episodic migraine patients do not differentially attend to headache-related faces. Although there is modest evidence of attentional biases in chronic headache sufferers, these findings do not confirm such bias in episodic migraineurs.",9.474389094274162e-08,0.1371902830283971,0.042103136430241245,0.0072537058591274906,0.10892384019686752,0.020823902218198284,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
165,0.9,8,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Is selective attention to headache-related facial stimuli present in episodic migraineurs? Based on the large sample size and prior pilot testing of images, results indicate that individuals with episodic migraines do not focus more on headache-related visual stimuli. Despite some modest evidence of attentional biases in chronic headache samples, these findings suggest no differential attention.",1.1842986367842703e-07,0.1820389134201723,0.060964083175803374,0.009067132323909363,0.12797203516756062,0.020823902218198284,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
165,0.9,9,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Do those with episodic migraines demonstrate selective attention toward headache-related visual cues? With a substantial sample and prior pilot testing of images, the findings imply that episodic migraineurs do not selectively attend to headache-related facial stimuli. While there is limited evidence of attentional bias in chronic headache sufferers, this study's findings indicate no such bias for episodic migraineurs.",1.8948778188548325e-07,0.23610613469044717,0.060964083175803374,0.014507411718254981,0.18303181235058918,0.020823902218198284,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
165,0.9,10,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Are headache-related facial stimuli selectively focused on by episodic migraineurs? Considering the large sample and previous pilot testing, the results suggest that individuals with episodic migraines do not display a differential attention pattern towards headache-related visual stimuli. Although some modest evidence exists for attentional biases in chronic headache groups, these findings do not support such biases in episodic migraine patients.",2.3685972735685406e-07,0.22359928157111097,0.027107511923110242,0.018134264647818726,0.21812313216185863,0.020823902218198284,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
166,0.9,1,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does Kenya's health care benefits distribution align with universal coverage principles? Despite efforts, disparities in access, resource constraints, and service delivery gaps remain, so it doesn't fully satisfy universal coverage principles.",6.395212638635049e-07,0.5421379759865785,0.0705125303951055,0.0489625145491106,0.5590348349543981,0.07100591715976332,0.04889164160572745,0.6247179710165436,0.03631185475258099,6.39521263863506e-07,0.667475062761429,0.01851192595229618
166,0.9,2,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Is the distribution of health care benefits in Kenya consistent with universal coverage ideals? Kenya aims for universal coverage, but unequal access, limited resources, and service gaps mean it does not yet fully achieve these principles.",5.210914001850784e-07,0.3417774841219905,0.10380622837370242,0.039895382225201205,0.39997014032470934,0.07100591715976332,0.03983763390096308,0.4604149197252676,0.03631185475258099,5.210914001850789e-07,0.497576025966032,0.01851192595229618
166,0.9,3,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does Kenya's health care benefits allocation fulfill the universal coverage criteria? Although progress is being made, regional inequalities, resource shortages, and service delivery issues prevent full adherence.",7.342651548062461e-07,0.6390290075899214,0.10380622837370242,0.05621622040823812,0.7074548400726712,0.07100591715976332,0.05613484776953894,0.7788686508438025,0.03631185475258099,7.342651548062476e-07,0.8278177128366089,0.01851192595229618
166,0.9,4,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Is the Kenyan health care benefits distribution in line with universal coverage standards? Efforts towards universal coverage are ongoing, but unequal regional access and resource limitations hinder complete fulfillment.",6.868932093348755e-07,0.6144315483333389,0.06814093344914823,0.05258936747867436,0.6304937989365418,0.07100591715976332,0.052513244687633194,0.6988259431702653,0.03631185475258099,6.868932093348768e-07,0.7444361038975584,0.01851192595229618
166,0.9,5,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does Kenya meet the universal coverage standards in distributing health care benefits? While pursuing universal health coverage, challenges like uneven access, resource scarcity, and service gaps mean these principles aren't fully met.",6.158352911278196e-07,0.4631383411262573,0.10380622837370242,0.04714908808432872,0.5251332832787163,0.07100591715976332,0.04708084006477457,0.5896266512052746,0.03631185475258099,6.158352911278206e-07,0.6311074185905543,0.01851192595229618
166,0.9,6,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Is the distribution of health care benefits in Kenya aligned with universal coverage goals? Kenya continues to work toward universal coverage, yet disparities in service and resources prevent full compliance.",6.632072365991902e-07,0.5298297156249308,0.10380622837370242,0.05077594101389248,0.5941261547656671,0.07100591715976332,0.05070244314668032,0.6610856151874183,0.03631185475258099,6.632072365991914e-07,0.705215390744276,0.01851192595229618
166,0.9,7,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does Kenya adhere to universal coverage principles in its health care benefit distribution? Despite striving for universal coverage, unequal regional access and resource constraints mean it falls short.",7.105791820705608e-07,0.6012886796070744,0.10380622837370242,0.05440279394345624,0.6682341269193888,0.07100591715976332,0.05432404622858607,0.7380466563235477,0.03631185475258099,7.105791820705622e-07,0.7852580984178132,0.01851192595229618
166,0.9,8,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Is the health care benefit distribution in Kenya compatible with universal coverage principles? Though Kenya pursues universal coverage, current disparities and service delivery gaps indicate it doesn't fully comply.",6.868932093348755e-07,0.5649210354361998,0.10380622837370242,0.05258936747867436,0.6304937989365418,0.07100591715976332,0.052513244687633194,0.6988259431702653,0.03631185475258099,6.868932093348768e-07,0.7444361038975584,0.01851192595229618
166,0.9,9,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does Kenya's health care benefits distribution satisfy universal coverage principles? The country is progressing towards universal coverage, but unequal access and limited resources mean the goals aren't fully achieved.",6.868932093348755e-07,0.5649210354361998,0.10380622837370242,0.05258936747867436,0.6304937989365418,0.07100591715976332,0.052513244687633194,0.6988259431702653,0.03631185475258099,6.868932093348768e-07,0.7444361038975584,0.01851192595229618
166,0.9,10,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Is the distribution of health care benefits across Kenya fulfilling universal coverage principles? Kenya is working towards universal health coverage, but existing inequalities and resource gaps mean full compliance is lacking.",6.395212638635049e-07,0.495928163949249,0.10380622837370242,0.0489625145491106,0.5590348349543981,0.07100591715976332,0.04889164160572745,0.6247179710165436,0.03631185475258099,6.39521263863506e-07,0.667475062761429,0.01851192595229618
167,0.9,1,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Can a new surgical method for the temporomandibular joint enhance accessibility and lower the risk of complications?,7.579511275419307e-07,0.8098009634347991,0.19390581717451527,0.05802964687302005,0.9061324029704196,0.16305062458908606,0.05794564931049187,1.008763063249503,0.1275,7.579511275419326e-07,1.1184869668759037,0.08804283164782867
167,0.9,2,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Is it possible for an innovative surgery technique targeting the temporomandibular joint to provide better access and minimize complications?,7.105791820705601e-07,0.6920179277784153,0.19390581717451527,0.054402793943456304,0.780969260016414,0.16305062458908606,0.05432404622858612,0.8752316706249803,0.1275,7.105791820705619e-07,0.9753861232352303,0.08804283164782867
167,0.9,3,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Could a novel approach to temporomandibular joint surgery improve access while reducing complications?,8.526950184846721e-07,1.0974830358865795,0.19390581717451527,0.06528335273214755,1.2162873312742595,0.16305062458908606,0.06518885547430336,1.345235299870716,0.1275,8.52695018484674e-07,1.4862117470012213,0.08804283164782867
167,0.9,4,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Does a fresh surgical technique for the temporomandibular joint help in improving access and decreasing complications?,7.816371002776161e-07,0.8743394845723698,0.19390581717451527,0.05984307333780193,0.9751252744573717,0.16305062458908606,0.05975645085144475,1.0828710354032243,0.1275,7.81637100277618e-07,1.19852967454944,0.08804283164782867
167,0.9,5,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Might a new surgical procedure for the temporomandibular joint facilitate better access and fewer complications?,8.053230730133015e-07,0.9433323560593219,0.19390581717451527,0.06165649980258381,1.049233246611093,0.16305062458908606,0.06156725239239762,1.1629137430767607,0.1275,8.053230730133033e-07,1.2855410515390702,0.08804283164782867
167,0.9,6,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Can an advanced surgical strategy for the temporomandibular joint increase access and reduce complication rates?,8.053230730133015e-07,0.9433323560593219,0.19390581717451527,0.06165649980258381,1.049233246611093,0.16305062458908606,0.06156725239239762,1.1629137430767607,0.1275,8.053230730133033e-07,1.2855410515390702,0.08804283164782867
167,0.9,7,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Is a novel surgical approach capable of enhancing access and lessening complications in temporomandibular joint treatment?,7.816371002776161e-07,0.8743394845723698,0.19390581717451527,0.05984307333780193,0.9751252744573717,0.16305062458908606,0.05975645085144475,1.0828710354032243,0.1275,7.81637100277618e-07,1.19852967454944,0.08804283164782867
167,0.9,8,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Could innovative surgical methods for the temporomandibular joint improve accessibility and lower complication risks?,8.290090457489868e-07,1.017440328213043,0.19390581717451527,0.06346992626736568,1.1292759542846293,0.16305062458908606,0.0633780539333505,1.2499251200663908,0.1275,8.290090457489886e-07,1.3808512313433954,0.08804283164782867
167,0.9,9,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Would adopting a new surgical approach to the temporomandibular joint enhance access and reduce complications?,8.053230730133015e-07,0.9433323560593219,0.19390581717451527,0.06165649980258381,1.049233246611093,0.16305062458908606,0.06156725239239762,1.1629137430767607,0.1275,8.053230730133033e-07,1.2855410515390702,0.08804283164782867
167,0.9,10,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Can improvements in surgical techniques for the temporomandibular joint lead to better access and fewer complications?,7.816371002776161e-07,0.8743394845723698,0.19390581717451527,0.05984307333780193,0.9751252744573717,0.16305062458908606,0.05975645085144475,1.0828710354032243,0.1275,7.81637100277618e-07,1.19852967454944,0.08804283164782867
168,0.9,1,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Does the position of the head affect anterior chamber depth in pseudoexfoliation syndrome? Yes, the anterior chamber depth can be affected by head positioning in pseudoexfoliation syndrome. Certain postures, like lying flat, may deepen the anterior chamber, which could complicate management. Hence, head positioning is important during evaluation and treatment of this condition.",1.6580180914979784e-07,0.09511565788059029,0.02142844227889669,0.012693985253473108,0.060193112533552195,0.04898710562414266,0.012675610786670066,0.058065401294831176,0.05246913580246911,1.6580180914979784e-07,0.08402087972738315,0.03566529492455417
168,0.9,2,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Can head positioning influence the anterior chamber depth in pseudoexfoliation syndrome? Indeed, head position can alter anterior chamber depth in pseudoexfoliation syndrome. For example, lying flat can increase the depth, potentially complicating management. Thus, considering head position is essential in assessing and treating this syndrome.",3.552895910352811e-07,0.28640565794794925,0.004725509533201833,0.02720139697172809,0.3003545984303386,0.0007878943758573426,0.027162023114293,0.2984328056357928,0.004969135802469098,3.552895910352811e-07,0.29608116872199197,0.011290294924554169
168,0.9,3,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Is anterior chamber depth in pseudoexfoliation syndrome affected by head positioning? Yes, the depth of the anterior chamber can be influenced by head position in pseudoexfoliation syndrome. Specific positions such as lying flat may increase this depth, making management more challenging. Therefore, head positioning should be taken into account during diagnosis and treatment.",1.6580180914979784e-07,0.0417966439913644,0.05901803119508882,0.012693985253473108,0.03301087015865267,0.06858710562414265,0.012675610786670066,0.058065401294831176,0.05246913580246911,1.6580180914979784e-07,0.08402087972738315,0.03566529492455417
168,0.9,4,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Does changing head position impact anterior chamber depth in pseudoexfoliation syndrome? Yes, altering head position can affect anterior chamber depth in pseudoexfoliation syndrome. Positions like lying flat can deepen the anterior chamber, which may complicate the condition’s management. Consequently, head position is a key factor to consider in patient assessment and therapy.",1.8948778188548325e-07,0.15458943078882115,0.043505917159763347,0.014507411718254981,0.13599115912202553,0.008831560128443217,0.014486412327622933,0.1348515519233655,0.011726718419037677,1.8948778188548325e-07,0.1335212994534496,0.014841392706355885
168,0.9,5,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Is anterior chamber depth influenced by head posture in pseudoexfoliation syndrome? Yes, head posture does influence anterior chamber depth in pseudoexfoliation syndrome. Certain positions, such as lying flat, can increase this depth and complicate management. Hence, the patient’s head posture must be considered during evaluation and treatment.",3.079176455639103e-07,0.24647957458385727,0.03936552453632486,0.023574544042164344,0.18898055447087803,0.04637636182248976,0.023540420032387266,0.18589877280471478,0.05246913580246911,3.079176455639103e-07,0.21464106214444767,0.03566529492455417
168,0.9,6,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Does the position of the head influence the anterior chamber depth in patients with pseudoexfoliation syndrome? Yes, head position can impact anterior chamber depth in pseudoexfoliation syndrome. Specific postures, for instance lying flat, may increase the depth, potentially complicating management strategies. Therefore, head positioning should be factored into assessment and treatment plans.",1.8948778188548325e-07,0.0627829361393264,0.057900332840236685,0.014507411718254981,0.10826527189962798,0.028656550068587083,0.014486412327622933,0.10655983026785787,0.03206983024691355,1.8948778188548325e-07,0.1046401669301189,0.03566529492455417
168,0.9,7,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Can the position of the head change anterior chamber depth in pseudoexfoliation syndrome? Yes, head position can modify anterior chamber depth in pseudoexfoliation syndrome. Positions like lying flat might increase the chamber’s depth and complicate management. Thus, it is important to consider the patient’s head position during evaluation and therapeutic planning.",2.1317375462116866e-07,0.13966827242279578,0.01772865074147123,0.016320838183036854,0.15789136973887485,0.0076230224483392756,0.0162972138685758,0.15664966086174736,0.010881234101145852,2.1317375462116866e-07,0.15518920083263055,0.014398754281832068
168,0.9,8,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Is the depth of the anterior chamber affected by how the head is positioned in pseudoexfoliation syndrome? Yes, head position can influence the anterior chamber depth in pseudoexfoliation syndrome. Certain positions such as lying flat can increase the depth and make management more complex. Therefore, head position must be accounted for in clinical assessment and treatment.",9.474389094274162e-08,0.03175541660828962,0.026494082840236702,0.0072537058591274906,0.0015245741172194016,0.050075179671846465,0.007243206163811466,0.00020350682914438423,0.05246913580246911,9.474389094274162e-08,0.024597459256582077,0.03566529492455417
168,0.9,9,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Does head orientation influence anterior chamber depth in pseudoexfoliation syndrome? Yes, the orientation of the head can affect anterior chamber depth in pseudoexfoliation syndrome. Positions such as lying flat have the potential to increase anterior chamber depth, complicating management. As a result, head orientation should be considered during patient evaluation and treatment.",1.8948778188548325e-07,0.15458943078882115,0.043505917159763347,0.014507411718254981,0.13599115912202553,0.008831560128443217,0.014486412327622933,0.1348515519233655,0.011726718419037677,1.8948778188548325e-07,0.1335212994534496,0.014841392706355885
168,0.9,10,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Can anterior chamber depth in pseudoexfoliation syndrome be affected by how the head is positioned? Yes, anterior chamber depth can be influenced by head positioning in pseudoexfoliation syndrome. Specific positions like lying flat may increase the depth, which could complicate management. Therefore, head positioning is important to consider in assessing and treating this syndrome.",1.4211583641411244e-07,0.04739591770531337,0.041525319824826434,0.010880558788691236,0.04025229124616336,0.04936372999938294,0.0108648092457172,0.03826277399865141,0.05246913580246911,1.4211583641411244e-07,0.06381817240986454,0.03566529492455417
169,0.9,1,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Is there a link between the CYP2D6*4 allele and the risk of breast cancer? It is suggested that individuals with the CYP2D6*4 poor metabolizer variant might have reduced activation of procarcinogens, leading to a protective effect against carcinogens.",1.894877818854824e-07,0.20615466749235,0.027006172839506164,0.01450741171825503,0.2513144282809061,0.0,0.014486412327622988,0.25951119548508395,0.0,1.8948778188548325e-07,0.2682639865946794,0.0
169,0.9,2,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Does the CYP2D6*4 allele influence breast cancer risk? Potentially, CYP2D6*4 poor metabolizers show decreased conversion of procarcinogens, which may offer protection from carcinogens.",1.658018091497971e-07,0.27625337662815763,0.0,0.012693985253473157,0.28768207245178257,0.0,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
169,0.9,3,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"What is the association between the CYP2D6*4 allele and breast cancer risk? The CYP2D6*4 poor metabolizers may have lowered transformation of procarcinogens, possibly providing a protective effect against carcinogens.",2.36859727356853e-08,0.08460183270840815,0.035665294924554176,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
169,0.9,4,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Is there any correlation between the CYP2D6*4 allele and breast cancer susceptibility? Because CYP2D6*4 poor metabolizers might reduce procarcinogen activation, they could be less vulnerable to carcinogens.",7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
169,0.9,5,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Could the CYP2D6*4 allele be connected to breast cancer risk? The allele's poor metabolizer status may lead to a decreased procarcinogen conversion, offering protection against carcinogens.",9.47438909427412e-08,0.14842000511827314,0.0,0.007253705859127518,0.15415067982725894,0.0,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
169,0.9,6,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Does the presence of the CYP2D6*4 allele impact breast cancer risk? Reduced transformation of procarcinogens by CYP2D6*4 poor metabolizers might result in a protective effect.,1.184298636784265e-07,0.18924199963852795,0.0,0.009067132323909398,0.19671029424605457,0.0,0.009054007704764368,0.20479441264601395,0.0,1.1842986367842703e-07,0.2135741002980609,0.0
169,0.9,7,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Is breast cancer risk associated with the CYP2D6*4 allele? A possible reduced activation of procarcinogens by CYP2D6*4 poor metabolizers could confer protection against carcinogens.,1.421158364141118e-07,0.23180161405732358,0.0,0.010880558788691277,0.24116205681688863,0.0,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
169,0.9,8,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,What is the relationship between the CYP2D6*4 allele and breast cancer risk? Decreased procarcinogen transformation by CYP2D6*4 poor metabolizers may provide a protective benefit.,1.421158364141118e-07,0.23180161405732358,0.0,0.010880558788691277,0.24116205681688863,0.0,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
169,0.9,9,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Is there a potential link between the CYP2D6*4 allele and breast cancer risk? The allele’s effect as a poor metabolizer may lead to less procarcinogen activation, thus protecting against carcinogens.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
169,0.9,10,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"How does the CYP2D6*4 allele relate to breast cancer risk? The poor metabolizer phenotype associated with CYP2D6*4 may reduce procarcinogen transformation, offering some protection.",1.421158364141118e-07,0.23180161405732358,0.0,0.010880558788691277,0.24116205681688863,0.0,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
170,0.9,1,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the boycott call from Catholic bishops impact Kenya's 2015 polio vaccination coverage? It did not significantly affect the campaign, but future repeats may negatively affect polio eradication, so caution is needed.",5.921493183921342e-07,0.390046540551201,0.24489795918367344,0.04533566161954685,0.4862871902610677,0.1507112648981161,0.04527003852382171,0.5606542005406845,0.07544378698224853,5.921493183921352e-07,0.6380874033769168,0.0
170,0.9,2,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Was Kenya's 2015 polio vaccination coverage influenced by the Catholic bishops' boycott call? The impact was minimal, though repeated calls could harm eradication efforts, making preventive measures vital.",6.868932093348754e-07,0.5281968790320182,0.24489795918367344,0.05258936747867437,0.6293880339017401,0.1507112648981161,0.0525132446876332,0.7090742056589576,0.07544378698224853,6.868932093348768e-07,0.7922380832041758,0.0
170,0.9,3,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the Catholic bishops' boycott call influence polio vaccination rates in Kenya in 2015? It had little effect, but recurring calls could threaten eradication, so vigilance is important.",6.868932093348754e-07,0.5281968790320182,0.24489795918367344,0.05258936747867437,0.6293880339017401,0.1507112648981161,0.0525132446876332,0.7090742056589576,0.07544378698224853,6.868932093348768e-07,0.7922380832041758,0.0
170,0.9,4,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Was the 2015 polio vaccination drive in Kenya significantly affected by the Catholic bishops' boycott? No significant impact was observed, but repeated boycotts could have serious consequences, requiring careful attention.",6.395212638635048e-07,0.4567379150498745,0.24489795918367344,0.04896251454911061,0.5552800617480185,0.1507112648981161,0.048891641605727454,0.6321131645228282,0.07544378698224853,6.39521263863506e-07,0.7121953755306385,0.0
170,0.9,5,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the Catholic bishops' boycott call reduce polio vaccination coverage in Kenya in 2015? The campaign was largely unaffected, but future calls might pose risks to eradication efforts, so it's crucial to address this.",5.447773729207636e-07,0.3275261835698675,0.24489795918367344,0.04170880868998309,0.4217486691234962,0.1507112648981161,0.04164843544191596,0.493962826042011,0.07544378698224853,5.447773729207643e-07,0.5690945318899661,0.0
170,0.9,6,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the boycott appeal by Catholic bishops impact Kenya's polio vaccination campaign in 2015? The effect was insignificant, yet repeated calls could harm eradication, making it essential to remain alert.",6.395212638635048e-07,0.4567379150498745,0.24489795918367344,0.04896251454911061,0.5552800617480185,0.1507112648981161,0.048891641605727454,0.6321131645228282,0.07544378698224853,6.39521263863506e-07,0.7121953755306385,0.0
170,0.9,7,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the 2015 Kenyan polio vaccination coverage suffer due to the Catholic bishops' boycott call? The impact was negligible, but future repetition could have negative effects, highlighting the need for caution.",6.158352911278195e-07,0.4228363633741927,0.24489795918367344,0.04714908808432873,0.5201887419367495,0.1507112648981161,0.04708084006477458,0.5957455203519535,0.07544378698224853,6.158352911278206e-07,0.6744550475477915,0.0
170,0.9,8,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did Kenya's 2015 polio vaccination efforts face setbacks from the Catholic bishops' boycott call? No major effect was recorded, but recurring boycotts could jeopardize eradication, thus preventive action is important.",6.395212638635048e-07,0.4567379150498745,0.24489795918367344,0.04896251454911061,0.5552800617480185,0.1507112648981161,0.048891641605727454,0.6321131645228282,0.07544378698224853,6.39521263863506e-07,0.7121953755306385,0.0
170,0.9,9,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the Catholic bishops' boycott affect Kenya's 2015 polio vaccination coverage? It did not significantly influence the campaign, though repeated calls might adversely impact eradication, so preventive measures are necessary.",6.395212638635048e-07,0.4567379150498745,0.24489795918367344,0.04896251454911061,0.5552800617480185,0.1507112648981161,0.048891641605727454,0.6321131645228282,0.07544378698224853,6.39521263863506e-07,0.7121953755306385,0.0
170,0.9,10,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Was the call for boycott by Catholic bishops a significant factor in Kenya's 2015 polio vaccination coverage? There was no notable impact, but future repeated calls could negatively affect eradication efforts, emphasizing the need for vigilance.",4.97405427449393e-07,0.26868568354693423,0.24489795918367344,0.03808195576041933,0.3611240473070607,0.1507112648981161,0.03802683236001021,0.4314424690606775,0.07544378698224853,4.974054274493935e-07,0.5045560107523945,0.0
171,0.9,1,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Does the stretch-sensitive KCNQ1 mutation connect genetic and environmental factors in atrial fibrillation development? Yes, this mutation links genetic predispositions with environmental influences in causing atrial fibrillation by altering the heart's stress response, such as to hypertension, which may lead to abnormal heart rhythms.",5.210914001850789e-07,0.0880849261729364,0.2782983941876071,0.0398953822252012,0.18294412175882346,0.16447134211463157,0.039837633900963065,0.2315206080986716,0.13888888888888887,5.210914001850789e-07,0.25937823917374914,0.1262002743484225
171,0.9,2,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Is the stretch-sensitive KCNQ1 mutation a link between genetics and environment in atrial fibrillation pathogenesis? Indeed, it serves as a connection by impacting how the heart responds to stresses like high blood pressure, potentially causing irregular heartbeats and bridging genetic and environmental factors.",5.447773729207643e-07,0.07937601983615661,0.3015410245730946,0.04170880868998307,0.20704167333788348,0.16447134211463157,0.04164843544191593,0.2562132206890433,0.13888888888888887,5.447773729207643e-07,0.28469604715804087,0.1262002743484225
171,0.9,3,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Can the stretch-sensitive KCNQ1 mutation be seen as a genetic and environmental factor link in atrial fibrillation? Yes, because this mutation modifies the heart's reaction to environmental stresses such as hypertension, thereby linking genetic susceptibility with these triggers in atrial fibrillation.",5.921493183921352e-07,0.1628235430335847,0.2765574611279927,0.045335661619546816,0.2570520939125469,0.16447134211463157,0.045270038523821665,0.307506515076593,0.13888888888888887,5.921493183921352e-07,0.3373397806434597,0.1262002743484225
171,0.9,4,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Does the KCNQ1 mutation sensitive to stretch provide a link between genetic and environmental factors in atrial fibrillation? Yes, it does by influencing the heart’s response to stressors like hypertension, which may induce abnormal rhythms, connecting both genetic and environmental causes.",5.921493183921352e-07,0.19748090206158242,0.2516795287282193,0.045335661619546816,0.29259810317203083,0.13884807341657063,0.045270038523821665,0.307506515076593,0.13888888888888887,5.921493183921352e-07,0.3373397806434597,0.1262002743484225
171,0.9,5,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Is there a connection between genetic and environmental contributors to atrial fibrillation through the stretch-sensitive KCNQ1 mutation? Yes, this mutation affects cardiac stress response mechanisms, such as to hypertension, thereby linking genetic predisposition with environmental factors in the disease's development.",6.158352911278205e-07,0.15348399198988005,0.3015410245730946,0.04714908808432869,0.2830275803158049,0.16447134211463157,0.04708084006477453,0.33417476215875386,0.13888888888888887,6.158352911278206e-07,0.36473875483157503,0.1262002743484225
171,0.9,6,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Does the mutation in stretch-sensitive KCNQ1 act as a bridge between genetic and environmental influences in atrial fibrillation? Yes, it disrupts how the heart reacts to stresses like hypertension, promoting arrhythmias and linking genetic and environmental factors in atrial fibrillation.",6.158352911278205e-07,0.26012201976833227,0.22515213568420572,0.04714908808432869,0.3195090108715912,0.1381747752775242,0.04708084006477453,0.33417476215875386,0.13888888888888887,6.158352911278206e-07,0.36473875483157503,0.1262002743484225
171,0.9,7,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Can the stretch-sensitive KCNQ1 mutation link genetic predisposition and environmental triggers in atrial fibrillation? Yes, since it changes how the heart handles stress, including hypertension, potentially causing abnormal heart rhythms and connecting these risk factors.",7.34265154806247e-07,0.29068511350336257,0.3015410245730946,0.056216220408238066,0.4241061785757112,0.16447134211463157,0.056134847769538886,0.479356772003253,0.13888888888888887,7.342651548062476e-07,0.5142704888025387,0.1262002743484225
171,0.9,8,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Is the atrial fibrillation pathogenesis influenced by the stretch-sensitive KCNQ1 mutation linking genetics and environment? Yes, as this mutation affects the cardiac response to stress such as hypertension, bridging genetic and environmental elements in the condition.",7.105791820705617e-07,0.26169757663011106,0.3015410245730946,0.054402793943456186,0.3942532154260294,0.16447134211463157,0.05432404622858601,0.4485851133364993,0.13888888888888887,7.105791820705622e-07,0.48252179048795885,0.1262002743484225
171,0.9,9,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Does the stretch-sensitive KCNQ1 mutation form a connection between genetic and environmental factors in atrial fibrillation? Yes, it plays a role by altering the heart's stress response, like to hypertension, which may result in arrhythmias, linking genetic and environmental causes.",6.158352911278205e-07,0.22457601050884834,0.25040881127871917,0.04714908808432869,0.3195090108715912,0.1381747752775242,0.04708084006477453,0.33417476215875386,0.13888888888888887,6.158352911278206e-07,0.36473875483157503,0.1262002743484225
171,0.9,10,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Could the stretch-sensitive KCNQ1 mutation be the missing link between genetic and environmental factors in atrial fibrillation? Yes, it impacts the heart’s reaction to environmental stressors, such as hypertension, potentially triggering abnormal rhythms and connecting both genetic and environmental factors.",6.158352911278205e-07,0.22457601050884834,0.25040881127871917,0.04714908808432869,0.3195090108715912,0.1381747752775242,0.04708084006477453,0.33417476215875386,0.13888888888888887,6.158352911278206e-07,0.36473875483157503,0.1262002743484225
172,0.9,1,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Is decompressive surgery an effective treatment for spinal cord sarcoidosis with compressive cervical myelopathy? Decompressive surgery has been found to be beneficial in managing spinal cord sarcoidosis when accompanied by compressive cervical myelopathy. Research indicates that this surgical approach can relieve neurological symptoms by removing the compressive element.,1.4211583641411244e-07,0.2552774393050661,0.07912487999685607,0.010880558788691236,0.17893982649376383,0.028133100783146937,0.0108648092457172,0.17864685290015903,0.025623268698060954,1.4211583641411244e-07,0.14660347419187536,0.0
172,0.9,2,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,"Can decompressive surgery effectively treat spinal cord sarcoidosis associated with compressive cervical myelopathy? Evidence suggests that decompressive surgery is an effective intervention for spinal cord sarcoidosis with compressive cervical myelopathy, as it helps reduce neurological deficits by relieving pressure.",7.1057918207056e-08,0.02170865663882493,0.03493649931208914,0.005440279394345618,0.0835816537445222,0.004016055175532843,0.0054324046228586,0.04449669841405024,0.025623268698060954,7.105791820705622e-08,0.08223809823697303,0.0
172,0.9,3,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,"Does decompressive surgery work well for spinal cord sarcoidosis with compressive cervical myelopathy? Decompressive surgery is considered an effective treatment for spinal cord sarcoidosis with accompanying compressive cervical myelopathy, as it can improve neurological outcomes by eliminating compression.",9.474389094274131e-08,0.09077424193446681,0.0074074007395698305,0.0072537058591274906,0.15157032769515633,0.03278313225429821,0.007243206163811466,0.1518843960161691,0.03130969732581415,9.474389094274162e-08,0.15199899867257427,0.029384756657483937
172,0.9,4,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Is decompressive surgery a viable option for spinal cord sarcoidosis cases involving compressive cervical myelopathy? Decompressive surgery has demonstrated effectiveness in treating spinal cord sarcoidosis with compressive cervical myelopathy by alleviating neurological symptoms through pressure relief.,1.421158364141119e-07,0.07997324336770895,0.051111875245293106,0.010880558788691243,0.13397757500412988,0.0204767391873914,0.010864809245717214,0.13150807540368037,0.025623268698060954,1.4211583641411244e-07,0.17185025692666,0.0
172,0.9,5,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,"How effective is decompressive surgery in treating spinal cord sarcoidosis with compressive cervical myelopathy? The procedure is effective, as studies have shown that decompressive surgery can mitigate neurological symptoms by decompressing the affected cervical spine region in sarcoidosis cases.",7.1057918207056e-08,0.12421706558432222,0.13719824285147394,0.005440279394345618,0.008646823413716476,0.049861495844875335,0.0054324046228586,0.04449669841405024,0.025623268698060954,7.105791820705622e-08,0.08223809823697303,0.0
172,0.9,6,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,"Can spinal cord sarcoidosis with compressive cervical myelopathy be successfully treated with decompressive surgery? Decompressive surgery can successfully treat this condition, as it helps reduce neurological impairments by removing the compression caused by sarcoidosis.",1.894877818854825e-07,0.01961989788020224,0.16349480968858132,0.014507411718255002,0.1538288332582156,0.049861495844875335,0.01448641232762296,0.19402843238501388,0.025623268698060954,1.8948778188548325e-07,0.23638877806423153,0.0
172,0.9,7,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Is surgical decompression beneficial for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? Surgical decompression has proven beneficial in alleviating neurological symptoms in patients with spinal cord sarcoidosis and compressive cervical myelopathy by removing the compressive pressure.,1.1842986367842661e-07,0.047401431921267,0.05411980968858132,0.009067132323909363,0.10382508488623987,0.021314783042107176,0.00905400770476434,0.10165511225399859,0.025623268698060954,1.1842986367842703e-07,0.14107859825990632,0.0
172,0.9,8,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Does decompressive surgery provide effective relief for patients with spinal cord sarcoidosis and compressive cervical myelopathy? This surgery is effective in relieving neurological symptoms by decompressing the spinal cord affected by sarcoidosis and associated cervical myelopathy.,1.421158364141119e-07,0.000756422732286488,0.10656184366470622,0.010880558788691243,0.09320421144178015,0.049861495844875335,0.010864809245717214,0.13150807540368037,0.025623268698060954,1.4211583641411244e-07,0.17185025692666,0.0
172,0.9,9,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Would decompressive surgery be effective for spinal cord sarcoidosis when compressive cervical myelopathy is present? Decompressive surgery has been shown to be effective in treating this condition by removing cervical spinal cord compression and improving neurological function.,1.1842986367842661e-07,0.008893255223492158,0.08085018158940778,0.009067132323909363,0.06421667456852864,0.049861495844875335,0.00905400770476434,0.10165511225399859,0.025623268698060954,1.1842986367842703e-07,0.14107859825990632,0.0
172,0.9,10,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Is decompressive surgery an effective method to treat spinal cord sarcoidosis with compressive cervical myelopathy? Clinical studies confirm that decompressive surgery can effectively alleviate neurological symptoms caused by compressive cervical myelopathy in patients with spinal cord sarcoidosis.,1.1842986367842661e-07,0.008893255223492158,0.08085018158940778,0.009067132323909363,0.06421667456852864,0.049861495844875335,0.00905400770476434,0.10165511225399859,0.025623268698060954,1.1842986367842703e-07,0.14107859825990632,0.0
173,0.9,1,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,The suggestion that Indigenous Australians age prematurely is not strongly backed by this study examining various specific conditions. The aged care services currently emphasized may not be adequately aligned with this notion.,2.842316728282239e-07,0.32721291120841567,0.0,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
173,0.9,2,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,This research on distinct health conditions does not provide strong evidence that Indigenous Australians experience premature aging. The existing aged care system's focus and service types may not fully address this issue.,2.842316728282239e-07,0.32721291120841567,0.0,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
173,0.9,3,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,"According to this study of several discrete conditions, there is little support for the claim that Indigenous Australians age faster than others. The aged care sector's current approach and services might not correspond to this belief.",1.8948778188548272e-07,0.2454604645218601,0.02854671280276816,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
173,0.9,4,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,The notion that Indigenous Australians undergo premature aging lacks solid support based on this study of various individual conditions. The services and priorities within aged care may not be properly suited to this perspective.,2.3685972735685332e-07,0.26469255422708216,0.0,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
173,0.9,5,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,This study investigating a range of discrete conditions does not strongly confirm that Indigenous Australians age prematurely. The aged care sector's current focus and services may not be well adapted for this assumption.,2.605457000925386e-07,0.29546421289383584,0.0,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
173,0.9,6,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,Premature aging among Indigenous Australians is not convincingly supported by the findings of this study of different conditions. The type of services provided by aged care currently might not reflect this reality.,2.842316728282239e-07,0.32721291120841567,0.0,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
173,0.9,7,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,The idea that Indigenous Australians age prematurely is not substantiated by this investigation into various specific health conditions. The current aged care service provision and focus may not be in line with this suggestion.,2.3685972735685332e-07,0.26469255422708216,0.0,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
173,0.9,8,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,This study examining a series of distinct conditions does not offer strong evidence that Indigenous Australians age prematurely. The aged care sector’s current service focus may not adequately address this premise.,3.079176455639092e-07,0.36000273403140737,0.0,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
173,0.9,9,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,"Based on this analysis of various discrete conditions, the concept that Indigenous Australians experience premature aging is not strongly supported. The existing services and focus in aged care may not correspond to this idea.",2.3685972735685332e-07,0.26469255422708216,0.0,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
173,0.9,10,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,The premise that Indigenous Australians age prematurely is not well supported by this study focused on multiple specific conditions. The current emphasis and types of aged care services might not align with this hypothesis.,2.3685972735685332e-07,0.26469255422708216,0.0,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
174,0.9,1,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is maintaining a zero rate of central line-associated bloodstream infections feasible over time? Consistent high-quality training, adherence to evidence-based protocols, and meticulous documentation have been linked with substantial decreases in CLABSI occurrences. Thoughtful organization might enhance comprehension of the factors enabling a unit to manage peak demands and uphold exceptional performance for the long haul.",4.737194547137081e-08,0.03774032798284743,0.0,0.0036268529295637453,0.038466280827795796,0.0,0.003621603081905733,0.03922071315328246,0.0,4.737194547137081e-08,0.04000533461369837,0.0
174,0.9,2,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can a zero central line-associated bloodstream infection rate be maintained indefinitely? Significant reductions in CLABSIs are connected to rigorous training, strict adherence to evidence-based guidelines, and detailed record-keeping. Careful coordination may improve insight into what allows a unit to cope with peak workload and sustain excellent performance over time.",9.474389094274162e-08,0.08004270767353683,0.0,0.0072537058591274906,0.0816780310142673,0.0,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
174,0.9,3,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is it possible to sustain a zero rate of central line-associated bloodstream infections? Effective training programs, strict compliance with proven clinical guidelines, and comprehensive documentation contribute to major declines in CLABSIs. Mindful management can foster a deeper understanding of how units handle peak demands and maintain outstanding long-term performance.",9.474389094274162e-08,0.08004270767353683,0.0,0.0072537058591274906,0.0816780310142673,0.0,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
174,0.9,4,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can zero central line-associated bloodstream infections be maintained continuously? High-quality training, rigorous observance of evidence-based standards, and detailed documentation correlate with marked reductions in CLABSI rates. Attentive organization may lead to better insights into a unit's capacity to manage peak demands and sustain exceptional long-term outcomes.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
174,0.9,5,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is sustaining a zero central line-associated bloodstream infection rate achievable? Strong training, strict compliance with scientific guidelines, and thorough record-keeping are associated with significant CLABSI reductions. Mindful structuring may improve understanding of how units manage peak demands and preserve superior performance over time.",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
174,0.9,6,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Could zero central line-associated bloodstream infection rates be kept consistently? Comprehensive training, steadfast adherence to evidence-based practices, and detailed documentation are linked with notable drops in CLABSIs. Thoughtful organization might clarify what enables a unit to meet peak demands and maintain excellent long-term results.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
174,0.9,7,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is a zero rate of central line-associated bloodstream infections maintainable? High-quality education, firm compliance with evidence-based protocols, and careful documentation contribute to substantial decreases in CLABSI incidence. Mindful planning may provide insights into a unit's ability to handle peak pressures and continue exceptional performance long-term.",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
174,0.9,8,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can zero central line-associated bloodstream infections be sustained? Effective training, strict guideline compliance, and thorough documentation correlate with significant reductions in infection rates. Mindful organization helps deepen understanding of how a unit manages peak demands and sustains extraordinary performance over extended periods.",2.6054570009253947e-07,0.23767165187712003,0.0,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
174,0.9,9,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is zero CLABSI rate sustainable? Intensive training, unwavering adherence to evidence-based policies, and comprehensive documentation significantly reduce CLABSI occurrences. Thoughtful organizational strategies may enhance a unit's ability to handle peak workload and maintain outstanding long-term performance.",4.026615365066514e-07,0.39589565709201446,0.0,0.030828249901291842,0.4054651081081633,0.0,0.030783626196198746,0.4155154439616653,0.0,4.026615365066519e-07,0.42608439531090037,0.0
174,0.9,10,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is maintaining a zero central line-associated bloodstream infection rate sustainable? Quality training, strict observance of evidence-based rules, and detailed documentation are linked with marked decreases in CLABSI cases. Mindful organization may improve comprehension of the factors enabling a unit to effectively manage peak demand and maintain exceptional long-term success.",9.474389094274162e-08,0.08004270767353683,0.0,0.0072537058591274906,0.0816780310142673,0.0,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
175,0.9,1,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Question: Does pretreatment with estradiol and antagonists before administering microdose leuprolide enhance IVF outcomes in poor responders compared to using oral contraceptive pills? Answer: Research shows that estradiol and antagonist pretreatment prior to microdose leuprolide does not significantly improve IVF results in poor responders compared to oral contraceptive pills, though it may offer slight advantages in certain cases. Further studies are needed.",4.737194547137081e-08,0.13872626428992962,0.10201796124828526,0.0036268529295637453,0.16621049675712296,0.13253850415512472,0.003621603081905733,0.12420578414975658,0.10926473052245486,4.737194547137081e-08,0.0808262575204477,0.08152935946103079
175,0.9,2,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Question: Can pretreatment with estradiol and antagonists before microdose leuprolide improve IVF success in poor responders compared to oral contraceptive pills? Answer: Studies indicate that pretreatment with estradiol and antagonists before microdose leuprolide does not markedly enhance IVF outcomes in poor responders versus oral contraceptive pills, but some minor benefits may be seen in select cases, warranting further investigation.",1.1842986367842703e-07,0.008362100977211462,0.04991319444444442,0.009067132323909363,0.013985244498563532,0.06200000000000008,0.009054007704764333,0.004763222073155493,0.05469377390125332,1.1842986367842703e-07,0.04920334895908729,0.026485539749668996
175,0.9,3,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Question: Does using estradiol and antagonist pretreatment prior to microdose leuprolide improve the IVF outcomes in poor responders more than oral contraceptive pills? Answer: Evidence suggests that estradiol and antagonist pretreatment before microdose leuprolide does not significantly improve IVF outcomes in poor responders compared to oral contraceptives; however, slight benefits might exist in particular situations. Additional research is required.",1.1842986367842703e-07,0.05616535480893159,0.08044375000000004,0.009067132323909363,0.06262715190627777,0.09549171597633137,0.009054007704764333,0.04474729082398321,0.08972151537429357,1.1842986367842703e-07,0.026412707101997945,0.08058984910836768
175,0.9,4,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Question: Is estradiol and antagonist pretreatment before microdose leuprolide more effective in enhancing IVF outcomes in poor responders than oral contraceptive pills? Answer: Research suggests no significant improvement in IVF outcomes with estradiol and antagonist pretreatment compared to oral contraceptive pills in poor responders, though there could be minimal benefits in some cases needing further study.",1.8948778188548325e-07,0.04303643269969504,0.10738852301124534,0.014507411718254981,0.07882046355825878,0.14541775147929,0.014486412327622933,0.03779678560704269,0.12426035502958585,1.8948778188548325e-07,0.004471407528683358,0.09876543209876548
175,0.9,5,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Question: Question: Does pretreatment with estradiol and antagonists enhance IVF success in poor responders when followed by microdose leuprolide compared to oral contraceptive pills? Answer: Findings indicate that estradiol and antagonist pretreatment prior to microdose leuprolide does not considerably improve IVF outcomes over oral contraceptive pills in poor responders, but minor advantages might be present in specific cases. More research is needed.",4.737194547137081e-08,0.20690467549254787,0.1495929035857187,0.0036268529295637453,0.2355252148131166,0.18240000000000006,0.003621603081905733,0.17119881334026132,0.14312130177514798,4.737194547137081e-08,0.10472788443630776,0.09876543209876548
175,0.9,6,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Question: Does estradiol and antagonist pretreatment before administering microdose leuprolide improve IVF outcomes in poor responders more effectively than oral contraceptive pills? Answer: Current research shows no significant improvement in IVF outcomes with estradiol and antagonist pretreatment versus oral contraceptive pills in poor responders. There may be subtle benefits in some instances, though further studies are necessary.",1.6580180914979784e-07,0.0637555116331261,0.10924374999999996,0.012693985253473108,0.09810313378276492,0.1460881452474191,0.012675610786670066,0.05697329820030106,0.1246093758228518,1.6580180914979784e-07,0.014576787442009742,0.09876543209876548
175,0.9,7,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Question: Question: Is estradiol and antagonist pretreatment before microdose leuprolide beneficial for IVF outcomes in poor responders compared to oral contraceptive pills? Answer: Studies reveal that estradiol and antagonist pretreatment prior to microdose leuprolide does not significantly better IVF outcomes in poor responders compared to oral contraceptive pills, although a slight benefit might exist in particular cases, requiring more research.",9.474389094274162e-08,0.017485371647914416,0.024712468877320065,0.0072537058591274906,0.013490979105305279,0.032462473969179534,0.007243206163811466,0.03353403865791105,0.02272130177514803,9.474389094274162e-08,0.054139717617809335,0.010337904224870825
175,0.9,8,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Question: Does pretreating poor responders with estradiol and antagonists before microdose leuprolide improve IVF outcomes compared to using oral contraceptive pills? Answer: Research suggests no significant enhancement of IVF outcomes with estradiol and antagonist pretreatment prior to microdose leuprolide compared to oral contraceptives in poor responders, yet marginal benefits may be found in some cases. Further studies are recommended.",1.1842986367842703e-07,0.12787023555651178,0.12940409175863296,0.009067132323909363,0.1599109667217098,0.1648617346938776,0.009054007704764333,0.11901306016969215,0.14312130177514798,1.1842986367842703e-07,0.05161805912235984,0.09876543209876548
175,0.9,9,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Question: Does the use of estradiol and antagonist pretreatment before microdose leuprolide improve in vitro fertilization outcomes in poor responders when compared with oral contraceptive pill administration? Answer: Evidence indicates no significant improvement in IVF results with estradiol and antagonist pretreatment versus oral contraceptive pills for poor responders, though minor improvements might be possible in certain patients. Additional studies are required.",7.105791820705622e-08,0.18886029773683521,0.1485172193877551,0.005440279394345618,0.17172506730623116,0.14854342874730694,0.0054324046228586,0.13020275306510154,0.1258852291374133,7.105791820705622e-08,0.08733614172443893,0.09876543209876548
175,0.9,10,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Question: Question: Is estradiol and antagonist pretreatment prior to microdose leuprolide an effective strategy to improve IVF outcomes in poor responders compared to oral contraceptive pills? Answer: Research findings show no significant improvement in IVF outcomes with estradiol and antagonist pretreatment before microdose leuprolide compared to oral contraceptive pills in poor responders, although slight benefits could exist in specific cases. Further research is needed.",0.0,0.13202803439237343,0.07595486111111113,0.0,0.17887669175740495,0.11819072532699175,0.0,0.15908295947277473,0.11037209177802071,0.0,0.1386294361119882,0.09876543209876548
176,0.9,1,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is the preoperative platelet count a prognostic indicator in esophageal squamous cell carcinoma? Preoperative platelet count serves as a predictive marker for long-term survival in ESCC, particularly among patients with nodal involvement. The study suggests that a cutoff value of 205 (×10(9)/L) platelet count is optimal for predicting survival outcomes in ESCC patients.",4.737194547137081e-08,0.09827412700355742,0.04491749836744979,0.0036268529295637453,0.06940653554981457,0.021142417383431443,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
176,0.9,2,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does preoperative platelet count predict prognosis in esophageal squamous cell carcinoma? The platelet count measured before surgery is a significant predictor of long-term survival in ESCC, especially in patients with positive lymph nodes. A threshold value of 205 (×10(9)/L) platelet count is identified as the best cutoff for survival prediction in these patients.",4.737194547137081e-08,0.12493363394817081,0.06480987654320994,0.0036268529295637453,0.0965887779247141,0.040742417383431435,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
176,0.9,3,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Can preoperative platelet levels forecast outcomes in esophageal squamous cell carcinoma? Preoperative platelet count is a prognostic factor for survival in ESCC patients, notably those with nodal-positive status. The optimal cutoff for predicting survival is determined to be 205 (×10(9)/L).",2.6054570009253936e-07,0.13491296957070542,0.11758660784514896,0.0199476911126006,0.19765069507322464,0.040742417383431435,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
176,0.9,4,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is platelet count before surgery a prognostic factor in esophageal squamous cell carcinoma? The preoperative platelet count predicts long-term survival in ESCC, primarily in patients with lymph node involvement. A platelet count of 205 (×10(9)/L) serves as the ideal cutoff point for survival prediction.",1.6580180914979784e-07,0.07837585972414862,0.048028436923935686,0.012693985253473108,0.09756723651624322,0.040742417383431435,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
176,0.9,5,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does the preoperative platelet count hold prognostic value in esophageal squamous cell carcinoma? It acts as a predictive factor for long-term outcomes, especially in nodal-positive ESCC patients. A cutoff platelet count of 205 (×10(9)/L) is concluded to best predict survival.",2.6054570009253936e-07,0.13491296957070542,0.11758660784514896,0.0199476911126006,0.19765069507322464,0.040742417383431435,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
176,0.9,6,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is the platelet count measured before surgery a prognostic marker in esophageal squamous cell carcinoma? Preoperative platelet count is linked to long-term survival in ESCC, particularly for patients with positive lymph nodes. The research identifies 205 (×10(9)/L) as the optimal threshold for survival prediction.",1.6580180914979784e-07,0.03396789449427784,0.11996724615772239,0.012693985253473108,0.09756723651624322,0.040742417383431435,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
176,0.9,7,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does preoperative platelet count influence prognosis in esophageal squamous cell carcinoma? The platelet count prior to surgery is a significant predictor for extended survival in ESCC patients, especially those with node-positive disease. The study concludes that 205 (×10(9)/L) is the best cutoff point for predicting survival.",1.1842986367842703e-07,0.012927341971233908,0.12099913274155702,0.009067132323909363,0.051047220881349276,0.040742417383431435,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
176,0.9,8,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is the preoperative platelet count an indicator of prognosis in esophageal squamous cell carcinoma? It is a predictor of long-term survival in ESCC, notably in patients with nodal involvement. The optimal cutoff platelet count for survival prediction is established at 205 (×10(9)/L).",2.1317375462116866e-07,0.08316859732484794,0.1188348765432099,0.016320838183036854,0.14635740068567493,0.040742417383431435,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
176,0.9,9,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Can the platelet count before surgery predict survival in esophageal squamous cell carcinoma? Yes, preoperative platelet levels are prognostic for long-term survival in ESCC cases with positive lymph nodes. The identified optimal cutoff for platelet count is 205 (×10(9)/L).",2.8423167282822466e-07,0.1983053078260526,0.09074074074074076,0.02176111757738247,0.2243189421553855,0.040742417383431435,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
176,0.9,10,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is preoperative platelet count a survival predictor in esophageal squamous cell carcinoma? It serves as a prognostic factor for long-term survival, especially among nodal-positive patients with ESCC. The finding indicates 205 (×10(9)/L) as the ideal cutoff value.",3.3160361829959526e-07,0.17940966798475566,0.1432098765432099,0.025387970506946217,0.27988879331019767,0.040742417383431435,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
177,0.9,1,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is cholecystectomy truly a reason to perform a simultaneous splenectomy in mild hereditary spherocytosis? The recommendation to carry out a concomitant splenectomy in children with mild HS having cholecystectomy for symptomatic gallstones requires reassessment. Given the advances in minimally invasive surgery, the decision for splenectomy in these children should be made independently.",4.737194547137081e-08,0.014748434477405592,0.01643331945022905,0.0036268529295637453,0.012561206208669073,0.01922337562475971,0.003621603081905733,0.04000533461369837,0.0,4.737194547137081e-08,0.04082199452025437,0.0
177,0.9,2,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is simultaneous splenectomy justified during cholecystectomy in mild hereditary spherocytosis cases? The current guidance advocating concomitant splenectomy in children with mild HS undergoing cholecystectomy due to gallstones calls for reevaluation. With minimally invasive surgical techniques now common, splenectomy indications must be considered separately.",2.6054570009253947e-07,0.14428019664376812,0.09639999999999999,0.0199476911126006,0.21101214493250664,0.01922337562475971,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
177,0.9,3,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Should cholecystectomy automatically lead to splenectomy in mild hereditary spherocytosis? The suggestion to perform splenectomy concurrently with cholecystectomy in children with mild HS presenting symptomatic gallstones should be reconsidered. In the era of minimal access surgery, the necessity for splenectomy should be assessed on individual merit.",1.8948778188548325e-07,0.10609386651503616,0.0741892561983471,0.014507411718254981,0.14039457771855268,0.01922337562475971,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
177,0.9,4,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.",Is a concomitant splenectomy truly indicated when performing cholecystectomy in mild hereditary spherocytosis patients? The advice to do splenectomy simultaneously in children with mild HS undergoing cholecystectomy for symptomatic gallstones merits reevaluation. Modern minimal access approaches necessitate individual consideration of splenectomy need.,2.8423167282822487e-07,0.16837774822282814,0.09639999999999999,0.02176111757738247,0.23570475752287834,0.01922337562475971,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
177,0.9,5,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Does cholecystectomy warrant a splenectomy in mild hereditary spherocytosis cases? Recommendations for concurrent splenectomy in children with mild HS undergoing cholecystectomy for gallstones need to be revisited. With advancements in minimal access surgery, decisions on splenectomy should be made independently.",3.316036182995956e-07,0.2539341780569755,0.07077673130193904,0.025387970506946217,0.28699805191042804,0.01922337562475971,0.025351221573340132,0.3209077200800996,0.0,3.316036182995957e-07,0.32850406697203516,0.0
177,0.9,6,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.",Is combining splenectomy with cholecystectomy necessary for mild hereditary spherocytosis? The advice for concurrent splenectomy in children with mild HS having cholecystectomy for symptomatic gallstones needs reassessment. The role of minimal access surgery means splenectomy indications should stand on their own.,3.079176455639103e-07,0.19307036081319984,0.09639999999999999,0.023574544042164344,0.26102256550717007,0.01922337562475971,0.023540420032387266,0.29423947299793873,0.0,3.079176455639103e-07,0.30110509278391984,0.0
177,0.9,7,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is it appropriate to perform a splenectomy alongside cholecystectomy in mild hereditary spherocytosis patients? The guidance advocating concomitant splenectomy for children with mild HS undergoing cholecystectomy due to gallstones warrants reconsideration. The strategy should be based on the merits of splenectomy itself, especially in the context of minimal access surgery.",9.474389094274162e-08,0.009870483183490819,0.09639999999999999,0.0072537058591274906,0.05338320072892344,0.01922337562475971,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
177,0.9,8,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.",Should children with mild hereditary spherocytosis having cholecystectomy also undergo splenectomy? The recommendation to perform simultaneous splenectomy in these cases requires reevaluation. Minimal access surgical techniques call for judgment of splenectomy needs on their individual basis.,4.263475092423368e-07,0.3266017534377226,0.09639999999999999,0.032641676366073714,0.3982236870206526,0.01922337562475971,0.03259442773715161,0.43531807125784505,0.0,4.263475092423373e-07,0.446287102628419,0.0
177,0.9,9,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is concurrent splenectomy required during cholecystectomy for mild hereditary spherocytosis? The advice to do so in children with mild HS with symptomatic gallstones should be revisited. With minimal access surgery available, splenectomy decisions should be independently considered.",4.026615365066515e-07,0.3369390531688006,0.06864489795918366,0.030828249901291835,0.3692361501474011,0.01922337562475971,0.03078362619619874,0.4054651081081633,0.0,4.026615365066519e-07,0.4155154439616653,0.0
177,0.9,10,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.",Is performing splenectomy along with cholecystectomy truly necessary in mild hereditary spherocytosis? The current advice for concomitant splenectomy in children with mild HS undergoing cholecystectomy due to gallstones needs reexamination. The minimal access surgery era suggests splenectomy indication should be assessed by its own criteria.,2.1317375462116866e-07,0.09776018100887418,0.09639999999999999,0.016320838183036854,0.1633840959432522,0.01922337562475971,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
178,0.9,1,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Does measuring visceral adipose tissue area at one level accurately reflect visceral adipose tissue volume? Answer: Measuring visceral adipose tissue area at a single level might give an estimate, but it cannot completely represent the total visceral adipose tissue volume. This is due to the uneven distribution of adipose tissue across different body regions, making a single measurement insufficient to capture its true volume.",9.474389094274162e-08,0.18561388974490134,0.16257268304260097,0.0072537058591274906,0.1700262362424909,0.08543531607905744,0.007243206163811466,0.1430223765848062,0.05380901223718273,9.474389094274162e-08,0.11965413701911354,0.03702651089998914
178,0.9,2,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Can a single-level measurement of visceral adipose tissue area represent the total visceral adipose tissue volume? Answer: A single-level measurement of visceral adipose tissue area may offer an approximation; however, it does not fully capture visceral adipose tissue volume because the distribution of adipose tissue varies throughout the body.",2.6054570009253947e-07,0.20127861676645864,0.03895787679571461,0.0199476911126006,0.20780496516003133,0.025118700541441052,0.019918816950481533,0.21436377086459224,0.002804277529552285,2.6054570009253947e-07,0.2376733922795795,0.016392079556398348
178,0.9,3,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Is measuring visceral adipose tissue area at one site sufficient to represent the entire visceral adipose tissue volume? Answer: While one-level visceral adipose tissue area measurement might provide an estimate, it cannot accurately represent the total visceral adipose tissue volume, as adipose tissue distribution differs across various body regions.",2.6054570009253947e-07,0.11640345179993483,0.042291666666666616,0.0199476911126006,0.0922804350667068,0.06587303499574901,0.019918816950481533,0.09638127204587832,0.08080446527443765,2.6054570009253947e-07,0.11712605653002406,0.06977572089711641
178,0.9,4,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.",Question: Can the area of visceral adipose tissue measured at a single level stand for the overall visceral adipose tissue volume? Answer: Measuring visceral adipose tissue area at a single level gives an approximation but cannot fully represent the visceral adipose tissue volume due to its variable distribution throughout the body.,2.3685972735685406e-07,0.06720681558410124,0.20265714852270472,0.018134264647818726,0.09700581518036389,0.04779452259905481,0.018108015409528666,0.07471337066669737,0.08124710369896146,2.3685972735685406e-07,0.0956198513090607,0.06977572089711641
178,0.9,5,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Does a single-level visceral adipose tissue area measurement reflect the overall volume of visceral adipose tissue? Answer: Although a single-level measurement may approximate the volume, it cannot entirely represent the visceral adipose tissue volume because adipose tissue is unevenly distributed in the body.",4.026615365066519e-07,0.0985790875729724,0.4471375807940905,0.030828249901291835,0.11441317367266635,0.2610859395537403,0.030783626196198732,0.20346118234694988,0.10207100591715974,4.026615365066519e-07,0.25688799890518244,0.06977572089711641
178,0.9,6,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Can measuring visceral adipose tissue area at one level accurately indicate the visceral adipose tissue volume? Answer: It might provide an estimate, but this method cannot fully represent the visceral adipose tissue volume since adipose tissue distribution differs across the body.",4.500334819780227e-07,0.21011954782750886,0.29605442176870744,0.03445510283085558,0.2472496099221111,0.1563203060327006,0.034405229278104466,0.2890176121810972,0.07644773721909878,4.500334819780227e-07,0.30818129329273214,0.06977572089711641
178,0.9,7,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Is it possible for single-level visceral adipose tissue area measurement to represent visceral adipose tissue volume? Answer: Such measurement may approximate volume but cannot fully represent it, given that adipose tissue distribution varies throughout the body.",5.684633456564493e-07,0.22078532386321115,0.5234159779614325,0.04352223515476494,0.30333613218624045,0.25633458665579073,0.043459236982868805,0.3906727244350958,0.10207100591715974,5.684633456564497e-07,0.44925989155263846,0.06977572089711641
178,0.9,8,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Does single-level measurement of visceral adipose tissue area suffice to represent visceral adipose tissue volume? Answer: No, it only estimates volume and cannot fully represent the visceral adipose tissue volume due to the heterogeneous distribution of adipose tissue in the body.",4.500334819780227e-07,0.17630749023921855,0.3248456790123458,0.03445510283085558,0.21259225089411427,0.18238822466631507,0.034405229278104466,0.2534716029216133,0.10207100591715974,4.500334819780227e-07,0.30818129329273214,0.06977572089711641
178,0.9,9,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.",Question: Can visceral adipose tissue volume be represented by measuring its area at a single level? Answer: Measuring area at a single level can approximate but not fully represent visceral adipose tissue volume because adipose tissue distribution varies throughout the body.,4.737194547137081e-07,0.24104832424202893,0.4389348025711661,0.03626852929563745,0.2976981742662348,0.1836568096626405,0.03621603081905733,0.3524099504364444,0.049601870114690604,4.737194547137081e-07,0.334849540374893,0.06977572089711641
178,0.9,10,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.",Question: Is a single-level area measurement of visceral adipose tissue an accurate reflection of its volume? Answer: It may offer an estimate but does not fully reflect visceral adipose tissue volume as the distribution varies in different body regions.,5.210914001850787e-07,0.10962176295105763,0.6141975308641975,0.0398953822252012,0.24562528587911947,0.2578751266190527,0.039837633900963065,0.33351431059514747,0.10207100591715974,5.210914001850789e-07,0.3904193915297052,0.06977572089711641
179,0.9,1,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"LITT facilitates localized entry of chemotherapy drugs into brain tissue, offering promise for brain tumor treatments.",7.105791820705599e-07,1.0986122886681091,0.0,0.05440279394345631,1.1451323043030035,0.0,0.05432404622858615,1.1962507582320252,0.0,7.105791820705618e-07,1.2527629684953672,0.0
179,0.9,2,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"The use of LITT enables region-specific delivery of chemotherapeutic agents to brain tissue, which may benefit brain tumor therapy.",6.395212638635038e-07,0.9162907318741547,0.0,0.048962514549110686,0.9509762898620457,0.0,0.04889164160572752,0.9886113934537812,0.0,6.395212638635056e-07,1.0296194171811575,0.0
179,0.9,3,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Localized opening of the blood-brain barrier by LITT allows chemotherapeutic drugs to reach brain tissue, potentially improving brain tumor treatment.",6.158352911278184e-07,0.8622235106038794,0.0,0.04714908808432881,0.893817876022097,0.0,0.04708084006477466,0.9279867716373462,0.0,6.158352911278203e-07,0.9650808960435868,0.0
179,0.9,4,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"LITT induces a targeted passage for chemotherapy into the brain, representing a novel approach for glioma treatment.",6.868932093348744e-07,1.0340737675305385,0.0,0.05258936747867443,1.0761394328160514,0.0,0.05251324468763327,1.122142786078304,0.0,6.868932093348764e-07,1.1727202608218308,0.0
179,0.9,5,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Using LITT promotes localized chemotherapy agent penetration into brain tissue, providing potential advantages for brain tumor therapy.",6.868932093348744e-07,1.0340737675305385,0.0,0.05258936747867443,1.0761394328160514,0.0,0.05251324468763327,1.122142786078304,0.0,6.868932093348764e-07,1.1727202608218308,0.0
179,0.9,6,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"LITT creates a locoregional route for chemotherapy drugs to access brain tissue, which is beneficial for treating brain tumors.",6.395212638635038e-07,0.9162907318741547,0.0,0.048962514549110686,0.9509762898620457,0.0,0.04889164160572752,0.9886113934537812,0.0,6.395212638635056e-07,1.0296194171811575,0.0
179,0.9,7,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,Localized chemotherapy delivery into the brain via LITT presents a new strategy for glioma therapy.,7.342651548062453e-07,1.1676051601550612,0.0,0.05621622040823819,1.2192402764567247,0.0,0.05613484776953902,1.2762934659055616,0.0,7.342651548062471e-07,1.3397743454849973,0.0
179,0.9,8,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"LITT causes a selective opening in the blood-brain barrier, allowing chemotherapy to enter brain tissue for tumor treatment.",6.632072365991891e-07,0.9734491457141035,0.0,0.05077594101389256,1.0116009116784808,0.0,0.050702443146680404,1.0531499145913519,0.0,6.63207236599191e-07,1.0986122886681096,0.0
179,0.9,9,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"The technique of LITT provides targeted chemotherapeutic access to brain tissue, useful in brain tumor treatment.",7.105791820705599e-07,1.0986122886681091,0.0,0.05440279394345631,1.1451323043030035,0.0,0.05432404622858615,1.1962507582320252,0.0,7.105791820705618e-07,1.2527629684953672,0.0
179,0.9,10,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"LITT enables localized passage of cancer drugs into the brain, suggesting new possibilities for glioma treatment.",7.105791820705599e-07,1.0986122886681091,0.0,0.05440279394345631,1.1451323043030035,0.0,0.05432404622858615,1.1962507582320252,0.0,7.105791820705618e-07,1.2527629684953672,0.0
180,0.9,1,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Does a geriatric oncology consultation change the cancer treatment plan for elderly patients? Yes, it can. This consultation evaluates the older patient's health, functionality, and vulnerabilities to customize treatment.",5.210914001850777e-07,0.3302855102513611,0.17132659131469363,0.039895382225201254,0.39794138051774164,0.13888888888888887,0.03983763390096313,0.46869881026975335,0.10275824770146022,5.210914001850789e-07,0.5427849027278224,0.06353305785123965
180,0.9,2,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Can a geriatric oncology consultation alter the cancer treatment plan for older adults? Indeed, it can, by assessing the patient's health status and individual needs to adjust the treatment accordingly.",4.974054274493924e-07,0.2951941904400921,0.17132659131469363,0.038081955760419374,0.36157373634686696,0.13888888888888887,0.038026832360010254,0.43095848228690636,0.10275824770146022,4.974054274493935e-07,0.50356418957454,0.06353305785123965
180,0.9,3,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Is the cancer treatment plan for elderly patients modified by a geriatric oncology consultation? Yes, such consultations assess health and vulnerabilities to tailor the treatment plan.",5.921493183921336e-07,0.44361419555836523,0.17132659131469363,0.04533566161954689,0.5157244161741259,0.13888888888888887,0.04527003852382175,0.5913011323620863,0.10275824770146022,5.921493183921352e-07,0.6706182742377069,0.06353305785123965
180,0.9,4,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Does consulting a geriatric oncologist impact the cancer treatment plan for elderly patients? Yes, it evaluates the patient's overall health and vulnerabilities to guide personalized treatment.",5.921493183921336e-07,0.44361419555836523,0.17132659131469363,0.04533566161954689,0.5157244161741259,0.13888888888888887,0.04527003852382175,0.5913011323620863,0.10275824770146022,5.921493183921352e-07,0.6706182742377069,0.06353305785123965
180,0.9,5,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Can a specialized geriatric oncology consultation influence cancer treatment plans in elderly patients? Yes, by reviewing their health and functional status, it helps adapt the plan.",5.921493183921336e-07,0.44361419555836523,0.17132659131469363,0.04533566161954689,0.5157244161741259,0.13888888888888887,0.04527003852382175,0.5913011323620863,0.10275824770146022,5.921493183921352e-07,0.6706182742377069,0.06353305785123965
180,0.9,6,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Does a geriatric oncology consult affect cancer treatment decisions for older patients? Yes, it assesses the patient's overall condition to customize their treatment approach.",6.395212638635042e-07,0.5269958044974157,0.17132659131469363,0.04896251454911065,0.6027357931637556,0.13888888888888887,0.048891641605727496,0.6822729105678143,0.10275824770146022,6.39521263863506e-07,0.7659284540420321,0.06353305785123965
180,0.9,7,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Is cancer treatment for elderly patients modified by a geriatric oncology consultation? Yes, this consultation helps doctors adjust plans based on the patient’s health and vulnerabilities.",5.921493183921336e-07,0.44361419555836523,0.17132659131469363,0.04533566161954689,0.5157244161741259,0.13888888888888887,0.04527003852382175,0.5913011323620863,0.10275824770146022,5.921493183921352e-07,0.6706182742377069,0.06353305785123965
180,0.9,8,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Can a geriatric oncology evaluation change the cancer treatment strategy for elderly patients? Yes, it considers their health and functionality to tailor care.",6.632072365991895e-07,0.5714475670682497,0.17132659131469363,0.05077594101389253,0.6492558087986495,0.13888888888888887,0.05070244314668037,0.7310630747372455,0.10275824770146022,6.632072365991913e-07,0.8172217484295823,0.06353305785123965
180,0.9,9,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Does consulting geriatric oncology specialists modify cancer treatment plans for the elderly? Yes, by evaluating health and risks, it helps physicians personalize treatment.",6.632072365991895e-07,0.5714475670682497,0.17132659131469363,0.05077594101389253,0.6492558087986495,0.13888888888888887,0.05070244314668037,0.7310630747372455,0.10275824770146022,6.632072365991913e-07,0.8172217484295823,0.06353305785123965
180,0.9,10,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Can a geriatric oncology consultation lead to changes in cancer treatment for elderly patients? Yes, it assesses health and vulnerabilities, guiding treatment adjustments.",6.632072365991895e-07,0.5714475670682497,0.17132659131469363,0.05077594101389253,0.6492558087986495,0.13888888888888887,0.05070244314668037,0.7310630747372455,0.10275824770146022,6.632072365991913e-07,0.8172217484295823,0.06353305785123965
181,0.9,1,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is it possible to implement an advance care planning model in community palliative care? Yes, an advance care planning model can be effectively applied within community palliative care services. Integral to the model are quality audit processes, with thorough documentation of advance care planning discussions serving as a key outcome measure.",7.105791820705622e-08,0.07559951880153548,0.015061857760951841,0.005440279394345618,0.07125577684989581,0.008354749307130233,0.0054324046228586,0.0683893388073491,0.0027603946750964226,7.105791820705622e-08,0.06796903311257019,0.0014484404281270083
181,0.9,2,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Can an advance care planning model be utilized in community palliative care? The advance care planning model is practical and feasible for use in community palliative care settings. Central to the model are quality audits, with documented discussions on advance care planning being vital outcome indicators.",4.737194547137081e-08,0.053651123112664845,0.011165166204986032,0.0036268529295637453,0.0504482305434073,0.0062131519274376545,0.003621603081905733,0.01608869510729205,0.02110566599093216,4.737194547137081e-08,0.015013325609441353,0.02271498107084911
181,0.9,3,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is the adoption of an advance care planning model viable in community palliative care? Indeed, the model is feasible for community palliative care services. Quality audit mechanisms are fundamental elements of the model, with recording advance care planning conversations recognized as an essential outcome metric.",7.105791820705622e-08,0.06825721352266134,0.17655822427126713,0.005440279394345618,0.03224161085410415,0.11054421768707484,0.0054324046228586,0.007379788770512263,0.04434829637641968,7.105791820705622e-08,0.03911087718850137,0.02271498107084911
181,0.9,4,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Does an advance care planning model work in community palliative care? Yes, it is feasible to use an advance care planning model in community palliative care services. Quality audit practices form a critical part of the model alongside documentation of advance care planning discussions as an important measure of outcomes.",4.737194547137081e-08,0.02271710745488864,0.010235350981558533,0.0036268529295637453,0.019175244203657016,0.015483027535874605,0.003621603081905733,0.046106945246820796,0.0018791605739505515,4.737194547137081e-08,0.04582161865889667,0.0009865860091207122
181,0.9,5,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is the advance care planning model applicable in community palliative care? The model is feasible and can be implemented within community palliative care services. A key feature of the model is quality audit processes, with the documentation of advance care planning discussions considered a crucial outcome measure.",2.3685972735685406e-08,0.05654487648290596,0.13729588042831653,0.0018134264647818726,0.0483303059613962,0.08943855169614268,0.0018108015409528666,0.03914022686438168,0.04434829637641968,2.3685972735685406e-08,0.008517171800753065,0.02271498107084911
181,0.9,6,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is it practical to have an advance care planning model in community palliative care? An advance care planning model is feasible for community palliative care, supported by essential quality audit procedures and the documentation of advance care planning discussions as significant outcome measures.",1.1842986367842703e-07,0.139708370497027,0.02991071428571418,0.009067132323909363,0.13115741458925134,0.01668795105088533,0.009054007704764333,0.12548467099593807,0.005513199468455653,1.1842986367842703e-07,0.12466730702264872,0.002908287627211844
181,0.9,7,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Can community palliative care effectively adopt an advance care planning model? Yes, this model is feasible for community palliative care services. Quality audits are essential components, with the documentation of advance care planning discussions serving as important indicators of success.",1.8948778188548314e-07,0.1000347412275353,0.14315051020408165,0.014507411718254981,0.1320958024776706,0.08131771227009321,0.014486412327622933,0.13413149440965455,0.04434829637641968,1.8948778188548325e-07,0.16916400543669896,0.02271498107084911
181,0.9,8,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is implementing an advance care planning model feasible in community palliative care? The advance care planning model is feasible for community palliative care services, with quality audit processes as a vital part and the documentation of planning discussions as a key outcome indicator.",1.1842986367842703e-07,0.048777775026338954,0.12750136961285619,0.009067132323909363,0.05077114956475581,0.08513464557420602,0.009054007704764333,0.09082731196794036,0.01936473293131776,1.1842986367842703e-07,0.0891212977631648,0.02271498107084911
181,0.9,9,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is an advance care planning approach practical in community palliative care settings? Yes, it is feasible; community palliative care services can utilize this model. Quality audits are crucial, and documenting advance care planning discussions is a significant outcome measure.",2.1317375462116844e-07,0.1297519128160043,0.14056877162629763,0.016320838183036854,0.16073601877906407,0.07990929705215419,0.0162972138685758,0.16153046859776987,0.04434829637641968,2.1317375462116866e-07,0.1973348824033958,0.02271498107084911
181,0.9,10,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is the advance care planning model functional within community palliative care? The model is feasible for community palliative care services. Quality audit procedures are important components, with careful documentation of advance care planning discussions regarded as an essential measure of outcomes.",1.6580180914979784e-07,0.03650497328929836,0.16986806062819582,0.012693985253473108,0.06870346422232343,0.10816357937450141,0.012675610786670066,0.10746324732749368,0.04434829637641968,1.6580180914979784e-07,0.14176503124858364,0.02271498107084911
182,0.9,1,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not","Does central venous pressure accurately predict fluid responsiveness? Central venous pressure (CVP) is not a reliable indicator of fluid responsiveness, which depends mainly on the heart and circulatory system interaction.",1.421158364141118e-07,0.16483350821324727,0.016373831875857336,0.010880558788691277,0.20289316377574718,0.00628053826707024,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
182,0.9,2,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not","Is fluid responsiveness predicted by central venous pressure? Central venous pressure (CVP) does not consistently predict fluid responsiveness, as it is primarily governed by heart-circulation dynamics.",2.36859727356853e-07,0.27309878011287525,0.04503038194444444,0.018134264647818796,0.30753333070586697,0.029384756657483937,0.018108015409528735,0.36101334553733055,0.0,2.3685972735685406e-07,0.3746934494414109,0.0
182,0.9,3,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not","Can central venous pressure forecast fluid responsiveness? Central venous pressure (CVP) fails to reliably forecast fluid responsiveness, which is mainly influenced by the relationship between the heart and circulatory system.",1.421158364141118e-07,0.2126367620449674,0.01711006841715977,0.010880558788691277,0.20289316377574718,0.00628053826707024,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
182,0.9,4,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not","Does the measurement of central venous pressure determine fluid responsiveness? Central venous pressure (CVP) is not a dependable predictor of fluid responsiveness, which is chiefly determined by cardiac and circulatory system interplay.",9.47438909427412e-08,0.09197397192983603,0.020751662826991688,0.007253705859127518,0.1305995914289868,0.003908941321112979,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
182,0.9,5,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Is fluid responsiveness linked to central venous pressure? Central venous pressure (CVP) cannot reliably forecast fluid responsiveness since it mainly depends on the heart’s interaction with the circulatory system.,1.658018091497971e-07,0.20333934615535476,0.01395502034023667,0.012693985253473157,0.1897502950494827,0.029384756657483937,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
182,0.9,6,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Is central venous pressure a good predictor of fluid responsiveness? Central venous pressure (CVP) does not reliably indicate fluid responsiveness; this response largely depends on heart and circulatory system functions.,1.421158364141118e-07,0.16483350821324727,0.016373831875857336,0.010880558788691277,0.20289316377574718,0.00628053826707024,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
182,0.9,7,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not","Does central venous pressure measurement predict fluid responsiveness? Central venous pressure (CVP) isn’t a reliable predictor of fluid responsiveness, which is chiefly influenced by heart and circulation interaction.",1.894877818854824e-07,0.24337443572601725,0.011360937500000015,0.014507411718255037,0.28080963692155647,0.009015243342516074,0.014486412327622988,0.2776317365982801,0.0,1.8948778188548325e-07,0.28768207245178123,0.0
182,0.9,8,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not","Can central venous pressure (CVP) indicate fluid responsiveness? Central venous pressure (CVP) is not a dependable marker for fluid responsiveness, which is mainly dictated by the heart and circulatory relationship.",1.421158364141118e-07,0.2126367620449674,0.01711006841715977,0.010880558788691277,0.25240367667288677,0.04162116050227939,0.010864809245717241,0.25201493105918393,0.03698224852071005,1.4211583641411244e-07,0.20763936477824396,0.0
182,0.9,9,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not","Does central venous pressure serve as a predictor for fluid responsiveness? No, central venous pressure (CVP) does not reliably predict fluid responsiveness, which is largely based on heart and circulatory system dynamics.",9.47438909427412e-08,0.09197397192983603,0.020751662826991688,0.007253705859127518,0.1305995914289868,0.003908941321112979,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
182,0.9,10,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Is fluid responsiveness effectively predicted by central venous pressure? Central venous pressure (CVP) is an unreliable predictor of fluid responsiveness because it depends mainly on the heart's interaction with the circulatory system.,9.47438909427412e-08,0.09197397192983603,0.020751662826991688,0.007253705859127518,0.08438977939165726,0.029384756657483937,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
183,0.9,1,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Is routine insertion of a nasobiliary drainage tube necessary after endoscopic clearance of the common bile duct in patients with cholangitis caused by choledocholithiasis? No, it is not routinely required; the decision should be individualized.",4.263475092423367e-07,0.001668917148546445,0.24691358024691368,0.03264167636607372,0.0819489203841468,0.22506925207756232,0.03259442773715162,0.14130234318204282,0.20249835634451027,4.263475092423373e-07,0.20320759872590832,0.174375
183,0.9,2,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Must a nasobiliary drainage tube be routinely placed after endoscopic removal of stones from the common bile duct in patients with choledocholithiasis-induced cholangitis? No, routine placement is not needed; decisions should be tailored to the patient.",4.026615365066514e-07,0.030656454021797952,0.24691358024691368,0.030828249901291842,0.05209595723446503,0.22506925207756232,0.030783626196198746,0.11053068451528913,0.20249835634451027,4.026615365066519e-07,0.1714589004113285,0.174375
183,0.9,3,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Is the routine use of a nasobiliary drainage tube mandatory following endoscopic clearance of the common bile duct in choledocholithiasis-related cholangitis cases? No, routine insertion is unnecessary and should be based on clinical judgment.",4.50033481978022e-07,0.028184046001135332,0.24691358024691368,0.0344551028308556,0.1127205790509005,0.22506925207756232,0.03440522927810449,0.17305104149662265,0.20249835634451027,4.500334819780227e-07,0.23599742154890002,0.174375
183,0.9,4,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Should a nasobiliary drainage tube be inserted routinely after endoscopic clearance of the common bile duct in patients with cholangitis due to choledocholithiasis? No, routine insertion is not required; the choice depends on the patient's condition.",4.026615365066514e-07,0.030656454021797952,0.24691358024691368,0.030828249901291842,0.05209595723446503,0.22506925207756232,0.030783626196198746,0.11053068451528913,0.20249835634451027,4.026615365066519e-07,0.1714589004113285,0.174375
183,0.9,5,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Is it required to routinely place a nasobiliary drainage tube after endoscopic treatment of the common bile duct in patients with choledocholithiasis-induced cholangitis? No, routine placement is not necessary; it should be decided case by case.",4.026615365066514e-07,0.030656454021797952,0.24691358024691368,0.030828249901291842,0.05209595723446503,0.22506925207756232,0.030783626196198746,0.11053068451528913,0.20249835634451027,4.026615365066519e-07,0.1714589004113285,0.174375
183,0.9,6,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Is routine nasobiliary drainage tube insertion warranted following endoscopic clearance of the common bile duct in patients with cholangitis from choledocholithiasis? No, routine insertion is not necessary and should be assessed individually.",4.974054274493926e-07,0.09070440298246885,0.24691358024691368,0.03808195576041936,0.17725910018847202,0.22506925207756232,0.03802683236001024,0.2397424159952961,0.20249835634451027,4.974054274493935e-07,0.3049902930358508,0.174375
183,0.9,7,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Does one need to routinely insert a nasobiliary drainage tube after endoscopic removal of common bile duct stones in patients with choledocholithiasis-induced cholangitis? No, it’s not routinely needed; the decision should be individualized.",4.737194547137073e-07,0.05895570466788902,0.24691358024691368,0.03626852929563748,0.14446927736548032,0.22506925207756232,0.03621603081905737,0.20584086431961435,0.20249835634451027,4.737194547137081e-07,0.2698989732245818,0.174375
183,0.9,8,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Is routine nasobiliary drainage tube placement essential after endoscopic clearance of the common bile duct in choledocholithiasis-related cholangitis patients? No, it's not essential routinely; decisions should be made on a case basis.",4.974054274493926e-07,0.09070440298246885,0.24691358024691368,0.03808195576041936,0.17725910018847202,0.22506925207756232,0.03802683236001024,0.2397424159952961,0.20249835634451027,4.974054274493935e-07,0.3049902930358508,0.174375
183,0.9,9,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Is it mandatory to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients suffering from choledocholithiasis-induced cholangitis? No, routine insertion is not mandatory and must be decided per patient needs.",3.789755637709661e-07,0.0588273309884948,0.24691358024691368,0.029014823436509962,0.023108420361213522,0.22506925207756232,0.028972824655245873,0.08067772136560736,0.20249835634451027,3.789755637709665e-07,0.1406872417445748,0.174375
183,0.9,10,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Should nasobiliary drainage tubes be routinely inserted post-endoscopic clearance of the common bile duct in patients with cholangitis caused by choledocholithiasis? No, routine insertion is unnecessary and should be guided by individual patient factors.",4.50033481978022e-07,0.028184046001135332,0.24691358024691368,0.0344551028308556,0.1127205790509005,0.22506925207756232,0.03440522927810449,0.17305104149662265,0.20249835634451027,4.500334819780227e-07,0.23599742154890002,0.174375
184,0.9,1,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Is the length of psychological treatment for depression associated with the likelihood of returning for treatment? Findings indicate that extended treatment duration might reduce the chance of re-entering mental health services in certain populations. Nonetheless, due to the study's design, causality cannot be established. Additional research, ideally through a randomized controlled trial (RCT), is necessary to confirm this.",0.0,0.07296286111157357,0.05246913580246911,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
184,0.9,2,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Does the duration of depression therapy influence the probability of revisiting treatment? Results imply that longer therapy may lower the risk of future mental health care visits among some groups. However, the study design prevents drawing definitive causal conclusions. More studies, preferably RCTs, are required to verify this relationship.",2.1317375462116866e-07,0.09888739581508554,0.05246913580246911,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
184,0.9,3,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Is there a link between the length of psychological treatment for depression and the risk of returning for treatment? The findings suggest that prolonged treatment could help prevent some groups from needing further mental health care. However, no causal relationship can be confirmed due to the study design. Further investigation, ideally randomized controlled trials, is needed.",4.737194547137081e-08,0.03724477850949448,0.05246913580246911,0.0036268529295637453,0.036367644170874236,0.0,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
184,0.9,4,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Does the time spent in psychological treatment for depression affect the likelihood of treatment relapse? The results show that longer treatment durations might reduce the need for follow-up mental health care in some populations. Because of the study's design, causality is not established. More research, especially RCTs, is necessary for confirmation.",1.6580180914979784e-07,0.058065401294831176,0.05246913580246911,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
184,0.9,5,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Is the duration of depression treatment connected to the chance of returning to care? Results suggest that extended treatment may prevent re-entry into mental health services for certain groups. However, causal inference is limited by the study design. Further research, preferably randomized controlled trials, is essential.",2.8423167282822487e-07,0.16342591695265707,0.05246913580246911,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
184,0.9,6,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Is there an association between treatment duration for depression and the probability of treatment recurrence? Evidence indicates that longer treatment might reduce relapse rates in some individuals. Due to the observational nature of the study, no causal conclusions can be drawn. Additional RCT-based research is needed.",2.8423167282822487e-07,0.16342591695265707,0.05246913580246911,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
184,0.9,7,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Does the length of psychological treatment for depression impact the likelihood of returning for care? The findings propose that a longer treatment period may help avoid future mental health service use in some groups. However, the study's design limits causal claims. More randomized controlled trials are warranted to explore this.",1.8948778188548325e-07,0.07826810861234978,0.05246913580246911,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
184,0.9,8,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Is the length of depression treatment related to the likelihood of re-entering treatment? Results imply longer treatments may prevent some patients from returning to mental health care. But because of the study design, causal inferences cannot be made. Further RCTs are required to validate this.",3.079176455639103e-07,0.18589877280471478,0.05246913580246911,0.023574544042164344,0.26415157504158726,0.0,0.023540420032387266,0.2696635669491032,0.0,3.079176455639103e-07,0.27541197985996746,0.0
184,0.9,9,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Does the duration of psychological treatment for depression influence the chance of needing further treatment? Findings suggest extended treatment durations might prevent some individuals from returning for mental health services. However, causal relationships cannot be confirmed due to the study setup. Additional randomized controlled trials are essential.",2.6054570009253947e-07,0.14144701023388206,0.05246913580246911,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
184,0.9,10,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Is the length of psychological therapy for depression associated with the risk of treatment recurrence? Results suggest that longer therapy may reduce the likelihood of returning to mental health care in certain groups. However, due to the study design, causal effects cannot be inferred. Further investigation, ideally by RCTs, is necessary.",1.6580180914979784e-07,0.058065401294831176,0.05246913580246911,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
185,0.9,1,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Is it possible to predict discordance in TEOAE and AABR results in newborns? No, discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns cannot be reliably predicted due to factors such as ear canal debris and background noise.",1.8948778188548325e-07,0.1137350707739393,0.03840000000000001,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
185,0.9,2,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Can discordance between TEOAE and AABR results be anticipated in newborns? No, the mismatch in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) findings in newborns is unpredictable because variables like ear canal debris and environmental noise affect outcomes.",2.6054570009253947e-07,0.18435263798789325,0.03840000000000001,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
185,0.9,3,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Is the discordance in TEOAE and AABR findings foreseeable in newborn infants? No, predicting differences between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) results in newborns is not feasible due to multiple factors including debris in the ear canal and ambient noise.",1.6580180914979784e-07,0.09126221492188158,0.03840000000000001,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
185,0.9,4,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Can the differences in TEOAE and AABR test results in newborns be predicted? No, discrepancies between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns are not predictable because of influences like ear canal debris and environmental sounds.",2.3685972735685406e-07,0.19326209500692482,0.014604640095181455,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
185,0.9,5,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Is it feasible to predict discordance between TEOAE and AABR in newborns? No, predicting discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) test results in newborns is not reliable due to factors such as debris in the ear canal and noise levels.",1.4211583641411244e-07,0.09942014214049522,0.016671604938271613,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
185,0.9,6,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Are discordant results in TEOAE and AABR testing in newborns predictable? No, discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns cannot be predicted reliably because of factors like ear canal debris and ambient noise.",2.6054570009253947e-07,0.21816469557618312,0.01402500000000001,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
185,0.9,7,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Is predicting discordance in TEOAE and AABR test outcomes in newborns possible? No, it is not possible to predict discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns due to variables such as debris in the ear canal and background noise.",1.1842986367842703e-07,0.10676835239150018,0.00406913580246912,0.009067132323909363,0.1333210701726193,0.021728395061728398,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
185,0.9,8,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Can we foresee differences in TEOAE and AABR results in newborn babies? No, differences in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) results among newborns are unpredictable because of factors like debris accumulation in the ear canal and environmental noise.",2.1317375462116866e-07,0.16896399274561302,0.015157369614512486,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
185,0.9,9,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Is the mismatch in TEOAE and AABR findings in newborns predictable? No, the mismatch between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns cannot be reliably foreseen owing to factors including ear canal debris and ambient noise conditions.",2.1317375462116866e-07,0.20120339649258723,0.008000951814396196,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
185,0.9,10,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Can discrepancies between TEOAE and AABR outcomes be predicted in newborns? No, such discrepancies in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) results in newborns are not predictable due to influencing factors like debris in the ear and background noise.",2.1317375462116866e-07,0.13672458899863882,0.03840000000000001,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
186,0.9,1,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Does laparoscopic cholecystectomy affect peri-sinusoidal cell activity? Present research does not offer direct proof that laparoscopic cholecystectomy impacts peri-sinusoidal cell activity. Since this surgical procedure targets the gallbladder, it is typically not linked to peri-sinusoidal cells, which are located mainly in the liver.",1.8948778188548325e-07,0.1467247797984772,0.05480873698506114,0.014507411718254981,0.17824823140631896,0.0,0.014486412327622933,0.1823215567939549,0.0,1.8948778188548325e-07,0.18658595558041347,0.0
186,0.9,2,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Is peri-sinusoidal cell activity influenced by laparoscopic cholecystectomy? There is currently no direct scientific evidence indicating that laparoscopic cholecystectomy affects peri-sinusoidal cell activity. Given that the procedure primarily involves the gallbladder, its effects are not generally related to liver peri-sinusoidal cells.",2.3685972735685406e-07,0.16415828579972125,0.07732517353995924,0.018134264647818726,0.22825865198098239,0.0,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
186,0.9,3,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Does performing a laparoscopic cholecystectomy alter peri-sinusoidal cell activity? Existing scientific literature lacks direct evidence that laparoscopic cholecystectomy impacts peri-sinusoidal cell function. Since the procedure focuses on the gallbladder, it is not usually associated with the liver's peri-sinusoidal cells.",2.8423167282822466e-07,0.2537570822708477,0.049839601182592015,0.02176111757738247,0.2809023854664012,0.0,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
186,0.9,4,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Can laparoscopic cholecystectomy influence the activity of peri-sinusoidal cells? Current studies do not provide direct evidence linking laparoscopic cholecystectomy to changes in peri-sinusoidal cell activity. The surgery is mainly directed at the gallbladder, and peri-sinusoidal cells are primarily found in the liver, so effects on these cells are unlikely.",4.737194547137081e-08,0.00494163502443179,0.0607208352837379,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
186,0.9,5,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Is there an effect of laparoscopic cholecystectomy on peri-sinusoidal cell activity? Scientific literature to date does not show direct evidence supporting an influence of laparoscopic cholecystectomy on peri-sinusoidal cell activity. Since it mainly targets the gallbladder, the procedure generally does not impact peri-sinusoidal cells in the liver.",9.474389094274162e-08,0.17055998802089922,0.025191263014938847,0.0072537058591274906,0.20838397377318607,0.08804283164782867,0.007243206163811466,0.18153144706598612,0.06781677572873293,9.474389094274162e-08,0.153426293510444,0.046400951814396206
186,0.9,6,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Does laparoscopic cholecystectomy impact peri-sinusoidal cells? Current scientific research does not demonstrate direct effects of laparoscopic cholecystectomy on peri-sinusoidal cell activity. The procedure focuses on the gallbladder, so it is not commonly associated with peri-sinusoidal cells in the liver.",2.8423167282822466e-07,0.2172756517150609,0.07601217014795378,0.02176111757738247,0.2809023854664012,0.0,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
186,0.9,7,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Is peri-sinusoidal cell activity changed by laparoscopic cholecystectomy? There is no direct scientific evidence confirming that laparoscopic cholecystectomy influences peri-sinusoidal cell activity. Since the procedure mainly involves the gallbladder, its effects usually do not extend to the liver's peri-sinusoidal cells.",2.6054570009253936e-07,0.19036474401550052,0.07668546828700021,0.0199476911126006,0.25423413838424036,0.0,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
186,0.9,8,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Does the laparoscopic cholecystectomy procedure affect peri-sinusoidal cells? Current literature does not provide direct evidence that laparoscopic cholecystectomy affects peri-sinusoidal cell activity. The procedure primarily involves the gallbladder, whereas peri-sinusoidal cells are located chiefly in the liver.",3.3160361829959526e-07,0.2733696191273256,0.07455363494424483,0.025387970506946217,0.3364722366212134,0.0,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
186,0.9,9,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Have studies shown that laparoscopic cholecystectomy influences peri-sinusoidal cell activity? Present scientific evidence does not directly associate laparoscopic cholecystectomy with changes in peri-sinusoidal cell activity. Because the operation mainly targets the gallbladder, its impact on liver peri-sinusoidal cells is generally not recognized.",2.1317375462116866e-07,0.1724324293579329,0.053656534486704814,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
186,0.9,10,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Is there any impact of laparoscopic cholecystectomy on peri-sinusoidal cell activity? The current body of scientific literature lacks direct proof that laparoscopic cholecystectomy affects peri-sinusoidal cell activity. As the surgery focuses mainly on the gallbladder, effects on peri-sinusoidal cells in the liver are not commonly observed.",1.1842986367842703e-07,0.10413751519000058,0.03598220637281627,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
187,0.9,1,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Does case-mix reimbursement encourage the adoption of process-oriented care delivery? Yes, it motivates healthcare providers to organize their services efficiently, fostering a process-oriented approach that enhances patient outcomes and resource use.",6.158352911278195e-07,0.4508675139330083,0.12244897959183677,0.04714908808432873,0.5140105951441893,0.08999999999999998,0.04708084006477458,0.579763182993521,0.05536332179930796,6.158352911278206e-07,0.6221420527885502,0.037677816224529016
187,0.9,2,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Is process-oriented care delivery promoted by case-mix based reimbursement? Indeed, this reimbursement model incentivizes efficient and effective structuring of care, supporting improved outcomes and better resource management.",7.105791820705607e-07,0.5939683575736807,0.12244897959183677,0.05440279394345625,0.6624306002624625,0.08999999999999998,0.054324046228586075,0.73391386282078,0.05536332179930796,7.105791820705622e-07,0.7824847028637301,0.037677816224529016
187,0.9,3,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Can case-mix based reimbursement drive the development of process-oriented care delivery? Yes, it encourages providers to streamline services, leading to a more process-focused approach with improved patient results and resource efficiency.",6.158352911278195e-07,0.4508675139330083,0.12244897959183677,0.04714908808432873,0.5140105951441893,0.08999999999999998,0.04708084006477458,0.579763182993521,0.05536332179930796,6.158352911278206e-07,0.6221420527885502,0.037677816224529016
187,0.9,4,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Does reimbursement based on case-mix encourage process-oriented care? Yes, by incentivizing efficient service delivery, it promotes a shift toward process-oriented care and improved healthcare outcomes.",7.579511275419313e-07,0.674011065247218,0.12244897959183677,0.05802964687302001,0.7458122092015129,0.08999999999999998,0.05794564931049182,0.8209252398104097,0.05536332179930796,7.57951127541933e-07,0.8734564810694581,0.037677816224529016
187,0.9,5,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Is process-oriented care delivery stimulated by case-mix based reimbursement? Yes, this approach rewards providers for organizing care efficiently, which enhances outcomes and optimizes resource allocation.",7.579511275419313e-07,0.674011065247218,0.12244897959183677,0.05802964687302001,0.7458122092015129,0.08999999999999998,0.05794564931049182,0.8209252398104097,0.05536332179930796,7.57951127541933e-07,0.8734564810694581,0.037677816224529016
187,0.9,6,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Can case-mix reimbursement foster process-oriented care delivery? Yes, it pushes healthcare providers to adopt efficient care structures, resulting in better patient outcomes and resource use.",7.579511275419313e-07,0.674011065247218,0.12244897959183677,0.05802964687302001,0.7458122092015129,0.08999999999999998,0.05794564931049182,0.8209252398104097,0.05536332179930796,7.57951127541933e-07,0.8734564810694581,0.037677816224529016
187,0.9,7,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Does case-mix based reimbursement promote a process-oriented approach to care? Yes, it incentivizes effective service structuring, improving patient care and resource management within health systems.",7.579511275419313e-07,0.674011065247218,0.12244897959183677,0.05802964687302001,0.7458122092015129,0.08999999999999998,0.05794564931049182,0.8209252398104097,0.05536332179930796,7.57951127541933e-07,0.8734564810694581,0.037677816224529016
187,0.9,8,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Is the development of process-oriented care delivery encouraged by case-mix reimbursement? Yes, it motivates providers to deliver care efficiently, supporting better outcomes and resource allocation.",7.579511275419313e-07,0.674011065247218,0.12244897959183677,0.05802964687302001,0.7458122092015129,0.08999999999999998,0.05794564931049182,0.8209252398104097,0.05536332179930796,7.57951127541933e-07,0.8734564810694581,0.037677816224529016
187,0.9,9,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Can case-mix reimbursement stimulate process-oriented healthcare delivery? Yes, it encourages providers to structure services effectively, which leads to improved patient outcomes and resource utilization.",7.816371002776166e-07,0.7165706796660136,0.12244897959183677,0.05984307333780189,0.790263971772347,0.08999999999999998,0.059756450851444695,0.8674452554453036,0.05536332179930796,7.816371002776184e-07,0.9222466452388893,0.037677816224529016
187,0.9,10,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Does case-mix based reimbursement support process-oriented care delivery? Yes, by incentivizing efficient and effective care processes, it enhances patient outcomes and optimizes resource use.",7.816371002776166e-07,0.7165706796660136,0.12244897959183677,0.05984307333780189,0.790263971772347,0.08999999999999998,0.059756450851444695,0.8674452554453036,0.05536332179930796,7.816371002776184e-07,0.9222466452388893,0.037677816224529016
188,0.9,1,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Is bedside assessment a reliable method to rule out aspiration after an acute stroke? Answer: Bedside swallowing evaluations do not have sufficient sensitivity to serve as effective screening tools in acute stroke cases, although the reliability of videofluoroscopy as the definitive standard is questioned. The significance of aspiration and bedside assessments in forecasting complications is still under consideration.",1.1842986367842703e-07,0.178493195619283,0.09639999999999999,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
188,0.9,2,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Can aspiration be reliably excluded through bedside assessment following an acute stroke? Answer: Bedside swallowing assessments lack the sensitivity required to be a dependable screening tool after an acute stroke, and there are doubts about using videofluoroscopy as the absolute benchmark. The relative roles of aspiration and bedside assessment in predicting complications remain important.",2.3685972735685406e-08,0.055689996040105605,0.05941775147928993,0.0018134264647818726,0.0190481949706931,0.0,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
188,0.9,3,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Does bedside assessment effectively rule out aspiration after acute stroke? Answer: Bedside swallowing assessments do not possess the necessary sensitivity to be used as screening measures in acute stroke, and concerns exist regarding videofluoroscopy as the gold standard. The importance of both aspiration and bedside assessments in predicting complications continues to be evaluated.",0.0,0.0621856012453641,0.07753905325443786,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
188,0.9,4,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Can bedside evaluation reliably exclude aspiration in patients after an acute stroke? Answer: Bedside swallowing assessment lacks adequate sensitivity to function as a screening instrument in acute stroke, with uncertainties about videofluoroscopy's status as the gold standard. The prognostic value of aspiration and bedside assessments for complications is a subject of ongoing study.",0.0,0.08834209862498499,0.09639999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
188,0.9,5,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Is bedside assessment sufficient to exclude aspiration following acute stroke? Answer: Bedside swallowing evaluations are not sensitive enough to rely on as screening tools in acute stroke, while there is skepticism about videofluoroscopy being the definitive standard. The predictive significance of aspiration and bedside assessments in complications is still being assessed.",4.737194547137081e-08,0.04987581779718919,0.09639999999999999,0.0036268529295637453,0.03922071315328246,0.0,0.003621603081905733,0.04000533461369837,0.0,4.737194547137081e-08,0.04082199452025437,0.0
188,0.9,6,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Can aspiration be confidently ruled out via bedside assessment after an acute stroke? Answer: Bedside swallowing assessments do not meet the sensitivity requirements for screening in acute stroke, and questions remain about the reliability of videofluoroscopy as the gold standard. The relative importance of aspiration and bedside assessment in forecasting complications is under review.",2.3685972735685406e-08,0.08136211383862246,0.0778880740477038,0.0018134264647818726,0.0190481949706931,0.0,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
188,0.9,7,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Is bedside assessment capable of reliably excluding aspiration after an acute stroke? Answer: The sensitivity of bedside swallowing assessment is insufficient for use as a screening tool in acute stroke, and concerns persist over videofluoroscopy’s role as the definitive reference. The significance of aspiration and bedside assessments for complication prediction continues to be explored.",2.3685972735685406e-08,0.10703423163713932,0.09639999999999999,0.0018134264647818726,0.0190481949706931,0.0,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
188,0.9,8,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Can aspiration be excluded reliably by bedside assessment following acute stroke? Answer: Bedside swallowing assessment lacks the necessary sensitivity to be an effective screening method in acute stroke, and the use of videofluoroscopy as the gold standard is somewhat disputed. The relative importance of aspiration and bedside assessments in predicting complications remains an area of interest.",7.105791820705622e-08,0.14340187580801356,0.09639999999999999,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
188,0.9,9,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Is it reliable to exclude aspiration with bedside assessment after acute stroke? Answer: Bedside swallowing assessments do not have sufficient sensitivity to be screening instruments in acute stroke, and videofluoroscopy as the gold standard is questioned. The role of aspiration and bedside assessment in predicting complications is still being examined.",7.105791820705622e-08,0.0023473032786114345,0.07640832986255724,0.005440279394345618,0.05942342047080107,0.0,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
188,0.9,10,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Can bedside swallowing assessment reliably rule out aspiration after acute stroke? Answer: Bedside swallowing assessments lack the sensitivity needed for screening in acute stroke, and there are concerns about relying on videofluoroscopy as the gold standard. The predictive relevance of aspiration and bedside assessments for complications is still being analyzed.",7.105791820705622e-08,0.0023473032786114345,0.07640832986255724,0.005440279394345618,0.05942342047080107,0.0,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
189,0.9,1,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Do aromatase inhibitor-related musculoskeletal symptoms hinge on preventing osteoporosis for their elimination? Patients on AIs developing osteoporosis face higher risk of musculoskeletal issues and bone fractures. Co-treatment with calcium and bisphosphonates lowers the chance of osteoporosis and musculoskeletal symptoms. Prior tamoxifen use before AIs decreases the likelihood of AI-induced musculoskeletal symptoms. We advise that patients using AIs...,1.1842986367842703e-07,0.04209901868411414,0.031197511816904312,0.009067132323909363,0.0639064709709638,0.016661878770468257,0.009054007704764333,0.08855339734144341,0.0,1.1842986367842703e-07,0.09015109699429802,0.0
189,0.9,2,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Is avoiding osteoporosis crucial to prevent musculoskeletal symptoms related to aromatase inhibitors? Osteoporosis in AI patients raises the risk of musculoskeletal problems and fractures. Using calcium and bisphosphonates in combination reduces osteoporosis and musculoskeletal symptoms. Those who took tamoxifen before starting AIs were less prone to AI-associated musculoskeletal symptoms. It is recommended that AI patients...,1.6580180914979784e-07,0.07938352420493455,0.030536825534029616,0.012693985253473108,0.1009477426513139,0.016661878770468257,0.012675610786670066,0.12629372532429084,0.0,1.6580180914979784e-07,0.12861737782209381,0.0
189,0.9,3,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Are musculoskeletal symptoms linked to aromatase inhibitors preventable by addressing osteoporosis? Patients on AIs who develop osteoporosis have increased musculoskeletal symptoms and fracture risk. Supplementing with calcium and bisphosphonates decreases the chance of osteoporosis and symptoms. Prior tamoxifen therapy appears to lessen AI-related musculoskeletal symptoms. We suggest patients on AIs...,2.8423167282822487e-07,0.20745859817108192,0.008306334102894365,0.02176111757738247,0.20003864529554383,0.016661878770468257,0.0217296184914344,0.22738984219566083,0.0,2.8423167282822487e-07,0.23180161405732447,0.0
189,0.9,4,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Is osteoporosis prevention key to eliminating musculoskeletal symptoms in patients taking aromatase inhibitors? Those with osteoporosis on AIs face a greater risk of musculoskeletal symptoms and fractures. Co-administration of calcium and bisphosphonates helps reduce these risks. Patients who used tamoxifen before AIs had fewer musculoskeletal symptoms associated with AIs. We recommend that individuals on AIs...,1.6580180914979784e-07,0.11474542244353536,0.02639503549592273,0.012693985253473108,0.1009477426513139,0.016661878770468257,0.012675610786670066,0.12629372532429084,0.0,1.6580180914979784e-07,0.12861737782209381,0.0
189,0.9,5,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Could preventing osteoporosis be essential to stop aromatase inhibitor-induced musculoskeletal symptoms? AI patients with osteoporosis are more likely to experience musculoskeletal symptoms and fractures. Treatment with calcium and bisphosphonates reduces the risk of these conditions. Previous tamoxifen use makes patients less susceptible to AI-related musculoskeletal issues. Our advice for patients taking AIs is to...,1.8948778188548325e-07,0.07240353941857203,0.0490487514863258,0.014507411718254981,0.119995937622007,0.016661878770468257,0.014486412327622933,0.14571181118139354,0.0,1.8948778188548325e-07,0.14842000511827358,0.0
189,0.9,6,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Is the prevention of osteoporosis the solution to aromatase inhibitor-related musculoskeletal symptoms? Osteoporotic patients on AIs are more vulnerable to musculoskeletal symptoms and bone fractures. Co-medication with calcium and bisphosphonates lowers these risks. Patients previously treated with tamoxifen experienced fewer AI-associated musculoskeletal symptoms. We recommend that AI patients...,3.316036182995957e-07,0.19254785126063512,0.0490487514863258,0.025387970506946217,0.24259825971434035,0.016661878770468257,0.025351221573340132,0.2708749541353992,0.0,3.316036182995957e-07,0.2762533766281572,0.0
189,0.9,7,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Does stopping osteoporosis prevent musculoskeletal symptoms caused by aromatase inhibitors? Patients on AIs who get osteoporosis have more musculoskeletal problems and bone fractures. Combining calcium and bisphosphonate therapy reduces osteoporosis and musculoskeletal symptom risks. Using tamoxifen before AIs reduces the chance of developing these symptoms. It is advisable that patients on AIs...,2.3685972735685406e-07,0.13805206262126735,0.029448751486325808,0.018134264647818726,0.15921665077528946,0.016661878770468257,0.018108015409528666,0.1857171457950919,0.0,2.3685972735685406e-07,0.18924199963852795,0.0
189,0.9,8,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Is tackling osteoporosis the key to eliminating AI-related musculoskeletal symptoms? Those developing osteoporosis while on AIs face heightened risk for musculoskeletal symptoms and fractures. Calcium and bisphosphonate co-treatment diminishes these risks. Those given tamoxifen before AI therapy are less prone to musculoskeletal symptoms. We encourage patients on AIs to...,3.079176455639103e-07,0.20037557458613264,0.028224849268127516,0.023574544042164344,0.221092054493377,0.016661878770468257,0.023540420032387266,0.2488960474166242,0.0,3.079176455639103e-07,0.25378052077609947,0.0
189,0.9,9,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Could preventing osteoporosis be the key to eradicating musculoskeletal symptoms associated with aromatase inhibitors? Osteoporosis in AI patients increases the risk of symptoms and fractures. Calcium and bisphosphonate co-medication decreases this risk. Patients who had tamoxifen before starting AIs experienced fewer musculoskeletal symptoms. We recommend patients on AIs...,3.316036182995957e-07,0.19254785126063512,0.0490487514863258,0.025387970506946217,0.24259825971434035,0.016661878770468257,0.025351221573340132,0.2708749541353992,0.0,3.316036182995957e-07,0.2762533766281572,0.0
189,0.9,10,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Is the key to stopping aromatase inhibitor-related musculoskeletal symptoms found in osteoporosis prevention? AI patients with osteoporosis are at higher risk of musculoskeletal symptoms and bone fractures. Ca and bisphosphonate co-medication reduces these risks. Prior tamoxifen use reduces the incidence of AI-related musculoskeletal symptoms. Our recommendation for AI patients is...,2.8423167282822487e-07,0.20745859817108192,0.008306334102894365,0.02176111757738247,0.20003864529554383,0.016661878770468257,0.0217296184914344,0.22738984219566083,0.0,2.8423167282822487e-07,0.23180161405732447,0.0
190,0.9,1,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Do higher depression rates in women result from differences in symptom reporting? Answer: Both men and women in this community sample showed comparable patterns of depressive symptoms. There was no indication that depressive symptom presentation varies by gender.,4.73719454713706e-08,0.016635935359553322,0.024983563445101917,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
190,0.9,2,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Are increased depression rates among women explained by varied symptom reporting? Answer: Men and women from this community sample reported similar depressive symptom patterns. No proof was found that depressive symptoms differ by gender.,1.421158364141118e-07,0.12786157046977786,0.024983563445101917,0.01088055878869125,0.1670540846631643,0.0,0.01086480924571722,0.17185025692666,0.0,1.4211583641411244e-07,0.17693070815907896,0.0
190,0.9,3,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Does differential symptom reporting explain why women have higher depression rates? Answer: In this community sample, men and women reported similar depressive symptom patterns. No evidence suggests symptom presentation changes by gender.",1.894877818854824e-07,0.18848619228621333,0.024983563445101917,0.014507411718255009,0.2295744416444978,0.0,0.014486412327622968,0.23638877806423153,0.0,1.8948778188548325e-07,0.24362208265775243,0.0
190,0.9,4,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Are women's higher depression rates due to differences in symptom reporting? Answer: Men and women in the community sample reported depressive symptoms in similar ways. There was no sign that symptom presentation differs by gender.,1.184298636784265e-07,0.09887403359652636,0.024983563445101917,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
190,0.9,5,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Is the greater prevalence of depression in women accounted for by differences in symptom reporting? Answer: Men and women from this community sample displayed similar depressive symptom patterns. No evidence supports gender differences in symptom presentation.,9.47438909427412e-08,0.1477195100253792,0.030379758354206057,0.0072537058591274906,0.14782199495794224,0.02854671280276816,0.007243206163811473,0.11122563511022454,0.0,9.474389094274162e-08,0.11441035117774545,0.0
190,0.9,6,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Could differential symptom reporting explain the higher depression rates in women? Answer: Both genders in this community sample reported similar depressive symptoms. No gender-based difference in symptom presentation was found.,2.36859727356853e-07,0.25302471342378485,0.024983563445101917,0.018134264647818768,0.29626581614317127,0.0,0.018108015409528715,0.3053816495511823,0.0,2.3685972735685406e-07,0.3150810466398961,0.0
190,0.9,7,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Are women's higher depression rates attributable to distinct symptom reporting patterns? Answer: Men and women in this community sample exhibited similar depressive symptoms. No indication of gender differences in symptom presentation was detected.,1.658018091497971e-07,0.15771453361945964,0.024983563445101917,0.01269398525347313,0.19782574332991798,0.0,0.012675610786670094,0.20359895524123983,0.0,1.6580180914979784e-07,0.20972053098207066,0.0
190,0.9,8,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Is the observed higher depression rate among women due to differences in how symptoms are reported? Answer: Men and women showed comparable depressive symptom patterns in this community sample. No evidence was found for gender-based differences in symptom presentation.,2.36859727356853e-08,0.02620645821577927,0.0006397052529590365,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
190,0.9,9,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Do women report depressive symptoms differently, explaining their higher rates of depression? Answer: This community sample showed men and women reporting similar depressive symptoms. No gender difference in symptom presentation was observed.",1.894877818854824e-07,0.18848619228621333,0.024983563445101917,0.014507411718255009,0.2295744416444978,0.0,0.014486412327622968,0.23638877806423153,0.0,1.8948778188548325e-07,0.24362208265775243,0.0
190,0.9,10,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Is differential symptom reporting responsible for the higher depression rates found in women? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. There was no evidence of gender differences in symptom presentation.,7.10579182070559e-08,0.04330418244171419,0.024983563445101917,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
191,0.9,1,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Question: Can an advance care planning model be effectively implemented in community palliative care? Answer: Yes, an advance care planning model can be effectively implemented in community palliative care. It promotes proactive conversations about care preferences, medical decisions, and end-of-life wishes, allowing healthcare providers to deliver patient-centered care. Furthermore, it improves the",9.474389094274162e-08,0.04350722257291828,0.023992346938775555,0.0072537058591274906,0.03998456806921036,0.029210766853411146,0.007243206163811466,0.0361188241374264,0.034396609883622836,9.474389094274162e-08,0.03187466944508888,0.03950724115137311
191,0.9,2,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Question: Is it possible to apply an advance care planning model in community palliative care? Answer: Yes, applying an advance care planning model in community palliative care is possible. This model encourages early discussions regarding care preferences, medical choices, and end-of-life wishes, helping healthcare professionals to offer care focused on the patient. Additionally, it strengthens the",1.8948778188548325e-07,0.18721749231263018,0.019809027777777807,0.014507411718254981,0.15699411297102417,0.0022958804283164658,0.014486412327622933,0.12526656095835786,0.02698944160997732,1.8948778188548325e-07,0.09192274691016511,0.05367390781803977
191,0.9,3,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Question: Does an advance care planning model work within community palliative care? Answer: Yes, an advance care planning model works well within community palliative care. It enables proactive dialogue about care preferences, medical decisions, and end-of-life wishes, supporting healthcare providers in delivering patient-centered care. In addition, it boosts the",2.3685972735685406e-08,0.054235986990596174,0.021926020408163244,0.0018134264647818726,0.05420787608919353,0.022709189879958278,0.0018108015409528666,0.05412486291865637,0.022938100860178764,2.3685972735685406e-08,0.023173004519290608,0.0005042372691962185
191,0.9,4,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Question: Is implementing an advance care planning model feasible in community palliative care? Answer: Yes, implementing an advance care planning model is feasible in community palliative care. It supports early and proactive discussions about care preferences, medical decisions, and end-of-life wishes, which allows healthcare professionals to provide patient-focused care. Moreover, it enhances the",1.1842986367842703e-07,0.09428943424721314,0.00438533057851237,0.009067132323909363,0.09077495167277538,0.008476435983872044,0.009054007704764333,0.0868765908428939,0.013068554453917677,1.1842986367842703e-07,0.08255391090680186,0.018027436312582325
191,0.9,5,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Question: Can community palliative care integrate an advance care planning model effectively? Answer: Yes, community palliative care can effectively integrate an advance care planning model. This facilitates proactive talks about care preferences, medical decisions, and end-of-life desires, enabling healthcare providers to deliver care centered on patients. Additionally, it improves the",4.737194547137081e-08,0.07839173940027022,0.02431010005408331,0.0036268529295637453,0.07771925401241653,0.024434491472509978,0.003621603081905733,0.07691348660504049,0.023857394809775757,4.737194547137081e-08,0.04582161865889667,0.0009865860091207122
191,0.9,6,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Question: Is an advance care planning model practical for use in community palliative care? Answer: Yes, an advance care planning model is practical for use in community palliative care. It promotes proactive discussions about care choices, medical decisions, and end-of-life wishes, helping healthcare professionals provide patient-focused care. Also, it enhances the",7.105791820705622e-08,0.018811791649256726,0.02695159131469363,0.005440279394345618,0.01582101971992067,0.03180976931720533,0.0054324046228586,0.012552482595575398,0.03643171708921533,7.105791820705622e-08,0.008977783703213227,0.04081807678039054
191,0.9,7,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Question: Can an advance care planning model be adopted in community palliative care settings? Answer: Yes, an advance care planning model can be adopted in community palliative care settings. It facilitates advance discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare providers to offer patient-centered care. Furthermore, it improves the",9.474389094274162e-08,0.04350722257291828,0.023992346938775555,0.0072537058591274906,0.03998456806921036,0.029210766853411146,0.007243206163811466,0.0361188241374264,0.034396609883622836,9.474389094274162e-08,0.03187466944508888,0.03950724115137311
191,0.9,8,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Question: Is the use of an advance care planning model viable in community palliative care? Answer: Yes, the use of an advance care planning model is viable in community palliative care. It encourages proactive conversations about care preferences, healthcare decisions, and end-of-life wishes, allowing clinicians to deliver patient-focused care. Moreover, it enhances the",1.1842986367842703e-07,0.04097042035798637,0.03703089569160997,0.009067132323909363,0.03641046692297634,0.04435408756731049,0.009054007704764333,0.03142481639809791,0.05144206442907738,1.1842986367842703e-07,0.025970467595785696,0.058272673250138546
191,0.9,9,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Question: Does community palliative care support the feasibility of an advance care planning model? Answer: Yes, community palliative care supports the feasibility of an advance care planning model. It fosters early discussions regarding care preferences, medical choices, and end-of-life wishes, enabling healthcare providers to provide patient-centered care. In addition, it strengthens the",9.474389094274162e-08,0.07068946494781825,0.0070582071389940215,0.0072537058591274906,0.06771045529160835,0.010689475469638762,0.007243206163811466,0.06441054579293448,0.014661123708742771,9.474389094274162e-08,0.03187466944508888,0.03950724115137311
191,0.9,10,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Question: Is an advance care planning model achievable within community palliative care? Answer: Yes, an advance care planning model is achievable within community palliative care. It enables proactive dialogue about care preferences, medical decisions, and end-of-life wishes, supporting healthcare professionals in providing patient-centered care. Additionally, it enhances the",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
192,0.9,1,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,Question: Advanced epithelial ovarian carcinoma in Thai women: Is it still advisable to perform second-look laparotomy? Answer: The use of second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women remains controversial. It can offer important insights into the disease status.,2.3685972735685406e-08,0.02891911978890782,0.002850214159737921,0.0018134264647818726,0.028872408910239677,0.002459057697152933,0.0018108015409528666,0.02878175029216612,0.001978458049886611,2.3685972735685406e-08,0.028640216301393462,0.001408415217939038
192,0.9,2,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: In cases of advanced epithelial ovarian carcinoma among Thai women, should second-look laparotomy still be recommended? Answer: The role of second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is debated. This procedure may provide useful information regarding the disease progression.",2.3685972735685406e-08,0.06112980512813815,0.02541593994733428,0.0018134264647818726,0.09569793352578015,0.05011322960040913,0.0018108015409528666,0.09729847673474756,0.051405325443786974,2.3685972735685406e-08,0.0989383475148311,0.05246913580246914
192,0.9,3,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Should second-look laparotomy continue to be used for advanced epithelial ovarian carcinoma in Thai women? Answer: There is ongoing discussion about the value of second-look laparotomy in managing advanced epithelial ovarian carcinoma in Thai women, as it can yield critical information about the cancer status.",9.474389094274162e-08,0.04650492149992225,0.030678242878150477,0.0072537058591274906,0.10791285581450483,0.008765432098765472,0.007243206163811466,0.10755828610144702,0.007013888888888903,9.474389094274162e-08,0.1070323024723705,0.004969135802469125
192,0.9,4,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: For advanced epithelial ovarian carcinoma in Thai women, is it necessary to keep offering second-look laparotomy? Answer: The necessity of second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is controversial, although it can offer significant data about the tumor condition.",2.3685972735685406e-08,0.004884212068046789,0.019290123456790056,0.0018134264647818726,0.005738239239089449,0.020833333333333343,0.0018108015409528666,0.006673600349244246,0.022376543209876573,2.3685972735685406e-08,0.0076996802636211115,0.023919753086419755
192,0.9,5,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Advanced epithelial ovarian carcinoma in Thai women: Is continuing second-look laparotomy advisable? Answer: The application of second-look laparotomy in advanced epithelial ovarian carcinoma among Thai women is a debated issue, with potential benefits in revealing disease status.",9.474389094274131e-08,0.08346352678024394,0.01307902254871958,0.0072537058591274906,0.04374743294138739,0.043402110299457494,0.007243206163811466,0.04118396717949002,0.047842176086120736,9.474389094274162e-08,0.03826277399865141,0.05246913580246914
192,0.9,6,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Should second-look laparotomy remain a treatment option for advanced epithelial ovarian carcinoma in Thai women? Answer: The use of second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is under debate, yet it can provide valuable information about the current state of the cancer.",9.474389094274162e-08,0.04650492149992225,0.030678242878150477,0.0072537058591274906,0.0764061657890549,0.013003141208269384,0.007243206163811466,0.0753188823544737,0.015655818540433936,9.474389094274162e-08,0.07402529387427581,0.01853678135729416
192,0.9,7,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: In Thai women with advanced epithelial ovarian carcinoma, should we still conduct second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is contentious, but it offers useful insights into disease status.",1.421158364141119e-07,0.14759735854428957,0.007215830988810595,0.010880558788691243,0.10543622051048596,0.04017168209876547,0.010864809245717214,0.06041605688471208,0.0763888888888889,1.4211583641411244e-07,0.09888739581508688,0.05246913580246914
192,0.9,8,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Is second-look laparotomy still recommended for advanced epithelial ovarian carcinoma in Thai women? Answer: The practice of second-look laparotomy in treating advanced epithelial ovarian carcinoma in Thai women remains disputed, though it can provide important status information.",9.474389094274131e-08,0.15839835711104788,0.03648864351691268,0.0072537058591274906,0.12076378633693707,0.010609567901234532,0.007243206163811466,0.12040078781491204,0.008572048611111105,9.474389094274162e-08,0.11980950112335131,0.00612461419753086
192,0.9,9,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: For advanced epithelial ovarian carcinoma in Thai women, do we continue to perform second-look laparotomy? Answer: Second-look laparotomy for this condition in Thai women is debated, as it may provide valuable information about disease progression.",1.421158364141119e-07,0.028772127591156327,0.09105205262933065,0.010880558788691243,0.023889493385786054,0.09876543209876547,0.010864809245717214,0.06041605688471208,0.0763888888888889,1.4211583641411244e-07,0.09888739581508688,0.05246913580246914
192,0.9,10,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Should the practice of second-look laparotomy continue for advanced epithelial ovarian carcinoma in Thai women? Answer: There is ongoing debate over second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women, but it can give important details about the cancer's status.",0.0,0.06762411517658062,0.04389604425648251,0.0,0.03465735902799727,0.023683547493071264,0.0,0.035546009259483924,0.024835600907029506,0.0,0.03648143055578723,0.025898211136306366
193,0.9,1,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Does obstructive sleep apnea impact aerobic fitness? Yes, it can lower maximum aerobic capacity by causing frequent sleep disruptions, resulting in daytime tiredness and decreased endurance for aerobic exercises. Ongoing sleep deprivation also harms cardiovascular health, further reducing aerobic fitness.",2.1317375462116855e-07,0.09211483468492254,0.08264462809917357,0.016320838183036854,0.18306581727899296,0.0212665406427221,0.0162972138685758,0.21772348384486895,0.0,2.1317375462116866e-07,0.22314355131420927,0.0
193,0.9,2,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Is aerobic fitness influenced by obstructive sleep apnea? Indeed, obstructive sleep apnea reduces aerobic capacity due to repeated sleep interruptions, which cause fatigue during the day and reduce stamina for aerobic workouts. Chronic lack of sleep also negatively impacts heart health, further compromising aerobic fitness.",9.474389094274162e-08,0.0029935369217577446,0.059929647028324456,0.0072537058591274906,0.05945186131181712,0.0212665406427221,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
193,0.9,3,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Can obstructive sleep apnea affect aerobic fitness? Yes, it diminishes maximum aerobic capacity because of frequent disturbances in sleep, leading to daytime fatigue and reduced endurance for aerobic activities. Prolonged sleep deprivation further impacts heart health, which lowers aerobic fitness.",2.1317375462116855e-07,0.09211483468492254,0.08264462809917357,0.016320838183036854,0.18306581727899296,0.0212665406427221,0.0162972138685758,0.21772348384486895,0.0,2.1317375462116866e-07,0.22314355131420927,0.0
193,0.9,4,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Does obstructive sleep apnea have an effect on aerobic fitness? Yes, due to recurrent sleep disruptions, obstructive sleep apnea lowers maximum aerobic capacity. This results in daytime tiredness and less stamina for aerobic exercise. Long-term sleep deprivation additionally impairs cardiovascular health, further decreasing aerobic fitness.",9.474389094274162e-08,0.03450022694720989,0.037293154176271076,0.0072537058591274906,0.09169126505879133,0.0019760897427654224,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
193,0.9,5,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Is there a connection between obstructive sleep apnea and aerobic fitness? Yes, the condition reduces maximum aerobic capacity by causing frequent sleep interruptions, leading to fatigue during the day and less endurance for aerobic activities. Chronic sleep loss also adversely affects heart health, further lowering aerobic fitness.",4.737194547137081e-08,0.07296491567452756,0.08264462809917357,0.0036268529295637453,0.013989487235059883,0.0212665406427221,0.003621603081905733,0.04445176257083272,0.0,4.737194547137081e-08,0.04546237407675724,0.0
193,0.9,6,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","How does obstructive sleep apnea affect aerobic fitness? It reduces the maximum aerobic capacity by interrupting sleep repeatedly, causing daytime fatigue and decreased stamina for aerobic tasks. Continuous sleep deprivation also negatively impacts heart health, which reduces aerobic fitness further.",2.1317375462116855e-07,0.09211483468492254,0.08264462809917357,0.016320838183036854,0.18306581727899296,0.0212665406427221,0.0162972138685758,0.21772348384486895,0.0,2.1317375462116866e-07,0.22314355131420927,0.0
193,0.9,7,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Does obstructive sleep apnea influence aerobic fitness? Yes, it decreases maximum aerobic capacity due to frequent disruptions in sleep, resulting in daytime tiredness and diminished endurance for aerobic activities. Chronic sleep deprivation also harms cardiovascular health, further lowering aerobic fitness levels.",1.8948778188548325e-07,0.06679702670063081,0.08264462809917357,0.014507411718254981,0.15709033087573498,0.0212665406427221,0.014486412327622933,0.19105523676270808,0.0,1.8948778188548325e-07,0.19574457712609394,0.0
193,0.9,8,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Can aerobic fitness be affected by obstructive sleep apnea? Yes, the disorder lowers maximum aerobic capacity through frequent sleep interruptions that cause daytime fatigue and reduce stamina for aerobic exercise. Prolonged sleep deprivation additionally impairs heart health, further diminishing aerobic fitness.",1.8948778188548325e-07,0.06679702670063081,0.08264462809917357,0.014507411718254981,0.15709033087573498,0.0212665406427221,0.014486412327622933,0.19105523676270808,0.0,1.8948778188548325e-07,0.19574457712609394,0.0
193,0.9,9,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Is aerobic fitness compromised by obstructive sleep apnea? Yes, it reduces the maximum aerobic capacity because of repeated sleep disturbances, which lead to daytime exhaustion and decreased endurance for aerobic workouts. Long-term sleep deprivation also negatively affects cardiovascular health, further reducing aerobic fitness.",1.4211583641411244e-07,0.018006862531199097,0.08264462809917357,0.010880558788691236,0.10707991030107156,0.0212665406427221,0.0108648092457172,0.13976194237515838,0.0,1.4211583641411244e-07,0.1431008436406751,0.0
193,0.9,10,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Does obstructive sleep apnea impact aerobic capacity? Yes, it lowers maximum aerobic fitness due to frequent sleep disruptions, causing daytime lethargy and reduced stamina for aerobic activities. Chronic lack of sleep also affects heart health, further decreasing aerobic fitness.",2.3685972735685385e-07,0.11809032108818052,0.08264462809917357,0.018134264647818726,0.20973406436115383,0.0212665406427221,0.018108015409528666,0.24512245803298427,0.0,2.3685972735685406e-07,0.2513144282809061,0.0
194,0.9,1,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is advanced age a contraindication for GERD laparoscopic surgery? No, advanced age does not contraindicate GERD laparoscopic surgery. Nonetheless, the patient's overall health, comorbidities, and surgical tolerance are crucial considerations.",3.079176455639091e-07,0.3009452529698713,0.048286524763001215,0.023574544042164393,0.2799313837642341,0.07271468144044323,0.02354042003238732,0.3237278700536126,0.049861495844875335,3.079176455639103e-07,0.369919098848678,0.025623268698060954
194,0.9,2,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Does being elderly rule out laparoscopic surgery for GERD? Advanced age alone is not a contraindication to laparoscopic GERD surgery. However, the patient's general health status, existing diseases, and capacity to tolerate surgery matter.",2.1317375462116791e-07,0.07612701382642406,0.11687363038714388,0.016320838183036875,0.1463999911397118,0.07271468144044323,0.016297213868575827,0.18557753157279544,0.049861495844875335,2.1317375462116866e-07,0.22681825520800558,0.025623268698060954
194,0.9,3,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is old age a factor against undergoing GERD laparoscopic surgery? No, age by itself is not a contraindication for GERD laparoscopic surgery. Important factors include the patient's overall health, other illnesses, and surgery endurance.",2.1317375462116791e-07,0.11813593386035981,0.08660019288714388,0.016320838183036875,0.1463999911397118,0.07271468144044323,0.016297213868575827,0.18557753157279544,0.049861495844875335,2.1317375462116866e-07,0.22681825520800558,0.025623268698060954
194,0.9,4,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is laparoscopic surgery for GERD contraindicated in elderly patients? Advanced age is not a contraindicated factor for GERD laparoscopic surgery. What is important is the patient’s health condition, presence of other medical conditions, and ability to withstand surgery.",1.1842986367842671e-07,0.0008159221859189714,0.08986745754763771,0.009067132323909363,0.028616955483327988,0.07271468144044323,0.009054007704764333,0.06421667456852864,0.049861495844875335,1.1842986367842703e-07,0.10165511225399859,0.025623268698060954
194,0.9,5,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Does advanced age prevent a patient from having GERD laparoscopic surgery? No, advanced age does not prevent one from receiving laparoscopic surgery for GERD. The critical factors are the patient's overall health, other diseases, and ability to cope with surgery.",7.105791820705611e-08,0.05538106157725631,0.09125036168908293,0.005440279394345618,0.0254502657869482,0.07271468144044323,0.0054324046228586,0.008646823413716476,0.049861495844875335,7.105791820705622e-08,0.04449669841405024,0.025623268698060954
194,0.9,6,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is being of advanced age a contraindication for GERD laparoscopic surgery? Advanced age itself is not a contraindication for laparoscopic surgery in GERD patients. Instead, the patient’s overall health, coexisting conditions, and surgical fitness are key factors.",1.42115836414112e-07,0.10464016693011846,0.034229002287970337,0.010880558788691236,0.09639624276773606,0.04416796863767507,0.010864809245717207,0.09320421144178015,0.049861495844875335,1.4211583641411244e-07,0.13150807540368037,0.025623268698060954
194,0.9,7,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is GERD laparoscopic surgery contraindicated due to old age? No, older age is not a contraindicated condition for GERD laparoscopic surgery. However, overall health status, additional diseases, and surgical tolerance are important considerations.",2.3685972735685321e-07,0.15022037127817534,0.08565614859734158,0.018134264647818754,0.17814868945429163,0.07271468144044323,0.0181080154095287,0.21836735439578714,0.049861495844875335,2.3685972735685406e-07,0.26071980688368734,0.025623268698060954
194,0.9,8,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Does advanced age exclude a patient from laparoscopic surgery for GERD? No, GERD laparoscopic surgery is not contraindicated by age alone. Important factors include the patient’s comprehensive health, other illnesses, and ability to endure surgical procedures.",1.6580180914979731e-07,0.056894924121202006,0.08832691758437572,0.012693985253473115,0.08577536932327634,0.07271468144044323,0.01267561078667008,0.12305717459146193,0.049861495844875335,1.6580180914979784e-07,0.16227973407043406,0.025623268698060954
194,0.9,9,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is elderly age a contraindication for laparoscopic GERD surgery? Age in itself is not a contraindication against GERD laparoscopic surgery. The key considerations are the patient's health condition, comorbidities, and capacity to withstand surgery.",2.1317375462116791e-07,0.11813593386035981,0.08660019288714388,0.016320838183036875,0.1463999911397118,0.07271468144044323,0.016297213868575827,0.18557753157279544,0.049861495844875335,2.1317375462116866e-07,0.22681825520800558,0.025623268698060954
194,0.9,10,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Can elderly patients undergo GERD laparoscopic surgery or is age a contraindication? Advanced age is not a contraindication for laparoscopic surgery in GERD. The determining factors are overall health, presence of other diseases, and surgical endurance.",1.6580180914979731e-07,0.056894924121202006,0.08832691758437572,0.012693985253473115,0.08577536932327634,0.07271468144044323,0.01267561078667008,0.12305717459146193,0.049861495844875335,1.6580180914979784e-07,0.16227973407043406,0.025623268698060954
195,0.9,1,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is there a link between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Both hsCRP levels and carotid intima-media thickness (IMT) were closely related to traditional cardiovascular risk factors, yet hsCRP levels showed no independent association with carotid IMT in healthy Korean adults.",0.0,0.032239403746973316,0.022669707429322852,0.0,0.03300700859809158,0.023795359904818555,0.0,0.0,0.0,0.0,0.0,0.0
195,0.9,2,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Does high-sensitivity C-reactive protein correlate with carotid atherosclerosis among healthy Koreans? While hsCRP levels and carotid IMT were strongly associated with conventional cardiovascular risk factors, no independent relationship was found between hsCRP levels and carotid IMT in healthy Korean individuals.",9.474389094274152e-08,0.11086489161395763,0.009179782366595557,0.0072537058591274906,0.1765207416262502,0.05457198703395695,0.007243206163811466,0.177588984390888,0.05387755102040818,9.474389094274162e-08,0.14386869235560074,0.02775510204081633
195,0.9,3,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is high-sensitivity C-reactive protein connected to carotid atherosclerosis in healthy Korean adults? Both hsCRP and carotid IMT displayed strong correlations with classical cardiovascular risk factors; however, hsCRP was not independently linked to carotid IMT in this population.",1.6580180914979742e-07,0.12573991564510534,0.03668138563001487,0.012693985253473108,0.14931454819586287,0.023795359904818555,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
195,0.9,4,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","In healthy Koreans, is there an association between high-sensitivity C-reactive protein and carotid atherosclerosis? Although both hsCRP levels and carotid IMT correlated strongly with established cardiovascular risk factors, no independent association existed between hsCRP and carotid IMT.",1.6580180914979742e-07,0.1402745863052317,0.022142143781749793,0.012693985253473108,0.14931454819586287,0.023795359904818555,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
195,0.9,5,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Does high-sensitivity C-reactive protein have an independent association with carotid atherosclerosis in healthy Koreans? hsCRP levels and carotid IMT correlated strongly with conventional cardiovascular risk factors, but no independent link between hsCRP and carotid IMT was observed.",1.6580180914979742e-07,0.12573991564510534,0.03668138563001488,0.012693985253473108,0.1889229585135741,0.004751352897949607,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
195,0.9,6,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is there an independent relationship between high-sensitivity C-reactive protein and carotid atherosclerosis among healthy Korean adults? While hsCRP and carotid IMT were both strongly associated with standard cardiovascular risk factors, hsCRP had no independent association with carotid IMT.",1.4211583641411212e-07,0.05879200322684275,0.06503853458981668,0.010880558788691236,0.12114367122916603,0.023795359904818555,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
195,0.9,7,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Among healthy Koreans, is high-sensitivity C-reactive protein related to carotid atherosclerosis? Both hsCRP and carotid IMT were significantly associated with traditional cardiovascular risk factors, yet hsCRP did not independently correlate with carotid IMT.",2.605457000925386e-07,0.16650659790593947,0.09204470742932284,0.019947691112600627,0.27067540520012967,0.023795359904818555,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
195,0.9,8,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is there a connection between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Korean individuals? hsCRP levels and carotid IMT were strongly linked to classic cardiovascular risk factors, but no independent association was found between hsCRP and carotid IMT.",1.1842986367842682e-07,0.08138889008465666,0.015979983928701813,0.009067132323909363,0.0937446970410507,0.023795359904818555,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
195,0.9,9,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","In healthy Korean adults, does high-sensitivity C-reactive protein associate with carotid atherosclerosis? hsCRP and carotid IMT both correlated with conventional cardiovascular risk factors; however, hsCRP independently showed no association with carotid IMT.",2.842316728282239e-07,0.2429744691598703,0.059822485207100644,0.021761117577382506,0.30346522802312137,0.023795359904818555,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
195,0.9,10,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Does an independent association exist between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Both hsCRP levels and carotid IMT were strongly correlated with conventional cardiovascular risk factors, but no independent relationship was established between hsCRP and carotid IMT.",9.474389094274152e-08,0.05318949216587532,0.013141559919106649,0.0072537058591274906,0.06707644995888984,0.023795359904818555,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
196,0.9,1,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is fondaparinux used in perioperative bridging? Yes, fondaparinux plays a role in perioperative bridging and is commonly employed as an alternative to heparin in patients at high risk.",2.131737546211677e-07,0.14648542455994074,0.0982935059017665,0.016320838183036916,0.13881788219708646,0.11238293444328822,0.016297213868575862,0.1851646090609136,0.08740894901144641,2.1317375462116866e-07,0.23443589105066254,0.06035379812695108
196,0.9,2,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Does fondaparinux have a function in perioperative bridging? Indeed, fondaparinux is utilized in perioperative bridging, frequently serving as a substitute for heparin in high-risk patients.",2.842316728282236e-07,0.2706864896659522,0.09368785272115329,0.021761117577382555,0.26142020428941937,0.11238293444328822,0.021729618491434483,0.3129979805707981,0.08740894901144641,2.8423167282822487e-07,0.36796728367518616,0.06035379812695108
196,0.9,3,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is fondaparinux applicable to perioperative bridging? Yes, fondaparinux is involved in perioperative bridging, often chosen over heparin for high-risk patients.",4.026615365066502e-07,0.44653907580079677,0.13527575442247655,0.030828249901291953,0.5065426623224041,0.11238293444328822,0.030783626196198847,0.5708270898728975,0.08740894901144641,4.0266153650665164e-07,0.6399009991588267,0.06035379812695108
196,0.9,4,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Can fondaparinux be used for perioperative bridging? Yes, fondaparinux serves a role in perioperative bridging and is often used as an alternative to heparin in patients with elevated risk.",1.894877818854824e-07,0.058773544792032784,0.13527575442247655,0.014507411718255037,0.10107755421423947,0.11238293444328822,0.014486412327622988,0.14594389590763113,0.08740894901144641,1.8948778188548325e-07,0.19361389653040773,0.06035379812695108
196,0.9,5,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is there an indication for fondaparinux in perioperative bridging? Yes, fondaparinux is indicated for perioperative bridging, commonly as an alternative to heparin in patients who are at high risk.",1.894877818854824e-07,0.058773544792032784,0.13527575442247655,0.014507411718255037,0.10107755421423947,0.11238293444328822,0.014486412327622988,0.14594389590763113,0.08740894901144641,1.8948778188548325e-07,0.19361389653040773,0.06035379812695108
196,0.9,6,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Does fondaparinux have a part in perioperative bridging? Yes, fondaparinux is involved in perioperative bridging and frequently replaces heparin for high-risk patients.",3.552895910352795e-07,0.4124696344400003,0.08777575442247654,0.027201396971728194,0.40118214666457863,0.11238293444328822,0.027162023114293103,0.45960145476267344,0.08740894901144641,3.5528959103528093e-07,0.5221179635024429,0.06035379812695108
196,0.9,7,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is fondaparinux relevant in perioperative bridging? Yes, fondaparinux holds a role in perioperative bridging and is often employed instead of heparin for patients with significant risk.",2.605457000925383e-07,0.227554004543832,0.095345198866921,0.019947691112600675,0.21886058987062373,0.11238293444328822,0.01991881695048161,0.26854621799996403,0.08740894901144641,2.6054570009253947e-07,0.3214472680402922,0.06035379812695108
196,0.9,8,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is fondaparinux used for perioperative bridging? Yes, fondaparinux has a role in perioperative bridging and is often an alternative to heparin in patients with high-risk profiles.",2.605457000925383e-07,0.1721022300990369,0.13527575442247655,0.019947691112600675,0.21886058987062373,0.11238293444328822,0.01991881695048161,0.26854621799996403,0.08740894901144641,2.6054570009253947e-07,0.3214472680402922,0.06035379812695108
196,0.9,9,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is fondaparinux applicable in the context of perioperative bridging? Yes, it is used in perioperative bridging, often substituting for heparin in high-risk patients.",3.316036182995942e-07,0.2999356016089214,0.13527575442247655,0.025387970506946314,0.35239198249514736,0.11238293444328822,0.02535122157334023,0.4083081603751233,0.08740894901144641,3.316036182995956e-07,0.4680507422321676,0.06035379812695108
196,0.9,10,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is there a place for fondaparinux in perioperative bridging? Yes, fondaparinux is utilized in perioperative bridging, typically as an alternative to heparin for patients with a high risk.",2.131737546211677e-07,0.14648542455994074,0.0982935059017665,0.016320838183036916,0.13881788219708646,0.11238293444328822,0.016297213868575862,0.1851646090609136,0.08740894901144641,2.1317375462116866e-07,0.23443589105066254,0.06035379812695108
197,0.9,1,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Are environmental influences crucial in primary systemic vasculitis? Yes, environmental factors significantly contribute to primary systemic vasculitis. Contact with specific infections, drugs, or toxic substances can provoke an abnormal immune reaction.",9.47438909427412e-08,0.049052864304288235,0.0541152510328495,0.007253705859127518,0.08720281144607123,0.0302734375,0.007243206163811494,0.1335313926245223,0.0,9.474389094274162e-08,0.13815033848081715,0.0
197,0.9,2,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Do environmental conditions matter in primary systemic vasculitis? Indeed, environmental elements have a major impact on primary systemic vasculitis. Exposure to some infections, medications, or harmful agents may initiate an abnormal immune response.",4.73719454713706e-08,0.01837377008561525,0.05619146722164411,0.003626852929563759,0.020511436947397765,0.0302734375,0.003621603081905747,0.06453852113757153,0.0,4.737194547137081e-08,0.06669137449867346,0.0
197,0.9,3,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Is the environment important in primary systemic vasculitis? Yes, environmental factors are key in primary systemic vasculitis. Being exposed to certain infections, medications, or hazardous materials can trigger an unusual immune response.",7.10579182070559e-08,0.059491575322669465,0.0231996743384381,0.005440279394345639,0.09951107180771901,0.003020260478596916,0.005432404622858621,0.09844007281325329,0.0,7.105791820705622e-08,0.10178269430994247,0.0
197,0.9,4,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Are environmental factors relevant to primary systemic vasculitis? Absolutely, environmental influences play a vital role in primary systemic vasculitis. Exposure to specific infections, drugs, or dangerous substances can cause an abnormal immune reaction.",4.73719454713706e-08,0.01837377008561525,0.05619146722164411,0.003626852929563759,0.020511436947397765,0.0302734375,0.003621603081905747,0.06453852113757153,0.0,4.737194547137081e-08,0.06669137449867346,0.0
197,0.9,5,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Does primary systemic vasculitis depend on environmental factors? Yes, environmental elements are important in primary systemic vasculitis. Contact with certain infections, medications, or harmful materials can induce an abnormal immune response.",9.47438909427412e-08,0.049052864304288235,0.0541152510328495,0.007253705859127518,0.08720281144607123,0.0302734375,0.007243206163811494,0.1335313926245223,0.0,9.474389094274162e-08,0.13815033848081715,0.0
197,0.9,6,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Are external environmental factors significant in primary systemic vasculitis? Yes, they are. Exposure to infections, drugs, or hazardous substances can trigger an abnormal immune response in primary systemic vasculitis.",1.421158364141118e-07,0.1708569495481882,0.016403031851683084,0.010880558788691277,0.21000601102524818,0.006708811020710047,0.010864809245717241,0.20763936477824396,0.0,1.4211583641411244e-07,0.2151113796169466,0.0
197,0.9,7,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Is there an environmental impact on primary systemic vasculitis? Yes, environmental factors contribute significantly. Exposure to certain infections, medications, or toxic agents can provoke an abnormal immune response.",1.658018091497971e-07,0.10820356792478414,0.08740894901144641,0.012693985253473157,0.1964021034110619,0.0302734375,0.012675610786670115,0.24686007793152642,0.0,1.6580180914979784e-07,0.2559333741372014,0.0
197,0.9,8,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Do environmental exposures influence primary systemic vasculitis? Yes, they do. Contact with specific infections, medications, or harmful materials can cause an abnormal immune reaction.",2.605457000925383e-07,0.26854621799996403,0.08740894901144641,0.019947691112600675,0.36345618807422886,0.0302734375,0.01991881695048161,0.42121346507630486,0.0,2.605457000925394e-07,0.4382549309311563,0.0
197,0.9,9,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","How important are environmental factors in primary systemic vasculitis? They are quite important, as exposure to infections, drugs, or hazardous substances can trigger an abnormal immune response.",1.894877818854824e-07,0.14594389590763113,0.08740894901144641,0.014507411718255037,0.23562281656434436,0.0302734375,0.014486412327622988,0.28768207245178123,0.0,1.8948778188548325e-07,0.29849298855599704,0.0
197,0.9,10,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Can environmental factors affect primary systemic vasculitis? Yes, they have a significant effect. Exposure to certain infections, medications, or toxic substances can provoke an abnormal immune response.",1.894877818854824e-07,0.14594389590763113,0.08740894901144641,0.014507411718255037,0.23562281656434436,0.0302734375,0.014486412327622988,0.28768207245178123,0.0,1.8948778188548325e-07,0.29849298855599704,0.0
198,0.9,1,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,"Does menopausal transition impact quality of life? This longitudinal research showed no significant influence of menopausal transition on quality of life in Taiwanese women. However, the decrease in role limitations caused by emotional issues was linked to vasomotor symptoms.",7.1057918207056e-08,0.0813246529129148,0.003816933304112799,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
198,0.9,2,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,"Is the quality of life affected by menopausal transition? According to this longitudinal study, menopausal transition did not significantly alter the quality of life in Taiwanese women. The reduction in role limitations due to emotional problems was associated with vasomotor symptoms.",2.3685972735685406e-08,0.061040574497782885,0.025854736873447894,0.0018134264647818726,0.09640982650326002,0.05113221329437545,0.0018108015409528666,0.06245691695904432,0.026296566837107373,2.3685972735685406e-08,0.026668247082160867,0.0
198,0.9,3,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does the menopausal transition influence quality of life? Findings from this longitudinal study indicate no notable effect on quality of life among Taiwanese women during menopausal transition. Emotional problem-related role limitations decreased in connection with vasomotor symptoms.,1.1842986367842661e-07,0.1009371897693927,0.02089710045754001,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
198,0.9,4,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,How does menopausal transition affect quality of life? This longitudinal study found no meaningful impact of menopausal transition on Taiwanese women’s quality of life. A decline in role limitations caused by emotional problems was tied to vasomotor symptoms.,9.474389094274131e-08,0.10996486921430826,0.005225348522051837,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
198,0.9,5,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Is the quality of life compromised by menopausal transition? The longitudinal study revealed no significant changes in quality of life among Taiwanese women undergoing menopausal transition. The fall in role limitations due to emotional problems corresponded with vasomotor symptoms.,7.1057918207056e-08,0.0813246529129148,0.003816933304112799,0.005440279394345618,0.11542895663511299,0.027006172839506164,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
198,0.9,6,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does menopausal transition reduce quality of life? This longitudinal study demonstrated no significant effect on quality of life for Taiwanese women during menopausal transition. The decline in role limitations linked to emotional problems was related to vasomotor symptoms.,9.474389094274131e-08,0.07249745404890495,0.021646029658850176,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
198,0.9,7,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does menopausal transition have an impact on quality of life? The study’s longitudinal data revealed no significant effect on Taiwanese women’s quality of life during menopausal transition. The reduction in role limitations stemming from emotional problems was connected to vasomotor symptoms.,2.3685972735685406e-08,0.008274143558211655,0.02366863905325442,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
198,0.9,8,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,What is the effect of menopausal transition on quality of life? This longitudinal research found no significant impact on the quality of life of Taiwanese women. The decrease in role limitations caused by emotional problems was associated with vasomotor symptoms.,4.7371945471370706e-08,0.017932314657567616,0.023028933800295387,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
198,0.9,9,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,How does the menopausal transition influence the quality of life? The longitudinal study indicated no significant effect on quality of life in Taiwanese women during menopausal transition. A decline in role limitations due to emotional issues was linked to vasomotor symptoms.,2.3685972735685406e-08,0.008274143558211655,0.02366863905325442,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
198,0.9,10,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,"Does transitioning through menopause affect quality of life? This longitudinal study found no major effect of menopausal transition on the quality of life of Taiwanese women, although a decline in role limitations related to emotional problems was tied to vasomotor symptoms.",2.3685972735685406e-08,0.008274143558211655,0.02366863905325442,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
199,0.9,1,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity an independent risk factor for negative perinatal outcomes? Yes, grandmultiparity is recognized as an independent risk factor for adverse perinatal outcomes and may cause complications like postpartum hemorrhage, gestational diabetes, preeclampsia, and increased cesarean rates.",1.1842986367842661e-07,0.08121348950955731,0.03266581632653065,0.009067132323909363,0.07906982843767052,0.03748804209183673,0.00905400770476434,0.07656381160024628,0.0426307397959184,1.1842986367842703e-07,0.0736432266264817,0.048093909438775506
199,0.9,2,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Does grandmultiparity independently increase the risk of adverse perinatal outcomes? Indeed, grandmultiparity is regarded as an independent risk factor for complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and a higher likelihood of cesarean delivery.",1.658018091497972e-07,0.015660803441593707,0.14204081632653065,0.012693985253473122,0.01908509750747056,0.12244897959183673,0.012675610786670087,0.05564170629198184,0.1012244897959184,1.6580180914979784e-07,0.09415466357387947,0.0783673469387755
199,0.9,3,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Can grandmultiparity be considered an independent risk factor for poor perinatal outcomes? Yes, it is seen as an independent risk factor that may lead to issues including postpartum hemorrhage, gestational diabetes, preeclampsia, and elevated cesarean section rates.",1.1842986367842661e-07,0.04270531281178247,0.05939618822735711,0.009067132323909363,0.03946141811995929,0.06551601356796163,0.00905400770476434,0.035790448037896105,0.07183973313843446,1.1842986367842703e-07,0.03163430659254596,0.0783673469387755
199,0.9,4,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity a standalone risk factor for negative perinatal results? Yes, grandmultiparity independently raises the risk for adverse outcomes including postpartum hemorrhage, gestational diabetes, preeclampsia, and more frequent cesarean sections.",2.842316728282237e-07,0.14340389118809505,0.14204081632653065,0.02176111757738252,0.18338814879874654,0.12244897959183673,0.021729618491434455,0.22554074308737881,0.1012244897959184,2.8423167282822487e-07,0.2700453300375436,0.0783673469387755
199,0.9,5,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Does being a grandmultipara independently increase the risk of adverse perinatal outcomes? Yes, grandmultiparity is identified as an independent risk factor associated with complications like postpartum hemorrhage, gestational diabetes, preeclampsia, and increased cesarean deliveries.",1.894877818854825e-07,0.01419215970808807,0.14204081632653065,0.014507411718255002,0.04985675617422425,0.12244897959183673,0.01448641232762296,0.08739040460656167,0.1012244897959184,1.8948778188548325e-07,0.12694448639687117,0.0783673469387755
199,0.9,6,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity independently linked to higher risks of adverse perinatal events? Yes, it serves as an independent risk factor that can cause difficulties such as postpartum hemorrhage, gestational diabetes, preeclampsia, and a rise in cesarean rates.",1.421158364141119e-07,0.044648340314845214,0.14204081632653065,0.010880558788691243,0.010767865642211216,0.12244897959183673,0.010864809245717214,0.024870047625228153,0.1012244897959184,1.4211583641411244e-07,0.062405965259299645,0.0783673469387755
199,0.9,7,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity an autonomous risk factor for unfavorable perinatal outcomes? Yes, it is considered an independent risk factor that may result in complications including postpartum hemorrhage, gestational diabetes, preeclampsia, and greater cesarean frequency.",2.131737546211678e-07,0.08828551715983934,0.11082333453672835,0.01632083818303688,0.08160545448880407,0.12244897959183673,0.016297213868575834,0.12018022742955337,0.1012244897959184,2.1317375462116866e-07,0.16084603807255293,0.0783673469387755
199,0.9,8,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Can grandmultiparity alone elevate the risk of adverse perinatal outcomes? Yes, grandmultiparity is deemed an independent risk factor potentially causing postpartum hemorrhage, gestational diabetes, preeclampsia, and increased cesarean section occurrences.",2.842316728282237e-07,0.14340389118809505,0.14204081632653065,0.02176111757738252,0.18338814879874654,0.12244897959183673,0.021729618491434455,0.22554074308737881,0.1012244897959184,2.8423167282822487e-07,0.2700453300375436,0.0783673469387755
199,0.9,9,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity independently associated with increased risk for negative perinatal outcomes? Yes, it is viewed as an independent risk factor that can lead to problems like postpartum hemorrhage, gestational diabetes, preeclampsia, and higher cesarean rates.",1.658018091497972e-07,0.015660803441593707,0.14204081632653065,0.012693985253473122,0.01908509750747056,0.12244897959183673,0.012675610786670087,0.05564170629198184,0.1012244897959184,1.6580180914979784e-07,0.09415466357387947,0.0783673469387755
199,0.9,10,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity considered an independent factor increasing the risk of adverse perinatal outcomes? Yes, grandmultiparity independently raises the risk for complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and greater cesarean delivery frequency.",2.131737546211678e-07,0.08828551715983934,0.11082333453672835,0.01632083818303688,0.08160545448880407,0.12244897959183673,0.016297213868575834,0.12018022742955337,0.1012244897959184,2.1317375462116866e-07,0.16084603807255293,0.0783673469387755
200,0.9,1,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Is the estimation of basal metabolic rate in Chinese populations accurate using current prediction equations? Answer: Currently, the Singapore equation is the most precise for predicting BMR in Chinese individuals and suits a wide BMI range, including overweight and obese persons.",9.474389094274162e-08,0.1607145382425914,0.04865220249835634,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
200,0.9,2,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Are existing equations effective for estimating basal metabolic rate in Chinese people? Answer: The Singapore equation recently developed is the most accurate for Chinese BMR prediction and works well across a broad BMI spectrum, including overweight and obese groups.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
200,0.9,3,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Can current basal metabolic rate prediction formulas be applied to the Chinese population? Answer: The newly formulated Singapore equation stands as the most reliable BMR predictor for Chinese individuals, valid for a diverse BMI range that includes overweight and obese categories.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
200,0.9,4,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: How well do current basal metabolic rate estimation equations work for Chinese individuals? Answer: The most accurate BMR equation for the Chinese population is the newly created Singapore equation, which is applicable over a large BMI range encompassing overweight and obesity.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
200,0.9,5,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Are the current prediction models suitable for estimating basal metabolic rate in Chinese people? Answer: To date, the Singapore equation is the most precise BMR prediction tool for Chinese subjects, effective for a wide BMI range including those who are overweight or obese.",4.737194547137081e-08,0.04546237407675724,0.0,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
200,0.9,6,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Is the estimation of basal metabolic rate in Chinese populations reliable with existing equations? Answer: The newly developed Singapore equation is currently the most accurate for predicting BMR in Chinese and is applicable across a broad BMI range, including overweight and obese individuals.",4.737194547137081e-08,0.07770177782373144,0.023242630385487524,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
200,0.9,7,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Do the current BMR prediction equations accurately estimate basal metabolic rate in Chinese? Answer: The Singapore equation, recently developed, is the best predictor of BMR in Chinese individuals and valid for a broad BMI range including overweight and obese populations.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
200,0.9,8,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Are current basal metabolic rate estimation equations valid for Chinese populations? Answer: At present, the Singapore equation offers the most accurate BMR prediction for Chinese individuals, suitable for a large BMI range, including overweight and obese persons.",1.8948778188548293e-07,0.23321199229149636,0.027006172839506164,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
200,0.9,9,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.",Question: How effective are current basal metabolic rate prediction equations for Chinese individuals? Answer: The newly introduced Singapore equation is the most accurate in estimating BMR for Chinese people and is applicable to a wide BMI range covering overweight and obese individuals.,9.474389094274162e-08,0.12690248065430154,0.024375,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
200,0.9,10,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Can the current basal metabolic rate estimation equations be applied to the Chinese population? Answer: The Singapore equation, developed recently, is the most precise BMR predictor for Chinese and applies across a large BMI spectrum including overweight and obese groups.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
201,0.9,1,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it essential to regularly place a nasobiliary drainage tube after endoscopic removal of common bile duct stones in patients with cholangitis caused by choledocholithiasis? Routine insertion of an ENBD tube did not enhance clinical outcomes and caused longer procedure times and more discomfort, making it unnecessary.",1.4211583641411244e-07,0.12260232209233335,0.0,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
201,0.9,2,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Should a nasobiliary drainage tube be routinely inserted following endoscopic clearance of the common bile duct in choledocholithiasis-induced cholangitis patients? Routine ENBD tube placement failed to improve patient recovery and led to longer procedures and greater discomfort, thus it is not required.",2.6054570009253947e-07,0.23767165187712003,0.0,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
201,0.9,3,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is routine nasobiliary drainage tube placement needed after endoscopic removal of common bile duct stones in patients with cholangitis due to choledocholithiasis? The standard insertion of an ENBD tube did not better the clinical progression but increased procedure duration and patient discomfort, so it is unnecessary.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
201,0.9,4,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","After endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis, is it necessary to routinely insert a nasobiliary drainage tube? Routine ENBD tube insertion did not improve clinical outcomes, despite adding procedure time and discomfort, thus it is not needed.",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
201,0.9,5,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is the routine use of a nasobiliary drainage tube required after endoscopic clearance of the common bile duct in cholangitis caused by choledocholithiasis? Placing an ENBD tube routinely did not benefit the clinical course and caused longer procedures and more discomfort, so it is unnecessary.",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
201,0.9,6,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Does routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct improve outcomes in choledocholithiasis-induced cholangitis patients? Routine ENBD tube placement did not improve clinical progress and resulted in longer procedure times and discomfort; hence, it is not necessary.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
201,0.9,7,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is routine nasobiliary drainage tube placement advised after endoscopic removal of common bile duct stones in patients with choledocholithiasis-related cholangitis? The routine insertion of an ENBD tube did not enhance clinical outcomes and caused increased procedural time and discomfort, so it is unnecessary.",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
201,0.9,8,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Should a nasobiliary drainage tube be routinely placed after endoscopic clearance of common bile duct stones in cholangitis caused by choledocholithiasis? Regular ENBD tube insertion did not improve the clinical course and led to longer procedure times plus discomfort, therefore it is not necessary.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
201,0.9,9,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it necessary to insert an ENBD tube routinely after endoscopic removal of common bile duct stones in patients with cholangitis caused by choledocholithiasis? Routine placement of a nasobiliary drainage tube failed to improve clinical outcomes and increased procedure time and patient discomfort, making it unnecessary.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
201,0.9,10,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is routine nasobiliary drainage tube insertion required after endoscopic common bile duct stone clearance in choledocholithiasis-induced cholangitis? A routinely placed ENBD tube did not improve clinical recovery and caused longer procedures and more discomfort, so it is deemed unnecessary.",3.316036182995955e-07,0.31365755885504143,0.0,0.025387970506946217,0.3209077200800996,0.0,0.025351221573340132,0.32850406697203516,0.0,3.316036182995957e-07,0.3364722366212134,0.0
202,0.9,1,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Are Pap smears showing glandular cell abnormalities identified through rapid prescreening? Pap smears with glandular cell abnormalities are frequently identified as abnormal by rapid prescreening (RPS), achieving a sensitivity rate of 36.4% at the atypical glandular cells (AGC) threshold. Notably, several AGC cases are detected during this process.",0.0,0.02949562470467848,0.020836871840485605,0.0,0.060273667874777725,0.04317155085498335,0.0,0.061613082716439393,0.04434829637641968,0.0,0.03150669002545259,0.02271498107084911
202,0.9,2,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Does rapid prescreening detect glandular cell abnormalities in Pap smears? Pap smears exhibiting glandular cell abnormalities are often flagged as abnormal by rapid prescreening, with a sensitivity of 36.4% at the AGC threshold. Importantly, some AGC cases are detected using this method.",1.4211583641411244e-07,0.08621715136361585,0.035717727193368916,0.010880558788691236,0.08400879959098839,0.03991638247160983,0.0108648092457172,0.08148776092423571,0.04434829637641968,1.4211583641411244e-07,0.11509678416642277,0.02271498107084911
202,0.9,3,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Can rapid prescreening identify Pap smears with glandular cell abnormalities? Pap smears that have glandular cell abnormalities are commonly detected as abnormal through rapid prescreening, showing a sensitivity of 36.4% at the AGC cutoff. Crucially, a portion of AGC cases are picked up by this screening.",4.737194547137081e-08,0.012884304162536164,0.040021633315305574,0.0036268529295637453,0.045958739241333646,0.06489994591671175,0.003621603081905733,0.016150708639682154,0.04434829637641968,4.737194547137081e-08,0.015013325609441353,0.02271498107084911
202,0.9,4,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Are glandular cell abnormalities in Pap smears detected by rapid prescreening? Rapid prescreening frequently flags Pap smears with glandular abnormalities as abnormal, yielding a sensitivity of 36.4% at the AGC threshold. Significantly, some AGC cases are identified via this method.",1.8948778188548314e-07,0.10414946602118347,0.0587466609936643,0.014507411718254981,0.10064473495054171,0.06489994591671175,0.014486412327622933,0.13413149440965455,0.04434829637641968,1.8948778188548325e-07,0.16916400543669896,0.02271498107084911
202,0.9,5,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Is rapid prescreening effective in detecting glandular cell abnormalities in Pap smears? Pap smears with glandular cell abnormalities are often detected as abnormal in rapid prescreening, with a sensitivity of 36.4% at the AGC threshold. Importantly, certain AGC cases are successfully identified.",1.4211583641411244e-07,0.08621715136361585,0.035717727193368916,0.010880558788691236,0.08400879959098839,0.03991638247160983,0.0108648092457172,0.08148776092423571,0.04434829637641968,1.4211583641411244e-07,0.11509678416642277,0.02271498107084911
202,0.9,6,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Do Pap smears with glandular cell abnormalities get detected by rapid prescreening? Rapid prescreening flags many Pap smears with glandular cell abnormalities as abnormal, achieving a sensitivity rate of 36.4% at the AGC threshold. Notably, some AGC cases are detected during this screening.",1.1842986367842703e-07,0.15953052759843978,0.03250370069541862,0.009067132323909363,0.15990705832577978,0.031520799152681994,0.009054007704764333,0.1601420300239349,0.030158642995384552,1.1842986367842703e-07,0.1602133162821331,0.02841723222352634
202,0.9,7,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","How well does rapid prescreening detect glandular cell abnormalities in Pap smears? Pap smears showing glandular cell abnormalities are often marked abnormal by rapid prescreening, demonstrating a sensitivity of 36.4% at the AGC threshold. Crucially, some AGC cases are detected by this approach.",1.1842986367842703e-07,0.06050950180416015,0.03686992969172524,0.009067132323909363,0.05847088556091018,0.04052494591671175,0.009054007704764333,0.05616995293994398,0.04434829637641968,1.1842986367842703e-07,0.0891212977631648,0.02271498107084911
202,0.9,8,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Are glandular cell abnormalities in Pap smears found through rapid prescreening? Rapid prescreening commonly identifies Pap smears with glandular cell abnormalities as abnormal, with a sensitivity of 36.4% at the AGC threshold. Importantly, a number of AGC cases are detected through this process.",1.1842986367842703e-07,0.09351651040225484,0.013364012531961955,0.009067132323909363,0.05847088556091018,0.04052494591671175,0.009054007704764333,0.05616995293994398,0.04434829637641968,1.1842986367842703e-07,0.0891212977631648,0.02271498107084911
202,0.9,9,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Does rapid prescreening identify glandular cell abnormalities in Pap smears? Pap smears with these abnormalities are often flagged as abnormal via rapid prescreening, yielding a sensitivity of 36.4% at the AGC cutoff. Notably, some AGC cases are detected.",2.3685972735685374e-07,0.12124719024711839,0.08436992969172526,0.018134264647818726,0.1547119562208179,0.06489994591671175,0.018108015409528666,0.18970134556446672,0.04434829637641968,2.3685972735685406e-07,0.2263224192766473,0.02271498107084911
202,0.9,10,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Are Pap smears with glandular cell abnormalities detected by rapid prescreening? Rapid prescreening often flags these Pap smears as abnormal, resulting in 36.4% sensitivity at the AGC threshold. Importantly, some cases of AGC are indeed detected.",2.8423167282822434e-07,0.21642545171964178,0.0558232168889571,0.02176111757738248,0.21187037006076626,0.06489994591671175,0.021729618491434413,0.2485418455874,0.04434829637641968,2.8423167282822487e-07,0.2869470410930828,0.02271498107084911
203,0.9,1,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Does treating migraines early help reduce the time to peak headache and lessen its intensity? Yes, early migraine treatment can shorten the duration to peak headache and decrease its severity by enabling medication to act more efficiently before symptoms worsen.",3.316036182995956e-07,0.2302728135435843,0.052628124343625265,0.025387970506946217,0.2533228852435485,0.042596504758870855,0.025351221573340132,0.276828408120803,0.03158757716049383,3.316036182995957e-07,0.2730522925272396,0.039930555555555566
203,0.9,2,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Can early migraine treatment shorten the time until headache peak and lower its severity? Yes, addressing migraines early can both reduce the time to headache peak and mitigate the severity, as medication works better if given before symptoms intensify.",3.552895910352809e-07,0.25905456383575043,0.050649666293738654,0.02720139697172809,0.24449568637953867,0.06805946772183383,0.027162023114293,0.2667599671435159,0.05859375,3.552895910352811e-07,0.30122316949393646,0.039930555555555566
203,0.9,3,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Is it true that early migraine treatment decreases the time to headache peak and diminishes its severity? Yes, early intervention in migraines shortens the time to headache peak and reduces severity by allowing medications to control symptoms sooner.",3.789755637709662e-07,0.36361559507756436,0.0028189242674858395,0.029014823436509962,0.38845995219335094,0.014309359438660005,0.028972824655245866,0.41375607506334644,0.0263671875,3.789755637709665e-07,0.41175743349188787,0.018663194444444434
203,0.9,4,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Does timely treatment of migraines reduce the duration to peak headache and alleviate its severity? Yes, initiating treatment early can both shorten the time to peak headache and lessen symptom severity through more effective medication action.",4.263475092423368e-07,0.3506736013584968,0.04405607573251416,0.032641676366073714,0.3731323863668998,0.036471890561339995,0.03259442773715161,0.3957802641670818,0.0283203125,4.263475092423373e-07,0.39083532818362343,0.039930555555555566
203,0.9,5,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Can early intervention in migraines speed up the time to headache peak and ease its severity? Yes, treating migraines early helps minimize time to headache peak and severity by enabling drugs to manage symptoms prior to worsening.",4.026615365066515e-07,0.35771020022976563,0.01964201323251416,0.030828249901291835,0.3814233533220821,0.010104703061339995,0.03078362619619874,0.40546510810816416,0.0,4.026615365066519e-07,0.4020725895508055,0.009657118055555566
203,0.9,6,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Will early migraine treatment reduce time to headache peak and its severity? Yes, early treatment can shorten the time to headache peak and reduce symptom severity because medications have greater effect before symptoms become severe.",4.500334819780221e-07,0.4239293615280131,0.013461457676958569,0.034455102830855594,0.44746538249368983,0.005065640561339957,0.034405229278104486,0.471186400369894,0.0036284722222222274,4.500334819780227e-07,0.4673031994375543,0.007708333333333366
203,0.9,7,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Does starting migraine treatment early shorten time until headache peak and reduce severity? Yes, early medication can decrease the time to headache peak and lessen severity since symptoms are controlled before escalating.",5.21091400185078e-07,0.4426475732883324,0.06480773855950585,0.03989538222520123,0.46295861423353646,0.06177194258274308,0.03983763390096311,0.482983075613153,0.05859375,5.210914001850789e-07,0.5243667208081457,0.039930555555555566
203,0.9,8,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Does early treatment for migraines lead to a shorter time to peak headache and milder symptoms? Yes, treating migraines promptly cuts down time to headache peak and reduces severity by allowing drugs to act before symptoms intensify.",4.026615365066515e-07,0.2421856701364411,0.10126191119169783,0.030828249901291835,0.2625981223689484,0.09506564056134,0.03078362619619874,0.32391838098346426,0.05859375,4.026615365066519e-07,0.36006366951686974,0.039930555555555566
203,0.9,9,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Is early migraine treatment effective in shortening time to headache peak and lowering severity? Yes, it can reduce both the time to headache peak and severity by making medication work more efficiently when given early.",4.500334819780221e-07,0.4239293615280131,0.013461457676958569,0.034455102830855594,0.44746538249368983,0.005065640561339957,0.034405229278104486,0.471186400369894,0.0036284722222222274,4.500334819780227e-07,0.4673031994375543,0.007708333333333366
203,0.9,10,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Does prompt migraine treatment cut down time to headache peak and ease symptom severity? Yes, early treatment helps shorten time to peak and reduces severity by intervening before symptoms grow severe.",5.447773729207633e-07,0.4784186743072807,0.06269048262026929,0.04170880868998311,0.4506503538718887,0.09506564056134,0.04164843544191598,0.518074395424422,0.05859375,5.447773729207643e-07,0.5607343649790204,0.039930555555555566
204,0.9,1,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Question: Does using oversized cups in cup-cage reconstruction offer initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, employing cup-cage reconstruction with oversized cups can deliver initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This technique helps minimize implant migration risk and encourages bone ingrowth for durable fixation.",4.737194547137081e-08,0.0338487413393902,0.04715105601469234,0.0036268529295637453,0.06528455406960143,0.07349099453896243,0.003621603081905733,0.04154139251100064,0.05859375,4.737194547137081e-08,0.013096107297856374,0.019991670137442734
204,0.9,2,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Question: Can cup-cage reconstruction with oversized cups ensure primary stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction utilizing oversized cups provides initial stability during Total Hip Arthroplasty (THA) in cases of osteoporotic acetabular fractures. This approach reduces the chance of implant migration while facilitating bone integration for long-term fixation.",4.737194547137081e-08,0.11539546846409054,0.1041128615702479,0.0036268529295637453,0.12073632851439697,0.113421550094518,0.003621603081905733,0.04154139251100064,0.05859375,4.737194547137081e-08,0.013096107297856374,0.019991670137442734
204,0.9,3,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Question: Is initial stability achievable with cup-cage reconstruction using oversized cups in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can achieve initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method lowers implant migration risks and supports bone growth to ensure lasting fixation.",7.105791820705622e-08,0.038510132180620715,0.06394117947148245,0.005440279394345618,0.07224189954137028,0.09302224453896245,0.0054324046228586,0.020922105308264882,0.05859375,7.105791820705622e-08,0.034149516495689536,0.019991670137442734
204,0.9,4,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Question: Does the utilization of oversized cups in cup-cage reconstruction contribute to initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, utilizing oversized cups in cup-cage reconstruction provides initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures by helping to reduce implant migration and encouraging bone ingrowth for stable fixation over time.",2.3685972735685406e-08,0.04872366704060749,0.019039314783858424,0.0018134264647818726,0.048222749740269855,0.02010557787229579,0.0018108015409528666,0.047645799092574936,0.02019374999999999,2.3685972735685406e-08,0.020346272143678235,0.00039167013744274143
204,0.9,5,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Question: Can the cup-cage method with oversized cups enhance initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, the cup-cage method that incorporates oversized cups enhances initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures by decreasing implant migration risk and promoting bone ingrowth for long-lasting fixation.",9.474389094274162e-08,0.04110519061346496,0.02381772268135901,0.0072537058591274906,0.006729063575850347,0.05119932787229578,0.007243206163811466,0.00013130388956827943,0.05859375,9.474389094274162e-08,0.055655721716652895,0.019991670137442734
204,0.9,6,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Question: Is cup-cage reconstruction combined with oversized cups effective for initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups is effective for providing initial stability in Total Hip Arthroplasty (THA) in patients with osteoporotic acetabular fractures by reducing the risk of implant migration and supporting bone integration to maintain fixation.",4.737194547137081e-08,0.09601228395440309,0.038140639348025696,0.0036268529295637453,0.14635313405349315,0.07643930157380795,0.003621603081905733,0.12001300795249481,0.05859375,4.737194547137081e-08,0.06694660037568045,0.019991670137442734
204,0.9,7,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Question: Does cup-cage reconstruction using oversized cups offer primary stability in THA for patients with osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction employing oversized cups offers primary stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures, assisting in reducing implant migration and facilitating bone ingrowth for stable, long-term fixation.",9.474389094274162e-08,0.01547825269755121,0.06198347107438018,0.0072537058591274906,0.05103320147081192,0.09259764787631972,0.007243206163811466,0.00013130388956827943,0.05859375,9.474389094274162e-08,0.055655721716652895,0.019991670137442734
204,0.9,8,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Question: Will cup-cage reconstruction with oversized cups provide the initial stability needed in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups provides the necessary initial stability during Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures, helping to prevent implant migration and encouraging bone growth for durable fixation.",7.105791820705622e-08,0.016941642264174384,0.026416725145153225,0.005440279394345618,0.012633265425153528,0.03243389577353034,0.0054324046228586,0.03684015973839694,0.01700584829867674,7.105791820705622e-08,0.06364514120036802,0.0012748705052793678
204,0.9,9,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Question: Can initial stability in THA for osteoporotic acetabular fractures be achieved through cup-cage reconstruction with oversized cups? Answer: Yes, initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures can be achieved using cup-cage reconstruction with oversized cups, which reduces implant migration and supports bone ingrowth for long-term fixation.",7.105791820705622e-08,0.07239341670897037,0.008619979744445755,0.005440279394345618,0.04092498708066161,0.012698409598650276,0.0054324046228586,0.03684015973839694,0.01700584829867674,7.105791820705622e-08,0.034149516495689536,0.019991670137442734
204,0.9,10,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Question: Is the use of oversized cups in cup-cage reconstruction beneficial for initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, the use of oversized cups in cup-cage reconstruction is beneficial for providing initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures, as it lowers the risk of implant migration and promotes bone ingrowth to ensure stable fixation.",1.6580180914979784e-07,0.08220225286258653,0.024793388429752095,0.012693985253473108,0.0982786502299513,0.018835274203828814,0.012675610786670066,0.09065597036749162,0.02684590824136704,1.6580180914979784e-07,0.061470334813371164,0.049784050759673674
205,0.9,1,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Question: Is imaging required to diagnose appendicitis in children? Answer: Yes, imaging is frequently needed to diagnose appendicitis in children. This can involve an ultrasound or a CT scan. These imaging methods help identify inflammation of the appendix, which indicates",1.4211583641411233e-07,0.15731924734446823,0.010062358276644007,0.010880558788691236,0.15655295525254376,0.007117661879566646,0.0108648092457172,0.15551021446776492,0.0037635424540186403,1.4211583641411244e-07,0.1541506798272576,0.0
205,0.9,2,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Question: Do children need imaging to confirm appendicitis? Answer: Yes, imaging is commonly essential to diagnose appendicitis in children. Ultrasound or CT scans are typically used. These imaging tests assist in detecting inflammation of the appendix, signaling",2.1317375462116823e-07,0.13072392723955018,0.06632653061224489,0.016320838183036854,0.16582819237794366,0.045351473922902494,0.016297213868575806,0.20260018733042617,0.023242630385487524,2.1317375462116866e-07,0.24116205681688774,0.0
205,0.9,3,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Question: Is it necessary to use imaging to diagnose appendicitis in children? Answer: Yes, imaging is often employed to diagnose appendicitis in children, including ultrasound or CT scan. These tests help visualize if the appendix is inflamed, which is a key sign of",7.105791820705622e-08,0.0755942732065713,0.004679386547518413,0.005440279394345618,0.07522830233962896,0.003300728575453847,0.0054324046228586,0.07473861686064831,0.0017409330596143968,7.105791820705622e-08,0.07410797215372344,0.0
205,0.9,4,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Question: Should imaging be used for diagnosing appendicitis in children? Answer: Yes, imaging is usually required to diagnose appendicitis in children, such as an ultrasound or CT scan. These imaging techniques help confirm inflammation of the appendix, indicating",1.8948778188548293e-07,0.14079236821683727,0.03932035777273872,0.014507411718254981,0.13765731541124682,0.045351473922902494,0.014486412327622933,0.17361265045717467,0.023242630385487524,1.8948778188548325e-07,0.21130909366720596,0.0
205,0.9,5,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Question: Is imaging needed to diagnose appendicitis in pediatric patients? Answer: Yes, imaging plays a crucial role in diagnosing appendicitis in children, often involving ultrasound or CT scans. These tests help identify appendix inflammation, which is indicative of",1.8948778188548293e-07,0.14079236821683727,0.03932035777273872,0.014507411718254981,0.13765731541124682,0.045351473922902494,0.014486412327622933,0.17361265045717467,0.023242630385487524,1.8948778188548325e-07,0.21130909366720596,0.0
205,0.9,6,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Question: For diagnosing appendicitis in children, is imaging necessary? Answer: Yes, imaging exams like ultrasound or CT scans are often necessary to accurately diagnose appendicitis in children. These methods detect inflammation of the appendix, a diagnostic sign of",1.8948778188548293e-07,0.14079236821683727,0.03932035777273872,0.014507411718254981,0.13765731541124682,0.045351473922902494,0.014486412327622933,0.17361265045717467,0.023242630385487524,1.8948778188548325e-07,0.21130909366720596,0.0
205,0.9,7,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Question: Does diagnosing appendicitis in children require imaging? Answer: Yes, imaging is generally necessary to diagnose appendicitis in children. Ultrasound and CT scans are commonly performed. These tests can reveal whether the appendix is inflamed, a sign of",1.8948778188548293e-07,0.14079236821683727,0.03932035777273872,0.014507411718254981,0.13765731541124682,0.045351473922902494,0.014486412327622933,0.17361265045717467,0.023242630385487524,1.8948778188548325e-07,0.21130909366720596,0.0
205,0.9,8,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Question: Is diagnostic imaging required for appendicitis in children? Answer: Yes, imaging such as ultrasound or CT scans are frequently needed to confirm appendicitis in children. They help visualize appendix inflammation, which is a critical indicator of",2.1317375462116823e-07,0.16923210393732502,0.03857142857142856,0.016320838183036854,0.16582819237794366,0.045351473922902494,0.016297213868575806,0.20260018733042617,0.023242630385487524,2.1317375462116866e-07,0.24116205681688774,0.0
205,0.9,9,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Question: When diagnosing appendicitis in children, is imaging often used? Answer: Yes, imaging like ultrasound or CT scans is often utilized to diagnose appendicitis in children. These imaging tools assist in detecting appendix inflammation, which signals",2.3685972735685353e-07,0.19850321452395825,0.03777981780947673,0.018134264647818733,0.19481572925119517,0.045351473922902494,0.01810801540952868,0.23245315048010795,0.023242630385487524,2.3685972735685406e-07,0.2719337154836414,0.0
205,0.9,10,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Question: Is it common to use imaging to diagnose appendicitis in children? Answer: Yes, imaging tests including ultrasound and CT scans are commonly employed to diagnose appendicitis in children. They help determine if the appendix is inflamed, which is a sign of",9.474389094274162e-08,0.10210697175622263,0.0063881508281983385,0.0072537058591274906,0.10161151780941502,0.004510021921972841,0.007243206163811466,0.10094507507642758,0.00238063831257343,9.474389094274162e-08,0.10008345855698142,0.0
206,0.9,1,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Yes, cognitive function reliably forecasts frequency compressed speech recognition in individuals with normal hearing and cognition. Particularly, working memory significantly influences effective use of frequency-compressed speech, aiding comprehension.",2.6054570009253947e-07,0.17763374726430792,0.027755102040816326,0.0199476911126006,0.13609236446301098,0.061601220883813396,0.019918816950481533,0.09917226214047048,0.09278018064717171,2.6054570009253947e-07,0.060145598639187,0.1264496436938921
206,0.9,2,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Is there a predictive relationship between cognitive function and frequency compressed speech recognition in listeners with normal hearing and cognition? Indeed, cognitive function, especially working memory, predicts how well frequency compressed speech is recognized in those with normal hearing and cognitive abilities, enhancing their understanding.",2.3685972735685406e-07,0.0542624491910737,0.09231305934602638,0.018134264647818726,0.04424503530327595,0.10909985127095728,0.018108015409528666,0.006645546394631996,0.14169950218279637,2.3685972735685406e-07,0.0007956270208189231,0.15143320713899402
206,0.9,3,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Can cognitive function determine frequency compressed speech recognition performance in listeners with normal hearing and normal cognition? Yes, cognitive function, notably working memory, predicts the recognition of frequency compressed speech among individuals with typical hearing and cognitive function, facilitating improved comprehension.",3.316036182995957e-07,0.13066861498012905,0.10531620055429577,0.025387970506946217,0.08071130288575468,0.15285158257289633,0.025351221573340132,0.07372199635352183,0.16549486208761494,3.316036182995957e-07,0.1034497810809012,0.15143320713899402
206,0.9,4,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Does an individual's cognitive function forecast their ability to recognize frequency compressed speech if they have normal hearing and cognition? Yes, cognitive function, particularly working memory capacity, predicts successful frequency compressed speech recognition in listeners with normal hearing and cognition, supporting better speech understanding.",2.6054570009253947e-07,0.048676132276410655,0.1120369252237384,0.0199476911126006,0.03707133866873136,0.13097485127095726,0.019918816950481533,0.0022639106243995677,0.16549486208761494,2.6054570009253947e-07,0.025488239611190622,0.15143320713899402
206,0.9,5,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Is cognitive function a predictor of frequency compressed speech recognition in listeners with normal hearing and normal cognitive status? Yes, the cognitive function, especially working memory, plays a vital role in frequency compressed speech recognition among those with normal hearing and cognitive abilities, aiding in better comprehension.",1.8948778188548325e-07,0.03309824011731477,0.07658163265306123,0.014507411718254981,0.025290615418474438,0.0904320196231286,0.014486412327622933,0.009868097787448793,0.12014338816471244,1.8948778188548325e-07,0.04683242196843551,0.15143320713899402
206,0.9,6,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Does cognitive function influence the recognition of frequency compressed speech in individuals with normal hearing and cognition? Yes, cognitive abilities, especially working memory, predict performance in frequency compressed speech recognition in listeners with normal hearing and normal cognitive function, enhancing their understanding.",3.079176455639103e-07,0.13640685421921805,0.08448286722096242,0.023574544042164344,0.12381956272596994,0.10396791189915304,0.023540420032387266,0.08329251920974778,0.139871593389554,3.079176455639103e-07,0.07678153399874033,0.15143320713899402
206,0.9,7,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Is frequency compressed speech recognition predicted by cognitive function in listeners with normal hearing and normal cognition? Yes, cognitive function, notably working memory, is predictive of frequency compressed speech recognition success in individuals with normal hearing and cognition, contributing to improved comprehension.",3.079176455639103e-07,0.17021891180750837,0.06204081632653058,0.023574544042164344,0.15847692175396721,0.0797094191721918,0.023540420032387266,0.11883852846923215,0.11436264879323949,3.079176455639103e-07,0.07678153399874033,0.15143320713899402
206,0.9,8,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Can cognitive function be used to predict frequency compressed speech recognition in people with normal hearing and cognition? Yes, cognitive function, particularly working memory, predicts how well listeners with normal hearing and cognition recognize frequency compressed speech, facilitating better understanding.",3.55289591035281e-07,0.15954102389036828,0.10285714285714283,0.02720139697172809,0.14410364114110186,0.12600571546848813,0.027162023114293,0.13785765860108512,0.13848868924810878,3.552895910352811e-07,0.13084875526901651,0.15143320713899402
206,0.9,9,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Does cognitive function predict how well listeners with normal hearing and normal cognition recognize frequency compressed speech? Yes, cognitive function, especially working memory, is a significant predictor of frequency compressed speech recognition success in those with normal hearing and cognition, aiding comprehension.",3.079176455639103e-07,0.10259479663092819,0.10766088758366749,0.023574544042164344,0.08916220369797312,0.12861335542608193,0.023540420032387266,0.08329251920974778,0.139871593389554,3.079176455639103e-07,0.07678153399874033,0.15143320713899402
206,0.9,10,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Is cognitive function predictive of frequency compressed speech recognition in listeners with normal hearing and cognition? Yes, cognitive abilities, notably working memory, predict effective recognition of frequency compressed speech in listeners with normal hearing and normal cognition, supporting enhanced understanding.",3.55289591035281e-07,0.30172506092830664,0.012614411008940424,0.02720139697172809,0.290029363364249,0.026131101270957274,0.027162023114293,0.2502599040972937,0.058975119204235704,3.552895910352811e-07,0.2078651086645662,0.09606988533968605
207,0.9,1,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,Question: Do Biochemical Markers of Bone Turnover Accurately Reflect Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers showed significant but modest correlations with bone turnover parameters obtained from iliac cancellous bone. The iliac crest bone might not fully represent overall bone turnover.,2.3685972735685406e-08,0.006775186142188527,0.021415823914336718,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
207,0.9,2,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,Question: Are Biochemical Markers of Bone Turnover Reliable Indicators of Bone Histomorphometry in 370 Postmenopausal Women? Answer: There was a significant yet modest association between bone turnover markers and bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not be a perfect representation of total bone turnover.,1.4211583641411244e-07,0.14060282031113225,0.014288526548549813,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
207,0.9,3,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,Question: Do Biochemical Markers of Bone Turnover Correspond to Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers demonstrated a significant but modest relationship with bone turnover parameters in iliac cancellous bone. The iliac crest bone may not accurately represent the entire bone turnover.,0.0,0.031506690025452144,0.023626741991660843,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
207,0.9,4,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,Question: Are Biochemical Markers of Bone Turnover Indicative of Bone Histomorphometric Changes in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly yet modestly linked to bone turnover parameters assessed in iliac cancellous bone. The iliac crest bone might not perfectly reflect whole bone turnover.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
207,0.9,5,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,Question: To What Extent Do Biochemical Markers of Bone Turnover Reflect Bone Histomorphometry in 370 Postmenopausal Women? Answer: There is a significant but modest association between biochemical markers and bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not be an exact representation of total bone turnover.,1.4211583641411244e-07,0.1787936704088211,0.07666670797805537,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
207,0.9,6,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry Measures in 370 Postmenopausal Women? Answer: Bone turnover markers have a significant, though modest, correlation with bone turnover parameters from iliac cancellous bone. The iliac crest bone might not completely represent overall bone turnover.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
207,0.9,7,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Question: Can Biochemical Markers of Bone Turnover Serve as Representatives for Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly associated, albeit modestly, with bone turnover parameters in iliac cancellous bone. The iliac crest bone may not fully represent the overall bone turnover status.",4.737194547137081e-08,0.03031650016501075,0.0878375661040309,0.0036268529295637453,0.04546237407675724,0.0,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
207,0.9,8,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,Question: Is There a Relationship Between Biochemical Markers of Bone Turnover and Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers showed significant but modest association with bone turnover metrics in iliac cancellous bone. The iliac crest bone might not perfectly mirror the entire bone turnover.,4.737194547137081e-08,0.07921520839273244,0.027754288326999374,0.0036268529295637453,0.04546237407675724,0.0,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
207,0.9,9,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Question: Are Biochemical Markers of Bone Turnover Useful Proxies for Bone Histomorphometry in 370 Postmenopausal Women? Answer: There was a significant, though modest, correlation between bone turnover markers and bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not ideally represent whole bone turnover.",7.105791820705622e-08,0.10224585249713902,0.02968368328669735,0.005440279394345618,0.06744128079553224,0.0,0.0054324046228586,0.06899287148695166,0.0,7.105791820705622e-08,0.07061756721395396,0.0
207,0.9,10,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,Question: How Representative Are Biochemical Markers of Bone Turnover of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not perfectly portray whole bone turnover.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
208,0.9,1,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Does profound hypotension in coronary disease patients trigger myocardial ischemic events? Evidence shows that symptomatic and silent ischemia temporally correlate with hypotension, especially low diastolic pressure, implying coronary disease patients may be vulnerable to ischemic events from hypotensive episodes.",4.026615365066517e-07,0.33237487592230996,0.05902644282113715,0.030828249901291835,0.36418931348841843,0.00997607568120389,0.030783626196198732,0.3867729750960107,0.0,4.026615365066519e-07,0.39589565709201446,0.0
208,0.9,2,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Can severe hypotensive episodes lead to myocardial ischemia in patients with coronary disease? In such patients, both symptomatic and silent ischemic episodes occur in temporal association with hypotension, notably related to diastolic pressures, indicating susceptibility to ischemic events due to hypotension.",3.552895910352811e-07,0.20811872042318713,0.11149557862360629,0.02720139697172809,0.27407816483759717,0.036982248520710054,0.027162023114293,0.33270575382573453,0.0,3.552895910352811e-07,0.3403258059372023,0.0
208,0.9,3,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Are profound hypotensive events capable of causing myocardial ischemic episodes in individuals with coronary disease? Findings reveal a temporal causal link between hypotension and both symptomatic and silent ischemia, particularly with low diastolic blood pressure, suggesting increased risk of ischemia in these patients.",3.079176455639103e-07,0.15932855625375542,0.11149557862360629,0.023574544042164344,0.22406774426293374,0.036982248520710054,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
208,0.9,4,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Does hypotension provoke myocardial ischemia in patients with ischemic heart disease? Clinical observations demonstrate that symptomatic and silent ischemia are temporally linked to hypotensive events, especially involving diastolic pressure drops, pointing to the susceptibility of coronary patients to ischemic incidents.",3.789755637709664e-07,0.23343652840747886,0.11149557862360629,0.029014823436509962,0.30005365124085515,0.036982248520710054,0.028972824655245866,0.3593740009078954,0.0,3.789755637709665e-07,0.3677247801253176,0.0
208,0.9,5,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Is there a causal relationship between profound hypotension and myocardial ischemic events in coronary disease patients? Symptomatic and silent ischemia have been observed in a temporal connection with hypotension, notably diastolic hypotension, indicating these patients may be prone to ischemic episodes due to low blood pressure.",2.3685972735685406e-07,0.09033568476680376,0.11149557862360629,0.018134264647818726,0.15345017704897979,0.036982248520710054,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
208,0.9,6,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Can low blood pressure precipitate ischemic myocardial events in patients who have coronary disease? Data indicates that hypotension, particularly decreased diastolic pressures, temporally associates with both symptomatic and silent ischemia, suggesting heightened vulnerability to ischemic damage.",4.737194547137076e-07,0.34165011304770987,0.11149557862360629,0.03626852929563746,0.4112792863510797,0.036982248520710054,0.036216030819057346,0.47378435208564085,0.0,4.737194547137081e-07,0.48550781578170144,0.0
208,0.9,7,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Do patients with coronary artery disease experience myocardial ischemic events due to severe hypotension? Research shows a temporal causal link between hypotension and ischemia, mostly connected to low diastolic pressure, implying these patients are susceptible to ischemic phenomena following hypotensive episodes.",3.552895910352811e-07,0.20811872042318713,0.11149557862360629,0.02720139697172809,0.27407816483759717,0.036982248520710054,0.027162023114293,0.33270575382573453,0.0,3.552895910352811e-07,0.3403258059372023,0.0
208,0.9,8,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","In coronary disease patients, can severe hypotension induce myocardial ischemic events? Evidence confirms a temporal association between hypotensive episodes and symptomatic or silent ischemia, especially when diastolic pressures fall, indicating a risk of ischemia related to hypotensive events.",4.26347509242337e-07,0.2860802618928977,0.11149557862360629,0.03264167636607371,0.35412087251113133,0.036982248520710054,0.0325944277371516,0.41494385206270756,0.0,4.263475092423373e-07,0.42488319396526597,0.0
208,0.9,9,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Are myocardial ischemic events triggered by profound hypotension in patients with ischemic heart disease? Clinical data associates symptomatic and silent ischemic episodes with hypotension in a temporal causal manner, with emphasis on diastolic pressure reductions, suggesting increased ischemic risk.",4.026615365066517e-07,0.2958934453665232,0.08519901178649891,0.030828249901291835,0.326721898323016,0.036982248520710054,0.030783626196198732,0.3867729750960107,0.0,4.026615365066519e-07,0.39589565709201446,0.0
208,0.9,10,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Can profound hypotension cause myocardial ischemia in patients with coronary disease? Observations indicate a temporal causal relationship between ischemic events—both symptomatic and silent—and hypotension, particularly diminished diastolic pressures, highlighting susceptibility to ischemic episodes in these patients.",4.737194547137076e-07,0.34165011304770987,0.11149557862360629,0.03626852929563746,0.4112792863510797,0.036982248520710054,0.036216030819057346,0.47378435208564085,0.0,4.737194547137081e-07,0.48550781578170144,0.0
209,0.9,1,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Does cognitive ability forecast recognition of frequency compressed speech in individuals with normal hearing and cognition? The link between cognitive function and understanding frequency compressed speech-in-noise was not statistically significant. Results might differ if participants were given training or time to adapt to frequency-compressed conditions.,2.3685972735685406e-07,0.21062898487294923,0.004203055118552929,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
209,0.9,2,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Is cognitive function a predictor for frequency compressed speech recognition among those with normal hearing and cognition? No significant statistical relationship was found between cognitive function and frequency compressed speech-in-noise recognition. The outcome could change if participants had acclimation time or training for frequency-compressed speech.,2.3685972735685406e-07,0.24213567489840138,0.026839547970606312,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
209,0.9,3,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Can cognitive functioning predict how well listeners with normal hearing and cognition recognize frequency compressed speech? The correlation between cognitive function and frequency compressed speech recognition in noise was not statistically significant. The findings might be different if participants received training or time to get used to the compressed speech.,1.1842986367842703e-07,0.09978335231063973,0.0018873796032593745,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
209,0.9,4,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Does cognitive performance influence recognition of frequency compressed speech in listeners with normal hearing and cognitive abilities? The study found no significant statistical relationship between cognition and frequency compressed speech-in-noise recognition. Results may vary if acclimatization or training was provided.,3.55289591035281e-07,0.33529629189559795,0.0071113427457647725,0.02720139697172809,0.33270575382573453,0.0,0.027162023114293,0.3403258059372023,0.0,3.552895910352811e-07,0.3483066942682149,0.0
209,0.9,5,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Is there a predictive role of cognitive function for frequency compressed speech recognition in normal hearing and cognitively normal individuals? Cognitive function and speech recognition in noise with frequency compression were not significantly related statistically. Findings might differ if participants were allowed time or training to adapt.,1.8948778188548325e-07,0.22508103408883073,0.046388019964415564,0.014507411718254981,0.19443596514002115,0.02221074380165289,0.014486412327622933,0.16705408466316607,0.0,1.8948778188548325e-07,0.1706255170307629,0.0
209,0.9,6,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,"Does cognitive ability predict recognition of frequency compressed speech among normally hearing, cognitively normal listeners? The connection between cognitive function and frequency compressed speech recognition in noise was statistically insignificant. Different results could emerge if training or acclimatization was given.",3.55289591035281e-07,0.3708423011550823,0.032620287342079266,0.02720139697172809,0.36918718438152087,0.026296566837107373,0.027162023114293,0.3403258059372023,0.0,3.552895910352811e-07,0.3483066942682149,0.0
209,0.9,7,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Do cognitive skills predict recognition performance for frequency compressed speech in those with normal hearing and cognition? The relationship between cognitive skills and speech-in-noise recognition under frequency compression was not statistically significant. The outcome might shift if participants had a chance to acclimate or train.,2.3685972735685406e-07,0.21062898487294923,0.004203055118552929,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
209,0.9,8,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Is cognitive functioning associated with recognition of frequency compressed speech in listeners with normal hearing and cognition? No significant statistical association was observed between cognition and frequency compressed speech-in-noise recognition. Different results might develop if training or adaptation time was provided.,3.316036182995957e-07,0.3090898336798187,0.0064716374928057395,0.025387970506946217,0.30673026742247655,0.0,0.025351221573340132,0.31365755885504143,0.0,3.316036182995957e-07,0.3209077200800996,0.0
209,0.9,9,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Can cognitive function be used to predict recognition of frequency compressed speech in people with normal hearing and cognition? The study did not find a statistically significant link between cognitive function and frequency compressed speech recognition in noise. The findings could change if participants received training or had acclimatization time.,1.1842986367842703e-07,0.15636679562165545,0.0424521572235072,0.009067132323909363,0.12797203516756062,0.020823902218198284,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
209,0.9,10,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Does cognitive ability serve as a predictor for recognizing frequency compressed speech in listeners who have normal hearing and cognition? There was no statistically significant relationship found between cognitive ability and recognition of frequency compressed speech-in-noise. The results might have differed if participants had training or time to acclimatize to frequency-compressed conditions.,7.105791820705622e-08,0.08585078079123276,0.020638428066862512,0.005440279394345618,0.05826890812397556,0.0,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
210,0.9,1,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Does increased neutrophil migratory activity following major trauma contribute to the development of acute respiratory distress syndrome? Data show that significant blunt trauma boosts the migration ability of circulating neutrophils. This effect appears within 2 hours of hospital admission and could be due to changes in interleukin-8 receptor expression, binding affinity, or downstream signaling. Patients who eventually develop ARDS exhibit initially high levels of this activity.",7.105791820705622e-08,0.04725288485054513,0.0,0.005440279394345618,0.04800921918636103,0.0,0.0054324046228586,0.04879016416943571,0.0,7.105791820705622e-08,0.04959694113937285,0.0
210,0.9,2,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Is enhanced neutrophil migration after major trauma a factor in causing acute respiratory distress syndrome? The findings suggest that major blunt trauma increases circulating neutrophils' migratory capacity. This is evident within 2 hours of admission and may result from altered interleukin-8 receptor expression, affinity, or signaling pathways. Those patients who develop ARDS later show initially elevated levels.",1.4211583641411244e-07,0.10178269430994202,0.0,0.010880558788691236,0.10354067894083929,0.0,0.0108648092457172,0.10536051565782412,0.0,1.4211583641411244e-07,0.10724553035359774,0.0
210,0.9,3,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Can an increase in neutrophil migration after severe trauma play a role in acute respiratory distress syndrome development? The data indicate major blunt trauma raises the migratory capacity of circulating neutrophils, observable within 2 hours of hospital admission, potentially due to modifications in interleukin-8 receptor expression, affinity, or downstream signaling. Patients developing ARDS subsequently have initially increased levels.",1.1842986367842703e-07,0.0840831172105414,0.0,0.009067132323909363,0.08552217343816082,0.0,0.009054007704764333,0.08701137698962835,0.0,1.1842986367842703e-07,0.08855339734144341,0.0
210,0.9,4,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Is heightened neutrophil migratory activity post-major trauma a contributing element to acute respiratory distress syndrome? Evidence reveals that major blunt trauma enhances neutrophil migration capacity in circulation, evident within 2 hours after admission, possibly from changes in interleukin-8 receptor expression, receptor affinity, or subsequent signaling. Individuals who later develop ARDS initially exhibit elevated levels.",2.1317375462116866e-07,0.1568424714929706,0.0,0.016320838183036854,0.1596301455918825,0.0,0.0162972138685758,0.16251892949777424,0.0,2.1317375462116866e-07,0.1655144384775733,0.0
210,0.9,5,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Does neutrophil migration increase after major trauma and influence acute respiratory distress syndrome? Data indicate that major blunt trauma significantly elevates the migratory ability of circulating neutrophils, noticeable within 2 hours post-admission, potentially linked to alterations in interleukin-8 receptor expression, affinity, or downstream signaling. Early on, patients progressing to ARDS show raised activity.",2.3685972735685406e-07,0.1758906664636637,0.0,0.018134264647818726,0.17904823144898518,0.0,0.018108015409528666,0.182321556793954,0.0,2.3685972735685406e-07,0.1857171457950919,0.0
210,0.9,6,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Is an increase in circulating neutrophil migration after major trauma a factor in the pathogenesis of acute respiratory distress syndrome? Findings suggest that major blunt trauma enhances neutrophil migratory capacity, evident within 2 hours of admission and possibly related to changes in interleukin-8 receptor expression, affinity, or signaling. Those who develop ARDS show initially increased levels.",1.6580180914979784e-07,0.1198011998126205,0.0,0.012693985253473108,0.12188981760903506,0.0,0.012675610786670066,0.12405264866997845,0.0,1.6580180914979784e-07,0.12629372532429084,0.0
210,0.9,7,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Does major blunt trauma lead to increased neutrophil migration that may contribute to acute respiratory distress syndrome? The data show that such trauma boosts circulating neutrophils' migratory function within 2 hours of admission, potentially due to alterations in interleukin-8 receptor expression, affinity, or downstream signaling. Patients who develop ARDS later have originally elevated levels.",2.1317375462116866e-07,0.1568424714929706,0.0,0.016320838183036854,0.1596301455918825,0.0,0.0162972138685758,0.16251892949777424,0.0,2.1317375462116866e-07,0.1655144384775733,0.0
210,0.9,8,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Is increased neutrophil migratory activity after severe trauma implicated in acute respiratory distress syndrome? Data demonstrate that major blunt trauma enhances neutrophil migration capacity in circulation within 2 hours of admission, possibly due to changes in interleukin-8 receptor expression, affinity, or signaling pathways. Patients who develop ARDS eventually exhibit initially heightened levels.",2.6054570009253947e-07,0.1953087523207664,0.0,0.0199476911126006,0.19885085874516495,0.0,0.019918816950481533,0.20252426411147262,0.0,2.6054570009253947e-07,0.20633643299782767,0.0
210,0.9,9,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Could increased neutrophil migration following major trauma play a role in the etiology of acute respiratory distress syndrome? Evidence suggests that major blunt trauma raises circulating neutrophils' migratory abilities within 2 hours of admission, potentially from altered interleukin-8 receptor expression, affinity, or downstream signaling. Initially, patients developing ARDS show elevated levels.",2.8423167282822487e-07,0.21511137961694615,0.0,0.02176111757738247,0.21905356606268356,0.0,0.0217296184914344,0.22314355131420838,0.0,2.8423167282822487e-07,0.22738984219566083,0.0
210,0.9,10,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Is the rise in neutrophil migration after trauma a contributing factor to acute respiratory distress syndrome? Data indicate that major blunt trauma increases circulating neutrophil migratory capacity within 2 hours of hospital admission, possibly due to changes in interleukin-8 receptor expression, affinity, or signaling. Patients who later develop ARDS display early elevated activity.",2.3685972735685406e-07,0.1758906664636637,0.0,0.018134264647818726,0.17904823144898518,0.0,0.018108015409528666,0.182321556793954,0.0,2.3685972735685406e-07,0.1857171457950919,0.0
211,0.9,1,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.",Master of Public Health (MPH) programs play a crucial role in strengthening health systems in low- and middle-income countries by building the capacity of local health workers with vital public health skills.,9.474389094274153e-07,0.7172096639608858,0.07863693625598397,0.07253705859127496,0.7284726294340711,0.0849609375,0.0724320616381147,0.7663545614861564,0.072021484375,9.474389094274162e-07,0.8057564678762041,0.05859375
211,0.9,2,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","In low- and middle-income countries, MPH programs contribute significantly to fortifying health systems by training healthcare professionals in public health practices, policy formulation, management, and disease control.",1.0658687731058418e-06,0.8483811574851989,0.11085915847820617,0.08160419091518437,0.910794186228026,0.0849609375,0.08148606934287908,0.9555965611246844,0.072021484375,1.0658687731058433e-06,1.0024667621222587,0.05859375
211,0.9,3,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.",MPH programs are instrumental in enhancing health system performance in low- and middle-income nations by providing health workers with skills necessary for public health practice and policy development.,1.0421828003701566e-06,0.810640829502352,0.11085915847820617,0.07979076445040248,0.8715734730747435,0.0849609375,0.0796752678019262,0.9147745666044296,0.072021484375,1.0421828003701579e-06,0.9599071477034631,0.05859375
211,0.9,4,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","The impact of MPH programs in low- and middle-income countries includes capacity building for local health professionals, leading to improved health system management and disease prevention strategies.",1.0658687731058418e-06,0.8483811574851989,0.11085915847820617,0.08160419091518437,0.910794186228026,0.0849609375,0.08148606934287908,0.9555965611246844,0.072021484375,1.0658687731058433e-06,1.0024667621222587,0.05859375
211,0.9,5,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","Health system strengthening in low- and middle-income countries is substantially supported by MPH programs, which equip health personnel with essential expertise in public health, policy, and management.",1.0658687731058418e-06,0.8483811574851989,0.11085915847820617,0.08160419091518437,0.910794186228026,0.0849609375,0.08148606934287908,0.9555965611246844,0.072021484375,1.0658687731058433e-06,1.0024667621222587,0.05859375
211,0.9,6,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.",MPH programs contribute to the enhancement of health systems in developing nations by teaching crucial public health skills and supporting policy and healthcare management improvements.,1.1132407185772124e-06,0.9284238651587362,0.11085915847820617,0.08523104384474813,0.9941757951670764,0.0849609375,0.08510767242478481,1.042607938114314,0.072021484375,1.113240718577214e-06,1.0934385403279867,0.05859375
211,0.9,7,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","In lower to middle-income countries, MPH programs boost health system capacities by training local health staff in public health, aiding policy development and disease prevention.",1.1132407185772124e-06,0.9284238651587362,0.11085915847820617,0.08523104384474813,0.9941757951670764,0.0849609375,0.08510767242478481,1.042607938114314,0.072021484375,1.113240718577214e-06,1.0934385403279867,0.05859375
211,0.9,8,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","The strengthening of health systems in low- and middle-income countries benefits greatly from MPH programs that develop the skills of health professionals in policy, management, and disease control.",1.0421828003701566e-06,0.8619850650993852,0.07387690995749613,0.07979076445040248,0.8715734730747435,0.0849609375,0.0796752678019262,0.9147745666044296,0.072021484375,1.0421828003701579e-06,0.9599071477034631,0.05859375
211,0.9,9,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","By providing essential public health education and training, MPH programs help improve health system performance and reduce disparities in low- and middle-income countries.",1.160612664048583e-06,1.015435242148366,0.11085915847820617,0.08885789677431188,1.0851475733728044,0.0849609375,0.08872927550669057,1.1379181179186393,0.072021484375,1.1606126640485847e-06,1.1935219988849681,0.05859375
211,0.9,10,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","MPH programs aid health system strengthening in low- and middle-income countries through capacity building, policy support, and enhanced disease prevention efforts.",1.2079846095199536e-06,1.110745421952691,0.11085915847820617,0.09248474970387564,1.1852310319297858,0.0849609375,0.09235087858859631,1.2432786335764647,0.072021484375,1.2079846095199555e-06,1.3047476339951922,0.05859375
212,0.9,1,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Is there a role for polymorphisms in the beta-adrenergic receptor (ADRB) genes in transient tachypnea of the newborn (TTN)? Answer: We conclude that homozygosity for beta1Gly49 and the TACC haplotype in the ADRB2 gene, both being loss-of-function variants, might increase susceptibility to TTN.",1.4211583641411212e-07,0.1180427993023625,0.023242630385487524,0.010880558788691236,0.1541506798272576,0.0,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
212,0.9,2,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Could polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes influence transient tachypnea of the newborn (TTN)? Answer: Our findings suggest that beta1Gly49 homozygosity and the TACC haplotype in the ADRB2 gene, which are loss-of-function mutations, may predispose individuals to TTN.",7.10579182070559e-08,0.04330418244171419,0.02498356344510192,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
212,0.9,3,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Transient tachypnea of the newborn (TTN): might polymorphisms in beta-adrenergic receptor genes (ADRB) play a role? Answer: We conclude that both beta1Gly49 homozygosity and the TACC haplotype in the ADRB2 gene, characterized as loss-of-function genetic variants, could predispose to TTN.",7.10579182070559e-08,0.07796154146971057,0.0,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
212,0.9,4,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.",Question: Is there an association between polymorphisms in the beta-adrenergic receptor (ADRB) genes and transient tachypnea of the newborn (TTN)? Answer: We found that loss-of-function genetic variations such as beta1Gly49 homozygosity and the TACC haplotype in ADRB2 may increase the risk for TTN.,1.1842986367842671e-07,0.1267517056391423,0.0,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
212,0.9,5,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Question: Does transient tachypnea of the newborn (TTN) involve polymorphisms in the beta-adrenergic receptor (ADRB) genes? Answer: It appears that the loss-of-function variants, beta1Gly49 homozygosity and ADRB2's TACC haplotype, could predispose newborns to TTN.",7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
212,0.9,6,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Question: What is the role of beta-adrenergic receptor (ADRB) gene polymorphisms in transient tachypnea of the newborn (TTN)? Answer: We conclude that TTN susceptibility may be linked to beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both being loss-of-function variations.",1.1842986367842671e-07,0.0937446970410507,0.023795359904818555,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
212,0.9,7,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Does transient tachypnea of the newborn (TTN) have a connection to polymorphisms in the beta-adrenergic receptor (ADRB) genes? Answer: Our conclusion is that genetic loss-of-function variants, specifically beta1Gly49 homozygosity and the TACC haplotype of ADRB2, may predispose to TTN.",4.73719454713706e-08,0.05264373348541884,0.0,0.0036268529295637453,0.05406722127027619,0.0,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
212,0.9,8,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.",Question: Transient tachypnea of the newborn (TTN): Are polymorphisms in beta-adrenergic receptor (ADRB) genes involved? Answer: We conclude that loss-of-function genetic variants like beta1Gly49 homozygosity and ADRB2's TACC haplotype might increase risk of TTN.,9.47438909427412e-08,0.11441035117774545,0.0,0.007253705859127511,0.11778303565638382,0.0,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
212,0.9,9,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Question: Is the polymorphism of beta-adrenergic receptor (ADRB) genes implicated in transient tachypnea of the newborn (TTN)? Answer: Evidence suggests that beta1Gly49 homozygosity and the TACC haplotype of ADRB2, both loss-of-function variants, may predispose infants to TTN.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
212,0.9,10,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.",Question: Are beta-adrenergic receptor (ADRB) gene polymorphisms associated with transient tachypnea of the newborn (TTN)? Answer: Findings indicate that the loss-of-function genetic variations beta1Gly49 homozygosity and the TACC haplotype in ADRB2 may predispose to TTN.,7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
213,0.9,1,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Diagnostic features of child bipolar I disorder: is the 'Treatment of Early Age Mania (TEAM)' sample generalizable? Generalization of the RCT sample was upheld, as only 7.8% of Phenomenology participants did not meet RCT inclusion criteria. However, since RCT participants exhibited more severe illness, it remains uncertain if RCT treatment results apply to children with milder mania.",1.8948778188548325e-07,0.04688799505453023,0.1451222789572694,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
213,0.9,2,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Are the diagnostic characteristics of child bipolar I disorder from the 'Treatment of Early Age Mania (TEAM)' study representative? The RCT sample was largely generalizable, with only 7.8% of Phenomenology subjects excluded by RCT criteria. Still, due to greater severity among RCT patients, it is unclear whether RCT treatment outcomes extend to children with less severe forms of mania.",1.4211583641411244e-07,0.011796675243260779,0.1451222789572694,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
213,0.9,3,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Does the 'Treatment of Early Age Mania (TEAM)' sample reflect the broader population regarding diagnostic features of child bipolar I disorder? Generalization was confirmed since only 7.8% of Phenomenology subjects failed RCT criteria. Nonetheless, as RCT cases were more severely affected, it is uncertain if RCT treatment findings apply to children experiencing milder mania.",2.6054570009253947e-07,0.1019477722375588,0.1451222789572694,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
213,0.9,4,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Are the diagnostic traits of child bipolar I disorder generalizable from the 'Treatment of Early Age Mania (TEAM)' study? Generalization of the RCT cohort is supported, with just 7.8% of Phenomenology individuals not meeting the RCT standards. Yet, because RCT subjects had more severe illness, the applicability of its treatment results to less severe mania cases is unclear.",1.4211583641411244e-07,0.03569830215912084,0.1278862063195347,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
213,0.9,5,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Examining diagnostic traits of child bipolar I disorder: does the 'Treatment of Early Age Mania (TEAM)' research sample generalize? Generalization of the RCT sample was affirmed since only 7.8% of Phenomenology subjects did not satisfy RCT criteria. However, given that RCT participants were more severely ill, applying RCT treatment findings to children with milder mania remains uncertain.",1.8948778188548325e-07,0.04688799505453023,0.1451222789572694,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
213,0.9,6,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Are the diagnostic markers for child bipolar I disorder from the 'Treatment of Early Age Mania (TEAM)' study generalizable? Evidence supports generalization since only 7.8% of Phenomenology subjects were excluded by RCT criteria. Nonetheless, because RCT participants were more severely ill, whether treatment results apply to children with less severe mania is unclear.",2.8423167282822487e-07,0.1209959672082519,0.1451222789572694,0.02176111757738247,0.21130909366720996,0.0,0.0217296184914344,0.21511137961694615,0.0,2.8423167282822487e-07,0.21905356606268356,0.0
213,0.9,7,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Regarding diagnostic characteristics of child bipolar I disorder: does the 'Treatment of Early Age Mania (TEAM)' sample generalize well? Only 7.8% of Phenomenology subjects did not meet the RCT criteria, supporting generalization. Still, as RCT subjects were more seriously ill, it’s unclear if RCT treatment findings can be applied to children with milder mania.",2.6054570009253947e-07,0.1019477722375588,0.1451222789572694,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
213,0.9,8,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Do the diagnostic characteristics of child bipolar I disorder in the 'Treatment of Early Age Mania (TEAM)' sample generalize? Generalization is supported since just 7.8% of Phenomenology subjects failed to meet RCT inclusion criteria. However, the greater severity of illness among RCT participants means it is uncertain if treatment outcomes apply to children with less severe mania.",1.8948778188548325e-07,0.04688799505453023,0.1451222789572694,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
213,0.9,9,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Can the diagnostic characteristics of child bipolar I disorder from the 'Treatment of Early Age Mania (TEAM)' study be generalized? The RCT sample generalizes well because only 7.8% of Phenomenology subjects fell outside RCT criteria. Still, given that RCT subjects were more severely affected, the applicability of treatment findings to children with milder mania is uncertain.",2.1317375462116866e-07,0.0649065005572087,0.1451222789572694,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
213,0.9,10,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Diagnostic features of child bipolar I disorder and generalizability of the 'Treatment of Early Age Mania (TEAM)' sample: generalization is supported as only 7.8% of Phenomenology subjects did not meet RCT criteria. However, since RCT subjects were more severely ill, it is unclear if RCT treatment results apply to children with less severe forms of mania.",2.1317375462116866e-07,0.0649065005572087,0.1451222789572694,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
214,0.9,1,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Is external palliative radiotherapy beneficial for gallbladder carcinoma? External palliative radiotherapy can help relieve symptoms like pain and blockage in gallbladder carcinoma cases, though it has a limited impact on survival because the disease often presents at an advanced stage.",1.1842986367842692e-07,0.03418655618032629,0.0606363600126594,0.009067132323909363,0.031137771535065806,0.06574814059221545,0.009054007704764333,0.02773067984486355,0.0710059171597633,1.1842986367842703e-07,0.062429013071617856,0.04865220249835634
214,0.9,2,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Does external palliative radiotherapy work for gallbladder carcinoma? It may effectively manage painful symptoms and obstructive issues, but its influence on overall survival is minimal given the late progression of the disease.",3.0791764556390933e-07,0.1926689793058558,0.11176857330703485,0.02357454404216438,0.231045119043511,0.09204470742932283,0.023540420032387308,0.271352762502616,0.0710059171597633,3.079176455639103e-07,0.31374344135252397,0.04865220249835634
214,0.9,3,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Is external palliative radiotherapy effective in gallbladder carcinoma treatment? While it helps alleviate symptoms such as pain and obstruction, its ability to prolong survival is restricted due to the advanced disease condition.",3.0791764556390933e-07,0.1926689793058558,0.11176857330703485,0.02357454404216438,0.231045119043511,0.09204470742932283,0.023540420032387308,0.271352762502616,0.0710059171597633,3.079176455639103e-07,0.31374344135252397,0.04865220249835634
214,0.9,4,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","How effective is external palliative radiotherapy for gallbladder carcinoma? It can ease symptoms like pain and obstruction, yet its effect on increasing survival rates is limited because the disease is usually advanced when treated.",2.605457000925387e-07,0.1301486223245223,0.11176857330703485,0.01994769111260062,0.16650659790593947,0.09204470742932283,0.01991881695048156,0.2046613880039425,0.0710059171597633,2.6054570009253947e-07,0.2447505698655732,0.04865220249835634
214,0.9,5,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Can external palliative radiotherapy control symptoms of gallbladder carcinoma? This therapy is useful for symptom relief, including pain and obstruction, but it does not significantly improve survival rates due to advanced stage at diagnosis.",2.605457000925387e-07,0.1301486223245223,0.11176857330703485,0.01994769111260062,0.16650659790593947,0.09204470742932283,0.01991881695048156,0.2046613880039425,0.0710059171597633,2.6054570009253947e-07,0.2447505698655732,0.04865220249835634
214,0.9,6,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","What is the efficacy of external palliative radiotherapy for gallbladder carcinoma? This treatment can mitigate symptoms such as pain and obstruction, but its impact on survival outcomes remains limited because of the disease’s advanced state.",2.3685972735685343e-07,0.10029565917484051,0.11176857330703485,0.01813426464781874,0.13573493923918578,0.09204470742932283,0.018108015409528687,0.1729126896893627,0.0710059171597633,2.3685972735685406e-07,0.2119607470425815,0.04865220249835634
214,0.9,7,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at",Is palliative radiotherapy externally applied effective for gallbladder cancer? It aids in managing symptomatic pain and obstructions but has little effect on survival improvements because the disease is typically advanced.,3.5528959103527993e-07,0.25936035380452926,0.11176857330703485,0.027201396971728138,0.30003799053046176,0.09204470742932283,0.027162023114293055,0.34281172648475966,0.0710059171597633,3.552895910352811e-07,0.38785141350624563,0.04865220249835634
214,0.9,8,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at",Does external palliative radiation therapy effectively treat gallbladder cancer symptoms? It can reduce symptom severity like pain and obstruction but offers limited survival advantage owing to advanced disease stages.,3.7897556377096523e-07,0.29445167361579827,0.11176857330703485,0.029014823436510018,0.33640563470133644,0.09204470742932283,0.028972824655245928,0.38055205446760665,0.0710059171597633,3.789755637709665e-07,0.4270721266595281,0.04865220249835634
214,0.9,9,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Is the use of external palliative radiotherapy advantageous in gallbladder carcinoma? It effectively manages symptoms such as pain and obstruction, while its role in extending survival is minimal due to late disease progression.",2.84231672828224e-07,0.16092028099127598,0.11176857330703485,0.0217611175773825,0.1982552962205193,0.09204470742932283,0.021729618491434434,0.2374512108269342,0.0710059171597633,2.8423167282822487e-07,0.27865212154125496,0.04865220249835634
214,0.9,10,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","How well does external palliative radiotherapy work for gallbladder carcinoma? It is effective in relieving pain and obstruction symptoms, but survival benefits are generally limited because of the advanced disease when therapy is applied.",2.605457000925387e-07,0.1301486223245223,0.11176857330703485,0.01994769111260062,0.16650659790593947,0.09204470742932283,0.01991881695048156,0.2046613880039425,0.0710059171597633,2.6054570009253947e-07,0.2447505698655732,0.04865220249835634
215,0.9,1,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from",Antral follicle assessment proves to be a superior predictor of IVF outcomes compared to maternal age and basal FSH levels.,1.3264144731983806e-06,1.1627493194887588,0.2532544378698224,0.10155188202778506,1.3129538765328168,0.09619827767275783,0.10140488629336067,1.4382557633782032,0.013695987654320991,1.3264144731983825e-06,1.5040773967762733,0.0
215,0.9,2,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","When predicting IVF success, antral follicle count outperforms age and follicle-stimulating hormone measurements.",1.492216282348178e-06,1.6222816488671983,0.2532544378698224,0.1142458672812582,1.805430361630611,0.09619827767275783,0.11408049708003078,1.9688840144403739,0.013695987654320991,1.49221628234818e-06,2.079441541679835,0.0
215,0.9,3,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from",The evaluation of antral follicles serves as a more accurate indicator for IVF results than either a woman’s age or her FSH levels.,1.2553565549913246e-06,1.0161458452968835,0.2532544378698224,0.09611160263343943,1.15880319670556,0.09619827767275783,0.09597248167050204,1.275736833880429,0.013695987654320991,1.2553565549913263e-06,1.3322271398496142,0.0
215,0.9,4,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","In vitro fertilization outcomes correlate strongly with maternal age, day 3 follicle count, FSH, and antral follicle assessment; however, antral follicle evaluation is the better predictor.",1.1842986367842686e-06,0.9437642482317941,0.21332388231426683,0.0906713232390938,1.0252718040810365,0.09619827767275783,0.09054007704764343,1.1359748915052696,0.013695987654320991,1.1842986367842703e-06,1.1856236656577388,0.0
215,0.9,5,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from",Assessing antral follicles provides a more reliable forecast of IVF success than the traditional predictors of age and FSH.,1.350100445934066e-06,1.2168165407590341,0.2532544378698224,0.10336530849256695,1.3701122903727656,0.09619827767275783,0.10321568783431354,1.4988803851946382,0.013695987654320991,1.350100445934068e-06,1.568615917913844,0.0
215,0.9,6,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Among the various markers for IVF outcomes, antral follicle count offers superior predictive value over age or follicle-stimulating hormone.",1.350100445934066e-06,1.2168165407590341,0.2532544378698224,0.10336530849256695,1.3701122903727656,0.09619827767275783,0.10321568783431354,1.4988803851946382,0.013695987654320991,1.350100445934068e-06,1.568615917913844,0.0
215,0.9,7,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from",Antral follicle measurements can more effectively predict the results of IVF than maternal age or basal cycle FSH.,1.3737864186697514e-06,1.273974954598983,0.2532544378698224,0.10517873495734882,1.4307369121892006,0.09619827767275783,0.10502648937526642,1.5634189063322088,0.013695987654320991,1.3737864186697531e-06,1.637608789400796,0.0
215,0.9,8,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from",IVF success is more accurately predicted by antral follicle assessment than by either age or basal follicle-stimulating hormone levels.,1.350100445934066e-06,1.2168165407590341,0.2532544378698224,0.10336530849256695,1.3701122903727656,0.09619827767275783,0.10321568783431354,1.4988803851946382,0.013695987654320991,1.350100445934068e-06,1.568615917913844,0.0
215,0.9,9,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Compared to age and FSH, antral follicle count is a stronger predictor of in vitro fertilization outcomes.",1.3974723914054366e-06,1.334599576415418,0.2532544378698224,0.1069921614221307,1.4952754333267713,0.09619827767275783,0.10683729091621928,1.632411777819161,0.013695987654320991,1.3974723914054385e-06,1.7117167615545172,0.0
215,0.9,10,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from",The antral follicle count may be a distinct marker of ovarian age and provides better prediction of IVF outcomes than age or follicle-stimulating hormone.,1.2316705822556394e-06,0.9716940827260494,0.2532544378698224,0.09429817616865754,1.1122831810706661,0.09619827767275783,0.09416168012954917,1.2269466697109976,0.013695987654320991,1.2316705822556411e-06,1.280933845462064,0.0
216,0.9,1,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Are reports of home blood pressure readings from stroke patients dependable? This cohort of elderly stroke patients recorded their blood pressures accurately at home, with minimal bias unlikely to influence treatment. Because blood pressure measurements in GP offices often poorly reflect true values, GPs might consider using readings taken at home by hypertensive patients.",1.1842986367842703e-07,0.14246409175353936,0.037677816224529016,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
216,0.9,2,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Can stroke patients reliably report their home blood pressure readings? This group of elderly stroke patients demonstrated reliable home blood pressure monitoring, with only minor bias unlikely to affect clinical decisions. Since GP office readings often do not represent true blood pressure, GPs may want to rely on home measurements from hypertensive patients.",1.4211583641411244e-07,0.18917781279883128,0.057476051645147866,0.010880558788691236,0.1384078774851245,0.019599999999999992,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
216,0.9,3,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Do stroke patients provide trustworthy home blood pressure readings? Elderly stroke patients in this study accurately recorded their blood pressure at home, with negligible bias unlikely to impact management. Given that blood pressure taken in a GP’s surgery often fails to reflect true levels, GPs could consider home readings from hypertensive individuals.",1.6580180914979784e-07,0.22042387247158812,0.10026041666666667,0.012693985253473108,0.13102826240640475,0.0,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
216,0.9,4,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","How reliable are home blood pressure reports from stroke patients? The elderly stroke patients studied were able to measure their blood pressure at home reliably, showing minor bias unlikely to alter treatment plans. Since blood pressure readings at GP offices often do not accurately represent true blood pressure, GPs might use data from home monitoring of hypertensive patients.",2.3685972735685406e-08,0.07521344211545378,0.07140495867768595,0.0018134264647818726,0.01769957709940062,0.0,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
216,0.9,5,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Are home blood pressure measurements reported by stroke patients accurate? This elderly stroke patient group consistently recorded their blood pressures at home with minimal bias unlikely to affect medical management. Because GP surgery readings are frequently poor indicators of actual blood pressure, GPs may rely on hypertensive patients' home readings.",2.1317375462116866e-07,0.1686227124357922,0.0,0.016320838183036854,0.17185025692665912,0.0,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
216,0.9,6,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Is the self-reporting of home blood pressure readings by stroke patients dependable? Elderly stroke patients in this group reliably took their blood pressure at home, with any bias too small to change management decisions. As blood pressure readings in GP clinics often poorly indicate true blood pressure, GPs might consider home blood pressure readings from hypertensive patients.",4.737194547137081e-08,0.24247708825276426,0.28571428571428575,0.0036268529295637453,0.12084774127706499,0.09282544378698228,0.003621603081905733,0.062039761969391094,0.01851192595229618,4.737194547137081e-08,0.037041271680350096,0.0
216,0.9,7,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Can elderly stroke patients report their home blood pressure readings reliably? This group was able to accurately track their blood pressure at home, with minimal bias unlikely to influence clinical management. Since GP surgery blood pressure readings often do not reflect actual pressure, GPs could look to home measurements from hypertensive patients.",1.6580180914979784e-07,0.22042387247158812,0.10026041666666667,0.012693985253473108,0.15875414962880274,0.019991670137442734,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
216,0.9,8,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Do elderly stroke patients provide reliable reports of their home blood pressure? They were able to record their blood pressures at home with only slight bias unlikely to affect treatment. Given that blood pressure taken at GP offices often misrepresents true blood pressure, GPs should consider home monitoring in hypertensive patients.",1.8948778188548325e-07,0.14842000511827358,0.0,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
216,0.9,9,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Are blood pressure readings taken at home and reported by stroke patients trustworthy? This group of elderly stroke patients reliably measured blood pressure at home, with a small bias unlikely to impact management. Since blood pressure recordings in GP surgeries are often inaccurate reflections of true pressure, GPs might use home readings from hypertensive patients.",9.474389094274162e-08,0.1581650978177782,0.09457900807381774,0.0072537058591274906,0.07275935428242919,0.0,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
216,0.9,10,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","How trustworthy are home blood pressure reports from elderly stroke patients? The patients reliably recorded their blood pressure readings at home with minimal bias unlikely to affect clinical treatment. Because blood pressure readings in general practitioner surgeries often poorly indicate true blood pressure, GPs might consider using hypertensive patients' home measurements.",1.8948778188548325e-07,0.24206262966075798,0.10230873698506115,0.014507411718254981,0.17952269137943144,0.020399305555555556,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
217,0.9,1,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Is untethering required before performing scoliosis correction on a patient with myelomeningocele? Generally, untethering is necessary prior to scoliosis correction in such patients to help avoid additional neurological decline, which might be worsened by the scoliosis surgery. Nevertheless, the choice should be tailored to the specific patient's condition and evaluated accordingly.",0.0,0.08317766166719309,0.059403414928719846,0.0,0.056583443311015724,0.040742417383431435,0.0,0.0,0.0,0.0,0.0,0.0
217,0.9,2,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","For a patient with myelomeningocele, is untethering needed before scoliosis correction? Typically, untethering is essential before correcting scoliosis to prevent further neurological damage that scoliosis correction could exacerbate. However, the approach depends on the individual case and requires careful consideration.",2.6054570009253936e-07,0.1375578104089099,0.07939508506616258,0.0199476911126006,0.19765069507322464,0.040742417383431435,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
217,0.9,3,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","In patients with myelomeningocele, is it necessary to perform untethering before scoliosis correction? Usually, untethering is recommended prior to scoliosis surgery in order to minimize the risk of neurological deterioration that scoliosis correction might aggravate. The final decision should be based on the patient's unique clinical state.",9.474389094274162e-08,0.027521939950540197,0.07939508506616258,0.0072537058591274906,0.02857436502929156,0.040742417383431435,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
217,0.9,4,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Does a patient with myelomeningocele require untethering before scoliosis correction? Untethering is customarily needed before scoliosis correction to reduce the chance of neurologic worsening caused by the surgery. The decision, though, varies depending on the patient's specific condition.",3.0791764556390996e-07,0.22766895905973117,0.05238891222665641,0.023574544042164344,0.2517179163435008,0.040742417383431435,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
217,0.9,5,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Is untethering indicated before scoliosis correction in a patient with myelomeningocele? Typically, surgeons perform untethering prior to scoliosis correction to prevent the aggravation of neurological symptoms. The necessity of this step is determined by individual patient factors.",3.3160361829959526e-07,0.2561086947802189,0.05163998302534625,0.025387970506946217,0.27988879331019767,0.040742417383431435,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
217,0.9,6,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","For managing scoliosis correction in myelomeningocele patients, is untethering necessary before surgery? Usually, untethering is performed beforehand to avoid further neurological impairment that might result from scoliosis correction. This should be decided on a case-by-case basis.",3.5528959103528056e-07,0.24577139504914092,0.07939508506616258,0.027201396971728097,0.3088763301834492,0.040742417383431435,0.027162023114293013,0.3746934494414109,0.0,3.552895910352811e-07,0.38441169891033145,0.0
217,0.9,7,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Should untethering be done prior to scoliosis correction in those with myelomeningocele? It is generally required to untether before scoliosis surgery to protect against neurological decline possibly caused by the correction procedure. The decision, however, depends on each patient’s particular condition.",2.3685972735685406e-07,0.11224000242461818,0.07939508506616258,0.018134264647818726,0.17167520866996666,0.040742417383431435,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
217,0.9,8,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Is it important to untether before scoliosis correction in patients who have myelomeningocele? Frequently, untethering is necessary to prevent worsening neurological issues that scoliosis correction might trigger. The treatment plan must be customized to the patient’s individual circumstances.",3.0791764556390996e-07,0.22766895905973117,0.05238891222665641,0.023574544042164344,0.2517179163435008,0.040742417383431435,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
217,0.9,9,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","In the case of myelomeningocele, is untethering mandatory before scoliosis correction? Standard practice involves untethering prior to scoliosis correction to stop further neurological deterioration that the correction might worsen. The decision is patient-specific and requires thorough evaluation.",3.3160361829959526e-07,0.21760051808244407,0.07939508506616258,0.025387970506946217,0.27988879331019767,0.040742417383431435,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
217,0.9,10,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Do patients with myelomeningocele need untethering before scoliosis correction? Generally, untethering precedes scoliosis surgery to avoid additional neurological decline associated with the correction. However, the choice depends on the patient’s clinical profile.",4.5003348197802176e-07,0.3671322520534077,0.07939508506616258,0.034455102830855615,0.43403947313745617,0.040742417383431435,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
218,0.9,1,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","Is reimplanting spinal cord arteries necessary during thoracic and thoracoabdominal aneurysm repair? Yes, it is essential as it helps prevent spinal cord ischemia and reduces the risk of paralysis, making it a vital step in the surgical process.",6.158352911278202e-07,0.3193273064351976,0.1782453064504346,0.04714908808432869,0.4094579277709265,0.09566326530612247,0.04708084006477453,0.4873473914812796,0.049048751486325794,6.158352911278206e-07,0.544879131587273,0.016661878770468257
218,0.9,2,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","During thoracic and thoracoabdominal aneurysm repair, reimplanting spinal cord arteries is crucial and not pointless. This procedure protects against spinal cord ischemia and lowers the chance of paralysis, playing a vital role in the surgery.",6.868932093348761e-07,0.40719064286020856,0.1758667226324568,0.05258936747867432,0.4964693047605566,0.09566326530612247,0.05251324468763315,0.5769595501709666,0.049048751486325794,6.868932093348768e-07,0.6372524517182883,0.016661878770468257
218,0.9,3,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","Reimplantation of spinal cord arteries in thoracic and thoracoabdominal aneurysm repair is important, not a waste. It prevents spinal cord ischemia and reduces paralysis risk, forming a key part of the surgical approach.",7.342651548062467e-07,0.4703635998992919,0.17403399750013845,0.05621622040823808,0.5589896617418901,0.09566326530612247,0.0561348477695389,0.6414980713085381,0.049048751486325794,7.342651548062476e-07,0.7039438262169617,0.016661878770468257
218,0.9,4,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","In thoracic and thoracoabdominal aneurysm repair, reimplanting the spinal cord arteries is a necessary procedure that prevents spinal cord ischemia and minimizes paralysis risk, making it a critical element of the surgery.",7.57951127541932e-07,0.5035097723682251,0.17302925706771854,0.05802964687301996,0.5917794845648818,0.09566326530612247,0.05794564931049177,0.6753996229842198,0.049048751486325794,7.57951127541933e-07,0.7390351460282307,0.016661878770468257
218,0.9,5,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is vital. It helps avoid spinal cord ischemia and reduces the likelihood of paralysis, thus being an important surgical step.",7.57951127541932e-07,0.5035097723682251,0.17302925706771854,0.05802964687301996,0.5917794845648818,0.09566326530612247,0.05794564931049177,0.6753996229842198,0.049048751486325794,7.57951127541933e-07,0.7390351460282307,0.016661878770468257
218,0.9,6,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","Reimplanting spinal cord arteries when repairing thoracic and thoracoabdominal aneurysms is not futile; it is an important procedure that safeguards against spinal cord ischemia and decreases paralysis risk, integral to the operation.",7.57951127541932e-07,0.5035097723682251,0.17302925706771854,0.05802964687301996,0.5917794845648818,0.09566326530612247,0.05794564931049177,0.6753996229842198,0.049048751486325794,7.57951127541933e-07,0.7390351460282307,0.016661878770468257
218,0.9,7,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","It's not a waste of time to reimplant spinal cord arteries during thoracic and thoracoabdominal aneurysm repair. This essential step helps prevent ischemia of the spinal cord and reduces paralysis risk, making it a key part of the surgery.",5.921493183921349e-07,0.3281545052992074,0.1527823434874716,0.045335661619546816,0.38205895358281117,0.09566326530612247,0.045270038523821665,0.45917651451458275,0.049048751486325794,5.921493183921352e-07,0.5158915947140215,0.016661878770468257
218,0.9,8,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is a critical procedure. It prevents spinal cord ischemia and lowers the risk of paralysis, thus it is a crucial part of the surgical strategy.",6.632072365991908e-07,0.41664656306002934,0.14831851326606565,0.05077594101389244,0.46661634161087484,0.09566326530612247,0.05070244314668028,0.5461878915042129,0.049048751486325794,6.632072365991914e-07,0.6055037534037084,0.016661878770468257
218,0.9,9,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","The process of reimplanting spinal cord arteries in thoracic and thoracoabdominal aneurysm repair is significant, not unnecessary. This step helps to prevent spinal cord ischemia and reduce paralysis risk, forming a vital surgical component.",7.105791820705614e-07,0.43827916248147636,0.17497804178994075,0.0544027939434562,0.5272409634273103,0.09566326530612247,0.054324046228586026,0.6087082484855464,0.049048751486325794,7.105791820705622e-07,0.67004227454128,0.016661878770468257
218,0.9,10,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","During thoracic and thoracoabdominal aneurysm surgery, reimplantation of spinal cord arteries is essential. It protects against spinal cord ischemia and lowers paralysis risk, making this procedure an important aspect of aneurysm repair.",7.57951127541932e-07,0.5035097723682251,0.17302925706771854,0.05802964687301996,0.5917794845648818,0.09566326530612247,0.05794564931049177,0.6753996229842198,0.049048751486325794,7.57951127541933e-07,0.7390351460282307,0.016661878770468257
219,0.9,1,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does participation in a preoperative medically supervised weight loss program enhance bariatric surgery results? The MSWM program does not seem to provide extra advantages over the standard preoperative protocol regarding weight loss and behavioral outcomes following LAGB in our patients.,1.4211583641411233e-07,0.11703377018371963,0.01872502767835873,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
219,0.9,2,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,"Is a preoperative medically supervised weight loss program effective in improving bariatric surgery outcomes? In our patient group, MSWM offers no additional benefit compared to the usual preoperative bariatric surgery approach in terms of post-LAGB weight loss and most behavioral measures.",1.1842986367842703e-07,0.12548467099593807,0.005513199468455653,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
219,0.9,3,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Can a medically supervised weight loss program before surgery improve results of bariatric surgery? Our findings suggest MSWM does not add benefits beyond the standard preoperative protocol for weight loss and behavioral outcomes after LAGB.,2.6054570009253883e-07,0.25946224600006795,0.014963539718935746,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
219,0.9,4,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a medically supervised weight loss program before bariatric surgery improve surgical outcomes? MSWM does not appear to provide extra benefit over the standard preoperative protocol for weight loss and most behavioral outcomes after LAGB in our study population.,1.6580180914979763e-07,0.14394467788328003,0.01805172953931231,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
219,0.9,5,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does undergoing a medically supervised weight loss program prior to bariatric surgery enhance postoperative outcomes? Our analysis indicates no additional benefit of MSWM compared to standard preoperative care in weight loss or behavioral outcomes after LAGB.,2.3685972735685353e-07,0.22930975588217795,0.015801583573651523,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
219,0.9,6,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Is there an improvement in bariatric surgery outcomes with a preoperative medically supervised weight loss program? MSWM shows no extra advantage relative to the standard protocol in weight loss and behavior after LAGB in our patients.,2.3685972735685353e-07,0.22930975588217795,0.015801583573651523,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
219,0.9,7,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a preoperative medically supervised weight loss program improve the results of bariatric surgery? Our data reveal that MSWM does not confer further benefits beyond the standard preoperative protocol concerning weight loss and behavioral outcomes post-LAGB.,2.3685972735685353e-07,0.22930975588217795,0.015801583573651523,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
219,0.9,8,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Will a medically supervised preoperative weight loss program enhance bariatric surgery outcomes? The MSWM program appears not to offer additional gains compared to the standard pre-op bariatric surgery protocol in weight loss and most behavioral outcomes after LAGB.,1.8948778188548293e-07,0.20906632474046027,0.009529254643988495,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
219,0.9,9,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a medically supervised weight loss program before surgery improve bariatric surgery outcomes? MSWM does not seem to provide additional benefits over the conventional preoperative protocol in weight reduction and behavioral outcomes following LAGB in our population.,2.1317375462116823e-07,0.16153046859776987,0.04434829637641968,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
219,0.9,10,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,"Is a preoperative medically supervised weight loss program beneficial in improving bariatric surgery outcomes? In terms of weight loss and behavioral results after LAGB, MSWM does not appear to offer advantages beyond the standard preoperative bariatric surgery protocol.",1.8948778188548293e-07,0.20906632474046027,0.009529254643988495,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
220,0.9,1,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does receiving birth center care for a woman's initial pregnancy influence her future reproductive outcomes? Answer: In Sweden, the model of care a woman experiences during her first pregnancy, including birth center care, appears not to significantly affect her later reproduction.",1.1842986367842703e-07,0.058470885560909736,0.04052494591671175,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
220,0.9,2,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.",Question: Is there any effect of birth center care during a woman’s first pregnancy on her subsequent reproduction? Answer: Birth center care as a model for first pregnancy care does not seem to play an important role in influencing future reproduction for women in Sweden.,4.737194547137081e-08,0.04856133083502279,0.002916829812021182,0.0036268529295637453,0.07770177782373144,0.023242630385487524,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
220,0.9,3,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Can birth center care in a woman’s first pregnancy impact her future ability to reproduce? Answer: Evidence from Sweden indicates that the type of care model, like birth center care, during a woman’s initial pregnancy is not a critical factor affecting later reproduction.",7.105791820705622e-08,0.04150958647731384,0.018498994102315543,0.005440279394345618,0.06899287148695166,0.0,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
220,0.9,4,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does the type of care, specifically birth center care, during a first pregnancy affect a woman's later reproductive outcomes? Answer: In Sweden, birth center care during the first pregnancy does not appear to be a significant determinant of subsequent reproduction.",1.4211583641411244e-07,0.11866615861898566,0.015038450071836414,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
220,0.9,5,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does birth center care provided during a woman’s first pregnancy influence her future reproductive patterns? Answer: In Sweden, the maternity care model, such as birth center care, in the first pregnancy seems not to have substantial influence on later reproduction.",1.4211583641411244e-07,0.11866615861898566,0.015038450071836414,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
220,0.9,6,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Is birth center care during a woman’s first pregnancy an important factor in her future reproductive history? Answer: According to data from Sweden, birth center care during the first pregnancy does not significantly impact subsequent reproductive events.",2.1317375462116834e-07,0.27718264269431314,0.04161979696666748,0.016320838183036854,0.30015990470975895,0.055363321799307974,0.0162972138685758,0.2684499827465596,0.02854671280276816,2.1317375462116866e-07,0.23483959107740038,0.0
220,0.9,7,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.",Question: Does birth center care in the initial pregnancy stage affect a woman’s future reproduction? Answer: The choice of care model like birth center care during a woman’s first pregnancy is not a notably influential factor on future reproduction in Sweden.,1.4211583641411244e-07,0.1533235176469825,0.009606993455092486,0.010880558788691236,0.17864685290015903,0.025623268698060954,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
220,0.9,8,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does receiving birth center care in a woman’s first pregnancy alter her chances of future reproduction? Answer: In Sweden, the specific model of care, such as birth center care, during the first pregnancy is not sufficiently important to modify later reproduction outcomes.",9.474389094274162e-08,0.0665752935897439,0.017399945916711734,0.0072537058591274906,0.09309042306601167,0.0,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
220,0.9,9,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.",Question: Does care at a birth center during a woman’s first pregnancy impact her reproductive future? Answer: Birth center care during first pregnancy does not appear to be a key factor affecting subsequent reproduction in Swedish women.,2.3685972735685364e-07,0.23172830961636715,0.009536624117403775,0.018134264647818726,0.2513144282809061,0.0,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
220,0.9,10,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does the provision of birth center care during a woman's initial pregnancy affect her future reproductive behavior? Answer: In Sweden, birth center care as a model during the first pregnancy does not seem to be a major factor influencing later reproduction.",1.1842986367842703e-07,0.0922829431491996,0.016247743418355408,0.009067132323909363,0.15244039468437975,0.02498356344510192,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
221,0.9,1,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Does preoperative anemia negatively impact the results of colon and rectal surgeries? Yes, it can worsen outcomes, increasing risks of postoperative complications such as infections, extended hospitalization, and higher mortality rates.",3.3160361829959463e-07,0.25696549215429787,0.09,0.02538797050694626,0.3616648819601149,0.023242630385487524,0.02535122157334018,0.4054651081081637,0.0,3.316036182995957e-07,0.4177352006999784,0.0
221,0.9,2,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Can preoperative anemia affect colon and rectal surgery outcomes detrimentally? Indeed, it is associated with greater postoperative complications, including infections, longer hospital stays, and elevated mortality.",4.5003348197802113e-07,0.43928704894825277,0.09,0.034455102830855656,0.5509068815986429,0.023242630385487524,0.03440522927810455,0.6021754023542183,0.0,4.500334819780227e-07,0.6225296133459923,0.0
221,0.9,3,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Is there an adverse effect of preoperative anemia on colon and rectal surgery results? Yes, studies indicate it raises the likelihood of postoperative infections, prolonged hospitalizations, and increased death rates.",3.5528959103527993e-07,0.29086704382997963,0.09,0.027201396971728138,0.39675620177138393,0.023242630385487524,0.027162023114293055,0.4418327522790384,0.0,3.552895910352811e-07,0.45547552868282537,0.0
221,0.9,4,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Does anemia before surgery worsen outcomes in colon and rectal procedures? Yes, preoperative anemia contributes to higher chances of postoperative complications, longer hospital stays, and increased mortality.",4.2634750924233583e-07,0.4000663357949703,0.09,0.03264167636607378,0.5100848870783881,0.023242630385487524,0.032594427737151675,0.5596157879354227,0.0,4.263475092423373e-07,0.5780778507751583,0.0
221,0.9,5,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Will preoperative anemia negatively influence the outcomes of colon and rectal surgery? Research suggests it does, leading to more postoperative complications, such as infections, extended hospital duration, and greater mortality.",3.5528959103527993e-07,0.29086704382997963,0.09,0.027201396971728138,0.39675620177138393,0.023242630385487524,0.027162023114293055,0.4418327522790384,0.0,3.552895910352811e-07,0.45547552868282537,0.0
221,0.9,6,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Is preoperative anemia harmful to the prognosis of colon and rectal surgeries? Yes, it increases risks including postoperative infections, lengthier hospital stays, and higher mortality rates.",4.5003348197802113e-07,0.43928704894825277,0.09,0.034455102830855656,0.5509068815986429,0.023242630385487524,0.03440522927810455,0.6021754023542183,0.0,4.500334819780227e-07,0.6225296133459923,0.0
221,0.9,7,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Does having anemia before colon or rectal surgery lead to worse outcomes? Yes, it is linked to elevated postoperative complications, longer hospital admissions, and increased risk of death.",4.0266153650665053e-07,0.3623260078121233,0.09,0.030828249901291897,0.4708641739251056,0.023242630385487524,0.0307836261961988,0.5187937934151678,0.0,4.026615365066519e-07,0.5355182363563626,0.0
221,0.9,8,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Can anemia prior to colon and rectal surgery detrimentally affect surgical outcomes? Yes, it is associated with increased postoperative infections, prolonged hospitalization, and higher mortality.",4.7371945471370643e-07,0.4801090434685076,0.09,0.036268529295637536,0.5934664960174385,0.023242630385487524,0.03621603081905742,0.6466271649250523,0.0,4.737194547137081e-07,0.6690496289808863,0.0
221,0.9,9,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Does preoperative anemia negatively impact colon and rectal surgery results? Yes, evidence shows it raises the risk of postoperative complications, longer hospital stays, and higher death rates.",4.2634750924233583e-07,0.4000663357949703,0.09,0.03264167636607378,0.5100848870783881,0.023242630385487524,0.032594427737151675,0.5596157879354227,0.0,4.263475092423373e-07,0.5780778507751583,0.0
221,0.9,10,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Is the presence of anemia before surgery a negative factor for colon and rectal surgery outcomes? Yes, it has been shown to increase the incidence of postoperative complications, including infection, longer hospital stays, and higher mortality.",2.1317375462116813e-07,0.10281481232703937,0.09,0.01632083818303686,0.20260018733042617,0.023242630385487524,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
222,0.9,1,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Is alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis a precursor to bronchiectasis? Yes, it can be. This impaired function hinders bacterial clearance from the lungs, causing persistent infection and inflammation that may lead to bronchiectasis.",4.26347509242337e-07,0.16956710440499023,0.15737240075614362,0.03264167636607371,0.20008816572003285,0.14366729678638948,0.0325944277371516,0.23184837040536355,0.12901701323251416,4.263475092423373e-07,0.26492615229758654,0.113421550094518
222,0.9,2,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Can alveolar macrophage phagocytic dysfunction in kids with protracted bacterial bronchitis lead to bronchiectasis? Yes, the dysfunction compromises bacterial clearance in the lungs, resulting in ongoing infections and inflammation that might develop into bronchiectasis.",5.210914001850782e-07,0.2839774555827357,0.15737240075614362,0.03989538222520122,0.31787120137641667,0.14366729678638948,0.03983763390096309,0.35320922740963034,0.12901701323251416,5.210914001850789e-07,0.3900892952515935,0.113421550094518
222,0.9,3,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Does alveolar macrophage phagocytic dysfunction in children suffering from protracted bacterial bronchitis serve as a forerunner to bronchiectasis? Yes, because this dysfunction hampers bacteria removal from the lungs, causing chronic infections and inflammation that can progress to bronchiectasis.",4.26347509242337e-07,0.16956710440499023,0.15737240075614362,0.03264167636607371,0.20008816572003285,0.14366729678638948,0.0325944277371516,0.23184837040536355,0.12901701323251416,4.263475092423373e-07,0.26492615229758654,0.113421550094518
222,0.9,4,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Is the phagocytic dysfunction of alveolar macrophages in children with protracted bacterial bronchitis an early indicator of bronchiectasis? Yes, since this dysfunction reduces bacterial clearance, leading to persistent lung infections and inflammation that may culminate in bronchiectasis.",4.500334819780223e-07,0.19696607859310555,0.15737240075614362,0.03445510283085558,0.2282590426867297,0.14366729678638948,0.03440522927810447,0.26083590727861505,0.12901701323251416,4.500334819780227e-07,0.2947791154472683,0.113421550094518
222,0.9,5,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Could alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis precede bronchiectasis? Yes, as this dysfunction limits bacterial clearance, resulting in continuous infection and inflammation that can develop into bronchiectasis.",5.921493183921341e-07,0.3792876353870609,0.15737240075614362,0.04533566161954686,0.41631127418966996,0.14366729678638948,0.045270038523821714,0.4549919217195728,0.12901701323251416,5.921493183921352e-07,0.495449810909419,0.113421550094518
222,0.9,6,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Does alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis act as a forerunner to bronchiectasis? Yes, it can, because this impaired function obstructs the removal of bacteria from the lungs, leading to persistent infections and inflammation that may cause bronchiectasis.",3.316036182995957e-07,0.06691295034490796,0.15737240075614362,0.025387970506946217,0.09472765006220696,0.14366729678638948,0.025351221573340132,0.12363478576513254,0.12901701323251416,3.316036182995957e-07,0.153700517187362,0.113421550094518
222,0.9,7,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Is alveolar macrophage phagocytic dysfunction a precursor to bronchiectasis in children with protracted bacterial bronchitis? Yes, this dysfunction diminishes the lungs' ability to clear bacteria, which results in chronic infections and inflammation that can trigger bronchiectasis.",4.737194547137076e-07,0.2251369555598024,0.15737240075614362,0.03626852929563746,0.2572465795599812,0.14366729678638948,0.036216030819057346,0.29068887042829683,0.12901701323251416,4.737194547137081e-07,0.325550774114022,0.113421550094518
222,0.9,8,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Is alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis an early stage in the development of bronchiectasis? Yes, due to its effect on impaired bacterial clearance, leading to recurrent infections and inflammation that may lead to bronchiectasis.",4.026615365066517e-07,0.14289885732282936,0.15737240075614362,0.030828249901291835,0.17268919153191753,0.14366729678638948,0.030783626196198732,0.2036774934386667,0.12901701323251416,4.026615365066519e-07,0.23593861542433503,0.113421550094518
222,0.9,9,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Can alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis initiate bronchiectasis? Yes, because the dysfunction impedes bacterial clearance in the lungs, causing persistent infections and inflammation that can progress to bronchiectasis.",5.447773729207635e-07,0.31474911424948937,0.15737240075614362,0.0417088086899831,0.3496198996909965,0.14366729678638948,0.04164843544191597,0.38599905023262204,0.12901701323251416,5.447773729207643e-07,0.4239908469272753,0.113421550094518
222,0.9,10,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Is alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis linked to the onset of bronchiectasis? Yes, since this dysfunction reduces the lungs’ capacity to clear bacteria, resulting in ongoing infections and inflammation that ultimately may lead to bronchiectasis.",3.789755637709664e-07,0.11692337091957139,0.15737240075614362,0.029014823436509962,0.14602094444975666,0.14366729678638948,0.028972824655245866,0.17627851925055138,0.12901701323251416,3.789755637709665e-07,0.20776773845763818,0.113421550094518
223,0.9,1,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Is neck dissection required for metastatic carcinoma to cervical nodes when the primary head and neck site is unknown? Yes, it is commonly needed to control regional disease, prevent further metastasis, and enhance overall survival, though individual evaluation is essential to weigh benefits against risks.",5.921493183921352e-07,0.20882219917988643,0.1662049861495845,0.045335661619546816,0.2340540898896215,0.15574022776238844,0.045270038523821665,0.2601133949703005,0.14465989535241613,5.921493183921352e-07,0.28704253516940437,0.13296398891966757
223,0.9,2,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","For metastatic carcinoma involving cervical nodes from an unidentified head and neck primary site, neck dissection is usually necessary to manage local disease and improve survival outcomes, with decisions tailored to each patient.",8.763809912203592e-07,0.5272759302984218,0.1662049861495845,0.06709677919692932,0.5612670010980372,0.15574022776238844,0.06699965701525609,0.5965856315915135,0.14465989535241613,8.7638099122036e-07,0.6333187718872391,0.13296398891966757
223,0.9,3,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Metastatic carcinoma to cervical lymph nodes with an unknown primary in the head and neck region often warrants neck dissection to control disease progression and increase survival chances, but each case must be assessed on its own merits.",7.579511275419327e-07,0.38209392045392265,0.1662049861495845,0.058029646873019924,0.41173526712707353,0.15574022776238844,0.05794564931049173,0.44243495176425496,0.14465989535241613,7.57951127541933e-07,0.4742540772575503,0.13296398891966757
223,0.9,4,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","In cases of metastatic carcinoma to cervical nodes from a head and neck primary site that is unknown, neck dissection is frequently performed to contain regional disease and improve survival, while personalizing treatment based on risks and benefits.",7.579511275419327e-07,0.38209392045392265,0.1662049861495845,0.058029646873019924,0.41173526712707353,0.15574022776238844,0.05794564931049173,0.44243495176425496,0.14465989535241613,7.57951127541933e-07,0.4742540772575503,0.13296398891966757
223,0.9,5,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Neck dissection is typically indicated for metastatic carcinoma in cervical nodes when the primary head and neck tumor is unknown, as it helps manage disease and reduce metastasis, though patient-specific evaluation is important.",8.763809912203592e-07,0.5272759302984218,0.1662049861495845,0.06709677919692932,0.5612670010980372,0.15574022776238844,0.06699965701525609,0.5965856315915135,0.14465989535241613,8.7638099122036e-07,0.6333187718872391,0.13296398891966757
223,0.9,6,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","When metastatic carcinoma affects cervical nodes from an unknown primary head and neck source, neck dissection is generally recommended for regional control and survival advantage, with careful individual case consideration.",9.474389094274151e-07,0.6257160031116751,0.1662049861495845,0.07253705859127496,0.6630496954079796,0.15574022776238844,0.07243206163811472,0.7019461472493389,0.14465989535241613,9.474389094274162e-07,0.7425180638522297,0.13296398891966757
223,0.9,7,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Management of metastatic carcinoma to cervical nodes from an unknown head and neck primary site often includes neck dissection to prevent metastasis and improve outcomes, with decisions customized to each patient's circumstances.",9.000669639560445e-07,0.5590246286130016,0.1662049861495845,0.06891020566171119,0.5940568239210289,0.15574022776238844,0.06881045855620897,0.6304871832671952,0.14465989535241613,9.000669639560454e-07,0.6684100916985081,0.13296398891966757
223,0.9,8,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","In metastatic carcinoma to cervical lymph nodes of unknown head and neck origin, neck dissection is often necessary to control regional spread and enhance survival, but individual cases require careful assessment.",9.237529366917298e-07,0.5918144514359933,0.1662049861495845,0.07072363212649307,0.6279583755967106,0.15574022776238844,0.07062126009716185,0.6655785030784642,0.14465989535241613,9.237529366917308e-07,0.7047777358693827,0.13296398891966757
223,0.9,9,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Performing neck dissection is commonly warranted in metastatic carcinoma to cervical nodes from an unknown head and neck primary to limit disease and improve prognosis, though benefits must be balanced against risks case-by-case.",8.763809912203592e-07,0.5272759302984218,0.1662049861495845,0.06709677919692932,0.5612670010980372,0.15574022776238844,0.06699965701525609,0.5965856315915135,0.14465989535241613,8.7638099122036e-07,0.6333187718872391,0.13296398891966757
223,0.9,10,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Neck dissection plays a key role in treating metastatic carcinoma to cervical nodes from an unknown primary head and neck tumor by controlling disease and improving survival, yet the approach should be personalized based on each patient's situation.",7.579511275419327e-07,0.38209392045392265,0.1662049861495845,0.058029646873019924,0.41173526712707353,0.15574022776238844,0.05794564931049173,0.44243495176425496,0.14465989535241613,7.57951127541933e-07,0.4742540772575503,0.13296398891966757
224,0.9,1,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: 30-Day and 1-year mortality rates following emergency general surgery laparotomies: a critical issue requiring improvement? Answer: Emergency laparotomy is associated with a significant mortality rate, particularly in patients older than 70 years, highlighting the need for enhanced efforts to improve outcomes, especially in this demographic. Strategies could include expanding acute surgical care staffing and early identification of patients in need.",2.3685972735685406e-08,0.01652930195121094,0.0,0.0018134264647818726,0.01680711831638071,0.0,0.0018108015409528666,0.01709443335929972,0.0,2.3685972735685406e-08,0.01739174271186883,0.0
224,0.9,2,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Are 30-day and 1-year mortality rates after emergency general surgery laparotomies a concern that demands improvement? Answer: Emergency laparotomies have a high mortality rate, notably among those aged over 70, necessitating further measures to enhance patient outcomes, especially in this age group. Improvements might involve boosting acute surgical care resources and prompt patient recognition.",1.6580180914979784e-07,0.12188981760903506,0.0,0.012693985253473108,0.12405264866997845,0.0,0.012675610786670066,0.12629372532429084,0.0,1.6580180914979784e-07,0.12861737782209381,0.0
224,0.9,3,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Is the mortality within 30 days and 1 year after emergency general surgery laparotomies an area needing improvement? Answer: Emergency laparotomies entail high mortality, particularly for patients above 70 years old, indicating a pressing need to improve outcomes with focused interventions like increasing surgical care manpower and timely patient identification.",2.6054570009253947e-07,0.19885085874516495,0.0,0.0199476911126006,0.20252426411147262,0.0,0.019918816950481533,0.20633643299782767,0.0,2.6054570009253947e-07,0.2102954088363611,0.0
224,0.9,4,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: 30-day and 1-year mortality in emergency general surgery laparotomies: a problem that requires better management? Answer: Emergency laparotomy shows a high death rate, especially in those over 70, calling for intensified efforts to improve survival, which may include augmenting acute surgical staff and early detection of critical patients.",3.079176455639103e-07,0.23967285326541932,0.0,0.023574544042164344,0.24419696051204154,0.0,0.023540420032387266,0.2488960474166242,0.0,3.079176455639103e-07,0.25378052077609947,0.0
224,0.9,5,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Are 30-day and 1-year mortality outcomes for emergency general surgery laparotomies an issue that needs addressing? Answer: There is a significant mortality risk associated with emergency laparotomies, particularly in elderly patients over 70 years, emphasizing the need for improvements such as increasing acute surgical care personnel and early patient assessment.",2.6054570009253947e-07,0.19885085874516495,0.0,0.0199476911126006,0.20252426411147262,0.0,0.019918816950481533,0.20633643299782767,0.0,2.6054570009253947e-07,0.2102954088363611,0.0
224,0.9,6,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Does 30-day and 1-year mortality following emergency general surgery laparotomies represent an area for improvement? Answer: Emergency laparotomy mortality rates are notably high, especially among those older than 70 years, underscoring the necessity for enhanced outcomes through strategies like expanding surgical care manpower and early patient recognition.",3.316036182995957e-07,0.2607262624632525,0.0,0.025387970506946217,0.2657031657330049,0.0,0.025351221573340132,0.2708749541353992,0.0,3.316036182995957e-07,0.2762533766281572,0.0
224,0.9,7,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Are mortality rates at 30 days and 1 year after emergency general surgery laparotomies a concern requiring intervention? Answer: The mortality following emergency laparotomies is high, primarily for patients aged over 70, and improved outcomes are needed, potentially via increased acute surgical workforce and earlier patient identification.",3.316036182995957e-07,0.2607262624632525,0.0,0.025387970506946217,0.2657031657330049,0.0,0.025351221573340132,0.2708749541353992,0.0,3.316036182995957e-07,0.2762533766281572,0.0
224,0.9,8,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Is there a concern with 30-day and 1-year mortality in emergency general surgery laparotomies that necessitates improvement? Answer: Emergency laparotomy carries a substantial mortality risk, especially in patients older than 70 years, demanding enhanced efforts such as boosting acute care surgeon availability and timely detection of those needing surgery.",2.8423167282822487e-07,0.21905356606268356,0.0,0.02176111757738247,0.22314355131420838,0.0,0.0217296184914344,0.22738984219566083,0.0,2.8423167282822487e-07,0.23180161405732447,0.0
224,0.9,9,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: 30-day and 1-year mortality in emergency general surgery laparotomies: an issue demanding enhanced care? Answer: Emergency laparotomy has a high fatality rate, particularly in individuals over 70, requiring more targeted improvement actions including increasing acute surgical manpower and early patient identification.",4.737194547137081e-07,0.3973017974690025,0.0,0.03626852929563745,0.4054651081081633,0.0,0.03621603081905733,0.4139757977760743,0.0,4.737194547137081e-07,0.42285685082003255,0.0
224,0.9,10,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Are the 30-day and 1-year mortality statistics following emergency general surgery laparotomies an area needing better management? Answer: Emergency laparotomy mortality is significantly high, notably among patients over 70, calling for improved outcomes by augmenting acute surgical staffing and early recognition of patients needing intervention.",3.789755637709665e-07,0.30421137440299084,0.0,0.029014823436509962,0.3101549283038376,0.0,0.028972824655245866,0.31633732821215643,0.0,3.789755637709665e-07,0.32277339226305113,0.0
225,0.9,1,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Is the vision loss caused by amblyopia permanent? Amblyopia, commonly referred to as lazy eye, typically develops in childhood. Without treatment, it may result in lasting vision impairment. Yet, early diagnosis and intervention, such as vision therapy or corrective lenses, can often reverse the effects and bring vision back to normal or close to normal.",1.1842986367842703e-07,0.0971637484536485,0.0,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
225,0.9,2,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Does amblyopia cause irreversible visual loss? Known as lazy eye, amblyopia usually appears in childhood. If it remains untreated, it can cause permanent vision loss. But if detected and treated early with methods like vision therapy or glasses, the condition can often be reversed to restore normal or nearly normal eyesight.",2.3685972735685406e-08,0.02020270731751861,0.0,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
225,0.9,3,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Is vision loss from amblyopia permanent? Amblyopia, or lazy eye, generally begins in childhood and can cause permanent vision loss if untreated. Nevertheless, early identification and treatment involving vision therapy or corrective glasses can frequently restore normal or near-normal vision.",2.3685972735685396e-07,0.2638046612404663,0.025623268698060954,0.018134264647818726,0.2336148511815046,0.0,0.018108015409528666,0.2392296890658323,0.0,2.3685972735685406e-07,0.24512245803298427,0.0
225,0.9,4,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Can amblyopia lead to permanent vision loss? Also called lazy eye, amblyopia often emerges during childhood. If not treated, it may cause permanent loss of vision. However, with timely detection and therapy, including vision exercises or eyeglasses, the condition can often be reversed to regain normal or near-normal vision.",2.3685972735685406e-08,0.02061928720273576,0.0,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
225,0.9,5,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Is the impairment caused by amblyopia permanent? Amblyopia (lazy eye) usually starts in childhood and can cause lasting vision loss if untreated. Early treatment, such as vision therapy or corrective eyewear, often allows the condition to be reversed, restoring normal or almost normal sight.",1.4211583641411244e-07,0.13062018241706452,0.0,0.010880558788691236,0.13353139262452318,0.0,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
225,0.9,6,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Does amblyopia result in permanent visual impairment? This condition, known as lazy eye, typically begins in childhood and can cause permanent vision loss if untreated. However, with early diagnosis and intervention like vision therapy or corrective lenses, it can often be reversed to achieve normal or near-normal vision.",4.737194547137081e-08,0.04167269640056892,0.0,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
225,0.9,7,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Is the vision loss from amblyopia permanent? Lazy eye, or amblyopia, starts frequently in childhood and can lead to permanent vision deficits if untreated. Early detection and treatment through vision therapy or corrective eyewear can often reverse the condition and restore normal or near-normal vision.",1.1842986367842703e-07,0.107630664192365,0.0,0.009067132323909363,0.11000089521432876,0.0,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
225,0.9,8,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Will vision loss from amblyopia be permanent? Amblyopia, also called lazy eye, generally occurs in childhood and if left untreated, can cause lasting vision loss. With early treatment including vision therapy or corrective glasses, normal or near-normal vision can often be restored.",1.8948778188548325e-07,0.17824823140631896,0.0,0.014507411718254981,0.1823215567939549,0.0,0.014486412327622933,0.18658595558041347,0.0,1.8948778188548325e-07,0.19105523676270808,0.0
225,0.9,9,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Is permanent vision loss inevitable with amblyopia? Amblyopia (lazy eye) commonly appears in childhood and if untreated, may cause permanent vision loss. Nonetheless, early diagnosis and interventions such as vision therapy or corrective lenses can often reverse the condition, recovering normal or near-normal vision.",1.4211583641411244e-07,0.16285958616403873,0.023242630385487524,0.010880558788691236,0.13353139262452318,0.0,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
225,0.9,10,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Does amblyopia cause lasting vision deficits? Also known as lazy eye, amblyopia often develops in childhood. If untreated, it can lead to permanent vision loss. However, early detection and appropriate treatment including vision therapy or corrective eyewear can often restore normal or nearly normal vision.",1.1842986367842703e-07,0.107630664192365,0.0,0.009067132323909363,0.11000089521432876,0.0,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
226,0.9,1,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Can student examiners reasonably replace faculty as examiners in an undergraduate OSCE on medical emergencies? It appears acceptable and justified to involve medical students as examiners in formative OSCE assessments in emergency medicine, though less so for summative evaluations.",1.6580180914979763e-07,0.2420391911555062,0.05246913580246914,0.012693985253473108,0.21073913643943865,0.027006172839506164,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
226,0.9,2,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it reasonable for student examiners to act as substitutes for faculty in an undergraduate medical emergency OSCE? Encouraging medical students to serve as examiners in formative OSCE testing of emergency medicine seems quite justifiable, but this may not extend to summative assessments.",7.105791820705622e-08,0.06899287148695166,0.0,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
226,0.9,3,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","May medical students serve as reasonable substitute examiners for faculty in an undergraduate OSCE on emergencies? It is generally acceptable and justified to have students officiate during formative OSCE exams in emergency medicine, but not necessarily during summative exams.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
226,0.9,4,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Are student examiners appropriate substitutes for faculty in an undergraduate emergency medicine OSCE? Inviting medical students to act as examiners in formative OSCE testing appears reasonable and justified, though it might not be suitable for summative assessment.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
226,0.9,5,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it permissible for student examiners to replace faculty in an undergraduate OSCE focusing on medical emergencies? It seems justified and reasonable to have medical students as examiners in formative OSCE assessments, but not definitely in summative evaluations.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
226,0.9,6,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Can student examiners reasonably substitute faculty examiners in an undergraduate OSCE exam on medical emergencies? It looks admissible and justified to include medical students as examiners during formative OSCE testing, but not necessarily for summative assessment purposes.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
226,0.9,7,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Are medical students reasonable substitutes for faculty examiners in an undergraduate emergency medicine OSCE? It appears acceptable to involve students as examiners during formative OSCEs, yet this approach may not extend to summative assessments.",2.8423167282822413e-07,0.3101549283038394,0.0,0.021761117577382492,0.31845373111853537,0.0,0.021729618491434427,0.32721291120841567,0.0,2.8423167282822487e-07,0.33647223662121295,0.0
226,0.9,8,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it justified for student examiners to replace faculty members in an undergraduate OSCE on medical emergencies? Encouraging medical students to officiate in formative OSCE testing is reasonable, but their involvement in summative assessments is not necessarily justified.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
226,0.9,9,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","May student examiners take on the role of substitute faculty examiners in an undergraduate OSCE focused on medical emergencies? It is quite admissible and justified to encourage student examiners in formative OSCE evaluations, but this does not necessarily apply to summative assessments.",9.474389094274162e-08,0.1607145382425914,0.04865220249835634,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
226,0.9,10,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Are student examiners reasonable alternatives to faculty in an undergraduate OSCE on emergency medicine? It is generally justified to have medical students officiate formative OSCE testing, although this may not be appropriate for summative evaluations.",2.6054570009253883e-07,0.2803019651541576,0.0,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
227,0.9,1,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Do high flow nasal cannulae produce more noise than bubble CPAP in preterm infants? Answer: Within the gas flow range studied, HFNC are not noisier than BCPAP for preterm infants.",7.10579182070559e-08,0.208048986851892,0.07359999999999998,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
227,0.9,2,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Are high flow nasal cannulae louder than bubble CPAP for premature babies? Answer: At the gas flows assessed, HFNC do not generate more noise than BCPAP for preterm infants.",4.73719454713706e-08,0.17414743517621023,0.07359999999999998,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
227,0.9,3,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Is the noise level of high flow nasal cannulae higher than that of bubble CPAP in preterm infants? Answer: At the studied gas flow rates, HFNC are not noisier than BCPAP in preterm infants.",1.658018091497971e-07,0.29243876624354925,0.04421524334251605,0.012693985253473157,0.23841102344499765,0.0,0.012675610786670115,0.24686007793152642,0.0,1.6580180914979784e-07,0.2559333741372014,0.0
227,0.9,4,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Do high flow nasal cannulae create more noise compared to bubble CPAP for preterm infants? Answer: Based on the gas flows examined, HFNC are not louder than BCPAP for preterm infants.",9.47438909427412e-08,0.19611963673553268,0.041377777777777784,0.007253705859127518,0.14310084364067244,0.0,0.007243206163811494,0.14842000511827314,0.0,9.474389094274162e-08,0.15415067982725894,0.0
227,0.9,5,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Are high flow nasal cannulae noisier than bubble CPAP devices for premature infants? Answer: At the gas flow levels studied, HFNC are not noisier than BCPAP for preterm infants.",4.73719454713706e-08,0.1263441813444901,0.03916122448979589,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
227,0.9,6,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Is the sound output of high flow nasal cannulae greater than bubble CPAP for preterm infants? Answer: Under the studied gas flow conditions, HFNC are not noisier than BCPAP for preterm infants.",1.184298636784265e-07,0.22926580920446593,0.04238251821019768,0.009067132323909398,0.17589066646366414,0.0,0.009054007704764368,0.1823215567939549,0.0,1.1842986367842703e-07,0.18924199963852795,0.0
227,0.9,7,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Are high flow nasal cannulae producing more noise than bubble CPAP in preterm infants? Answer: At the gas flow rates investigated, HFNC are not noisier than BCPAP for preterm infants.",7.10579182070559e-08,0.208048986851892,0.07359999999999998,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
227,0.9,8,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Is the noise generated by high flow nasal cannulae higher than bubble CPAP for preterm infants? Answer: At the gas flows reviewed, HFNC are not noisier than BCPAP for preterm infants.",9.47438909427412e-08,0.19611963673553268,0.041377777777777784,0.007253705859127518,0.14310084364067244,0.0,0.007243206163811494,0.14842000511827314,0.0,9.474389094274162e-08,0.15415067982725894,0.0
227,0.9,9,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Do high flow nasal cannulae emit more noise than bubble CPAP in preterm infants? Answer: Considering the studied gas flows, HFNC are not noisier than BCPAP for preterm infants.",4.73719454713706e-08,0.17414743517621023,0.07359999999999998,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
227,0.9,10,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Are high flow nasal cannulae louder than bubble CPAP at the gas flows used for preterm infants? Answer: At the gas flows evaluated, HFNC are not noisier than BCPAP for preterm infants.",1.184298636784265e-07,0.09930071284947628,0.04884897959183675,0.009067132323909398,0.08645232058496166,0.06420927467300831,0.009054007704764368,0.13611174475662535,0.033293697978596916,1.1842986367842703e-07,0.18924199963852795,0.0
228,0.9,1,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Does having both major depression and alcohol use disorder during adolescence result in worse depression outcomes? Yes, having both conditions together in adolescence typically leads to more severe depression outcomes. The coexistence of these disorders can intensify depressive symptoms, complicating treatment and potentially causing deeper and more persistent effects.",4.026615365066519e-07,0.14011894150986137,0.11406130186343437,0.030828249901291835,0.15710953590212595,0.1077254539858418,0.030783626196198732,0.20446996790879757,0.07877526753864447,4.026615365066519e-07,0.2533931358657444,0.048261993679977015
228,0.9,2,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Is the outcome of depression poorer when an adolescent has both major depression and alcohol use disorder? Indeed, the combination of major depression and alcohol use disorder in adolescents often results in worse depression outcomes. The simultaneous presence of both can worsen the severity of depression, making treatment more difficult and leading to longer-lasting impacts.",2.6054570009253947e-07,0.09614324452421341,0.06128520408163267,0.0199476911126006,0.11543471619892465,0.05132545398584177,0.019918816950481533,0.135186659705691,0.04037526753864446,2.6054570009253947e-07,0.15541223528663828,0.028661993679977023
228,0.9,3,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Does comorbidity of major depression and alcohol use disorder in adolescence worsen depression outcomes? Yes, adolescents with both major depression and alcohol use disorder frequently experience poorer outcomes in depression. The dual diagnosis can amplify depressive symptoms and severity, complicating therapy and potentially resulting in more significant and enduring effects.",3.789755637709665e-07,0.2320771300613349,0.03416206358576493,0.029014823436509962,0.2515806567976169,0.02508082588666824,0.028972824655245866,0.27145063680186965,0.01524220968740482,3.789755637709665e-07,0.29168789702174713,0.004873563927910891
228,0.9,4,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","When adolescents suffer from both major depression and alcohol use disorder, does it lead to worse depression results? Yes, having both disorders concurrently during adolescence often leads to poorer depression outcomes. The combined effect can intensify symptoms and severity, making effective treatment more challenging and causing more profound long-term consequences.",3.789755637709665e-07,0.09061852178379493,0.13488520408163265,0.029014823436509962,0.1360561267042928,0.1077254539858418,0.028972824655245866,0.1829637626878342,0.07877526753864447,3.789755637709665e-07,0.2314142291469694,0.048261993679977015
228,0.9,5,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Is there a decline in depression outcomes when adolescents have both major depression and alcohol use disorder? Yes, the comorbidity of major depression and alcohol use disorder during adolescence generally results in poorer depression outcomes. The presence of both disorders can increase symptom severity, hinder treatment efforts, and lead to more lasting impacts.",3.079176455639103e-07,0.1378331290914474,0.05849631519274377,0.023574544042164344,0.15697823201255767,0.049131703985841796,0.023540420032387266,0.17654013341454222,0.038844711983088906,3.079176455639103e-07,0.1965270491809452,0.02786268812442146
228,0.9,6,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Do adolescents with co-occurring major depression and alcohol use disorder experience worse depression outcomes? Yes, comorbid major depression and alcohol use disorder in adolescence often lead to worse outcomes in depression. The simultaneous existence of both conditions may exacerbate depressive symptoms, complicating treatment and causing more enduring effects.",4.263475092423373e-07,0.27976934170775625,0.030009920634920625,0.03264167636607371,0.29916307687264476,0.02155765353232704,0.0325944277371516,0.31886849870223166,0.012448736926399584,4.263475092423373e-07,0.33887937176870686,0.0029105197570745214
228,0.9,7,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Does having both major depression and alcohol use disorder in adolescence negatively affect depression recovery? Yes, adolescents with both major depression and alcohol use disorder tend to have poorer depression outcomes. The combined disorders can heighten symptom severity and complexity, making treatment more difficult and potentially leading to lasting repercussions.",3.789755637709665e-07,0.260368851716843,0.014820304135715959,0.029014823436509962,0.280461789320948,0.004967206284381576,0.028972824655245866,0.30094626150654813,0.005594662153080784,3.789755637709665e-07,0.3218247309591362,0.016637952236734734
228,0.9,8,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Is depression outcome adversely affected in adolescents with major depression and alcohol use disorder? Yes, the concurrent presence of major depression and alcohol use disorder in adolescence is associated with poorer outcomes in depression. This comorbidity can worsen symptoms and severity, complicating treatment and resulting in more enduring effects.",4.026615365066519e-07,0.22676233907985477,0.052240575982459084,0.030828249901291835,0.2455964100161614,0.044192396134602144,0.030783626196198732,0.2647436357835753,0.03538683778657835,4.026615365066519e-07,0.2841996772239641,0.026051249878324124
228,0.9,9,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Are depression outcomes worse in adolescents with both major depression and alcohol use disorder? Yes, having both disorders together during adolescence often results in poorer depression outcomes. The co-occurrence can amplify the intensity of depressive symptoms, making effective treatment harder and causing more significant long-term consequences.",4.737194547137081e-07,0.1757763301241022,0.13488520408163265,0.03626852929563745,0.22306750369392203,0.1077254539858418,0.03621603081905733,0.2719112487043298,0.07877526753864447,4.737194547137081e-07,0.32238600735269607,0.048261993679977015
228,0.9,10,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Does the presence of both major depression and alcohol use disorder during adolescence lead to poorer depression outcomes? Yes, the comorbidity of these two disorders in adolescence frequently results in worse depression outcomes. This co-occurrence can intensify symptoms and severity, complicating treatment and leading to more profound and lasting effects.",3.789755637709665e-07,0.09061852178379493,0.13488520408163265,0.029014823436509962,0.1360561267042928,0.1077254539858418,0.028972824655245866,0.1829637626878342,0.07877526753864447,3.789755637709665e-07,0.2314142291469694,0.048261993679977015
229,0.9,1,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Can severe hypotension in coronary disease patients lead to myocardial ischemic events? Yes, significant drops in blood pressure can reduce coronary blood flow, raising the risk of the heart muscle not getting enough oxygen and nutrients, causing ischemia.",4.26347509242337e-07,0.21997780844571313,0.12456597222222221,0.03264167636607371,0.30277663691409806,0.0736,0.0325944277371516,0.38878735468308667,0.018860946745562133,4.263475092423373e-07,0.42488319396526597,0.0
229,0.9,2,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Do profound hypotensive episodes in patients with coronary artery disease cause myocardial ischemia? Indeed, such hypotensive events may lower coronary circulation, resulting in insufficient oxygen supply to the heart muscle and potential ischemic damage.",5.210914001850782e-07,0.3343881596234586,0.12456597222222221,0.03989538222520122,0.4205596725704819,0.0736,0.03983763390096309,0.5101482116873535,0.018860946745562133,5.210914001850789e-07,0.550046336919273,0.0
229,0.9,3,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Is there a risk of myocardial ischemia due to severe hypotension in individuals with coronary disease? Yes, extreme hypotension can diminish coronary blood perfusion and increase the likelihood of ischemic injury to the heart muscle.",4.974054274493929e-07,0.3045351964737768,0.12456597222222221,0.03808195576041934,0.3897880139037282,0.0736,0.03802683236001022,0.47839951337277364,0.018860946745562133,4.974054274493935e-07,0.5172565140962813,0.0
229,0.9,4,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Can major hypotensive events trigger myocardial ischemia in coronary disease patients? Yes, because significant hypotension reduces coronary blood flow, it can lead to inadequate oxygen delivery to cardiac tissue and provoke ischemic episodes.",5.447773729207635e-07,0.36515981829021227,0.12456597222222221,0.0417088086899831,0.4523083708850617,0.0736,0.04164843544191597,0.5429380345103452,0.018860946745562133,5.447773729207643e-07,0.5839478885949547,0.0
229,0.9,5,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Are myocardial ischemic events caused by profound hypotension in coronary disease patients? Yes, extreme hypotension can compromise coronary circulation, leading to oxygen deprivation in the myocardium and ischemia.",6.6320723659919e-07,0.5350588550856092,0.12456597222222221,0.050775941013892496,0.6281990373487258,0.0736,0.050702443146680334,0.7252595913043001,0.018860946745562133,6.632072365991914e-07,0.7731898882334827,0.0
229,0.9,6,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Does profound hypotension induce myocardial ischemia in patients suffering from coronary disease? Yes, large drops in blood pressure may impair coronary blood flow, increasing ischemic risks to heart muscle due to insufficient oxygen and nutrients.",4.974054274493929e-07,0.3045351964737768,0.12456597222222221,0.03808195576041934,0.3897880139037282,0.0736,0.03802683236001022,0.47839951337277364,0.018860946745562133,4.974054274493935e-07,0.5172565140962813,0.0
229,0.9,7,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Can patients with coronary artery disease experience myocardial ischemia from severe hypotensive episodes? Yes, because hypotension can lower coronary blood flow, it may result in the heart muscle receiving inadequate oxygen, causing ischemic events.",5.210914001850782e-07,0.3343881596234586,0.12456597222222221,0.03989538222520122,0.4205596725704819,0.0736,0.03983763390096309,0.5101482116873535,0.018860946745562133,5.210914001850789e-07,0.550046336919273,0.0
229,0.9,8,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Is profound hypotension a cause of myocardial ischemia in those with coronary disease? Absolutely, because drastic hypotension reduces the blood supply through coronary arteries, it can cause the myocardium to become ischemic due to lack of oxygen and nutrients.",4.026615365066517e-07,0.19330956136355226,0.12456597222222221,0.030828249901291835,0.27537766272598274,0.0736,0.030783626196198732,0.3606164777163898,0.018860946745562133,4.026615365066519e-07,0.39589565709201446,0.0
229,0.9,9,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Can significant hypotension in coronary disease patients lead to heart muscle ischemia? Yes, significant decreases in blood pressure can reduce coronary perfusion, thereby increasing the chance of ischemic events by depriving the myocardium of oxygen and nutrients.",4.500334819780223e-07,0.24737678263382845,0.12456597222222221,0.03445510283085558,0.3309475138807949,0.0736,0.03440522927810447,0.4177748915563382,0.018860946745562133,4.500334819780227e-07,0.45473615711494775,0.0
229,0.9,10,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Might profound hypotensive incidents provoke myocardial ischemia in patients with coronary disease? Yes, such events may compromise coronary blood flow, resulting in insufficient oxygen delivery to the heart muscle and causing ischemic injury.",5.447773729207635e-07,0.36515981829021227,0.12456597222222221,0.0417088086899831,0.4523083708850617,0.0736,0.04164843544191597,0.5429380345103452,0.018860946745562133,5.447773729207643e-07,0.5839478885949547,0.0
230,0.9,1,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Question: Is it advisable to screen HIV-infected patients for silent myocardial ischaemia with gated myocardial perfusion SPECT? Answer: Among male HIV-infected patients over 52 years old with two or more cardiovascular risk factors, the likelihood of a positive myocardial SPECT for SMI was roughly four times higher than in the general population. This finding could encourage physicians to recommend more systematic screening for these patients.",0.0,0.02166084939249835,0.015596418549691434,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
230,0.9,2,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Question: Should gated myocardial perfusion SPECT be used to screen for silent myocardial ischaemia in HIV-infected patients? Answer: In men infected with HIV who are older than 52 years and have at least two additional cardiovascular risk factors, the detection rate of silent myocardial ischaemia by myocardial SPECT was about four times greater than in the general population. This may prompt physicians to suggest more consistent screening protocols.",7.105791820705622e-08,0.04774931358882917,0.0013949965827017054,0.005440279394345618,0.025515555617921848,0.01514792899408284,0.0054324046228586,0.04725288485054513,0.0,7.105791820705622e-08,0.04800921918636103,0.0
230,0.9,3,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for",Question: Is screening HIV-positive patients for silent myocardial ischaemia via gated myocardial perfusion SPECT justified? Answer: The likelihood of positive silent myocardial ischaemia detection by myocardial SPECT is approximately fourfold higher in male HIV-infected patients aged over 52 with two or more other cardiovascular risk factors compared to the general population. This may lead doctors to recommend more regular screening.,1.1842986367842703e-07,0.0850169698594625,0.002639089462890834,0.009067132323909363,0.1065933427609762,0.017236072637734686,0.009054007704764333,0.0840831172105414,0.0,1.1842986367842703e-07,0.08552217343816082,0.0
230,0.9,4,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Question: Should silent myocardial ischaemia screening with gated myocardial perfusion SPECT be performed in HIV-positive patients? Answer: Among male HIV-infected individuals older than 52 years and possessing at least two other cardiovascular risk factors, positive myocardial SPECT results for silent myocardial ischaemia were nearly four times as frequent as in the general population. Such findings might encourage more systematic screening.",1.1842986367842703e-07,0.0850169698594625,0.002639089462890834,0.009067132323909363,0.1065933427609762,0.017236072637734686,0.009054007704764333,0.0840831172105414,0.0,1.1842986367842703e-07,0.08552217343816082,0.0
230,0.9,5,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Question: Is gated myocardial perfusion SPECT screening for silent myocardial ischaemia warranted in HIV-infected patients? Answer: In male HIV-positive patients above 52 years old with two or more cardiovascular risk factors, the incidence of positive silent myocardial ischaemia detected with myocardial SPECT was about four times higher than that seen in the general population. This could motivate physicians to advocate for more thorough screening.",2.3685972735685406e-08,0.016436002980598552,0.0004944236119714257,0.0018134264647818726,0.03835992781611974,0.016124697661918846,0.0018108015409528666,0.016260520871781203,0.0,2.3685972735685406e-08,0.01652930195121094,0.0
230,0.9,6,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Question: Should HIV-infected males aged over 52 and with multiple cardiovascular risk factors be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Screening by myocardial SPECT for silent myocardial ischaemia in this group is approximately four times more likely to yield positive results compared to the general population, encouraging systematic screening recommendations.",2.3685972735685406e-07,0.2035936914059513,0.02414584000950567,0.018134264647818726,0.2251558075986555,0.03767781622452902,0.018108015409528666,0.20255017340827708,0.01922337562475971,2.3685972735685406e-07,0.17904823144898518,0.0
230,0.9,7,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Question: Is it beneficial to screen HIV-infected males over 52 years with multiple cardiovascular risk factors for silent myocardial ischaemia using myocardial perfusion SPECT? Answer: This patient group shows about a fourfold increase in positive SMI detection by myocardial SPECT compared to the general population, which may justify the call for more systematic screening.",2.6054570009253947e-07,0.1452694710225555,0.03121748178980229,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
230,0.9,8,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Question: Should clinicians screen HIV-positive patients older than 52 and having two or more cardiovascular risk factors for silent myocardial ischaemia with myocardial SPECT? Answer: Positive silent myocardial ischaemia findings via myocardial SPECT in this subgroup occur roughly four times as often as in the general population, supporting more systematic screening approaches.",3.079176455639103e-07,0.23810023660015078,0.007932872229356402,0.023574544042164344,0.2588376081857877,0.019991670137442734,0.023540420032387266,0.23531408693446476,0.0,3.079176455639103e-07,0.23967285326541932,0.0
230,0.9,9,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Question: Is systematic screening for silent myocardial ischaemia using gated myocardial perfusion SPECT recommended for HIV-infected males over 52 years old with additional cardiovascular risk factors? Answer: The chance of identifying silent myocardial ischaemia in these patients is about four times higher than in the general population, which may encourage regular screening practices.",2.8423167282822487e-07,0.21763667988247537,0.007182518210197719,0.02176111757738247,0.23849133604210948,0.019599999999999992,0.0217296184914344,0.21511137961694615,0.0,2.8423167282822487e-07,0.21905356606268356,0.0
230,0.9,10,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Question: Should male patients with HIV infection over age 52 and at least two other cardiovascular risk factors undergo screening for silent myocardial ischaemia with gated myocardial perfusion SPECT? Answer: Positive screening rates for silent myocardial ischaemia using myocardial SPECT in this group are approximately fourfold greater than in the general population, motivating systematic screening efforts.",2.1317375462116866e-07,0.18384425540329064,0.02314642353564151,0.016320838183036854,0.2054949154242931,0.036982248520710054,0.0162972138685758,0.18299896887259148,0.018860946745562133,2.1317375462116866e-07,0.1596301455918825,0.0
231,0.9,1,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Yes, it is generally viewed as less invasive compared to retropubic radical prostatectomy.",9.47438909427412e-08,0.1264088932565297,0.1573553719008265,0.007253705859127518,0.14772276350701796,0.20408163265306126,0.007243206163811494,0.04622197089373836,0.14876033057851235,9.474389094274162e-08,0.06344983825518646,0.0793950850661626
231,0.9,2,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Does robotically assisted laparoscopic radical prostatectomy offer a less invasive approach than retropubic radical prostatectomy? Yes, it is regarded as less invasive than the retropubic method.",7.10579182070559e-08,0.22730364342531217,0.2000694444444445,0.005440279394345639,0.1902823779258136,0.20408163265306126,0.005432404622858621,0.09067373346457241,0.14876033057851235,7.105791820705622e-08,0.016929822620292523,0.0793950850661626
231,0.9,3,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is the robotically assisted laparoscopic radical prostatectomy procedure less invasive than the retropubic radical prostatectomy? Yes, it is considered to be less invasive.",1.421158364141118e-07,0.15492204636022278,0.24000000000000005,0.010880558788691277,0.05675098530128997,0.20408163265306126,0.010864809245717241,0.04908820891058685,0.14876033057851235,1.4211583641411233e-07,0.16353329681216788,0.0793950850661626
231,0.9,4,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy a less invasive option compared to retropubic radical prostatectomy? Yes, it tends to be less invasive.",1.658018091497971e-07,0.10840203072532884,0.24000000000000005,0.012693985253473157,0.007960821131858697,0.20408163265306126,0.012675610786670115,0.100381503298137,0.14876033057851235,1.6580180914979768e-07,0.21760051808244318,0.0793950850661626
231,0.9,5,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is the invasiveness of robotically assisted laparoscopic radical prostatectomy lower than that of retropubic radical prostatectomy? Yes, it is seen as less invasive.",1.421158364141118e-07,0.15492204636022278,0.24000000000000005,0.010880558788691277,0.05675098530128997,0.20408163265306126,0.010864809245717241,0.04908820891058685,0.14876033057851235,1.4211583641411233e-07,0.16353329681216788,0.0793950850661626
231,0.9,6,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy less invasive than the retropubic approach? Yes, it is generally considered less invasive.",2.3685972735685316e-07,0.045748649101927885,0.24000000000000005,0.018134264647818792,0.15455810836591555,0.20408163265306126,0.018108015409528732,0.2722317602247961,0.14876033057851235,2.3685972735685374e-07,0.39992207487639764,0.0793950850661626
231,0.9,7,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy a less invasive surgical method than retropubic radical prostatectomy? Yes, it is typically less invasive.",1.8948778188548245e-07,0.059611866555897564,0.24000000000000005,0.014507411718255037,0.04333247325569145,0.20408163265306126,0.014486412327622988,0.1544487245684123,0.14876033057851235,1.8948778188548304e-07,0.274758931922392,0.0793950850661626
231,0.9,8,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy less invasive relative to retropubic radical prostatectomy? Yes, it is regarded as a less invasive procedure.",1.658018091497971e-07,0.0423880135291439,0.19250000000000003,0.012693985253473157,0.007960821131858697,0.20408163265306126,0.012675610786670115,0.100381503298137,0.14876033057851235,1.6580180914979768e-07,0.21760051808244318,0.0793950850661626
231,0.9,9,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy known to be less invasive than retropubic radical prostatectomy? Yes, it is believed to be less invasive.",1.421158364141118e-07,0.028895286258414643,0.15000000000000005,0.010880558788691277,0.009263031894894969,0.15658163265306124,0.010864809245717241,0.04908820891058685,0.14876033057851235,1.4211583641411233e-07,0.16353329681216788,0.0793950850661626
231,0.9,10,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Does robotically assisted laparoscopic radical prostatectomy represent a less invasive alternative to retropubic radical prostatectomy? Yes, it is considered less invasive.",1.8948778188548245e-07,0.059611866555897564,0.24000000000000005,0.014507411718255037,0.04333247325569145,0.20408163265306126,0.014486412327622988,0.1544487245684123,0.14876033057851235,1.8948778188548304e-07,0.274758931922392,0.0793950850661626
232,0.9,1,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",The Nd:YAG laser-induced thermo therapy represents a novel glioma treatment method by locally opening the rodent blood-brain barrier to facilitate...,6.158352911278184e-07,0.7081908038127809,0.109375,0.04714908808432881,0.7992978059457401,0.06781677572873293,0.04708084006477466,0.895747367890372,0.023242630385487524,6.158352911278203e-07,0.9650808960435868,0.0
232,0.9,2,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Using Nd:YAG laser-induced thermo therapy to locally disrupt the rodent blood-brain barrier offers a new strategy in adjuvant glioma treatment.,6.158352911278184e-07,0.7081908038127809,0.109375,0.04714908808432881,0.7992978059457401,0.06781677572873293,0.04708084006477466,0.895747367890372,0.023242630385487524,6.158352911278203e-07,0.9650808960435868,0.0
232,0.9,3,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",A new concept in glioma therapy involves Nd:YAG laser-induced thermo therapy to achieve local opening of the rodent blood-brain barrier.,6.158352911278184e-07,0.7081908038127809,0.109375,0.04714908808432881,0.7992978059457401,0.06781677572873293,0.04708084006477466,0.895747367890372,0.023242630385487524,6.158352911278203e-07,0.9650808960435868,0.0
232,0.9,4,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",The approach of Nd:YAG laser-induced thermo therapy provides a novel means to locally open the rodent blood-brain barrier for glioma treatment.,5.92149318392133e-07,0.6568975094252307,0.109375,0.04533566161954693,0.7452305846754648,0.06781677572873293,0.04527003852382178,0.8385889540504232,0.023242630385487524,5.921493183921349e-07,0.9044562742271518,0.0
232,0.9,5,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Nd:YAG laser-induced thermo therapy introduces a new glioma therapy by locally opening the rodent blood-brain barrier.,7.105791820705599e-07,0.9445795818770106,0.109375,0.05440279394345631,1.0506122342266466,0.06781677572873293,0.05432404622858615,1.164011354485051,0.023242630385487524,7.105791820705618e-07,1.2527629684953672,0.0
232,0.9,6,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Locoregional opening of the rodent blood-brain barrier via Nd:YAG laser-induced thermo therapy is a novel strategy for adjuvant glioma treatment.,6.158352911278184e-07,0.7081908038127809,0.109375,0.04714908808432881,0.7992978059457401,0.06781677572873293,0.04708084006477466,0.895747367890372,0.023242630385487524,6.158352911278203e-07,0.9650808960435868,0.0
232,0.9,7,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Nd:YAG laser-induced thermo therapy is an innovative glioma treatment technique that locally opens the rodent blood-brain barrier.,6.868932093348744e-07,0.88004106073944,0.109375,0.05258936747867443,0.9816193627396945,0.06781677572873293,0.05251324468763327,1.0899033823313298,0.023242630385487524,6.868932093348764e-07,1.1727202608218308,0.0
232,0.9,8,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",A new glioma treatment concept uses Nd:YAG laser-induced thermo therapy to locally open the rodent blood-brain barrier.,6.868932093348744e-07,0.88004106073944,0.109375,0.05258936747867443,0.9816193627396945,0.06781677572873293,0.05251324468763327,1.0899033823313298,0.023242630385487524,6.868932093348764e-07,1.1727202608218308,0.0
232,0.9,9,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",The novel glioma therapy concept involves locally opening the rodent blood-brain barrier with Nd:YAG laser-induced thermo therapy.,6.868932093348744e-07,0.88004106073944,0.109375,0.05258936747867443,0.9816193627396945,0.06781677572873293,0.05251324468763327,1.0899033823313298,0.023242630385487524,6.868932093348764e-07,1.1727202608218308,0.0
232,0.9,10,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Locoregional disruption of the rodent blood-brain barrier using Nd:YAG laser-induced thermo therapy is a novel adjuvant glioma treatment approach.,6.395212638635038e-07,0.7622580250830562,0.109375,0.048962514549110686,0.8564562197856889,0.06781677572873293,0.04889164160572752,0.956371989706807,0.023242630385487524,6.395212638635056e-07,1.0296194171811575,0.0
233,0.9,1,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young patients a unique clinical entity? Answer: Yes, colorectal cancer in young patients is seen as a distinct clinical entity. It typically exhibits more aggressive behavior and is frequently diagnosed at later stages. Genetic predisposition,",0.0,0.03554600925948437,0.02420803615563867,0.0,0.0,0.0,0.0,0.037467415165403306,0.026871378180902013,0.0,0.03850817669777484,0.02775510204081633
233,0.9,2,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Does colorectal cancer in young individuals represent a separate clinical entity? Answer: Yes, colorectal cancer in young individuals is recognized as a distinct clinical entity. It tends to be more aggressive and is often detected at advanced stages. Genetic predisposition,",2.36859727356853e-08,0.06441841816972405,0.026667093852791618,0.0018134264647818726,0.02878175029216612,0.001978458049886611,0.0018108015409528666,0.008827198864009844,0.025462962962962975,2.3685972735685406e-08,0.010068440977287096,0.027006172839506164
233,0.9,3,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in younger patients considered a distinct clinical condition? Answer: Yes, colorectal cancer in younger patients is regarded as a distinct clinical entity. It is usually more aggressive and often diagnosed at advanced stages. Genetic predisposition,",2.36859727356853e-08,0.06713402344055774,0.026911224048442928,0.0018134264647818726,0.06709361607641151,0.028152395944603725,0.0018108015409528666,0.06694791241826259,0.02835714895980181,2.3685972735685406e-08,0.06777928728440807,0.02854671280276816
233,0.9,4,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young patients a distinct medical entity? Answer: Yes, colorectal cancer in young patients is identified as a distinct clinical entity. It generally presents with more aggressive features and is frequently diagnosed late. Genetic predisposition,",2.36859727356853e-08,0.030652592884770957,0.0031257844249351074,0.0018134264647818726,0.029626200911009093,0.0020824800508438407,0.0018108015409528666,0.06694791241826259,0.02835714895980181,2.3685972735685406e-08,0.06777928728440807,0.02854671280276816
233,0.9,5,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in youth recognized as a separate clinical entity? Answer: Yes, colorectal cancer in youth is classified as a distinct clinical entity. It is often more aggressive and diagnosed in advanced stages. Genetic predisposition,",7.10579182070559e-08,0.05634536816721303,0.016057525951557072,0.005440279394345618,0.05201062720503469,0.0214343809149004,0.005432404622858607,0.08786333642501098,0.0023785838179777724,7.105791820705622e-08,0.08701137698963013,0.0
233,0.9,6,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young adults a unique clinical diagnosis? Answer: Yes, colorectal cancer in young adults is considered a distinct clinical entity. It tends to be more aggressive and is typically diagnosed at advanced stages. Genetic predisposition,",2.36859727356853e-08,0.0058288376710153855,0.021626297577854642,0.0018134264647818726,0.029626200911009093,0.0020824800508438407,0.0018108015409528666,0.06694791241826259,0.02835714895980181,2.3685972735685406e-08,0.06777928728440807,0.02854671280276816
233,0.9,7,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Does colorectal cancer in young patients constitute a distinct clinical entity? Answer: Yes, colorectal cancer in young patients constitutes a distinct clinical entity. It tends to be more aggressive and is often found at advanced stages. Genetic predisposition,",2.36859727356853e-08,0.06713402344055774,0.026911224048442928,0.0018134264647818726,0.06709361607641151,0.028152395944603725,0.0018108015409528666,0.06694791241826259,0.02835714895980181,2.3685972735685406e-08,0.06777928728440807,0.02854671280276816
233,0.9,8,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young individuals a distinct clinical syndrome? Answer: Yes, colorectal cancer in young individuals is classified as a distinct clinical entity. It is usually more aggressive and often identified at advanced stages. Genetic predisposition,",4.73719454713706e-08,0.09971817818041284,0.03065488299745442,0.0036268529295637453,0.0986556363940152,0.031007653061224494,0.003621603081905733,0.09731925662483176,0.02992679318436894,4.737194547137081e-08,0.09793177740229808,0.029384756657483937
233,0.9,9,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young patients considered a separate clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is frequently diagnosed at advanced stages. Genetic predisposition,",0.0,0.0,2.7755575615628914e-17,0.0,0.0,0.0,0.0,0.037467415165403306,0.026871378180902013,0.0,0.03850817669777484,0.02775510204081633
233,0.9,10,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Can colorectal cancer in young patients be regarded as a unique clinical entity? Answer: Yes, colorectal cancer in young patients is regarded as a distinct clinical entity. It tends to be more aggressive and is often diagnosed at later stages. Genetic predisposition,",7.105791820705611e-08,0.05379596686258781,0.013456362937331795,0.005440279394345618,0.05018196829212229,0.018053398130618237,0.0054324046228586,0.046114238579118894,0.02285532300536917,7.105791820705622e-08,0.04449669841405024,0.025623268698060954
234,0.9,1,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Can APC mutation analysis aid in making therapeutic decisions for familial adenomatous polyposis? Yes, analyzing APC mutations can assist in therapy choices by pinpointing mutation types, guiding targeted treatment selection, and forecasting disease progression to tailor personalized care.",3.3160361829959537e-07,0.1034497810809012,0.15143320713899402,0.025387970506946217,0.16214874363764853,0.11776859504132227,0.025351221573340132,0.2233053499991815,0.08098765432098766,3.316036182995957e-07,0.2581970887217362,0.06222222222222222
234,0.9,2,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Is APC mutation analysis useful in therapeutic decision-making for familial adenomatous polyposis? Indeed, APC mutation analysis helps identify mutation types, directs targeted therapies, and anticipates disease course, supporting individualized treatment planning.",4.974054274493925e-07,0.40558993613763095,0.08510667652674915,0.03808195576041937,0.42617510593900576,0.08332981953111818,0.03802683236001025,0.44644890131339077,0.08098765432098766,4.974054274493935e-07,0.48872074733356863,0.06222222222222222
234,0.9,3,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Does APC mutation testing play a role in therapy decisions regarding familial adenomatous polyposis? Yes, it allows detection of specific mutations, informs the choice of targeted treatments, and predicts disease progression, facilitating customized therapy.",4.2634750924233657e-07,0.21786013225864664,0.15143320713899402,0.03264167636607373,0.27993177929403235,0.11776859504132227,0.03259442773715163,0.3446662070034483,0.08098765432098766,4.263475092423373e-07,0.3833602316757432,0.06222222222222222
234,0.9,4,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Can analyzing APC mutations influence therapeutic strategies in familial adenomatous polyposis? Yes, mutation analysis helps determine mutation types, assists in selecting targeted therapies, and predicts how the disease will evolve, enabling personalized treatments.",4.5003348197802187e-07,0.24863179092540033,0.15143320713899402,0.03445510283085561,0.31168047760861217,0.11776859504132227,0.0344052292781045,0.37745602982644,0.08098765432098766,4.500334819780227e-07,0.41726178335142494,0.06222222222222222
234,0.9,5,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Is APC mutation analysis beneficial for therapeutic decisions in familial adenomatous polyposis? Absolutely, by identifying mutation types, guiding targeted therapy options, and forecasting disease progression, it supports personalized treatment plans.",5.210914001850778e-07,0.3470718637386536,0.15143320713899402,0.03989538222520125,0.41346317191855464,0.11776859504132227,0.03983763390096312,0.48281654548426545,0.08098765432098766,5.210914001850789e-07,0.5264610753164156,0.06222222222222222
234,0.9,6,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Does mutation analysis of APC contribute to treatment decisions in familial adenomatous polyposis? Yes, it identifies specific mutations, aids in choosing targeted therapies, and helps predict disease progression for personalized treatment.",4.974054274493925e-07,0.31317031206297186,0.15143320713899402,0.03808195576041937,0.37837185210728563,0.11776859504132227,0.03802683236001025,0.44644890131339077,0.08098765432098766,4.974054274493935e-07,0.48872074733356863,0.06222222222222222
234,0.9,7,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Can APC gene mutation analysis support therapeutic decision-making in familial adenomatous polyposis? Yes, by characterizing mutations, directing targeted treatments, and predicting disease outcomes, it informs personalized therapeutic strategies.",5.684633456564484e-07,0.4185308277207973,0.15143320713899402,0.043522235154765006,0.4875711440722763,0.11776859504132227,0.04345923698286887,0.5597775866203949,0.08098765432098766,5.684633456564497e-07,0.6065037829899529,0.06222222222222222
234,0.9,8,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Is APC mutation analysis helpful in guiding therapy for familial adenomatous polyposis? Yes, the analysis reveals mutation types, guides targeted therapy choices, and predicts disease progression, enabling tailored treatment plans.",5.210914001850778e-07,0.3470718637386536,0.15143320713899402,0.03989538222520125,0.41346317191855464,0.11776859504132227,0.03983763390096312,0.48281654548426545,0.08098765432098766,5.210914001850789e-07,0.5264610753164156,0.06222222222222222
234,0.9,9,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Does the analysis of APC mutations aid therapeutic decisions in familial adenomatous polyposis? Yes, it assists in mutation identification, targeted therapy selection, and disease forecast to support personalized treatments.",5.447773729207631e-07,0.3821631835499226,0.15143320713899402,0.041708808689983126,0.4498308160894293,0.11776859504132227,0.041648435441915994,0.5205568734671124,0.08098765432098766,5.447773729207643e-07,0.5656817884696981,0.06222222222222222
234,0.9,10,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Can APC mutation analysis inform treatment choices in familial adenomatous polyposis? Yes, it identifies the mutation type, helps select targeted therapies, and predicts disease progression for individualized therapy.",5.684633456564484e-07,0.4185308277207973,0.15143320713899402,0.043522235154765006,0.4875711440722763,0.11776859504132227,0.04345923698286887,0.5597775866203949,0.08098765432098766,5.684633456564497e-07,0.6065037829899529,0.06222222222222222
235,0.9,1,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are symptoms important when selecting patients for phase I clinical trials? Answer: Older adults in PICT with more symptoms might compromise quality of life for experimental therapies.,2.36859727356853e-08,0.03774032798284699,0.0,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
235,0.9,2,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Should symptoms be considered for patients in phase I trials? Answer: Older adults enrolled in phase I clinical trials who have more symptoms may trade off quality of life for new treatments.,1.421158364141118e-07,0.12099596720824968,0.06222222222222223,0.010880558788691277,0.17039220667759558,0.0322222222222222,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
235,0.9,3,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Do symptoms influence patient selection for phase I clinical studies? Answer: Older adults with higher symptom burden in phase I clinical trials might sacrifice quality of life to receive experimental treatments.,1.184298636784265e-07,0.08645232058496166,0.06420927467300831,0.009067132323909398,0.13611174475662535,0.033293697978596916,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
235,0.9,4,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are symptoms a factor in phase I clinical trial patient consideration? Answer: Older adults participating in phase I trials with increased symptoms may give up quality of life for investigational therapy.,1.184298636784265e-07,0.08645232058496166,0.06420927467300831,0.009067132323909398,0.13611174475662535,0.033293697978596916,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
235,0.9,5,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Is symptom status relevant when considering patients for phase I trials? Answer: Older adults enrolled in phase I trials who have more symptoms may accept reduced quality of life in exchange for experimental treatment.,1.894877818854824e-07,0.2274906230323297,0.029384756657483937,0.014507411718255037,0.2776317365982801,0.0,0.014486412327622988,0.28768207245178123,0.0,1.8948778188548325e-07,0.29849298855599704,0.0
235,0.9,6,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Should symptom presence be evaluated for phase I trial candidates? Answer: Older adults in phase I clinical trials experiencing more symptoms may forgo quality of life for the chance of experimental treatment.,1.421158364141118e-07,0.16431766599324638,0.031217481789802305,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
235,0.9,7,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Do symptoms play a role in selecting patients for phase I clinical trials? Answer: Older adults with significant symptoms enrolled in phase I studies may sacrifice quality of life for investigational treatments.,1.421158364141118e-07,0.16431766599324638,0.031217481789802305,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
235,0.9,8,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are symptoms significant when choosing patients for phase I clinical trials? Answer: Older adults with more symptoms who join phase I trials might compromise their quality of life for experimental therapies.,1.184298636784265e-07,0.13117149352431312,0.0322222222222222,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
235,0.9,9,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Does symptom burden affect patient consideration in phase I clinical trials? Answer: Older adults undergoing phase I trials with many symptoms may sacrifice quality of life for the opportunity of experimental treatment.,1.421158364141118e-07,0.16431766599324638,0.031217481789802305,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
235,0.9,10,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Is symptom consideration important for phase I clinical trial enrollment? Answer: Older adults in phase I clinical trials with a higher symptom burden may trade quality of life for experimental treatment.,1.184298636784265e-07,0.08645232058496166,0.06420927467300831,0.009067132323909398,0.13611174475662535,0.033293697978596916,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
236,0.9,1,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Question: Does a surgeon's prior experience affect their skill in performing transurethral resection of the prostate? Answer: The senior urologist resected tissue at a rate four times higher than less experienced surgeons, suggesting experience is crucial to minimizing the risk of repeat TURP caused by recurring or incompletely removed adenomas.",2.3685972735685406e-07,0.1857171457950919,0.0,0.018134264647818726,0.18924199963852795,0.0,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
236,0.9,2,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Question: Is the surgeon's ability to conduct transurethral prostate resection impacted by their past experience? Answer: The senior urologist could resect tissue four times faster than novice surgeons, indicating that greater experience may reduce the need for secondary TURP due to residual or recurring adenomas.",3.552895910352811e-07,0.2933478099874569,0.0,0.02720139697172809,0.2992428948528567,0.0,0.027162023114293,0.3053816495511823,0.0,3.552895910352811e-07,0.3117796240308417,0.0
236,0.9,3,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Question: Does previous surgical experience influence proficiency in transurethral resection of the prostate? Answer: The senior urologist removed tissue at a rate four times greater per time unit than less experienced surgeons, implying that experience may lower the chance of secondary TURP from recurring or incompletely resected adenomas.",2.8423167282822487e-07,0.22738984219566083,0.0,0.02176111757738247,0.23180161405732447,0.0,0.0217296184914344,0.23638877806423064,0.0,2.8423167282822487e-07,0.24116205681688774,0.0
236,0.9,4,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Question: Is there an effect of a surgeon's prior experience on performing transurethral prostate resection? Answer: Compared to less experienced surgeons, the senior urologist resected tissue four times as much per time unit, suggesting that experience helps mitigate the risk of repeat TURP due to persistent or recurring adenomas.",2.6054570009253947e-07,0.20633643299782767,0.0,0.0199476911126006,0.2102954088363611,0.0,0.019918816950481533,0.21440987134545564,0.0,2.6054570009253947e-07,0.21868920096483002,0.0
236,0.9,5,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Question: How does a surgeon's previous experience impact the ability to perform transurethral resection of the prostate? Answer: The senior urologist was able to resect four times more tissue per unit time than inexperienced surgeons, indicating that experience is important to prevent secondary TURP caused by incomplete or recurring adenomas.",2.3685972735685406e-07,0.1857171457950919,0.0,0.018134264647818726,0.18924199963852795,0.0,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
236,0.9,6,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Question: Does the level of prior experience affect the surgeon’s skill in transurethral resection of the prostate? Answer: The senior urologist resected tissue at four times the rate of less experienced surgeons, which may highlight the importance of experience in reducing secondary TURP due to adenoma recurrence or incomplete resections.",2.3685972735685406e-07,0.1857171457950919,0.0,0.018134264647818726,0.18924199963852795,0.0,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
236,0.9,7,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Question: Is the surgeon’s previous experience a factor in the proficiency of transurethral prostate resection? Answer: The senior urologist resected four times more tissue per time unit than inexperienced surgeons, suggesting that experience could be key to lowering the risk of secondary TURP from recurring or incompletely excised adenomas.",2.6054570009253947e-07,0.20633643299782767,0.0,0.0199476911126006,0.2102954088363611,0.0,0.019918816950481533,0.21440987134545564,0.0,2.6054570009253947e-07,0.21868920096483002,0.0
236,0.9,8,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Question: Does prior surgical experience influence effectiveness in performing transurethral resection of the prostate? Answer: The senior urologist’s resection rate was quadruple that of less experienced surgeons, implying that experience may play a significant role in avoiding secondary TURP caused by residual or recurrent adenomas.",3.552895910352811e-07,0.2933478099874569,0.0,0.02720139697172809,0.2992428948528567,0.0,0.027162023114293,0.3053816495511823,0.0,3.552895910352811e-07,0.3117796240308417,0.0
236,0.9,9,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Question: How important is a surgeon's prior experience for transurethral resection of the prostate? Answer: The senior urologist could resect tissue at four times the speed of inexperienced surgeons, suggesting that greater experience might reduce the likelihood of secondary TURP due to incomplete resection or recurring adenomas.",3.079176455639103e-07,0.2488960474166242,0.0,0.023574544042164344,0.25378052077609947,0.0,0.023540420032387266,0.25886163391628836,0.0,3.079176455639103e-07,0.26415157504158726,0.0
236,0.9,10,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Question: Can a surgeon’s previous experience affect their capability in transurethral prostate resection? Answer: The senior urologist resected tissue four times as efficiently as inexperienced surgeons, indicating that experience may be critical in minimizing the risk of repeat TURP from persistent or recurrent adenomas.",3.789755637709665e-07,0.31633732821215643,0.0,0.029014823436509962,0.32277339226305113,0.0,0.028972824655245866,0.3294792011302423,0.0,3.789755637709665e-07,0.3364722366212134,0.0
237,0.9,1,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,"Does pretreatment with estradiol and antagonist before microdose leuprolide improve IVF outcomes in poor responders compared to oral contraceptive pills? It appears that E2 plus antagonist pretreatment does not enhance IVF results in the microdose leuprolide protocol when compared to the standard OCP in poor responders. Further randomized, well-powered trials are justified to determine the best steroid pretreatment method.",1.1842986367842703e-07,0.04437323459905462,0.02720501960476019,0.009067132323909363,0.03936394427118994,0.0322222222222222,0.009054007704764333,0.0627960363706217,0.016388888888888897,1.1842986367842703e-07,0.08701137698962835,0.0
237,0.9,2,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,"In poor responders undergoing IVF, does estradiol and antagonist pretreatment before microdose leuprolide improve outcomes compared to oral contraceptive pills? Current evidence suggests E2 and antagonist pretreatment does not improve IVF success rates versus standard OCP. Randomized trials with sufficient sample size to identify the optimal steroid pretreatment are warranted.",3.316036182995957e-07,0.197874509598281,0.03803285015521305,0.025387970506946217,0.24009533372117975,0.011398320004023917,0.025351221573340132,0.23800012539571336,0.016388888888888897,3.316036182995957e-07,0.2657031657330049,0.0
237,0.9,3,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Does giving estradiol and antagonist pretreatment prior to microdose leuprolide improve IVF outcomes in poor responders compared to oral contraceptive pills? The use of E2 and antagonist pretreatment seems not to enhance results over the usual OCP in poor responders following the microdose leuprolide protocol. Adequately powered randomized studies are needed to optimize steroid pretreatment strategies.,1.8948778188548325e-07,0.1518049392672296,0.011224732461355497,0.014507411718254981,0.14477540113849852,0.004760026298487853,0.014486412327622933,0.11785581355365027,0.016388888888888897,1.8948778188548325e-07,0.14310084364067155,0.0
237,0.9,4,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,"When comparing estradiol and antagonist pretreatment to oral contraceptive pills before microdose leuprolide in IVF poor responders, does it improve outcomes? Evidence indicates that E2 plus antagonist pretreatment does not improve outcomes compared to OCP in poor responders. More randomized controlled trials with adequate power appear necessary to identify the best steroid pretreatment.",2.6054570009253947e-07,0.1085271527610776,0.059551891913884776,0.0199476911126006,0.15058957938141493,0.0322222222222222,0.019918816950481533,0.17612472167762583,0.016388888888888897,2.6054570009253947e-07,0.20252426411147262,0.0
237,0.9,5,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Does administering estradiol and antagonist as pretreatment before microdose leuprolide improve IVF outcomes in poor responders relative to oral contraceptive pills? Pretreatment with E2 and antagonist does not seem to offer better IVF results than standard OCP in poor responders. Well-designed randomized trials are justified to explore the most effective steroid pretreatment method.,2.6054570009253947e-07,0.135186659705691,0.040375267538644476,0.0199476911126006,0.15058957938141493,0.0322222222222222,0.019918816950481533,0.17612472167762583,0.016388888888888897,2.6054570009253947e-07,0.20252426411147262,0.0
237,0.9,6,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Is estradiol and antagonist pretreatment before microdose leuprolide more effective than oral contraceptive pills for improving IVF outcomes in poor responders? The current data suggests no improvement with E2 plus antagonist pretreatment compared to OCP in poor responders. Further randomized trials with adequate sample size are needed to determine optimal steroid pretreatment.,2.8423167282822487e-07,0.1556502164233664,0.03962491351948579,0.02176111757738247,0.1703922066775947,0.0322222222222222,0.0217296184914344,0.19632742899514444,0.016388888888888897,2.8423167282822487e-07,0.22314355131420838,0.0
237,0.9,7,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,"In IVF protocols using microdose leuprolide for poor responders, does estradiol and antagonist pretreatment improve outcomes compared to oral contraceptive pills? It appears that E2 and antagonist pretreatment does not enhance IVF outcomes versus standard OCP. Adequately powered randomized studies are justified to evaluate steroid pretreatment approaches.",4.026615365066519e-07,0.2647436357835753,0.03538683778657836,0.030828249901291835,0.3065592636936403,0.01001147842056931,0.030783626196198732,0.30395809318750944,0.016388888888888897,4.026615365066519e-07,0.33314444652853714,0.0
237,0.9,8,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Does estradiol combined with antagonist pretreatment before microdose leuprolide improve IVF success rates in poor responders compared to oral contraceptive pills? Evidence shows E2 plus antagonist pretreatment does not improve outcomes over OCP in poor responders. There is a need for randomized controlled trials with enough power to identify optimal steroid pretreatment.,2.8423167282822487e-07,0.1556502164233664,0.03962491351948579,0.02176111757738247,0.1703922066775947,0.0322222222222222,0.0217296184914344,0.19632742899514444,0.016388888888888897,2.8423167282822487e-07,0.22314355131420838,0.0
237,0.9,9,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,"In poor responders undergoing IVF, does pretreatment with estradiol and antagonist before microdose leuprolide yield better outcomes than oral contraceptive pills? Current findings indicate that E2 and antagonist pretreatment does not improve IVF results in the microdose leuprolide protocol compared to OCP, highlighting the need for randomized trials with adequate power.",3.079176455639103e-07,0.17654013341454222,0.03884471198308892,0.023574544042164344,0.1905949139951133,0.0322222222222222,0.023540420032387266,0.2169467161978802,0.016388888888888897,3.079176455639103e-07,0.24419696051204154,0.0
237,0.9,10,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,"Does pretreatment using estradiol and antagonist before microdose leuprolide improve IVF outcomes more than oral contraceptive pills in poor responders? It seems that E2 plus antagonist pretreatment does not enhance IVF success compared to standard OCP use. Randomized, well-powered trials are needed to define the optimal steroid pretreatment method.",3.552895910352811e-07,0.16191035349000105,0.07877526753864449,0.02720139697172809,0.23226761039568222,0.0322222222222222,0.027162023114293,0.2595063306166767,0.016388888888888897,3.552895910352811e-07,0.2876820724517799,0.0
238,0.9,1,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Does minimally invasive major surgery cause less pain in newborns?,5.447773729207625e-07,1.0952245303235197,0.12244897959183673,0.041708808689983196,1.220388143987257,0.09566326530612247,0.041648435441916085,1.362867608532182,0.06632653061224487,5.447773729207635e-07,1.5277331069266982,0.03443877551020409
238,0.9,2,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Is pain reduced in newborns undergoing minimal access major surgery?,5.447773729207625e-07,1.0952245303235197,0.12244897959183673,0.041708808689983196,1.220388143987257,0.09566326530612247,0.041648435441916085,1.362867608532182,0.06632653061224487,5.447773729207635e-07,1.5277331069266982,0.03443877551020409
238,0.9,3,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Do newborns experience less pain with minimal access major surgery?,5.447773729207625e-07,1.0952245303235197,0.12244897959183673,0.041708808689983196,1.220388143987257,0.09566326530612247,0.041648435441916085,1.362867608532182,0.06632653061224487,5.447773729207635e-07,1.5277331069266982,0.03443877551020409
238,0.9,4,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Is minimal access surgery less painful for newborn infants?,5.684633456564478e-07,1.2130075659799036,0.12244897959183673,0.043522235154765075,1.3539195366117789,0.09566326530612247,0.043459236982868965,1.517018288359441,0.06632653061224487,5.684633456564489e-07,1.7100546637206526,0.03443877551020409
238,0.9,5,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Does minimal access surgery in newborns result in less pain?,5.447773729207625e-07,1.0952245303235197,0.12244897959183673,0.041708808689983196,1.220388143987257,0.09566326530612247,0.041648435441916085,1.362867608532182,0.06632653061224487,5.447773729207635e-07,1.5277331069266982,0.03443877551020409
238,0.9,6,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Are newborns less pained after minimal access major surgery?,5.684633456564478e-07,1.2130075659799036,0.12244897959183673,0.043522235154765075,1.3539195366117789,0.09566326530612247,0.043459236982868965,1.517018288359441,0.06632653061224487,5.684633456564489e-07,1.7100546637206526,0.03443877551020409
238,0.9,7,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Does major surgery with minimal access in newborns hurt less?,5.447773729207625e-07,1.0952245303235197,0.12244897959183673,0.041708808689983196,1.220388143987257,0.09566326530612247,0.041648435441916085,1.362867608532182,0.06632653061224487,5.447773729207635e-07,1.5277331069266982,0.03443877551020409
238,0.9,8,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Is pain diminished in newborns by performing minimal access major surgery?,5.210914001850771e-07,0.9898640146656938,0.12244897959183673,0.03989538222520132,1.1026051083308732,0.09566326530612247,0.03983763390096322,1.2293362159076602,0.06632653061224487,5.210914001850782e-07,1.3735824270994392,0.03443877551020409
238,0.9,9,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Does minimal access technique in newborn surgery reduce pain?,5.684633456564478e-07,1.2130075659799036,0.12244897959183673,0.043522235154765075,1.3539195366117789,0.09566326530612247,0.043459236982868965,1.517018288359441,0.06632653061224487,5.684633456564489e-07,1.7100546637206526,0.03443877551020409
238,0.9,10,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Is minimal access major surgery associated with less pain in newborns?,5.210914001850771e-07,0.9898640146656938,0.12244897959183673,0.03989538222520132,1.1026051083308732,0.09566326530612247,0.03983763390096322,1.2293362159076602,0.06632653061224487,5.210914001850782e-07,1.3735824270994392,0.03443877551020409
239,0.9,1,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Does the angiotensin-converting enzyme-1 (ACE-1) gene polymorphism contribute to chronic kidney disease in patients with hypertension? Research suggests there may be a connection between ACE-1 gene polymorphism and chronic kidney disease among hypertensive individuals, though the association is not yet fully established.",7.1057918207056e-08,0.19343831754777163,0.07962906855955677,0.005440279394345618,0.1931738431033252,0.08153617943827732,0.0054324046228586,0.15705906106908385,0.055363321799307974,7.105791820705622e-08,0.12184650855468426,0.02854671280276816
239,0.9,2,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Is chronic kidney disease among hypertensive patients caused by angiotensin-converting enzyme-1 (ACE-1) gene polymorphism? Studies have found a possible association between ACE-1 gene polymorphism and chronic kidney disease in those with hypertension, but the link remains inconclusive.",4.73719454713706e-08,0.0878050086688944,0.09698042820069203,0.0036268529295637453,0.05469139918908761,0.07797303008061107,0.00362160308190574,0.019857939555601334,0.055363321799307974,4.737194547137081e-08,0.019232089705222055,0.02854671280276816
239,0.9,3,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Can the angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease in hypertensive patients? Evidence points to a potential correlation, yet the relationship is not completely clear.",2.605457000925383e-07,0.1228607103873367,0.15234375,0.01994769111260066,0.2029517139611321,0.10651974288337923,0.019918816950481602,0.28762676019236055,0.055363321799307974,2.6054570009253947e-07,0.337685820823757,0.02854671280276816
239,0.9,4,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Does polymorphism in the angiotensin-converting enzyme-1 (ACE-1) gene result in chronic kidney disease among patients with high blood pressure? Some studies indicate a possible connection, although the exact nature of this link is still uncertain.",9.47438909427412e-08,0.10766294822449574,0.15234375,0.007253705859127504,0.03545930948386555,0.10651974288337923,0.007243206163811487,0.04076668226083413,0.055363321799307974,9.474389094274162e-08,0.08175244668655557,0.02854671280276816
239,0.9,5,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Is there a connection between ACE-1 gene polymorphism and chronic kidney disease in hypertensive patients? Research indicates a potential link, but the relationship has not been definitively established.",2.605457000925383e-07,0.1228607103873367,0.15234375,0.01994769111260066,0.2029517139611321,0.10651974288337923,0.019918816950481602,0.28762676019236055,0.055363321799307974,2.6054570009253947e-07,0.337685820823757,0.02854671280276816
239,0.9,6,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Does the presence of angiotensin-converting enzyme-1 (ACE-1) gene polymorphism increase the risk of chronic kidney disease in patients suffering from hypertension? Studies suggest a potential association, but this connection is not fully proven.",1.421158364141118e-07,0.04703832640806027,0.15234375,0.010880558788691264,0.02706104749746796,0.10651974288337923,0.010864809245717234,0.10530520339840566,0.055363321799307974,1.4211583641411244e-07,0.14844382118522903,0.02854671280276816
239,0.9,7,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Could angiotensin-converting enzyme-1 (ACE-1) gene polymorphism cause chronic kidney disease among individuals with hypertension? Research points to a possible link, however, the relationship remains unclear.",3.316036182995942e-07,0.24064374604372096,0.15234375,0.0253879705069463,0.325554036053465,0.10651974288337923,0.025351221573340223,0.41546013170224505,0.055363321799307974,3.316036182995957e-07,0.4712172134482806,0.02854671280276816
239,0.9,8,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Is chronic kidney disease in hypertensive patients associated with angiotensin-converting enzyme-1 (ACE-1) gene polymorphism? Some studies suggest a potential association, yet the evidence is not conclusive.",3.079176455639089e-07,0.19982175152346615,0.15234375,0.02357454404216442,0.28299442163466937,0.10651974288337923,0.02354042003238735,0.371008369131411,0.055363321799307974,3.079176455639103e-07,0.42469719781338666,0.02854671280276816
239,0.9,9,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Does ACE-1 gene polymorphism contribute to the development of chronic kidney disease in patients with hypertension? Studies show a potential link, but the relationship has not been definitively confirmed.",2.36859727356853e-07,0.08649306621646202,0.15234375,0.018134264647818782,0.1652113859782851,0.10651974288337923,0.01810801540952873,0.2484060470390781,0.055363321799307974,2.3685972735685406e-07,0.29686382630350217,0.02854671280276816
239,0.9,10,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Is there an association between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive individuals? Research suggests a possible connection, but the relationship is not fully understood.",2.36859727356853e-07,0.08649306621646202,0.15234375,0.018134264647818782,0.1652113859782851,0.10651974288337923,0.01810801540952873,0.2484060470390781,0.055363321799307974,2.3685972735685406e-07,0.29686382630350217,0.02854671280276816
240,0.9,1,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Does receiving care at a birth center during a woman's first pregnancy affect her future reproductive outcomes? Yes, care at a birth center in the first pregnancy can influence future reproduction by offering thorough prenatal care, encouraging healthy habits, and lowering complication risks.",9.474389094274162e-08,0.014912149697078547,0.04933135576244059,0.0072537058591274906,0.009687347681562652,0.057462833352456236,0.007243206163811466,0.007091447733060363,0.06190707746215952,9.474389094274162e-08,0.004226863835505412,0.06642143873126188
240,0.9,2,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Is there an effect of birth center care during a woman's initial pregnancy on her subsequent reproductive health? Indeed, birth center care during the first pregnancy positively impacts future reproduction by providing comprehensive prenatal support, fostering healthy pregnancy behaviors, and minimizing complications.",1.1842986367842703e-07,0.02458916894945551,0.09349030470914123,0.009067132323909363,0.0022585055630583994,0.08031601894802412,0.009054007704764333,0.0013594530791580794,0.0861453046089739,1.1842986367842703e-07,0.005343659020720537,0.09204470742932283
240,0.9,3,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Can birth center care in a woman's first pregnancy influence her later reproductive outcomes? Yes, it can; birth center care supplies complete prenatal services, promotes healthy habits during pregnancy, and decreases the chance of complications, thus affecting future reproduction.",1.8948778188548304e-07,0.02292342637516942,0.11373585034711531,0.014507411718254981,0.04837274414217729,0.1031713419533933,0.014486412327622933,0.04313724533489216,0.11176857330703485,1.8948778188548325e-07,0.0768944392162525,0.09204470742932283
240,0.9,4,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Does first pregnancy birth center care have any bearing on a woman's future reproductive potential? Yes, it does, as birth center care during the initial pregnancy offers extensive prenatal care, supports healthy pregnancy practices, and reduces complication risks, influencing future reproduction.",1.4211583641411244e-07,0.03201801106795932,0.11634349030470911,0.010880558788691236,0.006192395249160043,0.10455424609483852,0.0108648092457172,0.010929975935384029,0.11176857330703485,1.4211583641411244e-07,0.02132458806144033,0.09204470742932283
240,0.9,5,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Is there an impact of birth center care during a woman’s first pregnancy on her subsequent reproductive health? Yes, birth center care in the first pregnancy delivers comprehensive prenatal care, encourages healthy habits, and lessens complication risks, affecting future reproduction.",1.6580180914979774e-07,0.03062310663879053,0.08981609726069556,0.012693985253473108,0.02071851245040035,0.10388094795579209,0.012675610786670066,0.01573827114677684,0.11176857330703485,1.6580180914979784e-07,0.04872356224955565,0.09204470742932283
240,0.9,6,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","How does birth center care during a woman’s first pregnancy affect her future reproduction? It has an impact, providing thorough prenatal care, promoting healthy pregnancy routines, and lowering the risk of complications, which benefits future reproductive health.",2.3685972735685364e-07,0.004027786533872479,0.16620498614958445,0.018134264647818726,0.06647518013158704,0.13017751479289946,0.018108015409528673,0.10029565917484051,0.11176857330703485,2.3685972735685406e-07,0.13573493923918578,0.09204470742932283
240,0.9,7,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Does care at a birth center during the first pregnancy influence a woman’s future reproductive outcomes? Yes, as it provides inclusive prenatal care, fosters healthy pregnancy habits, and reduces the likelihood of complications, thereby impacting future reproduction.",2.3685972735685364e-07,0.004027786533872479,0.16620498614958445,0.018134264647818726,0.06647518013158704,0.13017751479289946,0.018108015409528673,0.10029565917484051,0.11176857330703485,2.3685972735685406e-07,0.13573493923918578,0.09204470742932283
240,0.9,8,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Can care from a birth center during a woman’s initial pregnancy affect her subsequent reproductive health? Yes, birth center care during the first pregnancy offers comprehensive prenatal care, promotes healthy behaviors, and decreases complication risks, influencing future reproduction.",2.1317375462116834e-07,0.014096227511159576,0.1391988133100783,0.016320838183036854,0.0383043031648902,0.13017751479289946,0.0162972138685758,0.071308122301589,0.11176857330703485,2.1317375462116866e-07,0.105881976089504,0.09204470742932283
240,0.9,9,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Is birth center care in a woman’s first pregnancy linked to her future reproduction? Yes, it is, because it ensures complete prenatal care, encourages healthy pregnancy habits, and lowers complication risks, impacting future reproductive health.",2.8423167282822424e-07,0.06118620037382083,0.16620498614958445,0.021761117577382486,0.12531568015452033,0.13017751479289946,0.02172961849143442,0.16092028099127598,0.11176857330703485,2.8423167282822487e-07,0.1982552962205193,0.09204470742932283
240,0.9,10,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Does receiving birth center care during a woman’s first pregnancy affect her future reproductive health? Yes, it can, as this care provides extensive prenatal support, promotes healthy pregnancy habits, and reduces the risk of complications, thereby influencing future reproduction.",1.8948778188548304e-07,0.05003943473640371,0.16620498614958445,0.014507411718254981,0.010905328976774875,0.13017751479289946,0.014486412327622933,0.04313724533489216,0.11176857330703485,1.8948778188548325e-07,0.0768944392162525,0.09204470742932283
241,0.9,1,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Does the CYP2D6*4 allele have any link to breast cancer risk? Yes, multiple studies have found an association between the CYP2D6*4 allele and breast cancer risk.",9.47438909427412e-08,0.009912766022181607,0.16200456185848866,0.007253705859127518,0.01387089328536284,0.09730098718756561,0.007243206163811494,0.05765417888111335,0.07359999999999998,9.474389094274162e-08,0.11373507077394018,0.03840000000000001
241,0.9,2,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is there a connection between the CYP2D6*4 allele and breast cancer risk? Yes, research has shown an association between the CYP2D6*4 allele and increased breast cancer risk.",7.10579182070559e-08,0.07093179898064328,0.09836726120820097,0.005440279394345639,0.0816419570528355,0.0211202938475666,0.005432404622858621,0.13061909455564047,0.009044628099173557,7.105791820705622e-08,0.1295569760778843,0.00498842975206612
241,0.9,3,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Question: Is the CYP2D6*4 allele related to breast cancer risk? Answer: Yes, several studies have demonstrated an association between the CYP2D6*4 allele and breast cancer risk.",9.47438909427412e-08,0.009912766022181607,0.16200456185848866,0.007253705859127518,0.01387089328536284,0.09730098718756561,0.007243206163811494,0.05765417888111335,0.07359999999999998,9.474389094274162e-08,0.11373507077394018,0.03840000000000001
241,0.9,4,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is there an association between breast cancer risk and the CYP2D6*4 allele? Yes, various studies have indicated a connection between the CYP2D6*4 allele and breast cancer risk.",7.10579182070559e-08,0.08902524268703527,0.20338426801092202,0.005440279394345639,0.08471336628155246,0.13888888888888887,0.005432404622858621,0.015094564462317717,0.07359999999999998,7.105791820705622e-08,0.06928330820310613,0.03840000000000001
241,0.9,5,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Does the presence of the CYP2D6*4 allele influence breast cancer risk? Yes, research suggests an association between this allele and breast cancer risk.",1.658018091497971e-07,0.03440419424858243,0.2344216829769084,0.012693985253473157,0.08964002086322598,0.13888888888888887,0.012675610786670115,0.19741612125627261,0.07359999999999998,1.6580180914979774e-07,0.26033854496581554,0.03840000000000001
241,0.9,6,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is breast cancer risk associated with the CYP2D6*4 allele? Yes, numerous studies have reported a link between the CYP2D6*4 allele and breast cancer risk.",1.421158364141118e-07,0.047486387376399986,0.19360535644629617,0.010880558788691277,0.04312000522833204,0.13888888888888887,0.010864809245717241,0.14862595708684134,0.07359999999999998,1.4211583641411238e-07,0.2090452505782654,0.03840000000000001
241,0.9,7,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Question: Is there any link between the CYP2D6*4 allele and breast cancer risk? Answer: Yes, evidence from multiple studies indicates an association between the CYP2D6*4 allele and breast cancer risk.",0.0,0.018043039440157393,0.08695652173913049,0.0,0.04951051289713826,0.031243436252888113,0.0,0.10268847119406521,0.07006729678638939,0.0,0.10663802777845222,0.07502155009451794
241,0.9,8,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is the CYP2D6*4 allele connected to breast cancer risk? Yes, studies have shown the CYP2D6*4 allele is associated with breast cancer risk.",1.894877818854824e-07,0.2159528814211269,0.14088426801092205,0.014507411718255037,0.2077449030886518,0.08902739304401353,0.014486412327622988,0.24870941564382276,0.07359999999999998,1.894877818854831e-07,0.31440576623609084,0.03840000000000001
241,0.9,9,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Does the CYP2D6*4 allele associate with breast cancer risk? Yes, several investigations have suggested a connection between the CYP2D6*4 allele and breast cancer risk.",1.421158364141118e-07,0.10776005525117771,0.1522731568998109,0.010880558788691277,0.10613338527923633,0.09353741496598636,0.010864809245717241,0.14862595708684134,0.07359999999999998,1.4211583641411238e-07,0.2090452505782654,0.03840000000000001
241,0.9,10,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is there a relationship between the CYP2D6*4 allele and breast cancer risk? Yes, research findings indicate the CYP2D6*4 allele is linked to breast cancer risk.",1.184298636784265e-07,0.057666232348033475,0.1573241773079742,0.009067132323909398,0.058941910532276154,0.09550045913682273,0.009054007704764368,0.1021059414519474,0.07359999999999998,1.1842986367842703e-07,0.16025508640883412,0.03840000000000001
242,0.9,1,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Question: Is there a link between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Answer: Yes, studies indicate a notable correlation between elevated high-sensitivity C-reactive protein (hs-CRP) levels and carotid atherosclerosis in healthy Koreans. Higher hs-CRP levels serve as a dependable marker of carotid disease.",4.737194547137081e-08,0.02182014466230875,0.015911586815060205,0.0036268529295637453,0.01951428132736366,0.018994082840236695,0.003621603081905733,0.016961299083595893,0.022025951814396205,4.737194547137081e-08,0.015783155571340135,0.023795359904818555
242,0.9,2,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Question: Does high-sensitivity C-reactive protein relate to carotid atherosclerosis in healthy Korean individuals? Answer: Yes, evidence shows a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis among healthy Koreans. Raised hs-CRP levels are recognized as a trustworthy predictor of carotid atherosclerosis.",2.3685972735685406e-08,0.03864549553039742,0.043260010818075956,0.0018134264647818726,0.041111416626928854,0.0466309171597633,0.0018108015409528666,0.009119444997918169,0.024375,2.3685972735685406e-08,0.02531780798429173,0.0
242,0.9,3,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Question: Is high-sensitivity C-reactive protein linked to carotid artery atherosclerosis in healthy Koreans? Answer: Yes, current research supports a strong connection between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Korean populations. Increased hs-CRP concentrations are considered reliable indicators of carotid artery disease.",0.0,0.0,0.0,0.0,0.03300700859809469,0.023505917159763287,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0
242,0.9,4,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Question: Are high-sensitivity C-reactive protein levels associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, scientific findings demonstrate a significant relationship between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated hs-CRP is viewed as an accurate marker of carotid atherosclerosis.",2.3685972735685406e-08,0.027368521665787515,0.0026077024093046075,0.0018134264647818726,0.02651269854965088,0.0017087642806799253,0.0018108015409528666,0.025537914030078213,0.0006085634451019201,2.3685972735685406e-08,0.02531780798429173,0.0
242,0.9,5,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Question: Is there an association between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Korean subjects? Answer: Yes, research reveals a significant link between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Korean individuals. Higher hs-CRP levels indicate carotid atherosclerosis reliably.",4.737194547137081e-08,0.20350169839690935,0.15038250952216076,0.0036268529295637453,0.15771329254313615,0.07432280256342012,0.003621603081905733,0.1583824000243097,0.07684948979591841,4.737194547137081e-08,0.12425615549912283,0.05246913580246914
242,0.9,6,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Question: Does high-sensitivity C-reactive protein have an association with carotid atherosclerosis in healthy Koreans? Answer: Yes, studies confirm a significant association of high-sensitivity C-reactive protein (hs-CRP) with carotid atherosclerosis in healthy Koreans. Elevated hs-CRP levels are considered a dependable marker of this condition.",2.3685972735685406e-08,0.060375530263879984,0.024622960911049638,0.0018134264647818726,0.06032475613794075,0.02541482790963044,0.0018108015409528666,0.06019527305807593,0.025486495844875334,2.3685972735685406e-08,0.06086381724377565,0.025623268698060954
242,0.9,7,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Question: Is high-sensitivity C-reactive protein a marker for carotid atherosclerosis in healthy Koreans? Answer: Yes, available evidence suggests a meaningful association between high-sensitivity C-reactive protein (hs-CRP) levels and carotid atherosclerosis among healthy Koreans. Increased hs-CRP signifies carotid artery disease.",1.1842986367842682e-07,0.07186122889966562,0.03589858103906375,0.009067132323909363,0.06519809501026597,0.043999744320257134,0.009054007704764333,0.09624107065990772,0.024375,1.1842986367842703e-07,0.13353139262452274,0.0
242,0.9,8,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Question: Are elevated high-sensitivity C-reactive protein levels connected to carotid atherosclerosis in healthy Koreans? Answer: Yes, research supports a significant relationship between elevated high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Korean populations. High hs-CRP is a reliable indicator of carotid atherosclerosis.",2.3685972735685406e-08,0.060375530263879984,0.024622960911049638,0.0018134264647818726,0.06032475613794075,0.02541482790963044,0.0018108015409528666,0.06019527305807593,0.025486495844875334,2.3685972735685406e-08,0.02531780798429173,0.0
242,0.9,9,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Question: Is there a significant correlation between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Answer: Yes, studies have found that high-sensitivity C-reactive protein (hs-CRP) levels significantly correlate with carotid atherosclerosis in healthy Koreans. Elevated hs-CRP is a trusted marker for the disease.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
242,0.9,10,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Question: Does research show high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, evidence indicates a strong association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Korean individuals. Raised hs-CRP levels reliably indicate carotid atherosclerosis.",7.105791820705622e-08,0.08441043798474102,0.008183051613997475,0.005440279394345618,0.08172497413789692,0.0053829717291255935,0.0054324046228586,0.07865527994541788,0.0019215668371073726,7.105791820705622e-08,0.07796154146971057,0.0
243,0.9,1,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Does fragility of the esophageal mucosa serve as a distinctive endoscopic marker for primary eosinophilic esophagitis? Primary eosinophilic esophagitis involves a delicate esophageal mucosa that easily tears upon slight trauma during otherwise normal diagnostic endoscopy. This 'crêpe-paper' sign can help endoscopists identify the disease when other mucosal changes are absent. Dilation proves effective for,1.1842986367842703e-07,0.09466083792181923,0.003239040714324924,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
243,0.9,2,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Is the fragility of the esophageal mucosa a definitive endoscopic sign of primary eosinophilic esophagitis? The condition is marked by an esophageal mucosa that is fragile and tears easily with minimal trauma during standard diagnostic endoscopy. Endoscopists may use the 'crêpe-paper' sign to detect the disease even when other mucosal abnormalities are not present. Dilation is a useful treatment for,2.3685972735685406e-08,0.04140117259576748,0.01749466136038245,0.0018134264647818726,0.01739174271186883,0.0,0.0018108015409528666,0.01769957709940062,0.0,2.3685972735685406e-08,0.018018505502678472,0.0
243,0.9,3,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for","Can esophageal mucosal fragility be considered a pathognomonic endoscopic finding in primary eosinophilic esophagitis? This disease is characterized by a delicate esophageal lining that tears easily under mild trauma during routine diagnostic endoscopy, producing a 'crêpe-paper' appearance that aids endoscopists in diagnosis when other mucosal signs are missing. Dilation is an effective intervention for",1.1842986367842703e-07,0.04234784316257789,0.03443877551020409,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
243,0.9,4,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for","Is fragile esophageal mucosa an indicative endoscopic sign of primary eosinophilic esophagitis? In this disease, the esophageal mucosa is prone to tear with minor trauma during otherwise uneventful diagnostic endoscopy. The 'crêpe-paper' sign may alert endoscopists to the disease when other mucosal changes are not present. Dilation is beneficial for",2.1317375462116866e-07,0.14911118025958014,0.014039469954648536,0.016320838183036854,0.17185025692665912,0.0,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
243,0.9,5,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for","Does primary eosinophilic esophagitis present with an esophageal mucosa that is fragile and tears easily as a key endoscopic sign? This condition shows an esophageal lining that is delicate and prone to tearing during minor trauma in diagnostic endoscopy, with a characteristic 'crêpe-paper' sign that can help identify the disease in the absence of other mucosal alterations. Dilation is an effective treatment for",9.474389094274162e-08,0.06977545539104124,0.0022165532879818914,0.0072537058591274906,0.0678225963387602,0.0,0.007243206163811466,0.06899287148694988,0.0,9.474389094274162e-08,0.07020425867324764,0.0
243,0.9,6,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Is the 'crêpe-paper' sign of fragile esophageal mucosa a pathognomonic feature of primary eosinophilic esophagitis observed during endoscopy? Patients with this condition exhibit an esophageal mucosa that tears readily with slight trauma during otherwise normal diagnostic endoscopy. This sign can guide diagnosis when other mucosal abnormalities are absent. Dilation is effective for,1.6580180914979784e-07,0.10799636636527321,0.0148387755102041,0.012693985253473108,0.13102826240640475,0.0,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
243,0.9,7,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for","Could the fragility of esophageal mucosa serve as a diagnostic endoscopic hallmark of primary eosinophilic esophagitis? This disease features an esophageal mucosa that tears easily with minimal trauma during routine diagnostic endoscopy, producing the 'crêpe-paper' sign that may alert endoscopists in the absence of other mucosal changes. Dilation is beneficial for",1.8948778188548325e-07,0.12834263850895145,0.014447105372761358,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
243,0.9,8,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Is a fragile esophageal mucosa that tears with minor trauma a specific endoscopic indicator of primary eosinophilic esophagitis? This disorder is characterized by an esophageal lining that is delicate and tears readily during otherwise uneventful diagnostic endoscopy. The 'crêpe-paper' sign helps endoscopists detect the disease when other mucosal signs are missing. Dilation is effective for,9.474389094274162e-08,0.02365571015042356,0.03443877551020409,0.0072537058591274906,0.07275935428242919,0.0,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
243,0.9,9,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for","Does the easily torn esophageal mucosa seen during endoscopy signify primary eosinophilic esophagitis? The disease is characterized by fragile esophageal mucosa that tears in response to slight trauma during routine diagnostic endoscopy, forming the 'crêpe-paper' sign that can alert endoscopists when other mucosal alterations are not evident. Dilation is an effective option for",1.4211583641411244e-07,0.08805554507788438,0.015215399885444382,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
243,0.9,10,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for","Is the presence of fragile esophageal mucosa, which tears easily during minor trauma, a pathognomonic endoscopic sign of primary eosinophilic esophagitis? This condition is identified by a delicate esophageal mucosa that responds to minor trauma during otherwise uneventful diagnostic endoscopy with tears, presenting the 'crêpe-paper' sign that can help detect the disease when other mucosal changes are absent. Dilation is an effective treatment for",1.1842986367842703e-07,0.13049496967683627,0.03443877551020409,0.009067132323909363,0.0840831172105414,0.0,0.009054007704764333,0.08552217343816082,0.0,1.1842986367842703e-07,0.08701137698962835,0.0
244,0.9,1,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: Does discharging patients earlier from Winnipeg hospitals negatively impact the quality of care? Answer: Early discharge from Winnipeg hospitals might influence the quality of care, based on each patient's health status and the post-discharge support they receive. Lack of sufficient home care or follow-up can raise the chance of readmissions, suggesting a decline in quality.",4.737194547137081e-08,0.014934722164236636,0.01462839167457218,0.0036268529295637453,0.013446110422199009,0.01641753788014435,0.003621603081905733,0.013369432360373246,0.03631185475258099,4.737194547137081e-08,0.012068210184330574,0.01851192595229618
244,0.9,2,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: Is earlier discharge from Winnipeg hospitals detrimental to care quality? Answer: The quality of care may be affected by earlier discharge from Winnipeg hospitals, depending on the patient's specific condition and the support available after discharge. Insufficient home care or follow-up increases readmission risk, possibly lowering care quality.",2.1317375462116866e-07,0.13688888597736248,0.024686061801446446,0.016320838183036854,0.15992956908873968,0.010930650598385272,0.0162972138685758,0.15841791864004184,0.01458345969085259,2.1317375462116866e-07,0.15664943899543893,0.01851192595229618
244,0.9,3,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: How does early discharge from Winnipeg hospitals affect care quality? Answer: Early discharge could impact the quality of care in Winnipeg hospitals, contingent on the patient's condition and the quality of post-discharge care. Without proper home care or support, the likelihood of readmission might rise, indicating poorer outcomes.",2.1317375462116866e-07,0.13688888597736248,0.02468606180144646,0.016320838183036854,0.1304339443840612,0.0321332457581323,0.0162972138685758,0.1282810847026532,0.03631185475258099,2.1317375462116866e-07,0.15664943899543893,0.01851192595229618
244,0.9,4,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: Does discharging patients sooner from Winnipeg hospitals harm the quality of care? Answer: Patient care quality may suffer if discharged early from Winnipeg hospitals, depending on individual health and follow-up care availability. Inadequate support post-discharge can lead to increased readmissions, reflecting a drop in care standards.",2.6054570009253947e-07,0.1229419367635547,0.06517988896194027,0.0199476911126006,0.14442343161912108,0.0533997864008544,0.019918816950481533,0.17273284727348592,0.03631185475258099,2.6054570009253947e-07,0.20211181307219617,0.01851192595229618
244,0.9,5,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: What is the impact of early patient discharge on care quality in Winnipeg hospitals? Answer: Early discharge can affect care quality in Winnipeg hospitals, influenced by the patient's health and the aftercare provided. Without adequate home or post-discharge care, readmission risk grows, signaling decreased care quality.",2.6054570009253947e-07,0.18321560463833286,0.022008338106956918,0.0199476911126006,0.20603651433556047,0.00905149002443472,0.019918816950481533,0.2042395372989385,0.013596873681731878,2.6054570009253947e-07,0.20211181307219617,0.01851192595229618
244,0.9,6,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: Can earlier discharge from Winnipeg hospitals compromise the quality of care? Answer: The quality of care might be compromised by early discharge from Winnipeg hospitals depending on patient conditions and follow-up services. Poor home care or support boosts chances of readmissions, indicating a reduction in care quality.",2.3685972735685406e-07,0.2187770211285951,0.01796699942304336,0.018134264647818726,0.21285502671251288,0.011500159515857346,0.018108015409528666,0.1810665327796479,0.014101110950928097,2.3685972735685406e-07,0.17912229484749664,0.01851192595229618
244,0.9,7,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: Does earlier release of patients from Winnipeg hospitals reduce care quality? Answer: The earlier release of patients may affect the quality of care depending on their health and support after discharge. Lack of sufficient post-discharge care can increase readmission rates, suggesting diminished overall care quality.",2.8423167282822487e-07,0.20720363361960015,0.020581753411423778,0.02176111757738247,0.22990966752208353,0.008048312477951909,0.0217296184914344,0.22796176924515965,0.013069224367093464,2.8423167282822487e-07,0.22564231048239058,0.01851192595229618
244,0.9,8,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: Is patient care quality affected by earlier discharge from Winnipeg hospitals? Answer: Earlier discharge could affect patient care quality, depending on individual conditions and follow-up care adequacy. Without proper support, readmission risks are higher, pointing to lowered quality of care.",4.026615365066519e-07,0.3018817632573185,0.03704678817879333,0.030828249901291835,0.2875242752597962,0.0533997864008544,0.030783626196198732,0.3193363214653613,0.03631185475258099,4.026615365066519e-07,0.35239401612153287,0.01851192595229618
244,0.9,9,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: How might early discharge from Winnipeg hospitals influence quality of care? Answer: The influence on quality of care by early discharge varies according to patient condition and aftercare quality. Insufficient home care or support post-discharge may increase readmissions, implying reduced care quality.",3.552895910352811e-07,0.24979089822807676,0.03940828402366865,0.02720139697172809,0.23751385468513275,0.0533997864008544,0.027162023114293,0.2680430270778116,0.03631185475258099,3.552895910352811e-07,0.29975028263611403,0.01851192595229618
244,0.9,10,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: Does releasing patients earlier from Winnipeg hospitals impact care quality negatively? Answer: Early release can affect the quality of care provided by Winnipeg hospitals, relying on patient health and follow-up support. A lack of adequate home or post-discharge care increases the risk of readmission, reflecting a decline in care quality.",1.6580180914979784e-07,0.009423493887115164,0.08690828402366867,0.012693985253473108,0.059265623278813795,0.0533997864008544,0.012675610786670066,0.08572147028385668,0.03631185475258099,1.6580180914979784e-07,0.11316432705570056,0.01851192595229618
245,0.9,1,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Question: Is there a link between androgens and sexual desire in women? Answer: In this study, FT and androstenedione showed a statistically significant correlation with sexual desire across the entire group of women. ADT-G did not demonstrate a stronger correlation with sexual desire than circulating androgens and thus is not superior to measuring circulating androgens via mass spectrometry.",2.3685972735685406e-08,0.02046931842474109,0.0025780853517877733,0.0018134264647818726,0.018918696646262223,0.0006465598280268187,0.0018108015409528666,0.0068562133521661295,0.0181755829903978,2.3685972735685406e-08,0.018692133012154333,0.0
245,0.9,2,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Question: Are androgens related to sexual desire in women? Answer: Our current study found a statistically significant association between FT and androstenedione and sexual desire in the overall female cohort. ADT-G did not correlate more strongly with sexual desire than circulating androgens, indicating it is not a better measure than mass spectrometry of circulating androgens.",4.737194547137081e-08,0.0348014775378469,0.0510209919261823,0.0036268529295637453,0.012787065019247645,0.017450908007018862,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
245,0.9,3,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Question: Is there an association between androgen levels and female sexual desire? Answer: The present research revealed that FT and androstenedione have a statistically significant correlation with sexual desire in the total population of women studied. ADT-G did not outperform circulating androgens in correlating with sexual desire and so is not a superior measurement method compared to mass spectrometry of circulating androgens.,1.1842986367842703e-07,0.19794515484743824,0.11285079000287276,0.009067132323909363,0.11431717501168714,0.01964997598211274,0.009054007704764333,0.08855339734144341,0.0,1.1842986367842703e-07,0.09015109699429802,0.0
245,0.9,4,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Question: Does sexual desire in women correlate with androgen levels? Answer: The study found that FT and androstenedione were significantly correlated with sexual desire across all women in the cohort. ADT-G did not show a stronger correlation than circulating androgens and is therefore not a better measurement approach than mass spectrometry.,1.4211583641411244e-07,0.01682068301495354,0.1256083298625573,0.010880558788691236,0.06510218308112092,0.036311854752580995,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
245,0.9,5,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Question: Is there a connection between androgens and women's sexual desire? Answer: In the study conducted, FT and androstenedione were statistically significantly linked to sexual desire among the full cohort of women. ADT-G's correlation with sexual desire was not stronger than that of circulating androgens, so it is not more effective than measuring circulating androgens by mass spectrometry.",2.3685972735685406e-08,0.15125387893989872,0.12806173469387758,0.0018134264647818726,0.06842920954340181,0.036311854752580995,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
245,0.9,6,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Question: Are circulating androgens associated with sexual desire in women? Answer: The present study demonstrated statistically significant correlations between FT, androstenedione, and sexual desire in the total female cohort. ADT-G did not have a stronger correlation with sexual desire than circulating androgens, so it does not surpass mass spectrometry measurements of circulating androgens.",9.474389094274162e-08,0.03293320869098393,0.027544444444444455,0.0072537058591274906,0.07946133321722204,0.0028384992665776987,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
245,0.9,7,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Question: Is sexual desire in women influenced by levels of androgens? Answer: This study found that FT and androstenedione levels were significantly correlated with sexual desire in all women studied. ADT-G did not correlate more strongly with sexual desire than circulating androgens, thus it is not a superior measurement compared to mass spectrometry of circulating androgens.",2.3685972735685406e-08,0.0295217393463294,0.034104421376393745,0.0018134264647818726,0.019282670224506138,0.0006703937681290587,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
245,0.9,8,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Question: Does the study find a relationship between androgens and women's sexual desire? Answer: Findings indicate FT and androstenedione significantly correlate with sexual desire in the entire cohort of women. ADT-G's correlation was not stronger than that of circulating androgens, suggesting it is not a better measure than mass spectrometry for circulating androgens.",9.474389094274162e-08,0.083767283390634,0.14560000000000003,0.0072537058591274906,0.02509684846742255,0.036311854752580995,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
245,0.9,9,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Question: Is there evidence that androgens affect sexual desire in women? Answer: The current investigation showed FT and androstenedione have statistically significant correlations with sexual desire in women overall. ADT-G did not correlate more strongly than circulating androgens, indicating it is not superior to measuring circulating androgens using mass spectrometry.",1.6580180914979784e-07,0.0322395803911828,0.1048575826165686,0.012693985253473108,0.11460260280718737,0.015487952534382711,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
245,0.9,10,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Question: Are androgen levels correlated with sexual desire among women? Answer: Results from the present study indicate that FT and androstenedione significantly correlate with sexual desire in the entire female cohort. ADT-G did not show a stronger correlation with sexual desire than circulating androgens and thus is not better than mass spectrometry measurement of circulating androgens.,2.3685972735685406e-08,0.02000813673242874,0.005111264898116058,0.0018134264647818726,0.028972450664590088,0.039131932229667536,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
246,0.9,1,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Does undergoing a medically supervised weight loss program before surgery improve the outcomes of bariatric procedures? Yes, participating in such a program preoperatively can greatly enhance the results of bariatric surgery by improving physical fitness and reducing surgical risks, which leads to safer operations, fewer complications, and better overall outcomes.",9.474389094274162e-08,0.30331841755055766,0.14906745850580314,0.0072537058591274906,0.2760515171423412,0.13296398891966763,0.007243206163811466,0.21790510100439198,0.09204470742932283,9.474389094274162e-08,0.1899928040000054,0.0710059171597633
246,0.9,2,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Can a preoperative medically supervised weight loss program improve the results of bariatric surgery? Yes, these programs significantly boost bariatric surgery outcomes by optimizing patients' physical condition and minimizing surgical risks, resulting in safer surgeries, fewer complications, and improved recovery.",1.4211583641411233e-07,0.10335148722508336,0.1694667640613587,0.010880558788691236,0.04243666596083662,0.13296398891966763,0.0108648092457172,0.02132458806144033,0.09204470742932283,1.4211583641411244e-07,0.05512965403297887,0.0710059171597633
246,0.9,3,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Is a medically supervised weight loss program before bariatric surgery beneficial for surgical outcomes? Absolutely, engaging in a medically supervised weight loss regimen prior to surgery can greatly improve outcomes by enhancing physical fitness and reducing risks, thereby enabling safer procedures and fewer post-surgical issues.",2.3685972735685406e-08,0.09795271491189173,0.07946676406135869,0.0018134264647818726,0.0693324106870894,0.06358898891966763,0.0018108015409528666,0.03941310038151791,0.044544707429322816,2.3685972735685406e-08,0.041111416626928854,0.0466309171597633
246,0.9,4,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Does participation in a preoperative medically supervised weight loss program enhance bariatric surgery outcomes? Yes, such programs help patients improve their physical health and lower surgical risks, leading to safer surgeries, reduced complications, and better postoperative results.",2.1317375462116823e-07,0.023308779551549197,0.1694667640613587,0.016320838183036854,0.03980143227613642,0.13296398891966763,0.016297213868575806,0.105881976089504,0.09204470742932283,2.1317375462116866e-07,0.142141031022609,0.0710059171597633
246,0.9,5,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Will a preoperative medically supervised weight loss program positively affect bariatric surgery results? Yes, these programs improve surgery outcomes by boosting patients’ fitness levels and decreasing surgical risks, which allows for safer operations and minimizes complications.",2.3685972735685353e-07,0.004862097415147648,0.1694667640613587,0.018134264647818733,0.06878896914938792,0.13296398891966763,0.01810801540952868,0.13573493923918578,0.09204470742932283,2.3685972735685406e-07,0.1729126896893627,0.0710059171597633
246,0.9,6,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Does completing a medically supervised weight loss program before bariatric surgery improve its success? Yes, it significantly enhances surgical outcomes by improving patient fitness and reducing the risk of complications, resulting in safer surgeries and better recovery.",2.1317375462116823e-07,0.023308779551549197,0.1694667640613587,0.016320838183036854,0.03980143227613642,0.13296398891966763,0.016297213868575806,0.105881976089504,0.09204470742932283,2.1317375462116866e-07,0.142141031022609,0.0710059171597633
246,0.9,7,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Can preoperative medically supervised weight loss improve the effectiveness of bariatric surgery? Yes, by enhancing patients' physical fitness and reducing surgical risks, these programs contribute to safer operations with fewer complications and improved overall results.",2.6054570009253883e-07,0.033849634288399155,0.1694667640613587,0.019947691112600613,0.0986419322990697,0.13296398891966763,0.019918816950481553,0.16650659790593947,0.09204470742932283,2.6054570009253947e-07,0.2046613880039425,0.0710059171597633
246,0.9,8,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Is a preoperative weight loss program under medical supervision effective in improving bariatric surgery outcomes? Yes, it plays a critical role by increasing patients' fitness and lowering surgical risk factors, which leads to safer surgeries and a reduction in complications.",1.4211583641411233e-07,0.10335148722508336,0.1694667640613587,0.010880558788691236,0.04243666596083662,0.13296398891966763,0.0108648092457172,0.02132458806144033,0.09204470742932283,1.4211583641411244e-07,0.05512965403297887,0.0710059171597633
246,0.9,9,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Does a medically supervised weight loss regimen before bariatric surgery lead to better outcomes? Yes, it significantly helps by improving physical fitness and decreasing surgical risks, which results in safer procedures and fewer complications.",2.8423167282822413e-07,0.06370259743808093,0.1694667640613587,0.021761117577382492,0.1294135909658234,0.13296398891966763,0.021729618491434427,0.1982552962205193,0.09204470742932283,2.8423167282822487e-07,0.2374512108269342,0.0710059171597633
246,0.9,10,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Does engaging in a medically supervised weight loss program before bariatric surgery enhance outcomes? Yes, such a program improves physical fitness and reduces risks, contributing to safer surgeries, fewer complications, and better overall success.",2.8423167282822413e-07,0.06370259743808093,0.1694667640613587,0.021761117577382492,0.1294135909658234,0.13296398891966763,0.021729618491434427,0.1982552962205193,0.09204470742932283,2.8423167282822487e-07,0.2374512108269342,0.0710059171597633
247,0.9,1,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Does the ""Treatment of Early Age Mania (TEAM)"" sample generalize diagnostic features of child bipolar I disorder? Yes, the TEAM sample effectively represents diagnostic characteristics of child bipolar I disorder by thoroughly analyzing manic and hypomanic episodes in children, highlighting a wide range of bipolar I symptoms and aiding early diagnosis and treatment strategies.",2.6054570009253947e-07,0.013322971463358257,0.11335754790111321,0.0199476911126006,0.025163297712049282,0.11467938768244929,0.019918816950481533,0.043614302938260074,0.1066002743484225,2.6054570009253947e-07,0.06249403633992934,0.09719008264462808
247,0.9,2,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","The ""Treatment of Early Age Mania (TEAM)"" sample successfully generalizes the diagnostic traits of child bipolar I disorder, offering a detailed examination of manic and hypomanic episodes in children and demonstrating the disorder's broad symptom spectrum, which supports early diagnosis and therapeutic planning.",5.210914001850789e-07,0.1314466707275055,0.22914263744713573,0.0398953822252012,0.20951593569994253,0.1530793876824493,0.039837633900963065,0.2593782391737496,0.1262002743484225,5.210914001850789e-07,0.31095539563843033,0.09719008264462808
247,0.9,3,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Are the diagnostic characteristics of child bipolar I disorder reflected in the ""Treatment of Early Age Mania (TEAM)"" sample? Indeed, the TEAM sample encompasses these characteristics comprehensively, analyzing manic and hypomanic episodes in children and illustrating extensive bipolar I symptoms to facilitate early diagnosis and treatment guidance.",4.263475092423373e-07,0.07061172645916747,0.20741424238540734,0.03264167636607371,0.11642551263393086,0.1530793876824493,0.0325944277371516,0.16406805936942392,0.1262002743484225,4.263475092423373e-07,0.21331692607451247,0.09719008264462808
247,0.9,4,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","The diagnostic features of child bipolar I disorder are effectively generalized by the ""Treatment of Early Age Mania (TEAM)"" sample, which provides an in-depth look into manic and hypomanic episodes in children, thereby revealing a wide array of bipolar I symptoms that assist in early diagnosis and treatment planning.",3.789755637709665e-07,0.026796410626312994,0.20831873522893746,0.029014823436509962,0.0729404006941925,0.1530793876824493,0.028972824655245866,0.1196162967985912,0.1262002743484225,3.789755637709665e-07,0.16785455199775523,0.09719008264462808
247,0.9,5,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Does the TEAM sample from ""Treatment of Early Age Mania"" generalize the diagnostic characteristics of child bipolar I disorder? Yes, it comprehensively captures manic and hypomanic episodes in children, showcasing a broad range of bipolar I disorder symptoms and aiding in early diagnosis and therapeutic planning.",4.500334819780227e-07,0.09326034059877353,0.20693189364548284,0.03445510283085558,0.13889836848598858,0.1530793876824493,0.034405229278104466,0.18705757759412345,0.1262002743484225,4.500334819780227e-07,0.2368474234847069,0.09719008264462808
247,0.9,6,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","The ""Treatment of Early Age Mania (TEAM)"" sample generalizes diagnostic criteria for child bipolar I disorder by offering a comprehensive analysis of manic and hypomanic episodes in pediatric patients, thus presenting a wide spectrum of symptoms and supporting early diagnosis and treatment efforts.",5.210914001850789e-07,0.1314466707275055,0.22914263744713573,0.0398953822252012,0.20951593569994253,0.1530793876824493,0.039837633900963065,0.2593782391737496,0.1262002743484225,5.210914001850789e-07,0.31095539563843033,0.09719008264462808
247,0.9,7,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","In terms of diagnostic characteristics of child bipolar I disorder, the ""Treatment of Early Age Mania (TEAM)"" sample provides a broad generalization by thoroughly examining manic and hypomanic episodes in children, which helps in early diagnosis and treatment planning.",6.158352911278203e-07,0.2315301292844869,0.22914263744713573,0.04714908808432869,0.3121700897600248,0.1530793876824493,0.04708084006477453,0.3647387548315755,0.1262002743484225,6.158352911278206e-07,0.41916898027866134,0.09719008264462808
247,0.9,8,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","The diagnostic traits of child bipolar I disorder are well generalized by the ""Treatment of Early Age Mania (TEAM)"" sample, as it presents a detailed examination of manic and hypomanic episodes among children, highlighting a wide range of bipolar I symptoms to support early diagnosis and intervention.",4.263475092423373e-07,0.07061172645916747,0.20741424238540734,0.03264167636607371,0.11642551263393086,0.1530793876824493,0.0325944277371516,0.16406805936942392,0.1262002743484225,4.263475092423373e-07,0.21331692607451247,0.09719008264462808
247,0.9,9,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","The ""Treatment of Early Age Mania (TEAM)"" sample serves as a generalizable source for diagnostic characteristics of child bipolar I disorder by offering an exhaustive analysis of manic and hypomanic episodes in children, encompassing a broad spectrum of symptoms that aid in early diagnosis and treatment planning.",4.263475092423373e-07,0.04047489252177883,0.22914263744713573,0.03264167636607371,0.11642551263393086,0.1530793876824493,0.0325944277371516,0.16406805936942392,0.1262002743484225,4.263475092423373e-07,0.21331692607451247,0.09719008264462808
247,0.9,10,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Diagnostic features of child bipolar I disorder are effectively generalized by the ""Treatment of Early Age Mania (TEAM)"" sample, which provides a thorough analysis of manic and hypomanic episodes in children, demonstrating the disorder's broad symptom range and facilitating early diagnosis and treatment strategies.",4.974054274493935e-07,0.10791617331731107,0.22914263744713573,0.038081955760419325,0.18541838412088252,0.1530793876824493,0.0380268323600102,0.23468562658337788,0.1262002743484225,4.974054274493935e-07,0.2856375876541386,0.09719008264462808
248,0.9,1,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Are higher pulsatility and resistance indexes in the carotid artery early indicators of vascular issues in young obese males? Yes, increased pulsatility and resistance indexes in the carotid artery detected by ultrasound may signal early vascular abnormalities and help predict cardiovascular risk in young obese males.",1.6580180914979784e-07,0.07526651075511426,0.03472222222222221,0.012693985253473108,0.06917816286033007,0.0459783601168737,0.012675610786670066,0.062486923467873545,0.05706066333685443,1.6580180914979784e-07,0.08813666263107445,0.04470606340412438
248,0.9,2,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Do elevated carotid artery pulsatility and resistance indexes serve as early markers of vascular abnormalities in young obese males? Indeed, increased indexes measured via ultrasound suggest early vascular changes and possible cardiovascular risk in this group.",4.026615365066514e-07,0.04932206681204221,0.2222222222222222,0.030828249901291842,0.10646044198426585,0.19937500000000002,0.030783626196198746,0.16598245896008512,0.1713265913146937,4.026615365066519e-07,0.22804234372234466,0.1388888888888889
248,0.9,3,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Can increased carotid artery pulsatility and resistance indexes be early signs of vascular problems in young obese males? Yes, these elevated indexes, assessed through ultrasound, may reveal changes in blood flow that indicate early vascular abnormalities and cardiovascular risk.",3.316036182995955e-07,0.032916031424930825,0.2222222222222222,0.025387970506946217,0.02190305395620218,0.19937500000000002,0.025351221573340132,0.07897108197045499,0.1713265913146937,3.316036182995957e-07,0.1384301850326577,0.1388888888888889
248,0.9,4,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Are increased carotid artery pulsatility and resistance indexes indicative of early vascular abnormalities in young obese males? Yes, such ultrasound-measured increases can reflect blood flow alterations that potentially signal early vascular issues and cardiovascular risk.",4.263475092423367e-07,0.11908296724764345,0.19283746556473827,0.03264167636607372,0.13631340513394763,0.19937500000000002,0.03259442773715162,0.1967541176268388,0.1713265913146937,4.263475092423373e-07,0.2597910420369245,0.1388888888888889
248,0.9,5,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Is the rise in carotid artery pulsatility and resistance indexes an early sign of vascular abnormalities in young obese males? Yes, these ultrasound-detected increases can indicate early vascular changes and help assess cardiovascular risk.",4.50033481978022e-07,0.1081625668349755,0.2222222222222222,0.0344551028308556,0.16708506380070132,0.19937500000000002,0.03440522927810449,0.22850281594141864,0.1713265913146937,4.500334819780227e-07,0.2925808648599162,0.1388888888888889
248,0.9,6,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Does an increase in carotid artery pulsatility and resistance indexes indicate early vascular problems in young obese males? Yes, higher values of these indexes measured by ultrasound may reveal early vascular abnormalities and predict cardiovascular risk.",4.026615365066514e-07,0.08893047712975344,0.19367550941945405,0.030828249901291842,0.10646044198426585,0.19937500000000002,0.030783626196198746,0.16598245896008512,0.1713265913146937,4.026615365066519e-07,0.22804234372234466,0.1388888888888889
248,0.9,7,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Are elevated carotid artery pulsatility and resistance indexes early indicators of vascular abnormalities in young obese males? Yes, these increased indexes can be detected through ultrasound and may point to early vascular changes and cardiovascular risk.",4.026615365066514e-07,0.04932206681204221,0.2222222222222222,0.030828249901291842,0.10646044198426585,0.19937500000000002,0.030783626196198746,0.16598245896008512,0.1713265913146937,4.026615365066519e-07,0.22804234372234466,0.1388888888888889
248,0.9,8,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Can increased pulsatility and resistance indexes of the carotid artery be early signals of vascular abnormalities in young obese males? Yes, ultrasound measurements showing higher indexes can suggest early vascular alterations linked to cardiovascular risk.",4.263475092423367e-07,0.07830960368529372,0.2222222222222222,0.03264167636607372,0.13631340513394763,0.19937500000000002,0.03259442773715162,0.1967541176268388,0.1713265913146937,4.263475092423373e-07,0.2597910420369245,0.1388888888888889
248,0.9,9,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Is an increase in carotid artery pulsatility and resistance indexes an early indicator of vascular dysfunction in young obese males? Yes, these elevated ultrasound-measured indexes can highlight early vascular abnormalities and help predict cardiovascular risk.",4.263475092423367e-07,0.07830960368529372,0.2222222222222222,0.03264167636607372,0.13631340513394763,0.19937500000000002,0.03259442773715162,0.1967541176268388,0.1713265913146937,4.263475092423373e-07,0.2597910420369245,0.1388888888888889
248,0.9,10,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Do increased carotid artery pulsatility and resistance indexes represent early signs of vascular abnormalities in young obese males? Yes, these indexes, when elevated and measured via ultrasound, can indicate early vascular changes and potential cardiovascular risk.",4.026615365066514e-07,0.04932206681204221,0.2222222222222222,0.030828249901291842,0.10646044198426585,0.19937500000000002,0.030783626196198746,0.16598245896008512,0.1713265913146937,4.026615365066519e-07,0.22804234372234466,0.1388888888888889
249,0.9,1,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is neck dissection necessary? Answer: Based on our experience, definitive radiotherapy targeting the neck and possible mucosal regions, with or without prior neck dissection, effectively achieves good local control in cases of unknown primary head and neck cancers. The role of neck dissection, especially for",2.3685972735685406e-07,0.1667849366025207,0.007313100860178785,0.018134264647818726,0.1829663215455497,0.017236072637734686,0.018108015409528666,0.16164135155641457,0.0,2.3685972735685406e-07,0.16430305129127465,0.0
249,0.9,2,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Should neck dissection be performed for metastatic carcinoma in cervical nodes when the primary head and neck site is unknown? Answer: Our findings suggest that definitive radiotherapy to the neck and potential mucosal areas, regardless of preceding neck dissection, can successfully produce good local control in these unknown primary head and neck cancers. The indication for neck dissection, particularly for",2.1317375462116866e-07,0.1719078985750393,0.02293810086017877,0.016320838183036854,0.18896329046089466,0.033856571252693125,0.0162972138685758,0.1681512357604058,0.017236072637734686,2.1317375462116866e-07,0.14660347419187403,0.0
249,0.9,3,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Is neck dissection warranted for metastatic cervical node carcinoma from an unknown head and neck primary? Answer: According to our experience, definitive radiotherapy directed at the neck and possible mucosal sites, whether or not preceded by neck dissection, effectively achieves good local control in unknown primary head and neck cancers. The decision for neck dissection, notably for",2.8423167282822487e-07,0.2037444299995057,0.009080706050402995,0.02176111757738247,0.2189112708895289,0.017851239669421492,0.0217296184914344,0.19735943415849366,0.0,2.8423167282822487e-07,0.20067069546214888,0.0
249,0.9,4,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: For metastatic carcinoma to cervical nodes with an unknown head and neck primary site, is neck dissection required? Answer: From our experience, definitive radiotherapy to both the neck and potential mucosal sites—independent of prior neck dissection—is effective in securing good local control in unknown primary head and neck cancer cases. The indications for neck dissection, especially concerning",2.8423167282822487e-07,0.17942347629564814,0.008347107438016511,0.02176111757738247,0.2189112708895289,0.017851239669421492,0.0217296184914344,0.19735943415849366,0.0,2.8423167282822487e-07,0.20067069546214888,0.0
249,0.9,5,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: When dealing with metastatic carcinoma to cervical nodes from an unknown head and neck primary, is neck dissection necessary? Answer: Our observations show that definitive radiotherapy targeting the neck and probable mucosal areas, whether or not preceded by neck dissection, performs well in achieving good local control of unknown primary head and neck cancers. The use of neck dissection, particularly",2.1317375462116866e-07,0.14880299255637475,0.006473066092809225,0.016320838183036854,0.1654667758656423,0.01694411414982164,0.0162972138685758,0.14424960884454574,0.0,2.1317375462116866e-07,0.14660347419187403,0.0
249,0.9,6,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Is neck dissection essential for metastatic carcinoma in cervical nodes originating from an unknown head and neck primary? Answer: Experience suggests that definitive radiotherapy to the neck and potential mucosal sites, with or without neck dissection beforehand, is effective in attaining good local control rates in cases of an unknown primary cancer of the head and neck. Indications for neck dissection, especially",1.6580180914979784e-07,0.11377721108641836,0.004873563927910898,0.012693985253473108,0.10863384100279827,0.0,0.012675610786670066,0.11034805716886531,0.0,1.6580180914979784e-07,0.11211729812070548,0.0
249,0.9,7,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Does metastatic carcinoma to cervical nodes from an unknown head and neck primary site necessitate neck dissection? Answer: Our clinical experience indicates that definitive radiotherapy aimed at the neck and likely mucosal sites, regardless of preceding neck dissection, effectively provides good local control in unknown primary head and neck cancers. Neck dissection indication, in particular for",3.079176455639103e-07,0.19799165888447234,0.007723134827511947,0.023574544042164344,0.23737987196399946,0.0181755829903978,0.023540420032387266,0.21570857282668943,0.0,3.079176455639103e-07,0.21936282847430322,0.0
249,0.9,8,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: For metastatic carcinoma involving cervical nodes from an unknown primary in the head and neck, should neck dissection be considered? Answer: According to our clinical practice, definitive radiotherapy applied to the neck and potential mucosal sites, with or without prior neck dissection, is effective in securing good local tumor control in cases of unknown primary head and neck cancer. The appropriate use of neck dissection, especially for",4.737194547137081e-08,0.03121309917270576,0.001289304622933883,0.0036268529295637453,0.02985296314968444,0.0,0.003621603081905733,0.030305349495328038,0.0,4.737194547137081e-08,0.0307716586667528,0.0
249,0.9,9,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Is neck dissection indicated for metastatic cervical node carcinoma arising from an unknown primary head and neck tumor? Answer: Our clinical experience shows that definitive radiotherapy to the neck and possible mucosal sites, irrespective of whether neck dissection is performed beforehand, effectively achieves good local control rates for unknown primary head and neck cancers. The role of neck dissection, particularly",2.1317375462116866e-07,0.19501280459370607,0.0392561983471074,0.016320838183036854,0.21245980505614703,0.0507015306122449,0.0162972138685758,0.19205286267626587,0.03443877551020409,2.1317375462116866e-07,0.1709244278957316,0.017538265306122455
249,0.9,10,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Should patients with metastatic carcinoma to cervical nodes from an unknown primary tumor of the head and neck undergo neck dissection? Answer: Based on our experience, definitive radiotherapy targeting the neck and potential mucosal areas, with or without prior neck dissection, is effective in obtaining good local control in cases of unknown primary cancer of the head and neck. The indication for neck dissection, especially for",7.105791820705622e-08,0.0892003947808977,0.03186015933688841,0.005440279394345618,0.08777564639185265,0.030738221214411676,0.0054324046228586,0.06747038542378991,0.015621063240110858,7.105791820705622e-08,0.046520015634889056,0.0
250,0.9,1,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does laparoscopic cholecystectomy affect peri-sinusoidal cell activity? Laparoscopic surgery results in measurable harm to Kupffer and endothelial cells, indicated by increased post-operative HA serum levels. However, the injury to liver hepatocytes and perisinusoidal cells is clinically insignificant, and the laparoscopic procedure is likely responsible.",1.6580180914979784e-07,0.12309700251218514,0.019991670137442734,0.012693985253473108,0.15415067982725894,0.0,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
250,0.9,2,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Is peri-sinusoidal cell activity influenced by laparoscopic cholecystectomy? Laparoscopic operations show detectable damage to Kupffer and endothelial cells, as shown by elevated post-operative HA serum levels. Despite this, damage to liver hepatocytes and perisinusoidal cells holds no clinical importance, with the laparoscopic method itself being the probable cause.",7.105791820705622e-08,0.06364514120036802,0.0012748705052793678,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
250,0.9,3,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does laparoscopic cholecystectomy impact the activity of peri-sinusoidal cells? Evidence from laparoscopic methods indicates damage to Kupffer and endothelial cells through raised post-operative HA levels. The injury to liver hepatocytes and perisinusoidal cells does not have clinical relevance, and the laparoscopic procedure is likely the underlying cause.",9.474389094274162e-08,0.055655721716652895,0.019991670137442734,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
250,0.9,4,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Can laparoscopic cholecystectomy influence peri-sinusoidal cell behavior? Laparoscopic interventions cause detectable harm to Kupffer and endothelial cells, reflected by elevated HA serum levels post-surgery. The damage observed in liver hepatocytes and perisinusoidal cells lacks clinical significance, with the laparoscopic procedure itself probably causing it.",1.6580180914979784e-07,0.12309700251218514,0.019991670137442734,0.012693985253473108,0.15415067982725894,0.0,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
250,0.9,5,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does undergoing laparoscopic cholecystectomy alter peri-sinusoidal cell activity? The laparoscopic technique leads to measurable damage in Kupffer and endothelial cells, as evidenced by increased post-operative HA serum levels. However, damage to liver hepatocytes and perisinusoidal cells is clinically insignificant, and the laparoscopic procedure is the likely cause.",9.474389094274162e-08,0.08579255565404154,0.0017367249242856639,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
250,0.9,6,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Is peri-sinusoidal cell activity affected by laparoscopic cholecystectomy? Laparoscopic surgery causes detectable damage to Kupffer and endothelial cells, shown by elevated post-operative HA serum levels. The damage to liver hepatocytes and perisinusoidal cells is not clinically significant, with the laparoscopic procedure probably responsible.",1.8948778188548325e-07,0.17963450852047114,0.0038036897673758216,0.014507411718254981,0.17824823140631896,0.0,0.014486412327622933,0.1823215567939549,0.0,1.8948778188548325e-07,0.18658595558041347,0.0
250,0.9,7,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does the laparoscopic cholecystectomy procedure influence peri-sinusoidal cell activity? It induces measurable damage to Kupffer and endothelial cells, indicated by higher post-operative HA serum levels. This injury to liver hepatocytes and perisinusoidal cells lacks clinical significance, with the laparoscopic approach likely being the cause.",1.6580180914979784e-07,0.15533640625915934,0.0032509602480447902,0.012693985253473108,0.15415067982725894,0.0,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
250,0.9,8,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"How does laparoscopic cholecystectomy affect peri-sinusoidal cell activity? Laparoscopic techniques cause detectable harm to Kupffer and endothelial cells, as reflected by increased HA serum levels after surgery. Damage to liver hepatocytes and perisinusoidal cells does not have clinical importance, and the laparoscopic procedure is probably responsible.",1.1842986367842703e-07,0.0776346284354279,0.019991670137442734,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
250,0.9,9,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does laparoscopic cholecystectomy have an effect on peri-sinusoidal cell activity? The procedure causes measurable damage to Kupffer and endothelial cells, shown by elevated post-operative HA serum levels. Damage to liver hepatocytes and perisinusoidal cells is clinically insignificant, with the laparoscopic procedure likely causing it.",1.6580180914979784e-07,0.15533640625915934,0.0032509602480447902,0.012693985253473108,0.15415067982725894,0.0,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
250,0.9,10,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Is peri-sinusoidal cell activity altered by laparoscopic cholecystectomy? Evidence suggests laparoscopic surgery damages Kupffer and endothelial cells, as indicated by raised post-operative HA serum levels. The injury to liver hepatocytes and perisinusoidal cells is without clinical significance, and the laparoscopic procedure is the probable cause.",1.4211583641411244e-07,0.10010748428748562,0.019991670137442734,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
251,0.9,1,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: This study's findings challenge the significance of LOC as an indicator of neuropsychological test results in the early recovery period following mild traumatic brain injury. Neuropsychological assessments are proven effective in detecting cognitive aftereffects.,2.3685972735685406e-07,0.2047944126460135,0.0,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
251,0.9,2,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Is loss of consciousness a predictor of neuropsychological decline after a concussion? Answer: The study's outcomes question the role of LOC as a predictor of neuropsychological test outcomes during the acute recovery phase of mild traumatic brain injury. Neuropsychological testing is known for its sensitivity in identifying cognitive consequences.,1.1842986367842703e-07,0.1820389134201723,0.060964083175803374,0.009067132323909363,0.15685316769089175,0.04158790170132326,0.009054007704764333,0.13059174157604847,0.0212665406427221,1.1842986367842703e-07,0.10318423623523065,0.0
251,0.9,3,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Does experiencing loss of consciousness forecast neuropsychological impairments after concussion? Answer: The research findings cast doubt on the predictive value of LOC for neuropsychological test performance in the initial recovery stage after mild traumatic brain trauma. Neuropsychological tests are sensitive tools for measuring cognitive effects.,2.1317375462116866e-07,0.18232155679395579,0.0,0.016320838183036854,0.18610227963385917,0.0,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
251,0.9,4,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Can loss of consciousness predict neuropsychological deficits following a concussion? Answer: The findings from this study suggest that LOC may not be a reliable predictor of neuropsychological test outcomes during the acute phase of mild traumatic brain injury recovery. Neuropsychological testing is sensitive in detecting cognitive sequelae.,1.6580180914979784e-07,0.13883644485421742,0.0,0.012693985253473108,0.14165051706302645,0.0,0.012675610786670066,0.14458122881110835,0.0,1.6580180914979784e-07,0.14763599880606337,0.0
251,0.9,5,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Is loss of consciousness linked to neuropsychological decline post-concussion? Answer: This study questions the importance of LOC as a predictor of neuropsychological performance during the acute recovery from mild traumatic brain injury. Neuropsychological assessments are effective at measuring cognitive sequelae.,3.316036182995957e-07,0.30010459245033916,0.0,0.025387970506946217,0.30673026742247655,0.0,0.025351221573340132,0.31365755885504143,0.0,3.316036182995957e-07,0.3209077200800996,0.0
251,0.9,6,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Does losing consciousness indicate neuropsychological performance deficits after a concussion? Answer: The study indicates that LOC may not be a significant predictor of neuropsychological test results during the early recovery phase of mild traumatic brain injury. Neuropsychological testing is sensitive in measuring cognitive outcomes.,2.3685972735685406e-07,0.2047944126460135,0.0,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
251,0.9,7,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Is loss of consciousness a reliable predictor of cognitive impairments following concussion? Answer: The results challenge the predictive value of LOC for neuropsychological testing during the acute phase of mild traumatic brain injury recovery. Neuropsychological tests are effective in detecting cognitive deficits.,2.8423167282822487e-07,0.25131442828090744,0.0,0.02176111757738247,0.2567198468478131,0.0,0.0217296184914344,0.2623642644674917,0.0,2.8423167282822487e-07,0.26826398659468076,0.0
251,0.9,8,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Does loss of consciousness serve as a predictor of neuropsychological decrements after concussion? Answer: Findings from this study undermine the predictive importance of LOC for neuropsychological test performance in the acute recovery period after mild traumatic brain injury. Neuropsychological testing remains sensitive for cognitive sequelae.,2.1317375462116866e-07,0.18232155679395579,0.0,0.016320838183036854,0.18610227963385917,0.0,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
251,0.9,9,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Is consciousness loss an indicator of neuropsychological impairments following a concussion? Answer: This research calls into question the relevance of LOC as a predictor of neuropsychological test outcomes during the acute phase of mild traumatic brain injury recovery. Neuropsychological tests are sensitive to cognitive aftereffects.,2.1317375462116866e-07,0.21312809815217548,0.02221074380165289,0.016320838183036854,0.18610227963385917,0.0,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
251,0.9,10,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Does loss of consciousness forecast neuropsychological deficits after concussion? Answer: The study results suggest that LOC is not a crucial predictor of neuropsychological test performance during the early recovery phase from mild traumatic brain injury. Neuropsychological testing has proven sensitive in assessing cognitive sequelae.,2.3685972735685406e-07,0.2047944126460135,0.0,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
252,0.9,1,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","Question: Preoperative assessment of liver metastases in colorectal cancer patients. Does PET/CT offer advantages over multidetector CT? Answer: PET/CT plays a limited role in staging liver metastases from colorectal carcinoma. While PET/CT shows higher sensitivity for detecting extrahepatic disease in certain areas, its effectiveness is reduced due to low positive predictive value (PPV). PET/CT added valuable information in only 8% of cases but also...",2.3685972735685406e-08,0.016092179974367404,0.0002478233363719818,0.0018134264647818726,0.01600034134644357,0.0,0.0018108015409528666,0.016260520871781203,0.0,2.3685972735685406e-08,0.01652930195121094,0.0
252,0.9,2,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","Question: When staging liver metastases in colorectal carcinoma patients before surgery, does PET/CT provide benefits beyond multidetector CT? Answer: PET/CT has a minor role in hepatic staging of colorectal liver metastases. Although it is more sensitive for finding extrahepatic disease in some anatomical regions, the low PPV limits its reliability. In 8% of cases, PET/CT gave additional useful insights but also...",9.474389094274162e-08,0.042877671745075396,0.015621063240110858,0.0072537058591274906,0.06559728248581642,0.0,0.007243206163811466,0.06669137449867257,0.0,9.474389094274162e-08,0.0678225963387602,0.0
252,0.9,3,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","Question: In the preoperative staging of colorectal cancer liver metastases, does PET/CT improve on multidetector CT? Answer: PET/CT has a restricted role in liver metastasis staging from colorectal carcinoma. Despite higher sensitivity for detecting extrahepatic disease in certain locations, the low positive predictive value weakens its utility. PET/CT contributed extra helpful data in 8% of patients but also...",1.6580180914979784e-07,0.09417096613262466,0.015621063240110858,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
252,0.9,4,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","Question: For preoperative evaluation of liver metastases in colorectal carcinoma patients, does PET/CT add value compared to multidetector CT? Answer: PET/CT’s role in hepatic staging is limited. It has superior sensitivity for some extrahepatic disease sites, but low PPV affects the reliability of results. PET/CT provided additional useful findings in 8% of cases but also...",2.3685972735685406e-07,0.1482381874028995,0.015621063240110858,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
252,0.9,5,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","Question: Does PET/CT offer any advantage over multidetector CT in preoperative staging of colorectal liver metastases? Answer: PET/CT has a limited role in staging liver metastases from colorectal cancer. Although it detects extrahepatic disease more sensitively in some anatomical areas, its low PPV reduces accuracy. PET/CT added extra valuable information in 8% of cases but also...",2.1317375462116866e-07,0.12988904873470375,0.015621063240110858,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
252,0.9,6,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","Question: Preoperative staging for colorectal carcinoma liver metastases: Is PET/CT superior to multidetector CT? Answer: The use of PET/CT in hepatic staging of LMCRC is limited. It shows greater sensitivity for detecting extrahepatic disease in specific regions, but the low positive predictive value undermines its effectiveness. PET/CT provided additional useful data in 8% of cases but also...",1.8948778188548325e-07,0.11187054323202528,0.015621063240110858,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
252,0.9,7,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","Question: Assessing liver metastases from colorectal cancer before surgery, does PET/CT contribute beyond multidetector CT? Answer: PET/CT has a marginal role in staging hepatic metastases of colorectal origin. While more sensitive for some extrahepatic locations, its usefulness is decreased by low PPV. PET/CT yielded additional useful information in 8% of cases but also...",2.8423167282822487e-07,0.18597851538574695,0.015621063240110858,0.02176111757738247,0.21130909366720996,0.0,0.0217296184914344,0.21511137961694615,0.0,2.8423167282822487e-07,0.21905356606268356,0.0
252,0.9,8,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","Question: Is PET/CT beneficial over multidetector CT in preoperative liver metastasis staging in colorectal carcinoma? Answer: PET/CT’s utility is limited in hepatic staging of colorectal liver metastases. Despite enhanced sensitivity for extrahepatic disease detection in some sites, low positive predictive value impairs its performance. PET/CT provided supplementary useful information in 8% of cases but also...",2.3685972735685406e-07,0.1482381874028995,0.015621063240110858,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
252,0.9,9,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","Question: For preoperative staging of colorectal liver metastases, does PET/CT improve upon multidetector CT? Answer: PET/CT’s role in liver metastasis staging is limited. It shows better sensitivity for certain extrahepatic disease locations but suffers from low PPV. PET/CT contributed additional useful information in 8% of cases but also...",4.026615365066519e-07,0.28707463225711694,0.015621063240110858,0.030828249901291835,0.3144933299024406,0.0,0.030783626196198732,0.32047189527477205,0.0,4.026615365066519e-07,0.32668423025504856,0.0
252,0.9,10,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","Question: In preoperative evaluation of colorectal carcinoma liver metastases, does PET/CT add value over multidetector CT? Answer: PET/CT has a limited role in hepatic staging. Although it has greater sensitivity for detecting extrahepatic disease in some anatomic sites, low positive predictive value hinders its utility. PET/CT provided additional useful information in 8% of cases but also...",2.1317375462116866e-07,0.12988904873470375,0.015621063240110858,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
253,0.9,1,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is it justified to screen risk groups for coeliac disease? Long-term adherence to dietary recommendations in patients identified through screening was favorable. Their quality of life and bone mineral density were similar to those of non-coeliac individuals and the general population. Therefore, active screening for coeliac disease in high-risk groups appears to be beneficial rather than detrimental.",1.6580180914979784e-07,0.19365130114247675,0.04311284350638188,0.012693985253473108,0.13613217432458002,0.0,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
253,0.9,2,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Should screening for coeliac disease be conducted in at-risk groups? Patients detected through screening showed good long-term dietary compliance. Their quality of life and bone mineral density matched those of non-coeliac subjects and the wider population. Thus, proactive screening in risk groups for coeliac disease seems reasonable and not harmful.",0.0,0.028291721655508084,0.02022166579237194,0.0,0.028881132523330688,0.020823902218198284,0.0,0.0,0.0,0.0,0.0,0.0
253,0.9,3,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is screening for coeliac disease justified among risk groups? Those diagnosed via screening maintained good long-term dietary adherence. Their quality of life and bone density were comparable to non-coeliac persons and the general population. Hence, active screening in coeliac risk groups appears to be justified and safe.",7.105791820705622e-08,0.02169626334499153,0.060964083175803374,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
253,0.9,4,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is it appropriate to screen individuals at risk for coeliac disease? Screen-detected patients demonstrated strong long-term compliance with dietary guidelines. Their quality of life and bone mineral density were on par with non-coeliac subjects and the population at large. Consequently, active screening in coeliac disease risk groups is likely beneficial rather than harmful.",7.105791820705622e-08,0.14429858543732488,0.060964083175803374,0.005440279394345618,0.06062462181643413,0.0,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
253,0.9,5,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Does screening for coeliac disease in risk groups make sense? Patients found through screening adhered well to the diet over the long term. Their quality of life and bone density were similar to those of non-coeliac and general population groups. Active screening among coeliac risk groups therefore seems justified and not harmful.,4.737194547137081e-08,0.09769825720532266,0.04136408317580338,0.0036268529295637453,0.04082199452025437,0.0,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
253,0.9,6,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is coeliac disease screening warranted in populations at risk? Long-term diet compliance was good among patients identified by screening. Their quality of life and bone mineral density did not differ from non-coeliac individuals or the general population. Active screening in coeliac risk groups seems reasonable, not harmful.",7.105791820705622e-08,0.02169626334499153,0.060964083175803374,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
253,0.9,7,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Should individuals at risk be screened for coeliac disease? Screening-detected patients maintained good dietary compliance over time. Their quality of life and bone density were equivalent to those of non-coeliac subjects and the general populace. Thus, active screening in coeliac disease risk groups is reasonable and safe.",7.105791820705622e-08,0.02169626334499153,0.060964083175803374,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
253,0.9,8,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is screening for coeliac disease justified for at-risk groups? Long-term adherence to dietary treatment was favorable in patients identified by screening. Their quality of life and bone mineral density were comparable to non-coeliac and general population groups. Active screening among coeliac risk groups seems rational and harmless.,7.105791820705622e-08,0.02169626334499153,0.060964083175803374,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
253,0.9,9,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is it justified to conduct coeliac disease screening in risk groups? Patients detected through screening showed good long-term dietary adherence. Their quality of life and bone mineral density were comparable to those without coeliac disease and the general population. Active screening in coeliac risk groups appears reasonable and beneficial.,2.3685972735685406e-08,0.006493612717126229,0.019376181474480114,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
253,0.9,10,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is screening for coeliac disease in risk populations justified? Screen-detected patients exhibited good long-term compliance with diet. Their quality of life and bone mineral density were similar to non-coeliac individuals and the broader population. Therefore, active screening in coeliac risk groups is considered reasonable rather than harmful.",7.105791820705622e-08,0.02169626334499153,0.060964083175803374,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
254,0.9,1,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the insertion allele of the ACE gene I/D polymorphism a candidate gene for insulin resistance? Answer: We conclude that the elevated cardiovascular risk associated with the DD genotype is not due to insulin resistance or fibrinolysis abnormalities. In contrast, individuals with NIDDM carrying the ACE DD genotype show increased sensitivity.",2.3685972735685406e-08,0.020889916991175816,0.0007802015363968726,0.0018134264647818726,0.02020270731751861,0.0,0.0018108015409528666,0.02061928720273576,0.0,2.3685972735685406e-08,0.02105340919783316,0.0
254,0.9,2,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Could the insertion allele of the ACE gene I/D polymorphism be a candidate gene for insulin resistance? Answer: Our findings indicate that the higher cardiovascular risk in DD genotype carriers is not linked to insulin resistance or fibrinolysis defects. However, ACE DD genotype NIDDM patients exhibit greater sensitivity.",4.737194547137081e-08,0.014251352598789513,0.019106653337357282,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
254,0.9,3,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Does the insertion allele of the ACE gene I/D polymorphism serve as a candidate gene for insulin resistance? Answer: We determine that the increased cardiovascular risk in those with the DD genotype is not explained by insulin resistance or fibrinolytic abnormalities. On the contrary, NIDDM subjects with the ACE DD genotype show heightened sensitivity.",9.474389094274162e-08,0.055396462185375306,0.015432766243752394,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
254,0.9,4,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the ACE gene I/D polymorphism's insertion allele implicated as a candidate gene for insulin resistance? Answer: We find that the cardiovascular risk elevation in DD genotype individuals is not mediated by insulin resistance or fibrinolysis irregularities. Conversely, NIDDM patients with the ACE DD genotype demonstrate increased sensitivity.",4.737194547137081e-08,0.04313248512212153,0.0016573461457676936,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
254,0.9,5,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Could the insertion allele of the ACE gene I/D polymorphism be linked to insulin resistance? Answer: Our conclusion is that the higher cardiovascular risk in the DD genotype is independent of insulin resistance and fibrinolytic abnormalities, while NIDDM subjects with the ACE DD genotype exhibit enhanced sensitivity.",7.105791820705622e-08,0.06541487868264895,0.0025385802469135646,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
254,0.9,6,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Question: Is the insertion allele of the ACE gene I/D polymorphism a candidate gene for insulin resistance? Answer: We conclude that the increased cardiovascular risk in individuals with the DD genotype does not arise from insulin resistance or fibrinolytic dysfunction. Rather, there is reported increased sensitivity in NIDDM patients with the ACE DD genotype.",9.474389094274162e-08,0.08106857998389216,0.0029483070348455126,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
254,0.9,7,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the ACE gene I/D polymorphism insertion allele associated with insulin resistance? Answer: We conclude that the raised cardiovascular risk of the DD genotype is not caused by insulin resistance or fibrinolysis defects, yet NIDDM subjects with the ACE DD genotype show increased sensitivity.",1.4211583641411244e-07,0.1353949771159928,0.0054209183673469274,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
254,0.9,8,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Question: The insertion allele of the ACE gene I/D polymorphism: could it be a candidate gene for insulin resistance? Answer: Our results suggest that the cardiovascular risk linked to the DD genotype is not mediated by insulin resistance or fibrinolytic abnormalities. Instead, NIDDM subjects with ACE DD genotype show greater sensitivity.",2.3685972735685406e-08,0.048072159366075784,0.02033055555555557,0.0018134264647818726,0.02020270731751861,0.0,0.0018108015409528666,0.02061928720273576,0.0,2.3685972735685406e-08,0.02105340919783316,0.0
254,0.9,9,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the insertion allele of the ACE gene I/D polymorphism a possible candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk in the DD genotype is not driven by insulin resistance or fibrinolysis defects, but NIDDM individuals with the ACE DD genotype exhibit heightened sensitivity.",4.737194547137081e-08,0.043132485122120645,0.0016573461457676866,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
254,0.9,10,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the ACE gene I/D polymorphism insertion allele a candidate for insulin resistance? Answer: We conclude that the DD genotype’s increased cardiovascular risk is not due to insulin resistance or fibrinolysis abnormalities, while NIDDM subjects with the ACE DD genotype present increased sensitivity.",1.6580180914979784e-07,0.1276105190367618,0.016687925170068042,0.012693985253473108,0.15415067982725894,0.0,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
255,0.9,1,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.","Does the concurrent use of a neuroendoscope affect the rate of ventriculoperitoneal shunt infections? In this study, employing an endoscope during VPS surgeries did not raise the risk of infection.",1.421158364141118e-07,0.14844382118522903,0.02854671280276816,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
255,0.9,2,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Does simultaneous utilization of a neuroendoscope impact the incidence of infections in ventriculoperitoneal shunts? The current research found that endoscope use during VPS did not increase surgical infection risk.,1.658018091497971e-07,0.18353514099649804,0.02854671280276816,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
255,0.9,3,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Is there an effect on ventriculoperitoneal shunt infection rates from using a neuroendoscope simultaneously? This study showed no elevated infection risk when an endoscope was used in VPS procedures.,1.658018091497971e-07,0.18353514099649804,0.02854671280276816,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
255,0.9,4,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Does using a neuroendoscope at the same time influence the frequency of infections in ventriculoperitoneal shunt surgeries? The study demonstrated no increased surgical infection risk with endoscope use.,1.894877818854824e-07,0.21990278516737272,0.02854671280276816,0.014507411718255037,0.2682639865946794,0.0,0.014486412327622988,0.2776317365982801,0.0,1.8948778188548325e-07,0.28768207245178123,0.0
255,0.9,5,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.","Does simultaneous neuroendoscope use during VPS surgeries influence ventriculoperitoneal shunt infection rates? According to this study, endoscope application did not increase infection risk.",3.079176455639089e-07,0.42469719781338666,0.02854671280276816,0.023574544042164434,0.4818380868927403,0.0,0.023540420032387356,0.5007752879124898,0.0,3.079176455639102e-07,0.5212969236332863,0.0
255,0.9,6,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Is the incidence of ventriculoperitoneal shunt infections affected by the simultaneous use of a neuroendoscope? Findings suggest that endoscopic assistance during VPS does not heighten infection risk.,2.131737546211677e-07,0.2576431131502197,0.02854671280276816,0.016320838183036916,0.3074846997479619,0.0,0.016297213868575862,0.3184537311185349,0.0,2.1317375462116866e-07,0.33024168687057687,0.0
255,0.9,7,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Does employing a neuroendoscope concurrently affect infection rates in ventriculoperitoneal shunt procedures? This investigation reported no rise in surgical infection risk with endoscope usage.,2.842316728282236e-07,0.3802454352425526,0.02854671280276816,0.021761117577382555,0.4353180712578464,0.0,0.021729618491434483,0.45198512374305855,0.0,2.842316728282248e-07,0.47000362924573613,0.0
255,0.9,8,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Is the combined use of a neuroendoscope linked to a higher incidence of ventriculoperitoneal shunt infections? The present study indicates no increased risk of infection during VPS with endoscope use.,1.421158364141118e-07,0.14844382118522903,0.02854671280276816,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
255,0.9,9,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.","Does the simultaneous application of a neuroendoscope during VPS impact the likelihood of infection? In this research, using an endoscope did not increase surgical infection risk.",2.36859727356853e-07,0.29686382630350217,0.02854671280276816,0.018134264647818796,0.3483066942682167,0.0,0.018108015409528735,0.36101334553733055,0.0,2.3685972735685406e-07,0.3746934494414109,0.0
255,0.9,10,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Does the use of a neuroendoscope alongside VPS surgery influence the infection rate of ventriculoperitoneal shunts? The study concluded that endoscope use did not elevate infection risk.,2.131737546211677e-07,0.2576431131502197,0.02854671280276816,0.016320838183036916,0.3074846997479619,0.0,0.016297213868575862,0.3184537311185349,0.0,2.1317375462116866e-07,0.33024168687057687,0.0
256,0.9,1,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Can analyzing APC mutations aid in making treatment choices for familial adenomatous polyposis? Since the age at which symptoms appear and disease progression can differ widely, even among individuals with the same germline mutation, treatment decisions should rely on colonoscopy results of each patient instead of mutation location.",9.474389094274162e-08,0.05449578863936777,0.019599999999999992,0.0072537058591274906,0.08338160893905089,0.0,0.007243206163811466,0.08515780834030728,0.0,9.474389094274162e-08,0.08701137698962924,0.0
256,0.9,2,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Is APC mutation testing useful for guiding therapy in familial adenomatous polyposis? Given that symptom onset and disease trajectory vary greatly even among carriers of the identical germline mutation, therapeutic approaches should be guided by colonoscopic evaluations of the individual rather than mutation site.",1.8948778188548325e-07,0.17568267840283758,0.0036426303854875317,0.014507411718254981,0.17435338714477755,0.0,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
256,0.9,3,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Does APC mutation analysis help in selecting treatments for familial adenomatous polyposis? Due to the considerable variability in age of onset and disease course among patients with the same germline mutation, treatment should be determined by colonoscopy findings in each case rather than the mutation's position.",1.4211583641411244e-07,0.09798090057910613,0.019599999999999992,0.010880558788691236,0.1278333715098836,0.0,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
256,0.9,4,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Can APC mutation analysis inform therapeutic decisions in familial adenomatous polyposis? Because the timing and progression of the disease can vary significantly even for those sharing the same germline mutation, treatment choices should be based on individual colonoscopic findings, not on mutation location.",2.1317375462116866e-07,0.1669737720660578,0.019599999999999992,0.016320838183036854,0.19845093872383757,0.0,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
256,0.9,5,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Is the analysis of APC mutations valuable for therapy decisions in familial adenomatous polyposis? Since patients with identical germline mutations may show variable age at onset and disease progression, clinical treatment should depend on colonoscopy results of each patient instead of mutation site.",2.1317375462116866e-07,0.1669737720660578,0.019599999999999992,0.016320838183036854,0.19845093872383757,0.0,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
256,0.9,6,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Could APC mutation analysis play a role in treatment decisions for familial adenomatous polyposis? Given the variability in disease onset and course even among carriers of the same germline mutation, therapeutic choices should be informed by the individual's colonoscopic findings rather than by the mutation's location.",1.4211583641411244e-07,0.12878744193732583,0.002610743801652899,0.010880558788691236,0.1278333715098836,0.0,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
256,0.9,7,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Does the examination of APC gene mutations contribute to therapeutic decision-making in familial adenomatous polyposis? Because age of manifestation and disease progression vary considerably among those with identical germline mutations, treatment decisions should be based on colonoscopy results per patient instead of mutation site.",1.8948778188548325e-07,0.14344327465586337,0.019599999999999992,0.014507411718254981,0.17435338714477755,0.0,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
256,0.9,8,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Can analysis of APC mutations guide therapy in familial adenomatous polyposis? Considering the variable age at which symptoms appear and disease progression, even among carriers of the same germline mutation, therapy choice should rely on each patient's colonoscopic findings rather than mutation site.",2.1317375462116866e-07,0.1669737720660578,0.019599999999999992,0.016320838183036854,0.19845093872383757,0.0,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
256,0.9,9,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Is APC mutation testing important for making therapeutic decisions in familial adenomatous polyposis? Since age at symptom onset and disease course can vary widely among individuals with the same germline mutation, treatment planning should be grounded in colonoscopic data from individual patients, not mutation location.",1.6580180914979784e-07,0.12045375643116385,0.019599999999999992,0.012693985253473108,0.15082288973458313,0.0,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
256,0.9,10,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Does APC mutation analysis assist in making therapeutic choices for familial adenomatous polyposis? Because the age at manifestation and disease course differ significantly even among carriers of identical germline mutations, clinical decisions should be based on patient-specific colonoscopic findings rather than mutation site.",2.1317375462116866e-07,0.1669737720660578,0.019599999999999992,0.016320838183036854,0.19845093872383757,0.0,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
257,0.9,1,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Does the nature of a general practice impact the adoption of an IT innovation in primary care? The study indicates that while structural features of a practice don't relate to adopting new IT tools, use might be impacted by post-graduate training in the related medical field. At least for this diabetes management system, the practice nurse...",7.105791820705622e-08,0.03051192350258969,0.016263192519806284,0.005440279394345618,0.05406722127027486,0.0,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
257,0.9,2,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Are general practice traits linked to the acceptance of an IT innovation in primary care? Findings reveal no connection between a practice's structure and uptake of new IT, though advanced education in the pertinent clinical area could affect usage. For this diabetes system, the practice nurse...",3.079176455639103e-07,0.20597726694437934,0.034438775510204085,0.023574544042164344,0.25886163391628836,0.0,0.023540420032387266,0.26415157504158726,0.0,3.079176455639103e-07,0.2696635669491032,0.0
257,0.9,3,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Do characteristics of general practices affect how an IT innovation is embraced in primary care? Analysis suggests structural aspects of a practice aren't tied to adopting new IT facilities, but the level of post-graduate education in the clinical subject may influence its use. Specifically for the diabetes system, the practice nurse...",1.8948778188548325e-07,0.10061675128655345,0.034438775510204085,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
257,0.9,4,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Can the features of a general practice influence the implementation of an IT innovation in primary care? Results demonstrate that practice structure does not correlate with IT adoption, but post-graduate clinical education might shape how the system is used. Regarding this diabetes system, the practice nurse...",3.079176455639103e-07,0.20597726694437934,0.034438775510204085,0.023574544042164344,0.25886163391628836,0.0,0.023540420032387266,0.26415157504158726,0.0,3.079176455639103e-07,0.2696635669491032,0.0
257,0.9,5,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Is the uptake of an IT innovation in primary care affected by general practice characteristics? Analyses indicate no association with structural elements of the practice, yet usage could be swayed by continuing education in the relevant clinical condition. Concerning this diabetes system, the practice nurse...",3.316036182995957e-07,0.22845012279643706,0.034438775510204085,0.025387970506946217,0.2818511521409879,0.0,0.025351221573340132,0.2876820724517817,0.0,3.316036182995957e-07,0.2937611185281632,0.0
257,0.9,6,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Do structural traits of general practices impact the adoption of an IT innovation in primary care? The data show no link between practice structure and uptake, though post-graduate education related to the clinical condition might influence use. For the diabetes management system, at least, the practice nurse...",2.8423167282822487e-07,0.18399836022560434,0.034438775510204085,0.02176111757738247,0.23638877806423064,0.0,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
257,0.9,7,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Does uptake of an IT innovation in primary care depend on the characteristics of general practice? Research finds no association with practice structure, but usage may be affected by post-graduate clinical education. In the case of this diabetes system, the practice nurse...",4.026615365066519e-07,0.299067690010391,0.034438775510204085,0.030828249901291835,0.354171813720614,0.0,0.030783626196198732,0.3617900446055051,0.0,4.026615365066519e-07,0.3697470255060846,0.0
257,0.9,8,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Are general practice characteristics a factor in adopting an IT innovation in primary care? Analysis reveals no relation to structural features, but use may be influenced by advanced education in the relevant clinical area. Specifically for this diabetes system, the practice nurse...",4.026615365066519e-07,0.299067690010391,0.034438775510204085,0.030828249901291835,0.354171813720614,0.0,0.030783626196198732,0.3617900446055051,0.0,4.026615365066519e-07,0.3697470255060846,0.0
257,0.9,9,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Do general practice features influence the adoption of an IT innovation in primary care? Findings suggest structural practice characteristics don't impact uptake, but post-graduate clinical education could guide usage. At least regarding the diabetes system, the practice nurse...",4.974054274493932e-07,0.4017218440704733,0.034438775510204085,0.038081955760419325,0.4595323293784399,0.0,0.0380268323600102,0.47000362924573613,0.0,4.974054274493935e-07,0.48097266061630917,0.0
257,0.9,10,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Is the adoption of an IT innovation in primary care related to general practice characteristics? The analysis shows no connection with structural features, though post-graduate education in the clinical condition might influence usage. For the diabetes system, at least, the practice nurse...",4.026615365066519e-07,0.299067690010391,0.034438775510204085,0.030828249901291835,0.354171813720614,0.0,0.030783626196198732,0.3617900446055051,0.0,4.026615365066519e-07,0.3697470255060846,0.0
258,0.9,1,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does the timing affect the risk of non-communicable diseases for those living in urban Thailand? Yes, timing is important. Factors such as pollution, stress, and lifestyle habits in urban Thai environments can raise disease risks, and rapid urbanization without proper planning worsens these dangers.",3.789755637709665e-07,0.2545906735781225,0.044195386143438105,0.029014823436509962,0.2510685115154696,0.051570247933884296,0.028972824655245866,0.2808372937225263,0.035041322314049606,3.789755637709665e-07,0.3117169801726436,0.017851239669421492
258,0.9,2,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Is timing significant in the relationship between urban living and non-communicable disease risk in Thailand? Indeed, timing plays a key role. Urban living exposes people to risks like pollution and stress, and when urbanization happens quickly without health infrastructure, these risks increase.",4.263475092423373e-07,0.3037913764086926,0.04306301652892563,0.03264167636607371,0.2998586756849013,0.051570247933884296,0.0325944277371516,0.33084771429718973,0.035041322314049606,4.263475092423373e-07,0.3630102745601933,0.017851239669421492
258,0.9,3,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does timing influence the risk of non-communicable diseases among urban residents in Thailand? Absolutely, timing is critical. Exposure to urban stressors like pollution and lifestyle factors raises disease risk, and rapid city growth without health services aggravates the problem.",4.974054274493933e-07,0.3459652257983241,0.06743801652892563,0.038081955760419325,0.3778202171546119,0.051570247933884296,0.0380268323600102,0.4108904219707239,0.035041322314049606,4.974054274493935e-07,0.44524837279716634,0.017851239669421492
258,0.9,4,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Is there a timing factor in living in urban areas and the likelihood of non-communicable diseases in Thailand? Yes, timing matters. Urban lifestyles in Thailand bring risks from pollution and stress, and fast urban development lacking proper healthcare amplifies these risks.",4.500334819780227e-07,0.2946719314107744,0.06743801652892563,0.03445510283085558,0.32517648366919305,0.051570247933884296,0.034405229278104466,0.3568232007004477,0.035041322314049606,4.500334819780227e-07,0.38967852164235417,0.017851239669421492
258,0.9,5,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does the timing of living in urban environments impact non-communicable disease risk in Thailand? Yes, timing is crucial. Urban pollution, stress, and lifestyle contribute to disease risk, and rapid urban growth without adequate health support makes timing all the more important.",4.500334819780227e-07,0.2946719314107744,0.06743801652892563,0.03445510283085558,0.32517648366919305,0.051570247933884296,0.034405229278104466,0.3568232007004477,0.035041322314049606,4.500334819780227e-07,0.38967852164235417,0.017851239669421492
258,0.9,6,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does timing have an effect on the risk of non-communicable diseases for urban dwellers in Thailand? Yes, timing is significant. The urban environment introduces risk factors like pollution and stress, and when urbanization proceeds rapidly without adequate healthcare, the risks escalate.",4.500334819780227e-07,0.2946719314107744,0.06743801652892563,0.03445510283085558,0.32517648366919305,0.051570247933884296,0.034405229278104466,0.3568232007004477,0.035041322314049606,4.500334819780227e-07,0.38967852164235417,0.017851239669421492
258,0.9,7,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Is timing a relevant factor when considering non-communicable disease risk in Thailand’s urban areas? Certainly, timing is essential. Living in cities exposes people to pollution and stress that increase disease chances, particularly when urban growth lacks sufficient planning and health services.",4.500334819780227e-07,0.2946719314107744,0.06743801652892563,0.03445510283085558,0.32517648366919305,0.051570247933884296,0.034405229278104466,0.3568232007004477,0.035041322314049606,4.500334819780227e-07,0.38967852164235417,0.017851239669421492
258,0.9,8,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does the timing of exposure to urban living conditions affect non-communicable disease risk in Thailand? Yes, timing plays a vital role. Urban environments come with pollution and lifestyle hazards, and swift urbanization without proper health infrastructure heightens these risks.",4.974054274493933e-07,0.3459652257983241,0.06743801652892563,0.038081955760419325,0.3778202171546119,0.051570247933884296,0.0380268323600102,0.4108904219707239,0.035041322314049606,4.974054274493935e-07,0.44524837279716634,0.017851239669421492
258,0.9,9,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Is the timing of urban residency important for non-communicable disease risk in Thailand? Yes, timing matters. Pollution, lifestyle habits, and stress in urban areas heighten disease risks, especially if urbanization occurs rapidly without adequate health provision.",5.684633456564492e-07,0.42820332403529715,0.06743801652892563,0.04352223515476495,0.46237760518267557,0.051570247933884296,0.04345923698286881,0.497901798960354,0.035041322314049606,5.684633456564497e-07,0.5348605314868533,0.017851239669421492
258,0.9,10,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does timing influence how living in urban areas affects non-communicable disease risk in Thailand? Yes, timing is important. Risks linked to pollution, stress, and lifestyle in cities rise, and rapid urbanization lacking health services makes timing a key factor.",4.974054274493933e-07,0.3459652257983241,0.06743801652892563,0.038081955760419325,0.3778202171546119,0.051570247933884296,0.0380268323600102,0.4108904219707239,0.035041322314049606,4.974054274493935e-07,0.44524837279716634,0.017851239669421492
259,0.9,1,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is withdrawal-induced anxiety in alcoholism caused by a deficiency in beta-endorphin? Our findings provide the first evidence suggesting that reduced beta-endorphin levels during alcohol withdrawal might contribute to the common anxiety seen in this condition.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
259,0.9,2,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Does beta-endorphin deficiency underlie anxiety experienced during alcohol withdrawal? Our results offer initial evidence that decreased beta-endorphin during withdrawal could be a factor in the anxiety commonly observed.,1.421158364141118e-07,0.20067069546215066,0.0,0.010880558788691277,0.20763936477824396,0.0,0.010864809245717241,0.2151113796169466,0.0,1.4211583641411244e-07,0.2231435513142097,0.0
259,0.9,3,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is the anxiety associated with alcohol withdrawal related to a lack of beta-endorphin? Our study is the first to indicate that lowered beta-endorphin levels during withdrawal may play a role in anxiety as a frequent symptom.,4.73719454713706e-08,0.019232089705222055,0.02854671280276816,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
259,0.9,4,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,"Does a beta-endorphin shortage cause withdrawal-induced anxiety in alcoholism? We present preliminary evidence that reduced beta-endorphin during alcohol withdrawal may contribute to anxiety, a common symptom in this phase.",1.184298636784265e-07,0.16430305129127598,0.0,0.009067132323909398,0.16989903679539697,0.0,0.009054007704764368,0.17589066646366414,0.0,1.1842986367842703e-07,0.1823215567939549,0.0
259,0.9,5,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is anxiety during alcohol withdrawal due to beta-endorphin deficiency? Our results provide the first proof that diminished beta-endorphin levels during withdrawal may be linked with anxiety commonly experienced during this time.,7.10579182070559e-08,0.09531017980432521,0.0,0.005440279394345639,0.09844007281325329,0.0,0.005432404622858621,0.10178269430994247,0.0,7.105791820705622e-08,0.10536051565782545,0.0
259,0.9,6,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is the anxiety caused by alcohol withdrawal a result of beta-endorphin deficiency? Our findings initially show that decreased beta-endorphin during withdrawal may underlie the anxiety that often occurs.,1.421158364141118e-07,0.25201493105918393,0.03698224852071005,0.010880558788691277,0.20763936477824396,0.0,0.010864809245717241,0.2151113796169466,0.0,1.4211583641411244e-07,0.2231435513142097,0.0
259,0.9,7,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Could beta-endorphin deficiency be responsible for anxiety in alcohol withdrawal? Our data offers the first indication that lowered beta-endorphin during withdrawal might cause the anxiety frequently seen.,1.658018091497971e-07,0.23841102344499765,0.0,0.012693985253473157,0.24686007793152642,0.0,0.012675610786670115,0.2559333741372014,0.0,1.6580180914979784e-07,0.26570316573300534,0.0
259,0.9,8,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is the presence of anxiety in alcohol withdrawal explained by beta-endorphin deficiency? Our results are the first to suggest that reduced beta-endorphin during withdrawal may contribute to this common disturbance.,9.47438909427412e-08,0.12921173148000697,0.0,0.007253705859127518,0.1335313926245223,0.0,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
259,0.9,9,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is withdrawal-induced anxiety in alcoholism linked to a deficit of beta-endorphin? Our study provides initial evidence that lowered beta-endorphin levels during withdrawal might lead to anxiety as a common issue.,9.47438909427412e-08,0.12921173148000697,0.0,0.007253705859127518,0.1335313926245223,0.0,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
259,0.9,10,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is beta-endorphin deficiency behind the anxiety experienced in alcohol withdrawal? Our findings give the first evidence that reduced beta-endorphin during withdrawal may be a factor in the anxiety often seen.,9.47438909427412e-08,0.1770149853117271,0.03443877551020409,0.007253705859127518,0.1335313926245223,0.0,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
260,0.9,1,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Are globulomaxillary cysts truly real? Answer: Based on our study results and international literature, the concept of a globulomaxillary cyst is no longer supported.",9.47438909427412e-08,0.15415067982725894,0.0,0.007253705859127518,0.1603426500751799,0.0,0.007243206163811494,0.16705408466316696,0.0,9.474389094274162e-08,0.17435338714477844,0.0
260,0.9,2,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Do globulomaxillary cysts actually exist? Answer: Our research and global literature data indicate that the globulomaxillary cyst entity is no longer valid.,1.421158364141118e-07,0.24116205681688863,0.0,0.010880558788691277,0.2513144282809079,0.0,0.010864809245717241,0.26236426446749217,0.0,1.4211583641411233e-07,0.27443684570175986,0.0
260,0.9,3,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Is the globulomaxillary cyst a real condition? Answer: According to findings from our study and worldwide literature, the globulomaxillary cyst is not justified anymore.",9.47438909427412e-08,0.2696752099205817,0.08264462809917354,0.007253705859127518,0.22061631794995806,0.04338842975206613,0.007243206163811494,0.16705408466316696,0.0,9.474389094274162e-08,0.17435338714477844,0.0
260,0.9,4,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Are globulomaxillary cysts a genuine diagnosis? Answer: The results from our study alongside international sources show that the globulomaxillary cyst entity is obsolete.,1.184298636784265e-07,0.19671029424605457,0.0,0.009067132323909398,0.20479441264601395,0.0,0.009054007704764368,0.2135741002980609,0.0,1.1842986367842698e-07,0.2231435513142097,0.0
260,0.9,5,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Do globulomaxillary cysts really exist as a pathology? Answer: Our study’s outcomes and international literature suggest the globulomaxillary cyst entity lacks justification today.,1.184298636784265e-07,0.19671029424605457,0.0,0.009067132323909398,0.20479441264601395,0.0,0.009054007704764368,0.2135741002980609,0.0,1.1842986367842698e-07,0.2231435513142097,0.0
260,0.9,6,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Is there evidence that globulomaxillary cysts exist? Answer: Based on our study and data from international literature, globulomaxillary cysts are no longer recognized as a valid entity.",2.36859727356853e-08,0.08771187976790795,0.03698224852071005,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
260,0.9,7,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Are globulomaxillary cysts an established medical condition? Answer: Findings from our research and the global literature confirm that the globulomaxillary cyst is no longer a justified classification.,2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
260,0.9,8,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Do globulomaxillary cysts exist in reality? Answer: According to our study and international literature, the term globulomaxillary cyst is now considered unjustified.",1.421158364141118e-07,0.24116205681688863,0.0,0.010880558788691277,0.2513144282809079,0.0,0.010864809245717241,0.26236426446749217,0.0,1.4211583641411233e-07,0.27443684570175986,0.0
260,0.9,9,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Is the entity known as globulomaxillary cyst still accepted? Answer: The conclusions from our study and international data reveal that globulomaxillary cysts are no longer justified.,4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
260,0.9,10,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Are globulomaxillary cysts considered to be real? Answer: Our research combined with international literature shows that the globulomaxillary cyst entity is no longer warranted.,9.47438909427412e-08,0.15415067982725894,0.0,0.007253705859127518,0.1603426500751799,0.0,0.007243206163811494,0.16705408466316696,0.0,9.474389094274162e-08,0.17435338714477844,0.0
261,0.9,1,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Question: Is aerobic fitness impacted by obstructive sleep apnea? Answer: In a US Air Force cohort, obstructive sleep apnea (OSA) generally does not predict reduced aerobic fitness based on cycle ergometry results. Nevertheless, individuals with an apnea-hypopnea index above 20 show a statistically significant decline in aerobic fitness.",2.3685972735685406e-08,0.00659873896280283,0.019753086419753076,0.0018134264647818726,0.0374850441883936,0.04246913580246913,0.0018108015409528666,0.008157927218613636,0.021728395061728398,2.3685972735685406e-08,0.022472855852057716,0.0
261,0.9,2,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Question: Does obstructive sleep apnea influence aerobic capacity? Answer: Among US Air Force members, OSA overall does not correlate with decreased aerobic fitness measured by cycle ergometry. However, those with an apnea-hypopnea index exceeding 20 experience a significant drop in aerobic fitness.",1.6580180914979784e-07,0.07098554663359025,0.06222222222222221,0.012693985253473108,0.10227689818676478,0.04246913580246913,0.012675610786670066,0.13494291642206147,0.021728395061728398,1.6580180914979784e-07,0.16907633004393308,0.0
261,0.9,3,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Question: What is the effect of obstructive sleep apnea on aerobic fitness? Answer: In a population from the US Air Force, obstructive sleep apnea does not generally lead to lower aerobic fitness as assessed by cycle ergometry, though patients with an apnea-hypopnea index greater than 20 demonstrate a statistically meaningful decrease in aerobic fitness.",1.1842986367842703e-07,0.13342130545498154,0.02454440599769319,0.009067132323909363,0.13342785933611356,0.02324576017770942,0.009054007704764333,0.1333210701726193,0.021728395061728398,1.1842986367842703e-07,0.10536051565782589,0.0
261,0.9,4,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Question: Does having obstructive sleep apnea affect aerobic fitness levels? Answer: For the US Air Force population studied, OSA does not predict a decline in aerobic fitness measured by cycle ergometry. Yet, those with an apnea-hypopnea index over 20 show a significant decrease in aerobic fitness.",7.105791820705622e-08,0.039508206284017966,0.017873925845802524,0.005440279394345618,0.006966718382439119,0.04246913580246913,0.0054324046228586,0.0373044468581436,0.021728395061728398,7.105791820705622e-08,0.06899287148695166,0.0
261,0.9,5,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Question: Is aerobic fitness reduced by obstructive sleep apnea? Answer: Overall findings within a US Air Force group indicate that OSA does not predict diminished aerobic fitness using cycle ergometry. Nonetheless, individuals with an apnea-hypopnea index above 20 have a statistically significant reduction in aerobic fitness.",7.105791820705622e-08,0.00870166492579827,0.04001147842056932,0.005440279394345618,0.006966718382439119,0.04246913580246913,0.0054324046228586,0.0373044468581436,0.021728395061728398,7.105791820705622e-08,0.06899287148695166,0.0
261,0.9,6,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Question: How does obstructive sleep apnea impact aerobic fitness? Answer: Among the US Air Force population, OSA generally does not decrease aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index greater than 20 exhibit a statistically significant lowered aerobic fitness.",1.1842986367842703e-07,0.023357497644335812,0.06222222222222221,0.009067132323909363,0.05348673401733306,0.04246913580246913,0.009054007704764333,0.08493249584739804,0.021728395061728398,1.1842986367842703e-07,0.11778303565638337,0.0
261,0.9,7,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Question: Does obstructive sleep apnea cause a drop in aerobic fitness? Answer: In a US Air Force cohort, obstructive sleep apnea isn’t linked to reduced aerobic fitness based on cycle ergometry, except in patients with an apnea-hypopnea index over 20, who show significant decreases.",1.1842986367842703e-07,0.08783630513828422,0.015821270407826,0.009067132323909363,0.08649374261542464,0.018673775897650575,0.009054007704764333,0.08493249584739804,0.021728395061728398,1.1842986367842703e-07,0.11778303565638337,0.0
261,0.9,8,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Question: Is there an effect of obstructive sleep apnea on aerobic fitness? Answer: In US Air Force personnel, obstructive sleep apnea overall does not predict lower aerobic fitness from cycle ergometry testing, but those with an apnea-hypopnea index exceeding 20 have a statistically meaningful drop in aerobic fitness.",2.3685972735685406e-08,0.00659873896280283,0.019753086419753076,0.0018134264647818726,0.007348210251004961,0.020740740740740733,0.0018108015409528666,0.008157927218613636,0.021728395061728398,2.3685972735685406e-08,0.022472855852057716,0.0
261,0.9,9,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Question: Does obstructive sleep apnea lead to lower aerobic fitness? Answer: Data from the US Air Force suggests OSA does not generally cause a decline in aerobic fitness as measured by cycle ergometry; however, patients whose apnea-hypopnea index is above 20 have a significant decrease in fitness.",4.737194547137081e-08,0.04408378315119643,0.06222222222222221,0.0036268529295637453,0.015506137469618597,0.04246913580246913,0.003621603081905733,0.01431492863344408,0.021728395061728398,4.737194547137081e-08,0.04546237407675724,0.0
261,0.9,10,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Question: What relation does obstructive sleep apnea have with aerobic fitness? Answer: For the US Air Force population, obstructive sleep apnea does not predict reduced aerobic fitness on cycle ergometry, though a statistically significant decrease is found in patients with an apnea-hypopnea index greater than 20.",7.105791820705622e-08,0.039508206284017966,0.017873925845802524,0.005440279394345618,0.03847340840789171,0.01975415473162002,0.0054324046228586,0.0373044468581436,0.021728395061728398,7.105791820705622e-08,0.06899287148695166,0.0
262,0.9,1,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Are globulomaxillary cysts a genuine entity? Answer: Globulomaxillary cysts were previously considered a distinct cyst type originating from the fusion line of two embryonic processes. However,",4.73719454713706e-08,0.12742698604294844,0.03840000000000001,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
262,0.9,2,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Do globulomaxillary cysts truly exist? Answer: It was once believed that globulomaxillary cysts were a specific kind of cyst developing at the junction of two embryological processes. However,",0.0,0.04951051289713915,0.035665294924554176,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
262,0.9,3,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Is the existence of globulomaxillary cysts real? Answer: Globulomaxillary cysts used to be identified as a unique cyst arising from the fusion line between two embryonic processes. However,",0.0,0.04951051289713915,0.035665294924554176,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
262,0.9,4,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Are globulomaxillary cysts actually present? Answer: Globulomaxillary cysts were once thought to be a distinct cyst type formed along the fusion line of two embryonic processes. However,",2.36859727356853e-08,0.08771187976790795,0.03698224852071005,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
262,0.9,5,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Do globulomaxillary cysts exist in reality? Answer: There was a prior belief that globulomaxillary cysts represent a specific cyst arising at the fusion line between two embryonic processes. However,",2.36859727356853e-08,0.012711934020451121,0.03443877551020409,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
262,0.9,6,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Is the concept of globulomaxillary cysts valid? Answer: Globulomaxillary cysts were formerly regarded as a cyst type originating from the fusion line of two embryonic processes. However,",2.36859727356853e-08,0.08771187976790795,0.03698224852071005,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
262,0.9,7,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Can globulomaxillary cysts be considered real? Answer: Previously, globulomaxillary cysts were thought to be a unique cyst arising from the fusion of two embryonic processes. However,",4.73719454713706e-08,0.12742698604294844,0.03840000000000001,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
262,0.9,8,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Are globulomaxillary cysts a real pathological entity? Answer: Initially, globulomaxillary cysts were believed to be a specific cyst type formed along the fusion line of two embryonic processes. However,",2.36859727356853e-08,0.012711934020451121,0.03443877551020409,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
262,0.9,9,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Do globulomaxillary cysts have a true existence? Answer: Globulomaxillary cysts were once assumed to be a cyst type developing from the fusion line between two embryonic processes. However,",0.0,0.04951051289713915,0.035665294924554176,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
262,0.9,10,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Is the presence of globulomaxillary cysts confirmed? Answer: Globulomaxillary cysts were historically thought to be a distinct cyst arising from the fusion line of two embryonic processes. However,",0.0,0.04951051289713915,0.035665294924554176,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
263,0.9,1,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Are opioid dependence and methadone maintenance treatment (MMT) recorded in the medical records? Among patients undergoing MMT and receiving medical care at various sites, opioid dependence and MMT are documented for most, though a significant number lack such records. Many of these patients are also prescribed medications that may interact with...",1.8948778188548325e-07,0.10826527189962798,0.028656550068587083,0.014507411718254981,0.13088078397171543,0.014642016758494043,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
263,0.9,2,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Is opioid dependence and methadone maintenance treatment (MMT) noted in the medical records? For patients on MMT and receiving care at different locations, opioid dependence and MMT are documented in the medical record for the majority, yet a notable portion have missing documentation. Many of these patients are prescribed drugs that could interact with...",1.1842986367842703e-07,0.09917057884933866,0.0063816573912676006,0.009067132323909363,0.09648465573463305,0.003358677685950412,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
263,0.9,3,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Do medical records show opioid dependence and methadone maintenance treatment (MMT)? Among patients treated with MMT at various medical sites, most have opioid dependence and MMT documented, although a considerable number do not. A majority of these patients receive prescriptions for medications that might interact with...",3.079176455639103e-07,0.21978709582909772,0.024238809247722967,0.023574544042164344,0.24172641653402493,0.012326341243200489,0.023540420032387266,0.26415157504158726,0.0,3.079176455639103e-07,0.2696635669491032,0.0
263,0.9,4,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Are opioid dependence and methadone maintenance treatment (MMT) included in patients' medical records? In patients receiving MMT and medical care across different sites, documentation of opioid dependence and MMT is present for most, but absent for a substantial number. Many such patients are prescribed medications with potential interactions with...",2.3685972735685406e-07,0.15139775702174862,0.02699920392281939,0.018134264647818726,0.17375738342145475,0.013774781671327497,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
263,0.9,5,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Is documentation of opioid dependence and methadone maintenance treatment (MMT) found in the medical records? For patients receiving MMT and healthcare at multiple sites, opioid dependence and MMT are recorded for the majority, yet a significant segment lacks this documentation. Most of these patients are prescribed medications that may interact with...",1.8948778188548325e-07,0.10826527189962798,0.028656550068587083,0.014507411718254981,0.13088078397171543,0.014642016758494043,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
263,0.9,6,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Are opioid dependence and methadone maintenance treatment (MMT) documented in medical charts? Among patients who receive MMT at various healthcare sites, the majority have opioid dependence and MMT recorded in their medical charts; however, a substantial number do not. Many of these patients are also prescribed drugs that could have interactions with...",1.6580180914979784e-07,0.08737535490845216,0.029436751604983956,0.012693985253473108,0.11011224222108673,0.015049652176606865,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
263,0.9,7,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Is the presence of opioid dependence and methadone maintenance treatment (MMT) recorded in medical records? Patients undergoing MMT and receiving care at different facilities mostly have opioid dependence and MMT documented, though a notable portion lack such entries. Many of these patients are prescribed medications with potential for interaction with...",2.1317375462116866e-07,0.12959964808336677,0.027844688240711214,0.016320838183036854,0.1520894820422738,0.014217420095851314,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
263,0.9,8,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Are opioid dependence and methadone maintenance treatment (MMT) consistently recorded in the medical records? Among patients receiving MMT and care at various sites, most have documentation of opioid dependence and MMT, but a significant number do not. Many of these patients are prescribed medications that might interact with...",2.6054570009253947e-07,0.17368015058227693,0.02611796982167352,0.0199476911126006,0.19590479787512827,0.0133129272523212,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
263,0.9,9,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Is recording of opioid dependence and methadone maintenance treatment (MMT) in the medical record common? Among patients receiving MMT and medical care at different locations, documentation of both opioid dependence and MMT is found in most cases, though a considerable number are without it. Most are prescribed medications that potentially interact with...",1.6580180914979784e-07,0.08737535490845216,0.029436751604983956,0.012693985253473108,0.11011224222108673,0.015049652176606865,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
263,0.9,10,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Is opioid dependence and methadone maintenance treatment (MMT) noted in the medical record? Among patients on MMT with medical care at multiple sites, opioid dependence and MMT documentation occurs in the majority but is missing in a considerable number. Many are prescribed drugs that could interact with...",2.8423167282822487e-07,0.2266056082060497,0.003687159707430901,0.02176111757738247,0.21855341201473433,0.012830578512396707,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
264,0.9,1,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.",Does the number of acupuncture needles affect neck pain treatment? It appears that using either 5 or 11 needles does not significantly impact the therapeutic outcome when stimulation duration is consistent between groups.,3.3160361829959484e-07,0.30263182581459036,0.043388429752066124,0.025387970506946245,0.3418687439269532,0.02221074380165289,0.025351221573340167,0.3829922522561069,0.0,3.316036182995957e-07,0.39390428570708913,0.0
264,0.9,2,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","In treating neck pain with acupuncture, the quantity of needles, whether 5 or 11, does not seem crucial for the treatment’s effectiveness, provided the stimulation time is equal across groups.",4.0266153650665074e-07,0.40107189862784365,0.043388429752066124,0.030828249901291883,0.4436514382368957,0.02221074380165289,0.030783626196198788,0.48835276791393234,0.0,4.026615365066519e-07,0.5031035776720798,0.0
264,0.9,3,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","When it comes to acupuncture for neck pain, the difference between 5 and 11 needles doesn't notably influence the treatment results if both groups receive the same stimulation period.",4.2634750924233604e-07,0.43616321843911265,0.043388429752066124,0.03264167636607376,0.48001908240777036,0.02221074380165289,0.03259442773715166,0.5260930958967793,0.0,4.263475092423373e-07,0.5423242908253623,0.0
264,0.9,4,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","The number of acupuncture needles, 5 versus 11, appears irrelevant in neck pain therapy effectiveness when the stimulation time is matched in both groups.",5.447773729207625e-07,0.6328735126851672,0.043388429752066124,0.04170880868998316,0.6848134950537843,0.02221074380165289,0.04164843544191603,0.7396671961948402,0.0,5.447773729207643e-07,0.765467842139572,0.0
264,0.9,5,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Regarding neck pain and acupuncture treatment, the quantity of needles used—5 or 11—does not seem to play a key role in therapeutic effects if the duration of stimulation remains the same.",3.7897556377096544e-07,0.3671703469521619,0.043388429752066124,0.029014823436510004,0.4085601184256267,0.02221074380165289,0.028972824655245914,0.45198512374305766,0.0,3.789755637709665e-07,0.4653632496892328,0.0
264,0.9,6,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","For acupuncture treating neck pain, the number of needles, either 5 or 11, does not significantly change the therapy outcome when stimulation time is identical in both groups.",4.5003348197802134e-07,0.47253086260998733,0.043388429752066124,0.03445510283085564,0.5177594103906173,0.02221074380165289,0.034405229278104535,0.5653138090500618,0.0,4.500334819780227e-07,0.5831462853456171,0.0
264,0.9,7,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","In acupuncture for neck pain, using 5 or 11 needles seems not to impact treatment success if the stimulation length is consistent between the groups.",5.210914001850772e-07,0.5903138982663716,0.043388429752066124,0.03989538222520128,0.6403617324829503,0.02221074380165289,0.039837633900963156,0.6931471805599463,0.0,5.210914001850789e-07,0.7166776779701407,0.0
264,0.9,8,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","The therapeutic effect in neck pain acupuncture treatment does not appear to depend on whether 5 or 11 needles are used, assuming the stimulation time is equivalent.",4.7371945471370664e-07,0.5102711905928343,0.043388429752066124,0.03626852929563752,0.5569801235438998,0.02221074380165289,0.03621603081905741,0.6061358035703166,0.0,4.737194547137081e-07,0.6257058997644127,0.0
264,0.9,9,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.",Acupuncture therapy for neck pain shows no major difference in effectiveness between using 5 or 11 needles when the stimulation duration is the same.,5.447773729207625e-07,0.6328735126851672,0.043388429752066124,0.04170880868998316,0.6848134950537843,0.02221074380165289,0.04164843544191603,0.7396671961948402,0.0,5.447773729207643e-07,0.765467842139572,0.0
264,0.9,10,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Regarding acupuncture treatment of neck pain, the number of needles, 5 or 11, does not seem to significantly influence therapeutic results when the stimulation time is held equal.",4.5003348197802134e-07,0.47253086260998733,0.043388429752066124,0.03445510283085564,0.5177594103906173,0.02221074380165289,0.034405229278104535,0.5653138090500618,0.0,4.500334819780227e-07,0.5831462853456171,0.0
265,0.9,1,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.",Is the formation of endometrial polyps linked to elevated levels of vascular endothelial growth factor and transforming growth factor-beta1?,8.053230730133017e-07,0.7142983704052908,0.22222222222222215,0.061656499802583795,0.7996076225442117,0.19937500000000002,0.06156725239239759,0.8899012981867842,0.17132659131469363,8.053230730133035e-07,0.9574363237643526,0.15704937537180244
265,0.9,2,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.",Does endometrial polyp formation correlate with increased expression of vascular endothelial growth factor and transforming growth factor-beta1?,8.526950184846723e-07,0.8320814060616746,0.22222222222222215,0.06528335273214754,0.9247707654982174,0.19937500000000002,0.06518885547430334,1.023432690811307,0.17132659131469363,8.526950184846742e-07,1.100537167405026,0.15704937537180244
265,0.9,3,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.",Is there an association between endometrial polyp development and higher expression of vascular endothelial growth factor and transforming growth factor-beta1?,7.816371002776163e-07,0.6602311491350155,0.22222222222222215,0.059843073337801915,0.7424492087042629,0.19937500000000002,0.05975645085144472,0.8292766763703492,0.17132659131469363,7.816371002776182e-07,0.892897802626782,0.15704937537180244
265,0.9,4,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.",Are vascular endothelial growth factor and transforming growth factor-beta1 expressions elevated during endometrial polyp formation?,9.000669639560431e-07,0.9656127986861973,0.22222222222222215,0.0689102056617113,1.0678716091388907,0.19937500000000002,0.06881045855620908,1.1775833706385646,0.17132659131469363,9.000669639560449e-07,1.2675912520681925,0.15704937537180244
265,0.9,5,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.",Does the development of endometrial polyps involve increased levels of vascular endothelial growth factor and transforming growth factor-beta1?,8.29009045748987e-07,0.7714567842452396,0.22222222222222215,0.06346992626736567,0.8602322443606467,0.19937500000000002,0.06337805393335047,0.9544398193243548,0.17132659131469363,8.290090457489888e-07,1.0264291952513047,0.15704937537180244
265,0.9,6,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.",Is the increased expression of vascular endothelial growth factor and transforming growth factor-beta1 observed in endometrial polyp formation?,8.29009045748987e-07,0.7714567842452396,0.22222222222222215,0.06346992626736567,0.8602322443606467,0.19937500000000002,0.06337805393335047,0.9544398193243548,0.17132659131469363,8.290090457489888e-07,1.0264291952513047,0.15704937537180244
265,0.9,7,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.",Are vascular endothelial growth factor and transforming growth factor-beta1 upregulated in association with endometrial polyp formation?,8.763809912203577e-07,0.8966199271992452,0.22222222222222215,0.06709677919692941,0.9937636369851695,0.19937500000000002,0.06699965701525622,1.0975406629650282,0.17132659131469363,8.763809912203596e-07,1.1805798750785623,0.15704937537180244
265,0.9,8,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.",Is endometrial polyp formation accompanied by enhanced expression of vascular endothelial growth factor and transforming growth factor-beta1?,8.526950184846723e-07,0.8320814060616746,0.22222222222222215,0.06528335273214754,0.9247707654982174,0.19937500000000002,0.06518885547430334,1.023432690811307,0.17132659131469363,8.526950184846742e-07,1.100537167405026,0.15704937537180244
265,0.9,9,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.",Does endometrial polyp growth relate to higher expression levels of vascular endothelial growth factor and transforming growth factor-beta1?,8.29009045748987e-07,0.7714567842452396,0.22222222222222215,0.06346992626736567,0.8602322443606467,0.19937500000000002,0.06337805393335047,0.9544398193243548,0.17132659131469363,8.290090457489888e-07,1.0264291952513047,0.15704937537180244
265,0.9,10,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.",Is there a connection between endometrial polyp formation and the elevated expression of vascular endothelial growth factor and transforming growth factor-beta1?,7.579511275419309e-07,0.6089378547474653,0.22222222222222215,0.058029646873020035,0.6883819874339876,0.19937500000000002,0.05794564931049185,0.7721182625304004,0.17132659131469363,7.579511275419328e-07,0.832273180810347,0.15704937537180244
266,0.9,1,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Does misclassifying gestational age account for the birthweight differences between Australian Aborigines and whites? No, misclassification of gestational age does not completely explain the birthweight gap between Australian Aborigines and whites. Other elements like genetics, maternal health, socio-economic status, and healthcare access also play roles.",0.0,0.09452007007635777,0.061070932865804645,0.0,0.09671821124092217,0.06786497616344306,0.0,0.03300700859809247,0.02370464009518146,0.0,0.03381205758828987,0.024375
266,0.9,2,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Is the difference in birthweights between Australian Aborigines and whites due to errors in gestational age classification? No, errors in gestational age classification do not entirely account for the birthweight differences observed between Australian Aborigines and whites. Factors such as genetic makeup, maternal health conditions, socio-economic factors, and accessibility to care contribute as well.",2.1317375462116866e-07,0.28121681555975186,0.06147689865812701,0.016320838183036854,0.24460259384428262,0.037877039088950376,0.0162972138685758,0.20580554688734187,0.00834964598084132,2.1317375462116866e-07,0.23226299631212743,0.024375
266,0.9,3,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Can gestational age misclassification explain why Australian Aborigines and whites have different birthweights? No, gestational age misclassification alone does not fully explain the birthweight differences between Australian Aborigines and whites. Other influences include genetic variations, maternal health status, socio-economic inequalities, and healthcare availability.",4.737194547137081e-08,0.07350547017635156,0.07865668068807498,0.0036268529295637453,0.04594485456903641,0.06561372547948291,0.003621603081905733,0.017223853026752334,0.047500000000000014,4.737194547137081e-08,0.01619836298637356,0.024375
266,0.9,4,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Does the misclassification of gestational age clarify the birthweight disparities between Australian Aborigines and whites? No, the misclassification of gestational age cannot fully clarify the birthweight disparities between Australian Aborigines and whites. Contributing factors also involve genetics, maternal health, socio-economic differences, and access to medical care.",2.3685972735685406e-08,0.06434557888474313,0.04601862531504977,0.0018134264647818726,0.09937367326949875,0.07675448018542609,0.0018108015409528666,0.13613131162244052,0.10913580246913576,2.3685972735685406e-08,0.10712543382311379,0.09249863038714387
266,0.9,5,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Is the birthweight difference between Australian Aborigines and whites explained by gestational age misclassification? No, gestational age misclassification does not completely explain the birthweight difference between Australian Aborigines and whites. Other reasons include genetic diversity, maternal health, socio-economic status, and healthcare accessibility.",7.105791820705622e-08,0.05524845012836721,0.009344696484258175,0.005440279394345618,0.08441043798474102,0.008183051613997475,0.0054324046228586,0.15027799199547553,0.05372448979591839,7.105791820705622e-08,0.1516181410569919,0.053992346938775505
266,0.9,6,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Does gestational age misclassification account for the birthweight variation between Australian Aborigines and whites? No, gestational age misclassification does not fully account for the birthweight variation between Australian Aborigines and whites. Additional reasons include genetic factors, maternal health, socio-economic conditions, and access to healthcare.",2.3685972735685406e-08,0.09333003549082486,0.03836343230282624,0.0018134264647818726,0.12638954746006492,0.06566486786991164,0.0018108015409528666,0.16095587991261562,0.09454081632653064,2.3685972735685406e-08,0.1641673501420673,0.09807397959183672
266,0.9,7,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Is the discrepancy in birthweights between Australian Aborigines and whites due to gestational age misclassification? No, the discrepancy in birthweights is not fully explained by gestational age misclassification between Australian Aborigines and whites. Other contributing factors include genetic differences, maternal health, socio-economic disparities, and healthcare access.",2.3685972735685406e-08,0.05888058654813566,0.02256249786259021,0.0018134264647818726,0.05815977685776108,0.02426592797783926,0.0018108015409528666,0.025065707112430058,0.0010990481856038084,2.3685972735685406e-08,0.057909609167349885,0.024375
266,0.9,8,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Can differences in birthweights between Australian Aborigines and whites be explained by gestational age misclassification? No, differences in birthweights cannot be fully explained by gestational age misclassification. Factors like genetics, maternal health, socio-economic status, and healthcare access also contribute.",1.4211583641411222e-07,0.07695710676719214,0.04428119579634732,0.010880558788691236,0.10148742981067471,0.03381610098821991,0.0108648092457172,0.1266448393288484,0.019744897959183685,1.4211583641411244e-07,0.12441194762660457,0.024375
266,0.9,9,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Does gestational age misclassification fully explain why Australian Aborigines and whites differ in birthweight? No, it does not fully explain the difference in birthweights. Other aspects such as genetic background, maternal health, socio-economic factors, and medical care access also influence the difference.",7.105791820705622e-08,0.14762389540137288,0.1484645061728395,0.005440279394345618,0.08887635715524445,0.11426592797783926,0.0054324046228586,0.008093954957539395,0.047500000000000014,7.105791820705622e-08,0.042173849389631535,0.024375
266,0.9,10,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Is gestational age misclassification the cause of birthweight differences between Australian Aborigines and whites? No, it is not the sole cause. Other factors including genetic traits, maternal health, socio-economic status, and healthcare access also play significant roles.",1.8948778188548283e-07,0.05138282474146516,0.1728395061728395,0.014507411718254981,0.04465503546927829,0.11426592797783926,0.01448641232762294,0.1452950764710219,0.047500000000000014,1.8948778188548325e-07,0.18325244764953785,0.024375
267,0.9,1,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Does Kenya's distribution of health care benefits align with the principles of universal coverage? Universal coverage requires health care benefits to be accessible to everyone based on their needs. However, Kenya's health sector is evidently unequal, and benefits are not allocated according to need. Focused efforts are necessary to reorganize this system.",1.4211583641411244e-07,0.0683063050445929,0.030625366877957715,0.010880558788691236,0.09154405963226253,0.015673624787111436,0.0108648092457172,0.09030753510148237,0.0181755829903978,1.4211583641411244e-07,0.11778303565638426,0.0
267,0.9,2,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Is the allocation of health care benefits in Kenya consistent with the principles of universal coverage? Universal coverage means everyone should receive health care based on their needs. Currently, the Kenyan health sector is unequal, with benefits not distributed by need. Targeted reforms are needed to restructure it.",2.3685972735685406e-07,0.12511547601373918,0.04850918025439431,0.018134264647818726,0.14719978134891543,0.03566529492455417,0.018108015409528666,0.17546534344178966,0.0181755829903978,2.3685972735685406e-07,0.2047944126460135,0.0
267,0.9,3,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Does the way health care benefits are distributed in Kenya uphold the principles of universal coverage? Universal coverage mandates that health care should be provided based on individual needs. The Kenyan health system, however, is clearly inequitable, as benefits are not allocated on need. Intentional steps should be taken to reform the structure.",1.1842986367842703e-07,0.07450225527153087,0.012299669251968556,0.009067132323909363,0.04401554511368477,0.03566529492455417,0.009054007704764333,0.07010482778396376,0.0181755829903978,1.1842986367842703e-07,0.0971637484536485,0.0
267,0.9,4,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Does Kenya's health care benefit distribution satisfy the universal coverage principles? Universal coverage entails that health care benefits be given to all according to their needs. The Kenyan health sector is evidently inequitable, with benefits not based on need. Deliberate restructuring efforts are required.",3.316036182995957e-07,0.2490461448195047,0.023374769082720202,0.025387970506946217,0.2381715595546421,0.03566529492455417,0.025351221573340132,0.26855576650780133,0.0181755829903978,3.316036182995957e-07,0.30010459245033916,0.0
267,0.9,5,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Is the distribution of health care benefits in Kenya in line with universal coverage principles? Universal coverage requires that all individuals benefit from health care per their needs. The Kenyan health sector is clearly unequal, and benefits do not follow need-based distribution. Purposeful actions should be made to restructure it.",1.8948778188548325e-07,0.1105305982195075,0.02903330351368498,0.014507411718254981,0.1046401669301189,0.03566529492455417,0.014486412327622933,0.1319802315020513,0.0181755829903978,1.8948778188548325e-07,0.16034265007518078,0.0
267,0.9,6,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Does Kenya's system for distributing health care benefits fulfill universal coverage principles? Universal coverage demands that health care benefits reach everyone as needed. Kenya’s health sector remains inequitable, with benefits not allocated by need. Intentional efforts should be invested in restructuring the system.",3.552895910352811e-07,0.30711886053002946,0.0012301962626468932,0.02720139697172809,0.29608116872199197,0.011290294924554169,0.027162023114293,0.29324837909817303,0.0181755829903978,3.552895910352811e-07,0.3254224004346309,0.0
267,0.9,7,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Does the allocation of health care benefits in Kenya conform to the principles of universal coverage? Universal coverage stipulates that all individuals receive health care benefits according to their needs. The Kenyan health sector is notably inequitable, and benefits are not need-based. Focused restructuring initiatives are necessary.",2.6054570009253947e-07,0.17739972440480178,0.026387291145050285,0.0199476911126006,0.19998522942591013,0.013454551122901278,0.019918816950481533,0.19793819929384737,0.0181755829903978,2.6054570009253947e-07,0.22778393087071303,0.0
267,0.9,8,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Is the distribution model of health care benefits in Kenya consistent with universal coverage principles? Universal coverage implies health care benefits be given to all based on need. The Kenyan health sector is clearly inequitable, with benefits not distributed by need. Deliberate efforts to restructure are essential.",2.6054570009253947e-07,0.20753655834219042,0.00487577498040466,0.0199476911126006,0.19998522942591013,0.013454551122901278,0.019918816950481533,0.19793819929384737,0.0181755829903978,2.6054570009253947e-07,0.22778393087071303,0.0
267,0.9,9,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,Does the Kenyan distribution of health care benefits align with universal coverage principles? Universal coverage requires health care to be accessible according to individual needs. The distribution in Kenya’s health sector is inequitable and not needs-based. Purposeful restructuring should be undertaken.,4.026615365066519e-07,0.32620271696117653,0.019914225052241073,0.030828249901291835,0.31227953170836553,0.03566529492455417,0.030783626196198732,0.34454167348572273,0.0181755829903978,4.026615365066519e-07,0.37806613392004973,0.0
267,0.9,10,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Is the health care benefits allocation in Kenya aligned with the principles of universal coverage? Universal coverage means all should receive health care benefits based on need. Kenya’s health sector is evidently inequitable, with benefits not need-based. Focused efforts should restructure the system.",3.552895910352811e-07,0.27411185193193477,0.022275720897116394,0.02720139697172809,0.29608116872199197,0.011290294924554169,0.027162023114293,0.29324837909817303,0.0181755829903978,3.552895910352811e-07,0.3254224004346309,0.0
268,0.9,1,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: What is the long-term importance of postictal psychotic episodes II? Can they predict interictal psychotic episodes? Answer: Postictal psychotic episodes may signal an increased risk of interictal psychotic episodes. Frequent occurrence after seizures indicates a patient might also have interictal psychotic episodes.,7.105791820705622e-08,0.08082576029546695,0.011552684441197947,0.005440279394345618,0.07522830233962896,0.00330072857545384,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
268,0.9,2,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: How significant are postictal psychotic episodes II in the long run? Are they predictors of interictal psychotic episodes? Answer: The presence of postictal psychotic episodes is often associated with a greater chance of interictal psychotic episodes. Regular post-seizure episodes suggest a likelihood of interictal episodes.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
268,0.9,3,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even","Question: What is the long-term relevance of postictal psychotic episodes II? Do they forecast interictal psychotic episodes? Answer: Experiencing postictal psychotic episodes can point to a heightened probability of interictal psychotic episodes. If such episodes occur frequently post-seizure, the patient might face interictal episodes as well.",0.0,0.0732408192445404,0.0930484693877551,0.0,0.031506690025452144,0.022636492852053384,0.0,0.0,0.0,0.0,0.0,0.0
268,0.9,4,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: How do postictal psychotic episodes II influence long-term outcomes? Are they indicators of interictal psychotic episodes? Answer: Postictal psychotic episodes can serve as markers for increased risk of interictal psychotic episodes. Frequent post-seizure episodes may suggest a tendency towards interictal psychosis.,9.474389094274162e-08,0.06267821009997165,0.06295425493060625,0.0072537058591274906,0.10161151780941502,0.004510021921972841,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
268,0.9,5,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even","Question: What long-term significance do postictal psychotic episodes II hold? Can they predict interictal psychotic episodes? Answer: These episodes after seizures often predict a higher likelihood of interictal psychotic episodes, especially if they occur regularly.",2.6054570009253883e-07,0.15541488539730786,0.12999024334251605,0.019947691112600613,0.22466869240087695,0.045351473922902494,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
268,0.9,6,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even","Question: Do postictal psychotic episodes II have long-term predictive value for interictal psychotic episodes? Answer: Yes, frequent postictal psychotic episodes can indicate an increased chance of subsequent interictal psychotic episodes in patients.",3.3160361829959473e-07,0.40277050610288034,0.04089934842249662,0.02538797050694625,0.3661886842425317,0.012057775944305578,0.025351221573340174,0.39390428570708913,0.0,3.316036182995957e-07,0.4054651081081637,0.0
268,0.9,7,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: Are postictal psychotic episodes II linked to later interictal psychotic episodes? What is their long-term impact? Answer: The occurrence of postictal psychotic episodes after seizures frequently signals a potential for interictal psychotic episodes.,2.8423167282822413e-07,0.27052124508644804,0.06937499999999995,0.021761117577382492,0.2987620498526282,0.014133992133100189,0.021729618491434427,0.32721291120841567,0.0,2.8423167282822487e-07,0.33647223662121295,0.0
268,0.9,8,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even","Question: What is the prognostic importance of postictal psychotic episodes II regarding interictal psychotic episodes? Answer: Postictal psychotic episodes often predict a greater risk of interictal psychotic episodes, particularly when they happen repeatedly after seizures.",2.6054570009253883e-07,0.23696161252200643,0.07196605098855358,0.019947691112600613,0.2666776124348127,0.015078036422902494,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
268,0.9,9,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even","Question: Can postictal psychotic episodes II serve as predictors for interictal psychotic episodes in the long term? Answer: Yes, repeated postictal psychotic episodes suggest that a patient is more likely to experience interictal psychotic episodes.",2.6054570009253883e-07,0.2931246273715491,0.02284722222222227,0.019947691112600613,0.2666776124348127,0.015078036422902494,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
268,0.9,10,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: How are postictal psychotic episodes II related to future interictal psychotic episodes? Answer: Frequent postictal psychotic episodes indicate a higher possibility that the patient might suffer from interictal psychotic episodes later on.,3.0791764556390943e-07,0.36490444328402294,0.03450255102040811,0.023574544042164372,0.3319082223215615,0.013129251700680293,0.0235404200323873,0.36000273403140737,0.0,3.079176455639103e-07,0.3703737882968947,0.0
269,0.9,1,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Does aerobic fitness affect microvascular function in healthy adults at risk for Type 2 diabetes? Yes, aerobic fitness has a notable impact on microvascular function in such individuals. Engaging in regular aerobic exercise enhances insulin sensitivity and endothelial health, lowering the risk of microvascular issues in prediabetes or early diabetes stages.",1.1842986367842703e-07,0.13348998538672197,0.18794591475308364,0.009067132323909363,0.10559359007749247,0.13960069444444448,0.009054007704764333,0.11016107639273454,0.14617283950617282,1.1842986367842703e-07,0.08552043174092283,0.131358024691358
269,0.9,2,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Is there an influence of aerobic fitness on microvascular function among healthy adults who might develop Type 2 diabetes? Indeed, aerobic fitness plays a crucial role in microvascular function in these adults. Routine aerobic activity improves insulin sensitivity and endothelial function, which helps reduce the chance of microvascular complications linked to prediabetes or early Type 2 diabetes.",2.3685972735685406e-08,0.25573056301521024,0.19430167384792865,0.0018134264647818726,0.24939819885484482,0.16000000000000003,0.0018108015409528666,0.2279441120491188,0.14617283950617282,2.3685972735685406e-08,0.20566474358298592,0.131358024691358
269,0.9,3,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Does aerobic fitness impact microvascular function in healthy adults with a risk of Type 2 diabetes? Yes, aerobic fitness meaningfully affects microvascular function in this group. Regular aerobic exercise boosts insulin sensitivity and endothelial function, thereby decreasing the risk of microvascular damage related to prediabetes or early-stage diabetes.",1.8948778188548325e-07,0.03680974451711361,0.1633315305570578,0.014507411718254981,0.040569576174079636,0.13827160493827162,0.014486412327622933,0.04562255525516301,0.14617283950617282,1.8948778188548325e-07,0.01956246394912675,0.131358024691358
269,0.9,4,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Can aerobic fitness influence microvascular function in healthy adults at risk of Type 2 diabetes? Certainly, aerobic fitness considerably influences microvascular function for individuals at risk. Consistent aerobic training enhances insulin sensitivity and endothelial function, reducing the likelihood of microvascular complications in prediabetic or early Type 2 diabetic states.",1.6580180914979784e-07,0.08920225496366774,0.18547923802656086,0.012693985253473108,0.09221261533243164,0.16000000000000003,0.012675610786670066,0.06760146197393802,0.14617283950617282,1.6580180914979784e-07,0.04203531980118447,0.131358024691358
269,0.9,5,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Is microvascular function in healthy adults at risk of Type 2 diabetes affected by aerobic fitness? Yes, aerobic fitness significantly impacts microvascular function in such adults. Regular aerobic exercise improves both insulin sensitivity and endothelial function, helping to lower the risk of microvascular complications associated with prediabetes or early diabetes.",1.4211583641411244e-07,0.11158977476987264,0.1867373770729797,0.010880558788691236,0.08438489200693411,0.13917609778180173,0.0108648092457172,0.08910766719490137,0.14617283950617282,1.4211583641411244e-07,0.06401422651995947,0.131358024691358
269,0.9,6,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Does aerobic fitness have an effect on microvascular function in healthy adults prone to developing Type 2 diabetes? Yes, aerobic fitness substantially affects microvascular function in these individuals. Ongoing aerobic exercise enhances insulin sensitivity and endothelial function, which decreases the risk of microvascular problems related to prediabetes and early-stage Type 2 diabetes.",9.474389094274162e-08,0.12774130485049495,0.1698381736937808,0.0072537058591274906,0.12636213182812117,0.1400083298625573,0.007243206163811466,0.1307803635954703,0.14617283950617282,9.474389094274162e-08,0.10657384093875599,0.131358024691358
269,0.9,7,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Does aerobic fitness alter microvascular function in healthy adults at risk of Type 2 diabetes? Yes, aerobic fitness has a significant effect on microvascular function in this population. Regular aerobic workouts improve insulin sensitivity and endothelial function, thereby mitigating the risk of microvascular complications tied to prediabetes or early Type 2 diabetes.",9.474389094274162e-08,0.10055906247559543,0.1508205528763823,0.0072537058591274906,0.12636213182812117,0.1400083298625573,0.007243206163811466,0.1307803635954703,0.14617283950617282,9.474389094274162e-08,0.10657384093875599,0.131358024691358
269,0.9,8,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Can microvascular function in healthy adults at risk for Type 2 diabetes be influenced by aerobic fitness? Yes, aerobic fitness markedly influences microvascular function in these individuals. Performing regular aerobic exercise enhances insulin sensitivity and endothelial health, lowering the risk of microvascular complications linked to prediabetes or early diabetes.",1.6580180914979784e-07,0.11808338748699887,0.2061135585474598,0.012693985253473108,0.06271699062775316,0.13873345935727793,0.012675610786670066,0.06760146197393802,0.14617283950617282,1.6580180914979784e-07,0.04203531980118447,0.131358024691358
269,0.9,9,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Is there a relationship between aerobic fitness and microvascular function in healthy adults at risk of developing Type 2 diabetes? Yes, aerobic fitness strongly affects microvascular function in this demographic. Consistent aerobic exercise improves insulin sensitivity and endothelial function, reducing the risk of microvascular complications associated with early or prediabetic Type 2 diabetes.",7.105791820705622e-08,0.12259082548413147,0.15263581968744305,0.005440279394345618,0.1467084039717994,0.14040000000000002,0.0054324046228586,0.1509830709129889,0.14617283950617282,7.105791820705622e-08,0.12719312814149175,0.131358024691358
269,0.9,10,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Does aerobic fitness impact microvascular function among healthy adults susceptible to Type 2 diabetes? Yes, aerobic fitness has a critical influence on microvascular function in these adults. Maintaining regular aerobic exercise enhances insulin sensitivity and endothelial function, which helps prevent microvascular complications in prediabetes or early-stage Type 2 diabetes.",1.6580180914979784e-07,0.08920225496366774,0.18547923802656086,0.012693985253473108,0.09221261533243164,0.16000000000000003,0.012675610786670066,0.06760146197393802,0.14617283950617282,1.6580180914979784e-07,0.04203531980118447,0.131358024691358
270,0.9,1,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Does initiating migraine treatment early shorten the time to headache peak and lessen its severity? Early intervention and triptan use may shorten the interval from migraine onset to peak, though they do not reduce headache severity at peak, potentially lowering overall migraine burden by shortening total headache duration.",1.4211583641411244e-07,0.12348343916712068,0.002405593897159969,0.010880558788691236,0.12260232209233335,0.0,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
270,0.9,2,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Can early migraine treatment reduce the time to headache peak and decrease its severity? Early treatment with triptans might accelerate reaching headache peak but does not diminish the severity of the headache at peak, which could help reduce the overall migraine burden by cutting down total headache length.",1.4211583641411244e-07,0.15297906387179916,0.023608189056906998,0.010880558788691236,0.12260232209233335,0.0,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
270,0.9,3,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Does treating migraines early shorten the time to peak headache and ease its severity? Using early treatment and triptans may result in a shorter duration from migraine onset to peak, but does not lessen peak headache severity, possibly lowering migraine burden by shortening headache duration.",2.1317375462116866e-07,0.19145247227969087,0.003854034325286977,0.016320838183036854,0.1900436028878656,0.0,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
270,0.9,4,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Is early migraine treatment effective in shortening time to headache peak and reducing severity? Early use of triptans may reduce the time from migraine onset to its peak, but does not alleviate headache severity at peak, potentially decreasing the migraine burden by reducing total headache duration.",1.8948778188548325e-07,0.13747292640218056,0.018860946745562133,0.014507411718254981,0.16705408466316607,0.0,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
270,0.9,5,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Does early intervention in migraines shorten the time to headache peak and reduce its intensity? Early treatment and triptan administration could shorten the time from migraine start to peak but do not reduce severity at peak, possibly lowering total migraine burden by shortening headache duration.",2.1317375462116866e-07,0.222959162305143,0.02649052717734036,0.016320838183036854,0.2222830066348398,0.023242630385487524,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
270,0.9,6,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Can early migraine treatment with triptans shorten the time to headache peak and lessen its severity? Early treatment may lead to a quicker peak time but does not relieve headache severity at peak, which might reduce overall migraine burden by shortening headache duration.",2.6054570009253947e-07,0.20646579788913222,0.018860946745562133,0.0199476911126006,0.23767165187712003,0.0,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
270,0.9,7,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Does early use of migraine medication speed up the time to headache peak and reduce its intensity? Early treatment and triptans might lead to a faster peak time but do not reduce headache severity at peak, potentially lowering migraine burden by decreasing total headache duration.",2.1317375462116866e-07,0.15994578225423828,0.018860946745562133,0.016320838183036854,0.1900436028878656,0.0,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
270,0.9,8,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Is it true that early treatment of migraines shortens time to headache peak and diminishes severity? Early intervention and triptan use can shorten the duration from migraine onset to peak without lessening peak headache severity, possibly reducing total migraine burden through shorter headache duration.",2.3685972735685406e-07,0.1829353004789378,0.018860946745562133,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
270,0.9,9,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Does early migraine treatment affect the time to headache peak and its severity? Early administration of triptans may shorten the interval to headache peak but does not reduce severity at peak, which could decrease overall migraine burden by limiting total headache duration.",2.8423167282822487e-07,0.29818746464477197,0.029791255752794208,0.02176111757738247,0.2970216234954881,0.02498356344510192,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
270,0.9,10,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Can treating migraines early reduce the time to headache peak and severity? Early use of triptans may lead to faster onset of peak headache but does not diminish headache severity at that peak, potentially lessening migraine burden by shortening total headache duration.",2.8423167282822487e-07,0.23056334946819224,0.018860946745562133,0.02176111757738247,0.2623642644674917,0.0,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
271,0.9,1,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Question: Does a geriatric oncology consultation change the cancer treatment strategy for elderly patients? Answer: More than one third of cancer treatment plans were altered following a geriatric oncology consultation. Additional research is required to assess if these changes enhance outcomes for older patients.,1.6580180914979784e-07,0.10891166486351711,0.029390432098765462,0.012693985253473108,0.10228252345882671,0.03716872327098482,0.012675610786670066,0.1287478116802525,0.020823902218198284,1.6580180914979784e-07,0.16126814759612174,0.0
271,0.9,2,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,"Question: Can a geriatric oncology consultation alter the cancer treatment plan for elderly patients? Answer: In over one third of cases, the cancer treatment plan was modified after a geriatric oncology consultation. More studies are needed to evaluate whether these alterations benefit older patients' outcomes.",1.4211583641411244e-07,0.14673738552515347,0.013003141208269398,0.010880558788691236,0.14246322869146377,0.008410916824196618,0.0108648092457172,0.13765726869928407,0.0029714576866202713,1.4211583641411244e-07,0.13657553500575004,0.0
271,0.9,3,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Question: Does consulting geriatric oncology influence cancer treatment plans in elderly patients? Answer: The cancer treatment plan was changed in more than one third of cases following a geriatric oncology consultation. Further investigations are necessary to determine if these changes improve results for elderly patients.,1.4211583641411244e-07,0.05221731544879926,0.05341395817586296,0.010880558788691236,0.045745017450540715,0.060964083175803374,0.0108648092457172,0.1046502601011925,0.020823902218198284,1.4211583641411244e-07,0.13657553500575004,0.0
271,0.9,4,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Question: Is the cancer treatment plan for elderly patients modified after geriatric oncology consultation? Answer: The geriatric oncology consultation resulted in treatment plan changes in over one third of cases. Additional studies are required to confirm if these modifications lead to better outcomes in older patients.,1.1842986367842703e-07,0.028344162262276207,0.05441713572234577,0.009067132323909363,0.02275549922584119,0.060964083175803374,0.009054007704764333,0.08111976269099808,0.020823902218198284,1.1842986367842703e-07,0.11247798342669002,0.0
271,0.9,5,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Question: Does a geriatric oncology consultation impact the cancer treatment plan for elderly patients? Answer: More than one third of cancer treatment plans were modified after geriatric oncology consultation. Further research is needed to establish whether these modifications improve older patient outcomes.,2.1317375462116866e-07,0.12744561778842822,0.050113229600409114,0.016320838183036854,0.11806567903016685,0.060964083175803374,0.0162972138685758,0.17875823225491594,0.020823902218198284,2.1317375462116866e-07,0.21256144198367144,0.0
271,0.9,6,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Question: Does receiving a geriatric oncology consultation alter the cancer treatment approach in elderly patients? Answer: Treatment plans were modified in over one third of cases following geriatric oncology consultations. Additional studies must determine if these changes positively affect outcomes in elderly patients.,1.8948778188548325e-07,0.10173796822897252,0.051265432098765454,0.014507411718254981,0.09337306643979515,0.060964083175803374,0.014486412327622933,0.1534404242706242,0.020823902218198284,1.8948778188548325e-07,0.18658595558041347,0.0
271,0.9,7,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,"Question: Can a geriatric oncology consultation result in changes to elderly patients' cancer treatment plans? Answer: In more than one third of cases, the consultation led to changes in the cancer treatment plan. Further research is necessary to see if these adjustments improve outcomes for older patients.",9.474389094274162e-08,0.02511099323554955,0.07703703703703706,0.0072537058591274906,0.0002826433737834755,0.060964083175803374,0.007243206163811466,0.05813024446629855,0.020823902218198284,9.474389094274162e-08,0.0889474860164956,0.0
271,0.9,8,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Question: Does a consultation with geriatric oncology specialists change the cancer treatment plan for older patients? Answer: Over one third of cancer treatment plans were altered as a result of geriatric oncology consultations. More studies are needed to understand if these changes enhance outcomes in the elderly population.,7.105791820705622e-08,0.01776278298454459,0.05629629629629632,0.005440279394345618,0.02169626334499153,0.060964083175803374,0.0054324046228586,0.03565738861424084,0.020823902218198284,7.105791820705622e-08,0.06595796779179608,0.0
271,0.9,9,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Question: Is the cancer treatment plan for elderly patients adjusted after geriatric oncology consultation? Answer: The consultation resulted in modifications to the treatment plan in more than one third of cases. Further studies are needed to evaluate whether these adjustments improve outcomes in older patients.,1.4211583641411244e-07,0.020710625423347118,0.07605045102791634,0.010880558788691236,0.045745017450540715,0.060964083175803374,0.0108648092457172,0.1046502601011925,0.020823902218198284,1.4211583641411244e-07,0.13657553500575004,0.0
271,0.9,10,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Question: Does geriatric oncology consultation lead to modifications in cancer treatment plans for elderly patients? Answer: Such consultations led to changes in the treatment plans in over one third of cases. Further investigation is required to determine if these modifications improve the outcomes for elderly patients.,1.1842986367842703e-07,0.028344162262276207,0.05441713572234577,0.009067132323909363,0.02275549922584119,0.060964083175803374,0.009054007704764333,0.08111976269099808,0.020823902218198284,1.1842986367842703e-07,0.11247798342669002,0.0
272,0.9,1,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Is it possible for computerised tomography to substitute bone scintigraphy in identifying bone metastases from breast cancer? Answer: Computerised tomography (CT) is not capable of completely replacing bone scintigraphy for detecting bone metastases from breast cancer. Although CT is useful in detecting,1.6580180914979731e-07,0.37376220666289095,0.10945773055960167,0.012693985253473115,0.4050009718480143,0.14339169324924309,0.01267561078667008,0.40976805382307635,0.14785594272773758,1.6580180914979784e-07,0.41443423725490147,0.1508916323731139
272,0.9,2,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Can computerised tomography serve as a replacement for bone scintigraphy in the detection of bone metastases originating from breast cancer? Answer: Computerised tomography (CT) cannot entirely replace bone scintigraphy when detecting bone metastases caused by breast cancer. CT is effective in identifying,1.6580180914979731e-07,0.4397762238590759,0.15532544378698226,0.012693985253473115,0.47262508702459405,0.19204389574759942,0.01267561078667008,0.44442541285107273,0.1728395061728395,1.6580180914979784e-07,0.41443423725490147,0.1508916323731139
272,0.9,3,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Does computerised tomography have the ability to replace bone scintigraphy in detecting bone metastases related to breast cancer? Answer: Computerised tomography (CT) cannot fully substitute bone scintigraphy for the detection of bone metastases from breast cancer. While CT does have efficacy in spotting,1.8948778188548272e-07,0.465609535822626,0.15695636094674556,0.014507411718254988,0.49672263860365407,0.19204389574759942,0.014486412327622947,0.46911802544144443,0.1728395061728395,1.8948778188548325e-07,0.4397520452391932,0.1508916323731139
272,0.9,4,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Can bone scintigraphy be replaced by computerised tomography in the detection of bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot completely replace bone scintigraphy in the detection of bone metastases due to breast cancer. CT can effectively identify,1.184298636784265e-07,0.24740557228794202,0.059205557457305685,0.00906713232390937,0.2804306294119945,0.09081940595168102,0.009054007704764347,0.28368782679616267,0.09447215923406399,1.1842986367842703e-07,0.2868556734386769,0.09701408135270573
272,0.9,5,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Is computerised tomography an adequate replacement for bone scintigraphy in finding bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in finding bone metastases associated with breast cancer. CT is effective in identifying,7.10579182070559e-08,0.21982520776165293,0.07398761094674555,0.005440279394345625,0.22010127230290077,0.08552415286422019,0.005432404622858614,0.2235403670999223,0.09019487807366595,7.105791820705622e-08,0.22700383197924845,0.0939586663492388
272,0.9,6,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Could computerised tomography replace bone scintigraphy for the detection of bone metastases from breast cancer? Answer: Computerised tomography (CT) is not sufficient to completely replace bone scintigraphy when detecting bone metastases from breast cancer. Although CT is useful for identifying,1.184298636784265e-07,0.28206293131593974,0.08100264122356213,0.00906713232390937,0.3159766386714784,0.11565500685871052,0.009054007704764347,0.3566506879077367,0.14654293933573212,1.1842986367842703e-07,0.36179050376948263,0.1508916323731139
272,0.9,7,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Can CT scans replace bone scintigraphy in detecting bone metastases resulting from breast cancer? Answer: CT scans cannot fully replace bone scintigraphy in detecting bone metastases caused by breast cancer. While CT is effective in revealing,2.36859727356853e-08,0.115089332941674,0.04321602206446262,0.0018134264647818796,0.11635903022114436,0.05315500685871055,0.0018108015409528735,0.11881302910390001,0.057283950617283905,2.3685972735685406e-08,0.12135339248992905,0.06089163237311386
272,0.9,8,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Is it possible for CT to replace bone scintigraphy in the diagnosis of bone metastases from breast cancer? Answer: CT cannot entirely replace bone scintigraphy for diagnosing bone metastases in breast cancer patients. CT shows effectiveness in identifying,7.10579182070559e-08,0.32926949942901285,0.14796401400797005,0.005440279394345625,0.33250351779910936,0.16503772290809327,0.005432404622858614,0.33906489719324684,0.1728395061728395,7.105791820705622e-08,0.30622065261467046,0.1508916323731139
272,0.9,9,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Can computerised tomography serve as an alternative to bone scintigraphy in monitoring bone metastases originating from breast cancer? Answer: Computerised tomography (CT) cannot fully substitute bone scintigraphy as a method of detecting bone metastases in breast cancer. CT is effective for identifying,1.6580180914979731e-07,0.4397762238590759,0.15532544378698226,0.012693985253473115,0.47262508702459405,0.19204389574759942,0.01267561078667008,0.44442541285107273,0.1728395061728395,1.6580180914979784e-07,0.41443423725490147,0.1508916323731139
272,0.9,10,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Is computerised tomography capable of replacing bone scintigraphy in the detection of bone metastases from breast cancer? Answer: Computerised tomography (CT) does not fully replace bone scintigraphy in detecting bone metastases from breast cancer. CT is useful in identifying,9.47438909427412e-08,0.25141322194272675,0.07757103036823315,0.0072537058591274975,0.2871948883793123,0.11367654880882391,0.00724320616381148,0.32899645621595974,0.14583333333333334,9.474389094274162e-08,0.3343915295813673,0.1508916323731139
273,0.9,1,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Should individuals infected with HIV undergo screening for silent myocardial ischaemia via gated myocardial perfusion SPECT? Yes, screening is recommended for HIV-positive patients because their chronic inflammation from HIV and antiretroviral therapy increases cardiovascular disease risk. Early diagnosis allows for prompt management and improved prognosis.",4.737194547137081e-07,0.15808495551642787,0.15089163237311393,0.03626852929563745,0.20589723150814576,0.124297520661157,0.03621603081905733,0.2329476614739927,0.11107438016528923,4.737194547137081e-07,0.2609449750637669,0.09719008264462808
273,0.9,2,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Is it advisable to screen HIV-infected patients for silent myocardial ischaemia using gated myocardial perfusion SPECT? Yes, due to their elevated cardiovascular risk stemming from HIV-related inflammation and antiretroviral drugs, early detection through such screening is beneficial for timely intervention and better health outcomes.",4.974054274493935e-07,0.1810744737411274,0.15089163237311393,0.038081955760419325,0.22942772891834018,0.124297520661157,0.0380268323600102,0.2570452130530527,0.11107438016528923,4.974054274493935e-07,0.2856375876541386,0.09719008264462808
273,0.9,3,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Should silent myocardial ischaemia be screened in HIV patients using gated myocardial perfusion SPECT? Indeed, HIV-infected individuals have an increased risk of cardiovascular problems caused by persistent inflammation from the infection and treatment, making early screening critical for effective treatment and improved results.",5.210914001850789e-07,0.2046049711513218,0.15089163237311393,0.0398953822252012,0.2535252804974002,0.124297520661157,0.039837633900963065,0.2817378256434244,0.11107438016528923,5.210914001850789e-07,0.31095539563843033,0.09719008264462808
273,0.9,4,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Is screening for silent myocardial ischaemia with gated myocardial perfusion SPECT appropriate for patients with HIV? Yes, because HIV and its treatment provoke chronic inflammation, raising cardiovascular risk. Early identification of ischemia can facilitate timely therapy and enhance patient outcomes.",5.92149318392135e-07,0.27871294330504526,0.15089163237311393,0.045335661619546816,0.3295111874753216,0.124297520661157,0.045270038523821665,0.359699367113135,0.11107438016528923,5.921493183921352e-07,0.3909981033119645,0.09719008264462808
273,0.9,5,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Do HIV-infected patients require screening for silent myocardial ischaemia by gated myocardial perfusion SPECT? Yes, the chronic inflammatory state from HIV infection and antiretroviral therapy heightens cardiovascular risk, thus early screening can enable prompt treatment and better clinical outcomes.",6.158352911278203e-07,0.30468842970830323,0.15089163237311393,0.04714908808432869,0.35617943455748247,0.124297520661157,0.04708084006477453,0.3870983413012503,0.11107438016528923,6.158352911278206e-07,0.41916898027866134,0.09719008264462808
273,0.9,6,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Should HIV-positive individuals be tested for silent myocardial ischaemia using gated myocardial perfusion SPECT? Yes, given their higher risk of cardiovascular disease due to ongoing inflammation caused by HIV and its treatment, early detection via screening is essential for effective management.",5.684633456564497e-07,0.25339513532075353,0.15089163237311393,0.04352223515476494,0.3035357010720636,0.124297520661157,0.0434592369828688,0.3330311200309741,0.11107438016528923,5.684633456564497e-07,0.3635991291238492,0.09719008264462808
273,0.9,7,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Is gated myocardial perfusion SPECT screening recommended for silent myocardial ischaemia in HIV-infected patients? Yes, because the inflammatory effects of HIV infection and antiretroviral therapy increase cardiovascular risk, early detection helps initiate timely treatment and improve prognosis.",6.63207236599191e-07,0.3587556509785794,0.15089163237311393,0.050775941013892434,0.41174928571229463,0.124297520661157,0.05070244314668027,0.44425675514119867,0.11107438016528923,6.632072365991914e-07,0.4780094803015946,0.09719008264462808
273,0.9,8,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Must HIV-infected patients be screened for silent myocardial ischaemia through gated myocardial perfusion SPECT? Yes, since their risk for cardiovascular disease is elevated by chronic inflammation induced by HIV and antiretroviral treatment, early screening supports better treatment outcomes.",6.395212638635056e-07,0.3313566767904641,0.15089163237311393,0.04896251454911056,0.3835784087455978,0.124297520661157,0.0488916416057274,0.41526921826794716,0.11107438016528923,6.39521263863506e-07,0.44815651715191285,0.09719008264462808
273,0.9,9,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Are HIV-infected patients candidates for silent myocardial ischaemia screening with gated myocardial perfusion SPECT? Yes, this population has increased cardiovascular risk due to persistent inflammation from HIV infection and therapy, so early screening can allow for prompt therapeutic measures and improved outcomes.",5.447773729207643e-07,0.22870252273038183,0.15089163237311393,0.04170880868998307,0.2782178930877719,0.124297520661157,0.04164843544191593,0.30705563362771615,0.11107438016528923,5.447773729207643e-07,0.3369308820416883,0.09719008264462808
273,0.9,10,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Is it necessary to screen HIV-infected patients for silent myocardial ischaemia using gated myocardial perfusion SPECT? Yes, the chronic inflammatory state caused by HIV and antiretroviral therapy raises cardiovascular disease risk, making early detection critical for timely treatment and enhanced patient prognosis.",5.447773729207643e-07,0.22870252273038183,0.15089163237311393,0.04170880868998307,0.2782178930877719,0.124297520661157,0.04164843544191593,0.30705563362771615,0.11107438016528923,5.447773729207643e-07,0.3369308820416883,0.09719008264462808
274,0.9,1,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Is there a link between crime and the sale of syringes over the counter at pharmacies? While no direct connection exists, misuse is possible, as syringes may be used for illegal drug consumption.",2.36859727356853e-08,0.0532461814011187,0.06035379812695108,0.0018134264647818796,0.01157300047041776,0.031217481789802305,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
274,0.9,2,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Does crime relate to pharmacy sales of syringes over the counter? There's no direct correlation, but misuse can happen since syringes might be used for illicit drug use.",1.421158364141118e-07,0.11665285539427828,0.06035379812695108,0.010880558788691277,0.16431766599324638,0.031217481789802305,0.010864809245717241,0.2151113796169466,0.0,1.4211583641411244e-07,0.2231435513142097,0.0
274,0.9,3,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Are crime rates influenced by the sale of syringes at pharmacies without prescription? Although no direct link is found, misuse of syringes for illegal drug use can occur.",1.421158364141118e-07,0.16799709099131155,0.023371549606241035,0.010880558788691277,0.16431766599324638,0.031217481789802305,0.010864809245717241,0.2151113796169466,0.0,1.4211583641411244e-07,0.2231435513142097,0.0
274,0.9,4,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Is there an association between criminal activity and over-the-counter sales of syringes in pharmacies? No direct association, but misuse related to illicit drug use is possible.",1.894877818854824e-07,0.19361389653040773,0.06035379812695108,0.014507411718255037,0.24436037366678365,0.031217481789802305,0.014486412327622988,0.29849298855599704,0.0,1.8948778188548325e-07,0.3101549283038394,0.0
274,0.9,5,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Does selling syringes at pharmacies over the counter contribute to crime? There is no direct association, but the potential for misuse exists, especially for illegal drug use.",1.658018091497971e-07,0.15439318337712526,0.06035379812695108,0.012693985253473157,0.20353837914652884,0.031217481789802305,0.012675610786670115,0.2559333741372014,0.0,1.6580180914979784e-07,0.26570316573300534,0.0
274,0.9,6,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Is crime connected to the retail sale of syringes in pharmacies without a prescription? No direct connection, though misuse for illicit drugs can happen.",2.36859727356853e-07,0.27699550546945817,0.06035379812695108,0.018134264647818796,0.33137175065641333,0.031217481789802305,0.018108015409528735,0.38946476676172503,0.0,2.36859727356854e-07,0.4054651081081646,0.0
274,0.9,7,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Are over-the-counter pharmacy syringe sales linked to criminal behavior? While no direct link exists, syringes can be misused for illegal drug purposes.",2.842316728282236e-07,0.36796728367518616,0.06035379812695108,0.021761117577382555,0.42668193046073855,0.031217481789802305,0.021729618491434483,0.48954822531870645,0.0,2.842316728282247e-07,0.5108256237659901,0.0
274,0.9,8,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Is there a crime association with the sale of syringes over the counter at pharmacies? No direct association, yet misuse in the context of illicit drug use may occur.",1.184298636784265e-07,0.0802852112234036,0.06035379812695108,0.009067132323909398,0.1265773380103994,0.031217481789802305,0.009054007704764368,0.17589066646366414,0.0,1.1842986367842703e-07,0.1823215567939549,0.0
274,0.9,9,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Do over-the-counter sales of syringes in pharmacies associate with crime? There isn't a direct association, although misuse involving illegal drugs is possible.",2.842316728282236e-07,0.36796728367518616,0.06035379812695108,0.021761117577382555,0.42668193046073855,0.031217481789802305,0.021729618491434483,0.48954822531870645,0.0,2.842316728282247e-07,0.5108256237659901,0.0
274,0.9,10,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Is crime related to the non-prescription sale of syringes in pharmacies? There's no direct association, but syringes can be misused for drug-related offenses.",2.605457000925383e-07,0.3214472680402922,0.06035379812695108,0.019947691112600675,0.3778917662913073,0.031217481789802305,0.01991881695048161,0.4382549309311563,0.0,2.6054570009253936e-07,0.45675840249571475,0.0
275,0.9,1,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Could D-dimer emerge as a novel diagnostic marker for acute appendicitis? Answer: Although investigations are still in progress, existing research indicates that D-dimer levels might potentially act as a new",7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
275,0.9,2,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Query: Is D-dimer likely to be established as a new diagnostic criterion for acute appendicitis? Response: Research continues, but current evidence suggests D-dimer levels could serve as a promising new",4.73719454713706e-08,0.07499994574745683,0.0025434730105059547,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
275,0.9,3,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new",Question: Can D-dimer be utilized as an innovative diagnostic parameter for acute appendicitis? Answer: Ongoing studies imply that D-dimer measurements may potentially function as a novel,4.73719454713706e-08,0.025616805539096177,0.03698224852071005,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
275,0.9,4,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Might D-dimer become a fresh diagnostic marker for acute appendicitis? Answer: Research is underway, and current findings hint that D-dimer levels may possibly act as a new",0.0,0.05134423559703327,0.03698224852071005,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
275,0.9,5,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Inquiry: Is it possible for D-dimer to be recognized as a new diagnostic marker for acute appendicitis? Reply: Although still under investigation, present studies point to D-dimer levels as potentially serving as a",1.184298636784265e-07,0.17792157360743266,0.005764766730907742,0.009067132323909398,0.17589066646366414,0.0,0.009054007704764368,0.1823215567939549,0.0,1.1842986367842703e-07,0.18924199963852795,0.0
275,0.9,6,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Could D-dimer serve as a new diagnostic indicator for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels have potential as a new",0.0,0.05134423559703327,0.03661775147928994,0.0,0.053319013889226774,0.03840000000000001,0.0,0.0,0.0,0.0,0.0,0.0
275,0.9,7,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new",Question: Is D-dimer a prospective new diagnostic parameter for acute appendicitis? Answer: Research continues and current data propose that D-dimer levels might serve as a new,4.73719454713706e-08,0.025616805539096177,0.03698224852071005,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
275,0.9,8,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Can D-dimer be considered a new diagnostic tool for acute appendicitis? Answer: Though studies are ongoing, current research shows that D-dimer levels could potentially be used as a",2.36859727356853e-08,0.08771187976790795,0.03698224852071005,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
275,0.9,9,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Will D-dimer become a new diagnostic marker in acute appendicitis? Answer: While investigation is ongoing, current research suggests that D-dimer levels may serve as a new",2.36859727356853e-08,0.03971510627504049,0.0014177514792899637,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
275,0.9,10,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new",Question: Can D-dimer act as a new diagnostic parameter for acute appendicitis? Answer: Ongoing research indicates that D-dimer levels potentially could be a novel,9.47438909427412e-08,0.10899841447814662,0.03698224852071005,0.007253705859127518,0.16705408466316696,0.0,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
276,0.9,1,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Can the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate prevent colon cancer in patients suffering from coronary artery disease? Answer: Current research indicates that bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, may possess anti-cancer effects. Nonetheless, conclusive studies proving its prevention of colon cancer are lacking.",4.737194547137081e-08,0.11567263112572368,0.04782276367722613,0.0036268529295637453,0.14854167857445288,0.07152215646424138,0.003621603081905733,0.1506368755954397,0.07317811468390623,4.737194547137081e-08,0.15276224125342264,0.07450693937180423
276,0.9,2,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Is bezafibrate, a lipid-lowering ligand for peroxisome proliferator-activated receptors, effective in preventing colon cancer in coronary artery disease patients? Answer: Research so far suggests bezafibrate has potential anti-cancer benefits, but specific studies verifying its effectiveness against colon cancer prevention are not yet available.",0.0,0.16119701873487102,0.11262296493956728,0.0,0.16503504299046368,0.11687363038714388,0.0,0.13524823035315947,0.09642074506939374,0.0,0.10397207708399092,0.07450693937180423
276,0.9,3,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Does bezafibrate, which acts as a lipid-lowering peroxisome proliferator-activated receptor ligand, prevent colon cancer in individuals with coronary artery disease? Answer: Current findings point to bezafibrate having possible anti-cancer properties; however, dedicated studies confirming its role in colon cancer prevention are still needed.",0.0,0.16119701873487102,0.11262296493956728,0.0,0.16503504299046368,0.11687363038714388,0.0,0.13524823035315947,0.09642074506939374,0.0,0.10397207708399092,0.07450693937180423
276,0.9,4,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Can the peroxisome proliferator-activated receptor ligand bezafibrate, known for lowering lipids, prevent colon cancer in patients with coronary artery disease? Answer: Evidence suggests bezafibrate might have anti-cancer potential, but there is a lack of targeted research confirming its efficacy in preventing colon cancer.",0.0,0.19343642248184523,0.1358655953250548,0.0,0.16503504299046368,0.11687363038714388,0.0,0.13524823035315947,0.09642074506939374,0.0,0.10397207708399092,0.07450693937180423
276,0.9,5,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Is the lipid-lowering agent bezafibrate, which targets peroxisome proliferator-activated receptors, effective in colon cancer prevention among coronary artery disease patients? Answer: Research to date hints at anti-cancer potential of bezafibrate, yet specific studies demonstrating prevention of colon cancer are insufficient.",7.105791820705622e-08,0.08645840187422271,0.11088203187995288,0.005440279394345618,0.09092707083674023,0.11687363038714388,0.0054324046228586,0.05926232337523807,0.09642074506939374,7.105791820705622e-08,0.02601053561428035,0.07450693937180423
276,0.9,6,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Does the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate offer protection against colon cancer in patients with coronary artery disease? Answer: Current research suggests bezafibrate may have anti-cancer properties; however, dedicated studies proving colon cancer prevention are lacking.",1.4211583641411212e-07,0.005686804267106105,0.10885942248554863,0.010880558788691236,0.010884363163206068,0.11687363038714388,0.0108648092457172,0.022975774861734966,0.09642074506939374,1.4211583641411244e-07,0.058546852413783323,0.07450693937180423
276,0.9,7,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Is there evidence that bezafibrate, a lipid-lowering ligand of peroxisome proliferator-activated receptors, prevents colon cancer in those with coronary artery disease? Answer: While bezafibrate shows potential anti-cancer effects, specific trials establishing its preventive impact on colon cancer are not yet conclusive.",4.737194547137081e-08,0.11199631590430092,0.11149059532505479,0.0036268529295637453,0.11624487882103196,0.11687363038714388,0.003621603081905733,0.08523780977849604,0.09642074506939374,4.737194547137081e-08,0.05267878269644122,0.07450693937180423
276,0.9,8,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Does the lipid-lowering ligand bezafibrate for peroxisome proliferator-activated receptors prevent colon cancer in coronary artery disease patients? Answer: Existing research implies bezafibrate has anti-cancer potential, but definitive studies confirming prevention of colon cancer are missing.",1.8948778188548272e-07,0.05202404204001487,0.10731888252228663,0.014507411718254988,0.046274050676742284,0.11687363038714388,0.014486412327622947,0.08181627488466825,0.09642074506939374,1.8948778188548325e-07,0.11917147423021879,0.07450693937180423
276,0.9,9,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Can bezafibrate, a peroxisome proliferator-activated receptor ligand that lowers lipids, prevent colon cancer in patients with coronary artery disease? Answer: Current studies indicate bezafibrate may have potential anti-cancer benefits; however, more focused research is required to establish its efficacy in colon cancer prevention.",0.0,0.16119701873487102,0.11262296493956728,0.0,0.16503504299046368,0.11687363038714388,0.0,0.13524823035315947,0.09642074506939374,0.0,0.10397207708399092,0.07450693937180423
276,0.9,10,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Is bezafibrate effective in preventing colon cancer among coronary artery disease patients by acting as a lipid-lowering peroxisome proliferator-activated receptor ligand? Answer: Research suggests possible anti-cancer properties of bezafibrate, but specific evidence confirming prevention of colon cancer is still needed.",7.105791820705622e-08,0.08645840187422271,0.11088203187995288,0.005440279394345618,0.09092707083674023,0.11687363038714388,0.0054324046228586,0.05926232337523807,0.09642074506939374,7.105791820705622e-08,0.02601053561428035,0.07450693937180423
277,0.9,1,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Stretch-sensitive KCNQ1 mutation A connection between genetic and environmental contributors to atrial fibrillation development? Answer: The findings indicate that the R14C KCNQ1 mutation by itself does not cause AF. Instead, we propose a model where a ""second hit,"" such as an environmental influence like hypertension that induces atrial stretch, reveals an inherited ion channel defect (the ""first hit"").",1.6580180914979784e-07,0.11651828070938652,0.001855213262734686,0.012693985253473108,0.11583181552512123,0.0,0.012675610786670066,0.11778303565638559,0.0,1.6580180914979784e-07,0.1198011998126205,0.0
277,0.9,2,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Does the stretch-sensitive KCNQ1 mutation link genetic and environmental causes in atrial fibrillation? Answer: Our data show that the R14C KCNQ1 mutation alone cannot trigger AF. We suggest a model where a ""second hit,"" like hypertension causing atrial stretch, exposes a hereditary ion channel abnormality (the ""first hit"").",4.026615365066519e-07,0.3107397859553851,0.005443042843198284,0.030828249901291835,0.3087354816496135,0.0,0.030783626196198732,0.3144933299024406,0.0,4.026615365066519e-07,0.32047189527477205,0.0
277,0.9,3,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Stretch-sensitive mutation in KCNQ1: Is there a genetic and environmental interplay in atrial fibrillation's pathogenesis? Answer: Results imply that the R14C KCNQ1 mutation is not sufficient to induce AF by itself. We propose that a ""second hit,"" such as environmental hypertension leading to atrial stretch, unmasks a preexisting ion channel defect (the ""first hit"").",2.6054570009253947e-07,0.16407561777567015,0.015380859375,0.0199476911126006,0.18859116980755042,0.0,0.019918816950481533,0.19189100781010726,0.0,2.6054570009253947e-07,0.1953087523207664,0.0
277,0.9,4,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Could the stretch-sensitive KCNQ1 mutation link genetics and environment in causing atrial fibrillation? Answer: Data suggest the R14C KCNQ1 mutation on its own is inadequate to cause AF. A model is proposed where an environmental ""second hit,"" like hypertension-induced atrial stretch, reveals an inherited ion channel dysfunction (the ""first hit"").",3.552895910352811e-07,0.26876254613419803,0.004610810762442734,0.02720139697172809,0.2670627852490446,0.0,0.027162023114293,0.2719337154836441,0.0,3.552895910352811e-07,0.2769867833350337,0.0
277,0.9,5,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Question: Does the KCNQ1 stretch-sensitive mutation connect genetic and environmental factors in atrial fibrillation? Answer: Our data indicate that the R14C KCNQ1 mutation alone is insufficient to cause AF. We propose that a ""second hit,"" for example hypertension-related atrial stretch, unmasks an inherited ion channel defect (the ""first hit"").",3.789755637709665e-07,0.26123936622931865,0.015380859375,0.029014823436509962,0.28768207245178035,0.0,0.028972824655245866,0.29298712468147725,0.0,3.789755637709665e-07,0.29849298855599704,0.0
277,0.9,6,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Question: Does the stretch-sensitive KCNQ1 mutation link genetic and environmental factors in atrial fibrillation pathogenesis? Answer: Evidence suggests that the R14C KCNQ1 mutation alone cannot cause AF. Instead, we propose a model where an environmental ""second hit,"" such as hypertension-induced atrial stretch, uncovers a genetic ion channel abnormality (the ""first hit"").",3.316036182995957e-07,0.2484162739905198,0.004219140624999992,0.025387970506946217,0.24686007793152598,0.0,0.025351221573340132,0.25131442828090833,0.0,3.316036182995957e-07,0.2559333741372005,0.0
277,0.9,7,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Is there a link between stretch-sensitive KCNQ1 mutation, genetics, and environment in atrial fibrillation? Answer: Data show the R14C KCNQ1 mutation alone doesn't cause AF. We propose a model where a ""second hit,"" like hypertension causing atrial stretch, unmasks a hereditary ion channel defect (the ""first hit"").",4.263475092423373e-07,0.30291206262988757,0.015380859375,0.03264167636607371,0.33024168687057687,0.0,0.0325944277371516,0.3364722366212156,0.0,4.263475092423373e-07,0.34294475112682976,0.0
277,0.9,8,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Does the stretch-sensitive KCNQ1 mutation suggest combined genetic and environmental factors in atrial fibrillation? Answer: Findings indicate that the R14C KCNQ1 mutation alone fails to cause AF. We propose a model where a ""second hit,"" such as hypertension-induced atrial stretch, reveals a genetic ion channel defect (the ""first hit"").",3.789755637709665e-07,0.28953108788482673,0.005018446180555556,0.029014823436509962,0.28768207245178035,0.0,0.028972824655245866,0.29298712468147725,0.0,3.789755637709665e-07,0.29849298855599704,0.0
277,0.9,9,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Question: Stretch-sensitive KCNQ1 mutation: linking genetic and environmental elements in atrial fibrillation? Answer: Data suggest the R14C KCNQ1 mutation alone is not enough to cause AF. We propose a model where an environmental ""second hit,"" like hypertension-induced atrial stretch, unmasks an inherited ion channel kinetic defect (the ""first hit"").",3.789755637709665e-07,0.26123936622931865,0.015380859375,0.029014823436509962,0.28768207245178035,0.0,0.028972824655245866,0.29298712468147725,0.0,3.789755637709665e-07,0.29849298855599704,0.0
277,0.9,10,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Question: Does the stretch-sensitive KCNQ1 mutation link genetic predisposition and environmental triggers in atrial fibrillation? Answer: These findings suggest the R14C KCNQ1 mutation alone does not cause AF. We propose a model where a ""second hit,"" such as hypertension leading to atrial stretch, reveals an inherited ion channel kinetic defect (the ""first hit"").",2.8423167282822487e-07,0.20892424816744537,0.003480087370562133,0.02176111757738247,0.20763936477824352,0.0,0.0217296184914344,0.21130909366720996,0.0,2.8423167282822487e-07,0.21511137961694615,0.0
278,0.9,1,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors sufficient for identifying cervical spine fractures in elderly blunt trauma patients following low-energy incidents? Answer: Clinical predictors seem insufficient for assessing cervical spine injuries in geriatric trauma cases with low-energy mechanisms.,0.0,0.16309345424939803,0.10977359693877556,0.0,0.08401784006787238,0.06035379812695108,0.0,0.043321698784997587,0.031217481789802305,0.0,0.0,0.0
278,0.9,2,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Can clinical predictors reliably detect cervical spine fractures in geriatric blunt trauma patients with low-energy causes? Answer: Clinical predictors do not seem reliable for evaluating cervical spine injury in elderly trauma patients with low-energy mechanisms.,2.36859727356853e-08,0.07558566665879374,0.02947845804988669,0.0018134264647818796,0.03232407609285426,0.0017600481269510818,0.0018108015409528735,0.032084437417815526,0.0009440442898023052,2.3685972735685406e-08,0.031748698314579826,0.0
278,0.9,3,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors effective in diagnosing cervical spine fractures in elderly patients after blunt trauma with low-energy mechanisms? Answer: Clinical predictors appear to be inadequate for cervical spine assessment in geriatric trauma patients exposed to low-energy events.,7.10579182070559e-08,0.2542627390713559,0.11448979591836739,0.005440279394345632,0.17102921705750251,0.06035379812695108,0.005432404622858621,0.13293385747468456,0.031217481789802305,7.105791820705622e-08,0.09237332013101529,0.0
278,0.9,4,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Do clinical predictors adequately evaluate cervical spine fractures in geriatric blunt trauma cases following low-energy trauma? Answer: Clinical predictors are insufficient for the proper evaluation of cervical spine injuries in elderly patients with low-energy mechanisms of injury.,7.10579182070559e-08,0.2542627390713559,0.11448979591836739,0.005440279394345632,0.17102921705750251,0.06035379812695108,0.005432404622858621,0.13293385747468456,0.031217481789802305,7.105791820705622e-08,0.09237332013101529,0.0
278,0.9,5,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Is the use of clinical predictors appropriate for identifying cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors seem to fall short in assessing cervical spine trauma in geriatric patients sustaining low-energy injuries.,9.47438909427412e-08,0.28290295537274934,0.11589821113630641,0.007253705859127504,0.19842819124561784,0.06035379812695108,0.007243206163811487,0.1611047344413814,0.031217481789802305,9.474389094274162e-08,0.1213608570042668,0.0
278,0.9,6,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors adequate for assessing cervical spine fractures in geriatric blunt trauma patients with low-energy trauma? Answer: Clinical predictors are inadequate for evaluating cervical spine injuries in elderly trauma patients who experienced low-energy mechanisms.,2.36859727356853e-08,0.1548024872942162,0.08340640943877556,0.0018134264647818796,0.11387080321755416,0.06035379812695108,0.0018108015409528735,0.07409335745175127,0.031217481789802305,2.3685972735685406e-08,0.031748698314579826,0.0
278,0.9,7,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Can clinical predictors adequately detect cervical spine fractures in elderly blunt trauma patients after low-energy incidents? Answer: Clinical predictors appear insufficient for evaluating cervical spine injuries in geriatric trauma cases following low-energy trauma.,2.36859727356853e-08,0.13076937815654377,0.10801354881182448,0.0018134264647818796,0.0532461814011187,0.06035379812695108,0.0018108015409528735,0.01157300047041776,0.031217481789802305,2.3685972735685406e-08,0.0327898228229917,0.0
278,0.9,8,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors reliable for cervical spine fracture evaluation in geriatric blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors seem inadequate for the cervical spine assessment in elderly patients with low-energy blunt trauma.,0.0,0.08154672712469946,0.05281179138321998,0.0,0.042008920033936636,0.030080360626951082,0.0,0.043321698784997587,0.031217481789802305,0.0,0.0,0.0
278,0.9,9,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: How effective are clinical predictors in diagnosing cervical spine fractures in elderly patients with low-energy blunt trauma? Answer: Clinical predictors are not adequate for the evaluation of cervical spine injuries in geriatric trauma patients with low-energy mechanisms.,7.10579182070559e-08,0.1793279087405506,0.06184760405539633,0.005440279394345632,0.13252104035972767,0.03259869608613475,0.005432404622858621,0.13293385747468456,0.031217481789802305,7.105791820705622e-08,0.09237332013101529,0.0
278,0.9,10,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Do clinical predictors provide sufficient evaluation of cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors appear inadequate for the assessment of cervical spine trauma in elderly patients experiencing low-energy mechanisms.,4.73719454713706e-08,0.18627406512072175,0.08572271883960202,0.003626852929563759,0.10324992977309444,0.03180708532418292,0.003621603081905747,0.10394632060143305,0.031217481789802305,4.737194547137081e-08,0.06252035698133351,0.0
279,0.9,1,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Does interfractional motion of the prostate bed target, as defined by RTOG consensus and daily CT on rails, vary between the superior and inferior parts of the clinical target volume?",6.632072365991902e-07,0.3830653398257895,0.18513937484133736,0.05077594101389248,0.39608410317711096,0.19834710743801648,0.05070244314668032,0.43423744700416345,0.1875,6.632072365991914e-07,0.47416633055762736,0.17561983471074377
279,0.9,2,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Is there a difference in prostate bed target interfractional motion between the superior and inferior regions of the clinical target volume, according to RTOG consensus definitions and daily CT on rails?",6.395212638635049e-07,0.3013605343183876,0.21957815035154143,0.0489625145491106,0.36099278336584195,0.19834710743801648,0.04889164160572745,0.39786980283328877,0.1875,6.39521263863506e-07,0.43642600257478037,0.17561983471074377
279,0.9,3,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Using RTOG consensus definitions and daily CT on rails, does the prostate bed target show differing interfractional motion between the superior and inferior sections of the clinical target volume?",6.868932093348755e-07,0.3703534058053384,0.21957815035154143,0.05258936747867436,0.43245174734798564,0.19834710743801648,0.052513244687633194,0.47197777498701043,0.1875,6.868932093348768e-07,0.5133870437109098,0.17561983471074377
279,0.9,4,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"According to research using RTOG consensus and daily CT on rails, does interfractional motion of the prostate bed target differ between its superior and inferior portions within the clinical target volume?",6.395212638635049e-07,0.3013605343183876,0.21957815035154143,0.0489625145491106,0.36099278336584195,0.19834710743801648,0.04889164160572745,0.39786980283328877,0.1875,6.39521263863506e-07,0.43642600257478037,0.17561983471074377
279,0.9,5,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Does the interfractional motion of the prostate bed target, based on RTOG definitions and daily CT on rails, differ between superior and inferior areas of the clinical target volume?",6.868932093348755e-07,0.4198639187024775,0.18391285542698727,0.05258936747867436,0.43245174734798564,0.19834710743801648,0.052513244687633194,0.47197777498701043,0.1875,6.868932093348768e-07,0.5133870437109098,0.17561983471074377
279,0.9,6,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,Is there a variation in prostate bed target interfractional motion between the upper (superior) and lower (inferior) parts of the clinical target volume as measured by RTOG consensus and daily CT on rails?,5.921493183921343e-07,0.23682201318081608,0.21957815035154143,0.045335661619546844,0.2943014088671685,0.19834710743801648,0.0452700385238217,0.328876931346338,0.1875,5.921493183921352e-07,0.3649670385926367,0.17561983471074377
279,0.9,7,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,Research indicates that interfractional motion of the prostate bed target using RTOG consensus and daily CT on rails exhibits differences between the superior and inferior sections of the clinical target volume. Is this accurate?,5.68463345656449e-07,0.24805927454799814,0.18930471285154143,0.043522235154764964,0.26255271055258866,0.19834710743801648,0.043459236982868826,0.2960871085233463,0.1875,5.684633456564497e-07,0.3310654869169549,0.17561983471074377
279,0.9,8,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Using RTOG consensus definitions and daily CT on rails, does the clinical target volume's prostate bed target move differently in its superior portion compared to its inferior portion?",7.105791820705608e-07,0.40672104997621306,0.21957815035154143,0.05440279394345624,0.4701920753308326,0.19834710743801648,0.05432404622858607,0.5111984881402929,0.1875,7.105791820705622e-07,0.5542090382311646,0.17561983471074377
279,0.9,9,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,Does the daily CT on rails data and RTOG consensus definitions reveal distinct interfractional motion characteristics in the superior versus inferior parts of the prostate bed target within the clinical target volume?,6.158352911278196e-07,0.2685707114953959,0.21957815035154143,0.04714908808432872,0.3270912316901602,0.19834710743801648,0.04708084006477457,0.36277848302201976,0.1875,6.158352911278206e-07,0.4000583584039057,0.17561983471074377
279,0.9,10,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Can we observe a difference in interfractional motion between the superior and inferior regions of the prostate bed target within the clinical target volume, as defined by RTOG consensus and daily CT on rails?",5.68463345656449e-07,0.2060503545140624,0.21957815035154143,0.043522235154764964,0.26255271055258866,0.19834710743801648,0.043459236982868826,0.2960871085233463,0.1875,5.684633456564497e-07,0.3310654869169549,0.17561983471074377
280,0.9,1,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Can mental imagery functional magnetic resonance imaging forecast recovery in patients with consciousness disorders? Yes, this technique (fMRI) can potentially predict recovery by evaluating cognitive function and neural activity, assisting in prognosis, though more research is needed for definitive results.",4.263475092423372e-07,0.11195913096247079,0.18194706994328924,0.03264167636607371,0.16496822297163716,0.1548211860570394,0.0325944277371516,0.21997780844571357,0.12456597222222221,4.263475092423373e-07,0.2771045191155812,0.09162848812994587
280,0.9,2,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Is mental imagery functional MRI useful in predicting recovery for patients with disorders of consciousness? Indeed, it can assess brain responses and cognition to aid prognosis, but conclusive evidence awaits further study.",6.158352911278196e-07,0.3415335726069686,0.18194706994328924,0.04714908808432872,0.4013570010358687,0.1548211860570394,0.04708084006477457,0.463599891103466,0.12456597222222221,6.158352911278206e-07,0.5284189473964873,0.09162848812994587
280,0.9,3,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Does mental imagery fMRI have the ability to predict recovery in consciousness disorder patients? Yes, it shows promise by analyzing neural and cognitive function to inform outcomes, although more comprehensive research is required.",5.921493183921343e-07,0.30978487429238877,0.18194706994328924,0.045335661619546844,0.368567178212877,0.1548211860570394,0.0452700385238217,0.42969833942778424,0.12456597222222221,5.921493183921352e-07,0.4933276275852183,0.09162848812994587
280,0.9,4,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Can functional magnetic resonance imaging of mental imagery predict recovery in patients with consciousness disorders? Yes, fMRI can evaluate cognitive and neural responses to help predict recovery, but additional research is necessary for firm conclusions.",5.447773729207637e-07,0.2491602524759533,0.18194706994328924,0.041708808689983085,0.3060468212315435,0.1548211860570394,0.04164843544191595,0.3651598182902127,0.12456597222222221,5.447773729207643e-07,0.42663625308654485,0.09162848812994587
280,0.9,5,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Is it possible for mental imagery functional MRI to forecast recovery in patients with disorders of consciousness? Yes, this imaging method can assess brain function and support prognosis, yet more extensive studies are needed to confirm its reliability.",4.737194547137078e-07,0.16460286444788963,0.18194706994328924,0.03626852929563745,0.21903544424191335,0.1548211860570394,0.03621603081905733,0.27554765960052574,0.12456597222222221,4.737194547137081e-07,0.33426293295552956,0.09162848812994587
280,0.9,6,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Can mental imagery fMRI predict recovery in patients suffering from disorders of consciousness? Yes, it offers potential by measuring brain and cognitive responses to assist prognosis, although further investigation is essential.",6.395212638635049e-07,0.3743233954299603,0.18194706994328924,0.0489625145491106,0.43525855271155045,0.1548211860570394,0.04889164160572745,0.498691210914735,0.12456597222222221,6.39521263863506e-07,0.564786591567362,0.09162848812994587
280,0.9,7,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Does functional MRI using mental imagery predict recovery in patients with consciousness disorders? Yes, it can provide insights into cognitive and neural function for prognosis, but definitive claims require more research.",6.395212638635049e-07,0.3743233954299603,0.18194706994328924,0.0489625145491106,0.43525855271155045,0.1548211860570394,0.04889164160572745,0.498691210914735,0.12456597222222221,6.39521263863506e-07,0.564786591567362,0.09162848812994587
280,0.9,8,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Can mental imagery-based functional MRI serve as a predictive tool for recovery in consciousness disorder patients? Yes, it helps in assessing neural and cognitive status to aid prognosis, yet conclusive outcomes depend on additional research.",5.447773729207637e-07,0.2491602524759533,0.18194706994328924,0.041708808689983085,0.3060468212315435,0.1548211860570394,0.04164843544191595,0.3651598182902127,0.12456597222222221,5.447773729207643e-07,0.42663625308654485,0.09162848812994587
280,0.9,9,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Is mental imagery functional MRI capable of predicting recovery in patients with disorders of consciousness? Yes, by evaluating cognitive and neural responses, it aids prognosis, but more comprehensive research is necessary for certainty.",5.921493183921343e-07,0.30978487429238877,0.18194706994328924,0.045335661619546844,0.368567178212877,0.1548211860570394,0.0452700385238217,0.42969833942778424,0.12456597222222221,5.921493183921352e-07,0.4933276275852183,0.09162848812994587
280,0.9,10,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Can recovery in patients with disorders of consciousness be predicted by mental imagery functional MRI? Yes, this modality can evaluate brain and cognitive functions to assist in prognosis, though further studies are required for definitive conclusions.",5.210914001850784e-07,0.2201727156027018,0.18194706994328924,0.039895382225201205,0.2761938580818617,0.1548211860570394,0.03983763390096308,0.334388159623459,0.12456597222222221,5.210914001850789e-07,0.394887554771965,0.09162848812994587
281,0.9,1,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Question: Does case-mix reimbursement encourage the advancement of process-oriented healthcare delivery? Answer: This research shows that hospital management can promote care program development by incorporating case-mix reimbursement into hospital budgeting. Further studies are suggested to validate this result and to examine whether care program implementation will eventually...,2.3685972735685406e-07,0.13320767987798465,0.04503909812182854,0.018134264647818726,0.12505463940106631,0.05436390532544379,0.018108015409528666,0.17912229484749664,0.01851192595229618,2.3685972735685406e-07,0.2090917978585587,0.0
281,0.9,2,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Question: Is process-oriented care delivery fostered by case-mix based reimbursement? Answer: Findings indicate that hospital administrators can drive care program development by applying case-mix reimbursement within hospital budgets. Additional research should be conducted to confirm these outcomes and to assess if care programs will ultimately...,2.8423167282822487e-07,0.11738577457403965,0.08842752787389466,0.02176111757738247,0.17051701347782355,0.05436390532544379,0.0217296184914344,0.22564231048239058,0.01851192595229618,2.8423167282822487e-07,0.2567198468478131,0.0
281,0.9,3,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Question: Can case-mix reimbursement stimulate the creation of process-focused care? Answer: The study reveals that adopting case-mix reimbursement in hospital budgeting can incentivize management to develop care programs. Future investigations are needed to corroborate this and to evaluate whether care programs will over time...,3.079176455639103e-07,0.17261469654571338,0.06518489748840714,0.023574544042164344,0.19404751088801797,0.05436390532544379,0.023540420032387266,0.2497398620614506,0.01851192595229618,3.079176455639103e-07,0.2814124594381848,0.0
281,0.9,4,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Question: Does using case-mix reimbursement promote process-oriented healthcare program development? Answer: This study highlights that hospital management can encourage program development by integrating case-mix reimbursement into budgeting strategies. Further research is necessary to confirm these findings and to determine if care programs will eventually...,3.079176455639103e-07,0.17261469654571338,0.06518489748840714,0.023574544042164344,0.19404751088801797,0.05436390532544379,0.023540420032387266,0.2497398620614506,0.01851192595229618,3.079176455639103e-07,0.2814124594381848,0.0
281,0.9,5,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Question: Is the development of process-based care influenced by case-mix reimbursement? Answer: Evidence from the study suggests hospital management fosters care programs by adopting case-mix reimbursement in their budgets. Subsequent studies are recommended to validate this and to explore whether care programs will in due course...,2.6054570009253947e-07,0.12571946008020163,0.06621678407224177,0.0199476911126006,0.14752749525312403,0.05436390532544379,0.019918816950481533,0.20211181307219617,0.01851192595229618,2.6054570009253947e-07,0.2326222952687531,0.0
281,0.9,6,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Question: Does case-mix reimbursement drive the advancement of process-centered care delivery? Answer: The research demonstrates that hospital leaders can stimulate care program creation through case-mix reimbursement in budgeting processes. Further inquiry is advised to confirm this effect and to see if care programs will ultimately...,2.8423167282822487e-07,0.14889246459949224,0.06571254680304554,0.02176111757738247,0.17051701347782355,0.05436390532544379,0.0217296184914344,0.22564231048239058,0.01851192595229618,2.8423167282822487e-07,0.2567198468478131,0.0
281,0.9,7,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Question: Can the introduction of case-mix reimbursement encourage process-oriented care structures? Answer: Findings show hospital management can promote care initiatives by using case-mix reimbursement in financial planning. Future research is needed to validate this and to ascertain if these programs will in time...,3.316036182995957e-07,0.19691279880702517,0.0646321679690761,0.025387970506946217,0.218145062467078,0.05436390532544379,0.025351221573340132,0.2744324746518223,0.01851192595229618,3.316036182995957e-07,0.30673026742247655,0.0
281,0.9,8,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Question: Does case-mix based reimbursement support the development of process-oriented healthcare delivery? Answer: The study indicates that hospital administrators can foster care program growth by adopting case-mix reimbursement within budget management. Additional research is recommended to confirm this and to study whether care programs will eventually...,2.6054570009253947e-07,0.09491291872198193,0.08842752787389466,0.0199476911126006,0.14752749525312403,0.05436390532544379,0.019918816950481533,0.20211181307219617,0.01851192595229618,2.6054570009253947e-07,0.2326222952687531,0.0
281,0.9,9,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Question: How does case-mix reimbursement impact the development of process-oriented care? Answer: This study finds that hospital management can encourage care program development by integrating case-mix reimbursement into budgeting procedures. Further research is necessary to verify this and to determine if care programs will eventually...,2.8423167282822487e-07,0.14889246459949224,0.06571254680304554,0.02176111757738247,0.17051701347782355,0.05436390532544379,0.0217296184914344,0.22564231048239058,0.01851192595229618,2.8423167282822487e-07,0.2567198468478131,0.0
281,0.9,10,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Question: Will case-mix reimbursement promote the development of process-focused care delivery? Answer: The research suggests that hospital leadership can stimulate care program development by incorporating case-mix reimbursement into budgeting processes. Further studies are recommended to confirm these findings and to see whether care programs will in the future...,2.1317375462116866e-07,0.08092343148692205,0.06716098723117256,0.016320838183036854,0.10307573268229131,0.05436390532544379,0.0162972138685758,0.15664943899543893,0.01851192595229618,2.1317375462116866e-07,0.18610227963385917,0.0
282,0.9,1,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Does glomerular hyperfiltration during pregnancy harm the kidneys of women with multiple pregnancies? Glomerular hyperfiltration is a typical physiological change in pregnancy and usually does not damage kidneys in women with higher parity. However, in women with existing kidney diseases, this increased filtration might worsen their condition. Therefore, routine monitoring is advised.",0.0,0.037442009899695705,0.061822728044364006,0.0,0.02772588722239755,0.019938885418112832,0.0,0.028291721655508084,0.020399305555555556,0.0,0.0,0.0
282,0.9,2,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Is kidney damage from glomerular hyperfiltration more common in pregnant women with many children? Glomerular hyperfiltration is a normal adaptation in pregnancy and generally doesn't harm the kidneys even in women with multiple births. But for those with prior kidney issues, the elevated filtration can worsen their state. Regular check-ups are recommended in such cases.",7.105791820705622e-08,0.08736090536761587,0.021611501479289946,0.005440279394345618,0.1137206825687711,0.039930555555555566,0.0054324046228586,0.08771514212630915,0.020399305555555556,7.105791820705622e-08,0.06062462181643413,0.0
282,0.9,3,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","In women with many pregnancies, does glomerular hyperfiltration during pregnancy cause kidney damage? While glomerular hyperfiltration is a normal pregnancy response that usually doesn't damage kidneys, women with pre-existing kidney disease may experience aggravated conditions due to increased filtration rates. Hence, ongoing monitoring is important.",1.6580180914979784e-07,0.12910265173226865,0.013242276077097506,0.012693985253473108,0.09537111528978759,0.039930555555555566,0.012675610786670066,0.12585895817175086,0.020399305555555556,1.6580180914979784e-07,0.1576289442035832,0.0
282,0.9,4,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Does the increased glomerular filtration in pregnant women with multiple parities cause renal damage? This hyperfiltration is a standard physiological change in pregnancy and typically does not lead to kidney injury in women with more pregnancies. But if kidney disease is present beforehand, the higher filtration could worsen it, so regular assessment is necessary.",4.737194547137081e-08,0.09385651057287436,0.03973280325443787,0.0036268529295637453,0.094672487598078,0.039930555555555566,0.003621603081905733,0.06829705626920646,0.020399305555555556,4.737194547137081e-08,0.04082199452025437,0.0
282,0.9,5,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Can glomerular hyperfiltration during pregnancy cause kidney damage in women having many pregnancies? Though it is a common and normal adaptation in pregnancy, glomerular hyperfiltration usually doesn’t harm kidneys. However, in women with existing renal issues, the increased filtration rate might exacerbate the problem, making routine monitoring crucial.",9.474389094274162e-08,0.059122553298924796,0.01612461419753087,0.0072537058591274906,0.027929834494255346,0.039930555555555566,0.007243206163811466,0.0568660866847992,0.020399305555555556,9.474389094274162e-08,0.08701137698962924,0.0
282,0.9,6,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Is there kidney harm from glomerular hyperfiltration during pregnancy in women with multiple children? Glomerular hyperfiltration happens normally in pregnancy and typically doesn’t cause kidney damage, even with more parities. Yet, in cases of pre-existing kidney disease, the increased rate of filtration may aggravate the condition, thus regular evaluation is suggested.",2.3685972735685406e-08,0.0340182126061217,0.038602079862557266,0.0018134264647818726,0.035249067127276934,0.039930555555555566,0.0018108015409528666,0.007672434452772325,0.020399305555555556,2.3685972735685406e-08,0.02105340919783316,0.0
282,0.9,7,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Does pregnancy-related glomerular hyperfiltration damage kidneys in women with numerous pregnancies? This condition is a normal adaptation and generally does not cause renal injury in multiparous women. However, if kidney disease exists prior to pregnancy, the elevated filtration may worsen it, so routine surveillance is recommended.",1.4211583641411244e-07,0.0436164158293062,0.05859375,0.010880558788691236,0.07238159706508807,0.039930555555555566,0.0108648092457172,0.10232846076155644,0.020399305555555556,1.4211583641411244e-07,0.13353139262452318,0.0
282,0.9,8,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Does the kidney sustain damage from glomerular hyperfiltration in pregnant women with higher parity? Glomerular hyperfiltration is a typical physiological change during pregnancy and typically does not cause kidney damage in women with more pregnancies. But the presence of pre-existing kidney disease might be worsened by the increased filtration rate, warranting regular monitoring.",2.3685972735685406e-08,0.04764579909257538,0.02019374999999999,0.0018134264647818726,0.07525440174097531,0.039930555555555566,0.0018108015409528666,0.04849442897302669,0.020399305555555556,2.3685972735685406e-08,0.02061928720273576,0.0
282,0.9,9,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Does the increased glomerular filtration during pregnancy threaten kidney health in women with multiple births? While glomerular hyperfiltration is a normal adaptation in pregnancy not normally harmful to kidneys, women with existing kidney problems may experience deterioration due to the heightened filtration, thus continuous checks are advised.",1.1842986367842703e-07,0.051774343047919835,0.0368653549382716,0.009067132323909363,0.04990874121303035,0.039930555555555566,0.009054007704764333,0.07933894253685692,0.020399305555555556,1.1842986367842703e-07,0.11000089521432876,0.0
282,0.9,10,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Is kidney damage a risk from glomerular hyperfiltration in pregnancy among women with many parities? Glomerular hyperfiltration is a common physiological change in pregnancy that usually does not lead to kidney damage. Nevertheless, in women with pre-existing kidney conditions, the increased filtration can aggravate these, highlighting the importance of routine monitoring.",2.3685972735685406e-08,0.0214335618386734,0.001161795495699433,0.0018134264647818726,0.035249067127276934,0.039930555555555566,0.0018108015409528666,0.007672434452772325,0.020399305555555556,2.3685972735685406e-08,0.02105340919783316,0.0
283,0.9,1,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Does septoplasty alter the size of compensatory hypertrophy of the middle turbinate? Septoplasty, a surgery to fix a deviated septum, does not directly affect the size of the compensatory hypertrophy of the middle turbinate.",2.36859727356853e-08,0.013584499244938097,0.06065088757396456,0.0018134264647818796,0.09000398643081198,0.07429658253834076,0.0018108015409528735,0.13874314851669745,0.11330551822639996,2.3685972735685406e-08,0.14459622983643516,0.12203174580838533
283,0.9,2,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle",Can septoplasty modify the dimensions of compensatory hypertrophy of the middle turbinate? The surgical correction of a deviated septum via septoplasty does not directly change the size of the middle turbinate's compensatory hypertrophy.,4.73719454713706e-08,0.17891888911236808,0.15079552925706766,0.003626852929563759,0.18682291031686837,0.16452333990795528,0.003621603081905747,0.19539167157240822,0.17751479289940827,4.737194547137081e-08,0.15690449019808295,0.15532544378698224
283,0.9,3,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Is the size of compensatory hypertrophy in the middle turbinate affected by septoplasty? Septoplasty, which corrects a deviated septum, does not directly alter the dimensions of compensatory hypertrophy in the middle turbinate.",7.10579182070559e-08,0.010217723671026135,0.057692307692307654,0.005440279394345639,0.013913012283909065,0.06656804733727806,0.005432404622858621,0.018080358401566077,0.0754437869822485,7.105791820705622e-08,0.022792144592535202,0.08431952662721891
283,0.9,4,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Does undergoing septoplasty impact the compensatory hypertrophy size of the middle turbinate? Septoplasty, as a procedure to correct a deviated septum, does not directly modify the dimensions of compensatory hypertrophy of the middle turbinate.",2.36859727356853e-08,0.17030718524730792,0.12301775147928985,0.0018134264647818796,0.21996908278580163,0.1655280803403752,0.0018108015409528735,0.22818149439539992,0.17751479289940827,2.3685972735685406e-08,0.1908060418737647,0.15532544378698224
283,0.9,5,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle",Does septoplasty influence the dimension changes in compensatory hypertrophy of the middle turbinate? The surgical procedure aimed at fixing a deviated septum does not have a direct effect on the size of compensatory hypertrophy in the middle turbinate.,7.10579182070559e-08,0.3358094661960558,0.15914020045888172,0.005440279394345632,0.38107381722718303,0.1967455621301775,0.005432404622858621,0.3495423513996667,0.17751479289940827,7.105791820705622e-08,0.3159691848277717,0.15532544378698224
283,0.9,6,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Can the dimensions of compensatory hypertrophy of the middle turbinate be changed by septoplasty? Septoplasty, performed to correct a deviated septum, does not directly change the size of the compensatory hypertrophy of the middle turbinate.",0.0,0.10693043939985714,0.0013649571867810073,0.0,0.16803568013574477,0.10674556213017745,0.0,0.17328679513998546,0.11529257067718604,0.0,0.1788766917574054,0.12310322156476003
283,0.9,7,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle",Does the surgical septoplasty procedure alter the size of compensatory hypertrophy in the middle turbinate? Septoplasty does not directly affect the dimensions of compensatory hypertrophy in the middle turbinate.,1.421158364141118e-07,0.11552167042785477,0.04288542633751291,0.010880558788691277,0.11198519761272951,0.05307826534378812,0.010864809245717241,0.1076662137359432,0.06409324280489033,1.4211583641411244e-07,0.10241906380978216,0.07593035872081964
283,0.9,8,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Is compensatory hypertrophy of the middle turbinate dimensionally changed by septoplasty? Septoplasty, a surgery to correct septal deviation, does not directly change the dimensions of such hypertrophy.",1.894877818854824e-07,0.05792292190411841,0.2130177514792899,0.014507411718255037,0.016430703639272792,0.1967455621301775,0.014486412327622988,0.02775187974180149,0.17751479289940827,1.8948778188548325e-07,0.07489712385924063,0.15532544378698224
283,0.9,9,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Will septoplasty affect the size of compensatory hypertrophy in the middle turbinate? Septoplasty, intended to correct a deviated septum, does not directly affect the size of the hypertrophied middle turbinate.",1.184298636784265e-07,0.0237124523739487,0.11094674556213012,0.009067132323909398,0.030738363151998183,0.12573964497041418,0.009054007704764368,0.0386869203175495,0.14053254437869822,1.1842986367842703e-07,0.04770519823309227,0.15532544378698224
283,0.9,10,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle",Does performing septoplasty result in dimensional changes to compensatory hypertrophy of the middle turbinate? The procedure of septoplasty for correcting septal deviation does not directly modify the size of the compensatory hypertrophy in the middle turbinate.,2.36859727356853e-08,0.23634921441891565,0.1280568139792899,0.0018134264647818796,0.3239154033872347,0.1967455621301775,0.0018108015409528735,0.29070185137673343,0.17751479289940827,2.3685972735685406e-08,0.25534456301133623,0.15532544378698224
284,0.9,1,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Does premature aging affect Indigenous Australians? Studies suggest that Indigenous Australians might face some age-associated health problems sooner than non-Indigenous populations, influenced by socio-economic conditions, lifestyle choices, and healthcare availability. However, this does not definitively imply premature aging.",1.4211583641411212e-07,0.1180427993023625,0.023242630385487524,0.010880558788691236,0.1541506798272576,0.0,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
284,0.9,2,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Is premature aging a concern for Indigenous Australians? Research shows that Indigenous Australians could encounter age-related health issues earlier than their non-Indigenous counterparts, largely due to socio-economic status, lifestyle, and healthcare access. Nonetheless, this should not be interpreted as them aging prematurely.",4.737194547137081e-08,0.01538864524228023,0.023242630385487524,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
284,0.9,3,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Are Indigenous Australians prone to premature aging? Evidence points to Indigenous Australians experiencing certain health issues related to aging earlier than non-Indigenous Australians because of factors like socio-economic challenges, lifestyle, and healthcare access. Still, this does not confirm premature aging.",9.474389094274152e-08,0.10094507507642758,0.00238063831257343,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
284,0.9,4,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Do Indigenous Australians exhibit signs of aging earlier than others? Research indicates that some age-related health conditions might appear earlier among Indigenous Australians compared to non-Indigenous Australians, attributable to socio-economic, lifestyle, and healthcare disparities. However, this does not necessarily equate to premature aging.",2.3685972735685406e-08,0.024298102261311794,0.0005527295193310314,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
284,0.9,5,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Is there premature aging among Indigenous Australians? Studies highlight that Indigenous Australians may develop certain age-related health problems sooner than non-Indigenous groups, influenced by socio-economic, lifestyle, and healthcare factors. But this does not automatically mean they undergo premature aging.",1.1842986367842682e-07,0.09137455222020163,0.023242630385487524,0.009067132323909363,0.1267517056391423,0.0,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
284,0.9,6,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Do Indigenous Australians age faster than non-Indigenous Australians? Research suggests Indigenous Australians could experience certain age-related health issues earlier, due to socio-economic disadvantages, lifestyle factors, and healthcare access issues. It's important to clarify that this does not imply they age prematurely.",7.105791820705622e-08,0.07473861686064831,0.0017409330596143968,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
284,0.9,7,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Are age-related health issues appearing earlier in Indigenous Australians? Findings suggest that Indigenous Australians might face such conditions earlier than non-Indigenous Australians because of socio-economic, lifestyle, and healthcare access factors. This, however, does not confirm premature aging.",1.6580180914979742e-07,0.14544177349047782,0.023242630385487524,0.012693985253473108,0.18232155679395445,0.0,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
284,0.9,8,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Is premature aging observed in Indigenous Australians? Studies indicate some age-associated health problems may arise earlier in Indigenous Australians compared to non-Indigenous Australians, influenced by socio-economic status, lifestyle, and healthcare availability. Yet, this does not mean they age prematurely.",1.1842986367842682e-07,0.12785598277598798,0.0030539364516198493,0.009067132323909363,0.1267517056391423,0.0,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
284,0.9,9,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Do Indigenous Australians experience early onset of age-related health problems? Research points to Indigenous Australians encountering these issues earlier than their non-Indigenous peers due to socio-economic factors, lifestyle, and healthcare access. Still, this should not be taken as definitive evidence of premature aging.",2.3685972735685406e-08,0.024298102261311794,0.0005527295193310314,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
284,0.9,10,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Are Indigenous Australians aging prematurely? Research reveals that due to socio-economic conditions, lifestyle, and healthcare access, Indigenous Australians may develop certain age-related health problems earlier than non-Indigenous people. However, this does not necessarily indicate premature aging.",1.8948778188548272e-07,0.2132210607748859,0.005304082417280635,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
285,0.9,1,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Is there disagreement between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Yes, differences often exist due to variations in training, interpretation abilities, and communication issues, with clinicians potentially missing subtle changes that experienced pathologists detect.",4.974054274493934e-07,0.22283876192447272,0.14532871972318342,0.038081955760419325,0.27547568201256567,0.11649408284023667,0.0380268323600102,0.33001696332289177,0.08543965824136704,4.974054274493935e-07,0.38656946826686633,0.05246913580246911
285,0.9,2,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Do clinical pathologists and clinicians differ in how they report and interpret red blood cell morphology? Indeed, discordance can occur because of differing expertise, interpretive skills, and communication gaps, leading to clinicians sometimes misreading or missing nuances noted by pathologists.",4.974054274493934e-07,0.22283876192447272,0.14532871972318342,0.038081955760419325,0.27547568201256567,0.11649408284023667,0.0380268323600102,0.33001696332289177,0.08543965824136704,4.974054274493935e-07,0.38656946826686633,0.05246913580246911
285,0.9,3,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Is there a mismatch between clinical pathologists and clinicians when it comes to reporting and interpreting red blood cell morphology? Yes, such differences are common, often arising from disparities in training, interpretation proficiency, and communication challenges, where clinicians might overlook subtle details seen by pathologists.",3.789755637709665e-07,0.10221077413585533,0.14532871972318342,0.029014823436509962,0.15186172604538983,0.11649408284023667,0.028972824655245866,0.20326525768374948,0.08543965824136704,3.789755637709665e-07,0.25651634001866874,0.05246913580246911
285,0.9,4,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Are clinical pathologists and clinicians aligned in their reporting and interpretation of red blood cell morphology? Often not; discordance arises due to variations in training, interpretation skills, and communication barriers, with clinicians possibly missing subtle indicators identified by experienced pathologists.",4.974054274493934e-07,0.22283876192447272,0.14532871972318342,0.038081955760419325,0.27547568201256567,0.11649408284023667,0.0380268323600102,0.33001696332289177,0.08543965824136704,4.974054274493935e-07,0.38656946826686633,0.05246913580246911
285,0.9,5,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Do clinical pathologists and clinicians often disagree on red blood cell morphology interpretation and reporting? Yes, this discordance frequently results from differences in education, interpretive expertise, and communication, with clinicians sometimes failing to notice subtle morphological changes detected by pathologists.",4.974054274493934e-07,0.22283876192447272,0.14532871972318342,0.038081955760419325,0.27547568201256567,0.11649408284023667,0.0380268323600102,0.33001696332289177,0.08543965824136704,4.974054274493935e-07,0.38656946826686633,0.05246913580246911
285,0.9,6,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Is there frequently discordance between clinical pathologists and clinicians in interpreting red blood cell morphology? Yes, due to differences in training, interpretative skills, and communication, clinicians may misinterpret or miss subtle changes that pathologists would recognize.",5.921493183921346e-07,0.3310523465647037,0.14532871972318342,0.04533566161954682,0.3867013171227902,0.11649408284023667,0.04527003852382168,0.4444273145006372,0.08543965824136704,5.921493183921352e-07,0.5043525039232502,0.05246913580246911
285,0.9,7,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Are clinical pathologists and clinicians consistent in reporting and interpreting red blood cell morphology? Not always; discrepancies often arise from distinct training backgrounds, interpretation capabilities, and communication, leading clinicians to occasionally overlook subtle changes that pathologists would identify.",5.44777372920764e-07,0.27548249540989156,0.14532871972318342,0.04170880868998307,0.32954290328284186,0.11649408284023667,0.04164843544191593,0.38558681447770393,0.08543965824136704,5.447773729207643e-07,0.4437278821068147,0.05246913580246911
285,0.9,8,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Does discordance exist between clinicians and clinical pathologists regarding red blood cell morphology reporting? Yes, often caused by divergent training, interpretational skills, and communication gaps, with clinicians sometimes missing subtle morphological signs noticed by pathologists.",6.158352911278199e-07,0.36003988343795523,0.14532871972318342,0.0471490880843287,0.416554280272472,0.11649408284023667,0.04708084006477455,0.4751989731673909,0.08543965824136704,6.158352911278206e-07,0.53610120223783,0.05246913580246911
285,0.9,9,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Is there a difference between clinical pathologists and clinicians in the interpretation and reporting of red blood cell morphology? Yes, discordance can occur frequently because of varied training, skill levels, and communication, with clinicians potentially failing to catch subtle changes a pathologist would.",4.263475092423373e-07,0.14873078977074927,0.14532871972318342,0.03264167636607371,0.19948977503464427,0.11649408284023667,0.0325944277371516,0.2520554218531812,0.08543965824136704,4.263475092423373e-07,0.30652676059333217,0.05246913580246911
285,0.9,10,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Are clinical pathologists and clinicians often discordant in reporting and interpreting red blood cell morphology? Yes, such discordance stems from differences in education, interpretive skills, and communication lapses, where clinicians might miss subtle clues that a trained pathologist would observe.",4.974054274493934e-07,0.22283876192447272,0.14532871972318342,0.038081955760419325,0.27547568201256567,0.11649408284023667,0.0380268323600102,0.33001696332289177,0.08543965824136704,4.974054274493935e-07,0.38656946826686633,0.05246913580246911
286,0.9,1,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Question: Does a lower fasting plasma glucose at the time of type 2 diabetes diagnosis correlate with better clinical outcomes? Answer: Individuals diagnosed with type 2 diabetes exhibiting lower baseline blood glucose, possibly indicating an earlier disease stage, tend to experience fewer adverse health events despite comparable progression in glycemic levels. Because many of these patients show no symptoms at diagnosis, proactive case identification is important.",2.1317375462116866e-07,0.15589088094624604,0.004927073710142494,0.016320838183036854,0.15509440075506564,0.0025545197502869436,0.0162972138685758,0.15415067982725983,0.0,2.1317375462116866e-07,0.1568424714929706,0.0
286,0.9,2,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Question: Is there a link between lower fasting plasma glucose levels at type 2 diabetes diagnosis and improved patient outcomes? Answer: Patients with type 2 diabetes who have lower initial blood glucose, suggesting earlier disease onset, demonstrate fewer negative clinical outcomes even though their glycemic progression is similar. Since most of these patients are asymptomatic when diagnosed, active case detection is crucial.",1.1842986367842703e-07,0.08958041220022217,0.0029160849274268985,0.009067132323909363,0.0891118229913257,0.0015137042199295445,0.009054007704764333,0.08855339734144341,0.0,1.1842986367842703e-07,0.09015109699429802,0.0
286,0.9,3,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Question: Are reduced fasting plasma glucose readings at the diagnosis of type 2 diabetes associated with better health outcomes? Answer: People diagnosed with type 2 diabetes at a stage with lower blood sugar levels, likely earlier in disease development, show fewer adverse clinical events despite having comparable glycemic progression. Given that most are asymptomatic upon diagnosis, active case finding is important.",9.474389094274162e-08,0.07229357234676037,0.0023715969459572536,0.0072537058591274906,0.07191309609835717,0.0012314688405761602,0.007243206163811466,0.07145896398214369,0.0,9.474389094274162e-08,0.07275935428242919,0.0
286,0.9,4,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Question: Do lower fasting plasma glucose values at the time of type 2 diabetes diagnosis predict improved clinical outcomes? Answer: Individuals who present with type 2 diabetes and lower initial glycemia, possibly indicating an early phase of the disease, experience fewer harmful outcomes even with similar glycemic progression. Since most are symptom-free at diagnosis, active case identification is recommended.",4.737194547137081e-08,0.036798578876688914,0.0012265194143500774,0.0036268529295637453,0.036602480918583424,0.0006373176842753465,0.003621603081905733,0.036367644170874236,0.0,4.737194547137081e-08,0.037041271680350096,0.0
286,0.9,5,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Question: Is lower fasting plasma glucose at diagnosis linked to better outcomes in type 2 diabetes? Answer: People with type 2 diabetes who have lower baseline glucose levels, suggesting earlier disease stage, suffer fewer adverse health consequences despite similar progression in blood sugar. Because the majority are asymptomatic at diagnosis, proactive case detection is essential.",4.737194547137081e-08,0.012529249072251503,0.017153368972257988,0.0036268529295637453,0.011835919659988203,0.0181755829903978,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
286,0.9,6,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Question: Are initial lower fasting plasma glucose levels in type 2 diabetes diagnosis related to improved clinical outcomes? Answer: Patients diagnosed with type 2 diabetes at lower blood glucose levels, indicating a possible early stage of disease, face fewer negative clinical outcomes although their glycemic progression matches others. Most such patients are asymptomatic at diagnosis, highlighting the need for active case finding.",1.1842986367842703e-07,0.08958041220022217,0.0029160849274268985,0.009067132323909363,0.0891118229913257,0.0015137042199295445,0.009054007704764333,0.08855339734144341,0.0,1.1842986367842703e-07,0.09015109699429802,0.0
286,0.9,7,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Question: Does a lower fasting plasma glucose at type 2 diabetes diagnosis correlate with improved patient prognosis? Answer: Individuals with type 2 diabetes presenting lower initial glycemic levels, suggesting early disease course, have fewer adverse clinical outcomes even while experiencing similar glycemic progression. As most are asymptomatic when diagnosed, active case detection is vital.",7.105791820705622e-08,0.057862259045130315,0.002012521299974847,0.005440279394345618,0.05754362157529469,0.001047792634361909,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
286,0.9,8,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Question: Are decreased fasting plasma glucose levels at the point of type 2 diabetes diagnosis associated with better health outcomes? Answer: Those diagnosed with type 2 diabetes with initially lower glycemia—likely earlier in the disease—show fewer adverse clinical events despite having comparable glycemic progression. Since most are asymptomatic upon diagnosis, proactive case finding is important.",4.737194547137081e-08,0.03820136687076836,0.0013169535961558843,0.0036268529295637453,0.037992417039609094,0.0006853637551643317,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
286,0.9,9,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Question: Is the presence of lower fasting plasma glucose at type 2 diabetes diagnosis indicative of improved outcomes? Answer: People presenting with lower initial blood glucose at diabetes diagnosis, possibly earlier in the disease, experience fewer negative clinical outcomes even though glycemic progression is similar. Because most such individuals are asymptomatic at diagnosis, active case detection is necessary.",2.3685972735685406e-08,0.04288913629268265,0.018127029618431715,0.0018134264647818726,0.043223857523040365,0.0181755829903978,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
286,0.9,10,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Question: Are lower fasting plasma glucose levels at the diagnosis of type 2 diabetes associated with better outcomes? Answer: Patients with type 2 diabetes who have lower initial blood glucose, potentially indicating an earlier disease phase, show fewer adverse clinical outcomes despite similar glycemic progression rates. Since most are asymptomatic at diagnosis, active case finding is crucial.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
287,0.9,1,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Are there differences in body image perception among parents, their children, and the children’s doctors? Answer: Numerous children rated their overweight status lower than it actually was. This misjudgment was also common among their parents and the physicians treating them. The study highlights the importance of improving physician education to better identify obesity and overweight conditions, enabling them to advise children and families effectively.",2.1317375462116866e-07,0.15509440075506564,0.0025545197502869436,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
287,0.9,2,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: How do parents, their children, and their physicians perceive body image—do their views differ? Answer: Many children underestimated how overweight they were, a misconception also shared by their parents and physicians. The findings emphasize the necessity of educating doctors to better recognize excess weight and obesity to provide better guidance to children and their families.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
287,0.9,3,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Do parents, their kids, and the kids’ doctors have different perceptions of body image? Answer: A large number of children failed to accurately assess their overweight status. This mistaken view was also prevalent among their parents and their health care providers. The research underscores the need for enhanced physician training to detect overweight and obesity so they can effectively counsel children and families.",1.8948778188548325e-07,0.16100689317942596,0.0181755829903978,0.014507411718254981,0.13815033848081626,0.0,0.014486412327622933,0.1405819506211894,0.0,1.8948778188548325e-07,0.14310084364067155,0.0
287,0.9,4,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Are body image perceptions different among parents, children, and pediatricians? Answer: Many children underestimated their overweight condition, and both their parents and physicians often shared this misunderstanding. This study shows the necessity of educating physicians more thoroughly to identify obesity and overweight, allowing better counseling for children and their families.",1.1842986367842703e-07,0.07010482778396376,0.0181755829903978,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
287,0.9,5,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Do parents, their children, and children’s physicians differ in their perception of body image? Answer: Many children did not recognize the extent of their overweight status, a misconception also held by their parents and their doctors. The study highlights the importance of further training physicians to properly identify obesity and overweight in order to advise children and families accordingly.",9.474389094274162e-08,0.09540961069360954,0.0181755829903978,0.0072537058591274906,0.07145896398214369,0.0,0.007243206163811466,0.07275935428242919,0.0,9.474389094274162e-08,0.07410797215372167,0.0
287,0.9,6,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Is body image perception different among children, their parents, and their physicians? Answer: Numerous children underestimated how overweight they were, and this same misperception was shared by their parents and doctors. The study points to the need for more comprehensive education of physicians to accurately recognize overweight and obesity and support counseling for children and families.",2.3685972735685406e-08,0.043223857523040365,0.0181755829903978,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
287,0.9,7,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Do parents, children, and children's physicians see body image differently? Answer: Many children underestimated their overweight levels, and their parents along with their attending physicians shared this incorrect perception. This research stresses the need for physician education to improve identification of obesity and overweight to better counsel children and their families.",9.474389094274162e-08,0.07748444286268352,0.0014244170096021948,0.0072537058591274906,0.07696104113612989,0.0,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
287,0.9,8,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: How do perceptions of body image vary among children, their parents, and pediatricians? Answer: A majority of children underestimated their degree of overweight, a misperception also common among their parents and physicians. This study highlights the necessity of further educating doctors to recognize obesity and overweight more effectively so they can guide children and families.",0.0,0.025205352020361893,0.0181755829903978,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
287,0.9,9,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Are there discrepancies in body image perception between children, their parents, and their physicians? Answer: Many children did not fully acknowledge their overweight status, and similar misunderstandings existed among their parents and doctors. The findings indicate a need to better educate physicians to identify obesity and overweight in order to properly counsel children and their families.",2.3685972735685406e-08,0.01846860107447057,0.0003243433209763093,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
287,0.9,10,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Do parents, their children, and the children’s doctors perceive body shape differently? Answer: Many children underestimated their overweight condition, which was also a common misperception among parents and physicians. This study demonstrates a critical need for enhanced physician training to accurately identify obesity and overweight, enabling them to counsel children and families effectively.",4.737194547137081e-08,0.011835919659988203,0.0181755829903978,0.0036268529295637453,0.03774032798284743,0.0,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
288,0.9,1,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is it justifiable to screen risk groups for coeliac disease? Yes, screening is warranted as it facilitates early diagnosis and management, thereby preventing complications such as malnutrition, osteoporosis, and lymphoma. Individuals with family history, type 1 diabetes, Down syndrome, or other autoimmune disorders are particularly considered.",9.474389094274162e-08,0.05630079993723269,0.10072314049586772,0.0072537058591274906,0.028513153103694844,0.08264462809917357,0.007243206163811466,0.0004606119024601618,0.06353305785123965,9.474389094274162e-08,0.030698110330948936,0.043388429752066124
288,0.9,2,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Should coeliac disease screening be conducted in high-risk groups? Indeed, it is justified because early detection allows timely treatment, reducing risks of malnutrition, osteoporosis, and lymphoma. Those with relatives affected, type 1 diabetes, Down syndrome, or other autoimmune conditions are primarily targeted.",1.8948778188548325e-07,0.03678962312877898,0.10072314049586772,0.014507411718254981,0.06679702670063081,0.08264462809917357,0.014486412327622933,0.09809908146637802,0.06353305785123965,1.8948778188548325e-07,0.13078156888793036,0.043388429752066124
288,0.9,3,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is screening for coeliac disease appropriate in at-risk populations? Yes, it is justified since it promotes early identification and intervention, helping to avoid complications like malnutrition, osteoporosis, and lymphoma. People with a family history, type 1 diabetes, Down syndrome, or other autoimmune diseases are especially included.",9.474389094274162e-08,0.05630079993723269,0.10072314049586772,0.0072537058591274906,0.028513153103694844,0.08264462809917357,0.007243206163811466,0.0004606119024601618,0.06353305785123965,9.474389094274162e-08,0.030698110330948936,0.043388429752066124
288,0.9,4,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is coeliac disease screening justified among risk groups? Yes, screening is advised to enable early diagnosis and treatment, preventing issues such as malnutrition, osteoporosis, and lymphoma. Individuals with family history, type 1 diabetes, Down syndrome, or other autoimmune conditions should be prioritized.",1.8948778188548325e-07,0.03678962312877898,0.10072314049586772,0.014507411718254981,0.06679702670063081,0.08264462809917357,0.014486412327622933,0.09809908146637802,0.06353305785123965,1.8948778188548325e-07,0.13078156888793036,0.043388429752066124
288,0.9,5,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Does coeliac disease screening in risk groups make sense? Yes, it is warranted as it supports early detection and therapy, avoiding complications including malnutrition, osteoporosis, and lymphoma. Those with familial history, type 1 diabetes, Down syndrome, or other autoimmune disorders are particularly considered.",1.6580180914979784e-07,0.012692071549718964,0.10072314049586772,0.012693985253473108,0.042104414110259114,0.08264462809917357,0.012675610786670066,0.0727812734820863,0.06353305785123965,1.6580180914979784e-07,0.10480608248467238,0.043388429752066124
288,0.9,6,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is it reasonable to screen risk groups for coeliac disease? Yes, screening is justified to facilitate early diagnosis and treatment, preventing complications like malnutrition, osteoporosis, and lymphoma. Individuals with a family history, type 1 diabetes, Down syndrome, or other autoimmune diseases are especially targeted.",1.4211583641411244e-07,0.010838425860475454,0.10072314049586772,0.010880558788691236,0.018006862531199097,0.08264462809917357,0.0108648092457172,0.048088660891714596,0.06353305785123965,1.4211583641411244e-07,0.07948827450038065,0.043388429752066124
288,0.9,7,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is screening for coeliac disease in risk groups justified? Yes, it is appropriate as it helps with early detection and management, preventing complications such as malnutrition, osteoporosis, and lymphoma. Those with family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered.",1.1842986367842703e-07,0.03382794408517498,0.10072314049586772,0.009067132323909363,0.0055236348789953205,0.08264462809917357,0.009054007704764333,0.02399110931265458,0.06353305785123965,1.1842986367842703e-07,0.05479566191000895,0.043388429752066124
288,0.9,8,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Should individuals in risk groups be screened for coeliac disease? Yes, screening is justified because it enables early diagnosis and intervention, reducing risks of malnutrition, osteoporosis, and lymphoma. People with a family history, type 1 diabetes, Down syndrome, or other autoimmune diseases are especially prioritized.",1.1842986367842703e-07,0.03382794408517498,0.10072314049586772,0.009067132323909363,0.0055236348789953205,0.08264462809917357,0.009054007704764333,0.02399110931265458,0.06353305785123965,1.1842986367842703e-07,0.05479566191000895,0.043388429752066124
288,0.9,9,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is coeliac disease screening warranted in risk groups? Yes, it is justified since it allows for early detection and treatment, preventing complications like malnutrition, osteoporosis, and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially included.",1.4211583641411244e-07,0.010838425860475454,0.10072314049586772,0.010880558788691236,0.018006862531199097,0.08264462809917357,0.0108648092457172,0.048088660891714596,0.06353305785123965,1.4211583641411244e-07,0.07948827450038065,0.043388429752066124
288,0.9,10,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is screening for coeliac disease among at-risk groups justified? Yes, it is appropriate as it facilitates early diagnosis and treatment, helping to avoid complications such as malnutrition, osteoporosis, and lymphoma. Individuals with family history, type 1 diabetes, Down syndrome, or other autoimmune disorders are especially considered.",9.474389094274162e-08,0.05630079993723269,0.10072314049586772,0.0072537058591274906,0.028513153103694844,0.08264462809917357,0.007243206163811466,0.0004606119024601618,0.06353305785123965,9.474389094274162e-08,0.030698110330948936,0.043388429752066124
289,0.9,1,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does family practice at residency teaching sites mirror community practice? The residency training sites of the Northeastern Ohio Universities College of Medicine offer patient care experiences comparable to those reported in a national survey of family and general practitioners.,4.73719454713706e-08,0.051293294387549704,0.0,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
289,0.9,2,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Is family practice at residency teaching locations representative of community practice? Patient care opportunities at the Northeastern Ohio Universities College of Medicine residency sites align closely with those documented in a national survey of family and general practitioners.,7.10579182070559e-08,0.07796154146971057,0.0,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
289,0.9,3,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Do residency teaching sites for family practice reflect the nature of community practice? The residency sites of Northeastern Ohio Universities College of Medicine provide patient care similar to that found in a national survey of family and general practitioners.,4.73719454713706e-08,0.051293294387549704,0.0,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
289,0.9,4,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does family practice in residency training centers represent community practice? The residency sites at Northeastern Ohio Universities College of Medicine deliver patient care experiences consistent with those in a national survey of family and general practitioners.,1.184298636784265e-07,0.13353139262452274,0.0,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
289,0.9,5,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Is community practice reflected in family practice at residency teaching sites? Residency locations of Northeastern Ohio Universities College of Medicine offer patient care opportunities akin to a national survey of family and general practitioners.,1.658018091497971e-07,0.19237189264745602,0.0,0.01269398525347313,0.19782574332991798,0.0,0.012675610786670094,0.20359895524123983,0.0,1.6580180914979784e-07,0.20972053098207066,0.0
289,0.9,6,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Are family practice residency teaching sites reflective of community practice? The residency programs at Northeastern Ohio Universities College of Medicine provide patient care similar to that identified in a national survey of family and general practitioners.,1.184298636784265e-07,0.13353139262452274,0.0,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
289,0.9,7,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,"Does family medicine at residency teaching sites parallel community practice? At Northeastern Ohio Universities College of Medicine, residency training sites provide patient care opportunities matching those found in a national survey of family and general practitioners.",1.184298636784265e-07,0.13353139262452274,0.0,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
289,0.9,8,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Is the family practice provided at residency teaching sites indicative of community practice? The Northeastern Ohio Universities College of Medicine residency sites offer patient care experiences that resemble those in a national survey of family and general practitioners.,7.10579182070559e-08,0.07796154146971057,0.0,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
289,0.9,9,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Do residency teaching sites for family practice offer care representative of community practice? The residency sites at Northeastern Ohio Universities College of Medicine deliver patient care comparable to findings from a national survey of family and general practitioners.,7.10579182070559e-08,0.07796154146971057,0.0,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
289,0.9,10,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Are residency training sites for family practice consistent with community practice? Patient care opportunities at Northeastern Ohio Universities College of Medicine residency locations reflect those reported in a national survey of family and general practitioners.,1.421158364141118e-07,0.16251892949777424,0.0,0.01088055878869125,0.1670540846631643,0.0,0.01086480924571722,0.17185025692666,0.0,1.4211583641411244e-07,0.17693070815907896,0.0
290,0.9,1,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Does measuring end-tidal carbon dioxide correspond with arterial carbon dioxide levels in extremely low birth weight infants during the first week after birth? There is a strong correlation and agreement between end-tidal CO2 and arterial CO2 within the EtCO2 range of 30-50 mmHg in ELBW infants. Monitoring end-tidal CO2 is useful for tracking changes or screening for abnormal PaCO2 values in these infants during their first week of life.,4.737194547137081e-08,0.1452743783559467,0.10945795821791318,0.0036268529295637453,0.11561577171808946,0.06127385111529162,0.003621603081905733,0.05243250805924937,0.015621063240110858,4.737194547137081e-08,0.03125254350410156,0.0
290,0.9,2,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Is there a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants during their first week? End-tidal CO2 and arterial CO2 show good correlation and agreement in ELBW infants when EtCO2 is between 30-50 mmHg. End-tidal CO2 monitoring can aid in trending or screening abnormal PaCO2 levels in the first week of life.,1.6580180914979784e-07,0.014361300424500012,0.11735017760566828,0.012693985253473108,0.028633837126456285,0.06127385111529162,0.012675610786670066,0.09417096613262466,0.015621063240110858,1.6580180914979784e-07,0.11778303565638559,0.0
290,0.9,3,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Does end-tidal CO2 measurement correlate with arterial CO2 in extremely low birth weight infants within the first week of life? Studies show good correlation and agreement between end-tidal and arterial CO2 in ELBW infants with EtCO2 ranging from 30 to 50 mmHg. End-tidal CO2 monitoring helps in tracking or detecting abnormal PaCO2 values during the initial week.,2.3685972735685406e-07,0.04160067830602099,0.11465192181705877,0.018134264647818726,0.1069490144607661,0.04309826812489382,0.018108015409528666,0.1482381874028995,0.015621063240110858,2.3685972735685406e-07,0.17284281283941416,0.0
290,0.9,4,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Is there a relationship between end-tidal carbon dioxide and arterial carbon dioxide measurements in ELBW infants during their first week? There is strong correlation and agreement with end-tidal CO2 and arterial CO2 in the EtCO2 range of 30-50 mmHg for extremely low birth weight infants. Monitoring end-tidal CO2 is beneficial for trending or screening abnormal PaCO2 in their first week of life.,1.1842986367842703e-07,0.027282716207692292,0.10280086180363188,0.009067132323909363,0.005267714549224145,0.06127385111529162,0.009054007704764333,0.059684790061456106,0.015621063240110858,1.1842986367842703e-07,0.08269171584511614,0.0
290,0.9,5,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Do end-tidal carbon dioxide levels correlate with arterial carbon dioxide in extremely low birth weight newborns during their first week? Good correlation and agreement exist between end-tidal CO2 and arterial CO2 in ELBW infants when EtCO2 ranges from 30 to 50 mmHg. End-tidal CO2 monitoring is useful for trending or screening abnormal arterial CO2 values early in life.,2.1317375462116866e-07,0.022598192972485,0.11558257241544406,0.016320838183036854,0.06372515693772574,0.06127385111529162,0.0162972138685758,0.12988904873470375,0.015621063240110858,2.1317375462116866e-07,0.15415067982725983,0.0
290,0.9,6,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Does the measurement of end-tidal carbon dioxide match arterial carbon dioxide levels in extremely low birth weight infants during the first week? There is solid correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants within the EtCO2 range of 30-50 mmHg. End-tidal CO2 monitoring can be helpful for tracking or screening abnormal PaCO2 in the initial week of life.,1.1842986367842703e-07,0.07273499034277053,0.1353024982207859,0.009067132323909363,0.005267714549224145,0.06127385111529162,0.009054007704764333,0.059684790061456106,0.015621063240110858,1.1842986367842703e-07,0.08269171584511614,0.0
290,0.9,7,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Is end-tidal CO2 measurement reflective of arterial CO2 in extremely low birth weight infants during their first week? There exists good correlation and agreement between end-tidal and arterial CO2 measurements at EtCO2 levels of 30 to 50 mmHg in ELBW infants. End-tidal CO2 monitoring is valuable for trending or screening PaCO2 abnormalities in the first week.,2.6054570009253947e-07,0.03576411850371386,0.13173985346533218,0.0199476911126006,0.10009280110859997,0.06127385111529162,0.019918816950481533,0.16693032041505385,0.015621063240110858,2.6054570009253947e-07,0.19189100781010726,0.0
290,0.9,8,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Does end-tidal carbon dioxide monitoring correlate well with arterial carbon dioxide in ELBW infants in their first week of life? There is good correlation and agreement between end-tidal CO2 and arterial CO2 within the 30-50 mmHg EtCO2 range. This monitoring method can assist in trending or screening abnormal PaCO2 during the initial week.,3.316036182995957e-07,0.0681023880586471,0.14882833259315348,0.025387970506946217,0.1572512149485501,0.06127385111529162,0.025351221573340132,0.2251992285390294,0.015621063240110858,3.316036182995957e-07,0.25131442828090833,0.0
290,0.9,9,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Is there a correlation between end-tidal CO2 and arterial CO2 measurements in extremely low birth weight infants during their first week? Strong correlation and agreement are found between end-tidal and arterial CO2 in ELBW infants in the EtCO2 range of 30-50 mmHg. End-tidal CO2 monitoring aids in trending or detecting abnormal PaCO2 values early on.,2.8423167282822487e-07,0.10639102432525327,0.0944517082179132,0.02176111757738247,0.1449414315003752,0.042412904369729484,0.0217296184914344,0.18597851538574695,0.015621063240110858,2.8423167282822487e-07,0.21130909366720996,0.0
290,0.9,10,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Do end-tidal carbon dioxide levels provide a reliable correlation with arterial carbon dioxide in extremely low birth weight infants during the first week of life? There is good correlation and agreement between the two measurements within a 30-50 mmHg EtCO2 range in ELBW infants. End-tidal CO2 monitoring is beneficial for trending or screening abnormal arterial CO2 early in life.,1.8948778188548325e-07,0.04385478393509734,0.1508156355801785,0.014507411718254981,0.046025579838325115,0.06127385111529162,0.014486412327622933,0.11187054323202528,0.015621063240110858,1.8948778188548325e-07,0.13580154115906407,0.0
291,0.9,1,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Is antral follicle assessment a better predictor of IVF outcomes than age and FSH? Antral follicle count serves as a valuable predictor for IVF success, often reflecting ovarian reserve and response more accurately than age and FSH alone. Nevertheless, using all three indicators together may yield the most reliable prediction.",6.158352911278206e-07,0.37417886477082307,0.060791972187518376,0.04714908808432877,0.42427779965420687,0.00618227062130788,0.047080840064774546,0.4403118394383321,0.0,6.158352911278206e-07,0.4480247225269598,0.0
291,0.9,2,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","When predicting IVF outcomes, does antral follicle assessment outperform age and FSH? The antral follicle count is an effective predictor, providing a clearer picture of ovarian reserve and response than age and FSH levels. Combining these markers may offer the best overall prediction.",7.816371002776184e-07,0.5094683968277423,0.07425605536332174,0.05984307333780188,0.5530256113344594,0.027006172839506164,0.05975645085144461,0.6015799870344538,0.0,7.816371002776184e-07,0.6131044728864099,0.0
291,0.9,3,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Can antral follicle assessment predict IVF success better than age and FSH? It is a helpful measure, often giving a more precise estimation of ovarian reserve and responsiveness compared to age and FSH. Using all factors in conjunction might provide the most thorough prediction.",7.57951127541933e-07,0.452163285968338,0.09851342497783422,0.05802964687302001,0.5289280597553994,0.027006172839506164,0.057945649310491745,0.5768873744440821,0.0,7.57951127541933e-07,0.5877866649021182,0.0
291,0.9,4,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Is the antral follicle count a superior predictor of IVF results compared to age and FSH? This assessment is a useful tool, potentially offering a more accurate insight into ovarian reserve and response than age and FSH. The integration of all three can deliver a more comprehensive forecast.",6.632072365991914e-07,0.38996764561422514,0.07928691956085263,0.05077594101389252,0.4379562815496727,0.027006172839506164,0.05070244314668028,0.48379695137807044,0.0,6.632072365991914e-07,0.4924764850977925,0.0
291,0.9,5,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Does antral follicle assessment provide a better prediction of IVF outcomes than either age or FSH levels? It is a valuable predictor that may better reflect ovarian reserve and responsiveness. However, combining age, FSH, and antral follicle count tends to give the most complete prediction.",7.342651548062476e-07,0.42844105402211685,0.09904107429247264,0.056216220408238135,0.5053975623452049,0.027006172839506164,0.05613484776953888,0.5527898228650221,0.0,7.342651548062476e-07,0.5630940523117465,0.0
291,0.9,6,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Antral follicle count is a useful marker for predicting IVF success, potentially more accurate than using age and FSH alone. But the best predictive insight comes from considering all these factors together.",1.042182800370157e-06,0.7471367934297795,0.12175605536332175,0.07979076445040251,0.8654002963766123,0.027006172839506164,0.07967526780192619,0.9231636111619168,0.0,1.0421828003701579e-06,0.9444616088408502,0.0
291,0.9,7,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Is assessing antral follicles a more effective way to forecast IVF outcomes than relying on age and FSH? Antral follicle count can offer a more precise indication of ovarian reserve and responsiveness. Still, the most reliable prediction usually comes from a combined evaluation.",7.816371002776184e-07,0.4764613882296498,0.0979606954585032,0.05984307333780188,0.5530256113344594,0.027006172839506164,0.05975645085144461,0.6015799870344538,0.0,7.816371002776184e-07,0.6131044728864099,0.0
291,0.9,8,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Does antral follicle count predict IVF outcomes more accurately than age and FSH? It is a helpful tool giving a possibly better representation of ovarian reserve and responsiveness, yet the best predictive accuracy is achieved by combining it with age and FSH data.",7.816371002776184e-07,0.4764613882296498,0.0979606954585032,0.05984307333780188,0.5530256113344594,0.027006172839506164,0.05975645085144461,0.6015799870344538,0.0,7.816371002776184e-07,0.6131044728864099,0.0
291,0.9,9,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Is the antral follicle assessment a more accurate predictor of IVF success than age and FSH? This measure helps estimate ovarian reserve and response and might be more precise, though the most comprehensive prediction arises from integrating all three factors.",8.526950184846745e-07,0.5175623517852816,0.12175605536332175,0.0652833527321475,0.6290115183123808,0.027006172839506164,0.06518885547430321,0.6795415285041644,0.0,8.526950184846746e-07,0.6931471805599441,0.0
291,0.9,10,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Can antral follicle assessment offer a superior prediction of IVF outcomes compared to age and FSH? It is an effective predictor of ovarian reserve and responsiveness, and the most complete forecasting results when combined with age and FSH measures.",8.763809912203598e-07,0.580019268744326,0.09545948852621437,0.06709677919692937,0.6556797653945416,0.027006172839506164,0.06699965701525608,0.7069405026922797,0.0,8.7638099122036e-07,0.7213180575266409,0.0
292,0.9,1,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty an acceptable substitute for thrombolysis? Patients and their carers found the reorganization of care to provide a primary angioplasty service acceptable. Satisfaction was generally high across all types of care, except for aspects related to discharge and aftercare.",7.105791820705622e-08,0.042499213113674106,0.021417388369294285,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
292,0.9,2,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Can primary angioplasty serve as an acceptable alternative to thrombolysis? The restructuring of care to include primary angioplasty was well received by patients and their caregivers. High satisfaction levels were reported regardless of care type, except in discharge and aftercare areas.",7.105791820705622e-08,0.07715657214167182,0.003460544030479129,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
292,0.9,3,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Does primary angioplasty represent a viable alternative to thrombolysis? Patients and carers accepted the care system reorganization to offer primary angioplasty. Satisfaction remained high across care types, except for concerns about discharge and aftercare.",2.3685972735685332e-07,0.20021374673313375,0.046400951814396206,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
292,0.9,4,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is it acceptable to use primary angioplasty instead of thrombolysis? Offering primary angioplasty through a reorganization of care was satisfactory for patients and carers. Satisfaction levels were high overall irrespective of care type, aside from discharge and aftercare issues.",1.1842986367842682e-07,0.13209800958480056,0.006068183988072934,0.009067132323909363,0.1267517056391423,0.0,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
292,0.9,5,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.",Is primary angioplasty a suitable alternative to thrombolysis? Patients and carers accepted the shift in care organization to implement primary angioplasty. Satisfaction was high for all care types except for discharge and aftercare.,2.605457000925386e-07,0.23098540539988743,0.046400951814396206,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
292,0.9,6,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.",Could primary angioplasty replace thrombolysis as an acceptable option? The reorganization to provide primary angioplasty was acceptable to patients and their carers. Satisfaction was consistently high except for discharge and aftercare.,3.079176455639092e-07,0.3417337385747885,0.01310725383579929,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
292,0.9,7,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty an appropriate alternative to thrombolysis? Patients and carers found the restructured care to include primary angioplasty acceptable. Satisfaction was high regardless of care type, with the exception of discharge and aftercare.",2.3685972735685332e-07,0.2422226667670695,0.016127514314396206,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
292,0.9,8,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.",Is the use of primary angioplasty an acceptable alternative to thrombolysis? Patients and carers accepted reorganizing care to offer primary angioplasty. Satisfaction levels were high across care types except for discharge and aftercare.,2.605457000925386e-07,0.23098540539988743,0.046400951814396206,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
292,0.9,9,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.",Is primary angioplasty considered an acceptable substitute for thrombolysis? Reorganizing care to provide primary angioplasty was positively received by patients and their carers. Satisfaction remained high except regarding discharge and aftercare.,3.079176455639092e-07,0.3417337385747885,0.01310725383579929,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
292,0.9,10,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Does reorganizing care to offer primary angioplasty make it an acceptable alternative to thrombolysis? Patients and carers accepted this service reorganization, with high satisfaction levels irrespective of care type, except in discharge and aftercare.",2.3685972735685332e-07,0.20021374673313375,0.046400951814396206,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
293,0.9,1,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Are lower fasting plasma glucose levels at the time of type 2 diabetes diagnosis linked to better outcomes? Yes, having lower fasting plasma glucose at diagnosis typically means better glycemic control and is connected to improved outcomes, such as fewer diabetes complications and enhanced overall health, resulting in a better prognosis for the patient.",7.105791820705622e-08,0.16353380806094409,0.14194710743801645,0.005440279394345618,0.14264503966334674,0.13443950617283948,0.0054324046228586,0.12103628617328255,0.12406729678638949,7.105791820705622e-08,0.12482657353336846,0.12901701323251416
293,0.9,2,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Do reduced fasting plasma glucose levels when type 2 diabetes is diagnosed correlate with improved health outcomes? Indeed, lower fasting plasma glucose at diagnosis is usually a sign of superior glycemic regulation and is associated with positive outcomes, including a lower incidence of diabetes-related complications and improved general health, which contributes to a better prognosis.",4.737194547137081e-08,0.2093511976149265,0.16136485891730643,0.0036268529295637453,0.18885575114364572,0.15397855942727737,0.003621603081905733,0.16763661440528477,0.14366729678638948,4.737194547137081e-08,0.14462920082954822,0.12901701323251416
293,0.9,3,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Is there an association between lower fasting plasma glucose at type 2 diabetes diagnosis and improved patient outcomes? Yes, patients diagnosed with lower fasting plasma glucose generally experience better glycemic control and improved outcomes like fewer diabetes complications and better overall health, leading to a more favorable prognosis.",2.1317375462116866e-07,0.00387648953902886,0.11397717774629122,0.016320838183036854,0.01308806358546244,0.12945107642077336,0.0162972138685758,0.007751155764043283,0.1214565529847366,2.1317375462116866e-07,0.003006797976515152,0.12901701323251416
293,0.9,4,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Does having lower fasting plasma glucose levels upon diagnosis of type 2 diabetes predict better outcomes? Yes, lower fasting plasma glucose at diagnosis is typically linked to improved glycemic control and outcomes such as decreased complications related to diabetes and enhanced general health, promoting a better patient prognosis.",2.1317375462116866e-07,0.03337211424370734,0.13481404958677684,0.016320838183036854,0.01308806358546244,0.12945107642077336,0.0162972138685758,0.007751155764043283,0.1214565529847366,2.1317375462116866e-07,0.003006797976515152,0.12901701323251416
293,0.9,5,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Are better outcomes associated with lower fasting plasma glucose levels at the time type 2 diabetes is diagnosed? Yes, lower fasting plasma glucose at diagnosis usually indicates effective glycemic control and is correlated with improved outcomes, including fewer diabetes-related health issues and better overall health, which results in a more positive prognosis.",1.1842986367842703e-07,0.12199029224731062,0.13975335743801648,0.009067132323909363,0.10129156595449551,0.13290895061728392,0.009054007704764333,0.07992147227897561,0.12326799123083393,1.1842986367842703e-07,0.08400457901311409,0.12901701323251416
293,0.9,6,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Is there a connection between lower fasting plasma glucose levels at type 2 diabetes diagnosis and enhanced outcomes? Yes, lower fasting plasma glucose at diagnosis generally reflects improved glycemic management and is linked to positive outcomes like fewer complications and better overall health, leading to an improved prognosis.",2.1317375462116866e-07,0.03337211424370734,0.13481404958677684,0.016320838183036854,0.01308806358546244,0.12945107642077336,0.0162972138685758,0.007751155764043283,0.1214565529847366,2.1317375462116866e-07,0.003006797976515152,0.12901701323251416
293,0.9,7,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Are lower fasting plasma glucose levels at the diagnosis of type 2 diabetes indicative of improved outcomes? Yes, lower fasting glucose readings at diagnosis are commonly associated with better glycemic control and favorable outcomes, including reduced diabetes complications and improved health status, yielding a better prognosis.",2.6054570009253947e-07,0.04756733505978472,0.1761363636363636,0.0199476911126006,0.028909968889407445,0.1728395061728395,0.019918816950481533,0.022406988482580825,0.14366729678638948,2.6054570009253947e-07,0.04952681361140909,0.12901701323251416
293,0.9,8,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Do lower fasting plasma glucose levels at the time of type 2 diabetes diagnosis signify better outcomes? Yes, such lower levels at diagnosis are connected to superior glycemic control and better outcomes, including fewer diabetes-related complications and enhanced overall health, which contribute to a better patient prognosis.",2.3685972735685406e-07,0.07021594919939078,0.17661871237628807,0.018134264647818726,0.05138282474146516,0.1728395061728395,0.018108015409528666,0.0005825297421186981,0.14366729678638948,2.3685972735685406e-07,0.025996316201214675,0.12901701323251416
293,0.9,9,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Is improved outcome related to lower fasting plasma glucose levels at diagnosis in type 2 diabetes? Yes, lower fasting plasma glucose at diagnosis is generally a marker of good glycemic control and corresponds with better outcomes like reduced diabetes complications and improved general health, resulting in a superior prognosis.",1.8948778188548325e-07,0.027387867462251858,0.11570247933884292,0.014507411718254981,0.035876687271846563,0.13037037037037036,0.014486412327622933,0.014897458375562778,0.12193890172466108,1.8948778188548325e-07,0.019466057875542564,0.12901701323251416
293,0.9,10,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Are patients with lower fasting plasma glucose levels at initial type 2 diabetes diagnosis more likely to have improved outcomes? Yes, lower fasting plasma glucose levels at diagnosis indicate better glycemic control and are associated with positive outcomes, such as fewer complications and improved overall health, leading to a favorable prognosis.",1.4211583641411244e-07,0.04510495596384123,0.09958167533925102,0.010880558788691236,0.023373746459740552,0.09185185185185184,0.0108648092457172,0.0009505091617549866,0.08144507456416726,1.4211583641411244e-07,0.003959920405923967,0.08654787743004502
294,0.9,1,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Does head position affect the anterior chamber depth in cases of pseudoexfoliation syndrome? In individuals with clinically obvious unilateral pseudoexfoliation, the lens appears more mobile in the affected eye, causing a shallower anterior chamber when the head is prone. This mobility might lead to transient pupillary block during certain activities.",2.3685972735685406e-07,0.16701583826009525,0.013457265697137576,0.018134264647818726,0.18924199963852795,0.0,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
294,0.9,2,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Is anterior chamber depth influenced by head positioning in pseudoexfoliation syndrome? Patients with unilateral pseudoexfoliation show increased lens mobility in the affected eye, resulting in a shallower anterior chamber when lying face down. This could potentially cause transient pupillary block during some activities.",4.026615365066519e-07,0.3258818050299377,0.010061211347874577,0.030828249901291835,0.34687094384211115,0.0,0.030783626196198732,0.354171813720614,0.0,4.026615365066519e-07,0.3617900446055051,0.0
294,0.9,3,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Can head positioning alter anterior chamber depth in pseudoexfoliation syndrome? In clinically evident unilateral pseudoexfoliation, the lens of the affected eye is more mobile, leading to a shallower anterior chamber when the head is prone. This condition might cause temporary pupillary block during certain motions.",3.552895910352811e-07,0.27786147082240475,0.011141590181844022,0.02720139697172809,0.2992428948528567,0.0,0.027162023114293,0.3053816495511823,0.0,3.552895910352811e-07,0.3117796240308417,0.0
294,0.9,4,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Does the depth of the anterior chamber change with head position in pseudoexfoliation syndrome? Clinically obvious unilateral pseudoexfoliation causes greater lens mobility in the affected eye, resulting in shallower anterior chamber depth in prone head positions, possibly triggering transient pupillary block during activities.",4.026615365066519e-07,0.3258818050299377,0.010061211347874577,0.030828249901291835,0.34687094384211115,0.0,0.030783626196198732,0.354171813720614,0.0,4.026615365066519e-07,0.3617900446055051,0.0
294,0.9,5,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Is there an effect of head positioning on anterior chamber depth in pseudoexfoliation syndrome? The lens in eyes with unilateral pseudoexfoliation is more mobile, making the anterior chamber shallower when the head is in a prone position, which may lead to intermittent pupillary block with some activities.",3.079176455639103e-07,0.2320398521635081,0.012128176190964735,0.023574544042164344,0.25378052077609947,0.0,0.023540420032387266,0.25886163391628836,0.0,3.079176455639103e-07,0.26415157504158726,0.0
294,0.9,6,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","How does head positioning impact anterior chamber depth in pseudoexfoliation syndrome? In patients with unilateral pseudoexfoliation, the affected eye's lens is more mobile, causing shallower anterior chambers when the head is prone, potentially inducing transient pupillary block during certain activities.",4.73719454713708e-07,0.36698276858556955,0.03385657125269313,0.03626852929563745,0.42285685082003255,0.0,0.03621603081905733,0.4321333551903246,0.0,4.737194547137081e-07,0.4418327522790393,0.0
294,0.9,7,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Does head posture influence anterior chamber depth in pseudoexfoliation syndrome? In cases of clinically evident unilateral pseudoexfoliation, the affected eye's lens shows increased mobility, resulting in a shallower anterior chamber during prone head positioning, which could lead to temporary pupillary block.",4.500334819780227e-07,0.3763223196292742,0.008873007807591211,0.03445510283085558,0.3968813644167746,0.0,0.034405229278104466,0.4054651081081637,0.0,4.500334819780227e-07,0.41443377809092397,0.0
294,0.9,8,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Can anterior chamber depth be affected by head positioning in pseudoexfoliation syndrome? The lens mobility in the affected eye of unilateral pseudoexfoliation patients leads to a shallower anterior chamber with the head in a prone position, potentially causing transient pupillary block during activities.",4.026615365066519e-07,0.3258818050299377,0.010061211347874577,0.030828249901291835,0.34687094384211115,0.0,0.030783626196198732,0.354171813720614,0.0,4.026615365066519e-07,0.3617900446055051,0.0
294,0.9,9,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Is anterior chamber depth altered by head position in pseudoexfoliation syndrome? In unilateral pseudoexfoliation, the lens in the affected eye moves more freely, resulting in a reduced anterior chamber depth when the head is prone, which may cause transient pupillary block during certain activities.",3.789755637709665e-07,0.3338231065156001,0.012544380561703074,0.029014823436509962,0.3557804008611427,0.023795359904818555,0.028972824655245866,0.3294792011302423,0.0,3.789755637709665e-07,0.3364722366212134,0.0
294,0.9,10,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Does the positioning of the head influence anterior chamber depth in pseudoexfoliation syndrome? Patients with clinically apparent unilateral pseudoexfoliation exhibit greater lens mobility in the affected eye, resulting in a shallower anterior chamber when prone, possibly leading to transient pupillary block during activity.",4.026615365066519e-07,0.3258818050299377,0.010061211347874577,0.030828249901291835,0.34687094384211115,0.0,0.030783626196198732,0.354171813720614,0.0,4.026615365066519e-07,0.3617900446055051,0.0
295,0.9,1,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Does an automatic transmission enhance driving performance in senior drivers? Yes, it can notably improve their driving by simplifying vehicle operation, removing the necessity to shift gears manually.",1.894877818854824e-07,0.06146914389652869,0.13888888888888887,0.014507411718255037,0.14594389590763113,0.08740894901144641,0.014486412327622988,0.19361389653040773,0.06035379812695108,1.8948778188548325e-07,0.24436037366678365,0.031217481789802305
295,0.9,2,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Can automatic transmission lead to better driving habits in elderly motorists? Indeed, it considerably aids by making driving easier and eliminating manual gear changes.",2.842316728282236e-07,0.22181179397170858,0.13888888888888887,0.021761117577382555,0.3129979805707981,0.08740894901144641,0.021729618491434483,0.36796728367518616,0.06035379812695108,2.842316728282248e-07,0.42668193046073855,0.031217481789802305
295,0.9,3,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Is driving behavior improved in older drivers by using automatic transmission? Yes, automatic transmission helps by simplifying the driving task and avoiding the need for manual gear shifts.",1.894877818854824e-07,0.06146914389652869,0.13888888888888887,0.014507411718255037,0.14594389590763113,0.08740894901144641,0.014486412327622988,0.19361389653040773,0.06035379812695108,1.8948778188548325e-07,0.24436037366678365,0.031217481789802305
295,0.9,4,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Does having an automatic transmission benefit the driving skills of older individuals? Yes, it streamlines driving and removes the complication of manual gear changes, leading to improved behavior.",1.894877818854824e-07,0.06146914389652869,0.13888888888888887,0.014507411718255037,0.14594389590763113,0.08740894901144641,0.014486412327622988,0.19361389653040773,0.06035379812695108,1.8948778188548325e-07,0.24436037366678365,0.031217481789802305
295,0.9,5,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Can the use of automatic transmission enhance the driving of older drivers? Absolutely, it simplifies controlling the vehicle by doing away with the need to change gears manually.",1.894877818854824e-07,0.06146914389652869,0.13888888888888887,0.014507411718255037,0.14594389590763113,0.08740894901144641,0.014486412327622988,0.19361389653040773,0.06035379812695108,1.8948778188548325e-07,0.24436037366678365,0.031217481789802305
295,0.9,6,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Is there an improvement in driving behavior among older drivers with automatic transmission? Yes, because it makes driving less complex by removing manual shifting requirements.",2.605457000925383e-07,0.17925217955291295,0.13888888888888887,0.019947691112600675,0.26854621799996403,0.08740894901144641,0.01991881695048161,0.3214472680402922,0.06035379812695108,2.6054570009253947e-07,0.3778917662913073,0.031217481789802305
295,0.9,7,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Does automatic transmission contribute to better driving behavior for seasoned drivers? Yes, it makes the driving experience easier and more straightforward by eliminating gear changes.",2.605457000925383e-07,0.17925217955291295,0.13888888888888887,0.019947691112600675,0.26854621799996403,0.08740894901144641,0.01991881695048161,0.3214472680402922,0.06035379812695108,2.6054570009253947e-07,0.3778917662913073,0.031217481789802305
295,0.9,8,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Can an automatic transmission improve how older drivers operate their vehicles? Yes, it simplifies the process by not requiring gear shifts, thus improving their driving behavior.",2.36859727356853e-07,0.13843018503265814,0.13888888888888887,0.018134264647818796,0.2259866035811684,0.08740894901144641,0.018108015409528735,0.27699550546945817,0.06035379812695108,2.3685972735685406e-07,0.33137175065641333,0.031217481789802305
295,0.9,9,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Does automatic transmission help older drivers drive better? Yes, it simplifies vehicle operation by removing the need to manually shift gears, which enhances their driving behavior.",2.36859727356853e-07,0.13843018503265814,0.13888888888888887,0.018134264647818796,0.2259866035811684,0.08740894901144641,0.018108015409528735,0.27699550546945817,0.06035379812695108,2.3685972735685406e-07,0.33137175065641333,0.031217481789802305
295,0.9,10,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Is driving behavior in older drivers enhanced by automatic transmission? Yes, by simplifying the driving process and eliminating manual gear shifting, it significantly improves their behavior behind the wheel.",1.658018091497971e-07,0.02510149972565401,0.13888888888888887,0.012693985253473157,0.10820356792478414,0.08740894901144641,0.012675610786670115,0.15439318337712526,0.06035379812695108,1.6580180914979784e-07,0.20353837914652884,0.031217481789802305
296,0.9,1,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Does the use of provider service networks lead to reduced costs compared to HMOs or primary care case management within Florida's Medicaid program? The Medicaid Demonstration in Florida seems to yield lower per member per month (PMPM) costs. Provider service networks (PSNs) under the demonstration produced marginally larger expenditure decreases than the demonstration HMOs. PSNs show potential as an effective method for providing care to Medicaid enrollees.,1.8948778188548325e-07,0.137903232176682,0.006218774010981816,0.014507411718254981,0.13432935020925285,0.0021574059311224546,0.014486412327622933,0.13353139262452185,0.0,1.8948778188548325e-07,0.13580154115906407,0.0
296,0.9,2,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,"In Florida's Medicaid program, do provider service networks result in lower spending than HMOs or primary care case management? Findings from the Medicaid Demonstration suggest that PMPM expenditures are lower. Demonstration PSNs achieved slightly more significant cuts in spending compared to Demonstration HMOs. PSNs appear to be a promising approach to delivering care to Medicaid recipients.",7.105791820705622e-08,0.018595055433633156,0.05157024793388431,0.005440279394345618,0.029746267566417295,0.017538265306122455,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
296,0.9,3,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Are expenditures reduced by provider service networks compared to HMOs or primary care case management in Florida’s Medicaid program? Evidence from Florida’s Medicaid Demonstration indicates lower PMPM expenses. The Demonstration PSNs produced somewhat greater cost reductions than the Demonstration HMOs. PSNs seem to be a viable model for Medicaid patient care delivery.,1.6580180914979784e-07,0.11127698182431223,0.012419893914725616,0.012693985253473108,0.10670730870254719,0.017538265306122455,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
296,0.9,4,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks in Florida's Medicaid program reduce expenses more than HMOs or primary care case management? The Medicaid Demonstration shows that PMPM spending decreases. Demonstration PSNs led to slightly higher expenditure reductions relative to Demonstration HMOs. PSNs offer a promising care delivery model for Medicaid enrollees.,2.6054570009253947e-07,0.13859052808878003,0.05157024793388431,0.0199476911126006,0.19008891764159808,0.017538265306122455,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
296,0.9,5,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,"Within Florida's Medicaid program, do provider service networks lower costs compared to HMOs or primary care case management? The Medicaid Demonstration indicates a reduction in PMPM expenditures. PSNs under the demonstration provided modestly greater savings than HMOs. PSNs appear to be an effective option for Medicaid care provision.",2.6054570009253947e-07,0.13859052808878003,0.05157024793388431,0.0199476911126006,0.19008891764159808,0.017538265306122455,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
296,0.9,6,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks lead to lower Medicaid expenditures than HMOs or primary care case management in Florida? Florida's Medicaid Demonstration seems to produce lower PMPM costs. Provider service networks achieved somewhat more expenditure decreases than demonstration HMOs. PSNs are a promising delivery model for Medicaid enrollees.,2.8423167282822487e-07,0.22037040118452111,0.008181818181818186,0.02176111757738247,0.24287436571859278,0.004672478495530437,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
296,0.9,7,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,"In Florida’s Medicaid program, do provider service networks result in lower per-member expenditures versus HMOs or primary care case management? The Medicaid Demonstration results show decreased PMPM expenditures. Demonstration PSNs had slightly larger reductions in spending compared to HMOs. PSNs represent a promising model for Medicaid care delivery.",2.6054570009253947e-07,0.13859052808878003,0.05157024793388431,0.0199476911126006,0.19008891764159808,0.017538265306122455,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
296,0.9,8,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Does participation in provider service networks reduce Medicaid costs compared to HMOs or primary care case management in Florida? Medicaid Demonstration data from Florida indicate lower PMPM costs. PSNs in the demonstration generated slightly better expenditure reductions than HMOs. PSNs seem promising for providing Medicaid services.,3.079176455639103e-07,0.1820756400285184,0.05157024793388431,0.023574544042164344,0.2345406802124308,0.017538265306122455,0.023540420032387266,0.26415157504158726,0.0,3.079176455639103e-07,0.2696635669491032,0.0
296,0.9,9,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Are provider service networks associated with lower expenditures than HMOs or primary care case management in Florida’s Medicaid program? The Medicaid Demonstration in Florida shows lower PMPM spending. PSNs yielded marginally greater cost reductions than HMOs in the demonstration. PSNs could be an effective model for Medicaid care delivery.,2.3685972735685406e-07,0.14641825141427756,0.030746345715686026,0.018134264647818726,0.16858271242063472,0.017538265306122455,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
296,0.9,10,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,"In Florida’s Medicaid program, do provider service networks achieve lower costs than HMOs or primary care case management? The Medicaid Demonstration suggests PMPM expenditures are reduced. PSNs delivered slightly larger spending decreases compared to HMOs. PSNs present a hopeful model for Medicaid care provision.",3.552895910352811e-07,0.22753801410527563,0.05157024793388431,0.02720139697172809,0.28106069584732474,0.017538265306122455,0.027162023114293,0.3117796240308417,0.0,3.552895910352811e-07,0.3184537311185349,0.0
297,0.9,1,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is","Do mossy fibers secrete GABA? We have presented strong evidence indicating the presence of a GABAergic signal from mossy fibers. While the physiological function of this mossy fiber GABAergic activity remains unclear, it might play a role during development. Additional findings imply that this GABAergic signal is",2.3685972735685406e-08,0.11506823821426515,0.06631443658610028,0.0018134264647818726,0.08548623590296245,0.045351473922902494,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
297,0.9,2,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is","Is GABA released by mossy fibers? Our data provide convincing proof that mossy fibers produce a GABAergic signal. The exact physiological significance of this mossy fiber GABAergic transmission is unknown, though it may be important for developmental processes. Further evidence suggests this GABAergic signal is",2.3685972735685406e-08,0.10075330958082107,0.08804283164782868,0.0018134264647818726,0.04002386182620521,0.045351473922902494,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
297,0.9,3,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Are mossy fibers responsible for releasing GABA? We have shown compelling evidence supporting the existence of a mossy fiber GABAergic signal. The physiological role of this GABAergic signal from mossy fibers is not well understood but could be developmentally significant. Other studies indicate that this GABAergic activity is,4.737194547137081e-08,0.10772002796326019,0.045573695845359544,0.0036268529295637453,0.10746514262173745,0.045351473922902494,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
297,0.9,4,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Do mossy fibers emit GABA? We have demonstrated strong evidence for a mossy fiber GABAergic signal. The physiological function of this signal is uncertain but may hold developmental relevance. Additional data point to this GABAergic signal being,2.1317375462116823e-07,0.09991738588133048,0.08804283164782868,0.016320838183036854,0.16582819237794366,0.045351473922902494,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
297,0.9,5,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is","Does GABA come from mossy fibers? There is compelling evidence that mossy fibers produce a GABAergic signal. Although the physiological role is uncertain, it might be important during development. Other evidence indicates that this GABAergic signal is",2.1317375462116823e-07,0.09991738588133048,0.08804283164782868,0.016320838183036854,0.16582819237794366,0.045351473922902494,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
297,0.9,6,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is","Are mossy fibers a source of GABA release? We have established compelling evidence that a GABAergic signal emanates from mossy fibers. The physiological significance of this GABAergic signal is unclear, yet it might be crucial for development. Further findings suggest that this GABAergic signal is",2.3685972735685406e-08,0.03716545378836411,0.05195716835217136,0.0018134264647818726,0.0244549456677432,0.0010494778914937053,0.0018108015409528666,0.056537506008286,0.023795359904818555,2.3685972735685406e-08,0.024097551579060017,0.0
297,0.9,7,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Can mossy fibers release GABA? Our findings provide convincing evidence that mossy fibers generate a GABAergic signal. The physiological role of this GABAergic signal remains uncertain but could be important in development. Additional evidence supports that this GABAergic signal is,1.4211583641411233e-07,0.12651270598624853,0.011653942758939786,0.010880558788691236,0.12007152469675697,0.01905490708579512,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
297,0.9,8,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is","Is there a GABAergic signal from mossy fibers? We have provided strong evidence of a mossy fiber GABAergic signal. While the physiological role of this signal is unknown, it may have developmental importance. Other data support that this GABAergic signal is",1.1842986367842703e-07,0.06387158827949868,0.03818133580295334,0.009067132323909363,0.05761460773771265,0.045351473922902494,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
297,0.9,9,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is","Do mossy fibers discharge GABA? We have supplied compelling evidence for the presence of a mossy fiber GABAergic signal. The physiological function of this signal is uncertain, but it may be developmentally significant. Additional findings suggest that this GABAergic signal is",1.1842986367842703e-07,0.029214229251500967,0.06305926820272677,0.009067132323909363,0.05761460773771265,0.045351473922902494,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
297,0.9,10,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Are mossy fibers known to release GABA? Our research offers compelling evidence that mossy fibers have a GABAergic signal. The physiological role of this signal is not clear but might be important during development. Other studies propose that this GABAergic signal is,9.474389094274162e-08,0.03748837280971262,0.03939062914947235,0.0072537058591274906,0.032296799753420924,0.045351473922902494,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
298,0.9,1,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Does low-tone sudden deafness always develop into Meniere's disease? Answer: No, low-tone sudden deafness does not necessarily evolve into Meniere's disease. Although it is a symptom of Meniere's disease, low-tone sudden deafness can also result from other causes, such as viral infections.",9.474389094274162e-08,0.13023922978374802,0.11790261892356857,0.0072537058591274906,0.08105706401584811,0.03360772316816278,0.007243206163811466,0.06380348977887307,0.02271498107084911,9.474389094274162e-08,0.09763846956391786,0.0
298,0.9,2,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Is the prognosis of low-tone sudden deafness such that it inevitably leads to Meniere's disease? Answer: No, low-tone sudden deafness does not inevitably lead to Meniere's disease. It is one symptom associated with Meniere's disease but can stem from other causes, including viral infections.",4.737194547137081e-08,0.011712337039755383,0.03926234384295062,0.0036268529295637453,0.014717846250927646,0.043083900226757364,0.003621603081905733,0.015013325609441353,0.02271498107084911,4.737194547137081e-08,0.047628048989254435,0.0
298,0.9,3,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Does low-tone sudden deafness always progress into Meniere's disease? Answer: No, low-tone sudden deafness does not always progress to Meniere's disease. While it may be a symptom of Meniere's disease, it can also arise from other factors like viral infections.",1.4211583641411244e-07,0.09304984977220432,0.0325721801998793,0.010880558788691236,0.08622722882549994,0.040703261914183934,0.0108648092457172,0.11509678416642277,0.02271498107084911,1.4211583641411244e-07,0.1502822030493367,0.0
298,0.9,4,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Is progression from low-tone sudden deafness to Meniere's disease unavoidable? Answer: No, low-tone sudden deafness does not inevitably progress to Meniere's disease. Although it appears as a symptom in Meniere's disease, it can also have other causes, including viral infections.",1.4211583641411244e-07,0.09304984977220432,0.0325721801998793,0.010880558788691236,0.08622722882549994,0.040703261914183934,0.0108648092457172,0.11509678416642277,0.02271498107084911,1.4211583641411244e-07,0.1502822030493367,0.0
298,0.9,5,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Does low-tone sudden deafness inevitably lead to Meniere's disease? Answer: No, low-tone sudden deafness is not guaranteed to develop into Meniere's disease. It can be a symptom of Meniere's disease but may also be caused by different factors such as viral infections.",9.474389094274162e-08,0.006301625714965731,0.05957911957168352,0.0072537058591274906,0.03448285657964245,0.04195153061224489,0.007243206163811466,0.06380348977887307,0.02271498107084911,9.474389094274162e-08,0.09763846956391786,0.0
298,0.9,6,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Is low-tone sudden deafness a condition that always advances to Meniere's disease? Answer: No, low-tone sudden deafness does not always advance to Meniere's disease. It is just one symptom of Meniere's disease and can be triggered by other causes like viral infections.",9.474389094274162e-08,0.03930863431306042,0.03607320241192025,0.0072537058591274906,0.03448285657964245,0.04195153061224489,0.007243206163811466,0.06380348977887307,0.02271498107084911,9.474389094274162e-08,0.09763846956391786,0.0
298,0.9,7,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Does low-tone sudden deafness necessarily develop into Meniere's disease? Answer: No, low-tone sudden deafness does not necessarily develop into Meniere's disease. Although it is associated with Meniere's disease, other causes like viral infections can also lead to this condition.",1.6580180914979774e-07,0.19212562696992563,0.01835340637987351,0.012693985253473108,0.18610099763663435,0.012040816326530618,0.012675610786670066,0.17923244641398606,0.004291191768657054,1.6580180914979784e-07,0.17768117723745203,0.0
298,0.9,8,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Is it certain that low-tone sudden deafness will become Meniere's disease? Answer: No, it is not certain that low-tone sudden deafness will evolve into Meniere's disease. While it is a symptom of Meniere's disease, other factors such as viral infections can also cause it.",4.737194547137081e-08,0.08280773303659883,0.02588486934798409,0.0036268529295637453,0.08200036498999452,0.025718176817077942,0.003621603081905733,0.11403435140372009,0.04829093608891419,4.737194547137081e-08,0.11525216416583417,0.04865220249835634
298,0.9,9,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Does low-tone sudden deafness always result in Meniere's disease? Answer: No, low-tone sudden deafness does not always result in Meniere's disease. It is one of the symptoms but can also be caused by other factors like viral infections.",1.8948778188548304e-07,0.2227782198546966,0.021479190804808646,0.014507411718254981,0.21572719854764344,0.014123296377374459,0.014486412327622933,0.2076721821344738,0.00504012096996722,1.8948778188548325e-07,0.20585205420414887,0.0
298,0.9,10,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Is Meniere's disease an inevitable outcome of low-tone sudden deafness? Answer: No, Meniere's disease is not an inevitable outcome of low-tone sudden deafness. Though it is a symptom, low-tone sudden deafness can also occur due to other causes such as viral infections.",9.474389094274162e-08,0.1837949578426814,0.11006373757117366,0.0072537058591274906,0.13591902934451205,0.030094214457148855,0.007243206163811466,0.167775566862864,0.05179195830095512,9.474389094274162e-08,0.16873048808288615,0.05113221329437545
299,0.9,1,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Can functional MRI of mental imagery predict recovery in patients with consciousness disorders? The fMRI mental imagery paradigm aligns well with the subsequent clinical progression in vegetative state patients. All five vegetative state patients showing strong activation in specific brain regions experienced a favorable clinical course.,2.8423167282822487e-07,0.22503899966909646,0.00812083942604943,0.02176111757738247,0.21640680036831705,0.01785123966942149,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
299,0.9,2,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Is recovery prediction possible with mental imagery fMRI in patients with disorders of consciousness? The mental imagery fMRI method shows high agreement with later clinical outcomes in vegetative state patients. Each of the five patients in a vegetative state exhibiting notable ROI activation had a positive progression.,2.6054570009253947e-07,0.23185751204604887,0.012430810114242637,0.0199476911126006,0.22474048587447903,0.004359504132231403,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
299,0.9,3,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Does mental imagery fMRI predict recovery in patients suffering disorders of consciousness? The mental imagery fMRI approach corresponds closely with the clinical trajectory of vegetative state patients. All five patients displaying significant activations in ROIs had a beneficial clinical outcome.,4.263475092423372e-07,0.37761877911230046,0.0013369225080936617,0.03264167636607371,0.39949170511597876,0.008445327167685885,0.0325944277371516,0.3964152725882455,0.0,4.263475092423373e-07,0.40546510810816505,0.0
299,0.9,4,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Can mental imagery functional MRI forecast recovery for patients with consciousness disorders? This fMRI paradigm has a strong correlation with the clinical outcomes observed in vegetative state patients. Every one of the five patients in a VS who demonstrated significant ROI activation had a favorable course.,2.8423167282822487e-07,0.16342591695265707,0.05246913580246911,0.02176111757738247,0.21640680036831705,0.01785123966942149,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
299,0.9,5,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Is mental imagery fMRI effective in predicting recovery among patients with disorders of consciousness? The pattern of brain activation during mental imagery fMRI matches the later clinical progression in VS patients. All five VS patients with substantial ROI activation followed a positive clinical path.,3.316036182995957e-07,0.30560650227033737,0.01690586419753088,0.025387970506946217,0.2959338246013026,0.005944120235397067,0.025351221573340132,0.2937611185281632,0.0,3.316036182995957e-07,0.30010459245033916,0.0
299,0.9,6,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Can mental imagery-based functional MRI serve as a predictor of recovery in conscious disorder patients? The mental imagery fMRI paradigm shows high concordance with subsequent clinical outcomes in patients in a vegetative state. All five vegetative state patients with significant ROI activation experienced favorable recovery.,3.079176455639103e-07,0.18589877280471478,0.05246913580246911,0.023574544042164344,0.23939631859301658,0.01785123966942149,0.023540420032387266,0.2696635669491032,0.0,3.079176455639103e-07,0.27541197985996746,0.0
299,0.9,7,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Does the mental imagery fMRI paradigm predict clinical recovery in patients with disorders of consciousness? There is a strong correlation between mental imagery fMRI findings and the clinical course in vegetative state patients. Each of the five patients showing significant ROI activation had a positive outcome.,2.8423167282822487e-07,0.22503899966909646,0.00812083942604943,0.02176111757738247,0.24791349039376964,0.004863741401427622,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
299,0.9,8,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,"Can recovery in disorders of consciousness be predicted by mental imagery functional MRI? The mental imagery fMRI paradigm aligns highly with the clinical course of vegetative state patients, where all five patients with notable ROI activation had favorable results.",4.500334819780225e-07,0.3689836775523765,0.02617256896536174,0.03445510283085558,0.3896785216423533,0.01785123966942149,0.034405229278104466,0.4238142467763608,0.0,4.500334819780227e-07,0.4336359850748619,0.0
299,0.9,9,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Is it possible to predict recovery in patients with consciousness disorders using mental imagery fMRI? The mental imagery functional MRI paradigm displays substantial agreement with the later clinical development in vegetative state patients. All five patients who had significant ROI activations experienced positive clinical progression.,3.079176455639103e-07,0.21740546283016737,0.029754154731620002,0.023574544042164344,0.23939631859301658,0.01785123966942149,0.023540420032387266,0.2696635669491032,0.0,3.079176455639103e-07,0.27541197985996746,0.0
299,0.9,10,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,"Does using mental imagery in functional MRI predict recovery in patients with consciousness disorders? The mental imagery fMRI shows high concordance with the clinical outcome in vegetative state patients, where all five patients with significant ROI activation progressed favorably.",4.500334819780225e-07,0.4054651081081633,2.7755575615628914e-17,0.03445510283085558,0.3896785216423533,0.01785123966942149,0.034405229278104466,0.4238142467763608,0.0,4.500334819780227e-07,0.4336359850748619,0.0
